,index,trialid,source_register,date_registration,date_enrollement,retrospective_registration,normed_spon_names,recruitment_status,phase,study_type,countries,public_title,study_category,intervention,intervention_list,target_enrollment,web_address,cross_registrations
0,67,NCT04246242,ClinicalTrials.gov,2020-01-27,2020-01-25,True,Xiangya Hospital of Central South University,Not Recruiting,Phase 4,Interventional,No Country Given,A Randomized Multicenter Controlled Clinical Trial of Arbidol in Patients With 2019 Novel Coronavirus (2019-nCoV),Drug,Umifenovir,Umifenovir,500,https://clinicaltrials.gov/show/NCT04246242,None
1,70,ChiCTR2000029947,ChiCTR,2020-02-16,2020-03-01,False,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Qingyi No. 4 Compound in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49599,None
2,71,ChiCTR2000029941,ChiCTR,2020-02-16,2020-03-01,False,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for Traditional Chinese Medicine in the treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49596,None
3,72,ChiCTR2000029939,ChiCTR,2020-02-16,2020-02-10,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"A Single-blind, Randomized, Controlled Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19)",Drug,Chloroquine,Chloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49612,None
4,73,ChiCTR2000029935,ChiCTR,2020-02-16,2020-02-06,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,A Single-arm Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19),Drug,Chloroquine,Chloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49607,None
5,79,ChiCTR2000029869,ChiCTR,2020-02-15,2020-02-10,True,Huangshi Hospital of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=49486,None
6,80,ChiCTR2000029867,ChiCTR,2020-02-15,2020-02-15,False,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 4,Interventional,China,"The efficacy and safety of carrimycin treatment in patients with novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Drug,Carrimycin vs. lopinavir/ritonavir,Carrimycin; lopinavir; ritonavir,520,http://www.chictr.org.cn/showproj.aspx?proj=49514,None
7,81,ChiCTR2000029855,ChiCTR,2020-02-15,2020-02-15,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A randomized, open and controlled clinical trial for traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,180,http://www.chictr.org.cn/showproj.aspx?proj=49543,None
8,82,ChiCTR2000029853,ChiCTR,2020-02-15,2020-02-16,False,People's Hospital of Guangshan County,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,20,http://www.chictr.org.cn/showproj.aspx?proj=49532,None
9,83,ChiCTR2000029850,ChiCTR,2020-02-15,2020-02-15,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Study on convalescent plasma treatment for severe patients with novel coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,20,http://www.chictr.org.cn/showproj.aspx?proj=49533,None
10,84,ChiCTR2000029849,ChiCTR,2020-02-15,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Application of Regulating Intestinal Flora in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Intestinal microbiome,Intestinal microbiome,60,http://www.chictr.org.cn/showproj.aspx?proj=49530,None
11,86,ChiCTR2000029821,ChiCTR,2020-02-14,2020-02-14,False,Deyang Integrated Traditional Chinese and Western Medicine Hospital,Not Recruiting,Not Applicable,Prevention,China,Based on Delphi Method to Preliminarily Construct a Recommended Protocol for the Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using Chinese Medicine Technology and its Clinical Application Evaluation,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=49306,None
12,87,ChiCTR2000029819,ChiCTR,2020-02-14,2020-02-11,True,"Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University",Recruiting,Phase 4,Interventional,China,Ba-Bao-Dan in the adjuvant therapy of novel coronavirus pneumonia (COVID-19) patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://www.chictr.org.cn/showproj.aspx?proj=49490,None
13,89,ChiCTR2000029814,ChiCTR,2020-02-14,2020-02-14,False,Children's Hospital of Fudan University,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Integrated Chinese and Western Medicine in the Treatment of Children with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,30,http://www.chictr.org.cn/showproj.aspx?proj=49387,None
14,90,ChiCTR2000029813,ChiCTR,2020-02-14,2020-02-14,False,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Tanreqing Capsules in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,72,http://www.chictr.org.cn/showproj.aspx?proj=49425,None
15,91,ChiCTR2000029811,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Anti-aging Active Freeze-dried Powder Granules in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49355,None
16,93,ChiCTR2000029806,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Immunomodulatory Therapy for Severe Novel Coronavirus Pneumonia (COVID-19),Drug,PD1 vs. thymosin,PD1; Thymosin,120,http://www.chictr.org.cn/showproj.aspx?proj=49161,None
17,96,ChiCTR2000029790,ChiCTR,2020-02-13,2020-02-17,False,Shanghai Pulmonary Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for the integration of traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49453,None
18,97,ChiCTR2000029789,ChiCTR,2020-02-13,2020-02-15,False,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49348,None
19,98,ChiCTR2000029788,ChiCTR,2020-02-13,2020-03-01,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49452,None
20,101,ChiCTR2000029778,ChiCTR,2020-02-13,2020-02-14,False,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,600,http://www.chictr.org.cn/showproj.aspx?proj=49422,None
21,102,ChiCTR2000029777,ChiCTR,2020-02-13,2020-02-05,True,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49380,None
22,103,ChiCTR2000029776,ChiCTR,2020-02-13,2020-02-11,True,The First Affiliated Hospital of Wenzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Polyinosinic-Polycytidylic Acid Injection in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Polyinosinic-polycytidylic acid,Polyinosinic-polycytidylic acid,40,http://www.chictr.org.cn/showproj.aspx?proj=49342,None
23,104,ChiCTR2000029769,ChiCTR,2020-02-13,2020-02-15,False,Enze Hospital of Taizhou Enze Medical Center (Group),Not Recruiting,Not Applicable,Interventional,China,Babaodan Capsule used for the adjuvant treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=49415,None
24,105,ChiCTR2000029768,ChiCTR,2020-02-13,2020-02-12,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"A randomized, open, controlled trial for diammonium glycyrrhizinate enteric-coated capsules combined with vitamin C tablets in the treatment of common novel coronavirus pneumonia (COVID-19) in the basic of clinical standard antiviral treatment to evaluate the safety and efficiency",Drug,Diammonium glycyrrhizinate + Vitamin C,Diammonium glycyrrhizinate; Vitamin C,60,http://www.chictr.org.cn/showproj.aspx?proj=49131,None
25,106,ChiCTR2000029765,ChiCTR,2020-02-13,2020-02-10,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,Tocilizumab,188,http://www.chictr.org.cn/showproj.aspx?proj=49409,None
26,108,ChiCTR2000029763,ChiCTR,2020-02-12,2020-02-13,False,China Academy of Chinese Medical Sciences; Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"The efficacy of traditional chinese medicine on Novel Coronavirus Pneumonia (COVID-19) patients treated in square cabin hospital: a prospective, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,408,http://www.chictr.org.cn/showproj.aspx?proj=49408,None
27,110,ChiCTR2000029756,ChiCTR,2020-02-12,2020-02-15,False,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,Clinical study of nebulized Xiyanping injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,238,http://www.chictr.org.cn/showproj.aspx?proj=49222,None
28,113,ChiCTR2000029747,ChiCTR,2020-02-11,2020-02-11,False,The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Effect evaluation and prognosis of Chinese medicine based on Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49287,None
29,114,ChiCTR2000029742,ChiCTR,2020-02-11,2020-02-10,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, parallel controlled trial for the efficacy and safety of Sodium Aescinate Injection in the treatment of patients with pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://www.chictr.org.cn/showproj.aspx?proj=49297,None
30,115,ChiCTR2000029741,ChiCTR,2020-02-11,2020-02-12,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Phase 4,Interventional,China,"Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label, multicenter randomized controlled clinical study",Drug,Lopinavir/ritonavir vs. chloroquine,Lopinavir/ritonavir; Chloroquine,112,http://www.chictr.org.cn/showproj.aspx?proj=49263,None
31,116,ChiCTR2000029739,ChiCTR,2020-02-11,2020-02-12,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Parallel Controlled Clinical Study of Hydrogen-Oxygen Nebulizer to Improve the Symptoms of Patients With Novel Coronavirus Pneumonia (COVID-19)",Drug,Hydrogen + Oxygen vs Oxygen,Hydrogen; Oxygen,440,http://www.chictr.org.cn/showproj.aspx?proj=49283,None
32,121,ChiCTR2000029656,ChiCTR,2020-02-09,2020-02-14,False,Wuhan Pulmonary Hosptial,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of low-dose corticosteroids in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Corticosteroids,Methylprednisolone,100,http://www.chictr.org.cn/showproj.aspx?proj=49086,None
33,122,ChiCTR2000029639,ChiCTR,2020-02-08,2020-02-10,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,"Study for Mental health and psychological status of doctors, nurses and patients in novel coronavirus pneumonia (COVID-19) designated hospital and effect of interventions",Other (psych),No Intervention,No Intervention,192,http://www.chictr.org.cn/showproj.aspx?proj=49187,None
34,124,ChiCTR2000029636,ChiCTR,2020-02-08,2020-02-09,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial,ATMP,Vaccine,Vaccine,40,http://www.chictr.org.cn/showproj.aspx?proj=49215,None
35,129,ChiCTR2000029621,ChiCTR,2020-02-07,2020-02-07,False,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Phase 4,Interventional,China,Clinical study of arbidol hydrochloride tablets in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Umifenovir,Umifenovir,380,http://www.chictr.org.cn/showproj.aspx?proj=49165,None
36,130,ChiCTR2000029609,ChiCTR,2020-02-06,2020-02-10,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, open-label, multiple-center study for the efficacy of chloroquine phosphate in patients with novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine vs. lopinavir/ritonavir,Chloroquine; lopinavir; ritonavir,205,http://www.chictr.org.cn/showproj.aspx?proj=49145,None
37,131,ChiCTR2000029606,ChiCTR,2020-02-07,2020-01-25,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Human Menstrual Blood-Derived Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (stem cells),Cells (stem cells),63,http://www.chictr.org.cn/showproj.aspx?proj=49146,None
38,132,ChiCTR2000029603,ChiCTR,2020-02-06,2020-02-06,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A Randomized, Open-Label, Multi-Centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Novel Coronavirus Pneumonia (COVID-19)",Drug,ASCO9 + Ritonavir vs. Lopinavir/ritonavir,ASC09; Ritonavir; Lopinavir/ritonavir,160,http://www.chictr.org.cn/showproj.aspx?proj=49075,None
39,133,ChiCTR2000029602,ChiCTR,2020-02-06,2020-02-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=48985,None
40,134,ChiCTR2000029601,ChiCTR,2020-02-06,2020-02-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Community based prevention and control for Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=48988,None
41,135,ChiCTR2000029600,ChiCTR,2020-02-06,2020-01-30,True,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,China,Clinical study for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Favipiravir + interferon alpha vs. interferon alpha + Lopinavir/ritonavir + interferon alpha vs. interferon alpha,Favipiravir; interferon alpha; Lopinavir/ritonavir,90,http://www.chictr.org.cn/showproj.aspx?proj=49042,None
42,136,ChiCTR2000029578,ChiCTR,2020-02-05,2020-02-06,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, sing-arm trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,1000,http://www.chictr.org.cn/showproj.aspx?proj=49080,None
43,137,ChiCTR2000029559,ChiCTR,2020-02-04,2020-01-31,True,Renmin Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19),Drug,Hydroxychloroquine,Hydroxychloroquine,300,http://www.chictr.org.cn/showproj.aspx?proj=48880,None
44,138,ChiCTR2000029558,ChiCTR,2020-02-04,2020-01-29,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Diagnosis and Treatment of Novel Coronavirus Pneumonia (COVID-19) in Sichuan Province,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=48792,None
45,139,ChiCTR2000029548,ChiCTR,2020-02-04,2020-02-04,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"Randomized, open-label, controlled trial for evaluating of the efficacy and safety of Baloxavir Marboxil, Favipiravir, and Lopinavir-Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Baloxavir + Marboxil vs. Favipiravir vs. Lopinavir/ritonavir,Baloxavir; Marboxil; Favipiravir; Lopinavir/ritonavir,30,http://www.chictr.org.cn/showproj.aspx?proj=49015,None
46,140,ChiCTR2000029544,ChiCTR,2020-02-03,2020-02-04,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"A randomized controlled trial for the efficacy and safety of Baloxavir Marboxil, Favipiravir tablets in novel coronavirus pneumonia (COVID-19) patients who are still positive on virus detection under the current antiviral therapy",Drug,Baloxavir + Marboxil vs. Favipiravir,Baloxavir; Marboxil; Favipiravir,30,http://www.chictr.org.cn/showproj.aspx?proj=49013,None
47,141,ChiCTR2000029542,ChiCTR,2020-02-03,2020-02-03,False,Sun Yat sen Memorial Hospital of Sun Yat sen University,Recruiting,Phase 4,Interventional,China,Study for the efficacy of chloroquine in patients with novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,20,http://www.chictr.org.cn/showproj.aspx?proj=48968,None
48,142,ChiCTR2000029541,ChiCTR,2020-02-03,2020-02-10,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Darunavir + Cobicistat vs. Lopinavir/ritonavir,Darunavir; Cobicistat; Lopinavir/ritonavir,100,http://www.chictr.org.cn/showproj.aspx?proj=48992,None
49,143,ChiCTR2000029539,ChiCTR,2020-02-03,2020-02-04,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with mild novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,Lopinavir; Ritonavir,328,http://www.chictr.org.cn/showproj.aspx?proj=48991,None
50,144,ChiCTR2000029518,ChiCTR,2020-02-03,2020-02-04,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,140,http://www.chictr.org.cn/showproj.aspx?proj=48860,None
51,145,ChiCTR2000029517,ChiCTR,2020-02-03,2020-02-04,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for suspected novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48861,None
52,146,ChiCTR2000029495,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine, Psychological Intervention and Investigation of Mental Health for Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period",Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,90,http://www.chictr.org.cn/showproj.aspx?proj=48971,None
53,147,ChiCTR2000029493,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine for Pulmonary Fibrosis, Pulmonary Function and Quality of Life in Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period: a Randomized Controlled Trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48931,None
54,148,ChiCTR2000029487,ChiCTR,2020-02-02,2020-02-10,False,Wuhan Hospital of Integrated Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Prevention,China,Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=48965,None
55,149,ChiCTR2000029468,ChiCTR,2020-02-02,2020-02-01,True,"Institute of Emergency Medicine and Disaster Medicine Sichuan People's Hospital, Sichuan Academy of Medical Sciences",Not Recruiting,Not Applicable,Interventional,China,A real-world  study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Lopinavir/ritonavir + emtricitabine + tenofovir vs. lopinavir/ritonavir,Lopinavir/ritonavir; Emtricitabine; Tenofovir,120,http://www.chictr.org.cn/showproj.aspx?proj=48919,None
56,151,ChiCTR2000029461,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48927,None
57,152,ChiCTR2000029460,ChiCTR,2020-02-02,2020-02-02,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (exercise),Exercise,Exercise,100,http://www.chictr.org.cn/showproj.aspx?proj=48930,None
58,153,ChiCTR2000029459,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of pulmonary rehabilitation for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.chictr.org.cn/showproj.aspx?proj=48929,None
59,154,ChiCTR2000029439,ChiCTR,2020-02-01,2020-02-02,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=48904,None
60,155,ChiCTR2000029438,ChiCTR,2020-02-01,2020-02-04,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Phase 4,Interventional,China,A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48911,None
61,157,ChiCTR2000029436,ChiCTR,2020-02-01,2020-02-01,False,The First Hospital of He'nan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A single arm study for evaluation of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48884,None
62,158,ChiCTR2000029435,ChiCTR,2020-02-01,2020-02-01,False,Wuhan First Hospital,Not Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-19) in high risk population,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=48827,None
63,159,ChiCTR2000029432,ChiCTR,2020-02-01,2020-02-01,False,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,A Real World Study for the Efficacy and Safety of Large Dose Tanreqing Injection in the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,http://www.chictr.org.cn/showproj.aspx?proj=48881,None
64,160,ChiCTR2000029431,ChiCTR,2020-02-01,2020-01-29,True,Affiliated Zhongshan Hospital of Dalian University,Recruiting,Not Applicable,Interventional,China,Clinical study for the remedy of M1 macrophages target in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,45,http://www.chictr.org.cn/showproj.aspx?proj=48907,None
65,162,ChiCTR2000029418,ChiCTR,2020-01-30,2020-02-03,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,42,http://www.chictr.org.cn/showproj.aspx?proj=48886,None
66,163,ChiCTR2000029400,ChiCTR,2020-01-29,2020-01-29,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=48824,None
67,164,ChiCTR2000029381,ChiCTR,2020-01-27,2020-01-24,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Phase 4,Interventional,China,A prospective comparative study for Xue-Bi-Jing injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=48768,None
68,166,IRCT20190809044488N1,IRCT,2020-01-13,2019-09-07,True,Boushehr University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Effects of using Forced Hot air system on physiological parameters, waking time and arterial blood gases in patients undergoing coronary artery bypass grafting surgery",Not relevant,Not relevant,Not relevant,102,http://en.irct.ir/trial/41571,None
69,167,ChiCTR2000030188,ChiCTR,2020-02-24,2020-02-15,True,Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50025,None
70,169,ChiCTR2000030179,ChiCTR,2020-02-24,2020-02-24,False,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Experimental study of novel coronavirus pneumonia rehabilitation plasma therapy severe novel coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,100,http://www.chictr.org.cn/showproj.aspx?proj=50059,None
71,170,ChiCTR2000030173,ChiCTR,2020-02-24,2020-02-17,True,"Hunan yuanpin Cell Biotechnology Co., Ltd",Not Recruiting,Not Applicable,Interventional,China,Key techniques of umbilical cord mesenchymal stem cells for the treatment of novel coronavirus pneumonia (COVID-19) and clinical application demonstration,ATMP,Cells (mesenchymal),Cells (mesenchymal),60,http://www.chictr.org.cn/showproj.aspx?proj=49229,None
72,171,ChiCTR2000030170,ChiCTR,2020-02-24,2020-02-15,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Study for safety and efficacy of Jakotinib hydrochloride tablets in the treatment severe and acute exacerbation patients of novel coronavirus pneumonia (COVID-19),Drug,Jakotinib,Jakotinib,16,http://www.chictr.org.cn/showproj.aspx?proj=50017,None
73,172,ChiCTR2000030167,ChiCTR,2020-02-24,2020-03-02,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Interleukin-2,Interleukin-2,80,http://www.chictr.org.cn/showproj.aspx?proj=49567,None
74,173,ChiCTR2000030166,ChiCTR,2020-02-24,2020-02-25,False,The Fifth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,"Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined with antiviral therapy in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.chictr.org.cn/showproj.aspx?proj=49696,None
75,174,ChiCTR2000030165,ChiCTR,2020-02-24,2020-02-24,False,Tianjin University,Recruiting,Not Applicable,Interventional,China,Clinical study for ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,Ozone,60,http://www.chictr.org.cn/showproj.aspx?proj=49947,None
76,176,ChiCTR2000030138,ChiCTR,2020-02-24,2020-02-24,False,Chinese PLA General Hospital,Not Recruiting,Phase 2,Interventional,China,Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),60,http://www.chictr.org.cn/showproj.aspx?proj=50004,None
77,178,ChiCTR2000030136,ChiCTR,2020-02-24,2020-02-24,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,China,Humanistic Care in Patients With Novel Coronavirus Pneumonia (COVID-19),Other,Humanistic Care,Humanistic Care,130,http://www.chictr.org.cn/showproj.aspx?proj=50005,None
78,179,ChiCTR2000030118,ChiCTR,2020-02-23,2020-02-24,False,Shenzhen National Medicine Inheritance Medical Research Institute co. LTD,Not Recruiting,Not Applicable,Interventional,China,A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49594,None
79,180,ChiCTR2000030117,ChiCTR,2020-02-23,2020-02-15,True,Shanghai Public Health Clinical Center,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, parallel controlled trial for the evaluation of the effectiveness and safety of Xiyanping injection in the treatment of common type novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,348,http://www.chictr.org.cn/showproj.aspx?proj=49762,None
80,181,ChiCTR2000030116,ChiCTR,2020-02-23,2020-02-01,True,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Safety and effectiveness of human umbilical cord mesenchymal stem cells in the treatment of acute respiratory distress syndrome of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),16,http://www.chictr.org.cn/showproj.aspx?proj=49901,None
81,183,ChiCTR2000030113,ChiCTR,2020-02-23,2020-02-22,True,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,No Country Given,Randomized controlled trial for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19) with poorly responsive ritonavir/ritonavir,Drug,Favipiravir vs. ritonavir,Favipiravir,30,http://www.chictr.org.cn/showproj.aspx?proj=49988,None
82,184,ChiCTR2000030102,ChiCTR,2020-02-23,2020-02-24,False,Tianjin Huanhu Hospital,Recruiting,Not Applicable,Interventional,China,A multicenter randomized controlled trial for ozone autohemotherapy in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Ozone,Ozone,180,http://www.chictr.org.cn/showproj.aspx?proj=49747,None
83,187,ChiCTR2000030093,ChiCTR,2020-02-23,2020-03-01,False,The Second Hospital of Shanxi Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for application of simplified cognitive-behavioral therapy for related emergency psychological stress reaction of medical providers working in the position of treatment and control of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,60,http://www.chictr.org.cn/showproj.aspx?proj=49932,None
84,189,ChiCTR2000030090,ChiCTR,2020-02-22,2020-02-22,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A Prospective Randomized Controlled Trial for Home Exercise Prescription Intervention During Epidemic of Novel Coronary Pneumonia (COVID-19) in College Students,Other (exercise),Exercise,Exercise,400,http://www.chictr.org.cn/showproj.aspx?proj=49910,None
85,190,ChiCTR2000030089,ChiCTR,2020-02-22,2020-02-28,False,Shanghai Changzheng Hospital,Not Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of Adalimumab Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Drug,Adalimumab,Adalimumab,60,http://www.chictr.org.cn/showproj.aspx?proj=49889,None
86,191,ChiCTR2000030088,ChiCTR,2020-02-22,2020-03-01,False,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Umbilical cord Wharton's Jelly derived mesenchymal stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),40,http://www.chictr.org.cn/showproj.aspx?proj=49902,None
87,194,ChiCTR2000030084,ChiCTR,2020-02-22,2020-02-24,False,The First Hospital of Shanxi Medical University,Recruiting,Not Applicable,Interventional,China,A multicenter study for efficacy of intelligent psychosomatic adjustment system intervention in the treatment of novel coronavirus pneumonia (COVID-19) patients with mild to moderate anxiety and depression,Other (psych),Psychological,Psychological,180,http://www.chictr.org.cn/showproj.aspx?proj=49952,None
88,195,ChiCTR2000030058,ChiCTR,2020-02-22,2020-03-10,False,Renmin Hospital of Wuhan University,Not Recruiting,Phase 3,Interventional,China,"A multicenter, randomized, double-blind, controlled clinical trial for leflunomide in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Leflunomide,Leflunomide,200,http://www.chictr.org.cn/showproj.aspx?proj=49831,None
89,197,ChiCTR2000030054,ChiCTR,2020-02-22,2020-02-22,False,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, open label, randomized, control trial for chloroquine or hydroxychloroquine in patients with mild and common novel coronavirus pulmonary (COVIP-19)",Drug,Chloroquine + Hydroxychloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49869,None
90,198,ChiCTR2000030046,ChiCTR,2020-02-21,2020-02-07,True,"The First People's Hospital of Jiangxia District, Wuhan (Union Jiangnan Hospital)",Recruiting,Not Applicable,Interventional,China,A single arm trial to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of novel coronavirus pneumonia patient (COVID-19),ATMP,Plasma,Plasma,10,http://www.chictr.org.cn/showproj.aspx?proj=49861,None
91,199,ChiCTR2000030043,ChiCTR,2020-02-21,2020-02-21,False,Peking University Third Hospital,Not Recruiting,Phase 4,Interventional,China,"Shen-Fu injection in the treatment of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=49866,None
92,200,ChiCTR2000030041,ChiCTR,2020-02-21,2020-02-25,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A single-arm, single-center clinical trial for Azivudine tablets in the treatment of adult novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,40,http://www.chictr.org.cn/showproj.aspx?proj=49891,None
93,201,ChiCTR2000030039,ChiCTR,2020-02-21,2020-05-31,False,Affiliated Hospital of Xuzhou Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for infusing convalescent plasma to treat patients with new coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,90,http://www.chictr.org.cn/showproj.aspx?proj=49544,None
94,202,ChiCTR2000030034,ChiCTR,2020-02-21,2020-02-07,True,Tongde Hospital of Zhejiang Province,Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19): a multicentre, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,132,http://www.chictr.org.cn/showproj.aspx?proj=49647,None
95,203,ChiCTR2000030033,ChiCTR,2020-02-21,2020-02-24,False,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,A study for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,828,http://www.chictr.org.cn/showproj.aspx?proj=49703,None
96,206,ChiCTR2000030029,ChiCTR,2020-02-21,2020-02-20,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19),Drug,Suramin,Suramin,20,http://www.chictr.org.cn/showproj.aspx?proj=49824,None
97,207,ChiCTR2000030027,ChiCTR,2020-02-20,2020-02-20,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with Novel coronavirus pneumonia (COVID-19) and its effect on spermatogenesis: a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49852,None
98,209,ChiCTR2000030020,ChiCTR,2020-02-20,2020-02-06,True,"Second Hospital of University of South China, Hengyang",Recruiting,Not Applicable,Interventional,China,The clinical application and basic research related to mesenchymal stem cells to treat novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.chictr.org.cn/showproj.aspx?proj=49812,None
99,212,ChiCTR2000030016,ChiCTR,2020-02-19,2020-02-04,True,Guangxi Medical University,Recruiting,Phase 4,Interventional,China,Basic and clinical study of inhalation of inactivated mycobacterium vaccine in the treatment of Novel coronavirus pneumonia (COVID-19),ATMP,Vaccine,Vaccine,60,http://www.chictr.org.cn/showproj.aspx?proj=49799,None
100,214,ChiCTR2000030012,ChiCTR,2020-02-19,2020-02-19,False,"The First People's Hospital of Chenzhou, Institute of Translational Medicine,University of South China",Not Recruiting,Not Applicable,Interventional,China,Development of anti-2019-nCoV therapeutic antibody from the recovered novel coronavirus pneumonia patients (COVID-19),ATMP,Antibody,Antibody,20,http://www.chictr.org.cn/showproj.aspx?proj=49718,None
101,215,ChiCTR2000030010,ChiCTR,2020-02-19,2020-02-19,False,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia patients (COVID-19)",ATMP,Plasma,Plasma,100,http://www.chictr.org.cn/showproj.aspx?proj=49777,None
102,217,ChiCTR2000030007,ChiCTR,2020-02-19,2020-02-03,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Multicenter randomized controlled trial for rhG-CSF in the treatment of novel coronavirus pneumonia (COVID-19),Drug,G-CSF,G-CSF,200,http://www.chictr.org.cn/showproj.aspx?proj=49619,None
103,218,ChiCTR2000030006,ChiCTR,2020-02-19,2020-02-19,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,Ozone,60,http://www.chictr.org.cn/showproj.aspx?proj=49737,None
104,220,ChiCTR2000030003,ChiCTR,2020-02-19,2020-02-19,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Optimization Protocal of Integrated Traditional Chinese and Western Medicine in the Treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,480,http://www.chictr.org.cn/showproj.aspx?proj=49770,None
105,221,ChiCTR2000030002,ChiCTR,2020-02-19,2020-02-15,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Tranilast,Tranilast,60,http://www.chictr.org.cn/showproj.aspx?proj=49738,None
106,222,ChiCTR2000030001,ChiCTR,2020-02-19,2020-02-15,True,Health commission of Heilongjiang province,Recruiting,Phase 3,Interventional,China,"The efficacy and safety of Triazavirin for 2019 novel coronary pneumonia (COVID-19): a multicenter, randomized, double blinded, placebo-controlled trial",Drug,Triazavirin,Triazavirin,240,http://www.chictr.org.cn/showproj.aspx?proj=49723,None
107,223,ChiCTR2000030000,ChiCTR,2020-02-19,2020-02-16,True,The Ninth Hospital of Nanchang,Recruiting,Phase 4,Interventional,China,"An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19)",Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=49748,None
108,224,ChiCTR2000029999,ChiCTR,2020-02-19,2020-02-20,False,Shanghai 10th People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for probiotics in the regulation of intestinal function and microflora structure of novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,Probiotics,60,http://www.chictr.org.cn/showproj.aspx?proj=49717,None
109,225,ChiCTR2000029996,ChiCTR,2020-02-20,2020-02-20,False,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A randomized, open-label, controlled trial for the efficacy and safety of Farpiravir Tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)",Drug,Favipiravir,Favipiravir,60,http://www.chictr.org.cn/showproj.aspx?proj=49510,None
110,227,ChiCTR2000029994,ChiCTR,2020-02-18,2020-02-19,False,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Liu-Zi-Jue Qigong and Acupressure Therapy for Pulmonary Function and Quality of Life in Patient with Severe novel coronavirus pneumonia (COVID-19): A Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49309,None
111,228,ChiCTR2000029992,ChiCTR,2020-02-18,2020-02-17,True,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, randomized, open label, controlled trial for chloroquine and hydroxychloroquine in patients with severe novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine + Hydroxychloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49574,None
112,229,ChiCTR2000029990,ChiCTR,2020-02-18,2020-01-30,True,"Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences",Recruiting,Phase 1/Phase 2,Interventional,China,Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),120,http://www.chictr.org.cn/showproj.aspx?proj=49674,None
113,230,ChiCTR2000029989,ChiCTR,2020-02-18,2020-02-20,False,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A randomized controlled Trial for therapeutic efficacy of Recombinant Human Interferon alpha 1b Eye Drops in the treatment of elderly with novel coronavirus pneumonia (COVID-19),Drug,Interferon alfa,Interferon alfa,300,http://www.chictr.org.cn/showproj.aspx?proj=49720,None
114,231,ChiCTR2000029988,ChiCTR,2020-02-18,2020-02-13,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Clinical Study of Chloroquine Phosphate in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,80,http://www.chictr.org.cn/showproj.aspx?proj=49218,None
115,234,ChiCTR2000029978,ChiCTR,2020-02-18,2020-02-21,False,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,186,http://www.chictr.org.cn/showproj.aspx?proj=49702,None
116,235,ChiCTR2000029974,ChiCTR,2020-02-18,2020-02-09,True,"Qingdao East Sea Pharmaceutical Co., Ltd.",Recruiting,Not Applicable,Interventional,China,"A prospective, multicenter, open-label, randomized, parallel-controlled trial for probiotics to evaluate efficacy and safety in patients infected with 2019 novel coronavirus pneumonia (COVID-19)",Supplement,Probiotics,Probiotics,300,http://www.chictr.org.cn/showproj.aspx?proj=49321,None
117,236,ChiCTR2000029972,ChiCTR,2020-02-17,2020-02-17,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the Efficacy of Ultra Short Wave Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Other (physical),Ultra short wave electrotherapy,Ultra short wave electrotherapy,40,http://www.chictr.org.cn/showproj.aspx?proj=49664,None
118,237,ChiCTR2000029960,ChiCTR,2020-02-17,2020-02-28,False,The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Comparative study for integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49639,None
119,239,ChiCTR2000029956,ChiCTR,2020-02-17,2020-02-18,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Chinese Medicine Promotes Rehabilitation Recommendations after 2019 Novel Coronavirus Infection (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49618,None
120,240,ChiCTR2000029954,ChiCTR,2020-02-17,2020-04-30,False,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=49402,None
121,242,ChiCTR2000029851,ChiCTR,2020-02-15,2020-02-19,False,"Zhongshan Hospital, Fudan University",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of Alpha lipoic acid (iv) in the treatment of patients of severe novel coronavirus pneumonia (COVID-19)",Supplement,Alpha lipoic acid,Alpha lipoic acid,68,http://www.chictr.org.cn/showproj.aspx?proj=49534,None
122,243,ChiCTR2000029803,ChiCTR,2020-02-14,2020-02-20,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, randomized, open-label, controlled clinical study to evaluate the preventive effect of hydroxychloroquine on close contacts after exposure to the Novel Coronavirus Pneumonia (COVID-19)",Drug,Hydroxychloroquine vs. Umeprevir,Hydroxychloroquine; Umeprevir,320,http://www.chictr.org.cn/showproj.aspx?proj=49428,None
123,244,ChiCTR2000029781,ChiCTR,2020-02-13,2020-02-14,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open and controlled trial for the efficacy and safety of Kang-Bing-Du granules in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49138,None
124,245,ChiCTR2000029780,ChiCTR,2020-02-13,2020-02-14,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of Shen-Qi Fu-Zheng injection in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49220,None
125,246,ChiCTR2000029740,ChiCTR,2020-02-11,2020-02-11,False,The First Hospital of Peking University,Recruiting,Phase 4,Interventional,China,Efficacy of therapeutic effects of hydroxycholoroquine in novel coronavirus pneumonia (COVID-19) patients(randomized open-label control clinical trial),Drug,Hydroxychloroquine,Hydroxychloroquine,78,http://www.chictr.org.cn/showproj.aspx?proj=49317,None
126,247,ChiCTR2000030442,ChiCTR,2020-03-02,2020-03-05,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,No Country Given,"Combination of Tocilizumab, IVIG and CRRT in severe patients with novel coronavirus pneumonia (COVID-19)",Drug (+ ATMP + Other (renal)),Tocilizumab + immunoglobulin + renal replacement therapy,Tocilizumab; Immunoglobulin; Renal replacement therapy,100,http://www.chictr.org.cn/showproj.aspx?proj=50380,None
127,248,ChiCTR2000030433,ChiCTR,2020-03-01,2020-03-01,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Phase 1,Interventional,China,Application of Rehabilitation and Lung Eight-segment Exercise in Home Rehabilitation of Survivors from novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,http://www.chictr.org.cn/showproj.aspx?proj=50273,None
128,249,ChiCTR2000030432,ChiCTR,2020-03-01,2020-03-02,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Not Applicable,Interventional,China,Application of rehabilitation and Lung eight-segment exercise in front-line nurses in the prevention of novel coronavirus pneumonia (COVID-19) epidemic,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,http://www.chictr.org.cn/showproj.aspx?proj=50268,None
129,250,ChiCTR2000030424,ChiCTR,2020-03-01,2020-03-02,False,Henan Provincial People's Hospital,Not Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,30,http://www.chictr.org.cn/showproj.aspx?proj=50174,None
130,251,ChiCTR2000030420,ChiCTR,2020-03-01,2020-03-01,False,"Institute of Integrative Medicine of Dalian Medical University, Dalian, China",Not Recruiting,Not Applicable,Interventional,China,A Clinical Trial Study for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Other (psych),Psychological,Psychological,60,http://www.chictr.org.cn/showproj.aspx?proj=50286,None
131,252,ChiCTR2000030418,ChiCTR,2020-03-01,2020-03-01,False,The First Affiliated Hospital of Fujian Medical University,Recruiting,Not Applicable,Interventional,China,Application of rehabilitation lung exercise eight-segment exercise in patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,http://www.chictr.org.cn/showproj.aspx?proj=50341,None
132,253,ChiCTR2000030398,ChiCTR,2020-03-01,2020-02-27,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, placebo-controlled trial for evaluation of  the efficacy and safety of bismuth potassium citrate capsules in the treatment of patients with novel coronavirus pneumonia (COVID-19).",Drug,Bismuth potassium citrate,Bismuth potassium citrate,340,http://www.chictr.org.cn/showproj.aspx?proj=50173,None
133,258,ChiCTR2000030386,ChiCTR,2020-02-18,2020-03-01,False,Hunan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for moxibustion in the preventing of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,http://www.chictr.org.cn/showproj.aspx?proj=50323,None
134,264,ChiCTR2000030324,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine 'Zang-Fu Point-pressing' massage for children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=50231,None
135,266,ChiCTR2000030317,ChiCTR,2020-02-28,2020-03-01,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical study for a new type of Gastroscope isolation mask for preventing and controlling the novel coronavirus pneumonia (COVID-19) Epidemic period,Other (physical),Gastroscope mask,Gastroscope mask,300,http://www.chictr.org.cn/showproj.aspx?proj=50247,None
136,268,ChiCTR2000030314,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,No Country Given,Traditional Chinese medicine Ma-Xing-Shi-Gan-Tang and Sheng-Jiang-San in the treatment of children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=50248,None
137,273,ChiCTR2000030265,ChiCTR,2020-02-26,2020-02-24,True,The First Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for continuous renal replacement therapy with adsorption filter in the treatment of the novel coronavirus pneumonia (COVID-19),Other (renal),Renal replacement therapy,Renal replacement therapy,30,http://www.chictr.org.cn/showproj.aspx?proj=49691,None
138,276,ChiCTR2000030261,ChiCTR,2020-02-26,2020-03-01,False,Wuxi Fifth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A study for the key technology of mesenchymal stem cells exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),26,http://www.chictr.org.cn/showproj.aspx?proj=49963,None
139,277,ChiCTR2000030260,ChiCTR,2020-02-26,2020-02-27,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Interventional,China,Clinical study for individualized nutritional assessment and supportive treatment of novel coronavirus pneumonia (COVID-19) patients in Tibetan Plateau,Other (nutrition),Nutrition,Nutrition,20,http://www.chictr.org.cn/showproj.aspx?proj=50130,None
140,278,ChiCTR2000030258,ChiCTR,2020-02-26,2020-02-21,True,The Fourth Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for efficacy and safety of hydrogen inhalation in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Hydrogen,Hydrogen,60,http://www.chictr.org.cn/showproj.aspx?proj=49887,None
141,280,ChiCTR2000030255,ChiCTR,2020-02-26,2020-03-01,False,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Jing-Yin Granule in the treatment of novel coronavirus pneumonia (COVID-19) wind-heat syndrome,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=50089,None
142,283,ChiCTR2000030225,ChiCTR,2020-02-26,2020-02-22,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,Clinical Reseach of Acupuncture in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,186,http://www.chictr.org.cn/showproj.aspx?proj=49945,None
143,286,ChiCTR2000030219,ChiCTR,2020-02-25,2020-01-21,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for evaluation of integrated traditional Chinese and Western Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50110,None
144,287,ChiCTR2000030218,ChiCTR,2020-02-25,2020-01-22,True,The Fifth People's Hospital of Ganzhou,Recruiting,Not Applicable,Interventional,China,Study of Pinavir / Ritonavir Tablets (Trade Name: Kelizhi) Combined with Xiyanping Injection for Novel Coronavirus Pneumonia (COVID-19),Drug,Lopinavir/ritonavir (+ Tradtional Medicine),Lopinavir; Ritonavir; Traditional Medicine,80,http://www.chictr.org.cn/showproj.aspx?proj=50115,None
145,288,ChiCTR2000030215,ChiCTR,2020-02-25,2020-02-26,False,"The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50107,None
146,289,ChiCTR2000030196,ChiCTR,2020-02-25,2020-02-20,True,Central South Hospital of Wuhan University,Not Recruiting,Phase 2,Interventional,China,"A multicenter, single arm, open label trial for the efficacy and safety of CMAB806 in the treatment of cytokine release syndrome of novel coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,Tocilizumab,60,http://www.chictr.org.cn/showproj.aspx?proj=49883,None
147,291,ChiCTR2000030091,ChiCTR,2020-02-23,2020-02-22,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A prospective randomized controlled trial for the home exercise prescription intervention in nursing students during epidemic of novel coronary pneumonia (COVID-19),Other (exercise),Exercise,Exercise,200,http://www.chictr.org.cn/showproj.aspx?proj=49914,None
148,293,ChiCTR2000030022,ChiCTR,2020-02-20,2020-02-22,False,The First Affiliated Hospital of Anhui Medical University,Not Recruiting,Phase 4,Interventional,China,"A parallel, randomized controlled clinical trial for the efficacy and safety of Pediatric Huatanzhike granules (containing ipecacuanha tincture) in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49797,None
149,294,ChiCTR2000030013,ChiCTR,2020-02-19,2020-02-20,False,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A prospective clinical study for recombinant human interferon alpha 1b spray in the prevention of novel coronavirus (COVID-19) infection in highly exposed medical staffs.,Drug,Interferon alfa,Interferon alfa,450,http://www.chictr.org.cn/showproj.aspx?proj=49796,None
150,295,ChiCTR2000029991,ChiCTR,2020-02-18,2020-02-18,False,The First Affiliated Hospital of Nanchang University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for the safety and efficiency of Kesuting syrup and Keqing capsule in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,http://www.chictr.org.cn/showproj.aspx?proj=49666,None
151,296,ChiCTR2000029975,ChiCTR,2020-02-18,2020-02-24,False,The First Hospital of Jilin University,Not Recruiting,Phase 4,Interventional,China,Single arm study for exploration of chloroquine phosphate aerosol inhalation in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,10,http://www.chictr.org.cn/showproj.aspx?proj=49592,None
152,299,ChiCTR2000029899,ChiCTR,2020-02-16,2020-02-17,False,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Mild and Commen Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-label, Parallel, Controlled Trial",Drug,Hydroxychloroquine vs. Chloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49536,None
153,300,ChiCTR2000029898,ChiCTR,2020-02-16,2020-02-17,False,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Severe Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-Label, Parallel, Controlled Trial",Drug,Hydroxychloroquine vs. Chloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49482,None
154,306,ChiCTR2000029755,ChiCTR,2020-02-12,2020-02-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open, parallel-controlled clinical trial on the efficacy and safety of Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49301,None
155,308,ChiCTR2000029387,ChiCTR,2020-01-29,2020-01-25,True,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,"Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia",Drug,"Ribavirin + Interferon alfa
vs. lopinavir/ritonavir + interferon alfa
vs. ribavirin + interferon alfa vs. lopinavir/ritonavir",Ribavirin; Interferon alpha; Lopinavir; Ritonavir,108,http://www.chictr.org.cn/showproj.aspx?proj=48782,None
156,309,ChiCTR2000029386,ChiCTR,2020-01-29,2020-01-29,False,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: a randomized controlled trial,Drug,Corticosteroids,Methylprednisolone,48,http://www.chictr.org.cn/showproj.aspx?proj=48777,None
157,311,ChiCTR2000030627,ChiCTR,2020-03-08,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Study for using the healed novel coronavirus pneumonia (COVID-19) patients plasma in the treatment of severe critical cases,ATMP,Plasma,Plasma,30,http://www.chictr.org.cn/showproj.aspx?proj=50727,None
158,315,ChiCTR2000030578,ChiCTR,2020-03-08,2020-03-07,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical Prediction and Intervention of Pulmonary Function Impairment in Patients with Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=50690,None
159,326,ChiCTR2000030540,ChiCTR,2020-03-06,2020-03-08,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Research for the mechanism of improvement of novel coronavirus pneumonia (COVID-19) patients' pulmonary exudation by continuous renal replacement therapy,Other (renal),Renal replacement therapy,Renal replacement therapy,152,http://www.chictr.org.cn/showproj.aspx?proj=50658,None
160,327,ChiCTR2000030535,ChiCTR,2020-03-06,2020-02-20,True,Wuhan Red Cross Hospital,Recruiting,Phase 4,Interventional,China,Multi-Center Clinical Study on the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19) by Ebastine,Drug,Ebastine + Interferon alpha + Lopinavir vs. Interferon alpha + Lopinavir,Ebastine; interferon alpha; lopinavir,100,http://www.chictr.org.cn/showproj.aspx?proj=49790,None
161,328,ChiCTR2000030518,ChiCTR,2020-03-05,2020-02-29,True,The Second Affiliated Hospital of Wenzhou Medical University,Recruiting,Not Applicable,Interventional,China,"Zedoary Turmeric Oil for Injection in the treatment of Novel Coronavirus Pneumonia (COVID-19): a randomized, open, controlled trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50586,None
162,329,ChiCTR2000030503,ChiCTR,2020-03-05,2020-01-20,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Extracorporeal blood purification therapy using Li's Artifical Liver System for patients with severe novel coronavirus pneumonia (COVID19) patient,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49632,None
163,333,ChiCTR2000030490,ChiCTR,2020-03-04,2020-02-01,True,Huo-Shen-Shan Hospital,Recruiting,Not Applicable,Interventional,No Country Given,To evaluate the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsules combined with hydrogen-rich water in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Diammonium glycyrrhizinate + Hydrogen,Diammonium glycyrrhizinate; Hydrogen,100,http://www.chictr.org.cn/showproj.aspx?proj=50487,None
164,335,ChiCTR2000030487,ChiCTR,2020-03-04,2020-03-04,False,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,10,http://www.chictr.org.cn/showproj.aspx?proj=50507,None
165,337,ChiCTR2000030484,ChiCTR,2020-03-03,2020-02-02,True,Hubei Shiyan Taihe hospital,Not Recruiting,Not Applicable,Interventional,China,HUMSCs and Exosomes Treating Patients with Lung Injury following Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),90,http://www.chictr.org.cn/showproj.aspx?proj=50263,None
166,339,ChiCTR2000030481,ChiCTR,2020-03-03,2020-03-01,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,The clinical value of corticosteroid therapy timing in the treatment of novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,Drug,Corticosteroids,Corticosteroids,200,http://www.chictr.org.cn/showproj.aspx?proj=50453,None
167,340,ChiCTR2000030480,ChiCTR,2020-03-03,2020-03-03,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"Randomized, open, blank controlled trial for the efficacy and safety of recombinant human interferon alpha 1beta in the treatment of Wuhan patients with novel coronavirus pneumonia (COVID-19)",Drug,Interferon alfa,Interferon alfa,328,http://www.chictr.org.cn/showproj.aspx?proj=50470,None
168,341,ChiCTR2000030479,ChiCTR,2020-03-03,2020-02-26,True,"Affiliated Hospital of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine",Not Recruiting,Not Applicable,Interventional,China,Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50450,None
169,342,ChiCTR2000030477,ChiCTR,2020-03-03,2020-03-04,False,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,oXiris Membrane in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,19,http://www.chictr.org.cn/showproj.aspx?proj=50458,None
170,343,ChiCTR2000030475,ChiCTR,2020-03-03,2020-03-04,False,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,Cytosorb in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Other (physical),Blood purification,Blood purification,19,http://www.chictr.org.cn/showproj.aspx?proj=50452,None
171,344,ChiCTR2000030472,ChiCTR,2020-03-03,2020-02-25,True,Shenyang Sixth People's Hospital,Recruiting,Not Applicable,Interventional,China,An open and controlled clinical study to evaluate the efficacy and safety of Ganovo combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,20,http://www.chictr.org.cn/showproj.aspx?proj=49753,None
172,345,ChiCTR2000030471,ChiCTR,2020-03-02,2020-03-02,False,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of lipoic acid injection in reducing the risk of progression in common patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,394,http://www.chictr.org.cn/showproj.aspx?proj=50421,None
173,346,ChiCTR2000030469,ChiCTR,2020-03-02,2020-02-27,True,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A randomized parallel controlled trial for LIUSHENWAN in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,96,http://www.chictr.org.cn/showproj.aspx?proj=50082,None
174,348,ChiCTR2000030467,ChiCTR,2020-03-02,2020-03-01,True,"Dalian Medical University, Dalian, China.",Not Recruiting,Not Applicable,Interventional,China,A Randomized  Controlled Trial  for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50378,None
175,357,ChiCTR2000029993,ChiCTR,2020-02-18,2020-02-20,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,A pilot study for Integrated Chinese and Western Medicine in the treatment of non-critical novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=49435,None
176,359,ChiCTR2000029757,ChiCTR,2020-02-12,2020-02-14,False,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,ATMP,Plasma,Plasma,200,http://www.chictr.org.cn/showproj.aspx?proj=49081,None
177,360,ChiCTR2000029580,ChiCTR,2020-02-05,2020-01-31,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"Severe novel coronavirus pneumonia (COVID-19) patients treated with ruxolitinib in combination with mesenchymal stem cells: a prospective, single blind, randomized controlled clinical trial",Drug (+ ATMP),Ruxolimab + Cells (mesenchymal),Ruxolimab; Cells (mesenchymal),70,http://www.chictr.org.cn/showproj.aspx?proj=49088,None
178,362,ChiCTR2000029550,ChiCTR,2020-02-04,2020-01-29,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations for Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu University of Traditional Chinese Medicine Under the Raging of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=48775,None
179,363,ChiCTR2000029549,ChiCTR,2020-02-04,2020-02-03,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=49014,None
180,364,ChiCTR2000029308,ChiCTR,2020-01-23,2020-01-10,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,"A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,lopinavir/ritonavir,160,http://www.chictr.org.cn/showproj.aspx?proj=48684,None
181,368,ChiCTR2000030897,ChiCTR,2020-03-16,2020-02-10,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,Evaluation of the effect of taking Newgen beta-gluten probiotic composite powder to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,Probiotics,20,http://www.chictr.org.cn/showproj.aspx?proj=50462,None
182,369,ChiCTR2000030896,ChiCTR,2020-03-16,2020-02-06,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application and Theoretical Discussion of Fu-Zheng Qing-Fei Thought in Treating Non-Critical Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,24,http://www.chictr.org.cn/showproj.aspx?proj=51028,None
183,372,ChiCTR2000030892,ChiCTR,2020-03-16,2020-03-06,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Pirfenidone in the Treatment of Severe Post-Novel Coronavirus Pneumonia (COVID-19) Fibrosis: a prospective exploratory experimental medical study,Drug,Pirfenidone,Pirfenidone,40,http://www.chictr.org.cn/showproj.aspx?proj=51118,None
184,376,ChiCTR2000030864,ChiCTR,2020-03-16,2020-02-01,True,Xiangyang First People's Hospital,Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=50662,None
185,385,ChiCTR2000030855,ChiCTR,2020-03-16,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Phase 1,Interventional,No Country Given,Study for the effect of external diaphragmatic pacing assisted invasive ventilation and weaning in patients with severe novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,200,http://www.chictr.org.cn/showproj.aspx?proj=51090,None
186,387,ChiCTR2000030853,ChiCTR,2020-03-16,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the protective effect of dexmedetomidine on patients with severe novel coronavirus pneumonia (COVID-19),Drug,Dexmedetomidine,Dexmedetomidine,200,http://www.chictr.org.cn/showproj.aspx?proj=51081,None
187,390,ChiCTR2000030849,ChiCTR,2020-03-15,2020-03-16,False,Zhengzhou People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Investigation on psychological status of novel coronavirus pneumonia (COVID-19) rehabilitation patients in Zhengzhou City and research on coping strategies,Other (psych),No Intervention,No Intervention,81,http://www.chictr.org.cn/showproj.aspx?proj=51086,None
188,391,ChiCTR2000030841,ChiCTR,2020-03-15,2020-02-17,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Exploratory study for Immunoglobulin From Cured COVID-19 Patients in the Treatment of Acute Severe novel coronavirus pneuvirus (COVID-19),ATMP,Immunoglobulin,Immunoglobulin,10,http://www.chictr.org.cn/showproj.aspx?proj=51072,None
189,394,ChiCTR2000030836,ChiCTR,2020-03-15,2020-02-01,True,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on ''Internal and External Relieving -Truncated Torsion'' strategy,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=51054,None
190,395,ChiCTR2000030835,ChiCTR,2020-03-15,2020-02-14,True,The First Affiliated Hospital of Xinxiang Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for the efficacy of Mesenchymal stem cells (MSC) in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.chictr.org.cn/showproj.aspx?proj=51050,None
191,398,ChiCTR2000030832,ChiCTR,2020-03-15,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,No Country Given,Study for the pathogenesis and effective intervention of mood disorders caused by the novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,800,http://www.chictr.org.cn/showproj.aspx?proj=51044,None
192,406,ChiCTR2000030810,ChiCTR,2020-03-15,2020-02-23,True,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Recruiting,Phase 1,Interventional,China,Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50986,None
193,411,ChiCTR2000030804,ChiCTR,2020-03-15,2020-02-01,True,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Exocarpium Citri Grandis Relieves Symptoms of Novel Coronavirus Pneunomia (COVID-19): a Randomized Controlled Clinical Trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,128,http://www.chictr.org.cn/showproj.aspx?proj=51018,None
194,422,ChiCTR2000030779,ChiCTR,2020-03-14,2020-03-16,False,Shanghai Changzheng Hospital,Recruiting,Phase 4,Interventional,China,A clinical trial for Ulinastatin Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50973,None
195,424,ChiCTR2000030773,ChiCTR,2020-03-14,2020-02-12,True,Huashan Hospital Affiliated to Fudan University,Recruiting,Not Applicable,Interventional,China,Application of blood purification in the treatment of novel coronavirus pneumonia (COVID-19),Other (physical),Blood purification,Blood purification,20,http://www.chictr.org.cn/showproj.aspx?proj=50934,None
196,429,ChiCTR2000030761,ChiCTR,2020-03-13,2020-05-31,False,"Renji Hospital, Shanghai Jiaotong University School of Medicine",Not Recruiting,Not Applicable,Interventional,China,Continuous renal replacement therapy (CRRT) alleviating inflammatory response in severe patients with novel coronavirus pneumonia (COVID-19) associated with renal injury: A Prospective study,Other (renal),Renal replacement therapy,Renal replacement therapy,20,http://www.chictr.org.cn/showproj.aspx?proj=50956,None
197,431,ChiCTR2000030759,ChiCTR,2020-03-13,2020-02-15,True,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for the therapeutic effect and mechanism of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,70,http://www.chictr.org.cn/showproj.aspx?proj=49284,None
198,439,ChiCTR2000030751,ChiCTR,2020-03-13,2020-01-25,True,Affiliated Hospital of Inner Mongolia University for the Nationalities,Not Recruiting,Not Applicable,Interventional,China,Clinical Research for Traditional Mongolian Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50941,None
199,441,ChiCTR2000030744,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application of ECMO(or Ultra-Protective Lung Mechanical Ventilation) in the Treatment of Patients with ARDS due to novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,Oxygen,30,http://www.chictr.org.cn/showproj.aspx?proj=50910,None
200,448,ChiCTR2000030720,ChiCTR,2020-03-11,2020-03-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Prognosis Investigation and Intervention Study on Patients with novel coronavirus pneumonia (COVID-19) in recovery period Based on Community Health Management,Prognosis,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=50793,None
201,450,ChiCTR2000030718,ChiCTR,2020-03-11,2020-02-12,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Randomized controlled trial for Chloroquine Phosphate in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,80,http://www.chictr.org.cn/showproj.aspx?proj=50843,None
202,456,ChiCTR2000030703,ChiCTR,2020-03-10,2020-03-10,False,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Interventional,China,"A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19)",Drug,"Ixekizumab + up to three of interferon-alfa, lopinavir/ritonavir, chloroquine, ribavirin, umifenovir",Ixekizumab; Interferon alpha; Lopinavir; Ritonavir; Chloroquine; Ribavirin; Umifenovir,40,http://www.chictr.org.cn/showproj.aspx?proj=50251,None
203,457,ChiCTR2000030702,ChiCTR,2020-03-10,2020-02-15,True,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Plasma of the convalescent in the treatment of novel coronavirus pneumonia (COVID-19) common patient: a prospective clinical trial,ATMP,Plasma,Plasma,50,http://www.chictr.org.cn/showproj.aspx?proj=50537,None
204,458,ChiCTR2000030701,ChiCTR,2020-03-10,2020-03-10,False,The Third People's Hospital of Shenzhen,Not Recruiting,Not Applicable,Interventional,China,"A randomized, parallel controlled open-label trial for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in the treatment of adult patients with novel coronavirus pneumonia (COVID-19)",Drug,Heparin,Heparin,60,http://www.chictr.org.cn/showproj.aspx?proj=50795,None
205,459,ChiCTR2000030700,ChiCTR,2020-03-10,2020-03-09,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in treatment of novel coronavirus pneumonia (COVID-19) adult common patients,Drug,Heparin,Heparin,60,http://www.chictr.org.cn/showproj.aspx?proj=50786,None
206,465,ChiCTR2000030681,ChiCTR,2020-03-09,2020-03-16,False,Liaocheng People's Hospital,Not Recruiting,Not Applicable,Interventional,China,An anaesthesia procedure and extubation strategy for reducing patient agitation and cough after extubation that can be used to prevent the spread of Novel Coronavirus Pneumonia (COVID-19) and other infectious viruses in the operating Room,Other (physical),Extubation,Extubation,240,http://www.chictr.org.cn/showproj.aspx?proj=50763,None
207,470,ChiCTR2000030580,ChiCTR,2020-03-08,2020-02-01,True,Shanghai General Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of tozumab combined with adamumab(Qletli) in severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,Adamumab,Adamumab,60,http://www.chictr.org.cn/showproj.aspx?proj=50693,None
208,472,ChiCTR2000030545,ChiCTR,2020-03-06,2020-02-04,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=50126,None
209,477,ChiCTR2000030476,ChiCTR,2020-03-03,2020-03-03,False,"Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Study for meditation assists for the rehabilitation of patients with novel coronaviruse pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=50455,None
210,480,ChiCTR2000030388,ChiCTR,2020-03-01,2020-02-18,True,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Xue-Bi-Jing injection in the treatment of severe cases of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50306,None
211,485,ChiCTR2000030187,ChiCTR,2020-02-24,2020-02-25,False,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Lopinavir and Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Lopinavir/ritonavir,lopinavir/ritonavir,60,http://www.chictr.org.cn/showproj.aspx?proj=50057,None
212,508,ChiCTR2000031139,ChiCTR,2020-03-22,2020-03-20,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Human embryonic stem cell-derived M cells (CAStem) for Pulmonary Fibrosis Correlated with novel coronavirus pneumonia (COVID-19),ATMP,Cells (stem cells),Cells (stem cells),20,http://www.chictr.org.cn/showproj.aspx?proj=51404,None
213,509,ChiCTR2000031138,ChiCTR,2020-03-22,2020-02-26,True,"The Third Xiangya Hospital, Central South University",Recruiting,Not Applicable,Interventional,China,Prospective exploratory clinical research on the efficacy and safety of pirfenidone capsules in the treatment of severe novel coronavirus pneumonia (COVID-19),Drug,Pirfenidone,Pirfenidone,40,http://www.chictr.org.cn/showproj.aspx?proj=51416,None
214,512,ChiCTR2000031090,ChiCTR,2020-03-22,2020-03-23,False,Ningbo Kangning Hospital,Not Recruiting,Not Applicable,Interventional,China,Psychological Support for Diagnosed Patients with novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,60,http://www.chictr.org.cn/showproj.aspx?proj=51148,None
215,513,ChiCTR2000031089,ChiCTR,2020-03-22,2020-03-13,True,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=51136,None
216,515,ChiCTR2000031023,ChiCTR,2020-03-21,2020-03-16,True,Hu'nan Cancer Hospital,Recruiting,Not Applicable,Interventional,China,Perioperative immune prediction and intervention of tumor patients undergoing surgery during the novel coronavirus pneumonia (COVID-19) outbreak period,Prognosis,No Intervention,No Intervention,320,http://www.chictr.org.cn/showproj.aspx?proj=50984,None
217,517,ChiCTR2000030996,ChiCTR,2020-03-20,2020-03-18,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Effect of Auricular point pressing on insomnia of novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial.,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=51349,None
218,520,ChiCTR2000030989,ChiCTR,2020-03-20,2020-03-20,False,Beijing Normal University,Not Recruiting,Not Applicable,Interventional,China,Internet based Solution Focused Brief Therapy treating adolescent anxiety under the novel coronavirus pneumonia (COVID-19) outbreak: A randomized controlled trial,Other (psych),Psychological,Psychological,76,http://www.chictr.org.cn/showproj.aspx?proj=51331,None
219,528,ChiCTR2000030946,ChiCTR,2020-03-19,2020-02-10,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19),Drug,Heparin,Heparin,120,http://www.chictr.org.cn/showproj.aspx?proj=51265,None
220,529,ChiCTR2000030944,ChiCTR,2020-03-18,2020-09-01,False,The Second Affiliated Hospital of Nanchang University,Not Recruiting,Phase 1,Interventional,China,Clinical study of human NK cells and MSCs transplantation for severe novel coronavirus pneumonia (COVID-19),ATMP,"Cells, (mesenchymal/NK)",Cells (mesenchymal); Cells (NK),20,http://www.chictr.org.cn/showproj.aspx?proj=50199,None
221,533,ChiCTR2000030939,ChiCTR,2020-03-18,2020-03-16,True,PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Preliminary evaluation of the safety and efficacy of oral LL-37 antiviral peptide (CAS001) in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Gene-derived protein,Gene-derived protein,10,http://www.chictr.org.cn/showproj.aspx?proj=51059,None
222,535,ChiCTR2000030933,ChiCTR,2020-03-18,2020-03-31,False,The First Affiliated Hospital of Nanchang University,Not Recruiting,Not Applicable,Interventional,China,Effectiveness of ''Liu-Zi-Jue'' combined with respiratory muscle training for respiratory function in novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,108,http://www.chictr.org.cn/showproj.aspx?proj=51184,None
223,538,ChiCTR2000030929,ChiCTR,2020-03-17,2020-03-17,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia (COVID-19)",ATMP,Plasma,Plasma,60,http://www.chictr.org.cn/showproj.aspx?proj=50696,None
224,539,ChiCTR2000030922,ChiCTR,2020-03-17,2020-02-26,True,Foshan First People's Hospital,Recruiting,Not Applicable,Interventional,China,"Prospective, open-label, controlled, multicenter cohort study of long-acting interferon plus ribavirin in patients with novel coronavirus pneumonia (COVID-19)",Drug,Interferon + Ribavirin vs. Umifenovir + Ribavirin,Interferon; Ribavirin; Umifenovir,30,http://www.chictr.org.cn/showproj.aspx?proj=51141,None
225,540,ChiCTR2000030920,ChiCTR,2020-03-17,2020-02-20,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"Evaluation of the effect of taking tricholoma matsutake, cannabis sativa capsule and dendrobium candidum to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19) during convalescence.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50476,None
226,542,ChiCTR2000030906,ChiCTR,2020-03-17,2020-03-10,True,Jiangsu Provincial Center for Disease Control and Prevention,Recruiting,Phase 1,Prevention,China,A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector),ATMP,Adenovirus vector,Adenovirus vector,108,http://www.chictr.org.cn/showproj.aspx?proj=51154,None
227,545,ChiCTR2000030539,ChiCTR,2020-03-06,2020-03-06,False,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Study for clinical oral characteristics of patients with novel coronavirus pneumonia (COVID-19) and Effect of 3% hydrogen peroxide gargle on the Intraoral novel coronavirus,Drug,Hydrogen peroxide,Hydrogen peroxide,40,http://www.chictr.org.cn/showproj.aspx?proj=50660,None
228,547,ChiCTR2000030254,ChiCTR,2020-02-26,2020-02-20,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"the Efficacy and Safety of Favipiravir for novel coronavirusâ€“infected pneumonia: A multicenter, randomized, open, positive, parallel-controlled clinical study",Drug,Favipiravir vs. Umifenovir,Favipiravir; Umifenovir,240,http://www.chictr.org.cn/showproj.aspx?proj=50137,None
229,552,ChiCTR2000029868,ChiCTR,2020-02-15,2020-02-11,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Phase 4,Interventional,China,"Hydroxychloroquine treating novel coronavirus pneumonia (COVID-19): a randomized controlled, open label, multicenter trial",Drug,Hydroxychloroquine,Hydroxychloroquine,360,http://www.chictr.org.cn/showproj.aspx?proj=49524,None
230,554,ChiCTR2000029658,ChiCTR,2020-02-09,2020-02-10,False,Central Theater General Hospital of PLA,No Status Given,Not Applicable,Interventional,China,Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation in patients with critical novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,60,http://www.chictr.org.cn/showproj.aspx?proj=49074,None
231,555,ChiCTR2000029573,ChiCTR,2020-02-05,2020-02-06,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection",ATMP,Gene-derived protein,Gene-derived protein,480,http://www.chictr.org.cn/showproj.aspx?proj=49065,None
232,556,ChiCTR2000029496,ChiCTR,2020-02-03,2020-01-29,True,The First Hospital of Changsha; The Second Xiangya Hospital of Central South University,Recruiting,Phase 4,Interventional,China,"A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)",ATMP,Gene-derived protein,Gene-derived protein,90,http://www.chictr.org.cn/showproj.aspx?proj=48809,None
233,557,EUCTR2020-000890-25-FR,EU Clinical Trials Register,2020-03-10,2020-05-03,False,Fondation Méditerranée Infection (FMI) - IHU Méditerranée Infection,Authorised,Phase 3,Interventional,France,Hydroxychloroquine as a treatment for coronavirus disease COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,25,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000890-25,None
234,567,ChiCTR2000031328,ChiCTR,2020-03-27,2020-03-13,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The protective effect of sleep psychology and music therapy of novel coronavirus pneumonia (COVID-19) mild and moderate type patients,Other,Sleep aids,Sleep aids,60,http://www.chictr.org.cn/showproj.aspx?proj=51425,None
235,569,ChiCTR2000031319,ChiCTR,2020-03-27,2020-04-01,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe novel coronavirus pneumonia (COVID-19) patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.chictr.org.cn/showproj.aspx?proj=51647,None
236,573,ChiCTR2000031272,ChiCTR,2020-03-26,2020-02-18,True,China European International Business School (CEIBS),Not Recruiting,Not Applicable,Interventional,China,The effectiveness of mindfulness intervention in improving people's psychological and physical well-being during novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),Psychological,Psychological,110,http://www.chictr.org.cn/showproj.aspx?proj=51455,None
237,574,ChiCTR2000031271,ChiCTR,2020-03-26,2020-04-01,False,The Third Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Interventional,China,Metabolic abnormalities and rearrangement reversal treatment of patient with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=51194,None
238,582,ChiCTR2000031204,ChiCTR,2020-03-24,2020-01-30,True,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine,Chloroquine,300,http://www.chictr.org.cn/showproj.aspx?proj=49420,None
239,583,ChiCTR2000031203,ChiCTR,2020-03-24,2020-03-16,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Study for the effect of Moxibustion Guidance and Intervention based on internet for the discharged patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,28,http://www.chictr.org.cn/showproj.aspx?proj=51030,None
240,585,ChiCTR2000031196,ChiCTR,2020-03-23,2020-01-10,True,The Fifth Medical Center of PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and optimization of antiviral therapy for novel coronavirus pneumonia (COVID-19) patients,Drug,Lopinavir/ritonavir + Interferon,Lopinavir/ritonavir; Interferon,90,http://www.chictr.org.cn/showproj.aspx?proj=51112,None
241,588,ChiCTR2000030988,ChiCTR,2020-03-20,2020-03-23,False,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A RCT for Hua-Shi Bai-Du granules in patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,204,http://www.chictr.org.cn/showproj.aspx?proj=51317,None
242,590,ChiCTR2000030940,ChiCTR,2020-03-18,2020-02-01,True,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for ''Bai-Du Duan Fang'' application on the acupoint in the treatment of general type novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,76,http://www.chictr.org.cn/showproj.aspx?proj=51061,None
243,592,ChiCTR2000030937,ChiCTR,2020-03-18,2020-03-19,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for Gu-Shen Ding-Chuan-Wan in the treatment of patients with novel coronavirus pneumonia (COVID-19) at recovery phase with Fei-Pi-Qi-Xu Zhen",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,144,http://www.chictr.org.cn/showproj.aspx?proj=51240,None
244,593,ChiCTR2000030936,ChiCTR,2020-03-18,2020-03-10,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A real-world study for the Chinese medicines ''Xinguan 2'' and ''Xinguan 3'' in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,2840,http://www.chictr.org.cn/showproj.aspx?proj=51100,None
245,594,ChiCTR2000030923,ChiCTR,2020-03-17,2020-02-15,True,Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The treatment and diagnosis plan of integrated traditional Chinese and Western medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=51139,None
246,596,ChiCTR2000030704,ChiCTR,2020-03-10,2020-02-10,True,The First People's Hospital of Jiangxia District,No Status Given,Phase 4,Interventional,China,Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=50778,None
247,598,ChiCTR2000030288,ChiCTR,2020-02-27,2020-02-27,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,204,http://www.chictr.org.cn/showproj.aspx?proj=50202,None
248,600,ChiCTR2000030198,ChiCTR,2020-02-25,2020-02-24,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical research of pulmonary rehabilitation in survivors due to severe or critial novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,60,http://www.chictr.org.cn/showproj.aspx?proj=50066,None
249,601,ChiCTR2000030028,ChiCTR,2020-02-20,2020-02-24,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical comparative study of PD-1 mAb in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,PD1,PD1,40,http://www.chictr.org.cn/showproj.aspx?proj=49840,None
250,603,EUCTR2020-000919-69-NL,EU Clinical Trials Register,2020-03-17,2020-03-17,False,UMC Utrecht,Authorised,Phase 4,Interventional,Netherlands,Reducing health care workers absenteeism in Coronavirus 2019 pandemic nu enhancement of the immune system through vaccination with Bacillus Calmette-GuÃ©rin,ATMP,Vaccine,Vaccine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000919-69,None
251,605,ChiCTR2000031639,ChiCTR,2020-04-05,2020-03-27,True,Peking University Sixth Hospital,Not Recruiting,Not Applicable,Interventional,China,Effects of a single session internet-delivered cognitive behavioral therapy for Acute Insomnia during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,192,http://www.chictr.org.cn/showproj.aspx?proj=51119,None
252,606,ChiCTR2000031630,ChiCTR,2020-04-05,2020-02-17,True,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Celebrex in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Celecoxib,Celecoxib,60,http://www.chictr.org.cn/showproj.aspx?proj=50474,None
253,610,ChiCTR2000031540,ChiCTR,2020-04-03,2020-02-05,True,Affiliated Hospital of Zunyi Medical University,Recruiting,Phase 1,Interventional,China,Study for clinical effect of rehabilitation nursing program for patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.chictr.org.cn/showproj.aspx?proj=51684,None
254,614,ChiCTR2000031503,ChiCTR,2020-04-03,2020-04-01,True,Shanghai Sixth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Application of non-invasive multichannel cardiopulmonary monitoring cloud management platform in patients with Novel Coronavirus Pneumonia (COVID-19),Other (device),Cardiopulmonary monitoring,Cardiopulmonary monitoring,100,http://www.chictr.org.cn/showproj.aspx?proj=51911,None
255,617,ChiCTR2000031494,ChiCTR,2020-04-02,2020-02-01,True,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Phase 1,Interventional,China,Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),36,http://www.chictr.org.cn/showproj.aspx?proj=51904,None
256,619,ChiCTR2000031454,ChiCTR,2020-04-01,2020-01-25,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,Clinical study for prevention and treatment of digestive tract lesions caused by novel coronavirus pneumonia (COVID-19),Drug,Rabeprazole + chloroquine vs. lopinavir + rabeprazole,Rabeprazole; chloroquine; lopinavir; rabeprazole,56,http://www.chictr.org.cn/showproj.aspx?proj=51693,None
257,620,ChiCTR2000031453,ChiCTR,2020-04-01,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 4,Interventional,China,"Efficacy and safety of Nintedanib esilate soft capsules in the treatment of pulmonary fibrosis in healed moderate to severe patients of novel coronavirus pneumonia (COVID-19): a single-center, randomized, placebo-controlled trial",Drug,Nintedanib,Nintedanib,80,http://www.chictr.org.cn/showproj.aspx?proj=51859,None
258,624,ChiCTR2000031430,ChiCTR,2020-03-31,2020-03-20,True,The Fifth Medical Center of PLA General Hospital,Recruiting,Phase 2,Interventional,China,Clinical study of human umbilical cord mesenchymal stem cells in the treatment of novel coronavirus pneumonia (COVID-19) induced pulmonary fibrosis,ATMP,Cells (mesenchymal),Cells (mesenchymal),200,http://www.chictr.org.cn/showproj.aspx?proj=49254,None
259,630,ACTRN12620000443998,ANZCTR,2020-04-06,2020-01-05,True,Flinders Medical Centre,Not Recruiting,Not Applicable,Interventional,Australia,Home rehabilitation for people with COVID-19: Implementing telehealth approaches to care,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,58,https://anzctr.org.au/ACTRN12620000443998.aspx,None
260,632,ACTRN12620000447954,ANZCTR,2020-04-06,2020-03-31,True,Royal Brisbane & Women's Hospital,Recruiting,Not Applicable,Interventional,Australia,Use of therapeutic drug monitoring (TDM) to optimise oral/enteral hydroxychloroquine dosing in critically ill patients with COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,150,https://anzctr.org.au/ACTRN12620000447954.aspx,None
261,637,ChiCTR2000031834,ChiCTR,2020-04-11,2020-04-20,False,Jiangsu Province Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for the effect of remote monitoring exercise rehabilitation on the discharged patients with novel coronavirus pneumonia (COVID-19),Telehealth,Telehealth,Telehealth,120,http://www.chictr.org.cn/showproj.aspx?proj=52216,None
262,641,ChiCTR2000031781,ChiCTR,2020-04-10,2020-04-09,True,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 2,Interventional,China,"A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)",ATMP,Vaccine,Vaccine,500,http://www.chictr.org.cn/showproj.aspx?proj=52006,None
263,643,ChiCTR2000031772,ChiCTR,2020-04-09,2020-01-10,True,Fujian Provincial Maternity and Child Health Hospital,Recruiting,Not Applicable,Interventional,No Country Given,Impact of WeChat-based parenting education for children with autism spectrum disorder and their mothers during the epidemic of Coronavirus disease 2019 (COVID-19),Other,Health Education,Health Education,105,http://www.chictr.org.cn/showproj.aspx?proj=52165,None
264,647,ChiCTR2000031735,ChiCTR,2020-04-08,2020-03-01,True,Huzhou Central Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical study for natural killer (NK) cells from umbilical cord blood in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (NK),Cells (NK),20,http://www.chictr.org.cn/showproj.aspx?proj=50613,None
265,652,ChiCTR2000030750,ChiCTR,2020-03-13,2020-03-01,True,Shenzhen Third People's Hospital,Not Recruiting,Phase 1/Phase 2,Interventional,China,A clinical study for effectiveness and safety evaluation for recombinant chimeric COVID-19 epitope DC vaccine in the treatment of novel coronavirus pneumonia,ATMP,Vaccine,Vaccine,120,http://www.chictr.org.cn/showproj.aspx?proj=50928,None
266,656,EUCTR2020-001301-23-FR,EU Clinical Trials Register,2020-03-26,2020-10-04,False,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 3,Interventional,France,Efficacy of Addition of Naproxen for COVID-19 Infection / Enacovid Study,Drug,Naproxen,Naproxen,584,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001301-23,None
267,657,EUCTR2020-001381-11-FR,EU Clinical Trials Register,2020-03-29,2020-08-04,False,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 3,Interventional,France,COVID-19 - ACORES-2 study: ACE inhibitors or ARBs discontinuation for Clinical Outcome Risk reduction in patients hospitalized for the Endemic Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,554,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001381-11,None
268,658,EUCTR2020-001442-19-ES,EU Clinical Trials Register,2020-04-03,2020-02-04,True,Institut de Recerca Hospital de la Santa Creu i Sant Pau,Authorised,Phase 2,Interventional,Spain,"Clinical trial of combined use of hydroxychloroquine, azithromycin, and tocilizumab for the treatment of COVID-19",Drug,Tocilizumab + hydroxychloroquine + azithromycin,Tocilizumab; hydroxychloroquine; azithromycin,276,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001442-19,None
269,659,EUCTR2020-001385-11-ES,EU Clinical Trials Register,2020-04-03,2020-03-28,True,Plan Nacional sobre el Sida (PNS),Authorised,Phase 3,Interventional,Spain,EPICOS - Experimental clinical trial for PreventIon or COronavirus in health Care professionalS,Drug (Chemoprophylaxis),Emtricitabine/tenofovir + hydroxychloroquine,Emtricitabine; tenofovir; hydroxychloroquine,4000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001385-11,None
270,660,EUCTR2020-001409-21-ES,EU Clinical Trials Register,2020-04-03,2020-01-04,True,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Authorised,Phase 2,Interventional,Spain,DEFIBROTIDE AS PREVENTION AND TREATMENT OF RESPIRATORY DISTRESS AND CYTOKINE RELEASE SYNDROME OF COVID-19,Drug,Defibrotide,Defibrotide,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001409-21,None
271,661,EUCTR2020-001492-33-FR,EU Clinical Trials Register,2020-04-01,2020-10-04,False,L'Hôpital Fondation Adolphe de Rothschild,Authorised,Phase 3,Interventional,France,Interest in the administration of Dornase alpha aerosol in Acute Respiratory Distress Syndrome secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19,Drug,Dornase alfa,Dornase alfa,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001492-33,None
272,662,EUCTR2020-001194-69-ES,EU Clinical Trials Register,2020-04-07,2020-03-30,True,Félix Gutiérrez-Rodero,Authorised,Phase 3,Interventional,Spain,Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19),Drug (Chemoprophylaxis),Mefloquine,Mefloquine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001194-69,None
273,663,EUCTR2020-001565-37-ES,EU Clinical Trials Register,2020-04-07,2020-03-04,True,ISGlobal,Authorised,Phase 3,Interventional,Spain,Prevention of novel Coronavirus infection with hydroxychloroquine,Drug,Hydroxychloroquine,Hydroxychloroquine,440,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001565-37,None
274,664,EUCTR2020-001421-31-ES,EU Clinical Trials Register,2020-04-07,2020-06-04,False,Sociedad Espaola de Farmacia Hospitalaria,Authorised,Phase 4,Interventional,Spain,Clinical trial for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals.,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1530,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001421-31,None
275,665,EUCTR2020-001606-33-ES,EU Clinical Trials Register,2020-04-07,2020-07-04,False,Instituto Investigacin Sanitario Biocruces Bizkaia,Authorised,Phase 3,Interventional,Spain,Randomized clinical trial to evaluate the efficacy of hydroxychloroquine associated or not with azithromycin as a treatment for COVID-19 infection,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,Hydroxychloroquine; azithromycin,132,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001606-33,None
276,666,EUCTR2020-001307-16-ES,EU Clinical Trials Register,2020-04-08,2020-01-04,True,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Authorised,Phase 3,Interventional,Spain,Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to coronavirus infection.,Drug,Corticosteroids,Methylprednisolone,104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001307-16,None
277,667,NCT04337216,ClinicalTrials.gov,2020-04-01,2020-05-01,False,Virginia Commonwealth University,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,10,https://clinicaltrials.gov/show/NCT04337216,None
278,668,NCT04343677,ClinicalTrials.gov,2020-04-09,2020-04-01,True,United States Department of Defense,Not Recruiting,Phase 2,Interventional,United States,Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1450,https://clinicaltrials.gov/show/NCT04343677,None
279,669,ACTRN12620000468921,ANZCTR,2020-04-14,2020-04-20,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Covid 19-Related Anxiety and Depression,Other (psych),Psychological,Psychological,140,https://anzctr.org.au/ACTRN12620000468921.aspx,None
280,670,ACTRN12620000472976,ANZCTR,2020-04-15,2020-04-27,False,Dr. Simon Joosten,Not Recruiting,Not Applicable,Interventional,Australia,Adapting the Decathlon Group EasybreatheÂ® snorkelling face mask for the safer administration of oxygen and/or continuous positive airway pressure and in the intra/interhospital transportation of patients with proven or suspected COVID 19 infection.,Other (device),Masks,Masks,100,https://anzctr.org.au/ACTRN12620000472976.aspx,None
281,672,ACTRN12620000470998,ANZCTR,2020-04-14,2020-04-20,False,Firebrick Pharma Pty Ltd,Not Recruiting,Not Applicable,Interventional,Australia,Virucidal pilot study of NasodineÂ® Antiseptic Nasal Spray (povidone-iodine 0.5%) in people with COVID-19 and confirmed nasal shedding of SARS-CoV-2 virus.,Drug,Povidone Iodine,Povidone Iodine,20,https://anzctr.org.au/ACTRN12620000470998.aspx,None
282,673,ACTRN12620000478910,ANZCTR,2020-04-16,2020-01-06,True,Monash Health,Not Recruiting,Not Applicable,Interventional,Australia,Cord Blood Therapy to prevent progression of COVID-19 related pneumonia,ATMP,Cells (stem cells),Cells (stem cells),24,https://anzctr.org.au/ACTRN12620000478910.aspx,None
283,674,ACTRN12620000480987,ANZCTR,2020-04-16,2020-01-06,True,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Stress-reduction Using Probiotics to Promote Ongoing Resilience Throughout COVID-19 for Healthcare Workers (SUPPORT COVID-19 Healthcare Workers),Supplement,Probiotics,Probiotics,507,https://anzctr.org.au/ACTRN12620000480987.aspx,None
284,675,ChiCTR2000032098,ChiCTR,2020-04-19,2020-01-20,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=52477,None
285,678,ChiCTR2000032013,ChiCTR,2020-04-17,2020-02-02,True,The Fourth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,The prevention and treatment strategy of the protective respirator related facial pressure injuries among healthcare professionals fighting novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,8,http://www.chictr.org.cn/showproj.aspx?proj=52483,None
286,679,ChiCTR2000032011,ChiCTR,2020-04-17,2020-04-17,False,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Effecacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19),Drug,Oxygen,Oxygen,45,http://www.chictr.org.cn/showproj.aspx?proj=52142,None
287,684,ChiCTR2000031944,ChiCTR,2020-04-15,2020-04-16,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Chinese Herbal Tea in the Prevention of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,2000,http://www.chictr.org.cn/showproj.aspx?proj=52414,None
288,686,ChiCTR2000031888,ChiCTR,2020-04-13,2020-02-11,True,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,A medical records based study for ''Guangdong Pneumonia NO.1'' in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=52106,None
289,689,ChiCTR2000029976,ChiCTR,2020-02-18,2020-02-18,False,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The effect of Gymnastic Qigong Yangfeifang on functional recovery and quality of life in patients with mild novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49631,None
290,690,ChiCTR2000029434,ChiCTR,2020-02-01,2020-02-01,False,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule /Granule in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=48889,None
291,691,ChiCTR2000029433,ChiCTR,2020-02-01,2020-02-01,False,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the treatment of suspected novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=48898,None
292,692,EUCTR2020-001156-18-ES,EU Clinical Trials Register,2020-04-03,2020-03-27,True,Fundación para la investigación Biomédica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 3,Interventional,Spain,Efficacy of different treatments in patients infected with COVID-19,Drug,"Dolquine, Azithromycin, Lopinavir/ritonavir",Dolquine; Azithromycin; Lopinavir/ritonavir,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001156-18,None
293,694,EUCTR2020-001262-11-ES,EU Clinical Trials Register,2020-04-13,2020-09-04,True,Instituto de Investigación Sanitaria Fundación Jiménez Díaz,Authorised,Phase 4,Interventional,Spain,Clinical trial to assess the efficacy and safety of cyclosporin A treatment associated with standard treatment versus standard treatment only in hospitalized patients with confirmed coronavirus infection,Drug,Cyclosporine A vs. lopinavir/ritonavir + interferon beta + darunavir + spironolactone + tocilizumab + chloroquine,Cyclosporine; lopinavir/ritonavir; interferon beta; darunavir; spironolactone; tocilizumab; chloroquine,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001262-11,NCT04392531
294,695,EUCTR2020-001290-74-ES,EU Clinical Trials Register,2020-04-13,2020-11-04,False,Consorci Parc de Salut Mar (PSMAR),Authorised,Phase 3,Interventional,Spain,Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care,Drug,Sarilumab vs. Hydroxychloroquine + Azithromycin,Sarilumab; Hydroxychloroquine; Azithromycin,216,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001290-74,None
295,696,EUCTR2020-001406-27-FR,EU Clinical Trials Register,2020-04-03,2020-07-04,False,"University Hospital, Montpellier",Authorised,Phase 3,Interventional,France,efficacy and safety of a bitherapy by hydroxychloroquine + azythromycin vs monotherapy by hydroxychoroquine in adult patients with documentated infection by covid19,Drug,Hydroxychloroquine vs. Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001406-27,None
296,697,EUCTR2020-001321-31-ES,EU Clinical Trials Register,2020-04-13,2020-11-04,False,Hospital Universitario de Fuenlabrada,Authorised,Phase 2,Interventional,Spain,Clinical trial phase II to evaluate the efficacy of  3 types of treatment in patients with pneumonia by COVID-19,Drug,Hydroxychloroquine + baricitinib or imatinib or lopinavir/ritonavir,Hydroxychloroquine; baricitinib; imatinib; lopinavir/ritonavir,165,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001321-31,None
297,698,EUCTR2020-001437-12-ES,EU Clinical Trials Register,2020-04-13,2020-09-04,False,Vall d'Hebron Research Institute (VHIR),Authorised,Phase 4,Interventional,Spain,"Random, controlled, open, one-site clinical trial in adult patients with COVID-19 severe pneumonia treated with immunomodulatory drugs",Drug,"Cyclosporine, Tocilizumab",Cyclosporine; Tocilizumab,290,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001437-12,None
298,699,EUCTR2020-001689-12-ES,EU Clinical Trials Register,2020-04-13,2020-11-04,False,Montreal Heart Institute,Authorised,Phase 3,Interventional,Spain,COLCHICINA TEST IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),Drug,Colchicine,Colchicine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12,None
299,700,EUCTR2020-001379-34-ES,EU Clinical Trials Register,2020-04-14,2020-04-14,False,Instituto de Investigación Sanitaria INCLIVA,Authorised,Phase 4,Interventional,Spain,Sedation with sevoflurane versus propofol in patients with Acute Respiratory Distress Syndrome caused by COVID-19 infection,Drug,Sevoflurane vs. Propofol,Sevoflurane; Propofol,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001379-34,None
300,701,EUCTR2020-001511-25-ES,EU Clinical Trials Register,2020-04-15,2020-04-14,True,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Authorised,Phase 3,Interventional,Spain,Randomized open-blind controlled trial to study the benefit of Colchicine in Patients with COVID-19,Drug,Colchicine,Colchicine,102,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001511-25,None
301,702,EUCTR2020-001266-11-ES,EU Clinical Trials Register,2020-04-16,2020-04-16,False,Fundación Instituto de Investigación Sanitaria Fundación Jimenez Diaz,Authorised,Phase 2,Interventional,Spain,Clinical trial of administration of MSC to patients with respiratory distress type COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001266-11,None
302,703,IRCT20200310046736N1,IRCT,2020-04-01,2020-04-01,False,Ahvaz University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of The Therapeutic Effect of Convalescent Plasma and Plasma-derived Immunoglobulin-enriched solution on COVID-19 Patients,ATMP,Plasma,Plasma,45,http://en.irct.ir/trial/46424,None
303,704,IRCT20100228003449N30,IRCT,2020-03-22,2020-03-15,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Combination therapy in COVID 19,Drug,Hydroxychloroquine +  Oseltamivir + Lopinavir/ritonavir or Atazanavir/ritonavir ,Hydroxychloroquine; Oseltamivir; Lopinavir/ritonavir; Lopinavir/atazanavir,50,http://en.irct.ir/trial/46536,None
304,705,IRCT20100228003449N28,IRCT,2020-03-19,2020-03-15,True,Tehran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon in treatment of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,30,http://en.irct.ir/trial/46538,None
305,706,IRCT20100228003449N27,IRCT,2020-03-16,2020-03-15,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon ÃŸ in treatment  of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,30,http://en.irct.ir/trial/46545,None
306,707,IRCT20200316046792N1,IRCT,2020-03-17,2020-03-16,True,Iran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of herbal syrup and solution in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://en.irct.ir/trial/46554,None
307,708,IRCT20151227025726N12,IRCT,2020-03-23,2020-03-03,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluting the therapeutic and adverse effects of Interferon beta 1-a in patients with novel Coronavirus(COVID-19),Drug,Interferon beta + hydroxychloroquine + osletamivir + lopinavir/ritonavir,Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,20,http://en.irct.ir/trial/46561,None
308,709,IRCT20100228003449N29,IRCT,2020-03-19,2020-03-18,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Effect of sofosbuvir/ ledipasvir on COVID-19,Drug,Sofosbuvir + Ledipasvir vs. Hydroxychloroquine + Oseltamivir + Lopinavir/ritonavir,Sofosbuvir; Ledipasvir; Hydroxychloroquine; Oseltamivir; Lopinavir/ritonavir,50,http://en.irct.ir/trial/46567,None
309,710,IRCT20200317046797N1,IRCT,2020-04-03,2020-04-08,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Camostate mesylate on the outcome of Coronavirus (COVID-19)-induced pneumonia,Drug,Camostat Mesilate,Camostat Mesilate,40,http://en.irct.ir/trial/46573,None
310,711,IRCT20160625028622N1,IRCT,2020-03-22,2020-03-19,True,Qazvin University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of Noscapine  on clinical and pulmonary manifestations of COVID-19 patients,Drug,Noscapine,Noscapine,125,http://en.irct.ir/trial/46576,None
311,712,IRCT20120826010664N6,IRCT,2020-04-05,2020-03-29,True,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of hydroxychloroquine on prevention of covid-19 virus,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,310,http://en.irct.ir/trial/46603,None
312,713,IRCT20131113015393N6,IRCT,2020-03-30,2020-02-28,True,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Benson Relaxation on Quality of Life and job stress  in nurses,Other (psych),Psychological,Psychological,62,http://en.irct.ir/trial/46609,None
313,714,IRCT20140528017891N8,IRCT,2020-03-28,2020-03-24,True,MOM Research and Innovation Center,Not Recruiting,Phase 3,Interventional,Iran,The effect of stem cell transplantation in the treatment of COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,http://en.irct.ir/trial/46623,None
314,715,IRCT20200321046828N1,IRCT,2020-03-26,2020-03-22,True,RNA Biotechnology,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Remedy of human coroviruse infection with genetic nanocomposit drug,Drug,Unspecified,Unspecified,30,http://en.irct.ir/trial/46624,None
315,716,IRCT20190727044343N1,IRCT,2020-04-05,2020-03-16,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,?Effect of febuxostat against coronavirus,Drug,Acetaminophen + Febuxostat vs.  Acetaminophen + Hydroxychloroquine,Febuxostat; Acetaminophen; Hydroxychloroquine,60,http://en.irct.ir/trial/46629,None
316,717,IRCT20140617018126N2,IRCT,2020-03-29,2020-04-03,False,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Persian Medicine Products in Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46637,None
317,718,IRCT20150914024017N1,IRCT,2020-04-03,2020-03-27,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,ReciGen for treatment of Covid-19,Drug,Interferon beta,Interferon beta,40,http://en.irct.ir/trial/46665,None
318,719,IRCT20140911019125N6,IRCT,2020-04-04,2020-04-04,False,Kerman University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of  corona disease,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,http://en.irct.ir/trial/46668,None
319,720,IRCT20160316027081N1,IRCT,2020-03-31,2020-03-23,True,Artesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Licorice in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,374,http://en.irct.ir/trial/46678,None
320,721,IRCT20151227025726N13,IRCT,2020-03-26,2020-03-11,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the Efficacy and Safety of Tocilizumab in COVID-19,Drug,Tocilizumab + hydroxychloroquine + oseltamivir + lopinavir/ritonavir,Tocilizumab; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,40,http://en.irct.ir/trial/46681,None
321,722,IRCT20160310026998N11,IRCT,2020-03-27,2020-03-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of metformin in COVID-19  symptom improvement and death,Drug,Metformin,Metformin,200,http://en.irct.ir/trial/46690,None
322,723,IRCT20160310026998N10,IRCT,2020-03-26,2020-03-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Study of the metformin effect on the survival and recovery rate of patients with COVID-19,Drug,Metformin,Metformin,200,http://en.irct.ir/trial/46693,None
323,724,IRCT20180610040049N3,IRCT,2020-03-29,2020-04-08,False,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Trachyspermum copticum syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46697,None
324,725,IRCT20200324046851N1,IRCT,2020-04-03,2020-03-29,True,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of nano curcumin supplementation on the reduction of inflammation and mortality in patients with coronavirus 2019 admitted to ICU ward of imam Reza hospital in Tabriz,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,86,http://en.irct.ir/trial/46712,None
325,726,IRCT20200324046847N1,IRCT,2020-03-31,2020-03-28,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of patients with Corona virus infection,Drug,Septimeb,Septimeb,30,http://en.irct.ir/trial/46720,None
326,727,IRCT20140907019073N4,IRCT,2020-03-29,2020-04-03,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Ipecac homeopathic remedy  in control of Clinical manifestations of COVID-19,Other,Homeopathy,Homeopathy,60,http://en.irct.ir/trial/46736,None
327,728,IRCT20200325046860N1,IRCT,2020-03-30,2020-03-15,True,Darmanara Co.,Recruiting,Not Applicable,Interventional,Iran,Convalescent Plasma therapy for COVID-19 Patients,ATMP,Plasma,Plasma,200,http://en.irct.ir/trial/46759,None
328,729,IRCT20101219005416N2,IRCT,2020-04-03,2020-03-24,True,Kerman University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of  the effect of traditional  Iranian medicine product on improvement of clinical menifestation of COVID -19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/46775,None
329,730,IRCT20200317046797N2,IRCT,2020-04-03,2020-04-08,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Fingolimod for treatment of COVID-19-induced cytokine storm,Drug,Fingolimod,Fingolimod,40,http://en.irct.ir/trial/46786,None
330,731,IRCT20200325046860N2,IRCT,2020-04-01,2020-03-28,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 1,Interventional,Iran,Mesenchymal Stem Cell therapy in COVID19,ATMP,Cells (mesenchymal),Cells (mesenchymal),5,http://en.irct.ir/trial/46789,None
331,732,IRCT20170611034452N11,IRCT,2020-03-31,2020-03-30,True,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the effectiveness of psychological interventions on mental health,Other (psych),Psychological,Psychological,60,http://en.irct.ir/trial/46803,None
332,733,IRCT20190917044805N2,IRCT,2020-03-31,2020-04-03,False,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of High-dose Vitamin C on COVID-19,Drug,Vitamin C,Vitamin C,60,http://en.irct.ir/trial/46804,None
333,734,IRCT20120225009124N4,IRCT,2020-04-02,2020-04-18,False,Gorgan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Efficacy of dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19",Drug (+ ATMP),"Intreventional: Dexamethason + Immunoglobulin vs. Dexamethason + Immunoglobulin + interferon beta

All Arms: Hydroxychloroquine + antiviral ",Dexamethason; Immunoglobulin; interferon beta; Hydroxychloroquine,105,http://en.irct.ir/trial/46810,None
334,735,IRCT20180802040678N4,IRCT,2020-04-01,2020-03-31,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effects of Losartan in patients with corona virus disease 2019,Drug,Losartan vs. amlodipine,Losartan; amlodipine,100,http://en.irct.ir/trial/46824,None
335,736,IRCT20150704023055N2,IRCT,2020-04-03,2020-03-24,True,Babol University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Hemoperfusion in patients with COVID-19,Other (device),Hemoperfusion,Hemoperfusion,10,http://en.irct.ir/trial/46837,None
336,737,IRCT20200319046819N1,IRCT,2020-04-04,2020-04-02,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,supplementation in COVID-19,Drug,Vitamin A + Vitamin D + Vitamin C + Vitamin B,Vitamin A; Vitamin D; Vitamin C; Vitamin B,60,http://en.irct.ir/trial/46838,None
337,742,ACTRN12620000492954,ANZCTR,2020-04-20,2020-01-05,True,University of New South Wales,Not Recruiting,Not Applicable,Interventional,Australia,A Facebook delivered physical activity focused group lifestyle intervention for older adults during the COVID-19 pandemic,Other (exercise),Exercise,Exercise,20,https://anzctr.org.au/ACTRN12620000492954.aspx,None
338,743,ACTRN12620000482965,ANZCTR,2020-04-17,2020-03-17,True,Juan Pedro Fuentes García,Not Recruiting,Not Applicable,Interventional,Spain,"Impact of high intensity interval training and aerobic training on stress, depression symptoms, anxiety and resilience in self-isolated people during the COVID-19 health emergency in Spain",Other (exercise),Exercise,Exercise,34,https://anzctr.org.au/ACTRN12620000482965.aspx,None
339,747,ChiCTR2000032400,ChiCTR,2020-04-27,2020-01-01,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Not Applicable,Interventional,China,"the efficacy and safety of high dose intravenous vitamin C in the treatment of novel coronavirus pneumonia (COVID-19): a prospective, randomize, controlled trial",Drug,Vitamin C,Vitamin C,120,http://www.chictr.org.cn/showproj.aspx?proj=52958,None
340,748,ChiCTR2000032399,ChiCTR,2020-04-27,2020-04-20,True,Xiaogan Traditional Chinese Medicine Hospital,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiaoyao capsule in the improvement of sleep mood disorder of convalescence patients of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52942,None
341,750,ChiCTR2000032367,ChiCTR,2020-04-26,2020-02-19,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,186,http://www.chictr.org.cn/showproj.aspx?proj=52972,None
342,751,ChiCTR2000032346,ChiCTR,2020-04-26,2020-04-21,True,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"Lingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of novel coronavirus pneumonia (COVID-19): A Prospective, Randomized Controlled Trial",Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=52692,None
343,752,ChiCTR2000032314,ChiCTR,2020-04-25,2020-03-01,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,A randomized clinical trial for the efficacy and safety of Aliskiren and Nifedipine in novel coronavirus pneumonia (COVID-19) patients with hypertension,Drug,Aliskiren vs. Nifedipine,Aliskiren; Nifedipine,242,http://www.chictr.org.cn/showproj.aspx?proj=52867,None
344,753,ChiCTR2000032313,ChiCTR,2020-04-25,2020-05-01,False,"Beijing University of Chinese Medicine, Third Affiliated Hospital",Not Recruiting,Not Applicable,Interventional,China,Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=52916,None
345,754,ChiCTR2000032242,ChiCTR,2020-04-24,2020-04-24,False,Mudanjiang Kang'an Hospital,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of oral kolimycin in the treatment of patients with new coronavirus pneumonia (CoVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,350,http://www.chictr.org.cn/showproj.aspx?proj=52824,None
346,756,ChiCTR2000032237,ChiCTR,2020-04-23,2020-04-01,True,Ezhou Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,No Country Given,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiang-Sha-Liu-Jun Pill in the treatment of novel coronavirus pneumonia (COVID-19) decline in digestive function during convalescence",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52699,None
347,758,ChiCTR2000032214,ChiCTR,2020-04-23,2020-05-01,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Screening of proprietary Chinese medicines in convalescent rehabilitation of novel coronavirus pneumonia (COVID-19) convalescent patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52781,None
348,760,ChiCTR2000032205,ChiCTR,2020-04-23,2020-04-15,True,Wuhan Hospital Of Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,"A multicenter randomized, double-blind, placebo-controlled trial for Sheng-Mai-Yin for improvement of the pulmonary heart function related symptoms of convalescence patients of new coronavirus pneumonia",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52662,None
349,766,EUCTR2020-001329-30-AT,EU Clinical Trials Register,2020-04-03,2020-09-04,False,Massachusetts General Hospital,Authorised,Phase 4,Interventional,"Austria, China, United States",Therapy with Inhaled Nitric Oxide for Patients Infected with Coronavirus Suffering form Lung Failure,Drug,Nitric oxide,Nitric oxide,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001329-30,None
350,767,EUCTR2020-001527-14-NL,EU Clinical Trials Register,2020-04-06,2020-04-21,False,Erasmus MC,Authorised,Phase 4,Interventional,Netherlands,COVID-19: addition of azithromycin to chloroquine treatment,Drug,Chloroquine + Azithromycin,Chloroquine; Azithromycin,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001527-14,None
351,769,EUCTR2020-001659-42-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Fundación para la Investigación Biomédica de Córdoba,Authorised,Phase 2,Interventional,Spain,Study of antithrombin as prophylaxis of acute respiratory disease in patients with COVID-19,Drug (Chemoprophylaxis),Antithrombin,Antithrombin,46,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001659-42,None
352,770,EUCTR2020-001440-26-ES,EU Clinical Trials Register,2020-04-20,2020-04-19,True,Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI),Authorised,Phase 3,Interventional,Spain,Study for the prevention of COVID-19 infection in healthcare personnel,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,184,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001440-26,None
353,771,EUCTR2020-001459-42-DK,EU Clinical Trials Register,2020-04-14,2020-04-22,False,Zealand University Hospital,Authorised,Phase 2,Interventional,Denmark,"Ruxolitinib Treatment in Patients with Severe COVID-19 Infection. A Danish Safety and Efficacy Study.
",Drug,Ruxolitinib,Ruxolitinib,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001459-42,None
354,772,EUCTR2020-001500-41-BE,EU Clinical Trials Register,2020-04-04,2020-03-04,True,"University Hospital, Ghent",Authorised,Phase 3,Interventional,Belgium,Treatment of COVID-19 patients with anti-interleukin drugs,Drug,Anakinra or tocilizumab or siltuximab,Anakinra; tocilizumab; siltuximab,342,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001500-41,None
355,775,ACTRN12620000516987,ANZCTR,2020-04-27,2020-02-06,True,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing a wellbeing app to support wellbeing during the Covid-19 pandemic,Other (psych),Psychological,Psychological,90,https://anzctr.org.au/ACTRN12620000516987.aspx,None
356,777,ISRCTN13311119,ISRCTN,2020-04-24,2020-04-30,False,Eminentlabs GmbH,Recruiting,Phase 2,Interventional,India,START (Siddha Treatment Accelerating Recovery from SARS-CoV-2 Test) trial of Siddha treatment for patients with novel coronavirus infectious disease (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,116,http://isrctn.com/ISRCTN13311119,None
357,778,ChiCTR2000032632,ChiCTR,2020-05-04,2020-03-20,True,The First Affiliated Hospital of Xinjiang Medical University,Recruiting,Not Applicable,Interventional,China,The influence of COVID-19 pandemic on cardiovascular patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=53190,None
358,780,ChiCTR2000032573,ChiCTR,2020-05-03,2020-05-02,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, controlled trial for Bu-Fei-Huo-Xue Capsule in the treatment of novel coronavirus pneumonia (COVID-19) convalescence patient with ''Fei-Pi-Qi-Xu zhen''",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=53225,None
359,783,ChiCTR2000032487,ChiCTR,2020-04-29,2020-03-26,True,Shanghai Public Health Clinical Center,Not Recruiting,Phase 4,Interventional,China,Study for using sulfate in the prevention and control of novel coronavirus pneumonia (COVID-19) in high and low prevalence communities,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2000,http://www.chictr.org.cn/showproj.aspx?proj=52394,None
360,791,ChiCTR2000032456,ChiCTR,2020-04-29,2020-03-01,True,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,A Randomized Controlled Trial for the Effects of Low-Oxygen Consumption Instruction on the Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=53048,None
361,792,ChiCTR2000032455,ChiCTR,2020-04-29,2020-04-28,True,Ningxia Ning'an Hospital,Recruiting,Not Applicable,Interventional,China,A study for the mental health status of novel coronavirus pneumonia (COVID-19) convalescent patients and first-line medical staff and Isolate residents and Hospital staffand the intervention strategy of psychological crisis in Ningxia,Other (psych),No Intervention,No Intervention,140,http://www.chictr.org.cn/showproj.aspx?proj=53050,None
362,793,ChiCTR2000032135,ChiCTR,2020-04-20,2020-04-22,False,Shanghai Public Health Clinical Center,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of ulinastatin in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Ulinastatin,Ulinastatin,50,http://www.chictr.org.cn/showproj.aspx?proj=52506,None
363,796,ChiCTR2000031174,ChiCTR,2020-03-23,2020-03-23,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,China,Effectiveness and safety of hydroxychloroquine sulfate in the preventive treatment of novel coronavirus pneumonia (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,http://www.chictr.org.cn/showproj.aspx?proj=51437,None
364,797,EUCTR2020-001723-13-FR,EU Clinical Trials Register,2020-04-08,2020-04-17,False,Groupe Hospitalier Paris Saint-Joseph,Authorised,Phase 3,Interventional,France,A randomized trial of efficacy and safety of an early OUTpatient treatment of COVID-19 in patients with risk factor for poor outcome : a strategy to prevent hospitalization : OUTCOV Study,Drug,"Azithromycin, Hydroxychloroquine, Lopinavir/Ritonavir",Azithromycin; Hydroxychloroquine; Lopinavir/Ritonavir,640,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001723-13,None
365,798,EUCTR2020-001717-20-ES,EU Clinical Trials Register,2020-04-27,2020-04-20,True,Fundación para la Investigación Biomédica de Córdoba,Authorised,Phase 2,Interventional,Spain,Prevention and treatment with Calcifediol of respiratory problems caused by COVID-19,Drug,Calcifediol,Calcifediol,1008,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001717-20,None
366,799,ACTRN12620000524998,ANZCTR,2020-04-28,2020-04-28,False,South Eastern Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,Evaluation of a remote monitoring smartphone application and care model of COVID-19 patients in the community  (ReCOVER),Other (software),eHealth,eHealth,2000,https://anzctr.org.au/ACTRN12620000524998.aspx,None
367,801,ChiCTR2000032769,ChiCTR,2020-05-09,2020-05-12,False,Beijing Ditan Hospital,Recruiting,Not Applicable,Interventional,China,"A randomized,double blinded, parallel  controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,342,http://www.chictr.org.cn/showproj.aspx?proj=53368,None
368,805,ChiCTR2000032737,ChiCTR,2020-05-08,2020-05-08,False,The First Affiliated Hospital of Guangdong Pharmaceutical University; Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical trial for the washed microbiota transplantation in the treatment of novel coronavirus pneumonia (COVID-19) patients suspected with gut microbiota dysbiosis,Other,Washed microbiota transplantation,Washed microbiota transplantation,60,http://www.chictr.org.cn/showproj.aspx?proj=53458,None
369,806,ChiCTR2000032717,ChiCTR,2020-05-08,2020-02-12,True,Xi'an International Medical Center Hospital,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of high-dose vitamin C combined with traditional Chinese medicine in the treatment of moderate and severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine + Vitamin C,Traditional Medicine; Vitamin C,40,http://www.chictr.org.cn/showproj.aspx?proj=53322,None
370,807,ChiCTR2000032716,ChiCTR,2020-05-08,2020-02-05,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Interventional,China,High dose intravenous vitamin C might be used as an important rescue therapy for aggravation of severe and critical novel coronavirus pneumonia (COVID-19) patients,Drug,Vitamin C,Vitamin C,12,http://www.chictr.org.cn/showproj.aspx?proj=53389,None
371,810,ChiCTR2000032635,ChiCTR,2020-05-04,2020-05-06,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for Screening of Chinese Patent Drugs in the Rehabilitation Treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=52671,None
372,812,EUCTR2020-001700-42-FR,EU Clinical Trials Register,2020-04-11,2020-06-05,False,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 2,Interventional,France,Efficacy of captopril  in Covid-19 patients suffering of pneumonia,Drug,Captopril,Captopril,230,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001700-42,None
373,813,EUCTR2020-001709-21-FR,EU Clinical Trials Register,2020-04-16,2020-04-29,False,CHU de Nancy,Authorised,Phase 4,Interventional,France,Low-molecular-weight heparin to prevent venous thromboembolism in COVID-19 patients : a randomized controlled trial of different doses,Drug,Heparin,Heparin,550,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001709-21,None
374,814,EUCTR2020-001768-27-FR,EU Clinical Trials Register,2020-04-16,2020-04-27,False,Centre Hospitalier de Versailles,Authorised,Phase 2,Interventional,France,"""STUDY OF THE EFFICIENCY OF NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE"" GERONIMO 19",ATMP,Immunoglobulin,Immunoglobulin,39,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001768-27,None
375,815,EUCTR2020-001598-66-FR,EU Clinical Trials Register,2020-04-16,2020-04-05,True,Centre Hospitalier de Versailles,Authorised,Phase 2,Interventional,France,CurosurfÂ® in Adult Acute Respiratory Distress Syndrome â€“ 1,Drug,Poractant alfa,Poractant alfa,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001598-66,None
376,816,EUCTR2020-001783-28-HU,EU Clinical Trials Register,2020-04-29,2020-06-05,False,National Korányi Institute of Pulmonology,Authorised,Phase 3,Interventional,Hungary,BCG vaccination against COVID-19 infection in Hungary,ATMP,Vaccine,Vaccine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001783-28,None
377,817,NCT04380948,ClinicalTrials.gov,2020-05-06,2020-07-31,False,Washington University in St. Louis,Not Recruiting,Phase 1,Interventional,United States,"A Pilot Study Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Enhance Immune Clearance of SARS-CoV-2 (COVID-19)",Drug,NT-17,NT-17,30,https://clinicaltrials.gov/show/NCT04380948,None
378,820,ChiCTR2000033003,ChiCTR,2020-05-17,2020-06-01,False,Beijing TIL Therapeutics,Not Recruiting,Not Applicable,Prevention,China,Novel coronavirus pneumonia (COVID-19) s-vax loaded autologous dendritic cell trial,ATMP,Cells (dendritic),Cells (dendritic),25,http://www.chictr.org.cn/showproj.aspx?proj=53790,None
379,821,ChiCTR2000032919,ChiCTR,2020-05-15,2020-05-08,True,Wuhan Third Hospital,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Lu-Dang-Shen oral liquid in the treatment of reduced digestion function of convalescent new coronavirus pneumonia (COVID-19) patient",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=53274,None
380,822,ChiCTR2000032915,ChiCTR,2020-05-15,2020-05-07,True,Hongqi Hospital Affiliated to Mudangjiang Medical University,Recruiting,Phase 4,Interventional,China,A randomized controlled trial for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the mild and common type novel coronavirus pneumonia (COVID-19) patients whose nCoV Nucleic acid did not turn negative after treated by hydroxychloroquine and Abidor,Drug,Artemisinin/piperaquine,Artemisinin/piperaquine,240,http://www.chictr.org.cn/showproj.aspx?proj=53658,None
381,826,ChiCTR2000030262,ChiCTR,2020-02-26,2020-02-11,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical study of novel coronavirus (SARS-Cov-2) infection treated with aerosol inhalation (IFN-? plus anti-inflammatory factor TFF2),Drug,Interferon kappa + trefoil factor 2 (a gene-derived protein),Interferon Kappa; Gene-derived protein (trefoil factor 2),140,http://www.chictr.org.cn/showproj.aspx?proj=50136,None
382,827,ChiCTR2000029638,ChiCTR,2020-02-08,2020-02-10,False,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia",Drug,Interferon,Interferon,100,http://www.chictr.org.cn/showproj.aspx?proj=49224,None
383,828,ChiCTR2000029605,ChiCTR,2020-02-06,2020-02-06,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of ovel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=49051,None
384,829,IRCT20200314046764N1,IRCT,2020-04-20,2020-04-26,False,Kermanshah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Pirfenidine in SARS-COV2,Drug,"Interventional: Pirfenidine


Both Arms: Lopinavir/ritonavir + chloroquine + osiltamivir",Pirfenidine; Lopinavir/ritonavir; chloroquine; osiltamivir,40,http://en.irct.ir/trial/46533,None
385,830,IRCT20150303021315N17,IRCT,2020-04-12,2020-03-15,True,Aryogen Pharmed,Recruiting,Phase 3,Interventional,Iran,Tocilizumab in severe COVID-19,Drug,Tocilizumab,Tocilizumab,85,http://en.irct.ir/trial/46550,None
386,831,IRCT20200312046749N1,IRCT,2020-03-28,2020-03-27,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Tumor Necrosis Factor alpha inhibitor in COVID-19,Drug,TNF-alpha inhibitor,TNF-alpha inhibitor,80,http://en.irct.ir/trial/46551,None
387,832,IRCT20190727044343N2,IRCT,2020-04-19,2020-04-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Atorvastatin effect on COVID-19,Drug,Atorvastatin,Atorvastatin,100,http://en.irct.ir/trial/46639,None
388,833,IRCT20171122037571N2,IRCT,2020-04-12,2020-03-20,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Remdesivir in treatment of COVID-19,Drug,Remdesivir + hydroxychloroquine or chloroquine + lopinavir/ritonavir or atazanavir,Remdesivir; hydroxychloroquine; chloroquine; lopinavir/ritonavir; atazanavir,120,http://en.irct.ir/trial/46660,None
389,834,IRCT20200324046850N2,IRCT,2020-03-29,2020-03-18,True,Abadan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Comparison of the effect of Sofosbuvir + Daclatasvir (Sovodac) and Ribavirin in Covid-19,Drug,Daclatasvir/sofosbuvir vs. Ribavirin,Daclatasvir/sofosbuvir; Ribavirin,62,http://en.irct.ir/trial/46713,None
390,835,IRCT20200323046841N1,IRCT,2020-03-28,2020-03-28,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy evaluation of an herbal compound in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46715,None
391,836,IRCT20200322046833N1,IRCT,2020-04-03,2020-03-28,True,Center for Progress and Development of Iran,Not Recruiting,Phase 3,Interventional,Iran,Umifenovir effectiveness in the treatment of COVID-19,Drug,"Umifenovir

All Arms: Hydroxychloroquine + Atazanavir/Ritonavir",Umifenovir; Hydroxychloroquine; Atazanavir/Ritonavir,100,http://en.irct.ir/trial/46731,None
392,837,IRCT20190804044429N1,IRCT,2020-04-11,2020-03-25,True,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon beta 1b in COVID-19,Drug,"Interventional: Interferon beta

Both Arms: Hydroxychloroquine + lopinavir/ritonavir",Interferon beta; Hydroxychloroquine; lopinavir/ritonavir,70,http://en.irct.ir/trial/46741,None
393,838,IRCT20160313027033N2,IRCT,2020-04-16,2020-04-02,True,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The effect of MCT Oil on COVID-19,Drug,Medium-chain triglycerides,Medium-chain triglycerides,120,http://en.irct.ir/trial/46762,None
394,839,IRCT20200204046369N1,IRCT,2020-04-08,2020-04-14,False,Shiraz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Methylprednisolone in treatment of COVID-19 patients,Drug,Corticosteroids,Methylprednisolone,48,http://en.irct.ir/trial/46776,None
395,840,IRCT20180712040449N2,IRCT,2020-04-01,2020-03-23,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of oral multi-herbal preparation on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,68,http://en.irct.ir/trial/46782,None
396,841,IRCT20130812014333N145,IRCT,2020-03-30,2020-04-08,False,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparative assessment of the efficacy and safety of add ontreatment with â€œSofosbuvir standard of care therapeutic regimenVelpatasvirâ€ to â€œstandard of caretherapeutic regimenâ€ in patients with COVID-19,Drug,Sofosbuvir/Velpatasvir with and without Hydroxychloroquine + lopinavir/ritonavir,Sofosbuvir/Velpatasvir; Hydroxychloroquine; lopinavir/ritonavir,80,http://en.irct.ir/trial/46790,None
397,842,IRCT20200325046859N1,IRCT,2020-04-02,2020-04-04,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 who have not responded to standard three-drug protocol,ATMP,Plasma,Plasma,50,http://en.irct.ir/trial/46811,None
398,843,IRCT20161204031229N3,IRCT,2020-04-08,2020-03-30,True,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the Effect of Ticoplanin  in Patients With Coronavirus Disease,Drug,Teicoplanin with and without Hydroxychloroquine + lopinavir/ritonavir or atazanavir,Teicoplanin; Hydroxychloroquine; lopinavir/ritonavir; atazanavir,40,http://en.irct.ir/trial/46814,None
399,844,IRCT20130917014693N10,IRCT,2020-04-08,2020-04-07,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxis,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,100,http://en.irct.ir/trial/46849,None
400,845,IRCT20180610040049N4,IRCT,2020-04-03,2020-04-07,False,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of Tanacetum parthenium (L) Sch syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46850,None
401,846,IRCT20130812014333N147,IRCT,2020-04-22,2020-04-08,True,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Comparative assessment of the efficacy and safety of addon treatment with â€œSofosbuvir-Daclatasvirâ€, â€œLithiumâ€,and â€œTrifluoprazineâ€ to â€œstandard of care in three groups of patients with COVID-19",Drug,Hydroxychloroquine vs. Hydroxychloroquine + Sofosbuvir/Daclatasvir vs. Hydroxychloroquine + Lithium vs. Hydroxycholoquine + Trifluoprazine,Hydroxychloroquine; Sofosbuvir/Daclatasvir; Lithium; Trifluoprazine,80,http://en.irct.ir/trial/46853,None
402,847,IRCT20081019001369N2,IRCT,2020-04-07,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of berberine on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46868,None
403,848,IRCT20200402046923N1,IRCT,2020-04-09,2020-04-05,True,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,"Effect of herbal capsule, Viroherb, and herbal syrup, Fenugreek in treatment of COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,110,http://en.irct.ir/trial/46879,None
404,849,IRCT20200328046886N1,IRCT,2020-04-12,2020-03-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effectiveness of Sovodak (sofosbuvir+daclatasvir) in Covid-19 patients,Drug,Daclatasvir/sofosbuvir,Daclatasvir/sofosbuvir,48,http://en.irct.ir/trial/46885,None
405,850,IRCT20131215015805N2,IRCT,2020-05-04,2020-05-04,False,Shiraz University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Assessment of effect of levamisole on pneumonia caused by COVID-19,Drug,Levamisole,Levamisole,50,http://en.irct.ir/trial/46887,None
406,851,IRCT20200404046933N1,IRCT,2020-04-12,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of licorice for treatment of coronavirus,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46893,None
407,852,IRCT20200404046937N1,IRCT,2020-04-09,2020-04-09,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Marshmallow and Licorice on COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46903,None
408,853,IRCT20080901001157N16,IRCT,2020-04-08,2020-03-30,True,HomaPharmed  Company,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of IMFLUNA herbal compound on covid-19 pneumonia symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46907,None
409,854,IRCT20200404046934N1,IRCT,2020-04-13,2020-03-10,True,Qom University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Investigation of the effect of Zufa syrup on clinical symptoms in the with suspected Corona (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,130,http://en.irct.ir/trial/46913,None
410,855,IRCT20200403046926N1,IRCT,2020-04-11,2020-04-08,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of SOVODAK in the treatment of COVID-19 patients,Drug,Daclatasvir/sofosbuvir + hydroxychloroquine vs. hydroxychloroquine,Daclatasvir/sofosbuvir; hydroxychloroquine,60,http://en.irct.ir/trial/46926,None
411,856,IRCT20151228025732N53,IRCT,2020-04-10,2020-04-20,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Therapeutic effects of plasma of recovered people from COVID-19 on hospitalized patients with this disease,ATMP,Plasma,Plasma,12,http://en.irct.ir/trial/46931,None
412,857,IRCT20130306012728N8,IRCT,2020-04-12,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Post-exposure hydroxycloroquine prophylaxis for Covid 19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,http://en.irct.ir/trial/46932,None
413,858,IRCT20180429039463N2,IRCT,2020-04-10,2020-03-20,True,Torbate-Heidaria University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"The Impact of Family-Based Empowerment Model on Stress, Anxiety and Satisfaction",Other (psych),Psychological,Psychological,30,http://en.irct.ir/trial/46933,None
414,859,IRCT20200404046935N1,IRCT,2020-04-20,2020-04-18,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Effect of herbal medicine containing Saatar, Hofarigon and Fennel on COVID-19 patients",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46940,None
415,860,IRCT20151227025726N14,IRCT,2020-04-10,2020-04-05,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Favipiravir in COVID-19 patients,Drug,Favipiravir vs. Lopinavir/ritonavir,Favipiravir; Lopinavir/ritonavir,84,http://en.irct.ir/trial/46942,None
416,861,IRCT20200405046958N1,IRCT,2020-04-14,2020-04-13,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Prevention of Novel Coronavirus Disease by Hydroxychloroquine in cancer patients.,Drug,Hydroxychloroquine,Hydroxychloroquine,60,http://en.irct.ir/trial/46946,None
417,862,IRCT20200406046965N1,IRCT,2020-04-12,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of elderberry syrup against COVID-19 symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46958,None
418,863,IRCT20200405046960N1,IRCT,2020-04-08,2020-04-09,False,Ardabil University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,http://en.irct.ir/trial/46961,None
419,864,IRCT20200318046812N2,IRCT,2020-04-08,2020-04-10,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,evaluation of Safety and efficacy of anti inflammatory regimens in COVID-19,Drug,Corticosteroids + naproxen + azithromycin + hydroxychloroquine vs. naproxen + azithromycin + hydroxychloroquine vs. hydroxychloroquine + Lopinavit/ritonavir,Prednisolone; naproxen; azithromycin; hydroxychloroquine; Lopinavit/ritonavir,906,http://en.irct.ir/trial/46968,None
420,865,IRCT20200317046797N4,IRCT,2020-04-14,2020-04-18,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Bromhexine Hydrochloride on patients with COVID-19,Drug,Bromhexine,Bromhexine,60,http://en.irct.ir/trial/46969,None
421,866,IRCT20200404046948N1,IRCT,2020-04-15,2020-04-13,True,Artesh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of convalescent plasma in the treatment of COVID-19,ATMP,Plasma,Plasma,60,http://en.irct.ir/trial/46973,None
422,867,IRCT20180520039738N2,IRCT,2020-04-10,2020-04-07,True,Saveh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation and comparison of the effectiveness of standard treatment with stand treatment plus Vitamin A in treatment in covid19 patients,Drug,Vitamin A,Vitamin A,140,http://en.irct.ir/trial/46974,None
423,868,IRCT20081019001369N4,IRCT,2020-04-11,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of minocycline on COVID-19,Drug,Minocycline,Minocycline,40,http://en.irct.ir/trial/46977,None
424,869,IRCT20081019001369N3,IRCT,2020-04-11,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of crocetin on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46978,None
425,870,IRCT20200408046992N1,IRCT,2020-04-14,2020-04-16,False,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Trifluoperazine in treatment of COVID-19,Drug,Trifluoprazine + Hydroxychloroquine vs. Hydroxychloroquine,Trifluoprazine; hydroxychloroquine,70,http://en.irct.ir/trial/47006,None
426,871,IRCT20180129038542N1,IRCT,2020-04-13,2020-04-06,True,University of Baqiyatallah,Not Recruiting,Not Applicable,Interventional,Iran,Early tracheostomy in COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,30,http://en.irct.ir/trial/47013,None
427,872,IRCT20200317046797N3,IRCT,2020-04-11,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Intravenous immunoglobulin (IVIG) in the treatment of COVID-19-induced cytokine storm,ATMP,"Interventional: Immunoglobulin

Both Arms: hydroxychloroquine + ribavirin + lopinavir/ritonavir",Immunoglobulin; hydroxychloroquine; ribavirin; lopinavir/ritonavir,100,http://en.irct.ir/trial/47014,None
428,873,IRCT20200317046797N5,IRCT,2020-04-19,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of COVID-19-induced cytokine storm by hemoperfusion,Other (device),Hemoperfusion,Hemoperfusion,10,http://en.irct.ir/trial/47015,None
429,874,IRCT20180923041093N5,IRCT,2020-04-10,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation the efficacy of hot foot-bath on COVID-19,Procedure,Foot bath,Foot bath,60,http://en.irct.ir/trial/47018,None
430,875,IRCT20200406046968N1,IRCT,2020-04-14,2020-04-21,False,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The  effect of IL-6 inhibitor (Tocilizumab) on the prognosis of covid-19 patients with acute respiratory failure hospitalized in Imam Reza Hospital in Tabriz,Drug,Tocilizumab,Tocilizumab,10,http://en.irct.ir/trial/47021,None
431,876,IRCT20150808023559N20,IRCT,2020-04-11,2020-04-29,False,Ardabil University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in  hospitalized patients with COVID-19,Drug,Favipravir + hydroxychloroquine vs. lopinavir/ritonavir + hydroxychloroquine,Favipravir; hydroxychloroquine; lopinavir/ritonavir,100,http://en.irct.ir/trial/47022,None
432,877,IRCT20130616013690N7,IRCT,2020-05-01,2020-05-02,False,Shiraz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of interactive psycho-educational interventions on patients infected with COVID-19,Other (psych),Psychological,Psychological,50,http://en.irct.ir/trial/47034,None
433,878,IRCT20200410047009N1,IRCT,2020-04-26,2020-04-13,True,Iran University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,The effect of Naproxen in recovery and reducing mortality in patients with COVID-19,Drug,"Naproxen w/ and w/o Hydroxychloroquine, Oseltamivir, Lopinavir/ritonavir, chloroquine, ribavirin",Naproxen; Hydroxychloroquine; Oseltamivir; Lopinavir/ritonavir; chloroquine; ribavirin,101,http://en.irct.ir/trial/47052,None
434,879,IRCT20200408046990N1,IRCT,2020-04-18,2020-05-19,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of SinaCurcumin capsule efficacy as an supplement therapy for mild to moderate COVID-19 in Mashhad,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47061,None
435,880,IRCT20200411047025N1,IRCT,2020-04-14,2020-04-18,False,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Intravenous vitamin c in Patients with COVID-19,Drug,Vitamin C + Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychloroquine + Atazanavir/ritonavir,Vitamin C; Hydroxychloroquine; Atazanavir/ritonavir,110,http://en.irct.ir/trial/47078,None
436,881,IRCT20080901001165N46,IRCT,2020-04-15,2020-03-30,True,Center for Progress and Development of Iran,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Umifenovir in controlling the symptoms of patients with COVID-19,Drug,Umifenovir,Umifenovir,200,http://en.irct.ir/trial/47087,None
437,882,IRCT20200406046963N1,IRCT,2020-04-22,2020-03-30,True,Artesh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of methylprednisolone pulse therapy in treatment of Covid-19 patients with Acute respiratory distress syndrome,Drug,Hydroxychloroquine + Corticosteroids vs. Hydroxychloroquine,Methylprednisolone; Hydroxychloroquine,40,http://en.irct.ir/trial/47088,None
438,883,IRCT20190122042450N4,IRCT,2020-04-16,2020-04-20,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of hydroxychloroquine to prevent coronavirus disease,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,http://en.irct.ir/trial/47090,None
439,884,IRCT20200411047030N1,IRCT,2020-04-17,2020-04-14,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of melatonin on the quality of sleep in COVID-19 patients,Drug,Melatonin + Hydroxychloroquine + Azithormycin vs. Hydroxychloroquine + Azithormycin,Melatonin; Hydroxychloroquine; azithormycin,82,http://en.irct.ir/trial/47099,None
440,885,IRCT20200406046968N2,IRCT,2020-04-22,2020-05-04,False,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of convalescent plasma transfusion of COVID-19 survivors on the treatment of respiratory failure of these patients,ATMP,Plasma,Plasma,30,http://en.irct.ir/trial/47115,None
441,886,IRCT20170207032444N3,IRCT,2020-04-17,2020-04-15,True,Esfahan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Thalidomide in COVID19,Drug,Thalidomide + Hydroxychloroquine + Methylprednisolone + Antibiotic + Diphenhydramine + Enoxaparin vs. Hydroxychloroquine + Methylprednisolone + Antibiotic + Diphenhydramine + Enoxaparin,Thalidomide; Hydroxychloroquine; Methylprednisolone; Antibiotic; Diphenhydramine; Enoxaparin,60,http://en.irct.ir/trial/47119,None
442,887,IRCT20200413047053N1,IRCT,2020-04-15,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of asafoetida in the treatment of coronavirus infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47139,None
443,888,IRCT20081019001369N5,IRCT,2020-04-26,2020-05-02,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of lithium carbonate  on COVID-19,Drug,Lithium,Lithium,40,http://en.irct.ir/trial/47141,None
444,889,IRCT20200408046988N1,IRCT,2020-04-29,2020-04-14,True,Gonabad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the efficacy of melatonin tablets as auxiliary medication in accelerating the improvement of the COVID-19 symptoms and clinical findings,Drug,Melatonin + Hydroxychloroquine vs. Hydroxychloroquine,Melatonin; Hydroxychloroquine,60,http://en.irct.ir/trial/47142,None
445,890,IRCT20200413047062N1,IRCT,2020-05-04,2020-04-13,True,Islamic Azad University,Not Recruiting,Phase 3,Interventional,Iran,Effect of Atorvastatin in treatment of COVID-19 infection,Drug,Atorvastatin,Atorvastatin,76,http://en.irct.ir/trial/47146,None
446,891,IRCT20191125045492N2,IRCT,2020-04-18,2020-04-23,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Ozone therapy in treatment of COVID-19,Drug,Ozone,Ozone,80,http://en.irct.ir/trial/47149,None
447,892,IRCT20200406046968N3,IRCT,2020-05-08,2020-04-29,True,Zist Daru Danesh Company,Recruiting,Phase 2,Interventional,Iran,effect of Interfron-beta1(zifron) on clinical improvement and prognosis of COVID-19 in Tabriz Imam-Reza hospital,Drug,Interferon beta + Hydroxycholoquine + Lopinavir/ritonavir vs. Hydroxycholoquine + Lopinavir/ritonavir,Interferon beta; Hydroxycholoquine; Lopinavir/ritonavir,60,http://en.irct.ir/trial/47152,None
448,893,IRCT20200413047063N1,IRCT,2020-05-04,2020-03-20,True,National Institute for Medical Research Development,Recruiting,Phase 1/Phase 2,Interventional,Iran,Placental Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 1-2 Clinical Trial,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://en.irct.ir/trial/47156,None
449,894,IRCT20200413047052N1,IRCT,2020-05-07,2020-05-04,True,Esfahan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,"The effectiveness of educational-treatment package based on psychological flexibility in burnout, quality of working life, work-family conflict and mental health",Other (psych),Psychological,Psychological,60,http://en.irct.ir/trial/47160,None
450,895,IRCT20200414047070N1,IRCT,2020-04-21,2020-05-04,False,Fasa University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of ppd on recovery of covid disease 19,Drug,Tuberculin w/ and w/o Chloroquine + Lopinavir/ritonavir,Tuberculin; Chloroquine; Lopinavir/ritonavir,50,http://en.irct.ir/trial/47169,None
451,896,IRCT20170210032478N3,IRCT,2020-04-29,2020-04-18,True,National Research Institute of Tuberculosis and Lung Diseases,Recruiting,Phase 3,Interventional,Iran,Effect of  Formoterol in treatment of covid19,Drug,Formoterol,Formoterol,50,http://en.irct.ir/trial/47173,None
452,897,IRCT20200415047082N1,IRCT,2020-04-21,2020-05-04,False,Jahrom University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Effect evaluation of herbal supplementation from the combination of sugarcane, black myrobalan and mastic along with the treatment protocol of the Ministry of Health on the course of coronavirus disease",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,10,http://en.irct.ir/trial/47193,None
453,898,IRCT20200413047056N1,IRCT,2020-04-17,2020-04-18,False,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in COVID-19,ATMP,Plasma vs. Immunoglobulin,Plasma; Immunoglobulin,15,http://en.irct.ir/trial/47212,None
454,899,IRCT20200418047116N1,IRCT,2020-05-04,2020-03-10,True,Gonabad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of Intravenous immunoglobulin on COVID-19 infection,ATMP,Immunoglobulin,Immunoglobulin,20,http://en.irct.ir/trial/47219,None
455,900,IRCT20200415047089N1,IRCT,2020-04-19,2020-04-18,True,Saveh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of herbal drugs (Echinacea and Ginger) on Improvement of clinical symptoms and hospitalizations in suspected COVID-19 outpatient cases,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47234,None
456,901,IRCT20200415047092N1,IRCT,2020-04-20,2020-04-24,False,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of azithromycin in treatment of COVID19,Drug,Azithromycin +  Oseltamivir + Lopinavir/ritonavir or Atazanavir + Hydroxychloroquine vs. Oseltamivir + Lopinavir/ritonavir or Atazanavir + Hydroxychloroquine,Azithromycin; oseltamivir; lopinavir/ritonavir; atazanavir; hydroxychloroquine,110,http://en.irct.ir/trial/47244,None
457,902,IRCT20200416047104N1,IRCT,2020-04-23,2020-04-20,True,Shahre-kord University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of pomegranate tea on symptom relief of COVID-19 patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,66,http://en.irct.ir/trial/47251,None
458,903,IRCT20200417047113N1,IRCT,2020-04-24,2020-04-27,False,Middle East Gene Therapy Corporation,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of NK cell therapy in COVID-19,ATMP,Cells (NK),Cells (NK),70,http://en.irct.ir/trial/47264,None
459,904,IRCT20200419047128N1,IRCT,2020-04-22,2020-05-04,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Tranilast in COVID19,Drug,Tranilast,Tranilast,60,http://en.irct.ir/trial/47265,None
460,905,IRCT20200416047099N1,IRCT,2020-04-21,2020-04-05,True,Shahid Beheshti University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Plasma therapy in patient with COVID-19,ATMP,Plasma,Plasma,10,http://en.irct.ir/trial/47266,None
461,906,IRCT20200418047122N1,IRCT,2020-05-03,2020-04-25,True,Esfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the therapeutic effect of a combination drug including Apocynin, Niacin, and Tannin on COVID-19",Drug,Apocynin + Niacin + Tannin,Apocynin; Niacin; Tannin,80,http://en.irct.ir/trial/47268,None
462,907,IRCT20200418047121N2,IRCT,2020-05-05,2020-05-09,False,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Stem cell therapy in COVID-19,ATMP,Cells (stem cells),Cells (stem cells),6,http://en.irct.ir/trial/47275,None
463,908,IRCT20140407017169N2,IRCT,2020-04-28,2020-04-30,False,Social Development and Health Promotion Research Center,Recruiting,Not Applicable,Interventional,Iran,Effect of natural from Tahini oil product on corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47295,None
464,909,IRCT20200329046892N1,IRCT,2020-05-02,2020-05-04,False,Rasht University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Trifluoperazine Effectiveness in Treatment of Coronavirus,Drug,Trifluoperazine,Trifluoperazine,70,http://en.irct.ir/trial/47300,None
465,910,IRCT20080901001165N48,IRCT,2020-04-22,2020-03-30,True,Niak Pharmaceutical Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of Zofa (a herbal medicine) in symptom management of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47318,None
466,911,IRCT20200420047147N1,IRCT,2020-04-23,2020-05-04,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Evaluation the effects of Sitagliptin administration in patients with COVID-19,Drug,Sitagliptin + Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Sitagliptin; Hydroxychloroquine; Lopinavir/ritonavir,84,http://en.irct.ir/trial/47334,None
467,912,IRCT20190618043923N4,IRCT,2020-05-04,2020-04-25,True,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Ozone Autohemotherapy in Covid19,Drug,Ozone,Ozone,20,http://en.irct.ir/trial/47363,None
468,913,IRCT20200421047155N1,IRCT,2020-04-25,2020-04-29,False,Ardabil University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy of tenofovir in covid-19,Drug,Tenofovir vs. Hydroxychloroquine,Tenofovir vs. Hydroxychloroquine,86,http://en.irct.ir/trial/47387,None
469,914,IRCT20200419047128N2,IRCT,2020-04-24,2020-04-29,False,Ahvaz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Quercetin in COVID19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47396,None
470,915,IRCT20080901001165N49,IRCT,2020-04-25,2020-03-30,True,Andisheh Salamat Sabalan Medicinal Plants Company,Recruiting,Not Applicable,Interventional,Iran,"Evaluation efficacy of a herbal combination (contains Glycyrrhiza glabra, Mentha pulegium and Urtica) in controlling symptoms in patients with COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/47401,None
471,916,IRCT20200422047168N1,IRCT,2020-04-29,2020-04-18,True,Ahvaz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Clinical trial study on the therapeutic effect of Tenofovir besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19),Drug,Tenofovir + Chloroquine + Lopinavir/ritonavir vs. Chloroquine + Lopinavir/ritonavir,Tenofovir; Chloroquine; Lopinavir/ritonavir,60,http://en.irct.ir/trial/47437,None
472,917,IRCT20200408046990N2,IRCT,2020-04-25,2020-04-29,False,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the colchicine tablet efficacy as an adjuvant therapy for patients with mild to moderate COVID-19,Drug,Colchicine,Colchicine,40,http://en.irct.ir/trial/47468,None
473,918,IRCT20180114038350N3,IRCT,2020-05-01,2020-05-04,False,Sanandaj University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Deferiprone on the improvement of symptoms of Coronavirus 2019 (COVID 19),Drug,Deferiprone,Deferiprone,80,http://en.irct.ir/trial/47475,None
474,919,IRCT20200426047206N1,IRCT,2020-04-28,2020-05-09,False,Hamedan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of NBS powder in treatment of patients with  COVID-19,Supplement (+ Drug),NBS Powder vs. Hydroxychloroquine + Lopinavir/ritonavir,NBS Powder; Hydroxychloroquine; Lopinavir/ritonavir,46,http://en.irct.ir/trial/47495,None
475,920,IRCT20120215009014N353,IRCT,2020-04-27,2020-05-14,False,Hamedan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of plasma of patients recovered from covid-19 versus control group on treatment of covid-19,ATMP,Plasma,Plasma,100,http://en.irct.ir/trial/47501,None
476,921,IRCT20140305016852N4,IRCT,2020-05-04,2020-04-20,True,Sabzevar University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of three methods of treatment in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without coronavirus positive test,Drug,Vitamin D vs. Vitamin C,Vitamin D; Vitamin C,30,http://en.irct.ir/trial/47508,None
477,922,IRCT20180425039414N2,IRCT,2020-05-13,2020-04-20,True,Esfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of zinc on the treatment and clinical course of patients with SARS-cov2 (COVID-19),Drug,Hydroxychloroqine + Zinc vs. Hydroxychloroquine,Hydroxychloroqine; Zinc,80,http://en.irct.ir/trial/47516,None
478,923,IRCT20200427047215N1,IRCT,2020-05-05,2020-05-08,False,Isfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation effect of Indomethacin for Covid19 infection,Drug,Indomethacin,Indomethacin,60,http://en.irct.ir/trial/47520,None
479,924,IRCT20200426047212N1,IRCT,2020-05-02,2020-05-04,False,Shooshtar University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of of Inhalation of Thyme Oil in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,48,http://en.irct.ir/trial/47572,None
480,925,IRCT20080901001165N50,IRCT,2020-05-01,2020-05-01,False,Sina Darou Laboratories Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Azithromycin inhaled spray in controlling the symptoms of patients with COVID-19,Drug,Azithromycin,Azithromycin,80,http://en.irct.ir/trial/47576,None
481,926,IRCT20080901001165N51,IRCT,2020-05-01,2020-05-01,False,Sina Darou Laboratories Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,80,http://en.irct.ir/trial/47577,None
482,927,IRCT20200418047121N1,IRCT,2020-05-01,2020-05-09,False,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Study the effectiveness of concomitant use of vitamin C, metformin, azithromycin and doxycycline on improving patients with COVID-19",Drug,Vitamin C + Metformin + Azithromycin + Doxycycline,Vitamin C; Metformin; Azithromycin; Doxycycline,40,http://en.irct.ir/trial/47578,None
483,928,IRCT20150808023559N21,IRCT,2020-05-09,2020-05-12,False,Ardabil University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,The Effect of Convalescent Plasma Therapy on  Patients with 19-COVID,ATMP,Plasma,Plasma,60,http://en.irct.ir/trial/47594,None
484,929,IRCT20200501047258N1,IRCT,2020-05-04,2020-05-04,False,Oroumia University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,effects of  convalescent plasma in COVID-19,ATMP,Plasma,Plasma,120,http://en.irct.ir/trial/47629,None
485,930,IRCT20131129015584N2,IRCT,2020-05-08,2020-04-04,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of herbal syrup on patients with corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,152,http://en.irct.ir/trial/47639,None
486,931,IRCT20080901001165N52,IRCT,2020-05-05,2020-04-20,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of high dose of glucocorticoid in patients with moderate to severe pneumonia related to COVID-19,Drug,Corticosteroids,Methylprednisolone; Prednisone,50,http://en.irct.ir/trial/47641,None
487,932,IRCT20160706028815N5,IRCT,2020-05-05,2020-05-20,False,Sabzevar University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of addition of selenium to treatment regimen of hospitalized patients with corona on the outcome of disease compared with control group,Drug,Selenium,Selenium,40,http://en.irct.ir/trial/47682,None
488,933,IRCT20171213037866N2,IRCT,2020-05-07,2020-05-09,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of jujube product on Covid-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,68,http://en.irct.ir/trial/47684,None
489,934,IRCT20200326046868N1,IRCT,2020-05-09,2020-05-21,False,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,effect of propolis  in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,88,http://en.irct.ir/trial/47934,None
490,935,IRCT20200508047346N1,IRCT,2020-05-13,2020-05-21,False,Kowsar Biotechnology Co.,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of rabbit antibody against coronavirus in patients,ATMP,Antibodies,Antibodies,124,http://en.irct.ir/trial/47953,None
491,936,IRCT20120215009014N354,IRCT,2020-05-12,2020-06-04,False,Hamedan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,"Evaluating the effect of intravenous hydrocortisone, methylprednisolone, and dexamethasone in treatment of patients with moderate to severe acute respiratory distress syndrome caused by COVID-19",Drug,Corticosteroids,Hydrocortisone; Methylprednisolone; Dexamethasone,81,http://en.irct.ir/trial/48043,None
492,938,KCT0005003,CRIS,2020-05-11,2020-05-25,False,Gyeongsang National University Hospital,Not Recruiting,Phase 2,Interventional,South Korea,Clinical efficacy of Nafamostat for COVID-19 pneumonia,Drug,Nafamostat w/ or w/o Lopinavir / ritonavir + Hydroxychloroquine + Oxygen,Nafamostat; Lopinavir/ritonavir; Hydroxychloroquine; Oxygen,84,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16635,None
493,940,JPRN-UMIN000040235,JPRN,2020-04-25,2020-04-23,True,Yuri Kumiai General Hospital,Recruiting,Not Applicable,Interventional,Japan,Examination of test accuracy of COVID-19 rapid antibody kit,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045901,None
494,943,JPRN-UMIN000040286,JPRN,2020-05-11,2020-05-12,False,University of Tokyo,Not Recruiting,Not Applicable,Interventional,Japan,Study on risk perception and behavioral change related to COVID-19,Other (psych),No Intervention,No Intervention,1980,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045966,None
495,946,JPRN-UMIN000040401,JPRN,2020-05-15,2020-05-15,False,Tokyo Medical and Dental University,Recruiting,Not Applicable,Interventional,Japan,A feasibility study of remote rehabilitation using a wearable biological monitoring device in the patients with COVID-19,Other (device),Wearable,Wearable,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046104,None
496,948,ACTRN12620000579998,ANZCTR,2020-05-19,2020-05-20,False,Mackay Hospital and Health Service,Not Recruiting,Not Applicable,Interventional,Australia,"In a simulation environment, is there a difference in time taken for consultant anaesthetists to perform spinal anaesthesia as compared to general anaesthesia on women, with suspected or confirmed COVID-19, who require emergency caesarean delivery?",Other,No Intervention,No Intervention,10,https://anzctr.org.au/ACTRN12620000579998.aspx,None
497,949,ISRCTN85216856,ISRCTN,2020-05-11,2020-10-05,False,Universidad Tecnológica Equinoccial,Recruiting,Phase 2/Phase 3,Interventional,Ecuador,Using blood plasma to develop passive immunity to coronavirus in Ecuador,ATMP,Plasma,Plasma,200,http://isrctn.com/ISRCTN85216856,None
498,955,ChiCTR2000033133,ChiCTR,2020-05-21,2020-02-12,True,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=53925,None
499,959,ChiCTR2000033057,ChiCTR,2020-05-19,2020-02-25,True,The First Hospital of China Medical University,Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for determination of the clinical effect of Internet-assisted pulmonary rehabilitation on patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,160,http://www.chictr.org.cn/showproj.aspx?proj=53529,None
500,960,ChiCTR2000033056,ChiCTR,2020-05-19,2020-01-29,True,Guizhou Provincial Jiangjunshan Hospital,Not Recruiting,Not Applicable,Interventional,China,Convalescent Plasma in the treatment of 6 COVID-19 Patients,ATMP,Plasma,Plasma,6,http://www.chictr.org.cn/showproj.aspx?proj=53859,None
501,966,ChiCTR2000033049,ChiCTR,2020-05-18,2020-05-19,False,Hongqi Hospital Affiliated to Mudangjiang Medical University,Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the untreated mild or common type novel coronavirus pneumonia (COVID-19) patients,Drug,Artemisinin/pipequine,Artemisinin/pipequine,160,http://www.chictr.org.cn/showproj.aspx?proj=53840,None
502,967,EUCTR2020-001614-38-BE,EU Clinical Trials Register,2020-04-06,2020-04-22,False,UZ Leuven,Authorised,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Azithromycin,Azithromycin,282,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001614-38,None
503,968,NCT04404634,ClinicalTrials.gov,2020-05-22,2020-05-01,True,Yale University,Not Recruiting,Phase 2,Interventional,No Country Given,Convalescent Plasma To Limit COVID-19 Associated Complications,ATMP,Plasma,Plasma,300,https://clinicaltrials.gov/show/NCT04404634,None
504,973,ChiCTR2000033433,ChiCTR,2020-05-31,2020-06-18,False,"International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University",Not Recruiting,Not Applicable,Interventional,China,Study for the Effect of Internet-based Cognitive Behavior Intervention on Perinatal Depression and Anxiety during the novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),Psychological,Psychological,300,http://www.chictr.org.cn/showproj.aspx?proj=54482,None
505,974,ChiCTR2000033372,ChiCTR,2020-05-29,2020-03-12,True,Shandong University Qilu Hospital,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of leflunomide for Refractory novel coronavirus pneumonia (COVID-19): A non-Randomized Controlled Study,Drug,Leflunomide,Leflunomide,30,http://www.chictr.org.cn/showproj.aspx?proj=54408,None
506,980,ChiCTR2000033323,ChiCTR,2020-05-28,2020-05-11,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,Iraq,Severe Reluctant COVID-19 Patients Responding to Convalescent  Plasma; A case series,Drug,Plasma,Plasma,24,http://www.chictr.org.cn/showproj.aspx?proj=54346,None
507,981,ChiCTR2000033320,ChiCTR,2020-05-27,2020-01-21,True,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=54321,None
508,983,ChiCTR2000033318,ChiCTR,2020-05-27,2020-02-18,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,104,http://www.chictr.org.cn/showproj.aspx?proj=54326,None
509,985,ChiCTR2000033286,ChiCTR,2020-05-26,2020-02-15,True,Xiangyang Central Hospital,Not Recruiting,Not Applicable,Interventional,China,"A Randomized, Double-blind, Placebo-controlled trial for determination of the Efficacy and Safety of Baicalein in Hospitalized Adult  Mild and Moderate Patients of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Tradtional Medicine,Tradtional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=54176,None
510,986,ChiCTR2000033284,ChiCTR,2020-05-26,2020-06-01,False,Guangzhou Women and Children's Medical Center,Not Recruiting,Not Applicable,Interventional,China,Study for the improvement of the quality of life of severe patients of novel coronavirus pneumonia (COVID-19) by the integrated Chinese medicine and Western medicine therapy,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,150,http://www.chictr.org.cn/showproj.aspx?proj=49590,None
511,987,ChiCTR2000033261,ChiCTR,2020-05-25,2020-02-15,True,Jiangsu People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Usefulness of abdominal massage and ST-36 (Zusanli) acupressure in improving appetite of novel coronavirus pneumonia (COVID-19) patients treated in makeshift hospital,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=54185,None
512,989,ChiCTR2000029479,ChiCTR,2020-02-02,2020-01-30,True,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Research for Traditional Chinese Medicine Technology Prevention and Control of Novel Coronavirus Pneumonia  (COVID-19) in the Community Population,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,20000,http://www.chictr.org.cn/showproj.aspx?proj=48773,None
513,990,ISRCTN15254871,ISRCTN,2020-05-23,2020-05-18,True,Heim Pl National Pediatric Institute LaTRA Foundation,Recruiting,Not Applicable,Interventional,Hungary,Online parent training for reducing parenting stress during the coronavirus pandemic,Other (psych),Psychological,Psychological,300,http://isrctn.com/ISRCTN15254871,None
514,992,ISRCTN50212645,ISRCTN,2020-05-20,2020-01-06,True,"University College, London",Recruiting,Not Applicable,Interventional,United Kingdom,How effective are infection prevention and control measures that are informed by genetic analysis of coronavirus (rapid and standard) at preventing COVID-19 in NHS hospitals?,Genomics,Infection control,Infection control,2000,http://isrctn.com/ISRCTN50212645,None
515,995,EUCTR2020-001573-78-FR,EU Clinical Trials Register,2020-04-14,2020-06-05,False,Revimmune,Authorised,Phase 2,Interventional,"France, United States",Recombinant InterLeukin-7 (CYT107) to Improve clinical outcomes in lymphopenic pAtients with COVID-19 infection,Drug,Interleukin-7,Interleukin-7,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001573-78,None
516,996,EUCTR2020-001754-21-FR,EU Clinical Trials Register,2020-04-17,2020-05-19,False,Assistance Publique – Hôpitaux de Marseille,Authorised,Phase 3,Interventional,France,An open prospective randomized therapeutic trial using ANAKINRA or TOCILIZUMAB alone or in combination with RUXOLITINIB in severe stage 2b and 3 COVID-19 disease,Drug,"Anakinra, Tocilizumab, Ruxolitinib",Anakinra; Tocilizumab; Ruxolitinib,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001754-21,None
517,997,EUCTR2020-001536-98-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Mútua Terrassa University Hospital,Not Recruiting,Phase 3,Interventional,Spain,"Prophylaxis of COVID-19 infection with hydroxychloroquine in healthcare
personnel with high risk of infection.",Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001536-98,None
518,998,EUCTR2020-001673-75-FR,EU Clinical Trials Register,2020-04-17,2020-06-05,False,ABIVAX,Authorised,Phase 2/Phase 3,Interventional,France,"Phase 2/3 study of ABX464, once daily oral capsule, in high risk patients infected by SARS-CoV-2 prior to COVID-19 associated respiratory distress.",Drug,ABX464,ABX464,1034,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75,None
519,999,EUCTR2020-001497-30-FR,EU Clinical Trials Register,2020-04-28,2020-12-05,True,Alexion Pharmaceuticals,Authorised,Phase 3,Interventional,"United Kingdom, Italy, France, United States, Germany, Spain",ravulizumab for the treatment of patients with Coronavirus Disease 2019,Drug,Ravulizumab,Ravulizumab,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001497-30,None
520,1000,ACTRN12620000640909,ANZCTR,2020-06-01,2020-08-06,False,University of Melbourne,Not Recruiting,Not Applicable,Interventional,Australia,"A phase II, open label non-randomised clinical trial of the safety and efficacy of the CovidCare app to support self-monitoring for COVID-19 symptoms in self-isolation and to determine the impacts on mental health",Other (software),eHealth,eHealth,200,https://anzctr.org.au/ACTRN12620000640909.aspx,None
521,1001,ACTRN12620000635965,ANZCTR,2020-05-29,2020-05-06,True,South Western Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,"Open label, prospective study for the Biofourmis Everion armband telemonitoring solution for patients during COVID-19 home isolation within South Western Sydney",Other (software),eHealth,eHealth,50,https://anzctr.org.au/ACTRN12620000635965.aspx,None
522,1003,ACTRN12620000634976,ANZCTR,2020-05-29,2020-08-06,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing an Online Coping Skills Intervention for People Living with Chronic Illness During the Covid-19 Pandemic,Other (psych),Psychological,Psychological,46,https://anzctr.org.au/ACTRN12620000634976.aspx,None
523,1005,ChiCTR2000033627,ChiCTR,2020-06-07,2020-06-10,False,Rayak Hospital,Not Recruiting,Not Applicable,Interventional,Iraq,In vivo use of ivermectin (IVR) for treatment for corona virus infected patients: a randomized controlled trial,Drug,Ivermectin,Ivermectin,60,http://www.chictr.org.cn/showproj.aspx?proj=54707,None
524,1010,ChiCTR2000033491,ChiCTR,2020-06-02,2020-02-11,True,Huo-Shen-Shan Hospital,Not Recruiting,Phase 4,Interventional,China,Oral Favipiravir for Patients with Delayed SARS-Cov-2 viral RNA Clearance,Drug,Favipiravir,Favipiravir,9,http://www.chictr.org.cn/showproj.aspx?proj=54278,None
525,1012,ISRCTN11384058,ISRCTN,2020-05-26,2020-01-04,True,Policlinico San Martino Genoa,Recruiting,Not Applicable,Interventional,Italy,"A collaborative pilot study to monitor and optimise access to urgent surgery during the period of reduced resources in Genoa, Italy caused by the COVID-19 pandemic, using a bespoke referral process and the SWALIS 2020 model to prioritise surgery by clinical urgency and waiting time",Health System,No Intervention,No Intervention,300,http://isrctn.com/ISRCTN11384058,None
526,1014,EUCTR2020-001597-30-GB,EU Clinical Trials Register,2020-04-09,2020-05-29,False,4D Pharma,Authorised,Phase 2,Interventional,"Ireland, Italy, United Kingdom, United States",A study to test the effectiveness and safety of bacteria called Bifidobacterium breve in patients with COVID-19 infections,Drug,Bifidobacterium,Bifidobacterium,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001597-30,None
527,1015,EUCTR2020-001849-39-SE,EU Clinical Trials Register,2020-04-28,2020-05-18,False,Region Skåne,Authorised,Phase 2,Interventional,Sweden,Treatment of COVID-19 with the inhalation drug pulmozyme,Drug,Dornase alfa,Dornase alfa,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001849-39,None
528,1016,EUCTR2020-001951-42-PL,EU Clinical Trials Register,2020-04-29,2020-08-05,False,Nicolaus Copernicus University,Authorised,Phase 3,Interventional,"Poland, Italy, Canada, Spain",Amiodarone or Verapamil in COVID-19 hospitalized patients with symptoms: Randomized clinical trial,Drug,Amiodarone vs. Verapamil,Amiodarone; Verapamil,804,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001951-42,None
529,1018,EUCTR2020-002130-33-BE,EU Clinical Trials Register,2020-05-06,2020-05-26,False,"University Hospital, Ghent",Authorised,Phase 2,Interventional,Belgium,ZilucoplanÂ® in patients with acute hypoxic respiratory failure due to COVID-19,Drug,Zilucoplan,Zilucoplan,81,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002130-33,None
530,1027,ChiCTR2000033774,ChiCTR,2020-06-11,2020-03-02,True,Children's Hospital Affiliated to Zhejiang University School of Medicine,Not Recruiting,Phase 4,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets in Treating Pediatric novel coronavirus pneumonia (COVID-19),Drug,Bromhexine Hydrochloride,Bromhexine Hydrochloride,30,http://www.chictr.org.cn/showproj.aspx?proj=55097,None
531,1033,EUCTR2020-001257-51-DK,EU Clinical Trials Register,2020-03-26,2020-04-15,False,"Rigshospitalet, Denmark",Not Recruiting,Phase 3,Interventional,Denmark,Hydroxychloroquine for prevention of COVID-19 in patients on chronic dialysis,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,568,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001257-51,None
532,1034,EUCTR2020-001363-85-DK,EU Clinical Trials Register,2020-04-17,2020-04-23,False,Odense University Hospital,Not Recruiting,Phase 3,Interventional,Denmark,Medication for prevention of Corona-virus for Danish nursing home residents,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,206,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001363-85,None
533,1035,EUCTR2020-001937-11-GB,EU Clinical Trials Register,2020-06-08,2020-04-30,True,"University College, London",Authorised,Phase 2,Interventional,United Kingdom,"The COVASE study:
Investigation of an approved nebulised human Dnase enzyme (Pulmozyme) to reduce hyperinflammation in hospitalised people with COVID-19",Drug,Dornase alfa,Dornase alfa,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001937-11,None
534,1036,IRCT20200128046294N2,IRCT,2020-03-14,2020-03-26,False,Digestive Disease Research Institute,Not Recruiting,Phase 3,Interventional,Iran,Study to Evaluate the Safety and Efficacy of Sofosbuvir/Daclatasvir in Participants with Moderate to Severe Coronavirus Disease (COVID-19),Drug,Sofosbuvir + Daclatasvir,Sofosbuvir; Daclatasvir,70,http://en.irct.ir/trial/46463,None
535,1037,IRCT20200314046774N1,IRCT,2020-06-12,2020-05-04,True,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,treatment of COVID-19 whit vitamin A,Drug,Vitamin A,Vitamin A,94,http://en.irct.ir/trial/46519,None
536,1038,IRCT20200324046850N3,IRCT,2020-03-30,2020-04-20,False,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of naproxen on the healing process of patients with COVID-19,Drug,"Investigational: Naproxen

All Arms: Hydroxychloroquine + Lopinavir/Ritonavir",Naproxen; Hydroxychloroquine; Lopinavir/Ritonavi,80,http://en.irct.ir/trial/46718,None
537,1039,IRCT20180923041093N3,IRCT,2020-03-28,2020-04-02,False,Kerman University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of the myrtle syrup in the treatment of novel corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,http://en.irct.ir/trial/46721,None
538,1040,IRCT20180923041093N4,IRCT,2020-03-28,2020-04-02,False,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Efficacy of the barley-based remedy in the treatment of novel corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,http://en.irct.ir/trial/46728,None
539,1041,IRCT20200324046850N1,IRCT,2020-03-29,2020-06-06,False,Abadan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison of vitamin D3 and N-acetylcysteine prescription in COVID-19 patients   and their effect on recovery process,Drug,Vitamin D vs. N-acetylcysteine vs. Vitamin D + N-acetylcysteine,Vitamin D; N-acetylcysteine,100,http://en.irct.ir/trial/46732,None
540,1042,IRCT20190810044500N5,IRCT,2020-05-18,2020-04-04,True,Yazd Shahid Sadoughi University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of colchicine in treatment of COVID-19,Drug,Colchicine,Colchicine,200,http://en.irct.ir/trial/46867,None
541,1043,IRCT20200404046947N1,IRCT,2020-04-15,2020-03-28,True,Tehran University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Effect of Methylprednisolone on treatment of COVID-19,Drug,Corticosteroids,Methylprednisolone,68,http://en.irct.ir/trial/46904,None
542,1044,IRCT20151228025732N52,IRCT,2020-04-09,2020-04-07,True,Semnan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,A study on melatonin and Vitamin C and zinc efficacy in patients with COVID19,Drug,Melatonin + Vitamin C + Zinc,Melatonin; Vitamin C; Zinc,30,http://en.irct.ir/trial/46963,None
543,1045,IRCT20081027001411N3,IRCT,2020-06-01,2020-03-29,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of Prednisolone on treatment of COVID-19,Drug,Corticosteroids,Prednisolone,60,http://en.irct.ir/trial/46975,None
544,1046,IRCT20091201002804N12,IRCT,2020-06-01,2020-04-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of surfactant on clinical outcome of patients with COVID-19,Drug,Surfactant,Surfactant,60,http://en.irct.ir/trial/46983,None
545,1047,IRCT20200217046526N1,IRCT,2020-04-13,2020-03-15,True,Iranian Academic Center for Education Culture and Research,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),6,http://en.irct.ir/trial/47030,None
546,1048,IRCT20200411047016N1,IRCT,2020-05-31,2020-04-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of Stopcivir syrup in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://en.irct.ir/trial/47044,None
547,1049,IRCT20190727044343N3,IRCT,2020-06-12,2020-06-09,True,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,ANIF1 effect on COVID-19,Drug,ANIF1,ANIF1,60,http://en.irct.ir/trial/47062,None
548,1050,IRCT20200223046586N2,IRCT,2020-05-30,2020-05-18,True,Shahroud University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,web- based communication between nurse and family member,Telehealth,Telehealth,Telehealth,74,http://en.irct.ir/trial/47091,None
549,1051,IRCT20081019001369N6,IRCT,2020-05-17,2020-06-21,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Clinical trial of trans sodium crocetinate  against COVID-19,Drug,Trans Sodium Crocetinate,Trans Sodium Crocetinate,30,http://en.irct.ir/trial/47188,None
550,1052,IRCT20091012002582N21,IRCT,2020-05-18,2019-05-05,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Effect of intrapulmonary injection of processed serum derived from covid-19 patients in reduction of pulmonary complications,ATMP,Plasma,Plasma,30,http://en.irct.ir/trial/47197,None
551,1053,IRCT20200325046859N2,IRCT,2020-04-26,2020-04-22,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,effects of the 2-drug diet (hydroxychloroquine + umifenovir(Arbidol)) compared with Hydroxy chlorquine on the of mortality rate in patients with moderate symptoms of COVID-19 infections,Drug,Umifenovir + Hydroxycholoquine vs. Hydroxychloroquine,Umifenovir; Hydroxycholoquine,100,http://en.irct.ir/trial/47200,None
552,1054,IRCT20190418043307N1,IRCT,2020-05-17,2020-04-26,True,Ilam University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of selenium on covid-19 disease,Drug,Selenium,Selenium,100,http://en.irct.ir/trial/47209,None
553,1055,IRCT20200411047019N1,IRCT,2020-05-18,2020-06-04,False,Shiraz University of Mdical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of BCG Vaccine on Preventing COVID-19,ATMP,Vaccine,Vaccine,500,http://en.irct.ir/trial/47279,None
554,1056,IRCT20150303021315N19,IRCT,2020-05-27,2020-06-06,False,CinnaGen Company,Recruiting,Phase 2,Interventional,Iran,"Pembrolizumab (CinnaGen Co, Iran) in COVID-19",Drug,Pembrolizumab,Pembrolizumab,62,http://en.irct.ir/trial/47335,None
555,1057,IRCT20200209046427N1,IRCT,2020-06-07,2020-05-30,True,Shahid Beheshti University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of bee products on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47504,None
556,1058,IRCT20200428047228N1,IRCT,2020-05-16,2020-05-19,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficiency and safety of favipiravir + hydroxychloroquine drug regimen in comparison with hydroxychloroquine in hospitalized patients with covid-19,Drug,Favipiravir + Hydroxychloroquine vs. Hydroxychloroquine,Favipiravir; Hydroxychloroquine,50,http://en.irct.ir/trial/47559,None
557,1059,IRCT20200501047259N1,IRCT,2020-05-17,2020-05-09,True,Oroumia University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,IVIG and COVID19,ATMP,Immunoglobulin,Immunoglobulin,40,http://en.irct.ir/trial/47609,None
558,1060,IRCT20200115046144N2,IRCT,2020-05-21,2020-05-31,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effects of nokhod-ab on fatigue,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/47645,None
559,1061,IRCT20131129015584N3,IRCT,2020-05-20,2020-05-04,True,Mazandaran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of hot cupping on corona symptoms,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,68,http://en.irct.ir/trial/47665,None
560,1062,IRCT20150107020592N25,IRCT,2020-06-13,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Prone position effectiveness in Non invasive ventilation of covid-19 patients undergoing respiratory failure,Procedure,Positioning,Positioning,30,http://en.irct.ir/trial/47666,None
561,1063,IRCT20200502047268N1,IRCT,2020-05-16,2020-05-21,False,Semnan University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Evaluation of the effect of GCSF injection in treatment of COVID-19 patients with lymphopenia,Drug,Granulocyte colony-stimulating factor,Granulocyte colony-stimulating factor,10,http://en.irct.ir/trial/47692,None
562,1064,IRCT20200503047280N1,IRCT,2020-06-02,2020-05-09,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Laris-Teucrium Polium L.and Laris-Hyssop combined herbal medicine on the prevention of covid-19 disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://en.irct.ir/trial/47704,None
563,1065,IRCT20200418047126N1,IRCT,2020-05-14,2020-05-04,True,Ardabil University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of colchicine  in treatment of coronavirus,Drug,Colchicine,Colchicine,100,http://en.irct.ir/trial/47707,None
564,1066,IRCT20200405046951N1,IRCT,2020-06-11,2020-05-21,True,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Vitamin A and COVID-19,Drug,Vitamin A,Vitamin A,120,http://en.irct.ir/trial/47722,None
565,1067,IRCT20170211032494N3,IRCT,2020-05-25,2020-05-27,False,Tehran University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Low dose whole lung irradiation for treatment of COVID-19 pneumonia,Other,Radiation,Radiation,10,http://en.irct.ir/trial/47735,None
566,1068,IRCT20081011001323N25,IRCT,2020-05-17,2020-05-21,False,Yasouj University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy  of  extract of  of Zingiber  cinnamomum  and  zataria multiflora    in covid-19 disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/47935,None
567,1069,IRCT20200421047150N1,IRCT,2020-05-14,2020-05-12,True,DEY Company,Recruiting,Phase 2/Phase 3,Interventional,Iran,Stem cell treatment for COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),90,http://en.irct.ir/trial/47964,None
568,1070,IRCT20180923041093N6,IRCT,2020-06-11,2020-05-13,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The efficacy of  barely-based traditional remedy on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47974,None
569,1071,IRCT20200509047360N1,IRCT,2020-05-16,2020-05-03,True,Tehran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"The effect of cognitive-behavioral  intervention on improving COVID-19 fear symptoms, improving quality of life and improving mental health in patients with corona",Other (psych),Psychological,Psychological,60,http://en.irct.ir/trial/47979,None
570,1072,IRCT20140428017469N1,IRCT,2020-05-23,2020-06-13,False,Petroleum Industry Health Organization,Recruiting,Phase 3,Interventional,Iran,Polio Vaccine and COVID-19,ATMP,Vaccine,Vaccine,130000,http://en.irct.ir/trial/47989,None
571,1073,IRCT20200506047323N2,IRCT,2020-05-31,2020-05-21,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effects of Licorice in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47990,None
572,1074,IRCT20200509047373N1,IRCT,2020-05-23,2020-06-03,False,Health Medicine Chemistry Company,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation effect of Dinvl for Covid19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48001,None
573,1075,IRCT20151227025726N15,IRCT,2020-05-18,2020-04-08,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effects of Umifenovir (Arbidol) in COVID-19,Drug,Umifenovir,Umifenovir,100,http://en.irct.ir/trial/48018,None
574,1076,IRCT20150716023235N15,IRCT,2020-05-29,2020-05-21,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,sex hormones in coronavirus,Drug,Hormones,Hormones,80,http://en.irct.ir/trial/48019,None
575,1077,IRCT20200510047383N1,IRCT,2020-05-15,2020-05-21,False,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Tocilizumab on outcomes of the severe COVID-19 patients,Drug,Tocilizumab,Tocilizumab,100,http://en.irct.ir/trial/48024,None
576,1078,IRCT20120215009014N355,IRCT,2020-05-18,2020-06-04,False,Hamedan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluating the effect of intravenous N-acetyl cysteine versus placebo in the treatment of patients with mild and moderate acute respiratory distress syndrome caused by COVID-19,Drug,N-acetylcysteine,N-acetylcysteine,92,http://en.irct.ir/trial/48039,None
577,1079,IRCT20090609002017N35,IRCT,2020-05-17,2020-05-19,False,Tabriz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Assessment of boron-containing compounds  and Oleoylethanolamid  supplementation in the treatment of COVID-19,Drug,Boron vs. Oleoylethanolamid vs. Boron + Oleoylethanolamid,Boron; Oleoylethanolamid,40,http://en.irct.ir/trial/48058,None
578,1080,IRCT20080901001165N55,IRCT,2020-05-23,2020-05-13,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of N-Acetyl Cysteine (NAC) inhalation spray in controlling the symptoms of patients with COVID-19,Drug,N-acetylcysteine,N-acetylcysteine,72,http://en.irct.ir/trial/48061,None
579,1081,IRCT20080901001165N53,IRCT,2020-05-14,2020-05-14,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Interferon Beta1a nasal spray in controlling the symptoms of patients with COVID-19,Drug,Interferon beta,Interferon beta,100,http://en.irct.ir/trial/48066,None
580,1082,IRCT20200428047228N2,IRCT,2020-06-10,2020-05-19,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Hydroxychloroquine in comparison with hydroxychloroquine + azithromycin in  patients with covid-19,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,40,http://en.irct.ir/trial/48096,None
581,1083,IRCT20080901001165N60,IRCT,2020-05-28,2020-05-14,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of Provita Capsule in controlling the symptoms of patients with COVID-19,Supplement,Nutritional Supplement,Nutritional Supplement,30,http://en.irct.ir/trial/48102,None
582,1084,IRCT20200506047323N1,IRCT,2020-05-23,2020-05-21,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effects of Ginger in treatment COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,84,http://en.irct.ir/trial/48114,None
583,1085,IRCT20080901001165N56,IRCT,2020-05-23,2020-05-16,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Evaluation efficacy of ""Curcumin and Resveratrol"" capsule  in controlling symptoms in patients with COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48116,None
584,1086,IRCT20200405046960N2,IRCT,2020-05-19,2020-05-17,True,Ardabil University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48126,None
585,1087,IRCT20200516047462N1,IRCT,2020-05-17,2020-05-06,True,Kashan University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Intervention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://en.irct.ir/trial/48141,None
586,1088,IRCT20151227025726N17,IRCT,2020-05-31,2020-04-24,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evolution of the efficacy and safety of Dexamethasone administration in COVID-19,Drug,Corticosteroids vs. Lopinavir/ritonavir,Dexamethasone; Lopinavir/ritonavir,48,http://en.irct.ir/trial/48153,None
587,1089,IRCT20200516047468N1,IRCT,2020-05-19,2020-04-08,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Investigation of the effect of intravenous vitamin C on definite patients with coronavirus pneumonia,Drug,Vitamin C,Vitamin C,50,http://en.irct.ir/trial/48176,None
588,1090,IRCT20150107020592N23,IRCT,2020-05-31,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Plasmapheresis and plasma exchanges;usefulness in covid-19 critically ill patients,ATMP,Plasma,Plasma,15,http://en.irct.ir/trial/48185,None
589,1091,IRCT20160809029275N1,IRCT,2020-05-30,2020-06-14,False,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,stem cell therapy in Covid-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://en.irct.ir/trial/48187,None
590,1092,IRCT20151226025699N3,IRCT,2020-05-20,2020-06-04,False,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of omega-3 supplementation in COVID-19,Drug,Omega 3,Omega 3,50,http://en.irct.ir/trial/48213,None
591,1093,IRCT20180608040007N2,IRCT,2020-06-13,2020-04-28,True,Yazd Shahid Sadoughi University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Auriculotherapy  in treatment of Covid 19,Other,Auriculotherapy,Auriculotherapy,70,http://en.irct.ir/trial/48218,None
592,1094,IRCT20200517047485N1,IRCT,2020-05-29,2020-06-20,False,Arak University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Comparison of combination therapies of COVID_19,Drug,Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Atazanavir/ritonavir; Hydroxychloroquine; Lopinavir/ritonavir,108,http://en.irct.ir/trial/48226,None
593,1095,IRCT20150107020592N22,IRCT,2020-05-25,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Cyclosporin for the Prevention and Treatment of COVID-19 Disease,Drug,Cyclosporine,Cyclosporine,60,http://en.irct.ir/trial/48262,None
594,1096,IRCT20200518047497N1,IRCT,2020-05-21,2020-05-25,False,Tabriz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Laris - Hyssop combined herbal distilled on the improving clinical and paraclinical symptoms in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/48289,None
595,1097,IRCT20200519047510N1,IRCT,2020-05-28,2020-06-05,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the anti-inflammatory effects of curcumin in the treatment of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48292,None
596,1098,IRCT20151227025726N18,IRCT,2020-06-10,2020-06-22,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Pentaglobin effect in critically ill patients with COVID-19,Drug,Cyclosporine vs. Lopinavir/ritonavir,Cyclosporine; Lopinavir/ritonavir,30,http://en.irct.ir/trial/48312,None
597,1099,IRCT20161206031256N3,IRCT,2020-06-02,2020-05-23,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Using interferon to treat COVID-19,Drug,Interferon beta,Interferon beta,76,http://en.irct.ir/trial/48329,None
598,1100,IRCT20160126026217N4,IRCT,2020-06-08,2020-06-21,False,Khoram-Abad University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigation of the effects of prone position on  cardiac and respiratory status in patients with Coronavirus,Procedure,Positioning,Positioning,74,http://en.irct.ir/trial/48403,None
599,1101,IRCT20200422047168N2,IRCT,2020-05-30,2020-05-30,False,Ahvaz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Clinical trial study of the therapeutic effect of Ivermectin, besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19)",Drug,Ivermectin + Lopinavir/ritonavir + Chloriquine vs. Lopinavir/ritonavir + Chloriquine,Ivermectin; Lopinavir/ritonavir; Chloriquine,60,http://en.irct.ir/trial/48444,None
600,1102,IRCT20200523047550N1,IRCT,2020-06-06,2020-04-20,True,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Umifenovir in treatment of covid-19,Drug,Umifenovir + Hydroxychloroquine vs Hydroxychloroquine,Umifenovir; Hydroxychloroquine,50,http://en.irct.ir/trial/48495,None
601,1103,IRCT20160118026097N3,IRCT,2020-05-31,2020-03-20,True,Ghoum University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of interferon on the treatment of covid19 patients,Drug,Interferon beta,Interferon beta,60,http://en.irct.ir/trial/48517,None
602,1104,IRCT20150107020592N24,IRCT,2020-06-08,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Oxycodone administration on pain control in patients with COVID-19,Drug,Oxycodone,Oxycodone,60,http://en.irct.ir/trial/48534,None
603,1105,IRCT20200518047497N2,IRCT,2020-06-06,2020-06-20,False,Zahravi Pharmaceutical Company,Not Recruiting,Phase 3,Interventional,Iran,Effect of Dinvl on improving of clinical and paraclinical symptoms in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/48644,None
604,1106,IRCT20120703010178N20,IRCT,2020-06-13,2020-06-21,False,Persisgen Par Pharmaceutical Company,Not Recruiting,Phase 3,Interventional,Iran,effect of anakinra in treatment of COVID-19,Drug,Anakinra,Anakinra,30,http://en.irct.ir/trial/48702,None
605,1107,IRCT20200412047042N1,IRCT,2020-06-11,2020-06-19,False,Jahrom University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,"Evaluation the effect of raltegravir, and raltegravir/interferon beta combination on covid 19 patients",Drug,Hydroxychloroquine + Raltagravir vs. Hydroxychloroquine + Raltagravir + Interferon beta vs. Hydroxychloroquine,Raltagravir; Interferon beta; Hydroxychloroquine,60,http://en.irct.ir/trial/48749,None
606,1108,KCT0005096,CRIS,2020-06-08,2019-11-29,True,Chungnam National University Hospital,Recruiting,Phase 2,Interventional,South Korea,The Efficacy of Gentamicin-impregnated collagen (CollatampÂ®) in the Loop Electrosurgical Excision Procedure,Not relevant,Not relevant,Not relevant,52,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16278,None
607,1109,JPRN-jRCTs031190227,JPRN,2020-02-27,2020-01-04,True,Tokue Yutaka,Not Recruiting,Phase 2,Interventional,Japan,Triple combination therapy in patients infected with COVID-19,Drug,Lopinavir/ritonavir + hydroxychloroquine (w/ and w/o oseltamivir),Lopinavir/Ritonavir; Hydroxychloroquine; Oseltamivir,50,https://jrct.niph.go.jp/latest-detail/jRCTs031190227,None
608,1110,JPRN-jRCTs032200044,JPRN,2020-06-03,2020-03-06,True,Wakabayashi Kenji,Recruiting,Phase 1/Phase 2,Interventional,Japan,Clinical safety and usefulness of the simple ventilator,Other (physical),Mechanical ventilation,Mechanical ventilation,10,https://jrct.niph.go.jp/latest-detail/jRCTs032200044,None
609,1113,JPRN-UMIN000040341,JPRN,2020-05-09,2020-05-09,False,Takanawa Clinic,Not Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of Qing Fei Pai Du Tang for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046023,None
610,1115,JPRN-UMIN000040407,JPRN,2020-05-15,2020-05-15,False,Takanawa Clinic,Not Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of Jinhua Qinggan Granule for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046108,None
611,1118,JPRN-UMIN000040479,JPRN,2020-05-22,2020-05-22,False,Takanawa Clinic,Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of lactic acid bacteria for COVID-19,Drug,Lactic acid bacteria,Lactic acid bacteria,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046202,None
612,1127,JPRN-UMIN000040694,JPRN,2020-06-09,2020-06-10,False,Kinki Health Administration Center,Not Recruiting,Not Applicable,Interventional,Japan,SUrveillance of SARS-CoV-2 Virus Antibody in Health CarE and CloSe-Contact WorkerS,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046448,None
613,1128,ACTRN12620000500954,ANZCTR,2020-04-22,2020-01-05,True,Western Health,Not Recruiting,Not Applicable,Interventional,Australia,A reusable personalised ventilation hood: A phase 1 safety study of a new device (McMonty) in patients with suspected or confirmed COVID-19.,Other (device),Hood,Hood,20,https://anzctr.org.au/ACTRN12620000500954.aspx,None
614,1129,ACTRN12620000676910,ANZCTR,2020-06-15,2020-06-29,False,Monash Health,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Amnion cells for COVID-19 related respiratory failure,ATMP,Cells (amniotic epithelial),Cells (amniotic epithelial),40,https://anzctr.org.au/ACTRN12620000676910.aspx,None
615,1130,ISRCTN94091479,ISRCTN,2020-06-09,2020-06-15,False,"Tees, Esk and Wear Valleys NHS Foundation Trust",Recruiting,Not Applicable,Interventional,United Kingdom,Behavioural Activation in Social IsoLation (BASIL): Benefiting from activities to improve your mood while you are socially isolating,Other (psych),Psychological,Psychological,100,http://isrctn.com/ISRCTN94091479,None
616,1131,ISRCTN33578935,ISRCTN,2020-06-02,2020-01-06,True,Kimera Labs,Recruiting,Phase 2,Interventional,Germany,To study the treatment of COVID-19 with severe viral pneumonia by using purified stem cell exosomes,ATMP,Cells (mesenchymal),Cells (mesenchymal),64,http://isrctn.com/ISRCTN33578935,None
617,1132,ISRCTN21363594,ISRCTN,2020-05-18,2020-01-05,True,King Saud Medical City,Recruiting,Not Applicable,Interventional,"Saudi Arabia, United Arab Emirates, Oman",Therapeutic plasma exchange (removal of the non-cell portion of blood) in critically ill adult patients with serious SARS CoV-2 disease (COVID-19),ATMP,Plasma,Plasma,80,http://isrctn.com/ISRCTN21363594,None
618,1137,ChiCTR2000033936,ChiCTR,2020-06-17,2020-06-16,True,No Sponsor Name Given,Recruiting,Not Applicable,Prevention,China,Psychological Preparedness towards Novel Coronavirus Precautionary Measures â€“ an online survey,Other (psych),No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=55291,None
619,1141,EUCTR2020-001243-15-BE,EU Clinical Trials Register,2020-03-27,2020-03-26,True,UZ Leuven,Not Recruiting,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Itraconazole,Itraconazole,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001243-15,None
620,1142,EUCTR2020-001889-10-GB,EU Clinical Trials Register,2020-05-15,2020-02-06,True,University of Oxford,Authorised,Phase 2,Interventional,United Kingdom,Treating COVID-19 infections with inhaled corticosteroids,Drug,Budesonide,Budesonide,478,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001889-10,None
621,1143,EUCTR2020-002120-37-GB,EU Clinical Trials Register,2020-06-08,2020-06-16,False,Thirty Respiratory Limited,Authorised,Phase 2/Phase 3,Interventional,"Netherlands, United Kingdom, Italy, France, United States, Germany, Spain","An open-label, adaptive randomized, controlled multicenter study to evaluate the efficacy and safety of RESP301+SOC vs SOC in hospitalized participants with COVID-19 requiring supplemental oxygen",Drug,Sodium Nitrite,Sodium Nitrite,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002120-37,None
622,1144,EUCTR2020-002233-15-DE,EU Clinical Trials Register,2020-05-13,2020-06-17,False,Charité University,Authorised,Phase 2,Interventional,Germany,"A study to investigate the safety and efficacy of two approved drugs, niclosamide and camostat, administered alone and in combination and compared to placebo in COVID-19 patients",Drug,Niclosamide vs. Camostat Mesilate vs. Niclosamide + Camostat Mesilate,Niclosamide; Camostat Mesilate,72,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002233-15,None
623,1145,ACTRN12620000688987,ANZCTR,2020-06-19,2020-02-06,True,The Royal Melbourne Hospital,Not Recruiting,Not Applicable,Interventional,Australia,"Comparing the user seal check and fit test between two types of N95 respirators - the Halyard N95 Particulate Filter Respirators and the ProShieldÂ® N-95 masks
",Other (device),Mask,Mask,80,https://anzctr.org.au/ACTRN12620000688987.aspx,None
624,1149,ChiCTR2000034164,ChiCTR,2020-06-27,2020-07-08,False,Chinese Academy of Sciences,Not Recruiting,Not Applicable,Interventional,China,Trauma Healing Project Based on Chinese Mind-Body Wisdom in the novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,340,http://www.chictr.org.cn/showproj.aspx?proj=55154,None
625,1150,ChiCTR2000034112,ChiCTR,2020-06-24,2020-06-25,False,Shulan (Hangzhou) Hospital; Center for Disease Control and Prevention of Guangxi Zhuang Autonomous Region,Not Recruiting,Phase 1,Prevention,China,"A Phase I clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a SARS-CoV-2 mRNA vaccine in population aged 18-59 years and 60 years and above",ATMP,Vaccine,Vaccine,168,http://www.chictr.org.cn/showproj.aspx?proj=55524,None
626,1151,ChiCTR2000034076,ChiCTR,2020-06-22,2020-05-23,True,Beijing TIL Therapeutics,Recruiting,Not Applicable,Interventional,China,Novel coronavirus pneumonia (COVID-19) loaded autologous dendritic cell trial,ATMP,Cells (dendritic),Cells (dendritic),25,http://www.chictr.org.cn/showproj.aspx?proj=55582,None
627,1152,ChiCTR2000029589,ChiCTR,2020-02-05,2020-02-06,False,Beijing Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A prospective, randomized,open, multi-center clinical trial evaluating  the efficiency and safety of Reduning injection  in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49104,None
628,1153,EUCTR2020-001767-86-IE,EU Clinical Trials Register,2020-04-15,2020-06-25,False,University College Dublin,Authorised,Phase 2,Interventional,Ireland,trial comparing different doses of single-dose tocilizumab in adults with severe COVID-19 infection,Drug,Tocilizumab,Tocilizumab,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001767-86,None
629,1154,EUCTR2020-001777-71-GB,EU Clinical Trials Register,2020-04-30,2020-06-05,False,Guy's and St Thomas' NHS Foundation Trust,Authorised,Phase 4,Interventional,United Kingdom,Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patients,Drug,Ruxolitinib,Ruxolitinib,59,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001777-71,None
630,1155,EUCTR2020-001501-24-IT,EU Clinical Trials Register,2020-06-24,2020-04-28,True,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Authorised,Phase 2,Interventional,Italy,PROTECT: studio randomizzato con idrossiclorochina vs osservazione per la prevenzione e il trattamento precoce della malattia da coronavirus (COVID-19),Drug (+ Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001501-24,None
631,1156,EUCTR2020-001390-76-IT,EU Clinical Trials Register,2020-06-24,2020-04-27,True,IRCCS Istituto Nazionale per le Malattie Infettive “Lazzaro Spallanzani”,Authorised,Phase 3,Interventional,Italy,"A phase 3, randomized, open-labeled, multi-center study comparing clinical efficacy and safety of intravenous sarilumab plus standard of care compared to standard of care, in the treatment of patients with severe COVID-19 pneumonia .",Drug,Sarilumab,Sarilumab,171,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001390-76,None
632,1157,EUCTR2020-001528-32-IT,EU Clinical Trials Register,2020-06-24,2020-05-14,True,IRCCS Istituto Nazionale per le Malattie Infettive “Lazzaro Spallanzani”,Authorised,Phase 3,Interventional,Italy,Adaptive Randomized trial for therapy of COrona virus disease 2019 at home with oral antivirals,Drug,Lopinavir/ritonavir vs. Hydroxychloroquine vs. Darunavir vs. Favipiravir,Lopinavir/ritonavir; Hydroxychloroquine; Darunavir; Favipiravir,435,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001528-32,None
633,1158,EUCTR2020-001987-28-IT,EU Clinical Trials Register,2020-06-24,2020-06-05,True,IRCCS Ospedale San Raffaele,Authorised,Phase 3,Interventional,Italy,PRECOV: a randomized controlled clinical trial on the effects of hydroxychloroquine in the prevention of COVID-19 in healthcare workers at risk,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001987-28,None
634,1159,EUCTR2020-001921-30-IT,EU Clinical Trials Register,2020-06-26,2020-05-14,True,AOU di Modena,Authorised,Phase 3,Interventional,Italy,"Steroids and unfractionated heparin in critically-ill patients with pneumonia from COVID-19 infection. A multicenter, interventional, randomized, three arms study design.",Drug,"Corticosteroids, Heparin",Methylprednisolone; Heparin,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001921-30,None
635,1160,EUCTR2020-001795-15-IT,EU Clinical Trials Register,2020-06-26,2020-07-05,False,IRCCS Ospedale San Raffaele,Authorised,Phase 2,Interventional,Italy,Clinical study aimed to verify the efficacy and safety of mavrilimumab in COVID-19-associated pneumonia in patients who have signs of excessive inflammation,Drug,Mavrilimumab,Mavrilimumab,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001795-15,None
636,1161,EUCTR2020-001854-23-IT,EU Clinical Trials Register,2020-06-26,2020-04-27,True,Società Italiana di Malattie Infettive e Tropicali,Authorised,Phase 2/Phase 3,Interventional,Italy,A study with immunotherapy for Moderate COVID-19,Drug,Tocilizumab vs. Hydroxychloroquine vs. Siltuximab vs. Canakinumab vs. Sarilumab vs. Baricitinib vs. Methylprednisolone,Tocilizumab; Hydroxychloroquine; Siltuximab; Canakinumab; Sarilumab; Baricitinib; Methylprednisolone,1400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001854-23,None
637,1169,EUCTR2020-001271-33-FR,EU Clinical Trials Register,2020-03-24,2020-03-31,False,CHU Angers,Not Recruiting,Phase 3,Interventional,France,HYCOVID - Hydroxychloroquine versus placebo chez les patients ayant une infection COVID-19 Ã  risque dâ€™aggravation secondaire : Ã©tude prospective multicentrique randomisÃ©e en double aveugle,Drug,Hydroxychloroquine,Hydroxychloroquine,1300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001271-33,None
638,1170,EUCTR2020-001375-32-NL,EU Clinical Trials Register,2020-04-03,2020-03-04,False,University Medical Center Groningen,Authorised,Phase 2,Interventional,Netherlands,Early intervention with Tocilizumab in patients with COVID-19 and hypoxia,Drug,Tocilizumab,Tocilizumab,354,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001375-32,NL8504
639,1172,ISRCTN54917435,ISRCTN,2020-06-15,2020-06-25,False,Uppsala County Council,Recruiting,Not Applicable,Interventional,Sweden,Could prone positioning increase lung function for patients with severe COVID-19 infection?,Procedure,Positioning,Positioning,240,http://isrctn.com/ISRCTN54917435,None
640,1180,IRCT20151113025025N3,IRCT,2020-03-29,2020-04-05,False,Tehran University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Clinical Trial of renin-angiotensin-aldosterone system inhibitors with halting their administration and the effect on clinical outcomes of patients with coronavirus disease-2019 (COVID-19) referring to Sina and Imam-Khomeini Hospitals in 2020,Drug,RAAS inhibitors,RAAS inhibitors,60,http://en.irct.ir/trial/46531,None
641,1181,IRCT20200416047099N2,IRCT,2020-07-04,2020-06-21,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Plasma exchange in COVID-19 patients,ATMP,Plasma,Plasma,10,http://en.irct.ir/trial/47357,None
642,1182,IRCT20200428047229N1,IRCT,2020-06-27,2020-03-29,True,Esfahan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Medical Beer on COVID-19,Drug,Other,Other,60,http://en.irct.ir/trial/47530,None
643,1183,IRCT20200428047232N1,IRCT,2020-07-05,2020-05-09,True,Esfahan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Thalidomide in Covid 19 pneumonia,Drug,Thalidomide + Hydroxychloroquine vs. Hydroxychloroquine,Thalidomide; Hydroxychloroquine,60,http://en.irct.ir/trial/47637,None
644,1184,IRCT20200504047298N2,IRCT,2020-06-15,2020-07-10,False,Karaj University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Opuntia Cactus extract in patients with Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,48,http://en.irct.ir/trial/47675,None
645,1185,IRCT20171105037262N4,IRCT,2020-06-18,2020-04-29,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Adalimumab effect on COVID-19,Drug,Adalimumab + Chloroquine vs. Chloroquine,Adalimumab; Chloroquine,100,http://en.irct.ir/trial/47696,None
646,1186,IRCT20200508047345N1,IRCT,2020-06-14,2020-06-21,False,Shiraz University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Combined effects of Extracts on  Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47987,None
647,1187,IRCT20200511047396N1,IRCT,2020-05-16,2020-06-30,False,CinnaGen Company,Recruiting,Phase 3,Interventional,Iran,Efficacy evaluation of inhalation therapy (nasal spray) of Interferon Beta-1a in hospitalized Covid-19 patients,Drug,Interferon beta,Interferon beta,50,http://en.irct.ir/trial/48048,None
648,1188,IRCT20180425039414N3,IRCT,2020-06-17,2020-04-20,True,Esfahan University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of vitamin C and E in the treatment and clinical course of patients with SARS-cov2 (COVID-19),Drug,Vitamin C + Vitamin E + Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Vitamin C; Vitamin E; Hydroxychloroquine; Lopinavir/ritonavir,80,http://en.irct.ir/trial/48083,None
649,1189,IRCT20200510047385N1,IRCT,2020-07-07,2020-06-30,True,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of SVF and exosome in covid-19 patients with acute respiratory distress syndrome,ATMP,Exosomes,Exosomes,60,http://en.irct.ir/trial/48099,None
650,1190,IRCT20200513047426N1,IRCT,2020-06-27,2020-06-21,True,Boushehr University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The prophylactic effect of oral hydroxy-chloroquine in close contacts of COVID-19 patients,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,http://en.irct.ir/trial/48236,None
651,1191,IRCT20110726007117N11,IRCT,2020-07-05,2020-06-21,True,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of vitamin D supplementation in novel corona virus 2019,Drug,Vitamin D,Vitamin D,210,http://en.irct.ir/trial/48287,None
652,1192,IRCT20200112046089N1,IRCT,2020-06-25,2020-06-14,True,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Resveratrol in COVID19,Drug,Resveratrol,Resveratrol,50,http://en.irct.ir/trial/48330,None
653,1193,IRCT20200330046899N1,IRCT,2020-06-17,2020-04-20,True,Kerman University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effectiveness of herbal capsule in  COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://en.irct.ir/trial/48365,None
654,1194,IRCT20081027001411N4,IRCT,2020-07-09,2020-04-29,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of TOCILIZUMAB (ACTEMRA) on treatment of COVID-19,Drug,Tocilizumab,Tocilizumab,40,http://en.irct.ir/trial/48396,None
655,1195,IRCT20200525047562N1,IRCT,2020-06-14,2020-05-25,True,High Educational and Research Institute of Transfusion Medicine,Recruiting,Phase 3,Interventional,Iran,Treatment of Covid-19 patients with convalescent plasma,ATMP,Plasma,Plasma,100,http://en.irct.ir/trial/48493,None
656,1196,IRCT20200317046797N6,IRCT,2020-06-18,2020-06-21,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Edaravone in COVID-19,Drug,Edaravone,Edaravone,30,http://en.irct.ir/trial/48500,None
657,1197,IRCT20200504047298N1,IRCT,2020-06-14,2020-06-14,False,Alborz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Atazanavir/Ritonavirin treatment of COViD-19,Drug,Atazanavir/ritonavir vs. Lopinavir/ritonavir,Atazanavir/ritonavir; Lopinavir/ritonavir,100,http://en.irct.ir/trial/48640,None
658,1198,IRCT20200505047305N1,IRCT,2020-06-30,2020-06-06,True,Iran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Grief counseling in family members of the COVID-19 victims,Other (psych),Psychological,Psychological,120,http://en.irct.ir/trial/48683,None
659,1199,IRCT20150107020592N29,IRCT,2020-06-21,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of Blood Purification Techniques on  COVID-19 Pneumonia,Other (physical),Blood purification,Blood purification,12,http://en.irct.ir/trial/48695,None
660,1200,IRCT20200607047675N1,IRCT,2020-06-15,2020-06-19,False,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of traditional medicine combination based on the Ferula assa-foetida gum - Tragacanth in Participants with Moderate to Severe Coronavirus Disease (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/48700,None
661,1201,IRCT20200608047686N1,IRCT,2020-06-30,2020-05-31,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The role of metronidazole in COVID-19,Drug,Metronidazole,Metronidazole,30,http://en.irct.ir/trial/48717,None
662,1202,IRCT20150107020592N26,IRCT,2020-06-15,2020-03-20,True,Masih Daneshvari Hospital,Not Recruiting,Phase 3,Interventional,Iran,Favipiravir effectiveness in patients undergoing COVID19 Acute respiratory distress syndrome (ARDS),Drug,Favipiravir,Favipiravir,20,http://en.irct.ir/trial/48746,None
663,1203,IRCT20200609047707N1,IRCT,2020-06-24,2020-07-09,False,Esfarayen University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effective of Elman tablet on COVID-19 infection severity,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://en.irct.ir/trial/48764,None
664,1204,IRCT20200611047735N1,IRCT,2020-06-19,2020-07-05,False,Bandare-abbas University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of nano micelles containing curcumin (Sina Ccurcumin) as a therapeutic supplement in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/48843,None
665,1205,IRCT20150107020592N27,IRCT,2020-06-15,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of pentaglobin in the treatment of critically ill patients with COVID-19,ATMP,Immunoglobulin,Immunoglobulin,60,http://en.irct.ir/trial/48907,None
666,1206,IRCT20200515047456N1,IRCT,2020-06-28,2020-06-17,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The role of anticoagulant and thrombolitic in treatment of COVID patients,Drug,Heparin,Heparin,15,http://en.irct.ir/trial/48929,None
667,1207,IRCT20200611047727N1,IRCT,2020-06-24,2020-07-22,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The Effect of Inspiratory muscle training in patients with COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,40,http://en.irct.ir/trial/48941,None
668,1208,IRCT20150107020592N28,IRCT,2020-06-18,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effectiveness of borage based solutions in cytokine's levels in covid-19 ARDS patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://en.irct.ir/trial/48972,None
669,1209,IRCT20150107020592N30,IRCT,2020-07-10,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Prophylactic  Favipiravir  for Healthcare Workers in COVID-19 Pandemic,Drug (Chemoprophylaxis),Favipiravir,Favipiravir,30,http://en.irct.ir/trial/48992,None
670,1210,IRCT20200404046937N3,IRCT,2020-06-25,2020-06-27,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Evaluating the effect of Phyllanthus Emblica, Rosa Damascene, Marshmallow and Honey on COVID 19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/49029,None
671,1211,IRCT20150725023332N3,IRCT,2020-06-27,2020-04-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Bromelain and Montelukast  in Covid-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/49112,None
672,1212,IRCT20180712040446N2,IRCT,2020-07-01,2020-06-30,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the effect of  sweet almond on symptoms of COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/49120,None
673,1213,IRCT20190121042444N3,IRCT,2020-07-04,2020-02-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Considering the administration of Desferral supplementary and Vitamin C on the ferritin levels of Quid 19 patients,Drug,Deferoxamine + Vitamin C vs. Vitamin C,Deferoxamine; Vitamin C,78,http://en.irct.ir/trial/49132,None
674,1214,IRCT20111224008507N3,IRCT,2020-06-27,2020-05-21,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Ivermectin in the treatment of coronavirus infection,Drug,Ivermectin,Ivermectin,60,http://en.irct.ir/trial/49174,None
675,1215,IRCT20180519039711N6,IRCT,2020-06-29,2020-07-19,False,Arak University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Effect of mandala staining on anxiety in patients with COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/49186,None
676,1216,IRCT20200426047206N2,IRCT,2020-07-06,2020-07-22,False,Hamedan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The efficacy and safety of mesenchymal stem cell transplantation in patients with COVID-19 pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,http://en.irct.ir/trial/49385,None
677,1217,EUCTR2020-001325-31-NL,EU Clinical Trials Register,2020-04-07,2020-05-20,False,Radboud University Medical Centre,Authorised,Phase 2,Interventional,Netherlands,RDG-PET/CT imaging in COVID-19 patients.,Drug,Contrast agent,Contrast agent,10,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001325-31,None
678,1218,EUCTR2020-001270-29-GB,EU Clinical Trials Register,2020-03-30,2020-02-04,True,Sanofi,Not Recruiting,Phase 2/Phase 3,Interventional,"United Kingdom, Czech Republic, France, Germany, Denmark, Hungary",Hydroxychloroquine for COVID 19 in moderately to severely ill hospitalized patients,Drug,Hydroxychloroquine,Hydroxychloroquine,350,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001270-29,None
679,1219,EUCTR2020-001198-55-DK,EU Clinical Trials Register,2020-03-21,2020-03-04,True,Chronic Obstructive Pulmonary Disease Trial Network,Authorised,Phase 2,Interventional,Denmark,Early Treatment to Patients with Coronavirus (COVID),Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,226,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001198-55,None
680,1220,JPRN-jRCTs031190226,JPRN,2020-02-27,2020-03-14,False,Tokue Yutaka,Recruiting,Phase 2,Interventional,Japan,Favipiravir in patients infected with COVID-19,Drug,Favipiravir,Favipiravir,100,https://jrct.niph.go.jp/latest-detail/jRCTs031190226,None
681,1221,JPRN-jRCTs041200025,JPRN,2020-07-01,2020-01-07,True,Yuichiro Shindo,Recruiting,Phase 2,Interventional,Japan,Phase II trial of combination therapy with favipiravir and corticosteroids for COVID-19,Drug,Favipiravir + Corticosteroids,Favipiravir; Methylprednisolone,69,https://jrct.niph.go.jp/latest-detail/jRCTs041200025,None
682,1223,JPRN-UMIN000040733,JPRN,2020-06-22,2020-06-22,False,Kanagawa Dental University,Not Recruiting,Not Applicable,Interventional,Japan,A study on the prevalence of infection in dental institutions by measuring the antibody titer to COVID-19 of the staff members of Kanagawa Dental College Medical Center,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046461,None
683,1225,JPRN-UMIN000040838,JPRN,2020-07-01,2020-09-01,False,Hyogo College of Medicine,Not Recruiting,Not Applicable,Interventional,Japan,A seroprevalence study of COVID-19 in IBD patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046628,None
684,1226,NCT04471662,ClinicalTrials.gov,2020-07-13,2020-08-01,False,Tanta University,Not Recruiting,Phase 2,Interventional,No Country Given,Nelfinavir and Favipiravir Combination in Newly Diagnosed COVID19 Egyptian Patients,Drug,"Nelfinavir, Favipiravir",Nelfinavir; Favipiravir,50,https://clinicaltrials.gov/show/NCT04471662,None
685,1228,ACTRN12620000740998,ANZCTR,2020-07-16,2020-07-16,False,Royal Prince Alfred Hopsital,Not Recruiting,Not Applicable,Interventional,Australia,A Study of Lying Face Down to Help Improve Oxygen Levels of Adults Not Needing Ventilators in Intensive Care with COVID-19,Procedure,Positioning,Positioning,20,https://anzctr.org.au/ACTRN12620000740998.aspx,None
686,1229,ACTRN12620000731998,ANZCTR,2020-07-13,2020-01-09,True,Hunter New England Local Health District,Not Recruiting,Phase 1,Interventional,Australia,Will treating the overwhelming patient response with medications affect COVID-19 mortality?,Drug,Losartan,Losartan,36,https://anzctr.org.au/ACTRN12620000731998.aspx,None
687,1230,ACTRN12620000737932,ANZCTR,2020-07-14,2020-05-22,True,University of Southampton,Not Recruiting,Not Applicable,Interventional,United Kingdom,Nasal washout and gargling for healthcare staff in Care Homes during the COVID-19 pandemic: The Good-NIGHT COVID pilot study,Procedure,Gargling,Gargling,300,https://anzctr.org.au/ACTRN12620000737932.aspx,None
688,1233,ChiCTR2000034795,ChiCTR,2020-07-19,2020-01-28,True,Wuhan Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,The therapeutic efficacy of Xuan-Fei Bai-Du decoction in the treatment of novel coronavirus pneumonia (COVID-19): a pilot randomized controlled trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,42,http://www.chictr.org.cn/showproj.aspx?proj=56756,None
689,1234,ChiCTR2000034794,ChiCTR,2020-07-19,2020-05-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"Sancai granule improves lung and kidney function for patient with novel coronavirus pneumonia (COVID-19) in the recovery period: a randomized, parallel controlled trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=56771,None
690,1237,ChiCTR2000034780,ChiCTR,2020-07-18,2020-07-16,True,China National Biotec Group Co. Ltd,Recruiting,Phase 3,Interventional,UAE,A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells),ATMP,Vaccine,Vaccine,15000,http://www.chictr.org.cn/showproj.aspx?proj=56651,None
691,1239,EUCTR2020-001747-21-PT,EU Clinical Trials Register,2020-05-22,2020-06-07,False,Instituto de Saúde Pública da Universidade do Porto (ISPUP),Authorised,Phase 4,Interventional,Portugal,Efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19),Drug,Montelukast,Montelukast,160,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001747-21,None
692,1240,EUCTR2020-002106-68-GB,EU Clinical Trials Register,2020-07-07,2020-07-16,False,"University College, London",Authorised,Phase 2,Interventional,United Kingdom,FLARE: Favipiravir +/- Lopinavir: A RCT of Early antivirals,Drug,Favipiravir vs. Favipiravir + Lopinavir/ritonavir,Favipiravir; Lopinavir/ritonavir,240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002106-68,None
693,1241,EUCTR2020-001808-42-ES,EU Clinical Trials Register,2020-07-10,2020-06-17,True,Pharmamel S.L.,Authorised,Phase 2,Interventional,Spain,"PHASE II CLINICAL TRIAL, SINGLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED TO EXPLORE THE EFFECTIVENESS AND SAFETY OF MELATONIN  IN PATIENTS WITH COVID-19 ENTERED INTO THE INTENSIVE CARE UNIT",Drug,Melatonin,Melatonin,18,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001808-42,None
694,1246,EUCTR2020-001765-37-ES,EU Clinical Trials Register,2020-04-13,2020-11-04,False,Institut Català d'Oncologia,Not Recruiting,Phase 2,Interventional,Spain,Pragmatic clinical trial of hydroxychloroquine in the treatment of oncohematological patients and health professionals with COVID-19 infection without radiological alteration.,Drug,Hydroxychloroquine,Hydroxychloroquine,103,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001765-37,None
695,1247,EUCTR2020-001707-16-ES,EU Clinical Trials Register,2020-07-22,2020-06-25,True,IIS Biodonostia,Authorised,Phase 3,Interventional,Spain,"PHASE III RANDOMIZED, UNICENTRIC OPEN, CONTROLLED CLINICAL TRIAL TO DEMONSTRATE THE EFFECTIVENESS OF TOCILIZUMAB AGAINST SYSTEMIC CORTICOTHERAPY IN PATIENTS ENTERED BY COVID-19 WITH BILATERAL PNEUMONIA AND BAD EVOLUTION",Drug,Tocilizumab vs. Corticosteroids,Tocilizumab; Methylprednisolone,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001707-16,None
696,1248,EUCTR2020-001890-56-ES,EU Clinical Trials Register,2020-07-22,2020-10-06,False,Universidad Catlica de Murcia (UCAM),Authorised,Phase 4,Interventional,Spain,Clinical trial to evaluate the efficacy and safety of gammaglobulins in COVID-19 treatment,ATMP,Immunoglobulin,Immunoglobulin,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001890-56,None
697,1249,EUCTR2020-001794-77-ES,EU Clinical Trials Register,2020-07-22,2020-10-06,False,Institut Català d'Oncologia Girona - Hospital Dr. Josep Trueta,Authorised,Phase 2,Interventional,Spain,Randomised clinical trial to test if silibinin administration can prevent the respiratory failure secondary to the COVID19 lung infection in oncologic patients.,Drug,Silibinin,Silibinin,92,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001794-77,None
698,1250,EUCTR2020-001929-31-ES,EU Clinical Trials Register,2020-07-22,2020-06-16,True,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Authorised,Phase 4,Interventional,Spain,Controlled trial on the usefulness of pioglitazone treatment in patients with type 2 diabetes mellitus and COVID-19.,Drug,Pioglitazone,Pioglitazone,76,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001929-31,None
699,1251,EUCTR2020-002186-34-ES,EU Clinical Trials Register,2020-07-22,2020-03-06,True,Vall d'Hebron Research Institute (VHIR),Authorised,Phase 4,Interventional,Spain,Efficacy of the early use of corticotherapy in CoV-2 infection to prevent the progression of acute respiratory distress syndrome (ARDS),Drug,Corticosteroids,Methylprednisolone,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002186-34,None
700,1252,EUCTR2020-002310-41-ES,EU Clinical Trials Register,2020-07-22,2020-06-15,True,IIS Fundación Jiménez Díaz,Authorised,Phase 2,Interventional,Spain,â€œMADRID-COVIDâ€,Drug,Metoprolol,Metoprolol,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002310-41,None
701,1253,EUCTR2020-002166-13-ES,EU Clinical Trials Register,2020-07-22,2020-09-07,False,Dr. Ramn Lleonart Bellfill; Dr. Xavier Corbella Virs,Authorised,Phase 2,Interventional,Spain,Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients with SARS-CoV-2 (COVID-19) Infection,Drug,Icatibant,Icatibant,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002166-13,None
702,1254,EUCTR2020-002449-41-ES,EU Clinical Trials Register,2020-07-22,2020-06-15,True,Antonio Antela Lopez,Authorised,Phase 3,Interventional,Spain,"Pilot trial on early treatment with hydroxychloroquine in patients with
COVID-19 who do not have hospital admission at diagnosis.",Drug,Hydroxychloroquine,Hydroxychloroquine,340,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002449-41,None
703,1255,EUCTR2020-002668-29-GB,EU Clinical Trials Register,2020-06-10,2020-06-25,False,"University College, London",Authorised,Phase 2,Interventional,United Kingdom,plasma exchange in severe COVID-19 infection,ATMP,Plasma,Plasma,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002668-29,None
704,1256,ACTRN12620000588998,ANZCTR,2020-05-21,2020-05-29,False,Grand Medical Pty Ltd,No Status Given,Phase 2,Interventional,Australia,The safety and efficacy of STC3141 in patient with COVID-19 Acute Respiratory Distress Syndrome,Drug,STC3141,STC3141,160,https://anzctr.org.au/ACTRN12620000588998.aspx,None
705,1257,ACTRN12620000566932,ANZCTR,2020-05-14,2020-05-10,True,University of Sydney,Not Recruiting,Phase 3,Interventional,Australia,Randomised clinical trial of interventions for the treatment of COVID-19 in the community setting for high risk older people.,Drug,Hydroxychloroquine,Hydroxychloroquine,400,https://anzctr.org.au/ACTRN12620000566932.aspx,None
706,1265,EUCTR2020-002494-10-GB,EU Clinical Trials Register,2020-06-08,2020-07-17,False,Queen Mary University of London,Authorised,Phase 4,Interventional,United Kingdom,PERSONAL-COVIDBP,Drug,Amlodipine,Amlodipine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002494-10,None
707,1266,EUCTR2020-002476-13-GB,EU Clinical Trials Register,2020-06-29,2020-07-24,False,Imperial College London,Authorised,Phase 2,Interventional,United Kingdom,A study to look at the safety and success of using Clazakizumab in patients who have kidney disease and COVID-19.,Drug,Clazakizumab,Clazakizumab,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002476-13,None
708,1267,EUCTR2020-002952-18-GB,EU Clinical Trials Register,2020-07-09,2020-07-21,False,Ashford and St. Peter's Hospitals NHS Foundation Trust,Authorised,Phase 2/Phase 3,Interventional,United Kingdom,DEFEAT-COVID Study,Drug,Leflunomide,Leflunomide,178,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002952-18,None
709,1268,EUCTR2020-002091-12-BG,EU Clinical Trials Register,2020-05-05,2020-05-15,False,Huvepharma EOOD,Authorised,Phase 2,Interventional,Bulgaria,Study of ivermectin against COVID-19,Drug,Ivermectin,Ivermectin,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002091-12,None
710,1269,ACTRN12620000787987,ANZCTR,2020-08-04,2020-09-30,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Anxiety and Depression Arising from COVID-19-Related Financial Stress,Other (psych),Psychological,Psychological,206,https://anzctr.org.au/ACTRN12620000787987.aspx,None
711,1273,ChiCTR2000030259,ChiCTR,2020-02-26,2020-02-22,True,Shanghai Changzheng Hospital,Recruiting,Not Applicable,Interventional,China,"Evaluation Danoprevir sodium tablets combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19): a randomized, open and controlled trial",Drug,Danoprevir + Ritonavir,Danoprevir; Ritonavir,60,http://www.chictr.org.cn/showproj.aspx?proj=49918,None
712,1276,ISRCTN17896927,ISRCTN,2020-07-27,2020-07-17,True,Yale University,Not Recruiting,Not Applicable,Interventional,United States,Encouraging behavior to reduce the spread of COVID-19,Other,Other,Other,3000,http://isrctn.com/ISRCTN17896927,None
713,1277,ISRCTN17072692,ISRCTN,2020-06-04,2020-06-16,False,Imperial College London,Recruiting,Phase 1,Interventional,United Kingdom,Clinical trial to assess the safety of a coronavirus vaccine in healthy men and women,ATMP,Vaccine,Vaccine,320,http://isrctn.com/ISRCTN17072692,None
714,1278,EUCTR2020-001417-21-BE,EU Clinical Trials Register,2020-04-01,2020-12-04,False,Institute of Tropical Medicine,Not Recruiting,Phase 2,Interventional,Belgium,An open label single center randomized controlled trial to evaluate the effect of hydroxychloroquine on viral shedding in mild COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,206,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001417-21,None
715,1279,EUCTR2020-002102-58-BE,EU Clinical Trials Register,2020-05-06,2020-12-06,False,CHU de Liege,Authorised,Phase 2,Interventional,Belgium,Therapy with stem cells for Patients with severe COVID-19 infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002102-58,None
716,1280,EUCTR2020-001770-30-BE,EU Clinical Trials Register,2020-04-15,2020-04-21,False,CHU Ambroise Paré,Not Recruiting,Phase 2,Interventional,Belgium,Experimental use of tocilizumab in COVID-19 related pneumonia.,Drug,Tocilizumab,Tocilizumab,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001770-30,None
717,1281,EUCTR2020-002574-27-FR,EU Clinical Trials Register,2020-06-15,2020-07-08,False,Nantes University Hospital,Authorised,Phase 1/Phase 2,Interventional,France,A study to evaluate the safety and efficacy of XAV-19 in patients with COVID-19 induced moderate pneumonia,Drug,XAV-19,XAV-19,368,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002574-27,None
718,1282,JPRN-jRCTs051200036,JPRN,2020-07-27,2020-07-27,False,Umemura Yutaka,Recruiting,Phase 2,Interventional,Japan,Efficacy  of nintedanib on severe COVID-19 pneumonia.,Drug,Nintedanib,Nintedanib,30,https://jrct.niph.go.jp/latest-detail/jRCTs051200036,None
719,1284,JPRN-UMIN000040602,JPRN,2020-06-01,2020-06-15,False,Federal University of São Carlos,Recruiting,Phase 2,Interventional,South America,Homeopathy for Covid-19 in primary care,Other,Homeopathy,Homeopathy,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046338,None
720,1289,JPRN-UMIN000041160,JPRN,2020-08-01,2020-08-27,False,St. Luke's International University Graduate School,Not Recruiting,Not Applicable,Interventional,Japan,Evaluation study of preventing exacerbations for home care patients with chronic diseases by using dual-monitoring-based telenursing system-a prospective longitudinal mixed methods study,Telehealth,Telehealth,Telehealth,42,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047000,None
721,1294,ACTRN12620000786998,ANZCTR,2020-08-04,2020-08-24,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,A Digital Companion for Loneliness During the COVID-19 Pandemic: A Feasibility Study,Other,Other,Other,30,https://anzctr.org.au/ACTRN12620000786998.aspx,None
722,1295,ACTRN12620000795998,ANZCTR,2020-08-07,2020-05-31,True,Monash University,Not Recruiting,Not Applicable,Interventional,Bangladesh,COVID-19 Health and wellbeing Trial in Bangladesh,Other (psych),Psychological,Psychological,2402,https://anzctr.org.au/ACTRN12620000795998.aspx,None
723,1298,ACTRN12620000811909,ANZCTR,2020-08-13,2020-09-30,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Mood Training Program on Anxiety and Depression Arising from COVID-19-Related Stress,Other (psych),Psychological,Psychological,240,https://anzctr.org.au/ACTRN12620000811909.aspx,None
724,1299,ChiCTR2000035691,ChiCTR,2020-08-16,2020-08-20,False,Hunan Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 1,Prevention,China,"A randomized, double-blind, placebo-controlled phase I clinical trial for evaluation of the safety and tolerability of recombinant novel coronavirus vaccines (CHO cells) in healthy people aged 60 years and above",ATMP,Vaccine,Vaccine,50,http://www.chictr.org.cn/showproj.aspx?proj=58207,None
725,1301,ChiCTR2000032459,ChiCTR,2020-04-29,2020-04-29,False,Henan Provincial Center for Disease Control and Prevention,Recruiting,Phase 1/Phase 2,Interventional,China,A phase I/II clinical trial for inactivated novel coronavirus (2019-CoV) vaccine (Vero cells),ATMP,Vaccine,Vaccine,288,http://www.chictr.org.cn/showproj.aspx?proj=53003,None
726,1302,ChiCTR2000029822,ChiCTR,2020-02-14,2020-02-07,True,Nanjing Second Hospital,No Status Given,Not Applicable,Interventional,China,A randomized controlled trial for honeysuckle decoction in the treatment of patients with novel coronavirus (COVID-19) infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,110,http://www.chictr.org.cn/showproj.aspx?proj=49502,None
727,1303,ISRCTN15913068,ISRCTN,2020-08-07,2020-05-14,False,Revimmune,Recruiting,Phase 2,Interventional,United Kingdom,Study of investigational medicinal product CYT107 in patients with COVID-19 infection who have a low level of white blood cells in their blood (ILIAD 7 trial),Drug,CYT107,CYT107,48,http://isrctn.com/ISRCTN15913068,EUCTR2020-001786-36
728,1309,ISRCTN48734830,ISRCTN,2020-07-10,2020-03-08,True,Stockholm South General Hospital,Recruiting,Phase 4,Interventional,Sweden,Using the blood pressure medication losartan to improve outcomes for patients with SARS CoV-2,Drug,Losartan,Losartan,750,http://isrctn.com/ISRCTN48734830,None
729,1312,ISRCTN16912075,ISRCTN,2020-04-06,2020-06-04,False,University of Warwick,Recruiting,Not Applicable,Interventional,United Kingdom,"RECOVERY Respiratory Support: Respiratory Strategies in patients with coronavirus COVID-19 â€“ CPAP, high-flow nasal oxygen, and standard care",Drug,Oxygen,Oxygen,4002,http://isrctn.com/ISRCTN16912075,None
730,1315,IRCT20180725040596N2,IRCT,2020-04-18,2020-04-29,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Arbidol in treatment of COVID-19,Drug,Umifenovir + Hydroxychloroquine vs. Lopinavir/ritonavir vs. Hydroxychloroquine,Umifenovir; Hydroxychloroquine; Lopinavir/ritonavir,100,http://en.irct.ir/trial/46897,None
731,1316,IRCT20200408046987N1,IRCT,2020-04-27,2020-05-04,False,Chistasazan Notash Fartak Company Limited.,Not Recruiting,Phase 3,Interventional,Iran,Dose-Finding Study of Ivermectin in the Treatment of COVID-19,Drug,Ivermectin,Ivermectin,125,http://en.irct.ir/trial/47012,None
732,1317,IRCT20200404046937N2,IRCT,2020-04-13,2020-04-13,False,Ahvaz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Phyllanthus Emblica on COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47016,None
733,1318,IRCT20200414047076N1,IRCT,2020-08-01,2020-04-18,True,Esfahan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Evaluate the efficacy of hydroxychloroquine in the prevention of SARS-COV2 infection in high risk health care workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,160,http://en.irct.ir/trial/47286,None
734,1319,IRCT20170922036314N4,IRCT,2020-06-22,2020-07-10,False,Mashhad University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,"The effects of self-care cellphone application on stress, anxiety and depression among admitted patients with COVID-19",Other (psych),Psychological,Psychological,112,http://en.irct.ir/trial/47383,None
735,1320,IRCT20200503047281N1,IRCT,2020-07-25,2020-09-22,False,Yazd Shahid Sadoughi University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of Convalescent Plasma Therapy for COVID-19 Patients,ATMP,Plasma,Plasma,40,http://en.irct.ir/trial/47632,None
736,1321,IRCT20200505047318N1,IRCT,2020-08-06,2020-03-20,True,Qazvin University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of finasterid on COVID-19 treatment,Drug,Finasterid + Hydroxychloroquine + Ceftriaxone vs. Hydroxychloroquine + Ceftriaxone,Finasterid; Hydroxychloroquine; Ceftriaxone,80,http://en.irct.ir/trial/48007,None
737,1322,IRCT20110907007511N4,IRCT,2020-07-25,2020-05-16,True,Gorgan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Lavender syrup on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://en.irct.ir/trial/48013,None
738,1323,IRCT20200511047399N1,IRCT,2020-07-23,2020-02-20,True,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of omega-3 on diabetic patients with Covid-19,Drug,Omega 3,Omega 3,30,http://en.irct.ir/trial/48045,None
739,1324,IRCT20200522047545N1,IRCT,2020-08-05,2020-07-31,True,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of herbal compound containing Anacyclus pyrethrum, Senna, Ferrula asafoetida and Terminalia chebula in COVID19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://en.irct.ir/trial/48351,None
740,1325,IRCT20200522047542N1,IRCT,2020-08-04,2020-07-18,True,Mashhad University of Medical Sciences,Recruiting,Phase 1,Interventional,Iran,Effect of Corton on olfactory dysfunction in COVID-19 patients,Drug,Corticosteroids,Mometasone,70,http://en.irct.ir/trial/48379,None
741,1326,IRCT20080901001165N58,IRCT,2020-05-27,2020-04-29,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the efficacy and safety of Plasmapheresis in patients with Moderate to severe COVID-19,ATMP,Plasma,Plasma,100,http://en.irct.ir/trial/48394,None
742,1327,IRCT20200525047570N1,IRCT,2020-07-30,2020-07-31,False,Tabriz University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,"A comparative study of the effects of Tocilizumab?, interferon-gamma and vitamin C on the recovery of critically ill Covid-19 patients and cytokine storm",Drug,Tocilizumab vs. Interferon gamma + Vitamine C,Tocilizumab; Interferon gamma; Vitamine C,60,http://en.irct.ir/trial/48583,None
743,1328,IRCT20200607047682N1,IRCT,2020-07-27,2020-06-09,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Clinical trial of Annual SZ drug in Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48727,None
744,1329,IRCT20200610047722N1,IRCT,2020-07-07,2020-06-21,True,Hossein Nik Tale,Not Recruiting,Not Applicable,Interventional,Iran,?Effect of Allicin derivatives capsule in treatment of patients with new Coronavirus,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/48869,None
745,1330,IRCT20190602043787N3,IRCT,2020-07-20,2020-07-22,False,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Ivermectin effect in the treatment of patients with covid-19,Drug,Ivermectin vs. Hydroxychloroquine,Ivermectin; Hydroxychloroquine,40,http://en.irct.ir/trial/49180,None
746,1331,IRCT20190624043993N3,IRCT,2020-07-23,2020-08-22,False,Kermanshah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The evaluation of isotretinoineffects on treatment of COVID-19 infections,Drug,Isotretinoin,Isotretinoin,50,http://en.irct.ir/trial/49257,None
747,1332,IRCT20190624043993N2,IRCT,2020-07-12,2020-08-22,False,Kermanshah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of ivermectin effects on Covid-19,Drug,Ivermectin,Ivermectin,50,http://en.irct.ir/trial/49280,None
748,1333,IRCT20200105046009N4,IRCT,2020-07-18,2020-06-30,True,Babol University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,management of the  pulmonary diseases based on Persian medicine in patients infected with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/49365,None
749,1334,IRCT20200506047323N3,IRCT,2020-07-22,2020-07-25,False,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effects of Favipiravir and Lopinavir/Ritonavir in treatment COVID-19,Drug,Favipiravir + Lopinavir/ritonavir vs Lopinavir/ritonavir,Favipiravir; Lopinavir/ritonavir,60,http://en.irct.ir/trial/49463,None
750,1335,IRCT20200705048013N1,IRCT,2020-07-19,2020-02-20,True,Karaj University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of Pentoxifylline in patients with Covid-19,Drug,Pentoxifylline vs. Vitamin D + Hydroxychloroquine,Pentoxifylline; Vitamin D; Hydroxychloroquine,150,http://en.irct.ir/trial/49525,None
751,1336,IRCT20190406043175N3,IRCT,2020-07-12,2020-08-22,False,Mashhad University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The effect of diet based on traditional medicine on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/49530,None
752,1337,IRCT20170117032025N7,IRCT,2020-07-12,2020-07-11,True,Hamedan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effectiveness of Mouthwashes in Early Reducing the mouth Viral Load Among COVID-19 Patients,Drug,Povidone Iodine,Povidone Iodine,60,http://en.irct.ir/trial/49534,None
753,1338,IRCT20190415043279N6,IRCT,2020-07-24,2020-07-10,True,Sanandaj University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Afsantin on COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/49544,None
754,1339,IRCT20200426047206N3,IRCT,2020-07-21,2020-07-22,False,Hamedan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Cyclosporine in prognosis and clinical improvement in patients with COVID-19,Drug,Cyclosporine,Cyclosporine,48,http://en.irct.ir/trial/49579,None
755,1340,IRCT20200408046990N3,IRCT,2020-07-16,2020-07-21,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,"Evaluation of atorvastatin tablet as an adjuvant treatment for patients with mild to moderate COVID-19 in Qaem Hospital, Mashhad",Drug,Atorvostatin,Atorvostatin,40,http://en.irct.ir/trial/49629,None
756,1341,IRCT20151227025726N20,IRCT,2020-07-26,2020-07-09,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patients,ATMP,Immunoglobulin,Immunoglobulin,80,http://en.irct.ir/trial/49638,None
757,1342,IRCT20101020004976N6,IRCT,2020-07-18,2020-05-14,True,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of  LactocareÂ® synbiotic on the prevention of COVID-19 infection in the staff of emergency department,Supplement,Probiotics,Probiotics,80,http://en.irct.ir/trial/49670,None
758,1343,IRCT20180513039641N2,IRCT,2020-07-27,2020-07-26,True,Ghoum University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Determination of dandelion capsule on patient with Covid-19 virus,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/49803,None
759,1344,IRCT20200506047323N4,IRCT,2020-08-01,2020-08-10,False,Bandare-abbas University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Desferal in COVID-19,Drug,Deferoxamine vs. Hydroxychloroquine,Deferoxamine; Hydroxychloroquine,60,http://en.irct.ir/trial/49881,None
760,1345,IRCT20200723048178N1,IRCT,2020-07-28,2020-07-28,False,Shaheed Zulfiqar Ali Bhutto Medical University,Recruiting,Not Applicable,Interventional,Pakistan,nimesulide in COVID-19 infection,Drug,Nimesulide,Nimesulide,60,http://en.irct.ir/trial/49901,None
761,1346,IRCT20160131026298N4,IRCT,2020-08-04,2020-04-20,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effectiveness of Cyclotide complex herbal syrup in preventing COVID-19 virus in exposed individuals,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/49925,None
762,1347,IRCT20200404046937N4,IRCT,2020-08-06,2020-07-30,True,Ahvaz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluating the effect of Ivermectin on covid 19 patients,Drug,Ivermectin,Ivermectin,60,http://en.irct.ir/trial/49935,None
763,1348,KCT0005307,CRIS,2020-08-11,2020-09-30,False,Dong-A University Hospital,Recruiting,Phase 2,Interventional,South Korea,AN OPEN LABEL PHYSICIAN INITIATED 28 DAY PHASE 2A STUDY OF IFENPRODIL ON LUNG FUNCTION IN CONFIRMED COVID-19 INFECTED PATIENTS WITH SEVERE PNEUMONIA,Drug,Ifenprodil,Ifenprodil,40,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17062,None
764,1350,EUCTR2020-001333-13-FR,EU Clinical Trials Register,2020-04-02,2020-09-04,False,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Phase 3,Interventional,France,Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19 : a randomized controlled trial,Drug,Dexamethasone + hydroxychloroquine vs. hydroxychloroquine,Dexamethasone; hydroxychloroquine,122,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001333-13,None
765,1351,EUCTR2020-002038-33-FI,EU Clinical Trials Register,2020-06-26,2020-07-16,False,Porin Kaupunki,Authorised,Phase 2,Interventional,Finland,Trial of hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting,Drug,Hydroxychloroquine,Hydroxychloroquine,600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002038-33,None
766,1352,EUCTR2020-002458-25-IT,EU Clinical Trials Register,2020-08-10,2020-06-23,True,IRCCS Ospedale San Raffaele,Authorised,Phase 2,Interventional,Italy,"Clinical study for the treatment with Interferon-ÃŸ-1a (IFNÃŸ-1a) of COVID-19 patients: randomized, controlled, open label",Drug,Interferon beta,Interferon beta,126,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002458-25,None
767,1353,EUCTR2020-002283-32-IT,EU Clinical Trials Register,2020-08-10,2020-12-06,False,IRCCS Don Calabria Ospedale Sacro Cuore,Authorised,Phase 2,Interventional,"Italy, Spain","Randomized, Double-blind, Multi Centre Phase II, Dose Finding Clinical Trial on Ivermectin for the early Treatment of COVID-19",Drug,Ivermectin,Ivermectin,122,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002283-32,None
768,1354,EUCTR2020-001739-28-BE,EU Clinical Trials Register,2020-04-10,2020-05-20,False,UZ Leuven,Authorised,Phase 2,Interventional,Belgium,"A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19.

",Drug,"Aprotinin, Heparin, Anakinra, Nadroparin",Aprotinin; Heparin; Anakinra; Nadroparin,210,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001739-28,None
769,1356,ACTRN12620000816954,ANZCTR,2020-08-14,2020-08-17,False,Atossa Therapeutics Inc,Not Recruiting,Phase 1,Interventional,Australia,"A Double-blinded, Randomised, and Placebo-controlled Safety Study of AT-301 Nasal Spray in Healthy Adults",Drug,AT-301,AT-301,32,https://anzctr.org.au/ACTRN12620000816954.aspx,None
770,1359,ISRCTN40302986,ISRCTN,2020-05-26,2020-06-22,False,Lagos University Teaching Hospital,Recruiting,Phase 3,Interventional,Nigeria,Does ivermectin cure and/or prevent COVID-19?,Drug (+ Chemoprophylaxis),Ivermectin,Ivermectin,45,http://isrctn.com/ISRCTN40302986,None
771,1363,ACTRN12620000840987,ANZCTR,2020-08-26,2020-05-05,True,Royal Perth Hospital,Recruiting,Phase 1,Interventional,Australia,Mesenchymal stromal cell (MSC) therapy for COVID-19 pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,https://anzctr.org.au/ACTRN12620000840987.aspx,None
772,1365,ACTRN12620000843954,ANZCTR,2020-08-26,2020-01-09,True,Peter MacCallum Cancer Centre,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer. Arm 1 : Prevention in patients not infected with COVID-19.",Drug,"Interferon alpha, lenzilumab, selinexor",Interferon alpha; lenzilumab; selinexor,1914,https://anzctr.org.au/ACTRN12620000843954.aspx,None
773,1366,ACTRN12620000842965,ANZCTR,2020-08-26,2020-01-09,True,Peter MacCallum Cancer Centre,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer. 
Arm 2 : Post-exposure prevention in patients recently exposed to COVID-19",Drug,"Interferon alpha, lenzilumab, selinexor",Interferon alpha; lenzilumab; selinexor,170,https://anzctr.org.au/ACTRN12620000842965.aspx,None
774,1367,ACTRN12620000841976,ANZCTR,2020-08-26,2020-01-09,True,Peter MacCallum Cancer Centre,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer. 
Arm 3: treatment among cancer patients with moderate COVID-19 infection.",Drug,"Interferon alpha, lenzilumab, selinexor",Interferon alpha; lenzilumab; selinexor,126,https://anzctr.org.au/ACTRN12620000841976.aspx,None
775,1368,ACTRN12620000844943,ANZCTR,2020-08-26,2020-01-09,True,Peter MacCallum Cancer Centre,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer
Arm 4: treatment among cancer patients with severe COVID-19 infection.",Drug,"Interferon alpha, lenzilumab, selinexor",Interferon alpha; lenzilumab; selinexor,72,https://anzctr.org.au/ACTRN12620000844943.aspx,None
776,1373,ChiCTR2000035633,ChiCTR,2020-08-15,2020-11-13,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,China,"Clinical study of safety, tolerance, and pharmacokinetics of nebulizer (INF-K + anti-inflammatory factor TFF2) in healthy volunteers and exploration of PK/PD fitting modeling in clinical trials of Novel Coronavirus Pneumonia (COVID-19) patients",Drug,Interferon kappa + TFF2,Interferon kappa; TFF2,32,http://www.chictr.org.cn/showproj.aspx?proj=57741,None
777,1374,ChiCTR2000032165,ChiCTR,2020-04-21,2020-04-25,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, parallel-controlled trial for Qi-Mai-Fei-Luo-Ping Mixture in the improvement of lung function of novel coronavirus pneumonia (COVID-19) in the convalescent period",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=52679,None
778,1375,EUCTR2020-001408-41-DE,EU Clinical Trials Register,2020-04-07,2020-04-21,True,"University Hospital, Freiburg",Not Recruiting,Phase 2,Interventional,Germany,Evaluation of efficacy and safety of an tocilizumab treatment in patients with severe COVID-19 pneumonia,Drug,Tocilizumab,Tocilizumab,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001408-41,DRKS00021238
779,1376,ACTRN12620000876998,ANZCTR,2020-09-03,2020-08-14,True,University of New South Wales,Recruiting,Not Applicable,Interventional,Australia,The Building Educatorsâ€™ Skills in Adolescent Mental Health (BEAM) study: A cluster randomised-controlled trial of an adolescent mental health training program for secondary school Educators,Other (psych),Psychological,Psychological,234,https://anzctr.org.au/ACTRN12620000876998.aspx,None
780,1379,ISRCTN33260034,ISRCTN,2020-08-20,2020-10-20,True,University of Oxford,Recruiting,Phase 2,Interventional,United Kingdom,Adalimumab for coronavirus in community care,Drug,Adalimumab,Adalimumab,750,http://isrctn.com/ISRCTN33260034,EUCTR2020-003628-18
781,1381,ISRCTN99248812,ISRCTN,2020-05-29,2020-05-30,False,University of Oxford,Not Recruiting,Not Applicable,Interventional,United Kingdom,Peer support training for adolescents during the COVID-19 outbreak,Other (psych),Psychological,Psychological,100,http://isrctn.com/ISRCTN99248812,None
782,1382,EUCTR2020-002394-94-BE,EU Clinical Trials Register,2020-06-04,2020-06-22,False,Dr. De Backer Wilfried BV,Authorised,Phase 2,Interventional,Belgium,"Pulsed, inhaled nitric oxide (iNO) for the treatment of patients with mild or
moderate corona virus disease (COVID-19)",Drug,Nitric oxide,Nitric oxide,6,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002394-94,None
783,1383,JPRN-JapicCTI-205238,JPRN,2020-03-27,2020-03-31,False,"FUJIFILM Toyama Chemical Co., Ltd.",Not Recruiting,Phase 3,Interventional,Japan,Phase 3 Clinical Study of Favipiravir in Patients with COVID-19 Non-Severe Pneumonia,Drug,Favipiravir,Favipiravir,96,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238,None
784,1384,JPRN-JapicCTI-205416,JPRN,2020-08-19,2020-01-09,True,"Rohto Pharmaceutical Co., Ltd.",Not Recruiting,Phase 1,Interventional,Japan,An Exploratory Study of ADR-001 in Patients with Severe Pneumonia caused by SARS-CoV-2 infection (COVID-19),Drug,ADR-001,ADR-001,6,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205416,None
785,1386,JPRN-jRCT2071200023,JPRN,2020-07-21,2020-07-22,False,Miyazaki Taiga,Recruiting,Phase 1/Phase 2,Interventional,Japan,Evaluation of Nelfinavir for asymptomatic and mild COVID-19,Drug,Nelfinavir,Nelfinavir,120,https://jrct.niph.go.jp/latest-detail/jRCT2071200023,None
786,1387,JPRN-jRCTs021200020,JPRN,2020-08-25,2020-08-25,False,Takayama Takayama Shin,Recruiting,Phase 3,Interventional,Japan,Study of the additional effect of Kampo medicine on common cold symptoms in COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,https://jrct.niph.go.jp/latest-detail/jRCTs021200020,None
787,1388,JPRN-jRCTs041190120,JPRN,2020-03-02,2020-02-03,True,Doi Yohei,Not Recruiting,Phase 2,Interventional,Japan,Favipiravir for SARS-CoV-infected patients,Drug,Favipiravir,Favipiravir,86,https://jrct.niph.go.jp/latest-detail/jRCTs041190120,None
788,1391,JPRN-UMIN000040837,JPRN,2020-06-24,2020-05-27,True,Tokyo Dental College Ichikawa General Hospital,Not Recruiting,Not Applicable,Interventional,Japan,A Randomized Controlled trial Investigating the Effectiveness of VR(Virtual Reality)-based Cognitive Behavioral Therapy (VR-CBT) for Adult Depression in the Covid-19 Pandemic,Other (psych),Psychological,Psychological,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046623,None
789,1398,IRCT20200402046917N1,IRCT,2020-08-31,2020-08-22,True,Semnan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,therapeutic effect of Rosa Damascena extract in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://en.irct.ir/trial/46938,None
790,1399,IRCT20170128032241N3,IRCT,2020-08-17,2020-05-21,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the Efficacy of CURCUDEN 35 in Patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://en.irct.ir/trial/47031,None
791,1400,IRCT20200409047007N1,IRCT,2020-04-12,2020-04-13,False,Mashhad University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Effect of COVID 19 survivors plasma in COVID 19 patients with ARDS,ATMP,Plasma,Plasma,64,http://en.irct.ir/trial/47058,None
792,1401,IRCT20200418047119N1,IRCT,2020-09-01,2020-08-31,True,Kermanshah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of curcumin in treatment of respiratory syndrome of corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,42,http://en.irct.ir/trial/47231,None
793,1402,IRCT20151222025660N2,IRCT,2020-05-04,2020-04-13,True,Arak University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The prophylactic effect of Hydroxychloroquine on Novel Corona virus,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,90,http://en.irct.ir/trial/47319,None
794,1403,IRCT20200514047445N1,IRCT,2020-08-10,2020-08-05,True,Bandare-abbas University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of curcumin in improving patients with covid -19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48275,None
795,1404,IRCT20190131042569N5,IRCT,2020-08-23,2020-06-29,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of nebulizing Peppermint extract and Rose extract on percentage of blood oxygen saturation in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48311,None
796,1405,IRCT20200527047581N1,IRCT,2020-08-23,2020-06-05,True,Kashan University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of  oral health care and mouth rinse in treatment of Covid-19,Drug,Chlorhexidine + povidone iodine,Chlorhexidine; Povidone Iodine,200,http://en.irct.ir/trial/48447,None
797,1406,IRCT20200616047792N1,IRCT,2020-08-03,2020-08-18,False,Ahvaz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,A study of therapeutic effect of blood ozone therapy of severe Covid-19 patients,Drug,Ozone,Ozone,60,http://en.irct.ir/trial/48978,None
798,1407,IRCT20200616047799N1,IRCT,2020-08-23,2020-06-30,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Photobiomodulation anti-inflammatory effect in COVID-19,Other (device),Low-Level Laser Therapy,Low-Level Laser Therapy,40,http://en.irct.ir/trial/49012,None
799,1408,IRCT20090304001739N3,IRCT,2020-09-01,2020-04-02,True,Khoram-Abad University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of slow release mucoadhesive paste ofâ€ MUCODENTOL â€œ in oral vestibule on symptoms of COVID-19 disease  in hospital staff,Other,Mucodentol,Mucodentol,1600,http://en.irct.ir/trial/49065,None
800,1409,IRCT20200623047897N1,IRCT,2020-08-16,2020-05-21,True,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of N-acetylcysteine in patients with COVID-19,Drug,"N-acetylcysteine, Lopinavir/ritonavir, hydroxychloroquine, atazanavir",N-acetylcysteineN-acetylcysteine; Lopinavir/ritonavir; hydroxychloroquine; atazanavir,60,http://en.irct.ir/trial/49277,None
801,1410,IRCT20200509047364N1,IRCT,2020-08-09,2020-06-21,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of erythropoietin on COVID-19,Drug,"Erythropoietin + Standard Treatment (Hydroxychloroquine, Chloroquine, Lopinavir/Rionavir, Atazanavir) vs. Standard Treatment",Erythropoietin; Hydroxychloroquine; Chloroquine; Lopinavir/Rionavir; Atazanavir,20,http://en.irct.ir/trial/49282,None
802,1411,IRCT20200630047962N1,IRCT,2020-08-21,2020-08-07,True,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of progressive muscle relaxation on covid-19 anxiety in pregnant women,Other (psych),Psychological,Psychological,126,http://en.irct.ir/trial/49309,None
803,1412,IRCT20200705048011N1,IRCT,2020-08-16,2020-08-22,False,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Garlic and cinnamon on the treatment of patients with corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,45,http://en.irct.ir/trial/49481,None
804,1413,IRCT20190312043030N2,IRCT,2020-08-19,2020-06-29,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"The effect of selenium, vitamin C and methylprednisolone combination on mortality and morbidity of Covid-19 patients.",Drug,Corticosteroids + selenium + methylprednisolone + Lopinavir/ritonavir + hydroxychloroquine vs. Lopinavir/ritonavir + hydroxychloroquine ,Methylprednisolone; Selenium; Methylprednisolone; Lopinavir/ritonavir; Hydroxychloroquine ,40,http://en.irct.ir/trial/49508,None
805,1414,IRCT20170716035126N4,IRCT,2020-08-26,2020-07-10,True,Ardabil University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The efficacy of methylprednisolone mini pulse on the treatment of COVID-19 patients admitted to intensive care unit,Drug,Corticosteroids,Methylprednisolone,60,http://en.irct.ir/trial/49519,None
806,1415,IRCT20200711048076N1,IRCT,2020-09-05,2020-05-21,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of mucodentol on covid-19 symptoms,Other,Mucodentol,Mucodentol,600,http://en.irct.ir/trial/49555,None
807,1416,IRCT20200509047364N2,IRCT,2020-08-17,2020-06-21,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Famotidine and COVID-19,Drug,Famotidine + Hydroxychloroquine/Chloroquine + Lopinavir/Atazanavir/Ritonavir vs. Hydroxychloroquine/Chloroquine + Lopinavir/Atazanavir/Ritonavir,Famotidine; Hydroxychloroquine; Chloroquine; Lopinavir/ritonavir; Atazanavir/ritonavir,20,http://en.irct.ir/trial/49657,None
808,1417,IRCT20200718048129N1,IRCT,2020-08-11,2020-08-22,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Hydroxychloroquine and Clarithromycin in dyspnea and caugh caused by COVID-19 in recovery phase,Drug,Hydroxychloroquine vs. Clarithromycin,Hydroxychloroquine; Clarithromycin,45,http://en.irct.ir/trial/49729,None
809,1418,IRCT20200725048199N1,IRCT,2020-08-11,2020-08-10,True,Dezfoul University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Shalomin on the treatment and improvement of symptoms in patients with Covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,146,http://en.irct.ir/trial/49853,None
810,1419,IRCT20160808029264N9,IRCT,2020-08-15,2020-09-20,False,Semnan University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of chest physiotherapy in COVID-19 patients with respiratory infection,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,44,http://en.irct.ir/trial/49890,None
811,1420,IRCT20190831044653N5,IRCT,2020-08-24,2020-08-20,True,Bojnourd University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,?The effect of Atorvastatin therapy in COVID-19,Drug,Atorvastatin + Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Atorvastatin; Hydroxychloroquine; Lopinavir/ritonavir,160,http://en.irct.ir/trial/49893,None
812,1421,IRCT20200730048253N1,IRCT,2020-08-08,2020-08-22,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effectiveness of intravenous ozonized saline in COVID-19 disease,Drug,"Ozone + Standard Treatment (Hydroxychloroquine, Chloroquine, Lopinavir/Rionavir, Atazanavir, Corticosteroids, Anticoagulants) vs. Standard Treatment (Hydroxychloroquine, Chloroquine, Lopinavir/Rionavir, Atazanavir, Corticosteroids, Anticoagulants)",Ozone; Hydroxychloroquine; Chloroquine; Lopinavir/Rionavir; Atazanavir; Corticosteroids; Anticoagulants,60,http://en.irct.ir/trial/50031,None
813,1422,IRCT20091012002582N22,IRCT,2020-08-08,2020-08-22,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of hemoperfusion on short term outcome of critical ill COVID-19,Other (device),Blood filter,Blood filter,160,http://en.irct.ir/trial/50079,None
814,1423,IRCT20101219005416N3,IRCT,2020-08-26,2020-08-10,True,Kerman University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of traditional medicine protocol included Astraglus gossypinus  with  Ferula assa capsule on improvement of  COVID-19 outpatients symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://en.irct.ir/trial/50101,None
815,1424,IRCT20200806048318N1,IRCT,2020-08-20,2020-09-22,False,Esfahan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of herbal tea on improving respiratory symptoms in patients with Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/50227,None
816,1425,IRCT20200506047323N5,IRCT,2020-08-14,2020-08-22,False,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Melatonin in COVID-19,Drug,Melatonin + Hydroxychloroquine vs. Hydroxychloroquine,Melatonin; Hydroxychloroquine,60,http://en.irct.ir/trial/50239,None
817,1426,IRCT20090701002113N2,IRCT,2020-08-25,2020-08-15,True,Shiraz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Methylene Blue in COVID-19,Drug,Methylene Blue + Corticosteroids + Lopinavir/ritonavir vs. Corticosteroids + Lopinavir/ritonavir,Methylene Blue; Corticosteroids; Lopinavir/ritonavir,260,http://en.irct.ir/trial/50275,None
818,1427,IRCT20180922041089N4,IRCT,2020-08-23,2020-04-19,True,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of oral Ivermectin on patients with COVID-19,Drug,Ivermectin + Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin,Ivermectin; Hydroxychloroquine; Azithromycin,130,http://en.irct.ir/trial/50305,None
819,1428,IRCT20161108030776N3,IRCT,2020-08-26,2020-09-05,False,Kerman University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of donkey milk on the new corona virus infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,110,http://en.irct.ir/trial/50341,None
820,1430,ACTRN12620000448943,ANZCTR,2020-04-06,2020-06-20,False,Deakin University,Recruiting,Not Applicable,Interventional,Australia,Expressive Writing To Combat Distress Associated With The COVID-19 Pandemic In People With Inflammatory Bowel Disease,Other (psych),Psychological,Psychological,154,https://anzctr.org.au/ACTRN12620000448943.aspx,None
821,1431,ACTRN12620000477921,ANZCTR,2020-04-16,2020-04-23,False,Dr. Michael Soares,Not Recruiting,Not Applicable,Interventional,Australia,The design of an updated iron lung ventilator which can be easily built and used by people with minimal training in situations such as COVID-19 where skilled doctors or normal ventilators are unavailable.,Other (physical),Mechanical ventilation,Mechanical ventilation,1,https://anzctr.org.au/ACTRN12620000477921.aspx,None
822,1432,ACTRN12620000454976,ANZCTR,2020-04-08,2020-02-07,True,Austin Health,Recruiting,Phase 1/Phase 2,Interventional,Australia,Can intravenous high dose zinc improve clinical outcomes in patients with COVID-19 infection?,Drug,Zinc,Zinc,160,https://anzctr.org.au/ACTRN12620000454976.aspx,None
823,1434,ACTRN12620000473965,ANZCTR,2020-04-15,2020-08-18,False,University of Queensland,Recruiting,Phase 3,Interventional,Australia,Reducing acute severe respiratory events in health care workers during the Covid-19 pandemic with OM85,Drug (Chemoprophylaxis),OM85,OM85,1000,https://anzctr.org.au/ACTRN12620000473965.aspx,None
824,1435,ACTRN12620000517976,ANZCTR,2020-04-27,2020-09-07,False,"St. Vincents Hospital, Melbourne",Recruiting,Phase 3,Interventional,Australia,COVID-19: Can Nebulised HepArin Reduce Time to Extubation in SARS-CoV-2 patients requiring mechanical ventilation (CHARTER Study),Drug,Heparin,Heparin,206,https://anzctr.org.au/ACTRN12620000517976.aspx,None
825,1436,ACTRN12620000580976,ANZCTR,2020-05-19,2020-10-19,False,QIMR Berghofer Medical Research Institute,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Tocilizumab for tReatment Of COVID-19 in intensive cARe patients (â€œTROCARâ€),Drug,Tocilizumab,Tocilizumab,150,https://anzctr.org.au/ACTRN12620000580976.aspx,None
826,1437,ACTRN12620000612910,ANZCTR,2020-05-25,2020-01-06,True,Cynata Therapeutics Limited,Recruiting,Phase 1/Phase 2,Interventional,Australia,The MEND (MEseNchymal coviD-19) Trial: a pilot study to investigate early efficacy of mesenchymal stem cells in adults with COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://anzctr.org.au/ACTRN12620000612910.aspx,None
827,1439,ACTRN12620000698976,ANZCTR,2020-06-23,2020-10-06,False,Royal Prince Alfred Hopsital,Recruiting,Not Applicable,Interventional,Australia,Maintaining the health of people with and without COVID-19 during isolation,Other,Other,Other,40,https://anzctr.org.au/ACTRN12620000698976.aspx,None
828,1440,ACTRN12620000707965,ANZCTR,2020-06-29,2020-06-30,False,Accelagen Pty Ltd,No Status Given,Phase 3,Interventional,Australia,"A Placebo-Controlled Study to Evaluate the effect of the recombinant Bacillus Calmetteâ€“GuÃ©rin (BCG) vaccine VPM1002 on the Incidence or Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Participants in Australia
",ATMP,Vaccine,Vaccine,3468,https://anzctr.org.au/ACTRN12620000707965.aspx,None
829,1441,ACTRN12620000817943,ANZCTR,2020-08-14,2020-08-22,False,Accelagen Pty Ltd,Recruiting,Phase 1/Phase 2,Interventional,Australia,"A Phase 1/2 randomized, placebo-controlled, multi-centre study to evaluate the safety and immunogenicity of COVID-19 Vaccine in Healthy Adults",ATMP,Vaccine,Vaccine,280,https://anzctr.org.au/ACTRN12620000817943.aspx,None
830,1442,ACTRN12620000779976,ANZCTR,2020-07-30,2020-06-08,True,Dr. Sarah Egan,Recruiting,Not Applicable,Interventional,"United Kingdom, Australia",The effect of Cognitive behaviour therapy on adult mental health during the COVID-19 pandemic.,Other (psych),Psychological,Psychological,100,https://anzctr.org.au/ACTRN12620000779976.aspx,None
831,1443,ACTRN12620000860965,ANZCTR,2020-08-28,2020-01-09,True,Wesley Medical Research,Not Recruiting,Not Applicable,Interventional,Australia,A research study to determine the effect of a smartphone application (app) on management of patients with heart failure in isolation due to COVID-19,Other (software),eHealth,eHealth,400,https://anzctr.org.au/ACTRN12620000860965.aspx,None
832,1444,ISRCTN74727214,ISRCTN,2020-08-10,2020-06-15,True,Sultan Qaboos University,Not Recruiting,Not Applicable,Interventional,Oman,Effect of the anti-inflammatory test drug anakinra in patients with coronavirus (COVID-19) requiring oxygen support,Drug,Anakinra,Anakinra,75,http://isrctn.com/ISRCTN74727214,None
833,1445,ISRCTN67000769,ISRCTN,2020-07-20,2019-05-28,True,UMC Utrecht,Recruiting,Not Applicable,Interventional,"Belgium, Finland, Netherlands, Portugal, Canada, New Zealand, Croatia, United Kingdom, France, Ireland, Germany, Spain, Saudi Arabia, United States, Australia, Hungary",An international platform trial for severely ill patients with community-acquired pneumonia or COVID-19,Drug (+ ATMP),"COVID Portion of Trial: Lopinavir/ritonavir, Hydroxychloroquine, interferon beta, Anakinra, Tocilizumab, Sarilumab, Plasma, Heparin, Vitamin C, Simvastatin",Lopinavir/ritonavir; Hydroxychloroquine; interferon beta; Anakinra; Tocilizumab; Sarilumab; Plasma; Heparin; Vitamin C; Simvastatin,1000,http://isrctn.com/ISRCTN67000769,None
834,1447,ChiCTR2000034825,ChiCTR,2020-07-21,2020-07-20,True,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 1,Interventional,China,A Phase I clinical trial of novel coronavirus pneumonia (COVID-19) mRNA Vaccine (BNT162b1) in China,ATMP,Vaccine,Vaccine,144,http://www.chictr.org.cn/showproj.aspx?proj=56834,None
835,1448,ChiCTR2000031672,ChiCTR,2020-04-06,2020-04-01,True,Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://www.chictr.org.cn/showproj.aspx?proj=51940,None
836,1450,ACTRN12620000571976,ANZCTR,2020-05-15,2020-04-06,True,UNSW Sydney,Not Recruiting,Phase 1,Interventional,Australia,"Evaluation of Shift, a smartphone application for Junior Medical Officers in New South Wales during the COVID-19 epidemic.",Other (psych),Psychological,Psychological,75,https://anzctr.org.au/ACTRN12620000571976.aspx,None
837,1455,ISRCTN95933274,ISRCTN,2020-09-09,2020-06-30,True,National Dental Centre of Singapore,Recruiting,Not Applicable,Interventional,Singapore,Efficacy of mouth-rinses in reducing SARS CoV-2 viral load in the saliva of COVID-19 positive patients,Drug,povidone-iodine vs. chlorhexidine gluconate vs. cetylpyridinium chloride,povidone-iodine; chlorhexidine gluconate; cetylpyridinium chloride,68,http://isrctn.com/ISRCTN95933274,None
838,1456,ISRCTN44152751,ISRCTN,2020-05-04,2020-11-05,False,Norwegian Institute of Public Health,Not Recruiting,Not Applicable,Interventional,Norway,School opening in Norway during the COVID-19 pandemic,Other,Other,Other,116750,http://isrctn.com/ISRCTN44152751,None
839,1457,ISRCTN86534580,ISRCTN,2020-03-22,2020-03-25,True,University of Oxford,Recruiting,Phase 3,Interventional,United Kingdom,PRINCIPLE: A trial evaluating treatments for suspected COVID-19 in people aged 50 years and above with pre-existing conditions and those aged 65 years and above,Drug,Hydroxychloroquine,Hydroxychloroquine,3000,http://isrctn.com/ISRCTN86534580,EUCTR2020-001209-22
840,1458,ChiCTR2000031955,ChiCTR,2020-04-16,2020-04-01,True,Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for prevention of novel coronavirus pneumonia (COVID-19) in high risk population by Chinese medicine,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3808,http://www.chictr.org.cn/showproj.aspx?proj=52364,None
841,1459,EUCTR2020-002314-40-AT,EU Clinical Trials Register,2020-07-15,2020-09-14,False,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,A Pilot study to investigate the cardiac effect and pharmacokinetics of potential combination treatments for COVID-19,Drug,Lopinavir/ritonavir vs. Ribavirin,Lopinavir/ritonavir; Ribavirin,16,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002314-40,None
842,1460,EUCTR2020-002027-10-SE,EU Clinical Trials Register,2020-04-24,2020-07-13,False,University Hospital of Umeå,Authorised,Phase 2,Interventional,Sweden,"A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19)",Drug,Enzalutamide,Enzalutamide,600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002027-10,None
843,1463,ISRCTN34160010,ISRCTN,2020-09-14,2020-01-06,True,North-Western State Medical University,Not Recruiting,Not Applicable,Interventional,Russian Federation,A low-intervention study of pre-exposure prophylaxis (PrEP) in healthy volunteers at high risk of coronavirus (SARS-CoV-2) infection.,Drug (Chemoprophylaxis),inosine-glutathione + potassium chloride,inosine-glutathione; potassium chloride,100,http://isrctn.com/ISRCTN34160010,None
844,1465,ISRCTN10378358,ISRCTN,2020-07-08,2020-01-11,True,University of Portsmouth,Recruiting,Not Applicable,Interventional,United Kingdom,"Reducing the risk of COVID-19 spread in hospitals, by stopping droplets from spreading",Other (device),Rubber dam,Rubber dam,400,http://isrctn.com/ISRCTN10378358,None
845,1467,ChiCTR2000031501,ChiCTR,2020-04-02,2020-03-17,True,Eastern Theater General Hospital,No Status Given,Not Applicable,Interventional,China,"The efficacy  of convalescent plasma in patients with critical novel coronavirus pneumonia (COVID-19): a pragmatic, prospective cohort study",ATMP,Plasma,Plasma,20,http://www.chictr.org.cn/showproj.aspx?proj=50254,None
846,1468,ChiCTR2000029572,ChiCTR,2020-02-05,2020-02-05,False,Xiangyang First People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Withdraw       Safety and efficacy of umbilical cord blood mononuclear cells in the treatment of severe and critically novel coronavirus pneumonia(COVID-19): a randomized controlled clinical trial,ATMP,Cells (mononuclear),Cells (mononuclear),30,http://www.chictr.org.cn/showproj.aspx?proj=41760,None
847,1469,ChiCTR2000029569,ChiCTR,2020-02-04,2020-02-05,False,Xiangyang First People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Withdraw           Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial,ATMP,Cells (mononuclear),Cells (mononuclear),30,http://www.chictr.org.cn/showproj.aspx?proj=49062,None
848,1470,EUCTR2020-001530-35-ES,EU Clinical Trials Register,2020-04-13,2020-09-04,False,Fundación para la Investigación Biomédica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 4,Interventional,Spain,Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19,Drug,Melatonin,Melatonin,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001530-35,None
849,1471,EUCTR2020-001622-64-ES,EU Clinical Trials Register,2020-04-20,2020-04-19,True,Dr. Ana Pueyo Bastida,Authorised,Phase 4,Interventional,Spain,OUTPATIENT TREATMENT OF COVID-19 WITH EARLY PULMONARY CORTICOSTEROIDS AS AN OPPORTUNITY TO MODIFY THE COURSE OF THE DISEASE,Drug,Corticosteroids,Prednisone,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001622-64,None
850,1472,EUCTR2020-001722-66-ES,EU Clinical Trials Register,2020-04-27,2020-04-23,True,Fundació Clínic per a la Recerca Biomèdica,Authorised,Phase 2,Interventional,Spain,Plasma turnover in patients with COVID-19 disease and invasive mechanical ventilation,ATMP,Plasma,Plasma,116,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001722-66,None
851,1473,EUCTR2020-001505-22-ES,EU Clinical Trials Register,2020-04-27,2020-04-23,True,Banc de Sang i Teixits,Authorised,Phase 1/Phase 2,Interventional,Spain,Efficacy and safety evaluation of umbilical cord mesenchymal stem cells for the treatment of patients with respiratory failure due to coronavirus (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001505-22,None
852,1474,EUCTR2020-001541-39-ES,EU Clinical Trials Register,2020-04-27,2020-04-24,True,Fundación para la Investigación Biomédica de Córdoba,Authorised,Phase 2,Interventional,Spain,Pilot study of bevacizumab as a treatment for respiratory distress in patients with COVID-19,Drug,Bevacizumab,Bevacizumab,22,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001541-39,None
853,1475,EUCTR2020-001618-39-ES,EU Clinical Trials Register,2020-04-27,2020-04-24,True,Oryzon Genomics S. A.,Authorised,Phase 2,Interventional,Spain,Study to evaluate the efficacy and tolerability of treatment with vafidemstat in combination with standard of care treatment to prevent Acute Respiratory Distress Syndrome in adult severely ill patients with COVID-19.,Drug,Vafidemstat,Vafidemstat,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001618-39,None
854,1476,EUCTR2020-000705-86-ES,EU Clinical Trials Register,2020-05-05,2020-04-26,True,Vall d'Hebron University Hospital,Authorised,Phase 4,Interventional,Spain,Control of inflammatory parameters with fish oil in parenteral nutrition,Supplement,Fish oil,Fish oil,117,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000705-86,None
855,1477,EUCTR2020-001825-29-ES,EU Clinical Trials Register,2020-05-05,2020-04-28,True,Navarrabiomed - Fundación Miguel Servet,Authorised,Phase 2/Phase 3,Interventional,Spain,CLINICAL TRIAL OF THE USE OF ANAKINRA (ANTI IL-1) IN CYTOKINE STORM SYNDROME (CSS) SECONDARY TO COVID-19,Drug,Anakinra vs. Hydoxychloroquine + Azithromycin + Lopinavir/ritonavir,Anakinra; Hydoxychloroquine; Azithromycin; Lopinavir/ritonavir,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001825-29,None
856,1478,EUCTR2020-001697-30-ES,EU Clinical Trials Register,2020-05-07,2020-04-23,True,Navarrabiomed - Fundación Miguel Servet,Authorised,Phase 3,Interventional,Spain,PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE IN SANITARIES HIGHLY EXPOSED TO COVID-19. (COVIDNA),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001697-30,None
857,1479,EUCTR2020-001376-15-DE,EU Clinical Trials Register,2020-04-06,2020-05-13,False,Vakzine Projekt Management GmbH,Not Recruiting,Phase 3,Interventional,Germany,A study to investigate whether vaccination with VPM1002 can reduce the sick days of healthcare professionals during the SARS-CoV-2 pandemic,ATMP,Vaccine,Vaccine,1200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001376-15,None
858,1480,EUCTR2020-002299-11-HU,EU Clinical Trials Register,2020-06-02,2020-09-17,False,SigmaDrugs Research Ltd.,Authorised,Phase 2,Interventional,Hungary,"A randomized, double-blind, placebo-controlled, adaptive-design study to assess the safety and efficacy of daily 200 mg fluvoxamine as add-on therapy to standard of care in moderate severity COVID-19 patients",Drug,Fluvoxamine,Fluvoxamine,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002299-11,None
859,1481,EUCTR2020-002728-35-HU,EU Clinical Trials Register,2020-08-13,2020-09-17,False,Hungarian Ministry of Innovation and Technology,Authorised,Phase 3,Interventional,Hungary,Clinical trial of Favipiravir treatment of patients with COVID-19,Drug,Favipiravir,Favipiravir,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002728-35,None
860,1482,EUCTR2020-001645-40-IT,EU Clinical Trials Register,2020-09-22,2020-06-05,True,Dompe Farmaceutici,Authorised,Phase 2/Phase 3,Interventional,Italy,Reparixin in COVID-19 pneumonia,Drug,Reparixin,Reparixin,159,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001645-40,None
861,1483,EUCTR2020-003470-47-NL,EU Clinical Trials Register,2020-09-26,2020-08-27,True,UMC Utrecht,Authorised,Phase 4,Interventional,Netherlands,Investigation IN VULNERABLE ELDERLY to evaluate the reduction of respiratory infections during the coronapandemie by training of the immuunsystem through a BCG vaccination,ATMP,Vaccine,Vaccine,5200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003470-47,None
862,1484,EUCTR2020-001686-36-FR,EU Clinical Trials Register,2020-04-14,2020-04-23,False,Assistance Publique – Hôpitaux de Marseille,Authorised,Phase 2,Interventional,France,"A double-blind, randomized study versus placebo of avdoralimab (IPH5401), an anti-C5aR antibody, in patients with COVID-19 induced pneumonia",Drug,Avdoralimab,Avdoralimab,168,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001686-36,None
863,1485,ACTRN12620000834954,ANZCTR,2020-08-24,2020-09-16,False,"CytoAgents, Inc",Not Recruiting,Phase 1,Interventional,Australia,"A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of GP1681 in Healthy Adult Participants",Drug,GP1681,GP1681,24,https://anzctr.org.au/ACTRN12620000834954.aspx,None
864,1487,ACTRN12620000975998,ANZCTR,2020-09-30,2020-05-10,True,Bolton Clarke,Not Recruiting,Not Applicable,Interventional,Australia,Feasibility and acceptability of a volunteer-peer telephone support programme - A COVID-19 response,Other (psych),Psychological,Psychological,100,https://anzctr.org.au/ACTRN12620000975998.aspx,None
865,1488,ISRCTN57085639,ISRCTN,2020-09-24,2020-08-05,True,University Hospital Southampton NHS Foundation Trust,Recruiting,Phase 2,Interventional,United Kingdom,A platform to investigate the safety and effectiveness of several new medicines for the treatment of COVID-19 in hospitalised patients,Drug,"Bemcentinib,  MEDI3506,  Acalabrutinib,  Zilucoplan ",Bemcentinib;  MEDI3506;  Acalabrutinib;  Zilucoplan ,1800,http://isrctn.com/ISRCTN57085639,EUCTR2020-001736-95
866,1489,ISRCTN53038326,ISRCTN,2020-09-23,2020-06-22,False,University Hospitals Coventry and Warwickshire NHS Trust,Recruiting,Phase 2,Interventional,United Kingdom,IMU838 and oseltamivir in the treatment of COVID-19,Drug,Vidofludimus calcium + Oseltamivir vs. Oseltamivir,Vidofludimus calcium; Oseltamivir,120,http://isrctn.com/ISRCTN53038326,EUCTR2020-001805-21
867,1491,JPRN-jRCT2031200120,JPRN,2020-09-16,2020-09-16,False,Yamaoka Kunihiro,Recruiting,Phase 2,Interventional,Japan,double-blind study in COvid-19 patients with iveRmectin,Drug,Ivermectin,Ivermectin,240,https://jrct.niph.go.jp/latest-detail/jRCT2031200120,None
868,1492,JPRN-jRCTs031190269,JPRN,2020-03-27,2020-03-04,True,Sugiyama Haruhito,Not Recruiting,Phase 2,Interventional,Japan,"A multicenter, open-label, randomized controlled phase II study to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19",Drug,Ciclesonide,Ciclesonide,90,https://jrct.niph.go.jp/latest-detail/jRCTs031190269,None
869,1493,JPRN-jRCTs031200124,JPRN,2020-09-17,2020-09-17,False,Kutsuna Satoshi,Recruiting,Not Applicable,Interventional,Japan,COVIPLA-R,ATMP,Plasma,Plasma,59,https://jrct.niph.go.jp/latest-detail/jRCTs031200124,None
870,1494,JPRN-jRCTs032200131,JPRN,2020-09-28,2020-09-28,False,Izumi Shinnyuu,Recruiting,Phase 2,Interventional,Japan,PMX-DHP for COVID-19,Procedure,PMX-DHP,PMX-DHP,30,https://jrct.niph.go.jp/latest-detail/jRCTs032200131,None
871,1495,JPRN-jRCTs051200060,JPRN,2020-09-25,2020-09-25,False,Kakeya Hiroshi,Not Recruiting,Phase 1,Interventional,Japan,Prohylaxis with hydroxichloroquine aiming at prevention of COVID-19 for medical care workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,https://jrct.niph.go.jp/latest-detail/jRCTs051200060,None
872,1500,JPRN-UMIN000041458,JPRN,2020-10-01,2020-07-01,True,Okayama University,Not Recruiting,Not Applicable,Interventional,Japan,Research on the maintenance and improvement of physical and mental functions of elderly people under the self-restraint caused by COVID-19 by using a remote system to connect their homes,Other (psych),Psychological,Psychological,40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047327,None
873,1504,EUCTR2020-001264-28-DE,EU Clinical Trials Register,2020-04-27,2020-05-28,False,Immunic AG,Authorised,Phase 2/Phase 3,Interventional,"Russian Federation, Macedonia, the former Yugoslav Republic of, Ukraine, Bulgaria, Bosnia and Herzegovina, Romania, Germany, United States, Moldova, Republic of, Hungary, Greece",A study to investigate whether the experimental medication IMU-838 is safe and effective when it is given to Covid-19 patients in addition to their normal treatment,Drug,Vidofludimus calcium,Vidofludimus calcium,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001264-28,None
874,1505,EUCTR2020-001498-63-BE,EU Clinical Trials Register,2020-05-03,2020-05-18,True,Biophytis S.A.,Authorised,Phase 2,Interventional,"Belgium, United Kingdom, France, Brazil, United States","Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA study)",Drug,BIO101,BIO101,465,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001498-63,None
875,1506,EUCTR2020-001327-13-AT,EU Clinical Trials Register,2020-03-30,2020-04-21,False,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,"A SINGLE-BLINDED RANDOMIZED, PLACEBO-CONTROLLED PHASE II TRIAL OF PROPHYLACTIC TREATMENT WITH ORAL AZITHROMYCIN VERSUS PLACEBO IN CANCER PATIENTS UNDERGOING ANTINEOPLASTIC TREATMENT DURING THE COVID-19 PANDEMIC",Drug,Azithromycin,Azithromycin,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001327-13,None
876,1507,EUCTR2020-002110-41-GB,EU Clinical Trials Register,2020-05-29,2020-06-18,False,Cancer Research UK,Authorised,Phase 2/Phase 3,Interventional,United Kingdom,A clinical study in a community setting to see whether use of camostat reduces the worsening of COVID-19.,Drug,Camostat Mesilate,Camostat Mesilate,389,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002110-41,None
877,1508,IRCT20170117032004N3,IRCT,2020-03-29,2020-04-03,False,Tabriz University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Effect of vitamin A in patients with COVID19,Drug,Vitamin A,Vitamin A,30,http://en.irct.ir/trial/46564,None
878,1509,IRCT20200318046812N1,IRCT,2020-04-01,2020-04-01,False,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19,Drug,Favipiravir + hydroxychloroquine vs. Lopinavir/ritonavir + hydroxychloroquine,Favipiravir; hydroxychloroquine; Lopinavir/ritonavir,324,http://en.irct.ir/trial/46783,None
879,1510,IRCT20190810044500N7,IRCT,2020-09-19,2020-04-08,True,Yazd Shahid Sadoughi University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation of Levamisole efficacy in treatment of Covid-19,Drug,Levamisole,Levamisole,50,http://en.irct.ir/trial/46826,None
880,1511,IRCT20151228025732N51,IRCT,2020-04-08,2020-03-18,True,Semnan University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"Effect of Algomed, Menta longifolia, Chamomile, Althaea rosea, Malva sylvestris supplements on the Severity and Consequences of Coronavirus 19 disease (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46828,None
881,1512,IRCT20190717044241N2,IRCT,2020-04-22,2020-04-20,True,Barakat Pharmaceutical Group,Recruiting,Phase 1,Interventional,Iran,Cell therapy in patients with COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),5,http://en.irct.ir/trial/47110,None
882,1513,IRCT20081019001369N7,IRCT,2020-09-27,2020-10-22,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Clinical trial of trans sodium crocetinate against COVID-19,Drug,Sodium crocetinate,Sodium crocetinate,30,http://en.irct.ir/trial/47441,None
883,1514,IRCT20200504047295N1,IRCT,2020-09-16,2020-08-10,True,Ahvaz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effectiveness of Shallomin syrup on patients affected by COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://en.irct.ir/trial/47661,None
884,1515,IRCT20160118026097N4,IRCT,2020-09-13,2020-03-29,True,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of dexamethasone in the treatment of high-risk covid19 patients,Drug,Corticosteroids,Dexamethasone,60,http://en.irct.ir/trial/48310,None
885,1516,IRCT20160118026097N5,IRCT,2020-09-19,2020-03-29,True,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of plasmapheresis in the treatment of high-risk covid patients in Qom province,Procedure (+ Drug),Plasmapheresis vs. Hydroxychloroquine or chloroquine and lopinavir/ritonavir or atazanavir/ritonavir,Plasmapheresis; Hydroxychloroquine; Chloroquine; Lopinavir/ritonavir; Atazanavir/ritonavir,60,http://en.irct.ir/trial/48401,None
886,1517,IRCT20190226042851N1,IRCT,2020-10-05,2020-08-22,True,Ahvaz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of nano-based inhalation solution to relieve shortness of breath in COVID-19 patients,Drug,"Deionized water + Silver (and Interferon beta, dexamethasone, corticosteroids, heparin)","Deionized water; Silver; Interferon beta; Dexamethasone, Heparin",40,http://en.irct.ir/trial/48462,None
887,1518,IRCT20180624040213N2,IRCT,2020-09-14,2020-07-21,True,Babol University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Montelukast in COVID-19,Drug,Montelukast,Montelukast,114,http://en.irct.ir/trial/49420,None
888,1519,IRCT20200504047298N3,IRCT,2020-09-09,2020-08-22,True,Karaj University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Diphenhydramine Compound in Covid-19,Drug,Diphenhydramine,Diphenhydramine,120,http://en.irct.ir/trial/49696,None
889,1520,IRCT20200727048217N1,IRCT,2020-09-13,2020-08-22,True,Shahroud University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of ethanol and DMSO in prophylaxis and treatment of COVID-19,Drug,Ethanol + Dimethyl Sulfoxide,Ethanol; Dimethyl Sulfoxide,610,http://en.irct.ir/trial/49924,None
890,1521,IRCT20200802048266N1,IRCT,2020-09-22,2020-11-19,False,Ahvaz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of MMR vaccine in preventing Covid disease 19,ATMP,Vaccine,Vaccine,323,http://en.irct.ir/trial/50035,None
891,1522,IRCT20131112015390N5,IRCT,2020-09-26,2020-05-21,True,Oroumia University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"Effects of guided imagery on anxiety, muscle pain and vial signs in patients with COVID-19",Other,Other,Other,110,http://en.irct.ir/trial/50268,None
892,1523,IRCT20200317046797N7,IRCT,2020-09-14,2020-04-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The efficacy of bromhexine hydrochloride in the prevention of COVID-19 disease,Drug (Chemoprophylaxis),Bromhexine hydorchloride,Bromhexine hydorchloride,3500,http://en.irct.ir/trial/50556,None
893,1524,IRCT20200831048568N1,IRCT,2020-09-11,2020-09-10,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy of sofosbuvir and daclatasvir in ambulatory patients with coronavirus disease,Drug,Sofosbuvir/daclatasvir,Sofosbuvir/daclatasvir,2000,http://en.irct.ir/trial/50601,None
894,1525,IRCT20181203041832N1,IRCT,2020-10-05,2020-09-22,True,Oroumia University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effectiveness of online mindfulness training on mental health and quality of work life of nurses fighting on the frontlines against COVID-19,Other (psych),Psychological,Psychological,36,http://en.irct.ir/trial/50750,None
895,1526,IRCT20200902048598N1,IRCT,2020-09-28,2020-09-22,True,Hamedan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of education in the prevention of covid-19,Other,Other,Other,200,http://en.irct.ir/trial/50796,None
896,1527,IRCT20140911019125N8,IRCT,2020-09-26,2020-09-10,True,Kerman University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of corona disease,ATMP,Cells (mesenchymal),Cells (mesenchymal),120,http://en.irct.ir/trial/50848,None
897,1528,IRCT20200913048701N1,IRCT,2020-09-22,2020-09-22,False,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of effects of eucalyptus tablets on the process of covid 19 disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://en.irct.ir/trial/50912,None
898,1529,IRCT20200907048644N1,IRCT,2020-10-04,2020-09-22,True,Zahedan University of Medical Sciences,Recruiting,Phase 1,Interventional,Iran,Celecoxib effects on  COVID-19 patients,Drug,Celecoxib,Celecoxib,60,http://en.irct.ir/trial/50932,None
899,1530,IRCT20200913048708N1,IRCT,2020-10-01,2020-10-31,False,Mazandaran University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Efficacy and safety of Chlorpromazine  in the treatment of COVID-19 patients,Drug,Chlorpormazine + Atazanavir/ritonavior vs. Atazanavir/ritonavior,Chlorpormazine; Atazanavir/ritonavior,60,http://en.irct.ir/trial/50959,None
900,1531,IRCT20131115015405N4,IRCT,2020-10-03,2020-07-22,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of fluvoxamine on cytokine in COVID-19 patients,Drug,Fluvoxamine,Fluvoxamine,40,http://en.irct.ir/trial/50977,None
901,1532,IRCT20131125015536N13,IRCT,2020-10-03,2020-05-21,True,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Assessment of the effect of nanocurcumin supplement in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,48,http://en.irct.ir/trial/51310,None
902,1533,IRCT20201001048893N1,IRCT,2020-10-03,2020-03-10,True,Shiraz University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Effect of Online Psycho-educational Interventions on Psychological Health of Patients with COVID-19,Other (psych),Psychological,Psychological,50,http://en.irct.ir/trial/51328,None
903,1538,ChiCTR2000030522,ChiCTR,2020-03-06,2020-03-09,False,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Canceled by the investigator                                       Efficacy and safety of Ma-Xing-Gan-Shi decoction in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=44213,None
904,1539,EUCTR2020-001610-38-DK,EU Clinical Trials Register,2020-04-07,2020-09-16,False,Slagelse Hospital,Authorised,Phase 4,Interventional,Denmark,Irbesartan and Oseltamivir treatment of COVID-19 infection.,Drug,Irbesartan + Oseltamivir,Irbesartan; Oseltamivir,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001610-38,None
905,1540,EUCTR2020-001608-40-DE,EU Clinical Trials Register,2020-04-14,2020-07-15,False,Zhejiang Hisun Pharmaceutical Co. Ltd.,Authorised,Phase 3,Interventional,"Germany, China","A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study Evaluating the Efficacy and Safety of Favipiravir in the Treatment of Adult Patients with COVID-19-Moderate Typ",Drug,Favipiravir,Favipiravir,256,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001608-40,None
906,1541,ACTRN12620001048976,ANZCTR,2020-10-15,2020-02-11,True,Gilead Sciences,Not Recruiting,Phase 1,Interventional,"New Zealand, United States, Puerto Rico, Germany","A Phase 1 Open-Label, Parallel-Group, Single-Dose Study to
Evaluate the Pharmacokinetics of Remdesivir and Metabolites in
Participants with Normal Renal Function and Renal Impairment",Not relevant,Not relevant,Not relevant,80,https://anzctr.org.au/ACTRN12620001048976.aspx,None
907,1542,ISRCTN18428598,ISRCTN,2020-10-08,2020-01-01,True,Education Endowment Foundation,Recruiting,Not Applicable,Interventional,United Kingdom,Does the Flexible Phonics programme lead to improved reading outcomes for children in Reception when taught in addition to existing phonics programmes/practice?,Not relevant,Not relevant,Not relevant,2875,http://isrctn.com/ISRCTN18428598,None
908,1543,ISRCTN10197987,ISRCTN,2020-10-05,2020-08-09,True,Hamad Medical Corporation,Recruiting,Not Applicable,Interventional,Qatar,The possible beneficial role of the regular use of potent mouthwash solutions in the treatment of COVID-19,Drug,Chlorhexidine gluconate + Hydrogen peroxide,Chlorhexidine gluconate; Hydrogen peroxide,100,http://isrctn.com/ISRCTN10197987,None
909,1544,ISRCTN14602359,ISRCTN,2020-08-12,2020-01-10,True,University of Bristol,Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19 Germ Defence: a website to improve infection control during the COVID-19 pandemic,Other,Other,Other,6822,http://isrctn.com/ISRCTN14602359,None
910,1545,ISRCTN43900695,ISRCTN,2020-04-08,2020-08-17,False,Northumbria University,Recruiting,Not Applicable,Interventional,United Kingdom,Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic,Other,Sleep aids,Sleep aids,60,http://isrctn.com/ISRCTN43900695,None
911,1546,EUCTR2020-003349-12-IE,EU Clinical Trials Register,2020-08-14,2020-09-10,False,National University of Ireland Galway,Authorised,Phase 2,Interventional,Ireland,This is a proof of principle / feasibility study aiming to evaluate the effect of nebulised unfractionated heparin on procoagulant markers related to acute respiratory distress syndrome in patients invasively ventilated for Covid 19 lung disease.,Drug,Heparin,Heparin,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003349-12,None
912,1547,EUCTR2020-004928-42-HU,EU Clinical Trials Register,2020-10-12,2020-12-10,False,Hungarian Ministry of Innovation and Technology,Authorised,Phase 3,Interventional,Hungary,Clinical trail of remdesivir in Covid-19 patinets,Drug,Remdesivir,Remdesivir,2000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004928-42,None
913,1548,EUCTR2020-001420-34-DK,EU Clinical Trials Register,2020-04-01,2020-04-14,False,Aarhus University,Authorised,Phase 2,Interventional,Denmark,Senicapoc treatment of COVID-19 positive patients in intensive care,Drug,Senicapoc,Senicapoc,46,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001420-34,None
914,1550,ISRCTN12107048,ISRCTN,2020-05-28,2020-08-06,False,University of Cambridge,Recruiting,Not Applicable,Interventional,United Kingdom,Supporting weight management during COVID-19,Other (exercise),Exercise,Exercise,360,http://isrctn.com/ISRCTN12107048,None
915,1552,ISRCTN14966673,ISRCTN,2020-03-18,2020-03-20,False,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,Does point-of-care testing for coronavirus in hospital improve patient care compared to laboratory testing?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,http://isrctn.com/ISRCTN14966673,None
916,1553,EUCTR2020-001010-38-NO,EU Clinical Trials Register,2020-03-16,2020-03-23,False,Akershus University Hospital,Not Recruiting,Phase 4,Interventional,Norway,NORWEGIAN CORONAVIRUS DISEASE 2019 [NO-COVID-19] STUDY: A TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFECTION,Drug,Hydroxychloroquine,Hydroxychloroquine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001010-38,None
917,1554,EUCTR2020-001867-94-FR,EU Clinical Trials Register,2020-04-20,2020-10-15,False,CHU Caen,Authorised,Phase 3,Interventional,France,Effet du tenofovir/emtricitabine en cure courte sur la clairance virale chez des patients infectÃ©s par le SARS-CoV2 (COVID-19) non hospitalisÃ©s,Drug,Tenofovir + Emtricitabine,Tenofovir; Emtricitabine,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001867-94,None
918,1555,EUCTR2020-001244-26-AT,EU Clinical Trials Register,2020-03-31,2020-11-04,False,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS - a pilot-trial.,Drug,Solnatide,Solnatide,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001244-26,None
919,1556,EUCTR2020-001504-42-BE,EU Clinical Trials Register,2020-05-03,2020-12-06,True,Inotrem,Authorised,Phase 2,Interventional,"Belgium, France, United States","A study evaluating the efficacy, safety and tolerability of Nangibotide in patients with Covid-19.",Drug,Nangibotide,Nangibotide,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001504-42,None
920,1557,EUCTR2020-001558-23-IT,EU Clinical Trials Register,2020-06-26,2020-09-04,False,Azienda Sanitaria Unica Regionale (ASUR),Authorised,Phase 3,Interventional,Italy,Hydroxychloroquine sulfate early administration in symptomatic out of hospital COVID-19 positive patients. Hydro-Stop-COVID19 Trial,Drug,Hydroxychloroquine,Hydroxychloroquine,216,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001558-23,None
921,1558,EUCTR2020-001745-40-IT,EU Clinical Trials Register,2020-06-24,2020-04-23,True,ASST Fatebenefratelli Sacco,Authorised,Phase 2,Interventional,Italy,PILOT STUDY ON THE USE OF SARILUMAB IN PATIENTS WITH COVID-19 INFECTION,Drug,Sarilumab,Sarilumab,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001745-40,None
922,1559,EUCTR2020-001732-10-DE,EU Clinical Trials Register,2020-04-27,2020-05-28,False,Philipps University Marburg,Authorised,Phase 2,Interventional,Germany,"Ruxolitinib for treatment of Covid-19 Patienten with acute respiratory
distress syndrome",Drug,Ruxolitinib,Ruxolitinib,15,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001732-10,None
923,1560,ACTRN12620000457943,ANZCTR,2020-04-08,2020-04-14,False,Medical Research Institute of New Zealand,No Status Given,Phase 2,Interventional,New Zealand,Hydroxychloroquine for the Community-Based Treatment of COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,70,https://anzctr.org.au/ACTRN12620000457943.aspx,None
924,1561,ACTRN12620000557932,ANZCTR,2020-05-11,2020-07-09,False,Dr Karin Ried,Recruiting,Not Applicable,Interventional,"Turkey, Australia","International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trial",Drug,Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B + Vitamin C vs. Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B,Hydroxychloroquine; Azithromycin; Zinc; Vitamin D; Vitamin B; Vitamin C,200,https://anzctr.org.au/ACTRN12620000557932.aspx,None
925,1563,ISRCTN12890382,ISRCTN,2020-10-23,2020-02-11,True,University of Oxford,Recruiting,Not Applicable,Interventional,United Kingdom,Child anxiety treatment in the context of COVID-19,Other (psych),Psychological,Psychological,560,http://isrctn.com/ISRCTN12890382,None
926,1566,ISRCTN13177364,ISRCTN,2020-09-09,2020-01-11,True,University of Exeter,Recruiting,Not Applicable,Interventional,United Kingdom,"The development, testing and evaluation of a COVID-19 fundamental nursing care protocol",Health System,Other,Other,1080,http://isrctn.com/ISRCTN13177364,None
927,1567,ISRCTN13447477,ISRCTN,2020-05-22,2020-04-11,True,Royal Surrey County Hospital NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,A pilot study of the ability of povidone-iodine (PVP-I) 0.5% aqueous solution oral/nasal spray and mouthwash to kill the SARS-CoV-2 virus in people with COVID-19,Drug,Povidone Iodine,Povidone Iodine,22,http://isrctn.com/ISRCTN13447477,None
928,1568,ISRCTN83971151,ISRCTN,2020-03-25,2020-03-26,True,World Health Organization,Recruiting,Phase 3,Interventional,"Philippines, Canada, South Africa, Lebanon, Iran, Indonesia, Saudi Arabia, Peru, Italy, Israel, Argentina, Qatar, Honduras, Malaysia, India, Germany, Switzerland, Thailand, Kenya, Brazil, Ireland, Spain, Norway",Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients,Drug,Remdesivir vs. chloroquine/hydroxychloroquine vs. lopinavir/ritonavir vs. interferon beta,Remdesivir; chlorquine; hydroxychloroquine; lopinavir/ritonavir; interferon beta,10000,http://isrctn.com/ISRCTN83971151,EUCTR2020-001366-11; NCT04330690; PER-010-20; IRCT20200405046953N1; NCT04321616; EUCTR2020-000982-18; CTRI/2020/04/024773; LBCTR2020043495; EUCTR2020-002060-31; EUCTR2020-001549-38; NCT04575064; NCT04647669
929,1569,EUCTR2020-003486-19-GB,EU Clinical Trials Register,2020-08-14,2020-08-10,True,University of Dundee,Authorised,Phase 2,Interventional,United Kingdom,SFX-01 treatment for Acute Respiratory Infections (STAR-Covid19),Drug,Sulforadex,Sulforadex,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003486-19,None
930,1570,EUCTR2020-003689-37-FR,EU Clinical Trials Register,2020-10-01,2020-10-27,False,CHU de Nantes,Authorised,Phase 2,Interventional,France,"REmimazolam infusion in the context of Hypnotic Shortage in the Critical care Unit during the pandemic of COVID-19. The non-randomized, non-controlled, pilot, open, mono-centric REHSCU study.",Drug,Remimazolam,Remimazolam,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003689-37,None
931,1571,EUCTR2020-002677-95-IT,EU Clinical Trials Register,2020-08-10,2020-08-25,False,RedHill Biopharma Limited,Authorised,Phase 2/Phase 3,Interventional,"Russian Federation, United Kingdom, Italy, Brazil, United States, Mexico",A clinical trial using opaganib in adult patients hospitalised with severe pneumonia due to COVID-19,Drug,Opaganib,Opaganib,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002677-95,None
932,1572,JPRN-jRCT2021200018,JPRN,2020-08-18,2020-07-10,True,Harigae Hideo,Recruiting,Phase 2,Interventional,Japan,An exploratory Phase II investigator-initiated clinical trial of the efficacy and safety of TM5614 in patients with novel coronavirus  pneumonia,Drug,TM5614,TM5614,30,https://jrct.niph.go.jp/latest-detail/jRCT2021200018,None
933,1573,JPRN-jRCT2071200041,JPRN,2020-10-12,2020-01-11,True,Kita Toshihiro,Not Recruiting,Phase 2,Interventional,Japan,Therapeutic development of adrenomedullin for severe pneumonia caused by COVID-19,Drug,Adrenomedullin,Adrenomedullin,40,https://jrct.niph.go.jp/latest-detail/jRCT2071200041,None
934,1574,JPRN-jRCTs031200026,JPRN,2020-05-01,2020-11-06,False,Kyoji Moriya,Recruiting,Phase 3,Interventional,Japan,Combination therapy of Favipiravir and Nafamostat Mesilate in Patients with COVID-19 Pneumonia,Drug,Favipiravir + Nafamostat Mesilate,Favipiravir; Nafamostat Mesilate,160,https://jrct.niph.go.jp/latest-detail/jRCTs031200026,None
935,1575,JPRN-jRCTs031200150,JPRN,2020-10-14,2020-10-14,False,Namiki Takao,Recruiting,Phase 3,Interventional,Japan,Prophylactic study for COVID-19 with Kampo medicines,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,6000,https://jrct.niph.go.jp/latest-detail/jRCTs031200150,None
936,1576,JPRN-jRCTs051200049,JPRN,2020-08-26,2020-01-09,True,Iwahori Kota,Recruiting,Phase 2,Interventional,Japan,Therapeutic drug development program for COVID-19,Drug,Demethylchlortetracycline + Favipiravir,Demethylchlortetracycline; Favipiravir,30,https://jrct.niph.go.jp/latest-detail/jRCTs051200049,None
937,1577,JPRN-jRCTs052200053,JPRN,2020-09-07,2020-07-09,True,Fukushima Norihide,Recruiting,Phase 3,Interventional,Japan,Specified clinical trial for ECMO system for COVID-19 resipiratory failure,Drug,Oxygen,Oxygen,50,https://jrct.niph.go.jp/latest-detail/jRCTs052200053,None
938,1578,JPRN-jRCTs061200002,JPRN,2020-05-20,2020-05-20,False,Eiki Ichihara,Recruiting,Phase 2,Interventional,Japan,Teprenone for preventing aggravation of COVID-19,Drug,Teprenone,Teprenone,100,https://jrct.niph.go.jp/latest-detail/jRCTs061200002,None
939,1579,JPRN-jRCTs071200048,JPRN,2020-10-29,2020-10-29,False,Izumikawa Koichi,Recruiting,Phase 2,Interventional,Japan,Exploratory examination of Efficacy and safety of functional food included 5-aminolevulinic phosphoric acid/sodium ferrous citrate on COVID-19,Drug,5-aminolevulinic phosphoric acid + sodium ferrous citrate,5-aminolevulinic phosphoric acid; sodium ferrous citrate,50,https://jrct.niph.go.jp/latest-detail/jRCTs071200048,None
940,1587,JPRN-UMIN000041990,JPRN,2020-10-02,2020-09-29,True,Kobe University,Not Recruiting,Not Applicable,Interventional,Japan,Intervention to promote exercise behavior among older adults under the epidemic of COVID-19,Other (exercise),Exercise,Exercise,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047925,None
941,1588,JPRN-UMIN000042034,JPRN,2020-10-07,2020-09-09,True,St. Marianna University School of Medicine,Not Recruiting,Not Applicable,Interventional,Japan,About preventive measures against covid-19 infection in sports,Other,No Intervention,No Intervention,5,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047574,None
942,1596,ACTRN12620000982910,ANZCTR,2020-09-30,2020-05-10,True,Neuroscience Trials Australia,Not Recruiting,Phase 3,Interventional,Australia,A randomized double-blind placebo-controlled trial of oral ivermectin for outpatient treatment of those at high risk for hospitalization due to COVID-19,Drug,Ivermectin,Ivermectin,400,https://anzctr.org.au/ACTRN12620000982910.aspx,None
943,1597,ACTRN12620001104943,ANZCTR,2020-10-26,2020-12-11,False,Linear Clinical Research Ltd,Not Recruiting,Phase 1,Interventional,Australia,A Single Dose Study to Determine the Safety and Tolerability of Intranasal REVTx-99 in Healthy Adult Volunteers,Drug,REVTx-99,REVTx-99,32,https://anzctr.org.au/ACTRN12620001104943.aspx,None
944,1600,ISRCTN13455972,ISRCTN,2020-08-04,2020-04-08,True,Department of Health and Social Care,Not Recruiting,Not Applicable,Interventional,United Kingdom,Evaluation of coronavirus self-isolation interventions,Other,Self-isolation,Self-isolation,10000,http://isrctn.com/ISRCTN13455972,None
945,1602,ChiCTR2000039715,ChiCTR,2020-11-06,2020-11-17,False,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial of Influenza virus Vector COVID-19 Vaccine for intranasal Spray (DelNS1-2019-nCoV-RBD-OPT1),ATMP,Vaccine,Vaccine,720,http://www.chictr.org.cn/showproj.aspx?proj=63754,None
946,1603,ChiCTR2000039640,ChiCTR,2020-11-04,2020-11-30,False,Beijing Tsinghua Chang Gung Hospital,Recruiting,Not Applicable,Interventional,China,Application of an intelligent mobile isolation operating cabin preventing COVID-19 infection,Other,Other,Other,10,http://www.chictr.org.cn/showproj.aspx?proj=61895,None
947,1605,ChiCTR2000039592,ChiCTR,2020-11-02,2020-06-01,True,Xiangya Nursing School of Central South University,Not Recruiting,Not Applicable,Interventional,China,Effect of Group Otago Exercise Program on Cognitive Frailty in the Nursing Home: a Randomised Controlled Trial,Other (exercise),Exercise,Exercise,62,http://www.chictr.org.cn/showproj.aspx?proj=62882,None
948,1606,ChiCTR2000039462,ChiCTR,2020-10-28,2020-10-27,True,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 2,Prevention,China,A phase II clinical trial for inactivated SARS-CoV-2 (COVID-19) Vaccine (Vero Cells),ATMP,Vaccine,Vaccine,1000,http://www.chictr.org.cn/showproj.aspx?proj=63353,None
949,1607,ChiCTR2000039212,ChiCTR,2020-10-22,2020-10-28,False,Shulan (Hangzhou) Hospital,Not Recruiting,Phase 1,Prevention,China,"A Phase Ib clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a novel coronavirus pneumonia (COVID-19) mRNA vaccine in population aged 18-59 years",ATMP,Vaccine,Vaccine,120,http://www.chictr.org.cn/showproj.aspx?proj=63183,None
950,1609,ChiCTR2000039000,ChiCTR,2020-10-13,2020-09-02,True,China National Biotec Group Co. Ltd,Recruiting,Phase 3,Interventional,Morocco,A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells),ATMP,Vaccine,Vaccine,600,http://www.chictr.org.cn/showproj.aspx?proj=62581,None
951,1611,ChiCTR2000038866,ChiCTR,2020-10-07,2020-10-15,False,Sun Yat-Sen University,Not Recruiting,Not Applicable,Interventional,China,A mHealth-based randomized controlled trial for improving mental health among people living with HIV during the COVID-19 outbreak,Other (psych),Psychological,Psychological,120,http://www.chictr.org.cn/showproj.aspx?proj=61662,None
952,1613,ChiCTR2000038827,ChiCTR,2020-10-05,2020-11-02,False,The Hong Kong Jockey Club Charities Trust,Not Recruiting,Not Applicable,Interventional,China,Online multicomponent health intervention to support children with special education needs (SEN) and their families during COVID-19 pandemic,Other (software),eHealth,eHealth,1500,http://www.chictr.org.cn/showproj.aspx?proj=61884,None
953,1614,ChiCTR2000038740,ChiCTR,2020-09-30,2020-08-01,True,"Beijing University of Chinese Medicine, Third Affiliated Hospital",Not Recruiting,Not Applicable,Interventional,China,Study on Traditional Chinese Medicine Intervention Program for the Sequela of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=62250,None
954,1617,ChiCTR2000037782,ChiCTR,2020-09-01,2020-09-01,False,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 1,Interventional,China,A Phase I Clinical Trial of Influenza virus Vector COVID-19 Vaccine for intranasal Spray (DelNS1-2019-nCoV-RBD-OPT1),ATMP,Vaccine,Vaccine,60,http://www.chictr.org.cn/showproj.aspx?proj=55421,None
955,1618,ChiCTR2000037524,ChiCTR,2020-08-29,2020-08-29,False,Chinese Academy of Medical Sciences,Not Recruiting,Not Applicable,Interventional,China,Effects of an online mindfulness-based intervention on quality of life and psychological symptoms in novel coronavirus pneumonia (COVID-19) patients in China: a randomized controlled trial,Other (psych),Psychological,Psychological,1600,http://www.chictr.org.cn/showproj.aspx?proj=60034,None
956,1619,ChiCTR2000037518,ChiCTR,2020-08-28,2020-08-28,False,West China Hospital of Sichuan University,Not Recruiting,Phase 1,Interventional,China,"Randomized double blind, placebo controlled phase I trial for anti novel coronavirus pneumonia (COVID-19) recombinant vaccine (Sf9)",ATMP,Vaccine,Vaccine,168,http://www.chictr.org.cn/showproj.aspx?proj=60581,None
957,1622,ChiCTR2000036871,ChiCTR,2020-08-25,2020-09-01,False,Beijing Hospital of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,Pakistan,"Multi-center, Randomized, Double Blind and Placebo Controlled Clinical Trial on the Efficacy and Safety of Jinhua Qinggan Granules (JHQG) for the Treatment of COVID-19 Patients.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=55984,None
958,1625,ChiCTR2000036333,ChiCTR,2020-08-22,2020-02-01,True,The Second Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Interventional,China,Using Mindfulness to Reduce Anxiety and Depression of Patient with Fever Undergoing Screening in an Isolation Ward During novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),Psychological,Psychological,51,http://www.chictr.org.cn/showproj.aspx?proj=57115,None
959,1627,IRCT20100623004251N13,IRCT,2020-04-04,2019-10-23,True,Iran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Comparison of the Effect of Types of Orthosis and Back School Program on Physical Fitness and Respiratory Capacity of Elderly with Thoracic Kyphosis,Not relevant,Not relevant,Not relevant,60,http://en.irct.ir/trial/42393,None
960,1628,IRCT20200324046850N5,IRCT,2020-04-04,2020-10-17,False,Abadan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effectiveness of vitamin C on the improvement process of patients with COVID-19,Drug,Vitamin C w or w/o Hydroxychloroquine or Chloroquine + Lopinavir/Ritonavir,Vitamin C; Hydroxychloroquine; Chloroquine; Lopinavir/Ritonavir,400,http://en.irct.ir/trial/46751,None
961,1629,IRCT20200414047072N1,IRCT,2020-04-28,2020-04-14,True,Hilton Pharma Pvt. Ltd.,Recruiting,Not Applicable,Interventional,Pakistan,Use of Convalescent Plasma in the treatment of COVID-19,ATMP,Plasma,Plasma,357,http://en.irct.ir/trial/47163,None
962,1630,IRCT20080901001165N59,IRCT,2020-05-27,2020-05-25,True,Niwasha Company,Not Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Niwasha mouthwash in controlling the symptoms of patients with COVID-19,Drug,Mouthwash,Mouthwash,80,http://en.irct.ir/trial/47477,None
963,1631,IRCT20200328046885N1,IRCT,2020-10-12,2020-07-19,True,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Comparison of the effectiveness of two treatment regimens in patients with COVID-19,Drug,Hydroxychloroquine + Sofosbuvir/daclatsivir vs. Hydroxychloroquine + lopinavir/ritonavir,Hydroxychloroquine; Sofosbuvir/daclatsivir; Lopinavir/ritonavir,300,http://en.irct.ir/trial/47565,None
964,1632,IRCT20170731035423N2,IRCT,2020-06-12,2020-05-21,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of the combination of BCc1 & Hep-S on hospitalized COVID-19 patients,Drug,BCc1 vs. Hep-S vs. BCc1 + Hep-S,BCc1; Hep-S,120,http://en.irct.ir/trial/48049,None
965,1633,IRCT20200531047619N1,IRCT,2020-10-18,2020-08-21,True,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Tofacitinib in covid-19 patients,Drug,Tofacitinib,Tofacitinib,10,http://en.irct.ir/trial/48766,None
966,1634,IRCT20200516047462N2,IRCT,2020-07-17,2020-07-08,True,Kashan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of hyoscyamus niger with propolis on covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://en.irct.ir/trial/49628,None
967,1635,IRCT20200802048267N1,IRCT,2020-10-20,2020-08-22,True,Esfahan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Propolis supplementation AND Coronavirus,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/50162,None
968,1636,IRCT20200816048422N1,IRCT,2020-10-16,2020-06-25,True,Ahvaz University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Daclatasvir+Sofosbuvir in patients with severe acute respiratory syndrome coronavirus (SARS-COVID-19),Drug,Sofosbuvir/daclatsivir,Sofosbuvir/daclatsivir,70,http://en.irct.ir/trial/50363,None
969,1637,IRCT20150808023559N23,IRCT,2020-10-11,2020-09-20,True,Ardabil University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effectiveness of favipiravir in comparison with Tenofovir Alafenamid in patients with COVID-19,Drug,Favipiravir vs. Tenofovir alafenamid,Favipiravir; Tenofovir alafenamid,100,http://en.irct.ir/trial/50405,None
970,1638,IRCT20200825048514N1,IRCT,2020-10-10,2020-05-04,True,Yazd Shahid Sadoughi University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of ÃŸ-interferon and methylprednisolone in COVID-19,Drug,Interferon beta + Lopinavir/ritonavir + naproxen + hydroxychloroquine + corticosteroids vs. Interferon beta + Lopinavir/ritonavir + naproxen + hydroxychloroquine ,Interferon beta; Lopinavir/ritonavir; naproxen; hydroxychloroquine; methylprednisolone,60,http://en.irct.ir/trial/50543,None
971,1639,IRCT20200328046886N2,IRCT,2020-10-12,2020-08-22,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of Atazanavir/Ritonavir plus Hydroxychloroquine regimen in patients with moderate COVID-19,Drug,Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychlroquine + Lopinavir/ritonavir,Atazanavir/ritonavir; Hydroxychlroquine; Lopinavir/ritonavir,120,http://en.irct.ir/trial/50980,None
972,1640,IRCT20080901001165N63,IRCT,2020-10-22,2020-07-22,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Myrtus nasal spray in controlling the symptoms of patients with mild  COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/51157,None
973,1641,IRCT20100228003449N31,IRCT,2020-10-08,2020-09-26,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Corticosteroids in COVID-19,Drug,Corticosteroids,Dexamethasone,119,http://en.irct.ir/trial/51163,None
974,1642,IRCT20200923048815N1,IRCT,2020-10-15,2020-10-22,False,Esfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of synbiotic on inflammatory markers and clinical manifestations in patients with C0VID-19,Supplement,Probiotics,Probiotics,80,http://en.irct.ir/trial/51166,None
975,1643,IRCT20200922048804N1,IRCT,2020-10-06,2020-08-05,True,Tehran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Melatonin in COVID-19,Drug,Melatonin,Melatonin,20,http://en.irct.ir/trial/51177,None
976,1644,IRCT20200404046937N5,IRCT,2020-10-14,2020-09-27,True,Ahvaz University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of remdesivir in COVID-19,Drug,Remdesivir,Remdesivir,50,http://en.irct.ir/trial/51178,None
977,1645,IRCT20200928048867N1,IRCT,2020-10-22,2020-10-01,True,Mashhad University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Evaluation of short term outcomes of liver transplantation from COVID-19 positive deceased donors,Clinical Presentation,No Intervention,No Intervention,10,http://en.irct.ir/trial/51319,None
978,1646,IRCT20201003048904N1,IRCT,2020-10-11,2020-10-11,False,Boushehr University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Blood Transfusion in Covid-19,Procedure,Blood transfusion,Blood transfusion,40,http://en.irct.ir/trial/51364,None
979,1647,IRCT20201003048905N1,IRCT,2020-10-07,2020-05-23,True,Larestan University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Effect of spiritual care based on Ghalbe Salim on anxiety related to COVID-19 (corona phobia),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,14,http://en.irct.ir/trial/51394,None
980,1648,IRCT20201004048922N1,IRCT,2020-10-10,2020-10-11,False,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of intravenous infusion of human COVID-19 hyperimmune plasma with specific antibody titer in hospitalized patients with Covid-19: a randomized clinical trial,ATMP,Plasma,Plasma,75,http://en.irct.ir/trial/51443,None
981,1649,IRCT20201005048936N1,IRCT,2020-10-26,2020-10-31,False,Dr. Abidi Pharmacutical Co.,Recruiting,Phase 3,Interventional,Iran,The evaluation of efficacy of Favipiravir in patients with mild to moderate COVID-19,Drug,Favipiravir vs. Hydroxychloroquine,Favipiravir; Hydroxychloroquine,126,http://en.irct.ir/trial/51499,None
982,1650,IRCT20181208041886N1,IRCT,2020-10-18,2020-10-22,False,Esfahan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Levamizole in treatment of COVID19.,Drug,Levamizole,Levamizole,60,http://en.irct.ir/trial/51501,None
983,1651,IRCT20200128046294N3,IRCT,2020-10-22,2020-10-24,False,Tehran University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Safety of Sofosbuvir /Daclatasvir in outpatients with COVID-19,Drug,Sofosbuvir/daclatsivir,Sofosbuvir/daclatsivir,50,http://en.irct.ir/trial/51585,None
984,1652,IRCT20200930048892N1,IRCT,2020-10-18,2020-10-20,False,Shiraz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,evaluation the effect of virtual pulmonary rehabilitaion on covid 19 patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,70,http://en.irct.ir/trial/51595,None
985,1653,EUCTR2020-002122-82-DE,EU Clinical Trials Register,2020-05-07,2020-12-06,False,"University Hospital, Erlangen",Authorised,Phase 2,Interventional,Germany,Clinical study for the Evaluation of efficacy and safety of a Treatment with Plasma gained from patients who recovered from COVID-19 infection and given to patients who are currently suffering from a severe COVID-19 infection,ATMP,Plasma,Plasma,58,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002122-82,None
986,1654,EUCTR2020-001936-86-DE,EU Clinical Trials Register,2020-08-20,2020-10-19,False,Hannover Medical School,Authorised,Phase 2,Interventional,Germany,Clinical trial to evaluate superiority of anti-SARS-CoV-2 convalescent plasma versus standard-of-care in hospitalized patients with mild COVID-19,ATMP,Plasma,Plasma,340,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001936-86,None
987,1655,EUCTR2020-001782-37-SK,EU Clinical Trials Register,2020-06-15,2020-07-11,False,NPO Petrovax,Authorised,Phase 2/Phase 3,Interventional,"Russian Federation, Italy, France, Poland, Brazil, Romania, Slovakia","A multi-centre, adaptive, randomized, double-blind, placebo-controlled comparative clinical study of the safety and efficacy of 12 mg PolyoxidoniumÂ®, lyophilizate solution for injections (NPO Petrovax Pharm LLC, Russia) in patients with coronavirus disease (COVID-19).",Drug,Azoximer bromide,Azoximer bromide,464,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001782-37,None
988,1656,ACTRN12620000445976,ANZCTR,2020-04-06,2020-07-28,False,University of Melbourne,Recruiting,Phase 3,Interventional,"India, New Zealand, Australia","Australasian COVID-19 Trial (ASCOT). A multi-centre randomised clinical trial to assess clinical, virological and immunological outcomes in patients with SARS-CoV-2 infection (COVID-19).",Drug,Lopinavir/ritonavir + hydroxychloroquine vs. lopinavir/ritonavir vs. hydroxychloroquine,Lopinavir/ritonavir; hydroxychloroquine,2500,https://anzctr.org.au/ACTRN12620000445976.aspx,None
989,1659,ISRCTN25647404,ISRCTN,2020-11-09,2020-09-20,True,Cardiff University,Recruiting,Not Applicable,Interventional,United Kingdom,Measurement of the effect of mouthwash against COVID-19,Drug,Cetylperidium chloride vs. povidone iodine vs. Cetylperidium chloride,Cetylperidium chloride; povidone iodine; Cetylperidium chlorid,104,http://isrctn.com/ISRCTN25647404,None
990,1661,ISRCTN79623250,ISRCTN,2020-11-04,2020-04-30,True,Coventry University,Not Recruiting,Not Applicable,Interventional,United Kingdom,The digital Hope programme for people living with cancer during COVID-19,Other (psych),Psychological,Psychological,40,http://isrctn.com/ISRCTN79623250,None
991,1668,EUCTR2020-001891-14-ES,EU Clinical Trials Register,2020-05-05,2020-04-05,True,Fundación Neumosur,Authorised,Phase 2,Interventional,Spain,"Impact of the use of low molecular weight heparins (LMWH), at prophylactic versus intermediate doses, on SARS-CoV2 infection (COVID-19)",Drug,Heparin,Heparin,140,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001891-14,None
992,1669,EUCTR2020-002032-69-ES,EU Clinical Trials Register,2020-05-05,2020-04-05,True,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Authorised,Phase 2,Interventional,Spain,Clinical trial on the efficacy of tocilizumab in modifying the inflammatory parameters of patients with COVID-19,Drug,Tocilizumab,Tocilizumab,78,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002032-69,None
993,1670,EUCTR2020-001603-16-ES,EU Clinical Trials Register,2020-05-08,2020-06-05,False,Instituto de Investigación Marqués de Valdecilla (IDIVAL),Authorised,Phase 3,Interventional,Spain,Ensayo clÃ­nico aleatorizado para investigar la eficacia de la administraciÃ³n anticipada de la colchicina en pacientes mayores de 70 aÃ±os y de alto riesgo en tener complicaciones pulmonares como neumonÃ­a asociada al coronavirus.,Drug,Colchicine,Colchicine,1024,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001603-16,None
994,1671,EUCTR2020-001994-66-ES,EU Clinical Trials Register,2020-05-08,2020-06-05,False,Fundació Assistencial Mútua Terrassa,Authorised,Phase 3,Interventional,Spain,Study of the efficacy of ivermectin in the treatment and prevention of COVID-19,Drug,Ivermectin,Ivermectin,266,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001994-66,None
995,1672,EUCTR2020-001934-37-ES,EU Clinical Trials Register,2020-05-08,2020-07-05,False,Instituto de Investigación Marqués de Valdecilla (IDIVAL),Authorised,Phase 4,Interventional,Spain,USE OF CORTICOSTEROIDS IN PATIENTS WITH SARS-COV2 CORONAVIRUS INFECTION,Drug,Corticosteroids,Methylprednisolone,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001934-37,None
996,1673,EUCTR2020-002123-11-ES,EU Clinical Trials Register,2020-05-08,2020-07-05,False,Tatiana Cobo-Ibáñez,Authorised,Phase 4,Interventional,Spain,CLINICAL STUDY IN WHICH PATIENTS ARE RANDOMIZED TO RECEIVE HYDROXYCHLOROQUINE VS. CYCLOSPORINE - HYDROXYCHLOROQUINE TO COMPARE THEIR EFFICACY IN THE TREATMENT OF COVID-19 PNEUMONIA.,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Cyclosporine,Hydroxychloroquine; Cyclosporine,280,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002123-11,None
997,1674,EUCTR2020-001474-29-ES,EU Clinical Trials Register,2020-05-08,2020-07-05,False,Clínica Universidad de Navarra,Authorised,Phase 2,Interventional,Spain,Pilot study to evaluate the potential of ivermectin to reduce COVID-19 transmission,Drug,Ivermectin,Ivermectin,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001474-29,None
998,1675,EUCTR2020-002472-12-NL,EU Clinical Trials Register,2020-05-14,2020-11-06,False,Radboud University Medical Centre,Authorised,Phase 4,Interventional,Netherlands,Lanadelumab for treatment of COVID-19 disease,Drug,Lanadelumab,Lanadelumab,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002472-12,None
999,1676,EUCTR2020-001903-17-ES,EU Clinical Trials Register,2020-05-15,2020-10-06,False,Hospital Universitario de Móstoles,Authorised,Phase 3,Interventional,Spain,Effects of Tocilizumab  and its combination with Vitamin D to treat the increased defensive response in COVID-19,Drug,Tocilizumab + Vitamin D,Tocilizumab; Vitamin D,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001903-17,None
1000,1677,EUCTR2020-002114-40-FR,EU Clinical Trials Register,2020-06-17,2020-07-30,False,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 3,Interventional,France,Nintedanib for the treatment of pulmonary fibrosis induced by Covid-19,Drug,Nintedanib,Nintedanib,250,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002114-40,None
1001,1678,EUCTR2020-001852-16-NL,EU Clinical Trials Register,2020-07-14,2020-07-14,False,Máxima Medisch Centrum,Authorised,Phase 2,Interventional,Netherlands,Iodine treatment Coronavirus infection,Drug,Potassium Iodine,Potassium Iodine,224,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001852-16,None
1002,1679,EUCTR2020-001857-31-DE,EU Clinical Trials Register,2020-07-21,2020-09-11,False,Pluristem Ltd.,Authorised,Phase 2,Interventional,"Israel, Germany, Bulgaria",A clinical study to test if a drug called PLX-PAD is both safe and can help in the treatment of COVID-19 patients,Drug,Emiplacel,Emiplacel,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001857-31,None
1003,1680,EUCTR2020-002497-27-CZ,EU Clinical Trials Register,2020-10-22,2020-10-27,False,Thomayer Hospital,Authorised,Phase 4,Interventional,Czech Republic,"A randomized, open-label, phase IV monocentric study evaluating the clinical effect of oral immunomodulatory therapy with IMUNORÂ® in patients with moderate COVID-19 disease",Drug,IMUNOR,IMUNOR,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002497-27,None
1004,1681,EUCTR2020-001623-13-GR,EU Clinical Trials Register,2020-04-22,2020-05-20,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Authorised,Phase 2,Interventional,Greece,Triiodothyronine for the treatment of critically ill patients with COVID-19 infection (Thy-Support Study),Drug,Triiodothyronine,Triiodothyronine,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001623-13,None
1005,1682,EUCTR2020-002225-29-FR,EU Clinical Trials Register,2020-04-30,2020-12-11,False,GCS Ramsay Sant pour l'Enseignement et la Recherche,Authorised,Phase 2,Interventional,France,Evaluation of the effects of bradykinin antagonists on pulmonary manifestations of COVID-19 infections.,Drug,Icatibant Acetate vs. C1 Estrerase Inhibitor,Icatibant Acetate; C1 Estrerase Inhibitor,45,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002225-29,None
1006,1683,EUCTR2020-001236-10-NL,EU Clinical Trials Register,2020-03-31,2020-03-31,True,UMC Amsterdam,Authorised,Phase 2,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection: the CounterCovid Study,Drug,Imatinib,Imatinib,386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001236-10,NL8491
1007,1685,ISRCTN16842454,ISRCTN,2020-11-10,2020-05-19,True,Ministry of Research and Technology/National Research and Innovation Agency (Indonesia),Recruiting,Not Applicable,Interventional,Indonesia,Effectiveness and safety of plasma convalescent therapy in patients with COVID-19,ATMP,Plasma,Plasma,5,http://isrctn.com/ISRCTN16842454,None
1008,1687,EUCTR2020-001467-82-NL,EU Clinical Trials Register,2020-04-28,2020-10-23,False,Leiden University Medical Center,Authorised,Phase 2,Interventional,Netherlands,Investigation of the antiviral effect of Voclosporine on COVID-19 in renal transplant patients,Drug,Voclosporin,Voclosporin,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001467-82,None
1009,1688,EUCTR2020-004743-83-GB,EU Clinical Trials Register,2020-10-26,2020-09-11,True,Synairgen Research Limited,Authorised,Phase 3,Interventional,"Canada, South Africa, Serbia, United States, Moldova, Republic of, Romania, Colombia, Portugal, Chile, Peru, Italy, France, Israel, Argentina, Netherlands, Turkey, United Kingdom, India, Poland, Germany, Mexico, Belgium, Russian Federation, Ukraine, Brazil, Spain",A trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients hospitalised with moderate COVID-19,Drug,Interferon beta,Interferon beta,900,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004743-83,None
1010,1692,ACTRN12620001249943,ANZCTR,2020-11-20,2020-01-12,True,Aegros Ltd.,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,"Intravenous immunoglobulin rich in neutralising antibodies to SARS-CoV-2 as a passive
immunity modality in healthy individuals at risk of infection with COVID-19: an open label,
active control Phase 1/2 Study",ATMP,Immunoglobulin,Immunoglobulin,30,https://anzctr.org.au/ACTRN12620001249943.aspx,None
1011,1694,ISRCTN12792822,ISRCTN,2020-11-18,2020-11-21,False,Population Council - Kenya,Recruiting,Not Applicable,Interventional,Kenya,Cash transfers to stimulate school re-enrollment among vulnerable adolescent girls in urban informal settlements as Kenya responds to COVID-19,Other,Other,Other,1700,http://isrctn.com/ISRCTN12792822,None
1012,1695,ISRCTN90437126,ISRCTN,2020-11-17,2020-09-15,True,Federal University of Pernambuco,Recruiting,Phase 3,Interventional,Brazil,Study on the effects of using ivermectin to prevent COVID-19 in an adult population in Brazil,Drug (Chemoprophylaxis),Ivermectin,Ivermectin,800,http://isrctn.com/ISRCTN90437126,None
1013,1698,ISRCTN68675756,ISRCTN,2020-07-01,2020-10-02,False,Bengbu Medical College,Not Recruiting,Not Applicable,Interventional,China,Psychological intervention to improve the mental health of patients with COVID-19,Other (psych),Psychological,Psychological,93,http://isrctn.com/ISRCTN68675756,None
1014,1700,EUCTR2020-001546-19-BE,EU Clinical Trials Register,2020-04-09,2020-04-21,False,Argenx BV,Not Recruiting,Phase 1/Phase 2,Interventional,Belgium,A First-in-Human Study in Adult Subjects Hospitalized with Covid-19 to Investigate a new product called ARGX-117,Drug,ARGX-117,ARGX-117,6,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001546-19,None
1015,1701,EUCTR2020-001319-26-ES,EU Clinical Trials Register,2020-05-14,2020-05-14,False,Instituto de Investigación Sanitaria Fundación Jiménez Díaz,Authorised,Phase 3,Interventional,Spain,Clinical trial to assess the prognostic repercussions of rosuvastatin treatment in patients discharged after hospitalization for COVID-19 Positive.,Drug,Rosuvastatin,Rosuvastatin,1080,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001319-26,None
1016,1702,EUCTR2020-001995-13-ES,EU Clinical Trials Register,2020-05-21,2020-05-15,True,Fundación SEIMC-GESIDA,Authorised,Phase 2,Interventional,Spain,Clinical trial to evaluate the efficacy and safety of tocilizumab for treating patients with COVID-19 pneumonia: the BREATH-19 Study,Drug,Tocilizumab,Tocilizumab,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001995-13,None
1017,1703,EUCTR2020-002274-28-ES,EU Clinical Trials Register,2020-05-21,2020-05-19,True,Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias (FINBA),Authorised,Phase 4,Interventional,Spain,Evaluation of the likely beneficial effects of vitamin D on infection with coronavirus.,Drug,Vitamin D,Vitamin D,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002274-28,None
1018,1704,EUCTR2020-001704-42-ES,EU Clinical Trials Register,2020-05-21,2020-05-15,True,Instituto de Investigación Marqués de Valdecilla (IDIVAL),Authorised,Phase 4,Interventional,Spain,Controlled and randomised trial to assess the safety and efficacy of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in hospital healthcare personnel (Sanitarios sin COVID-19).,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001704-42,None
1019,1705,EUCTR2020-002287-31-ES,EU Clinical Trials Register,2020-05-25,2020-05-22,True,Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS),Authorised,Phase 3,Interventional,Spain,COVID 19 prevention in nursing homes,Drug,Hydroxychloroquine,Hydroxychloroquine,1930,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002287-31,None
1020,1706,EUCTR2020-002037-15-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Cristina Avendaño-Solá,Authorised,Phase 2,Interventional,Spain,"Multicenter, randomized, open-label study to evaluate the efficacy and safety of SOC + Sarilumab versus Standard of Care for the Early Treatment of COVID-19-pneumonia in Hospitalized Patients",Drug,Sarilumab,Sarilumab,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002037-15,None
1021,1707,EUCTR2020-001960-28-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Investigation Institute Bioaraba,Authorised,Phase 4,Interventional,Spain,Efficacy of vitamin D treatment in patients diagnosed with pneumonia who require hospital admission and have vitamin D deficiency and a positive diagnosis for SARS-Cov-2 (COVID-19),Drug,Vitamin D,Vitamin D,108,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001960-28,None
1022,1708,EUCTR2020-001841-38-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Sociedad Española de Cardiología,Authorised,Phase 3,Interventional,Spain,"Colchicine for the Treatment of Hyperinflammation associated with Pneumonia due to COVID-19
",Drug,Colchicine,Colchicine,240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001841-38,None
1023,1709,EUCTR2020-002456-21-NL,EU Clinical Trials Register,2020-05-26,2020-05-28,False,Radboud University Medical Centre,Not Recruiting,Phase 4,Interventional,Netherlands,Boosting the BCG-induced immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against the coronavirus (BCG-PLUS),ATMP,Vaccine,Vaccine,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002456-21,None
1024,1710,EUCTR2020-001605-23-ES,EU Clinical Trials Register,2020-05-31,2020-05-29,True,Basque Health Service,Authorised,Phase 4,Interventional,Spain,Effectiveness of the combined treatment with hydroxycloroquine and azithromycin vs lopinavir/ritonavir + hydroxycloroquine in hospitalized patients with confirmed COVID-19 infection,Drug,Hydroxychloroquine + Azithromycin vs. Lopinavir/ritonavir + Hydroxychloroquine,Hydroxychloroquine; Azithromycin; Lopinavir/ritonavir,108,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001605-23,None
1025,1711,EUCTR2020-002312-43-ES,EU Clinical Trials Register,2020-05-31,2020-05-28,True,Hospital Universitario Severo Ochoa,Authorised,Phase 3,Interventional,Spain,"Clinical trial,  randomized, open-label, to evaluate the efficacy of  high-dose vitamin D  in patients with COVID-19 pneumonia",Drug,Vitamin D,Vitamin D,82,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002312-43,None
1026,1712,EUCTR2020-001671-32-ES,EU Clinical Trials Register,2020-05-31,2020-05-28,False,"Staidson (Beijing) Biopharmaceuticals Co., Ltd; Beijing Defengrui Biological Technology Co., Ltd.",Authorised,Phase 2,Interventional,Spain,"A clinical trial to investigate the efficacy and safety of a new compound for the treatment of COVID-19, called BDB-001. Patients in the trial will be randomly allocated to either the new treatment or the conventional treatment and will be aware of which treatment they are receiving",Drug,BDB-001,BDB-001,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001671-32,CTRI/2020/08/027109
1027,1713,EUCTR2020-002009-25-CZ,EU Clinical Trials Register,2020-06-04,2020-01-10,True,"University Hospital, Pilsen",Authorised,Phase 2,Interventional,Czech Republic,The efficacy and safety of Eftilagimod Alpha Treatment in COVID-19 disease (EAT COVID trial),Drug,Eftilagimod Alpha,Eftilagimod Alpha,104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002009-25,None
1028,1714,EUCTR2020-001971-33-ES,EU Clinical Trials Register,2020-07-22,2020-02-06,True,Carmen Hidalgo,Authorised,Phase 3,Interventional,Spain,"Pragmatic study ""CORIVER"": Ivermectin as antiviral treatment for patients infected by SARS-COV2 (COVID19)",Drug,Ivermectin vs. Hydroxychloroquine + Azithormycin,Ivermectin; Hydroxychloroquine; Azithormycin,45,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001971-33,None
1029,1715,EUCTR2020-002234-32-BE,EU Clinical Trials Register,2020-10-26,,False,"University Hospital, Bern",Authorised,Phase 3,Interventional,Belgium,Efficacy and Safety of Edoxaban and or Colchicine for patients with SARS-CoV-2 infection managed in the out of hospital setting (COVID 19),Drug,Endoxaban vs. Colchicine vs. Endoxaban + Colchicine,Endoxaban; Colchicine,420,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002234-32,None
1030,1716,EUCTR2020-004682-39-CZ,EU Clinical Trials Register,2020-11-13,2020-11-16,False,Thomayer Hospital,Authorised,Phase 4,Interventional,Czech Republic,"Pilot, open-label, monocentric study evaluating safety and clinical effect of application of NORMOSANGÂ® in patients with COVID-19 disease",Drug,Normosang,Normosang,8,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004682-39,None
1031,1717,EUCTR2020-001206-35-DE,EU Clinical Trials Register,2020-04-09,2020-04-14,False,Medical University Innsbruck,Authorised,Phase 4,Interventional,"Germany, Austria",Discontinuation of ACE inhibitors in patients with COVID-19 infection,Drug,ACE inhibitors,ACE inhibitors,798,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001206-35,None
1032,1718,EUCTR2020-002322-85-SE,EU Clinical Trials Register,2020-05-14,2020-02-07,True,Kancera AB,Authorised,Phase 2,Interventional,Sweden,"KAND567 Versus Placebo in Subjects Hospitalized with COVID-19. A Phase II, Randomized, 2-Arm Parallel-Group, Double-blind Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics.",Drug,KAND567,KAND567,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002322-85,None
1033,1719,EUCTR2020-003936-25-IT,EU Clinical Trials Register,2020-11-23,2020-10-31,True,Dompe Farmaceutici,Authorised,Phase 2/Phase 3,Interventional,Italy,Trial to study efficacy and safety of two doses of raloxifene in adult paucisymptomatic COVID-19 patients,Drug,Raloxifene,Raloxifene,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003936-25,None
1034,1720,EUCTR2020-003904-15-DK,EU Clinical Trials Register,2020-08-11,2020-08-27,False,University of Southern Denmark,Authorised,Phase 3,Interventional,Denmark,BCG vaccine for seniors to prevent infections during the COVID-19 pandemic.,ATMP,Vaccine,Vaccine,1900,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003904-15,None
1035,1721,EUCTR2020-001784-88-FI,EU Clinical Trials Register,2020-04-17,2020-04-29,False,University of Helsinki,Authorised,Phase 3,Interventional,Finland,"A clinical study to evaluate the efficacy of different anti-viral drugs in
SARS-CoV-2 infected patients (COVID-19)",Drug,"Oxiklorin, Hydroxychloroquine, Remdesivir","Oxiklorin, Hydroxychloroquine, Remdesivir",582,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001784-88,None
1036,1725,DRKS00021447,German Clinical Trials Register,2020-04-27,2020-01-05,True,Charité University,Not Recruiting,Phase 2,Interventional,Germany,CytoResc - CytoSorb Rescue for COVID-19 Cytokine Storm,Other (device),Cytokine Adsorber,Cytokine Adsorber,100,http://www.drks.de/DRKS00021447,None
1037,1727,DRKS00021420,German Clinical Trials Register,2020-04-16,2020-01-04,True,Technische Universität München,Recruiting,Phase 1,Interventional,Germany,Observational clinical trial for the evaluation of an automated nasal and pharyngeal swab exam to test COVID-19 patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,http://www.drks.de/DRKS00021420,None
1038,1739,DRKS00021527,German Clinical Trials Register,2020-04-24,2020-04-14,True,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: a group chat program in the psychiatric outpatient clinic of the Leipzig University Hospital,Other (psych),Psychological,Psychological,100,http://www.drks.de/DRKS00021527,None
1039,1745,DRKS00021573,German Clinical Trials Register,2020-04-27,2020-04-30,False,"University Hospital, Heidelberg",Not Recruiting,Phase 1,Interventional,Germany,"Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Covid-19",Drug,Proton pump inhibitor + Hydoxychloroquine + Midazolam + Yohimbine vs. Hydoxychloroquine + Midazolam + Yohimbine,Proton pump inhibitor; Hydoxychloroquine; Midazolam; Yohimbine,24,http://www.drks.de/DRKS00021573,None
1040,1753,DRKS00021585,German Clinical Trials Register,2020-04-29,2020-04-24,True,Vivantes Humboldt Klinikum,Recruiting,Not Applicable,Interventional,Germany,Lung Ultrasound in Covid-19 Pneumonia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,220,http://www.drks.de/DRKS00021585,None
1041,1754,DRKS00021588,German Clinical Trials Register,2020-05-04,2020-08-05,False,"University Hospital, Erlangen",Recruiting,Not Applicable,Interventional,Germany,Naturalistic evaluation of an Internet-based psychological training program for mental strain associated with the coronavirus / COVID-19 pandemic,Other (psych),Psychological,Psychological,1000,http://www.drks.de/DRKS00021588,None
1042,1756,DRKS00021582,German Clinical Trials Register,2020-05-12,2020-05-31,False,Heidelberg University,Not Recruiting,Not Applicable,Interventional,"United Kingdom, France, United States, Germany, Spain, Mexico","A short, animated video to improve COVID-19 hygiene uptake: an online randomized experiment with 20,000 participants",Other,Other,Other,20000,http://www.drks.de/DRKS00021582,None
1043,1766,DRKS00021214,German Clinical Trials Register,2020-04-01,2020-07-04,False,"University Hospital, Schleswig-Holstein",Recruiting,Not Applicable,Interventional,Germany,Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease,Drug,Vitamin B3,Vitamin B3,1300,http://www.drks.de/DRKS00021214,None
1044,1773,DRKS00022553,German Clinical Trials Register,2020-09-14,2020-01-10,True,"University Hospital, Hamburg-Eppendorf",Recruiting,Phase 4,Interventional,Germany,Psychodiagnostic Screening in U-Examinations,Other (psych),No Intervention,No Intervention,5670,http://www.drks.de/DRKS00022553,None
1045,1791,DRKS00021153,German Clinical Trials Register,2020-04-06,2020-07-04,False,Leuphana Universität Lüneburg,Recruiting,Not Applicable,Interventional,Germany,get.calm and move.on â€“ tackling worries and finding strength for the crisis (COVID-19) in 10 steps,Other (psych),Psychological,Psychological,352,http://www.drks.de/DRKS00021153,None
1046,1792,DRKS00022484,German Clinical Trials Register,2020-07-17,2020-09-04,False,"University Hospital, Regensburg",Recruiting,Not Applicable,Interventional,Germany,Clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2 (COVID-19),Drug,Hydrogen peroxide,Hydrogen peroxide,50,http://www.drks.de/DRKS00022484,None
1047,1794,DRKS00021301,German Clinical Trials Register,2020-04-16,2020-04-06,True,Universität Duisburg-Essen,Recruiting,Not Applicable,Interventional,Germany,An e-Mental Health Intervention to Support burdened People in Times of the COVID-19 pandemic: CoPE It,Other (psych),Psychological,Psychological,240,http://www.drks.de/DRKS00021301,None
1048,1803,DRKS00021273,German Clinical Trials Register,2020-04-20,2020-04-25,False,Goethe University Frankfurt,Recruiting,Not Applicable,Interventional,"Chile, Italy, Singapore, France, Brazil, Austria, Germany, Spain, Argentina",Effects of digital home exercise programs on physical and mental well-being during the COVID-19 pandemic: a multi-center trial,Other (exercise),Exercise,Exercise,544,http://www.drks.de/DRKS00021273,None
1049,1804,DRKS00022305,German Clinical Trials Register,2020-07-31,2020-03-08,True,LMU Klinikum,Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of the Patient-Doctor-Relationship during the COVID-19 pandemia,Other,No Intervention,No Intervention,500,http://www.drks.de/DRKS00022305,None
1050,1841,DRKS00023406,German Clinical Trials Register,2020-11-09,2020-11-15,False,"University Hospital, Cologne",Not Recruiting,Not Applicable,Interventional,Germany,Intubation with VieScope vs. Videolaryngoskopy in complete personal protecion gear in asimulated COVID-19-Patient - A randomized controll trail,Procedure,Intubation,Intubation,35,http://www.drks.de/DRKS00023406,None
1051,1848,DRKS00022067,German Clinical Trials Register,2020-06-12,2020-06-25,False,MSB Medical School Berlin,Not Recruiting,Not Applicable,Interventional,Germany,An intensive longitudinal study on habit formation of hand washing behavior during the COVID-19 pandemic,Procedure,Hand washing,Hand washing,134,http://www.drks.de/DRKS00022067,None
1052,1853,DRKS00022083,German Clinical Trials Register,2020-06-09,2020-05-20,True,Landesklinikum Neunkirchen,Recruiting,Not Applicable,Interventional,Austria,Evaluation of three commercially available rapid assays for detection of IgG and/or IGM antibodies to SARS-CoV-2 (COVID-19) for assessment of contact personsâ€™ immune status and termination of quarantine and self-isolation â€“ a prospective pilot study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,70,http://www.drks.de/DRKS00022083,None
1053,1857,DRKS00023500,German Clinical Trials Register,2020-11-05,2020-06-18,True,"University Hospital, Frankfurt",Not Recruiting,Not Applicable,Interventional,Germany,"Rapidly applicable surveillance process for COVID-19 
in day care centers with dual swabs",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1250,http://www.drks.de/DRKS00023500,None
1054,1863,DRKS00022203,German Clinical Trials Register,2020-06-15,2020-06-20,False,Pharco Corporate,Recruiting,Phase 2/Phase 3,Interventional,Egypt,"Efficacy & Safety of Sofosbuvir/Daclatasvir treatment in COVID-19: A randomized, controlled study",Drug,Sofosbuvir + Daclatasvir vs. Hydroxychloroquine,Sofosbuvir; Daclatasvir; Hydroxychloroquine,90,http://www.drks.de/DRKS00022203,None
1055,1874,DRKS00023184,German Clinical Trials Register,2020-10-07,2020-09-20,True,Arbeitsgemeinschaft Intensivmedizin (AIM) Arnsberg,Recruiting,Not Applicable,Interventional,Germany,Impact of personal protective equipment (PPE) during a simulated cardiac arrest in times of the COVID-19 pandemic,Other,Other,Other,400,http://www.drks.de/DRKS00023184,None
1056,1875,DRKS00023171,German Clinical Trials Register,2020-10-26,2020-02-11,True,BKK Verkehrsbau Union GmbH,Not Recruiting,Not Applicable,Interventional,Germany,Virtual Assisted Living,Other,Other,Other,207,http://www.drks.de/DRKS00023171,None
1057,1886,DRKS00023091,German Clinical Trials Register,2020-09-24,2020-09-16,True,Hessian Ministry for Social Affairs and Integration,Recruiting,Not Applicable,Interventional,Germany,"Early detection of SARS-CoV-2 (COVID-19) in schools in the state of Hesse, Germany",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,http://www.drks.de/DRKS00023091,None
1058,1905,DRKS00022958,German Clinical Trials Register,2020-10-07,2021-04-01,False,University of Osnabruck,Not Recruiting,Not Applicable,Interventional,Germany,Covid-19-associated research on hand eczema in the health sector â€“ Part 2,Other,No Intervention,No Intervention,35,http://www.drks.de/DRKS00022958,None
1059,1921,DRKS00021732,German Clinical Trials Register,2020-06-10,2020-06-30,True,Klinikum St. Georg gGmbH,Recruiting,Not Applicable,Interventional,Germany,"Treatment of Sars-CoV2 infections (Covid-19) with valsartan vs placebo, a three-armed randomized, partly blinded trial",Drug,Valsartan,Valsartan,300,http://www.drks.de/DRKS00021732,EUCTR2020-001431-27
1060,1923,DRKS00021706,German Clinical Trials Register,2020-05-15,2020-05-25,False,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: Online cognitive behavioral therapy for obsessive-compulsive disorder (OCD NET program),Other (psych),Psychological,Psychological,40,http://www.drks.de/DRKS00021706,None
1061,1938,ChiCTR2000038152,ChiCTR,2020-09-11,2020-09-14,False,Huashan Hospital Affiliated to Fudan University,Recruiting,Phase 1,Interventional,China,"A Single-center, Randomized, Double-blind, Placebo-controlled, Dose Ranging Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of INO-4800, Administered Intradermally Followed by Electroporation in Healthy Volunteers",ATMP,Vaccine,Vaccine,45,http://www.chictr.org.cn/showproj.aspx?proj=59326,None
1062,1941,SLCTR/2020/011,SLCTR,2020-05-04,2020-05-04,False,University of Kelaniya,Not Recruiting,Phase 4,Interventional,Sri Lanka,"Hydroxychloroquine for Post-Exposure Prophylaxis of COVID-19 among naval personnel: a placebo-controlled, randomized, clinical trial",Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://slctr.lk/trials/slctr-2020-011,None
1063,1942,IRCT20160131026298N2,IRCT,2020-04-20,2020-03-10,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of PHR spray on patients with coronavirus-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,64,http://en.irct.ir/trial/46733,None
1064,1943,IRCT20160131026298N3,IRCT,2020-04-30,2020-05-04,False,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the effect of Iranian medicine product, Algro, on patients with coronavirus 19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/47019,None
1065,1944,IRCT20200415047080N2,IRCT,2020-11-07,2020-04-04,True,Tehran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effectiveness of TAC cocktail in critically ill patients with Covid 19 induced pneumonia,Drug,Thiamine + Vitamin C + Corticosteroids,Thiamine; Vitamin C; Methlyprednisolone,30,http://en.irct.ir/trial/47186,None
1066,1945,IRCT20140312016968N2,IRCT,2020-11-01,2020-04-21,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Study of the effects of grapefruit extract on COVID-19,Supplement,Grapefruit extract,Grapefruit extract,20,http://en.irct.ir/trial/47381,None
1067,1946,IRCT20121216011763N46,IRCT,2020-05-04,2020-05-04,False,Esfahan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of curcumin-piperine in patients with coronavirus (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47529,None
1068,1947,IRCT20200415047080N1,IRCT,2020-11-02,2020-09-22,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effectiveness of Tissue plasminogen activator (TPA) for treatment of ARDS induced by Covid-19,ATMP,Tissue plasminogen activator,Tissue plasminogen activator,30,http://en.irct.ir/trial/47982,None
1069,1948,IRCT20200608047686N2,IRCT,2020-11-19,2020-10-17,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The role of hemoperfusion in COVID-19,Other (device),Blood filter,Blood filter,40,http://en.irct.ir/trial/48933,None
1070,1949,IRCT20151227025726N24,IRCT,2020-11-25,2020-07-10,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of bromhexine administration in COVID-19,Drug,Bromhexine,Bromhexine,100,http://en.irct.ir/trial/49043,None
1071,1950,IRCT20200624047908N1,IRCT,2020-07-05,2020-07-13,False,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of sofosbuvir/daclatasvir  in COVID-19 patients,Drug,Sofosbuvir + Daclatasvir + Lopinavir/ritonavir vs. Lopinavir/ritonavir,Sofosbuvir; Daclatasvir; Lopinavir/ritonavir,1000,http://en.irct.ir/trial/49198,None
1072,1951,IRCT20130428013151N2,IRCT,2020-10-28,2020-04-25,True,Khoram-Abad University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of mucodentol on people with coronavirus,Drug,Mucodentol,Mucodentol,200,http://en.irct.ir/trial/49356,None
1073,1952,IRCT20200506047323N6,IRCT,2020-11-17,2020-11-15,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Ivermectin in treatment of COVID-19,Drug,Ivermectin + Hydroxycholoroquine vs. Hydroxychloroquine,Ivermectin; Hydroxychloroquine,120,http://en.irct.ir/trial/49501,None
1074,1953,IRCT20180103038199N3,IRCT,2020-08-30,2020-10-22,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,effects of two products containing Noscapine on COVID-19,Drug,Noscapine,Noscapine,120,http://en.irct.ir/trial/49775,None
1075,1954,IRCT20191211045691N1,IRCT,2020-07-28,2020-07-30,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of inhaled magnesium sulfate in combination with standard treatment in Covid-19 patients,Drug,Magnesium sulfate,Magnesium sulfate,100,http://en.irct.ir/trial/49879,None
1076,1955,IRCT20160131026298N5,IRCT,2020-08-23,2020-09-22,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effect of SINA anti-flu natural product on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/49886,None
1077,1956,IRCT20160131026298N6,IRCT,2020-09-08,2020-11-05,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effectiveness of Nigel-7 capsule and black seed mixture on corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/50246,None
1078,1957,IRCT20160919029870N3,IRCT,2020-11-24,2020-03-20,True,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of selenium in patients with Covid-19,Drug,Selenium,Selenium,80,http://en.irct.ir/trial/50425,None
1079,1958,IRCT20200711048077N1,IRCT,2020-11-16,2020-11-21,False,Mashhad University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Evaluation of respiratory Tele-rehabilitation in patient with COVID-19,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,60,http://en.irct.ir/trial/50721,None
1080,1959,IRCT20200818048444N1,IRCT,2020-09-15,2020-09-22,False,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Verification of the efficacy of Bromhexine-hydrochloride in treatment of patients with COVID19 disease,Drug,Bromhexine hydorchloride,Bromhexine hydorchloride,1300,http://en.irct.ir/trial/50780,None
1081,1960,IRCT20200408046987N2,IRCT,2020-11-07,2020-10-16,True,Akam Tejarat Fartak Farasoo,Recruiting,Phase 2/Phase 3,Interventional,Iran,Determination the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19,Drug,Ivermectin + Sofosbuvir/daclatsivir,Ivermectin; Sofosbuvir/daclatsivir,150,http://en.irct.ir/trial/51007,None
1082,1961,IRCT20200921048786N1,IRCT,2020-11-11,2020-09-22,True,Dezfoul University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of interferon beta-1b in the treatment of COVID-19,Drug,Interferon beta,Interferon beta,82,http://en.irct.ir/trial/51086,None
1083,1962,IRCT20200921048794N1,IRCT,2020-11-19,2020-11-20,False,Hamedan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the Effects of L-carnitine Supplementation on Patients with COVID-19,Drug,L-carnitine,L-carnitine,96,http://en.irct.ir/trial/51120,None
1084,1963,IRCT20151227025726N23,IRCT,2020-11-10,2020-08-06,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluating the effects of Adalimumab in patients with acute respiratory distress syndrome caused by COVID-19,Drug,Adalimumab,Adalimumab,60,http://en.irct.ir/trial/51473,None
1085,1964,IRCT20181030041504N1,IRCT,2020-11-08,2020-10-07,True,Sirjan Faculty of Medical Science,Not Recruiting,Phase 3,Interventional,Iran,"Evaluation of the combined effect of Hesperidin,Artemisinin- Artemisia annua, Noscapine, N-acetylcysteine, Resveratrol supplements and high dose of vitamin C on treatment, clinical symptoms of non-hospitalization and hospitalization patients with symptomatic COVID-19",Supplement,Artemisinin; Vitamin C; Noscapine; Hesperdin; Resveratrik; N-acetylcysteine,Artemisinin; Vitamin C; Noscapine; Hesperdin; Resveratrik; N-acetylcysteine,100,http://en.irct.ir/trial/51482,None
1086,1965,IRCT20200428047229N3,IRCT,2020-11-25,2020-09-08,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of cupping on respiratory symptoms of COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,72,http://en.irct.ir/trial/51516,None
1087,1966,IRCT20201012049010N1,IRCT,2020-11-12,2020-07-22,True,Qazvin University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The effect of balloon-blowing on dyspnea and oxygenation in non-critical adult covid-19 patients.,Other,Other,Other,90,http://en.irct.ir/trial/51591,None
1088,1967,IRCT20200426047206N4,IRCT,2020-11-01,2020-10-22,True,Hamedan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Melatonin in treatment of COVID-19,Drug,Melatonin,Melatonin,60,http://en.irct.ir/trial/51687,None
1089,1968,IRCT20150825023753N17,IRCT,2020-11-01,2020-04-13,True,Shiraz University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Evaluation of the effect of ghamz with needle on improvement of respiratory symptoms of COVID-19 patients admitted to hospital,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,18,http://en.irct.ir/trial/51709,None
1090,1969,IRCT20201015049030N1,IRCT,2020-11-07,2020-09-11,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of  Dexamethasone on treatment of COVID-19,Drug,Corticosteroids,Dexamethasone,200,http://en.irct.ir/trial/51736,None
1091,1970,IRCT20201020049088N1,IRCT,2020-11-15,2020-11-05,True,Kerman University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effects of aromatherapy on the anxiety and sleep quality of the patients with COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/51748,None
1092,1971,IRCT20201016049048N1,IRCT,2020-11-04,2020-11-07,False,Shiraz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Iranian Borage on the management of Covid-19 symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/51767,None
1093,1972,IRCT20201015049036N1,IRCT,2020-11-27,2020-09-12,True,Dezfoul University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Efficacy of Date Palm Leaf Extract (Phoenix dactylifera) in Patients with COVID-19 Hospitalized in Ganjavian Hospital in Dezful,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/51772,None
1094,1973,IRCT20181208041886N2,IRCT,2020-10-29,2020-11-21,False,Exir Danesh Asia Pharmaceutical Co.,Recruiting,Not Applicable,Interventional,Iran,Aftogel and COVID-19 PCR test,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/51774,None
1095,1974,IRCT20200720048139N1,IRCT,2020-11-09,2020-11-21,False,Islamic Azad University,Recruiting,Phase 2,Interventional,Iran,Investigating effect of Spirulina dietary supplementation on COVID-19 disease outcomes in patients admitted to Intensive Care Units,Drug,Spirulina,Spirulina,138,http://en.irct.ir/trial/51784,None
1096,1975,IRCT20200404046936N4,IRCT,2020-11-01,2020-12-21,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,RF ablation vs EVLA in lower limb varicosis,Not relevant,Not relevant,Not relevant,1090,http://en.irct.ir/trial/51802,None
1097,1976,IRCT20201024049134N1,IRCT,2020-11-02,2020-11-15,False,Babol University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Efficacy of Arbidol in treatment of COVID-19,Drug,Umifenovir,Umifenovir,100,http://en.irct.ir/trial/51847,None
1098,1977,IRCT20200927048848N2,IRCT,2020-11-04,2020-10-31,True,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,squalene and COVID-19,Drug,Squalene vs. Hydroxychloroquine + Lopinavir/ritonavir,Squalene; Hydroxychloroquine; Lopinavir/ritonavir,15,http://en.irct.ir/trial/51922,None
1099,1978,IRCT20170809035597N2,IRCT,2020-11-16,2020-08-17,True,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of  pentoxifylline in treatment and recovery of patients with COVID-19,Drug,Pentoxifylline + Hydroxychloroquine + Sofosbuvir/daclatasvir vs. Hydroxychloroquine + Sofosbuvir/daclatasvir,Pentoxifylline; Hydroxychloroquine; Sofosbuvir/daclatasvir,86,http://en.irct.ir/trial/51927,None
1100,1979,IRCT20191211045691N2,IRCT,2020-11-02,2020-09-14,True,Yazd Shahid Sadoughi University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of Doxycycline in combination with standard treatment in Covid-19 patients,Drug,Doxycycline,Doxycycline,60,http://en.irct.ir/trial/51951,None
1101,1980,IRCT20190713044192N2,IRCT,2020-11-21,2020-11-21,False,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of the online child birth preparation classes on pregnant women during COVID_19  pandemic,Other,Other,Other,100,http://en.irct.ir/trial/52153,None
1102,1981,IRCT20170315033086N7,IRCT,2020-11-12,2020-11-21,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,An Investigation of the impact of Faramir on the clinical symptoms in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,128,http://en.irct.ir/trial/52223,None
1103,1982,IRCT20190804044429N4,IRCT,2020-11-25,2020-11-10,True,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,pentoxifyliine in COVID-19,Drug,Pentoxyfylline + Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Pentoxyfylline; Hydroxychloroquine; Lopinavir/ritonavir,60,http://en.irct.ir/trial/52284,None
1104,1984,PACTR202004801273802,PACTR,2020-04-02,2020-04-20,False,Lagos State Government,Recruiting,Phase 3,Interventional,Nigeria,"Lagos COVID-19 Chloroquine Treatment Trial (LACCTT)
",Drug,Chloroquine vs. Hydroxychloroquine,Chloroquine; Hydroxychloroquine,800,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928,None
1105,1985,PACTR202004693933092,PACTR,2020-04-12,2020-04-15,False,Misr University for Science and Technology,Not Recruiting,Not Applicable,Interventional,Egypt,Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial),ATMP,Vaccine,Vaccine,200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953,None
1106,1986,PACTR202004761408382,PACTR,2020-04-13,2020-01-05,True,International Centre for Ethnomedicine and Drug Development and Neimeth International Pharmaceuticals Plc.,Not Recruiting,Not Applicable,Interventional,Nigeria,"Efficacy and safety of IHP Detox Tea (a special blend of Andrographis paniculata, Garcinia kola and Psidium guajava) for treatment of Corona virus disease 2019 (COVID-19): a pilot randomized trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957,None
1107,1987,PACTR202005599385499,PACTR,2020-04-16,2020-04-20,False,Cairo University,Not Recruiting,Phase 2,Interventional,Egypt,Folic acid: A new suggested prevention and treatment of COVID-19 infection.,Drug,Folic Acid,Folic Acid,60,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10971,None
1108,1988,PACTR202004893013257,PACTR,2020-04-21,2020-04-25,False,Dr. Birgit Whitman,Not Recruiting,Phase 3,Interventional,Ghana,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Drug,Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine vs. Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir,6400,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10981,None
1109,1989,PACTR202005681895696,PACTR,2020-04-26,2020-01-10,True,University of Oxford,Recruiting,Phase 1,Interventional,Kenya,A study to determine if a new vaccine safely generates good immune responses to protect adults in Kenya from Coronavirus Disease,ATMP,Vaccine,Vaccine,400,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10988,None
1110,1990,PACTR202009786901147,PACTR,2020-05-07,2020-01-10,True,Dr. William Schilling,Not Recruiting,Phase 3,Interventional,Kenya,Hydroxychloroquine for prevention of COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1600,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11019,None
1111,1991,PACTR202006473370201,PACTR,2020-05-12,2020-04-30,True,London School of Hygiene and Tropical Medicine,Not Recruiting,Phase 3,Interventional,"Pakistan, Nigeria",Coronavirus Response - Active Support for Hospitalised COVID-19 patients,Drug,Aspirin vs. Losartan vs. Simvastatin vs. Aspirin + Losartan vs. Aspirin + Simvastatin vs. Lostartan + Simvastatin vs. Aspirin + Losartan + Simvastatin,Aspirin; Losartan; Simvastatin,10000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11037,None
1112,1992,PACTR202007653923168,PACTR,2020-05-13,2020-01-08,True,Kenyatta University Teaching Referral and Research Hospital,Not Recruiting,Phase 3,Interventional,Kenya,A clinical trial comparing use of convalescent plasma therapy plus standard treatment to standard treatment alone in patients with severe COVID-19 infection,ATMP,Plasma,Plasma,206,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11047,None
1113,1993,PACTR202005622389003,PACTR,2020-05-14,2020-01-06,True,Universite Cheikh Anta Diop ,Not Recruiting,Phase 3,Interventional,Senegal,"Hydroxychloroquine, Azithromycine and Zinc for the treatment of SARS-Cov2 infection in Senegal. COVID-19",Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,384,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11053,None
1114,1994,PACTR202006717277937,PACTR,2020-05-25,2020-01-10,True,Awolola Eniola Oladejo,Not Recruiting,Not Applicable,Interventional,Nigeria,Effect of Interferential Therapy on SARS-CoV-2. COVID-19,Other,Inferential Therapy,Inferential Therapy,48,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11088,None
1115,1995,PACTR202006899597082,PACTR,2020-05-29,2020-04-29,True,Malagasy Government,Not Recruiting,Phase 2,Interventional,Madagascar,Efficacy of a new COVID-19 treatment,Drug,Artesunate vs. Artesunate + Vitamin C,Artesunate; Vitamin C,60,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11103,None
1116,1996,PACTR202007589336711,PACTR,2020-06-04,2020-07-13,False,Caleb Ademola Omuwa Gbiri,Not Recruiting,Not Applicable,Interventional,Nigeria,"Physiotherapy as a Complimentary treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors with COVID-19: A Clinical-Controlled Study",Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,30,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11115,None
1117,1997,PACTR202010519682638,PACTR,2020-06-12,2020-08-27,False,National Institute for Pharmaceutical Research and Development (NIPRD),Not Recruiting,Phase 3,Interventional,Nigeria,Efficay of two hydroxychloroquine based drug combination regimens in comparison to standard of care  in The Treatment of Hospitalized COVID-19 Patients,Drug,Hydroxychloroquine vs. Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir,210,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12147,None
1118,1998,PACTR202006537901307,PACTR,2020-06-15,2020-07-20,False,Drugs for Neglected Diseases initiative (DNDi),Recruiting,Phase 3,Interventional,"Ghana, Sudan, Mozambique, Kenya, Ethiopia, Burkina Faso, Guinea, Cameroon, Tanzania, Equatorial Guinea, Uganda, Cote d'Ivoire, Democratic Republic of the Congo","An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild/moderate cases of COVID-19",Drug,Lopinavir/ritonavir vs. Hydroxychloroquine,Lopinavir/ritonavir; Hydroxychloroquine,3000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12150,None
1119,1999,PACTR202007606032743,PACTR,2020-06-19,2020-06-15,True,Dr. Tarek Ismail,Recruiting,Not Applicable,Interventional,Egypt,Nebulized heparin in patients with mainly moderate coronavirus disease 2019: Randomized controlled trial. COVID-19,Drug,Heparin,Heparin,100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12158,None
1120,2000,PACTR202006922165132,PACTR,2020-06-22,2020-06-24,False,University of Oxford,Recruiting,Phase 1,Interventional,South Africa,COVID-19 vaccine (ChAdOx1 nCoV-19) trial in South African Adults with and without HIV-infection,ATMP,Vaccine,Vaccine,2000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12166,None
1121,2001,PACTR202006760881890,PACTR,2020-06-23,2020-01-08,True,Lagos State Government,Recruiting,Phase 2,Interventional,Nigeria,Lagos Covid-19 Convalescent Plasma Trial (LACCPT),ATMP,Plasma,Plasma,100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12168,None
1122,2002,PACTR202006883882711,PACTR,2020-06-30,2020-01-07,True,Dar Al Fouad Hospital,Not Recruiting,Phase 3,Interventional,Egypt,"Effectiveness of Measles, Mumps and Rubella Vaccine in Health Care Professionals for COVID-19",ATMP,Vaccine,Vaccine,200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12175,None
1123,2003,PACTR202007720062393,PACTR,2020-07-02,2020-07-20,False,Inserm-ANRS,Not Recruiting,Phase 2,Interventional,Cote d'Ivoire,Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial (INTENSE-COV),Drug,Lopinavir/ritonavir vs. Lopinavir/ritonavir + Telmisartan vs. Lopinavir/ritonavir + Atorvastatin,Lopinavir/ritonavir; Telmisartan; Atorvastatin,294,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12183,None
1124,2004,PACTR202007611764617,PACTR,2020-07-06,2020-01-09,True,Lagos State Government,Not Recruiting,Phase 3,Interventional,Nigeria,Lagos COVID-19 Black Seed Oil Trial (LACBSOT),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12192,None
1125,2005,PACTR202007700757139,PACTR,2020-07-07,2020-07-13,False,Cytel Inc,Not Recruiting,Phase 2,Interventional,South Africa,TOGETHER 3 Trial. COVID-19,Drug,Lopinavir/ritonavir vs. Vitamin C,Lopinavir/ritonavir; Vitamin C,420,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12194,None
1126,2006,PACTR202008485004797,PACTR,2020-07-17,2020-03-08,True,Desmond Tutu Health Foundation,Not Recruiting,Not Applicable,Interventional,South Africa,TRACE - Transmission of Covid-19 in Crowded Environments,Clinical Presentation (Epidemiology),No Intervention,No Intervention,720,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12214,None
1127,2007,PACTR202009726132275,PACTR,2020-08-25,2020-07-30,True,Novavax,Recruiting,Phase 2,Interventional,South Africa,A Study Looking at the Safety and Effectiveness of a COVID-19 Vaccine Plus Adjuvant in South African Adults,ATMP,Vaccine,Vaccine,2904,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12319,None
1128,2008,PACTR202009769021840,PACTR,2020-08-31,2020-09-15,False,Aga Khan University,Not Recruiting,Phase 2,Interventional,Kenya,Whole-lung low dose radiation therapy (LDRT) in the treatment of severe COVID-19 pneumonia,Other,Radiation,Radiation,20,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12333,None
1129,2009,PACTR202009642148520,PACTR,2020-09-02,2020-01-11,True,Liverpool School of Tropical Medicine,Not Recruiting,Phase 3,Interventional,"Kenya, Burkina Faso",Malaria as a risk factor for COVID-19 in western Kenya and Burkina Faso,Clinical Presentation,No Intervention,No Intervention,142,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12343,None
1130,2010,PACTR202010537777617,PACTR,2020-09-13,2020-01-11,True,EMSKE Phytochem,Not Recruiting,Phase 2,Interventional,Kenya,FLAVOCOV Distributed Clinical Trial. COVID-19,Drug,Diosmin + hesperidin,Diosmin; hesperidin,200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12365,None
1131,2011,PACTR202009483194545,PACTR,2020-09-20,2020-10-15,False,University of Lome,Not Recruiting,Phase 2,Interventional,Togo,Evaluation of phytopharmaceuticals to improve the prognosis of Covid-19 disease in Togo.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,250,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13381,None
1132,2012,PACTR202010729372570,PACTR,2020-09-25,2020-05-10,True,Government of Uganda; Makerere University,Not Recruiting,Phase 3,Interventional,Uganda,The COVID-19 Community Engagement Study,Other,No Intervention,No Intervention,800,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13392,None
1133,2013,PACTR202010690466874,PACTR,2020-10-01,2020-01-11,True,Kwame Nkrumah University of Science and Technology,Not Recruiting,Phase 2,Interventional,Ghana,KNUST COVID-19 CLINICAL TRIAL,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13403,None
1134,2014,PACTR202010781639956,PACTR,2020-10-07,2020-09-21,True,Drugs for Neglected Diseases Initiative (DNDi),Recruiting,Phase 3,Interventional,"Sudan, Mozambique, Kenya, Ethiopia, Democratic Republic of the Congo, Equatorial Guinea, Ghana","The impact of COVID-19 treatment on the type, strength and duration of antibody and cellular immune responses in SARS-CoV-2 patients in sub-Saharan Africa
Ancillary Study of the ANTICOV Study:
An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild / moderate cases of COVID-19",Drug,Hydroxychloroquine vs. Lopinavir/ritonavir vs. Paracetamol,Hydroxychloroquine; Lopinavir/ritonavir; Paracetamol,1000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13420,None
1135,2015,PACTR202010472402152,PACTR,2020-10-07,2020-12-10,False,MRC Unit The Gambia at LSHTM,Not Recruiting,Not Applicable,Interventional,Gambia,COVADIS study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13421,None
1136,2016,PACTR202010718451278,PACTR,2020-10-14,2020-02-11,True,Drugs for Neglected Diseases Initiative (DNDi),Not Recruiting,Phase 3,Interventional,"Mozambique, Kenya, Equatorial Guinea, Ghana","Factors affecting transmission of SARS-CoV-2 in Households of SARS-CoV-2 patients in Sub-Saharan Africa Ancillary study of the ANTICOV Study: An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild / moderate cases of COVID-19",Drug,Hydroxychloroquine vs. Lopinavir/ritonavir vs. Paracetamol,Hydroxychloroquine; Lopinavir/ritonavir; Paracetamol,2800,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13432,None
1137,2017,PACTR202011523101903,PACTR,2020-11-02,2020-01-12,True,No Sponsor Name Given,Not Recruiting,Phase 3,Interventional,Kenya,"Study of Recombinant Protein Vaccine with Adjuvant against COVID-19 in Adults 18 Years of Age and Older.
",ATMP,Vaccine,Vaccine,34520,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13475,None
1138,2018,RPCEC00000306,RPCEC,2020-04-13,2020-03-27,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 1/Phase 2,Interventional,Cuba,CIGB 2020 in contacts and SARS-CoV-2 infection suspects,ATMP,Vaccine,Vaccine,80,https://rpcec.sld.cu/en/trials/RPCEC00000306-En,None
1139,2019,RPCEC00000307,RPCEC,2020-04-14,2020-10-04,False,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 2,Interventional,Cuba,ESPERANZA study,Drug,Interferon alpha,Interferon alpha,120,https://rpcec.sld.cu/en/trials/RPCEC00000307-En,None
1140,2020,RPCEC00000308,RPCEC,2020-05-03,2020-04-05,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1,Interventional,Cuba,Pharmacodynamics of the Nasalferon in healthy volunteers.,Drug,Nasalferon,Nasalferon,30,https://rpcec.sld.cu/en/trials/RPCEC00000308-En,None
1141,2021,RPCEC00000309,RPCEC,2020-05-05,2020-05-20,False,Colima State Health Service ,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Therapy for COVID-19-Phase I-II,Drug,Homeostec + Paracetamol,Homeostec; Paracetamol,100,https://rpcec.sld.cu/en/trials/RPCEC00000309-En,None
1142,2023,RPCEC00000311,RPCEC,2020-05-12,2020-03-28,True,Center of Molecular Immunology (CIM),Recruiting,Not Applicable,Interventional,Cuba,Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab,Drug,Itolizumab,Itolizumab,80,https://rpcec.sld.cu/en/trials/RPCEC00000311-En,None
1143,2025,RPCEC00000313,RPCEC,2020-05-14,2020-03-31,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Not Applicable,Interventional,Cuba,CIGB-258 at COVID-19,Drug,CIGB-258,CIGB-258,16,https://rpcec.sld.cu/en/trials/RPCEC00000313-En,None
1144,2026,RPCEC00000314,RPCEC,2020-05-22,2020-04-24,True,Finlay Vaccine Institute (IFV),Recruiting,Not Applicable,Interventional,Cuba,VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2,ATMP,Vaccine,Vaccine,115000,https://rpcec.sld.cu/en/trials/RPCEC00000314-En,None
1145,2027,RPCEC00000315,RPCEC,2020-05-22,2020-05-19,True,Finlay Vaccine Institute (IFV),Recruiting,Not Applicable,Interventional,Cuba,Evaluation of the synergistic effect of  sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study,Drug,Immunostimulants,Immunostimulants,60,https://rpcec.sld.cu/en/trials/RPCEC00000315-En,None
1146,2028,RPCEC00000316,RPCEC,2020-05-28,2020-03-07,True,Centro Nacional de Biopreparados (BioCen),Not Recruiting,Not Applicable,Interventional,Cuba,Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis,Drug,Biomodulin T,Biomodulin T,20,https://rpcec.sld.cu/en/trials/RPCEC00000316-En,None
1147,2029,RPCEC00000317,RPCEC,2020-05-28,2020-01-06,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,ATENEA-Co-300 study,Drug,CIGB-300,CIGB-300,20,https://rpcec.sld.cu/en/trials/RPCEC00000317-En,None
1148,2032,RPCEC00000320,RPCEC,2020-06-05,2020-08-06,False,National Center for Scientific Research (CNIC),Not Recruiting,Not Applicable,Interventional,Cuba,Rectal Ozone in the COVID-19 treatment,Drug,Ozone,Ozone,32,https://rpcec.sld.cu/en/trials/RPCEC00000320-En,None
1149,2033,RPCEC00000321,RPCEC,2020-06-22,2020-04-27,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Not Applicable,Interventional,Cuba,VIDA study,Drug,CIGB-258 Peptide,CIGB-258 Peptide,0,https://rpcec.sld.cu/en/trials/RPCEC00000321-En,None
1150,2034,RPCEC00000322,RPCEC,2020-07-03,2020-05-05,True,Dr. José Manuel Ballester Santovenia Institute of Hematology and Immunology,Recruiting,Not Applicable,Interventional,Cuba,Stem cells in patients with lung lesions (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://rpcec.sld.cu/en/trials/RPCEC00000322-En,None
1151,2036,RPCEC00000330,RPCEC,2020-08-11,2020-11-08,False,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 2,Interventional,Mexico,DALIA Study,Drug,CIGB-258 Peptide,CIGB-258 Peptide,60,https://rpcec.sld.cu/en/trials/RPCEC00000330-En,None
1152,2037,RPCEC00000332,RPCEC,2020-08-13,2020-08-24,False,Finlay Vaccine Institute (IFV),Recruiting,Phase 1/Phase 2,Interventional,Cuba,SOBERANA 01,ATMP,Vaccine,Vaccine,676,https://rpcec.sld.cu/en/trials/RPCEC00000332-En,None
1153,2038,RPCEC00000334,RPCEC,2020-09-10,2020-09-14,False,Centro Nacional de Biopreparados (BioCen),Recruiting,Not Applicable,Interventional,Cuba,Biomodulin T in older adult for protection in events of local transmission of COVID-19,Drug,Biomodulin T,Biomodulin T,0,https://rpcec.sld.cu/en/trials/RPCEC00000334-En,None
1154,2039,RPCEC00000335,RPCEC,2020-09-19,2020-09-26,False,Centro Nacional de Biopreparados (BioCen),Recruiting,Not Applicable,Interventional,Cuba,BIOMODULINA T in a long-lived population at high risk of COVID-19 infection,Drug,Biomodulin T,Biomodulin T,0,https://rpcec.sld.cu/en/trials/RPCEC00000335-En,None
1155,2040,RPCEC00000337,RPCEC,2020-10-01,2020-12-10,False,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,OLIVO Study,Drug,Interferon alpha,Interferon alpha,80,https://rpcec.sld.cu/en/trials/RPCEC00000337-En,None
1156,2041,RPCEC00000338,RPCEC,2020-10-17,2020-10-19,False,Finlay Vaccine Institute (IFV),Not Recruiting,Phase 1,Interventional,Cuba,SOBERANA 01A,ATMP,Vaccine,Vaccine,60,https://rpcec.sld.cu/en/trials/RPCEC00000338-En,None
1157,2042,RPCEC00000340,RPCEC,2020-10-27,2020-02-11,True,Finlay Vaccine Institute (IFV),Not Recruiting,Phase 1,Interventional,Cuba,SOBERANA 02,ATMP,Vaccine,Vaccine,40,https://rpcec.sld.cu/en/trials/RPCEC00000340-En,None
1158,2046,RPCEC00000345,RPCEC,2020-11-26,2020-07-12,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,MAMBISA Study,ATMP,Vaccine,Vaccine,88,https://rpcec.sld.cu/en/trials/RPCEC00000345-En,None
1159,2047,RPCEC00000346,RPCEC,2020-11-26,2020-07-12,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,ABDALA Clinical Study,ATMP,Vaccine,Vaccine,0,https://rpcec.sld.cu/en/trials/RPCEC00000346-En,None
1160,2050,TCTR20201015003,TCTR,2020-08-10,2020-01-10,True,Ratchadapiseksompotch Fund,Recruiting,Phase 4,Interventional,Thailand,Clinical outcomes and safety of preoperative non-preserved steroid eye drop in trabeculectomy: A randomised controlled trial,Not relevant,Not relevant,Not relevant,162,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6630,None
1161,2056,TCTR20200819003,TCTR,2020-08-15,2020-09-15,False,Mahidol University,Not Recruiting,Phase 2,Interventional,Thailand,"Efficacy and feasibility of an audio-based mindfulness intervention in reducing anxiety, depression and stress among people with the risk of anxiety and depression during the coronavirus disease 2019 (COVID-19) pandemic in Thailand",Other (psych),Psychological,Psychological,70,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6659,None
1162,2059,TCTR20200601002,TCTR,2020-05-28,2020-01-06,True,Self-sponsored,Recruiting,Not Applicable,Interventional,Malaysia,"A Randomized Controlled Trial on Effectiveness of Mental Health & Psychosocial Support Module (MHPSS) in Reduction of Depression, Anxiety and Stress among Healthcare Workers during COVID-19 Pandemic in Jerantut, Pahang",Other (psych),Psychological,Psychological,110,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6322,None
1163,2061,TCTR20200514001,TCTR,2020-05-12,2020-01-06,True,Siriraj Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,Thailand,An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without Pneumonia Ã¢?? An open-label randomized controlled study Ã¢??,Drug,Favipiravir,Favipiravir,96,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6236,None
1164,2064,TCTR20200409006,TCTR,2020-04-03,2020-01-05,True,King Chulalongkorn Memorial Hospital,Not Recruiting,Not Applicable,Interventional,Thailand,Efficacy of HA330 Hemoperfusion in Critically Ill Patients with Severe COVID-19,Other (device),HA330,HA330,206,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6016,None
1165,2066,TCTR20200404004,TCTR,2020-03-31,2020-04-27,False,Health Systems Research Institute (HSRI),Not Recruiting,Phase 4,Interventional,Thailand,Comparative effectiveness of Chloroquine and Vitamin C prophylaxis in household contacts of confirmed COVID-19 patients,Drug,Chloroquine + Vitamin C,Chloroquine; Vitamin C,400,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5995,None
1166,2070,PER-013-20,REPEC,2020-06-25,2020-01-06,True,Seguro Social de Salud,Recruiting,Phase 2,Interventional,Peru,CONVALESCENT PLASMA AS TREATMENT FOR COVID-19,ATMP,Plasma,Plasma,192,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=013-20,None
1167,2071,PER-031-20,REPEC,2020-07-27,2020-06-07,True,Oncosalud,Not Recruiting,Phase 2,Interventional,Peru,PHASE 2 STUDY OF EFFICACY AND SAFETY OF PLASMA FROM CONVALESCENT PATIENTS WITH COVID-19 IN PATIENTS WITH MODERATE DISEASE (AUNA 20-01),ATMP,Plasma,Plasma,50,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=031-20,None
1168,2072,PER-032-20,REPEC,2020-07-23,2020-07-22,True,"Kiniksa Pharmaceuticals, Ltd.",Recruiting,Phase 2,Interventional,"United Kindgdom, Chile, South Africa, Peru, Italy, Ireland, United States","A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MAVRILIMUMAB (KPL-301) TREATMENT IN ADULT SUBJECTS HOSPITALIZED WITH SEVERE COVID-19 PNEUMONIA AND HYPER-INFLAMMATION",Drug,Mavrilimumab,Mavrilimumab,115,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=032-20,None
1169,2073,PER-034-20,REPEC,2020-07-17,2020-09-07,False,Universidad Peruana Cayetano Heredia,Recruiting,Phase 2,Interventional,Peru,RANDOMIZED PHASE IIA CLINICAL TRIAL TO COMPARE THE EFFICACY OF IVERMECTIN VERSUS PLACEBO TO OBTAIN NEGATIVE PCR RESULTS IN PATIENTS WITH EARLY PHASE COVID-19,Drug,Ivermectin,Ivermectin,68,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=034-20,None
1170,2074,PER-050-20,REPEC,2020-09-17,2020-09-28,False,"Telios Pharma, Inc.",Not Recruiting,Phase 2,Interventional,"Russian Federation, Philippines, Argentina, Ukraine, Peru, Italy, France, Brazil, Romania, Germany, Denmark, Spain, United States, Hungary","â€œA PHASE 1/2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF TL-895 WITH STANDARD AVAILABLE TREATMENT VERSUS STANDARD AVAILABLE TREATMENT FOR THE TREATMENT OF COVID-19 IN PATIENTS WITH CANCERâ€",Drug,TL-895,TL-895,30,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=050-20,None
1171,2075,PER-054-20,REPEC,2020-08-20,2020-10-09,False,CureVac AG,Recruiting,Phase 2,Interventional,"Peru, Brazil, Panama","COVID-19: A PHASE 2A, PARTIALLY OBSERVER-BLIND, MULTICENTER, CONTROLLED, DOSE-CONFIRMATION CLINICAL TRIAL TO EVALUATE THE SAFETY, REACTOGENICITY AND IMMUNOGENICITY OF THE INVESTIGATIONAL SARS-COV-2 MRNA VACCINE CVNCOV IN ADULTS >60 YEARS OF AGE AND 18 TO 60 YEARS OF AGE",ATMP,Vaccine,Vaccine,270,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=054-20,None
1172,2076,PER-060-20,REPEC,2020-09-21,2020-07-09,True,Marina de Guerra del Peru,Recruiting,Phase 2,Interventional,Peru,"RANDOMIZED PHASE 2 CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF THE USE OF PLASMA FROM CONVALESCENT PATIENTS WITH THE NEW CORONAVIRUS DISEASE (COVID-19) FOR THE EXPERIMENTAL TREATMENT  OF PATIENTS HOSPITALIZED IN THE CENTRO MEDICO NAVAL ""CIRUJANO MAYOR SANTIAGO TAVARA""
""",ATMP,Plasma,Plasma,100,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=060-20,None
1173,2077,PER-064-20,REPEC,2020-09-29,2020-01-10,True,Universidad Peruana Cayetano Heredia,Recruiting,Phase 2,Interventional,Peru,LACTOFERRIN FOR PREVENTION OF COVID-19 IN HEALTH CARE PERSONNEL.,Drug (Chemoprophylaxis),Lactoferrin,Lactoferrin,336,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=064-20,None
1174,2078,PER-067-20,REPEC,2020-10-29,2020-09-18,True,Oncotelic Inc.,Not Recruiting,Phase 2,Interventional,Argentina,"A DOUBLE BLIND, RANDOMIZED, PLACEBO CONTROLLED, MULTI CENTER STUDY OF OT 101 IN HOSPITALIZED COVID 19 SUBJECTS",Drug,Trabedersen,Trabedersen,48,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=067-20,None
1175,2079,JPRN-JapicCTI-205270,JPRN,2020-04-23,2020-05-25,False,"Chugai Pharmaceutical Co., Ltd.",Not Recruiting,Phase 3,Interventional,Japan,A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia in Japan,Drug,Tocilizumab,Tocilizumab,10,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205270,None
1176,2080,JPRN-JapicCTI-205465,JPRN,2020-08-27,2020-10-30,False,Human Life CORD Japan Inc.,Not Recruiting,Phase 1,Interventional,Japan,Umbilical cord-derived mesenchymal stromal cells therapy for SARS-CoV-2 infection (COVID-19) related Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),12,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205465,None
1177,2081,JPRN-jRCT1051200078,JPRN,2020-11-24,2020-11-24,False,Matsuyama Akifumi,Recruiting,Phase 2,Interventional,Japan,Study on reduction of salivary virus by povidone iodine on COVID-19,Drug,Povidone iodine,Povidone iodine,440,https://jrct.niph.go.jp/latest-detail/jRCT1051200078,None
1178,2083,JPRN-jRCT2031200180,JPRN,2020-11-04,2020-11-24,False,Taniguchi Masaki,Not Recruiting,Phase 2/Phase 3,Interventional,Japan,A Phase II/III Study of Sargramostim,Drug,Sargramostim,Sargramostim,60,https://jrct.niph.go.jp/latest-detail/jRCT2031200180,None
1179,2084,JPRN-jRCT2051200085,JPRN,2020-11-12,2020-11-25,False,Tomono Kazunori,Recruiting,Phase 1/Phase 2,Interventional,Japan,Phase I / II study of intracutaneous inoculation of COVID-19 DNA vaccine (AG0302-COVID19),ATMP,Vaccine,Vaccine,30,https://jrct.niph.go.jp/latest-detail/jRCT2051200085,None
1180,2085,JPRN-jRCTs031200196,JPRN,2020-11-11,2020-11-11,False,Tsushima Kenji,Recruiting,Phase 2/Phase 3,Interventional,Japan,"Combination therapy of favipiravir, camostat mesilate and inhaled ciclesonide for COVID-19 pneumonia",Drug,Favipiravir + Camostat mesilate + ciclesonide,Favipiravir; Camostat mesilate; ciclesonide,100,https://jrct.niph.go.jp/latest-detail/jRCTs031200196,None
1181,2091,JPRN-UMIN000040744,JPRN,2020-06-16,2020-06-22,False,Yokohama City University,Not Recruiting,Not Applicable,Interventional,Japan,Clinical study to evaluate the efficiency of specific antibody against SARS-CoV-2 for the purpose of its social implementation,Clinical Presentation (Epidemiology),No Intervention,No Intervention,5000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046508,None
1182,2092,JPRN-UMIN000041421,JPRN,2020-08-14,2020-08-14,False,Kanazawa University,Not Recruiting,Not Applicable,Interventional,Japan,Detecting Exacerbation Early Signs of SARS-CoV-2 infection by Fitbit: Pilot Study,Other (device),Biosensors,Biosensors,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047290,None
1183,2098,JPRN-UMIN000042384,JPRN,2020-11-16,2020-11-16,False,Jinseikai Kohnan Hospital,Not Recruiting,Not Applicable,Interventional,Japan,Verification of stress relief by introducing online visits to the restrictions on visits of COVID-19,Other (psych),No Intervention,No Intervention,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048379,None
1184,2101,JPRN-UMIN000042477,JPRN,2020-11-17,2020-11-17,False,Yokohama City University,Recruiting,Not Applicable,Interventional,Japan,Prospective research for early detection of COVID-19 pneumonia using mobile CT vehicle at specialized accommodation facilities,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,150,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048432,None
1185,2107,CTRI/2020/03/024402,CTRI,2020-03-31,2020-08-04,False,Dr. Remesh Bhasi,Not Recruiting,Phase 3,Interventional,India,"Hydroxy Chloroquine, in open labelled, Randomised intervention for prevention of new infection and adverse outcomes following COVID-19 infection -A Tertiary Hospital based study",Drug,Hydroxychloroquine,Hydroxychloroquine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638,None
1186,2112,CTRI/2020/04/024479,CTRI,2020-04-07,2020-04-13,False,Command Hospital Airforce,Not Recruiting,Not Applicable,Interventional,India,Study of the effect of Hydroxychloroquine in addition to standard therapy in COVID-19 patients,Drug,Chloroquine,Chloroquine,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713,None
1187,2114,CTRI/2020/04/024659,CTRI,2020-04-15,2020-04-27,False,SSV Phytopharmaceuticals,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation to improve immunity in quarantine patients of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967,None
1188,2116,CTRI/2020/04/024731,CTRI,2020-04-20,2020-04-24,False,Parul University,Not Recruiting,Phase 3,Interventional,India,Study to Evaluate Preventive Effect of Ayurveda and Homeopathy Treatment in COVID 19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42912,None
1189,2117,CTRI/2020/04/024729,CTRI,2020-04-20,2020-04-21,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2,Interventional,India,"Topical Chloroquine Nasal Drops in Early Stage Covid 19-
Impact on Viral load and cure rates
",Drug,Chloroquine,Chloroquine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42933,None
1190,2119,CTRI/2020/04/024747,CTRI,2020-04-21,2020-01-05,True,GSL Medical College,Not Recruiting,Not Applicable,Interventional,India,EFFECTIVENESS TO MANAGE COVID 19 PANDEMIC BY  TEACHING  VENTILATORY MANAGEMENT TO NON-ANAESTHESIOLOGY RESIDENTS,Other,Other,Other,26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43115,None
1191,2120,CTRI/2020/04/024775,CTRI,2020-04-21,2020-04-22,False,Indian Council Of Medical Research,Not Recruiting,Phase 2,Interventional,India,Study to assess the efficacy and safety of convalescent plasma in moderate COVID-19 disease.,ATMP,Plasma,Plasma,452,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43149,None
1192,2121,CTRI/2020/04/024749,CTRI,2020-04-21,2020-04-21,False,Serum Institute of India Pvt Ltd,Not Recruiting,Phase 3,Interventional,India,Study to Evaluate the Efficacy of Recombinant BCG VPM1002 in Reducing Infection Incidence and Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Subjects,ATMP,Vaccine,Vaccine,5946,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42972,None
1193,2122,CTRI/2020/04/024806,CTRI,2020-04-22,2020-04-26,False,All India Institute of Medical Sciences,Recruiting,Phase 2,Interventional,India,Imatinib in COVID-19 infection,Drug,Imatinib,Imatinib,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42843,None
1194,2123,CTRI/2020/04/024804,CTRI,2020-04-22,2020-11-05,False,International Stemcell Services Ltd,Recruiting,Phase 1/Phase 2,Interventional,India,Evaluation of safety and efficacy of convalescent plasma in COVID-19 patients,ATMP,Plasma,Plasma,24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42849,None
1195,2124,CTRI/2020/04/024776,CTRI,2020-04-22,2020-04-23,False,Dr. Mahesh Mahich,Recruiting,Not Applicable,Interventional,India,"Novel Artificial Intelligence Algorithm to screen COVID-19 Patients from X-Ray , CT-Scan of Thorax and Voice Sampling through Android App and storage through Cloud",Other (software),eHealth,eHealth,1650,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43160,None
1196,2127,CTRI/2020/04/024833,CTRI,2020-04-24,2020-01-05,True,Dr. Narayanan Parameswaran,Not Recruiting,Not Applicable,Interventional,India,BCG-Denmark versus no-BCG for COVID 19 prevention,ATMP,Vaccine,Vaccine,1826,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43105,None
1197,2128,CTRI/2020/04/024857,CTRI,2020-04-25,2020-04-05,True,Welling Healthcare Private Limited,Not Recruiting,Phase 1/Phase 2,Interventional,India,Proving the efficacy of  Homeopathic treatment in prevention and cure of COVID-19.,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43212,None
1198,2130,CTRI/2020/04/024858,CTRI,2020-04-25,2020-04-25,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Interventional,India,"Ã¢??To study the effectiveness of Ivermectin with standard of care treatment
versus standard of care treatment for COVID 19 cases. A Pilot Study",Drug,Ivermectin,Ivermectin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43236,None
1199,2131,CTRI/2020/04/024882,CTRI,2020-04-27,2020-04-28,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,A study to assess the effectiveness of Ayurvedic formulation in addition to standard of care in COVID-19 positive patients in a tertiary hospital.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42899,None
1200,2132,CTRI/2020/04/024904,CTRI,2020-04-28,2020-11-05,False,Director General Armed Forces Medical Services,Not Recruiting,Phase 3,Interventional,India,Treatment of COVID19 : A randomised controlled trial,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43130,None
1201,2133,CTRI/2020/04/024883,CTRI,2020-04-28,2020-04-29,False,Pankajakasthuri Herbal Research Foundation,Not Recruiting,Phase 4,Interventional,India,Clinical research on safety and efficacy of ZingiVir-H as an add on therapy in COVID-19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,112,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43168,None
1202,2135,CTRI/2020/04/024915,CTRI,2020-04-29,2020-09-05,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Phase 2,Interventional,India,"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications",ATMP,Plasma,Plasma,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43332,None
1203,2136,CTRI/2020/04/024948,CTRI,2020-04-30,2020-05-15,False,Lady Hardinge Medical College,Not Recruiting,Phase 2,Interventional,India,"A clinical Trial to Study the Effects of Hydroxychloroquine, Ciclesonide and Ivermectin in treatment of moderate COVID-19 illness",Drug,Hydroxychloroquine vs. Ciclesonide vs. Ivermectin,Hydroxychloroquine; Ciclesonide; Ivermectin,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43364,None
1204,2137,CTRI/2020/04/024949,CTRI,2020-04-30,2020-05-15,False,Lady Hardinge Medical College,Recruiting,Phase 2,Interventional,India,A study to evaluate the effect of Oral Niclosamide in mild and very mild COVID-19 cases,Drug,Niclosamide,Niclosamide,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43400,None
1205,2138,CTRI/2020/04/024947,CTRI,2020-04-30,2020-08-05,False,Dr. Priti Katre,Not Recruiting,Phase 3,Interventional,India,Clinical trial on effects of homeopathic medicine made from cadamba on COVID-19,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43259,None
1206,2139,CTRI/2020/05/024967,CTRI,2020-05-01,2020-11-05,False,MiLab LifeSciences,Not Recruiting,Phase 4,Interventional,India,Herbal product Clinical trial on COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,42,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43338,None
1207,2140,CTRI/2020/05/024959,CTRI,2020-05-01,2020-01-05,True,Biocon Limited,Not Recruiting,Phase 2,Interventional,India,Efficacy and Safety of Itolizumab in COVID-19 Complications,Drug,Itolizumab,Itolizumab,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42878,None
1208,2141,CTRI/2020/05/024969,CTRI,2020-05-01,2020-10-15,False,Naiminath Homoeopathic Medical College Hospital and Research Centre,Not Recruiting,Phase 2/Phase 3,Interventional,India,Homoeopathy as adjuvant in management of Covid-19 infection,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43393,None
1209,2142,CTRI/2020/05/024962,CTRI,2020-05-01,2020-05-05,False,Win medicare,Not Recruiting,Not Applicable,Interventional,India,The use of topical Povidone Iodine (PVP-I) oropharyngeal and intranasal application during the current coronavirus pandemic as a potential measure to reduce viral transmission,Drug,Povidone Iodine,Povidone Iodine,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43237,None
1210,2143,CTRI/2020/05/024981,CTRI,2020-05-02,2020-05-15,False,Dabur India Ltd,Not Recruiting,Not Applicable,Interventional,India,Clinical study on Dabur Chyawanprash as a preventive remedy in pandemic of Covid-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43374,None
1211,2145,CTRI/2020/05/024983,CTRI,2020-05-02,2020-05-05,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,"Usage of topical lignocaine to decrease the gag reflex
while sampling for Covid-19: Does it affect the yield of

specimen?",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43204,None
1212,2149,CTRI/2020/05/024986,CTRI,2020-05-04,2020-05-13,False,Central Council for Research in Homoeopathy,Not Recruiting,Not Applicable,Interventional,India,HOMOEOPATHY IN PREVENTION OF COVID-19,Other,Homeopathy,Homeopathy,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43455,None
1213,2151,CTRI/2020/05/025013,CTRI,2020-05-05,2020-06-05,False,Haffkine Institute for Training Research and Testing,Not Recruiting,Phase 2,Interventional,India,Evaluation of BCG as potential therapy for COVID-19,ATMP,Vaccine,Vaccine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42858,None
1214,2152,CTRI/2020/05/025022,CTRI,2020-05-05,2020-06-05,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2,Interventional,India,Hydroxychloroquine in patients with mild COVID-19 illness with risk factors for severe disease,Drug,Hydroxychloroquine,Hydroxychloroquine,166,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43183,None
1215,2153,CTRI/2020/05/025067,CTRI,2020-05-06,2020-06-15,False,George Institute for Global Health India,Recruiting,Not Applicable,Interventional,India,A randomized controlled trial of hydroxychloroquine prophylaxis for Healthcare Workers exposed to COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,6950,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43019,None
1216,2155,CTRI/2020/05/025049,CTRI,2020-05-06,2020-08-05,False,Sai Nidan Homeopathy Clinic,Not Recruiting,Phase 2/Phase 3,Interventional,India,A CLINICAL TRIAL TO STUDY THE EFFICACY OF HOMOEOPATHIC MEDICINE IN PREVENTION AND CURE OF CORONA VIRUS DISEASE 19,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43313,None
1217,2156,CTRI/2020/05/025069,CTRI,2020-05-07,2020-05-16,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Ayurvedic Interventions in prevention of COVID-19 infection-A survey study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,9200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43522,None
1218,2158,CTRI/2020/05/025068,CTRI,2020-05-07,2020-05-27,False,Christian Medical College Vellore,Not Recruiting,Phase 3,Interventional,India,Can a medicine help in curing viral infection,Drug,Ivermectin,Ivermectin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43449,None
1219,2159,CTRI/2020/05/025071,CTRI,2020-05-08,2020-05-16,False,All India Institute of Medical Sciences,Not Recruiting,Phase 3,Interventional,India,Clinical trial evaluating two ventilator settings in Corona virus related severe lung diseases ( known as ARDS),Other (physical),Mechanical ventilation,Mechanical ventilation,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43447,None
1220,2160,CTRI/2020/05/025088,CTRI,2020-05-09,2020-05-20,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,India,Study of GUDUCHI TABLET on healthy individuals to prevent covid 19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43555,None
1221,2162,CTRI/2020/05/025093,CTRI,2020-05-11,2020-05-18,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,Study of effect of Yashtimadhu tablet for the prevention of COVID -19 on healthy individuals.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43539,None
1222,2165,CTRI/2020/05/025114,CTRI,2020-05-12,2020-05-20,False,Glenmark Pharmaceuticals Ltd,Not Recruiting,Phase 3,Interventional,India,A Clinical Study on Favipiravir Compared to Standard Supportive Care in Patients With Mild to Moderate COVID-19.,Drug,Favipiravir,Favipiravir,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43504,None
1223,2166,CTRI/2020/05/025156,CTRI,2020-05-13,2020-05-18,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43590,None
1224,2169,CTRI/2020/05/025162,CTRI,2020-05-13,2020-05-26,False,Jawaharlal Institute of Postgraduate Medical Education and Research,Recruiting,Not Applicable,Interventional,India,Effect of pranayama and meditation on psychological well-being of healthcare workers during COVID-19 pandemic.,Other (psych),Psychological,Psychological,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43650,None
1225,2170,CTRI/2020/05/025161,CTRI,2020-05-13,2020-05-16,False,Ms Shukla Ashar Impex Pvt Ltd,Not Recruiting,Phase 2,Interventional,India,To study the Effectiveness of herbal formulation - Aayudh Advance as a supplementary treatment for the Corona Virus 2019 (Covid-19) infected patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43442,None
1226,2171,CTRI/2020/05/025166,CTRI,2020-05-14,2020-05-19,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,Study of ASHWAGANDHA TABLET on healthy individuals to prevent covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43553,None
1227,2172,CTRI/2020/05/025178,CTRI,2020-05-14,2020-05-18,False,All India Institute of Ayurveda,Not Recruiting,Phase 2,Interventional,India,Evaluation of the Immuno-Stimulatory Potential (Shareera Bala) of an Ayurveda Management Protocol in Cohort of Quarantined Delhi Police under Covid-19 Care Centers- An Exploratory Clinical Study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43557,None
1228,2173,CTRI/2020/05/025167,CTRI,2020-05-14,2020-05-17,False,Intas Pharmaceuticals Ltd,Recruiting,Phase 2,Interventional,India,Evaluation of Efficacy and Safety of Thymoquinone compared to Best supportive care in Patients with COVID-19,Drug,Thymoquinone,Thymoquinone,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43378,None
1229,2174,CTRI/2020/05/025171,CTRI,2020-05-14,2020-05-16,False,All India Institute of Ayurveda,Not Recruiting,Phase 2,Interventional,India,Ayurveda protocol & COVID-19 exposed individuals: Clinical trial of an Ayurveda Intervention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43487,None
1230,2178,CTRI/2020/05/025213,CTRI,2020-05-15,2020-05-23,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Not Applicable,Interventional,India,Ayurveda formulation for COVID-19 prevention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43698,None
1231,2179,CTRI/2020/05/025205,CTRI,2020-05-15,2020-05-24,False,Central Council for Research in Homoeopathy,Not Recruiting,Phase 2/Phase 3,Interventional,India,Arsenicum album Ã¢?? 30 as prophylactic for Covid-19,Other,Homeopathy,Homeopathy,33000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43721,None
1232,2180,CTRI/2020/05/025214,CTRI,2020-05-15,2020-05-24,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,India,To observe the effect of Ayurvedic medicine for the treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43727,None
1233,2183,CTRI/2020/05/025209,CTRI,2020-05-15,2020-05-20,False,Council of Scientific and Industrial Research,Recruiting,Phase 2,Interventional,India,A clinical trial for validating therapeutic efficacy of convalescent plasma in severe COVID-19 disease,ATMP,Plasma,Plasma,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43251,None
1234,2185,CTRI/2020/05/025215,CTRI,2020-05-16,2020-05-25,False,Dean,Not Recruiting,Phase 1/Phase 2,Interventional,India,"Effectiveness of Siddha medicine, Kabasura kudineer and vitamin c-zinc supplementation in the management of Mild COVID 19 patients.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43769,None
1235,2191,CTRI/2020/05/025222,CTRI,2020-05-18,2020-01-06,True,Shree Dhootapapeshwar Limited,Not Recruiting,Phase 4,Interventional,India,Efficacy of Tablet AOIM - Z in Prevention of  COVID - 19   in High Risk Healthy Police Personnel,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,275,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43803,None
1236,2192,CTRI/2020/05/025224,CTRI,2020-05-18,2020-05-24,False,R D Gardi Medical College,Not Recruiting,Phase 2,Interventional,India,Study to efficacy of Ivermectin in patients of COVID-19,Drug,Ivermectin,Ivermectin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43728,None
1237,2193,CTRI/2020/05/025242,CTRI,2020-05-19,2020-05-25,False,Indian Council of Medical Research,Not Recruiting,Not Applicable,Interventional,India,Hydroxychloroquine of pharmacokinetics in healthcare workers,Drug,Hydroxychloroquine,Hydroxychloroquine,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43057,None
1238,2196,CTRI/2020/05/025272,CTRI,2020-05-20,2020-05-30,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,"A study to assess the efficacy of Homoeopathic medicine in the prevention of Covid-19 
",Other,Homeopathy,Homeopathy,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43790,None
1239,2197,CTRI/2020/05/025254,CTRI,2020-05-20,2020-05-29,False,Central Council for Research in Unani Medicine,Not Recruiting,Phase 3,Interventional,India,To Study effectiveness and outcomes of Unani Medicine prophylactic interventions on population at risk of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43630,None
1240,2198,CTRI/2020/05/025276,CTRI,2020-05-20,2020-05-29,False,Ch Brahm Prakash Ayurved Charak Sansthan,Not Recruiting,Phase 3,Interventional,India,effect of Ayurvedic intervention in COVID-19 positive cases,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43892,None
1241,2199,CTRI/2020/05/025273,CTRI,2020-05-20,2020-05-29,False,Patanjali Research Institute,Not Recruiting,Not Applicable,Interventional,India,Impact of effect of Ayurvedic treatment on novel Corona virus disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43900,None
1242,2200,CTRI/2020/05/025275,CTRI,2020-05-20,2020-05-30,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3,Interventional,India,Role of Chyawanprash in the prevention of COVID-19 in health care workers,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43917,None
1243,2202,CTRI/2020/05/025271,CTRI,2020-05-20,2020-05-31,False,Cadila Pharnmaceuticals,Recruiting,Phase 3,Interventional,India,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",Drug,Mycobacterium,Mycobacterium,480,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43206,None
1244,2203,CTRI/2020/05/025248,CTRI,2020-05-20,2020-06-15,False,Dr. Rahul Taneja,Not Recruiting,Not Applicable,Interventional,India,COVID-19 telephonic counseling model for addressing mental health concerns in different populations during corona outbreak in India,Telehealth,Telehealth,Telehealth,128,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43479,None
1245,2210,CTRI/2020/05/025277,CTRI,2020-05-21,2020-05-31,False,Cadila Pharnmaceuticals,Recruiting,Phase 3,Interventional,India,Clinical Trial of Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,Drug,Mycobacterium,Mycobacterium,4000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43176,None
1246,2211,CTRI/2020/05/025299,CTRI,2020-05-21,2020-01-06,True,Wockhardt Ltd,Not Recruiting,Phase 2,Interventional,India,Convalescent Plasma treatment trial in COVID 19 patients,ATMP,Plasma,Plasma,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43752,None
1247,2212,CTRI/2020/05/025298,CTRI,2020-05-21,2020-05-25,False,Central Council for Research in Siddha,Not Recruiting,Not Applicable,Interventional,India,Siddha Intervention Population Study.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,21500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43761,None
1248,2213,CTRI/2020/05/025320,CTRI,2020-05-22,2020-05-22,False,Government Yoga And Naturopathy Medical College Chennai,Recruiting,Phase 3/Phase 4,Interventional,India,Effect of Yoga & Naturopathy in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,658,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43576,None
1249,2214,CTRI/2020/05/025317,CTRI,2020-05-22,2020-05-26,False,Ms Gelnova Laboratories India Pvt Ltd,Not Recruiting,Phase 4,Interventional,India,SURVEY OF MOUTH-DISSOLVING TURMERIC LOZENGES IN HEALTHCARE WORKERS,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43754,None
1250,2215,CTRI/2020/05/025319,CTRI,2020-05-22,2020-01-06,True,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Recruiting,Phase 3,Interventional,India,Trial of antihypertensive losartan for additional benefit in treating COVID 19 infection.,Drug,Losartan,Losartan,186,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42751,None
1251,2216,CTRI/2020/05/025331,CTRI,2020-05-23,2020-05-24,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Home based prehabilitation via telemedicine in lung cancer patients during COVID 19,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43339,None
1252,2218,CTRI/2020/05/025326,CTRI,2020-05-23,2020-05-31,False,Shree Bharadi Ayurvedic,Not Recruiting,Phase 2,Interventional,India,Tablet PINAK given as treatment  to COVID positive patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43951,None
1253,2219,CTRI/2020/05/025328,CTRI,2020-05-23,2020-01-06,True,Apollo Hospitals,Not Recruiting,Phase 2,Interventional,India,Study to Assess the Safety and Efficacy of Convalescent Plasma on outcome of COVID-19 Associated Complications,ATMP,Plasma,Plasma,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43703,None
1254,2220,CTRI/2020/05/025338,CTRI,2020-05-24,2020-02-06,True,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,India,Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44033,None
1255,2222,CTRI/2020/05/025336,CTRI,2020-05-24,2020-01-06,True,Tata Memorial Centre,Not Recruiting,Phase 3,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper Or Sodium-Copper-Chlorophyllin Vs Standard Treatment In Mild Covid-19 infection,Drug,Copper,Copper,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43934,None
1256,2223,CTRI/2020/05/025334,CTRI,2020-05-24,2020-05-30,False,Health Solutions,Not Recruiting,Phase 2,Interventional,India,Protect and prevent onset of COVID like infections in Health Care Workers and High risk person.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43935,None
1257,2224,CTRI/2020/05/025337,CTRI,2020-05-24,2020-01-06,True,Tata Memorial Centre,Not Recruiting,Phase 2,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper OR Sodium-Copper-Chlorophyllin Versus Standard Treatment In Severe Covid-19,Drug,Copper,Copper,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43940,None
1258,2225,CTRI/2020/05/025335,CTRI,2020-05-24,2020-06-20,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3,Interventional,India,"Efficacy of AYUSH-64 (a polyherbal formulation) in COVID - 19 Cases
",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43949,None
1259,2227,CTRI/2020/05/025341,CTRI,2020-05-24,2020-02-06,True,No Sponsor Name Given,Recruiting,Not Applicable,Interventional,India,A study to know the effect of Ayurvedic Kwath(Kiratiktadi Kwath) & Ashwagandha Churna along with yoga exercises in the treatment of COVID-19 Positive patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44013,None
1260,2228,CTRI/2020/05/025343,CTRI,2020-05-25,2020-05-30,False,Health Solutions,Not Recruiting,Phase 2/Phase 3,Interventional,India,Study results of Ayurvedic treatment on COVID patients using proprietary herbal formulation SUVED and whole colostrum REIMMUGEN.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43919,None
1261,2233,CTRI/2020/05/025346,CTRI,2020-05-25,2020-01-06,True,Government of Tamil Nadu,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial to Assess the Safety and Efficacy of Convalescent Plasma in Severe Covid-19 patients.,ATMP,Plasma,Plasma,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43005,None
1262,2234,CTRI/2020/05/025350,CTRI,2020-05-26,2020-05-31,False,R D Gardi Medical College,Not Recruiting,Phase 2,Interventional,India,Study to assess safety and efficacy of Inj Sepsivac in patients of Covid-19,Drug,Sepsivac,Sepsivac,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43559,None
1263,2235,CTRI/2020/05/025370,CTRI,2020-05-27,2020-04-06,True,Ayurved University,Not Recruiting,Not Applicable,Interventional,India,Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illness,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44064,None
1264,2236,CTRI/2020/05/025385,CTRI,2020-05-27,2020-01-06,True,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Not Applicable,Interventional,India,Research study to evaluate the impact of Selected Ayurvedic interventions in containment zone,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43953,None
1265,2237,CTRI/2020/05/025369,CTRI,2020-05-27,2020-05-30,False,Medanta Institute of Education and Research,Recruiting,Phase 3,Interventional,India,A study on treatment of COVID-19 patients with study drug along with standard of care,Drug,Tocilizumab,Tocilizumab,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43485,None
1266,2239,CTRI/2020/05/025425,CTRI,2020-05-28,2020-02-06,True,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Ayurvedic intervention (Chyawanprash) in the prevention of COVID-19 pandemic  among Health Care Personnel,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44043,None
1267,2241,CTRI/2020/05/025398,CTRI,2020-05-28,2020-05-28,False,No Sponsor Name Given,Recruiting,Not Applicable,Interventional,India,Study to find out the results of Ayurvedic Kwath & Ashwagandha churna with Yoga exercises to prevent our health workers against corona virus infection.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43831,None
1268,2242,CTRI/2020/05/025397,CTRI,2020-05-28,2020-05-06,True,Sun Pharmaceutical Industries Limited,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the effect and safety of a phytopharmaceutical drug in treatment of Coronavirus infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,210,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43702,None
1269,2244,CTRI/2020/05/025429,CTRI,2020-05-29,2020-10-06,False,Central Council for Research in Ayurvedic Sciences,Recruiting,Phase 2/Phase 3,Interventional,India,effect of Ashwagandha (Withania somnifera) as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44058,None
1270,2249,CTRI/2020/05/025434,CTRI,2020-05-29,2020-05-31,False,Pankajakasthuri Herbal Research Foundation,Recruiting,Phase 4,Interventional,India,A clinical trial to evaluate the Medicinal effects of ZingiVir-H as Anti-Viral therapy in COVID-19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,135,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43957,None
1271,2252,CTRI/2020/05/025483,CTRI,2020-05-30,2020-02-06,True,Apex Laboratories Pvt Ltd,Not Recruiting,Phase 3/Phase 4,Interventional,India,Use of Clevira in COVID19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44041,None
1272,2253,CTRI/2020/05/025485,CTRI,2020-05-30,2020-06-29,False,Central Council for Research in Ayurvedic Sciences,Recruiting,Phase 2/Phase 3,Interventional,India,the effect of Guduchi (Tinospora cordifolia) as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44052,None
1273,2254,CTRI/2020/05/025484,CTRI,2020-05-30,2020-03-06,True,Central Council for Research in Ayurvedic Sciences,Recruiting,Phase 2/Phase 3,Interventional,India,study on the effect of Chyavanprash Lehyam as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44055,None
1274,2257,CTRI/2020/05/025490,CTRI,2020-05-31,2020-07-06,False,Siddhartha Hospital,Recruiting,Phase 2/Phase 3,Interventional,India,A Clinical trial to study the efficacy of pH based Integrated  SARS Cov-2 Immunity in Human Subjects.,Clinical Presentation,No Intervention,No Intervention,110,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44042,None
1275,2258,CTRI/2020/05/025488,CTRI,2020-05-31,2020-03-06,True,National Institute of Ayurveda,Not Recruiting,Phase 2/Phase 3,Interventional,India,Clinical study on Guduchi Ghana Vati as a preventive remedy in pandemic of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,12000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44062,None
1276,2259,CTRI/2020/05/025491,CTRI,2020-05-31,2020-08-06,False,Life Force Foundation Trust,Recruiting,Phase 2,Interventional,India,The efficacy of Homeopathic medicines in the prevention of COVID-19 in Quarantined or Exposed Individuals,Other,Homeopathy,Homeopathy,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44065,None
1277,2260,CTRI/2020/05/025489,CTRI,2020-05-31,2020-01-06,True,All India Institute of Medical Sciences,Recruiting,Not Applicable,Interventional,India,To compare two intubation scopes for securing the airway during COVID pandemic in patients undergoing surgery,Other (device),Intubation scope,Intubation scope,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43376,None
1278,2261,CTRI/2020/05/025492,CTRI,2020-05-31,2020-06-15,False,JIPMER Intramural fund,Not Recruiting,Not Applicable,Interventional,India,Impact of tele-consultation for following up newborns during COVID-19 pandemic,Telehealth,Telehealth,Telehealth,2978,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43382,None
1279,2264,CTRI/2020/05/025496,CTRI,2020-05-31,2020-08-06,False,Life Force Foundation Trust,Recruiting,Phase 1,Interventional,India,Study to observe safety of CNV01 homeopathy preparation in healthy volunteers,Other,Homeopathy,Homeopathy,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44192,None
1280,2267,CTRI/2020/06/025523,CTRI,2020-06-01,2020-08-06,False,NCI Jhajjar,Not Recruiting,Not Applicable,Interventional,India,The effect of meditation on well-being of SARS-Cov-2 infected patients.,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,84,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43396,None
1281,2269,CTRI/2020/06/025522,CTRI,2020-06-01,2020-02-06,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Comparison of two devices for intubation in COVID simulated scenario in mannequin,Other (device),Intubation,Intubation,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43438,None
1282,2270,CTRI/2020/06/025527,CTRI,2020-06-01,2020-01-06,True,Vopec Pharmaceuticals Pvt Ltd,Not Recruiting,Phase 4,Interventional,India,Clinical trial on Immunity and antiviral for quarantine patients of COVID-19,Clinical Presentation,No Intervention,No Intervention,42,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43968,None
1283,2271,CTRI/2020/06/025557,CTRI,2020-06-02,2020-11-06,False,"Ministry of Ayush, Government of India",Recruiting,Phase 2,Interventional,India,A clinical study of  Ayurvedic formulations  in the treatment  of Mild to Moderate COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,420,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43812,None
1284,2272,CTRI/2020/06/025530,CTRI,2020-06-02,2020-06-18,False,Cancer Aid Society,Not Recruiting,Not Applicable,Interventional,India,Using Homeopathic Combinations for Prevention and Treatment of Viral Fevers including COVID19,Other,Homeopathy,Homeopathy,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43305,None
1285,2273,CTRI/2020/06/025556,CTRI,2020-06-02,2020-06-15,False,Natural Solutions,Not Recruiting,Not Applicable,Interventional,India,A clinical trial to know the effect of VirulinaÃ‚Â® along with standard treatment in covid 19 positive patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44144,None
1286,2274,CTRI/2020/06/025558,CTRI,2020-06-02,2020-06-15,False,Aarogya Homoeopathic Medical College and Hospital,Not Recruiting,Phase 4,Interventional,India,Homoeopathic Medicines Bryonia alba 30C as a Prophylaxis for COVID-19,Other,Homeopathy,Homeopathy,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43411,None
1287,2277,CTRI/2020/06/025575,CTRI,2020-06-03,2020-06-15,False,All India Institute of Medical Sciences,Recruiting,Phase 3/Phase 4,Interventional,India,Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised control trial,Drug,Hydroxychloroquine + Ribavirin vs. Lopinavir/Ritonavir,Hydroxychloroquine + Ribavirin; Lopinavir/ritonavir,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43076,None
1288,2279,CTRI/2020/06/025590,CTRI,2020-06-03,2020-08-06,False,Dalmia Centre for Research and Development,Not Recruiting,Phase 3,Interventional,India,A clinical trial to evaluate safety and efficacy of polyherbal capsule Astha-15 used as an add on therapy with standard care of therapy as an immunity booster in the suspected and COVID-19 diagnosed patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44121,None
1289,2280,CTRI/2020/06/025589,CTRI,2020-06-03,2020-06-15,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,comparison of two different  laryngoscopes using COVID barrier box,Other (device),Barrier,Barrier,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44164,None
1290,2282,CTRI/2020/06/025613,CTRI,2020-06-04,2020-06-15,False,Rohit Walia,Not Recruiting,Phase 4,Interventional,India,Melatonin Immune Boost COVID 19 Study,Drug,Melatonin,Melatonin,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44346,None
1291,2284,CTRI/2020/06/025637,CTRI,2020-06-05,2020-06-22,False,ABVMC RC VIDISHA,Not Recruiting,Not Applicable,Interventional,India,"As the present outbreak of novel coronavirus in Indian scenario we want to study about the prophylactic study in Distric Hospital, Vidisha.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43550,None
1292,2285,CTRI/2020/06/025625,CTRI,2020-06-05,2020-11-05,False,Eminentlabs Business Solutions Pvt Ltd,Recruiting,Phase 2,Interventional,India,Study of the effect of Siddha Treatment in addition to standard therapy in COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,86,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43345,None
1293,2286,CTRI/2020/06/025664,CTRI,2020-06-05,2020-06-15,False,Dr. Reddy's Laboratories Limited,Recruiting,Phase 2,Interventional,India,Phase II study to evaluate the Safety and Efficacy of 2-Deoxy-D-Glucose in COVID -19 patients,Drug,2-Deoxy-D-Glucose,2-Deoxy-D-Glucose,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44369,None
1294,2288,CTRI/2020/06/025650,CTRI,2020-06-05,2020-06-15,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2,Interventional,India,To assess the safety and outcome of herbal medicine in prevention of COVID-19 infection among high risk population,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,4000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44412,None
1295,2290,CTRI/2020/06/025672,CTRI,2020-06-06,2020-06-15,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,To evaluate the effect of herbal medicine in prevention and management of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44415,None
1296,2291,CTRI/2020/06/025671,CTRI,2020-06-06,2020-06-15,False,Dr. Giridhara Kaje,Not Recruiting,Phase 3,Interventional,India,A clinical trial to evaluate the medicinal efficacy of Ayurvedic Tablet Bhoumya and Tablet Saathmya in COVID-19 positive Patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44425,None
1297,2295,CTRI/2020/06/025702,CTRI,2020-06-08,2020-06-15,False,Jagdale Industries Pvt Ltd,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Clinical Trial On Mildly Symptomatic Covid -19 Patients And Health Care Workers Posted To Covid Wards

",Other (nutrition),Nutrition,Nutrition,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44376,None
1298,2296,CTRI/2020/06/025704,CTRI,2020-06-08,2020-01-07,True,Bharat Serums and Vaccines ltd,Recruiting,Phase 3,Interventional,India,Ulinastatin for COVID-19 in patients with breathlessness,Drug,Ulinastatin + Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin,Ulinastatin; Hydroxychloroquine; Azithromycin,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44170,None
1299,2297,CTRI/2020/06/025714,CTRI,2020-06-08,2020-02-06,True,Government Yoga And Naturopathy Medical College Chennai,Not Recruiting,Phase 3/Phase 4,Interventional,India,Holistic Health Management through Yoga and Naturopathy for Frontline COVID Health Care Providers Ã¢?? The H2M trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44020,None
1300,2298,CTRI/2020/06/025763,CTRI,2020-06-09,2020-07-17,False,National Institute of Siddha,Not Recruiting,Phase 2/Phase 3,Interventional,India,A Randomized controlled Clinical Trial to determine the efficacy of Siddha drugs in COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44340,None
1301,2300,CTRI/2020/06/025766,CTRI,2020-06-09,2020-11-06,False,Dr. Jagdeep Kakadia,Not Recruiting,Not Applicable,Interventional,India,A study of 254nm UVC ray therapy in pharynx for asymptomatic to mild cases of Corona Virus Disease,Other,Ultraviolet Therapy,Ultraviolet Therapy,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44171,None
1302,2301,CTRI/2020/06/025760,CTRI,2020-06-09,2020-06-17,False,Dr. N Babu,Not Recruiting,Phase 3,Interventional,India,A clinical trial to study the effect of drug named Sofosbuvir in hospitalized patients with COVID 19.,Drug,Sofosbuvir + Hydroxychloroquine vs. Hydroxychloroquine,Sofosbuvir; Hydroxychloroquine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44441,None
1303,2302,CTRI/2020/06/025768,CTRI,2020-06-09,2020-07-20,False,National Institute of Siddha,Recruiting,Phase 2/Phase 3,Interventional,India,An open label Randomized Controlled Clinical trial to Evaluate the Safety and Efficacy of selected Siddha formulations in patients diagnosed with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44445,None
1304,2304,CTRI/2020/06/025762,CTRI,2020-06-09,2020-06-15,False,National Institute of Siddha,Not Recruiting,Phase 3,Interventional,India,"An Open-Label Randomized Controlled, Proof-of-Concept (PoC) Study to
Evaluate the Safety and Efficacy of selected Siddha formulations in patients
diagnosed with COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44259,None
1305,2305,CTRI/2020/06/025769,CTRI,2020-06-09,2020-06-15,False,National Institute of Siddha,Recruiting,Phase 2/Phase 3,Interventional,India,"A prophylactic interventional study to determine the possible protective effect of Siddha Polyherbal formulation Kabasura Kudineer against the COVID 19 on
intermittent, month-long consumption by public with close contacts to COVID patients and frontline workers in Tamil Nadu, India",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44260,None
1306,2306,CTRI/2020/06/025801,CTRI,2020-06-10,2020-06-19,False,The Himalaya Drug Company,Not Recruiting,Phase 2/Phase 3,Interventional,India,Role of Herbal Immunomodulators   in mild COVID-19 confirmed cases,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44293,None
1307,2307,CTRI/2020/06/025796,CTRI,2020-06-10,2020-06-15,False,Vaidhya Tushar Trivedi,Not Recruiting,Not Applicable,Interventional,India,Effect of aragwadhadi kwath (kadha in Hindi) in treatment of mild corona virus disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44181,None
1308,2308,CTRI/2020/06/025798,CTRI,2020-06-10,2020-06-18,False,No Sponsor Name Given,Not Recruiting,Phase 4,Interventional,India,A Clinical trial to establish the appropriate line of management of Non Muscle Invasive Bladder Cancers who have had their intravesical BCG therapy interrupted,ATMP,Vaccine,Vaccine,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44460,None
1309,2309,CTRI/2020/06/025779,CTRI,2020-06-10,2020-06-17,False,Ayurved University,Not Recruiting,Not Applicable,Interventional,India,Study of AYUSH KWATH in quarantine persons,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44463,None
1310,2311,CTRI/2020/06/025799,CTRI,2020-06-10,2020-06-17,False,Cipla Ltd,Not Recruiting,Phase 3,Interventional,India,"A study of Favipiravir in patients with mild to moderate coronavirus disease (COVID-19)
",Drug,Favipiravir,Favipiravir,156,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44480,None
1311,2312,CTRI/2020/06/025800,CTRI,2020-06-10,2020-06-22,False,National Health Mission Uttar Pradesh,Not Recruiting,Phase 2,Interventional,India,Role of Ayurveda in Covid 19 management.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44485,None
1312,2314,CTRI/2020/06/025804,CTRI,2020-06-11,2020-06-20,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of lying face down in improving the outcome of COVID-19 patients,Procedure,Positioning,Positioning,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44572,None
1313,2315,CTRI/2020/06/025803,CTRI,2020-06-11,2020-06-18,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Phase 3,Interventional,India,Effect of convalescent plasma in COVID-19 patients,ATMP,Plasma,Plasma,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44478,None
1314,2317,CTRI/2020/06/025849,CTRI,2020-06-12,2020-06-15,False,Dr. Reddy's Laboratories Limited,Not Recruiting,Phase 2,Interventional,India,Study to Evaluate the Safety and Efficacy of a Combination of Nitazoxanide and Hydroxychloroquine Versus Hydroxychloroquine Alone in COVID-19 Patients,Drug,Nitazoxanide + Hydroxycholorquine vs. Hydroxychloroquine,Nitazoxanide; Hydroxycholorquine,158,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44408,None
1315,2318,CTRI/2020/06/025852,CTRI,2020-06-12,2020-06-14,False,Intramural,Not Recruiting,Phase 1/Phase 2,Interventional,India,RNB in UPUMS SAIFAI,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44204,None
1316,2321,CTRI/2020/06/025844,CTRI,2020-06-12,2020-06-22,False,Central Council for Research in Homoeopathy,Not Recruiting,Phase 2/Phase 3,Interventional,India,Pre-Identified Homoeopathic Medicines In Asymptomatic Covid -19 Individuals Receiving Standard Treatment Protocol,Other,Homeopathy,Homeopathy,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43760,None
1317,2322,CTRI/2020/06/025854,CTRI,2020-06-13,2020-06-25,False,Indian Council of Medical Research,Not Recruiting,Not Applicable,Interventional,India,BCG vaccination against COVID-19,ATMP,Vaccine,Vaccine,1450,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44078,None
1318,2323,CTRI/2020/06/025856,CTRI,2020-06-13,2020-06-25,False,Directorate of Indian Medicine and Homeopathy,Not Recruiting,Phase 2,Interventional,India,Evaluation of siddha regimen in the management of covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44606,None
1319,2324,CTRI/2020/06/025855,CTRI,2020-06-13,2020-06-15,False,Institute for Postgraduate Teaching & Research in Ayurveda,Not Recruiting,Phase 2,Interventional,India,Effect of AYUSH 64 in COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44386,None
1320,2327,CTRI/2020/06/025861,CTRI,2020-06-14,2020-06-20,False,"Department of Ayush, Uttarakhand",Recruiting,Phase 3,Interventional,India,Scientific evaluation of Immuno-modulatory effects of AYUSH INTERVENTIONS on normal healthy and high-risk individuals in context with COVID-19 pandemic: An open level study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44072,None
1321,2328,CTRI/2020/06/025862,CTRI,2020-06-14,2020-06-13,True,No Sponsor Name Given,Recruiting,Phase 1,Interventional,India,Low Dose Radiation Therapy for COVID-19,Other,Radiation,Radiation,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43858,None
1322,2329,CTRI/2020/06/025874,CTRI,2020-06-15,2020-06-24,False,Dean Government Theni Medical College,Not Recruiting,Phase 2,Interventional,India,To observe the effect of Siddha formulation Kabasura kudineer in COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44684,None
1323,2330,CTRI/2020/06/025927,CTRI,2020-06-16,2020-06-20,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Comparison of C-MAC and Mc-GRATH laryngoscopes for intubation in COVID scenario.,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43316,None
1324,2331,CTRI/2020/06/025928,CTRI,2020-06-16,2020-06-30,False,Dr. Sumita Shankar,Recruiting,Not Applicable,Interventional,India,Local application of Povidone Iodine solution in nose and oral gargle for house hold contacts of COVID19 cases,Drug,Povidone Iodine,Povidone Iodine,204,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44664,None
1325,2332,CTRI/2020/06/025917,CTRI,2020-06-16,2020-06-28,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Psychological assessment of the health care-workers amid COVID-19 working at a tertiary care teaching hospital of the central India and impact of tele-counselling on their psychological problems,Other (psych),Psychological,Psychological,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44505,None
1326,2333,CTRI/2020/06/025957,CTRI,2020-06-17,2020-06-29,False,Glenmark Pharmaceuticals Ltd,Recruiting,Phase 3,Interventional,India,A Clinical Study on Favipiravir and Umifenovir Compared to Favipiravir alone in Hospitalized Patients with Moderate COVID-19.,Drug,Favipiravir + Umifenovir vs. Favipiravir,Favipiravir; Umifenovir,158,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44709,None
1327,2334,CTRI/2020/06/025977,CTRI,2020-06-18,2020-06-22,False,Ms Shukla Ashar Impex Pvt Ltd,Recruiting,Phase 2,Interventional,India,Clinical Study to Study Safety and Efficacy of herbal formulation - Aayudh Advance,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44449,None
1328,2335,CTRI/2020/06/025996,CTRI,2020-06-19,2020-06-27,False,Bansi Gir Gaushala,Not Recruiting,Not Applicable,Interventional,India,"A study to evaluate the effect of a combination Giloy Gomutra Capsules, Asthi Churna and Kamdhenu Asava in COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44622,None
1329,2336,CTRI/2020/06/025998,CTRI,2020-06-20,2020-06-30,False,Uttar Pradesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,India,Efficacy of An Ayurvedic Preparation Raj Nirwan Bati (RNB) on symptomatic COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44707,None
1330,2338,CTRI/2020/06/026001,CTRI,2020-06-21,2020-06-25,False,All India Institute of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,India,Ivermectin in COVID,Drug,Ivermectin,Ivermectin,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44196,None
1331,2339,CTRI/2020/06/025999,CTRI,2020-06-21,2020-06-27,False,BVG Life Sciences Ltd,Not Recruiting,Phase 2,Interventional,India,Clinical trial of ShatPlus as an immunomodulator in adult Covid 19 positive patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44764,None
1332,2341,CTRI/2020/06/026002,CTRI,2020-06-21,2020-01-07,True,National Institute of Ayurveda,Not Recruiting,Phase 2,Interventional,India,Study of use of Ayurveda Intervention (Ayush-64) in COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44799,None
1333,2344,CTRI/2020/06/026045,CTRI,2020-06-22,2020-01-07,True,Father Muller Homoeopathic Medical College,Not Recruiting,Phase 3,Interventional,India,A study to improve the resistance against Covid 19 illness with the help of Homoeopathic remedies.,Other,Homeopathy,Homeopathy,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44677,None
1334,2345,CTRI/2020/06/026055,CTRI,2020-06-23,2020-06-26,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Ayurvedic medicine ASA-20 as a prohylaxis in high risk population exposed to COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44306,None
1335,2346,CTRI/2020/06/026056,CTRI,2020-06-23,2020-06-26,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Homoeopathic medicine Arsenicum album 30 C as a prohylaxis in high risk population exposed to COVID-19.,Other,Homeopathy,Homeopathy,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44130,None
1336,2348,CTRI/2020/06/026087,CTRI,2020-06-23,2020-08-07,False,Cadila Healthcare Ltd,Not Recruiting,Phase 2,Interventional,India,"Phase II, randomized, controlled, open-label study of
Pegylated IFN alfa-2b with SARS-CoV-2",Drug,Interferon alpha,Interferon alpha,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43775,None
1337,2350,CTRI/2020/06/026123,CTRI,2020-06-24,2020-06-25,False,Dr. Sushant Meshram,Not Recruiting,Phase 2,Interventional,India,Plasma therapy in corona patients(Severe COVID-19).,ATMP,Plasma,Plasma,472,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44667,None
1338,2352,CTRI/2020/06/026119,CTRI,2020-06-24,2020-06-30,False,Swami Vivekaanand Homoeopathic Medical College And Hospital,Not Recruiting,Not Applicable,Interventional,India,"Efficacy of Arsenic Album 30C and 200C potency in mild case of COVID-19 positive . (Isolation ward of Sir T General Hospital, Bhavnagar) patients: A randomized controlled study.",Other,Homeopathy,Homeopathy,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44218,None
1339,2354,CTRI/2020/06/026147,CTRI,2020-06-25,2020-10-06,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,India,Ayurveda and Yoga trial for preventing COVID 19 among quarantined individuals exposed to COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,604,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43778,None
1340,2355,CTRI/2020/06/026151,CTRI,2020-06-25,2020-10-06,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2,Interventional,India,Ayurveda and Yoga trial for preventing COVID 19 among healthcare workers,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,452,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43770,None
1341,2356,CTRI/2020/06/026161,CTRI,2020-06-26,2020-09-21,False,AYUSHCSIR,Not Recruiting,Not Applicable,Interventional,India,Drug Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation II [Sanshamani Vati Plus] as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44832,None
1342,2358,CTRI/2020/06/026181,CTRI,2020-06-26,2020-04-07,True,Haoma Wellness Center,Not Recruiting,Phase 3/Phase 4,Interventional,India,Herbal Steaminhaler clinical trial on  COVID patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44976,None
1343,2359,CTRI/2020/06/026190,CTRI,2020-06-26,2020-07-14,False,Prof Jaya Chakravarty,Not Recruiting,Phase 2,Interventional,India,A Trial of Shirashadi Kasai in patients with Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45005,None
1344,2361,CTRI/2020/06/026187,CTRI,2020-06-26,2020-05-07,True,Mr Ghanshyam Goti,Not Recruiting,Phase 2,Interventional,India,Clinical trial of herbal supplement as an immunomodulator in adult Covid 19 positive patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45027,None
1345,2362,CTRI/2020/06/026189,CTRI,2020-06-26,2020-01-08,True,Suraksha Pharma Private Limited,Not Recruiting,Phase 2,Interventional,India,"To Compare the safety and efficacy of Vitamin D, with Magnesium in mild to moderate Covid 19 patients",Drug,Vitamin D + Magnesium,Vitamin D; Magnesium,210,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45029,None
1346,2364,CTRI/2020/06/026191,CTRI,2020-06-27,2020-01-08,True,Suraksha Pharma Private Limited,Not Recruiting,Phase 2,Interventional,India,"To study the safety and efficacy   of Vitamin D3, Vitamin K2-7 & magnesium ,  in prevention of COVID 19 infection in health care professional (HCP)",Drug (Chemoprophylaxis),Vitamin D + Magnesium + Vitamin K,Vitamin D; Magnesium; Vitamin K,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45075,None
1347,2365,CTRI/2020/06/026192,CTRI,2020-06-28,2020-07-13,False,Vicore Pharma AB,Not Recruiting,Phase 2,Interventional,"India, United Kingdom, Russian Federation, Ukraine",The study of C21 in hospitalised subjects with COVID-19 infection not requiring mechanical ventilation,Drug,Compound 21,Compound 21,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44815,None
1348,2366,CTRI/2020/06/026195,CTRI,2020-06-28,2020-08-07,False,Central Council for Research in Homoeopathy,Not Recruiting,Phase 2/Phase 3,Interventional,India,Homoeopathy as an add-on in treatment of COVID-19,Other,Homeopathy,Homeopathy,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45129,None
1349,2368,CTRI/2020/06/026196,CTRI,2020-06-28,2020-08-15,False,University of Birmingham,Not Recruiting,Phase 3/Phase 4,Interventional,"South Africa, United Kingdom, Benin, Italy, India, Rwanda, Ghana, Mexico, Nigeria",Prevention of Respiratory Complications In At Surgery in COVID-19 Pandemic,Drug,"Lopinavir/ritonavir, Hydroxychloroquine",Lopinavir/ritonavir; Hydroxychloroquine,6400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43482,None
1350,2369,CTRI/2020/06/026193,CTRI,2020-06-28,2020-07-30,False,Maulana Azad Medical College,Recruiting,Not Applicable,Interventional,India,A study of drug Lithium on patients of Covid 19 disease,Drug,Lithium + Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44766,None
1351,2370,CTRI/2020/06/026197,CTRI,2020-06-28,2020-06-07,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3/Phase 4,Interventional,India,Validation of Classical Ayurvedic formulations in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45052,None
1352,2371,CTRI/2020/06/026228,CTRI,2020-06-29,2020-06-29,False,Acerta Pharma B.V.,Not Recruiting,Phase 2,Interventional,"Russian Federation, Sweden, Japan, Turkey, Italy, France, India, Brazil, Germany, Spain",Study in Hospitalized COVID-19 patients with Acalabrutinib along with the Best Supportive Care versus Best Supportive Care,Drug,Acalabrutinib,Acalabrutinib,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44554,None
1353,2372,CTRI/2020/06/026222,CTRI,2020-06-29,2020-06-29,False,Virchow Biotech Private Limited,Not Recruiting,Phase 2,Interventional,India,Intravenous Immunoglobulin Therapy in the treatment of Moderate Pneumonia in COVID-19 patients,ATMP,Immunoglobulin,Immunoglobulin,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44299,None
1354,2373,CTRI/2020/06/026227,CTRI,2020-06-29,2020-07-07,False,Central Council for Research in Unani Medicine,Not Recruiting,Phase 3,Interventional,India,"A Study on Unani regimen 
for prevention of high/moderate risk population of COVID 19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44584,None
1355,2374,CTRI/2020/06/026229,CTRI,2020-06-29,2020-10-07,False,Dr. Namrata Joshi,Recruiting,Phase 2,Interventional,India,A clinical trial of Ayurveda formulations in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45105,None
1356,2375,CTRI/2020/06/026220,CTRI,2020-06-29,2020-07-17,False,Sun Pharmaceutical Industries Limited,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the efficacy and safety of Nafamostat Mesilate in treatment of Coronavirus infection,Drug,Nafamostat Mesilate,Nafamostat Mesilate,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44350,None
1357,2376,CTRI/2020/06/026232,CTRI,2020-06-29,2020-10-07,False,DVFM,Not Recruiting,Phase 3,Interventional,India,Ivermectin in the prevention of covid-19,Drug,Ivermectin,Ivermectin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45156,None
1358,2377,CTRI/2020/06/026231,CTRI,2020-06-29,2020-07-15,False,"Ministry of Ayush, Government of India",Not Recruiting,Not Applicable,Interventional,India,"To study effect of ayurvedic treatment for prevention and management of asymptomatic, mild and moderate cases of COVID-19.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44497,None
1359,2378,CTRI/2020/06/026221,CTRI,2020-06-29,2020-01-07,True,"Directorate of AYUSH, Government of Madhya Pradesh",Not Recruiting,Phase 2,Interventional,India,Intervention of Ayurvedic Medicine (Arogya Kashayam) in Covid-19 positive cases (Asymptomatic and Mild Symptomatic),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44542,None
1360,2381,CTRI/2020/06/026262,CTRI,2020-06-30,2020-01-07,True,Bhaktivedanta Hospital and Research Institute,Not Recruiting,Not Applicable,Interventional,India,"Single Center,Study on Evaluation of use of,Ã¢??AYURCOVÃ¢?? as add on therapy for Treatment of SARS-CoV-2 Infection in COVID-19 Patients,at Tertiary Care Center.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43889,None
1361,2382,CTRI/2020/07/026301,CTRI,2020-07-01,2020-08-07,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Role of Yoga in deStressing HCWs in COVID-19 : A RCT,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44651,None
1362,2385,CTRI/2020/07/026337,CTRI,2020-07-02,2020-11-07,False,AVP Research Foundation,Not Recruiting,Phase 2/Phase 3,Interventional,India,The Covid-19 Study with Ayurveda add-on to ICMR Guideline,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,36,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44863,None
1363,2386,CTRI/2020/07/026338,CTRI,2020-07-02,2020-07-13,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,Study to assess the Health care workersÃ¢?? knowledge of the Medical cause of death certification for COVID-19 related deaths in cancer patients,Other,No Intervention,No Intervention,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45181,None
1364,2387,CTRI/2020/07/026340,CTRI,2020-07-02,2020-11-07,False,Ramen Goel,Not Recruiting,Not Applicable,Interventional,India,To study the role of Zinc combined with standard treatment for COVID-19,Drug,Zinc,Zinc,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44929,None
1365,2392,CTRI/2020/07/026343,CTRI,2020-07-03,2020-11-07,False,Ayurved Rasayani,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic Rasayana treatment as an addon therapy to improve the results in management of coronavirus disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45204,None
1366,2393,CTRI/2020/07/026349,CTRI,2020-07-03,2020-04-07,True,Anant Mohan,Recruiting,Phase 3,Interventional,India,Effect of awake proning in patients with COVID-19 related respiratory failure,Procedure,Positioning,Positioning,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42918,None
1367,2395,CTRI/2020/07/026355,CTRI,2020-07-04,2020-07-14,False,Ayurved University,Not Recruiting,Not Applicable,Interventional,India,"Evaluation Of The Efficacy of AYUSH KWATH in The Prevention  of COVID-19 

",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45327,None
1368,2396,CTRI/2020/07/026354,CTRI,2020-07-04,2020-07-13,False,Bisleri Charitable Trust,Not Recruiting,Phase 1/Phase 2,Interventional,India,Clinical trial of ozone therapy  in mild to moderate Covid-19 subjects.,Drug,Ozone,Ozone,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45173,None
1369,2397,CTRI/2020/07/026353,CTRI,2020-07-04,2020-12-07,False,Bansi Gir Gaushala,Not Recruiting,Not Applicable,Interventional,India,"A study to evaluate the effect of a combination Giloy Gomutra Capsules, Asthi Churna and Kamdhenu Asava in COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45266,None
1370,2398,CTRI/2020/07/026352,CTRI,2020-07-04,2020-07-13,False,Cadila Healthcare Ltd,Not Recruiting,Phase 1/Phase 2,Interventional,India,Novel Corona Virus-2019-nCov vaccine by intradermal route in healthy subjects.,ATMP,Vaccine,Vaccine,1048,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45306,None
1371,2403,CTRI/2020/07/026371,CTRI,2020-07-05,2020-07-13,False,Sriveda Sattva Private Limited Sri Sri Tattva,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Kabasura Kudineer, Shakti drops and Turmeric plus in the management of COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45272,None
1372,2406,CTRI/2020/07/026431,CTRI,2020-07-08,2020-01-09,True,KVG Dental College Hospital,Not Recruiting,Phase 1/Phase 2,Interventional,India,A clinical trial to find out the effectiveness of traditional awareness method and anticipatory guidance through motivational interviewing.,Other,Other,Other,700,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45340,None
1373,2407,CTRI/2020/07/026433,CTRI,2020-07-08,2020-07-15,False,Ayush Govt of Gujarat,Not Recruiting,Not Applicable,Interventional,India,Effect of Ayurveda medicinein Covid-19 mild symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45252,None
1374,2408,CTRI/2020/07/026463,CTRI,2020-07-09,2020-10-07,False,Radhika Ayurveda Research and Development,Recruiting,Not Applicable,Interventional,India,Clinical study to evaluate efficacy and safety of GanjhuVir syrup and tablet in Covid-19 positive patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43844,None
1375,2409,CTRI/2020/07/026462,CTRI,2020-07-09,2020-07-20,False,Central Council for Research in Unani Medicine,Not Recruiting,Phase 3,Interventional,India,A study to observe and assess the safety and efficacy of Unani regimen in preventing the progression of severity of asymptomatic mild to moderate symptomatic cases.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44637,None
1376,2412,CTRI/2020/07/026471,CTRI,2020-07-10,2020-07-20,False,The Directorate of Indian Medicine and Homoeopathy,Not Recruiting,Phase 2,Interventional,India,A clinical trial to study the effect and safety of the Siddha medicines in patients with Corona Virus disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45318,None
1377,2413,CTRI/2020/07/026469,CTRI,2020-07-10,2020-07-14,False,HealthCubed India Pvt Ltd,Not Recruiting,Phase 4,Interventional,India,Rapid diagnostic test for the detection of COVID-19 antibodies,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45336,None
1378,2414,CTRI/2020/07/026468,CTRI,2020-07-10,2020-09-18,False,AYUSHCSIR,Recruiting,Not Applicable,Interventional,India,"Drug Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients 
",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44844,None
1379,2415,CTRI/2020/07/026470,CTRI,2020-07-10,2020-07-15,False,Almaa Siddha Multispeciality Hospital Pvt Ltd,Not Recruiting,Phase 2,Interventional,India,Safety and Effectiveness of  Siddha Sastric Medicines for the Management of Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45363,None
1380,2423,CTRI/2020/07/026514,CTRI,2020-07-13,2020-07-22,False,Tata Memorial Centre,Not Recruiting,Phase 2,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper OR Sodium-Copper-Chlorophyllin Versus Standard Treatment In Severe Covid-19 Cancer Patients.,Drug,Resveratrol + Copper; Sodium-Copper-Chlorophyllin,Resveratrol; Copper; Sodium-Copper-Chlorophyllin,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45580,None
1381,2424,CTRI/2020/07/026515,CTRI,2020-07-13,2020-07-22,False,Tata Memorial Centre,Not Recruiting,Phase 3,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper Or Sodium-Copper-Chlorophyllin Vs Standard Treatment In Mild Covid-19 infection with Cancer Patients.,Drug,Resveratrol + Copper; Sodium-Copper-Chlorophyllin,Resveratrol; Copper; Sodium-Copper-Chlorophyllin,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45584,None
1382,2425,CTRI/2020/07/026532,CTRI,2020-07-13,2020-07-14,False,Dr. Souvik Maitra,Not Recruiting,Not Applicable,Interventional,India,Comparison to two different position to relieve difficulty in breathing in COVID- 19 patients,Procedure,Positioning,Positioning,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44354,None
1383,2426,CTRI/2020/07/026534,CTRI,2020-07-13,2020-07-20,False,"Indian Institute of Technology, Bombay",Not Recruiting,Phase 3,Interventional,India,Study of antiviral nutraceutical PICOVRID in COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45137,None
1384,2428,CTRI/2020/07/026529,CTRI,2020-07-13,2020-07-20,False,Dr. Abhay Vispute Shantaram,Not Recruiting,Phase 2/Phase 3,Interventional,India,A Study to evaluate the safety and efficacy of Eflornithine against the standard of care in human adult hospitalized COVID-19 patients,Drug,Eflomithine,Eflomithine,18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45475,None
1385,2430,CTRI/2020/07/026528,CTRI,2020-07-13,2020-08-13,False,Aparna Abhay Raut,Not Recruiting,Not Applicable,Interventional,India,Herbal formulation for immunity boosting during pandemic,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45269,None
1386,2431,CTRI/2020/07/026530,CTRI,2020-07-13,2020-01-08,True,SASTRA Deemed University,Not Recruiting,Phase 2/Phase 3,Interventional,India,Ayurvedic formulations for the prevention of COVID-19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45532,None
1387,2432,CTRI/2020/07/026535,CTRI,2020-07-13,2020-07-20,False,Dr. Bharat S Mody,Not Recruiting,Not Applicable,Interventional,India,A clinical study to observe the effects of 8.4% Sodium Bicarbonate impregnated steam inhalation on Covid-19 infected patients,Drug,Sodium bicarbonate,Sodium bicarbonate,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45535,None
1388,2434,CTRI/2020/07/026560,CTRI,2020-07-14,2020-07-21,False,Nisarga Biotech Pvt Ltd,Not Recruiting,Phase 3,Interventional,India,Neem Prophylaxis for Subjects Coming in Contact with COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45385,None
1389,2437,CTRI/2020/07/026575,CTRI,2020-07-14,2020-07-20,False,Parul University,Not Recruiting,Phase 2,Interventional,India,Sahadevi Choorna for COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45500,None
1390,2438,CTRI/2020/07/026570,CTRI,2020-07-14,2020-07-15,False,AMAI Charitable Trust Pune,Not Recruiting,Not Applicable,Interventional,India,Safety and efficacy of Ayurvedic Capsule in mild to moderate COVID-19 infection.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45007,None
1391,2440,CTRI/2020/07/026579,CTRI,2020-07-14,2020-07-24,False,The Himalaya Drug Company,Not Recruiting,Phase 3,Interventional,India,Role of Herbal Immunomodulators in in Boosting the Immunity among healthcare workers assigned to COVID-19 wards,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45034,None
1392,2441,CTRI/2020/07/026568,CTRI,2020-07-14,2020-07-15,False,Ayurved Rasayani,Not Recruiting,Not Applicable,Interventional,India,Ayurveda Rasayan therapy for reducing risk of COVID infection in high risk individuals with comorbidities,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45035,None
1393,2444,CTRI/2020/07/026602,CTRI,2020-07-15,2020-07-24,False,Deenanath Mangeshkar Hospital Research Centre,Not Recruiting,Phase 2,Interventional,India,Study of an Ayurveda regimen in COVID Positive patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45628,None
1394,2445,CTRI/2020/07/026608,CTRI,2020-07-15,2020-07-27,False,Dr. Ananthakumar P K,Not Recruiting,Not Applicable,Interventional,India,A clinical trial to study the effects of two drugs methylprednisolone and dexamethasone in patients with severe COVID-19,Drug,Corticosteroids,Dexamethasone; Methylprednisolone,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45638,None
1395,2447,CTRI/2020/07/026609,CTRI,2020-07-15,2020-07-24,False,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Yoganidra benefits on COVID health care workers,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45139,None
1396,2448,CTRI/2020/07/026607,CTRI,2020-07-15,2020-07-22,False,CSIR National Aerospace Laboratories,Not Recruiting,Phase 2,Interventional,India,Evaluation of Non Invasive Ventilator,Other (physical),Mechanical ventilation,Mechanical ventilation,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43998,None
1397,2449,CTRI/2020/07/026601,CTRI,2020-07-15,2020-07-21,False,Aarti Foundation Mumbai and Kutchhi Jain Foundation Mumbai,Not Recruiting,Phase 2/Phase 3,Interventional,India,A study to check effect of an Ayurvedic treatment on corona positive patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45564,None
1398,2450,CTRI/2020/07/026630,CTRI,2020-07-16,2020-07-22,False,Mr Ghanshyam Goti,Recruiting,Phase 2,Interventional,India,Clinical trial of ACT 12 tablet and ACT 13 dry syrup in Covid 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45581,None
1399,2451,CTRI/2020/07/026632,CTRI,2020-07-16,2020-07-27,False,Government Siddha Medical College,Not Recruiting,Phase 2,Interventional,India,Siddha Treatment for COVID 19- a Pilot Study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45680,None
1400,2452,CTRI/2020/07/026631,CTRI,2020-07-16,2020-07-19,False,Kumarans Fertility Centre,Not Recruiting,Not Applicable,Interventional,India,Uses of herbal combination by taking it in hot water  in  covid 19 positive patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45494,None
1401,2454,CTRI/2020/07/026667,CTRI,2020-07-17,2020-07-17,False,"Ministry of Ayush, Government of India",Not Recruiting,Not Applicable,Interventional,India,: Efficacy of Pranayama on Positivity rate in People exposed to Covid-19 Patients and mental status,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44342,None
1402,2459,CTRI/2020/07/026669,CTRI,2020-07-18,2020-03-08,True,Z V M Unani Medical College,Not Recruiting,Not Applicable,Interventional,India,Unani Herbal tablets for mild cases od Covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45623,None
1403,2460,CTRI/2020/07/026673,CTRI,2020-07-18,2020-05-08,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,Siddha formulations for the prevention of COVID-19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45673,None
1404,2461,CTRI/2020/07/026668,CTRI,2020-07-18,2020-05-08,True,Indian Council of Medical Research,Not Recruiting,Not Applicable,Interventional,India,To study the effect of BCG vaccine in Reducing the Incidence and severity of COVID-19 in the high-risk population,ATMP,Vaccine,Vaccine,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45677,None
1405,2462,CTRI/2020/07/026670,CTRI,2020-07-18,2020-07-28,False,All India Institute of Ayurveda,Not Recruiting,Not Applicable,Interventional,India,Role of immune boosting kit in covid disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45713,None
1406,2463,CTRI/2020/07/026671,CTRI,2020-07-18,2020-07-27,False,Bisleri Charitable Trust,Not Recruiting,Not Applicable,Interventional,India,Ozone Therapy for Covid 19 patients,Drug,Ozone,Ozone,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45728,None
1407,2466,CTRI/2020/07/026674,CTRI,2020-07-19,2020-07-27,False,Suraj Ayurveda Clinic and Research Center,Not Recruiting,Phase 1,Interventional,India,Effect of Ayurveda Spice Mix Tablet for the Prevention of COVID-19 infection in people exposed to Covid 19 and in high risk patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45712,None
1408,2467,CTRI/2020/07/026675,CTRI,2020-07-19,2020-07-27,False,Suraj Ayurveda Clinic and Research Center,Not Recruiting,Phase 1/Phase 2,Interventional,India,Efficacy of Ayurveda treatment Protocol with Tulsimmune Tablet in Covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,76,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45731,None
1409,2470,CTRI/2020/07/026705,CTRI,2020-07-20,2020-07-28,False,Central Council for Research in Ayurveda and Siddha,Not Recruiting,Phase 1,Interventional,India,Efficacy and safety of AYUSH 64 tablets in treating mild to moderate Covid 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45088,None
1410,2472,CTRI/2020/07/026700,CTRI,2020-07-20,2020-07-27,False,Ayurved Rasayani,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic Rasayana therapies,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45207,None
1411,2477,CTRI/2020/07/026757,CTRI,2020-07-23,2020-07-31,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Homoeopathic medicine in positive cases of COVID-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45824,None
1412,2482,CTRI/2020/07/026756,CTRI,2020-07-23,2020-07-28,False,All India Institute of Ayurveda,Not Recruiting,Not Applicable,Interventional,India,Ayurveda strength and immunity enhancing protocol and immunity in health care workers : Clinical trial of an Ayurveda Intervention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,425,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45755,None
1413,2483,CTRI/2020/07/026791,CTRI,2020-07-25,2020-01-08,True,Dr. Deepti Siddharthan,Recruiting,Phase 2/Phase 3,Interventional,India,Statin and Aspirin in SARS-CoV-2 infection,Drug,"Atorvostatin, Aspirin",Atorvostatin; Aspirin,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44814,None
1414,2485,CTRI/2020/07/026796,CTRI,2020-07-25,2020-03-08,True,National Institute of Nutrition,Not Recruiting,Not Applicable,Interventional,India,A trial to evaluate the effect of cotton face-masks and other behavioral factors on COVID-19 risk in rural Telangana,Other (device),Masks,Masks,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45868,None
1415,2487,CTRI/2020/07/026789,CTRI,2020-07-25,2020-07-31,False,MGC Pharmaceuticals,Not Recruiting,Phase 2,Interventional,India,A clinical study to see effect of  ArtemiC in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45111,None
1416,2489,CTRI/2020/07/026790,CTRI,2020-07-25,2020-03-08,True,Dr. Ankit Agarwal,Not Recruiting,Not Applicable,Interventional,India,This is the comparative study between two protective boxes which can be used by the doctors while managing critical COVID 19 patients in addition to personal protective equipment.,Other (device),Protective Boxes,Protective Boxes,21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45143,None
1417,2491,CTRI/2020/07/026799,CTRI,2020-07-25,2020-04-08,True,Sri Devaraj Urs Academy of Higher Education and Research,Recruiting,Phase 2/Phase 3,Interventional,India,Yoga for Nurses (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45964,None
1418,2492,CTRI/2020/07/026793,CTRI,2020-07-25,2020-07-31,False,Ionisation Filtration Industries,Not Recruiting,Phase 2,Interventional,India,Panchgavya Therapy in prophylaxis and as an adjuvant therapy in management of Covid 19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45721,None
1419,2496,CTRI/2020/07/026831,CTRI,2020-07-27,2020-01-08,True,George Institute for Global Health India,Not Recruiting,Phase 3,Interventional,India,"Controlled evaluation of Angiotensin Receptor Blockers for COVID-19
Respiratory Disease
",Drug,ARBs,ARBs,605,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44605,None
1420,2497,CTRI/2020/07/026820,CTRI,2020-07-27,2020-09-08,False,Rohit Walia,Not Recruiting,Phase 4,Interventional,India,Curcumin for COVID-19 Pre Exposure Prophylaxis,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45936,None
1421,2498,CTRI/2020/07/026834,CTRI,2020-07-27,2020-07-08,True,Director,Not Recruiting,Not Applicable,Interventional,India,REaCHing to you with listening ears; A friendly telephonic interaction Program for the DDU-GKY members,Other (psych),Psychological,Psychological,1480,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45953,None
1422,2500,CTRI/2020/07/026840,CTRI,2020-07-27,2020-07-28,False,"Directorate of AYUSH, Government of Madhya Pradesh",Not Recruiting,Not Applicable,Interventional,India,A study to assess the effectiveness of Ayurvedic formulation Guduchi Ghan vati in Covid-19 cases,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45981,None
1423,2502,CTRI/2020/07/026839,CTRI,2020-07-27,2020-05-08,True,Shreepad Shree Vallabh SSV Phytopharmaceuticals,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation in management of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45994,None
1424,2503,CTRI/2020/07/026835,CTRI,2020-07-27,2020-07-27,False,All India Institute of Medical Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Comparison of two different types of simple non-invasive oxygen therapy devices in coronavirus lung infection,Drug,Oxygen,Oxygen,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44539,None
1425,2505,CTRI/2020/07/026841,CTRI,2020-07-28,2020-03-08,True,Dr. Sarang Phadke,Not Recruiting,Phase 2,Interventional,India,"A clinical trial to study the effects of an Ayurvedic medicine, Haldi 30 ( Turmeric extract ) drops in patients with Corona virus infection.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,260,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45659,None
1426,2507,CTRI/2020/07/026925,CTRI,2020-07-30,2020-07-31,False,Sterling Multispeciality Hosptal and Ayurved Rugnalay,Not Recruiting,Phase 3/Phase 4,Interventional,India,"to see the effect of twakadi(tea made up of dalcheeni, tulasi pepper, clove, etc)tea on police worker who have a duty in covid 19 pandemic",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45587,None
1427,2508,CTRI/2020/07/026922,CTRI,2020-07-30,2020-04-08,True,"State Plan Management Unit, National Health Mission, Uttar Pradesh",Not Recruiting,Not Applicable,Interventional,India,Ayurvedic intervention in COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45909,None
1428,2512,CTRI/2020/07/026953,CTRI,2020-07-31,2020-03-08,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3/Phase 4,Interventional,India,COMPARISON OF THREE HOMOEOPATHIC DRUGS FOR COVID 19 IMMUNE BOOSTERS AGAINST STANDARD TREATMENT,Other,Homeopathy,Homeopathy,704,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45668,None
1429,2513,CTRI/2020/07/026952,CTRI,2020-07-31,2020-01-08,True,SDM College of Ayurveda and Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,India,"Survey and Management 
 of depression, Anxiety and Stress due to COVID-19 fear",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45683,None
1430,2517,CTRI/2020/08/026957,CTRI,2020-08-02,2020-07-08,True,Corival Lifesciences Private Limited,Recruiting,Phase 3/Phase 4,Interventional,India,A Clinical trial to evaluate the effect of a combination of treatment of Reginmune capsule and Immunofree tablets in the treatment of mild to moderate COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45825,None
1431,2518,CTRI/2020/08/026980,CTRI,2020-08-04,2020-10-08,False,Rashtriyakamdhenu Ayog,Not Recruiting,Phase 3,Interventional,India,"Effect  Ayurveda decoctions, tablet and Panchagavya on COVID 19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46082,None
1432,2520,CTRI/2020/08/026977,CTRI,2020-08-04,2020-10-08,False,Poonam Joshi,Not Recruiting,Not Applicable,Interventional,India,Comparison of two online learning method of resuscitation training.,Other,Other,Other,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44057,None
1433,2522,CTRI/2020/08/026985,CTRI,2020-08-04,2020-08-14,False,Chettinad Hospital and Research Institute,Not Recruiting,Phase 2,Interventional,India,"Assessment of safety and efficacy of Kabasura
Kudineer in mild to moderate COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,126,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46168,None
1434,2524,CTRI/2020/08/026978,CTRI,2020-08-04,2020-08-19,False,Nepal Health Research Council,No Status Given,Not Applicable,Interventional,Nepal,Effectiveness of Ayurvedic Formulation for COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44435,None
1435,2525,CTRI/2020/08/027007,CTRI,2020-08-05,2020-07-31,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Ayurvedic medicine in positive cases of COVID-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45827,None
1436,2527,CTRI/2020/08/026999,CTRI,2020-08-05,2020-10-08,False,"Indian Medicine and Homeopathy Department, Chennai",Not Recruiting,Phase 2,Interventional,India,Evaluate the Efficacy of Siddha Treatment in Patients with Novel Coronavirus Infectious Disease (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46134,None
1437,2528,CTRI/2020/08/027005,CTRI,2020-08-05,2020-12-08,False,Homoeocon Foundation,Not Recruiting,Phase 2,Interventional,India,Investigation of effect of homoeopathic remedy as add on therapy to standard of care (regular treatment) in adult patients with moderate to severe COVID-19,Other,Homeopathy,Homeopathy,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46189,None
1438,2531,CTRI/2020/08/027009,CTRI,2020-08-05,2020-08-15,False,Sriveda Sattva Private Limited Sri Sri Tattva,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Use of Herbal Medicine like Tulasi,Amruth(Giloy), Turmeric,Ashwagandha for Improving the Immunity among Health care workers.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46269,None
1439,2533,CTRI/2020/08/027033,CTRI,2020-08-07,2020-07-08,True,Government Siddha Medical College,Not Recruiting,Phase 2,Interventional,India,SARS-COV-2 and COVID-19 - A Randomized controlled trail (unblinded),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46096,None
1440,2534,CTRI/2020/08/027032,CTRI,2020-08-07,2020-11-08,False,Sonalika Social Development Society,Not Recruiting,Not Applicable,Interventional,India,A clinical study to assess the effects of MEDITATION (MINDFUL HAPPINESS) as an additional therapy in asymptomatic and mildly symptomatic covid-19 confirmed cases,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45920,None
1441,2536,CTRI/2020/08/027038,CTRI,2020-08-07,2020-08-20,False,SN Medical College,Not Recruiting,Phase 3,Interventional,India,Study  to assess effects of nano ozonised hydrogen peroxide nebulisation on results of RT-PCR for novel corona Virus thus infectivity and clinical course among mild to moderate sick COVID-19 Patients,Drug,Hydrogen Peroxide,Hydrogen Peroxide,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46197,None
1442,2537,CTRI/2020/08/027035,CTRI,2020-08-07,2020-08-19,False,Dr. Divya Jain,Not Recruiting,Not Applicable,Interventional,India,A randomized trial to evaluate effect of mediatation on Stress and Anxiety due to COVID-19 in healthy adult population,Other (psych),Psychological,Psychological,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46262,None
1443,2539,CTRI/2020/08/027037,CTRI,2020-08-07,2020-08-17,False,Sri Devaraj Urs Academy of Higher Education and Research,Recruiting,Phase 3,Interventional,India,Effect of Yoga for COVID-19 patients in addition to regular treatment,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46324,None
1444,2540,CTRI/2020/08/027040,CTRI,2020-08-08,2020-12-08,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Ayurvedic medicine in positive cases of COVID-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45846,None
1445,2542,CTRI/2020/08/027048,CTRI,2020-08-09,2020-08-17,False,Sri Devaraj Urs Academy of Higher Education and Research,Recruiting,Phase 3,Interventional,India,Yoga for Police personnel,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46344,None
1446,2546,CTRI/2020/08/027045,CTRI,2020-08-09,2020-08-17,False,Dr. Ashish Agarwal,Not Recruiting,Phase 2,Interventional,India,A clinical study to evaluate efficacy and safety of Camphora tablets in Covid positive patients,Other,Homeopathy,Homeopathy,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46226,None
1447,2547,CTRI/2020/08/027043,CTRI,2020-08-09,2020-10-08,False,Neurogen Brain and Spine Institute,Not Recruiting,Phase 1,Interventional,India,Mesenchymal Stem Cell Therapy For Covid 19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43175,None
1448,2549,CTRI/2020/08/027041,CTRI,2020-08-09,2020-08-14,False,Venkat Pharma,Not Recruiting,Phase 3/Phase 4,Interventional,India,Clinical trial on COVID 19 patients to Improve Immunity,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46258,None
1449,2551,CTRI/2020/08/027044,CTRI,2020-08-09,2020-08-14,False,Shri Krishna Ayush University,Not Recruiting,Phase 2/Phase 3,Interventional,India,To observe the outcome of Classical Ayurvedic medicine for the treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44249,None
1450,2555,CTRI/2020/08/027084,CTRI,2020-08-10,2020-08-20,False,Leaf BioLab - Leaf Research Institute,Not Recruiting,Not Applicable,Interventional,India,Evaluate the medicinal effects of both Ayurveda combinations Bio-Immune as Anti-viral and Covalix Vaccoil as alternate to Vaccine of COVID-19 on exposed individuals and Covid19 contact.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,61000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44420,None
1451,2556,CTRI/2020/08/027061,CTRI,2020-08-10,2020-08-13,False,Dr. Rahul Pandit,Not Recruiting,Not Applicable,Interventional,India,Investigator Initiated Study to see the safety and efficacy of adding Thymosin Alpha to existing standard of care in severe COVID patients.,Drug,Thymosin alpha,Thymosin alpha,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45729,None
1452,2557,CTRI/2020/08/027080,CTRI,2020-08-10,2020-08-15,False,"GCS Medical College, Hospital & Research Centre",Not Recruiting,Phase 3/Phase 4,Interventional,India,Benefit of positioning in COVID-19 patient on Bipap mechnical support,Procedure,Positioning,Positioning,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46272,None
1453,2558,CTRI/2020/08/027081,CTRI,2020-08-10,2020-08-17,False,"GCS Medical College, Hospital & Research Centre",Not Recruiting,Phase 3/Phase 4,Interventional,India,Comparision of two barrier devices for placement of tube into trachea(windpipe)in COVID19 patients,Other (device),Barrier devices,Barrier devices,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46289,None
1454,2560,CTRI/2020/08/027085,CTRI,2020-08-11,2020-08-17,False,Germkill India,Not Recruiting,Not Applicable,Interventional,India,Safety and efficacy of citrobioShield product in improving immunity in COVID 19 patients via inhalation.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46278,None
1455,2562,CTRI/2020/08/027102,CTRI,2020-08-13,2020-08-15,False,Dr. Krishna Kishore C,Not Recruiting,Phase 2,Interventional,India,Colchichine use for preventing COVID infection in haemodialysis patients,Drug,Colchicine,Colchicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45658,None
1456,2563,CTRI/2020/08/027106,CTRI,2020-08-13,2020-08-20,False,Natural Supplemets LLC,Recruiting,Not Applicable,Interventional,India,"TO EVALUATE EFFICACY AND SAFETY OF Ã¢??VIRACIDEÃ¢?? 
IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)
",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44639,None
1457,2569,CTRI/2020/08/027120,CTRI,2020-08-13,2020-08-20,False,Amulya Herbs,Recruiting,Phase 3/Phase 4,Interventional,India,A clinical trial to know the efficacy and safety of herbal product Virowin in combination with Energy-Z capsule in treating mild to moderate COVID-19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46319,None
1458,2571,CTRI/2020/08/027163,CTRI,2020-08-14,2020-08-23,False,Central Council for Research in Ayurvedic Sciences,Recruiting,Phase 2/Phase 3,Interventional,India,Ashwagandha in the prevention of COVID-19 in Health Care workers,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46406,None
1459,2573,CTRI/2020/08/027162,CTRI,2020-08-14,2020-08-20,False,Themis Medicare,Not Recruiting,Phase 2,Interventional,India,A clinical study to understand the effect of Inosine Pranobex in Covid-19 patients when used along with the standard of Care in Covid patients.,Drug,Inosine Pranobex,Inosine Pranobex,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46240,None
1460,2574,CTRI/2020/08/027168,CTRI,2020-08-14,2020-08-21,False,SRV Hospital,Recruiting,Not Applicable,Interventional,India,Clinical trial study to investigate safety and efficacy of ImmunoSEB and ProbioSEB,Supplement,Nutritional Supplement,Nutritional Supplement,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45750,None
1461,2576,CTRI/2020/08/027170,CTRI,2020-08-15,2020-08-24,False,Serum Institute of India Pvt Ltd,Not Recruiting,Phase 2/Phase 3,Interventional,India,Study to check the safety and immune response of a COVID-19 vaccine in healthy Indian adults.,ATMP,Vaccine,Vaccine,1600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46186,None
1462,2578,CTRI/2020/08/027171,CTRI,2020-08-15,2020-08-25,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Measurement of renal biomarker in COVID-19 associated acute renal failure,Clinical Presentation,No Intervention,No Intervention,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46527,None
1463,2586,CTRI/2020/08/027224,CTRI,2020-08-18,2020-08-25,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,India,To observe the effect of Ayurvedic medicine (Ashwagandha and Shunti) for the treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46608,None
1464,2587,CTRI/2020/08/027225,CTRI,2020-08-18,2020-08-28,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Ivermectin as a possible treatment for COVID-19,Drug,Ivermectin,Ivermectin,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46660,None
1465,2591,CTRI/2020/08/027222,CTRI,2020-08-18,2020-08-24,False,Hamdard Laboratories,Not Recruiting,Phase 2,Interventional,India,Unani formulations for prevention of COVID-19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46308,None
1466,2598,CTRI/2020/08/027282,CTRI,2020-08-20,2020-08-31,False,Department of Community Medicine,Not Recruiting,Phase 3,Interventional,India,Prophylactic Ivermectin in COVID 19 Contacts,Drug (Chemoprophylaxis),Ivermectin,Ivermectin,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46676,None
1467,2599,CTRI/2020/08/027284,CTRI,2020-08-20,2020-08-28,False,Dyuthi Biosciences Private Limited,Not Recruiting,Not Applicable,Interventional,India,A study to evaluate the efficacy and safety of Aceinavir combined with supportive Standard of Care (SoC) in hospitalized patients with moderate coronavirus disease (COVID-19),Drug,Aceinavir,Aceinavir,44,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46679,None
1468,2601,CTRI/2020/08/027283,CTRI,2020-08-20,2020-08-24,False,Dr. Vishwa Santhosha Bharathi,Not Recruiting,Phase 2/Phase 3,Interventional,India,A clinical trial to evaluate the medicinal efficacy and safety of Ayurvedic kit in COVID-19 positive Patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46591,None
1469,2603,CTRI/2020/08/027316,CTRI,2020-08-21,2020-08-28,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,The effect of Ayurvedic intervention (Ayurveda Raksha Kit) as a preventive measure in the Pandemic of COVID-19 - A community based study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46680,None
1470,2605,CTRI/2020/08/027286,CTRI,2020-08-21,2020-08-22,False,Government Institute of Medical Sceinces,Recruiting,Phase 2,Interventional,India,Effectiveness of Siddha Medicines Kabasura Kudineer and Nilavembu Kudineer in the Management of Smptomatic COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46511,None
1471,2606,CTRI/2020/08/027300,CTRI,2020-08-21,2020-01-09,True,Prof RK Dhamija,Not Recruiting,Not Applicable,Interventional,India,Efficacy and feasibility of Teleneurorehabilitation in Persons with Parkinsons Disease,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44285,None
1472,2607,CTRI/2020/08/027324,CTRI,2020-08-23,2020-01-09,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,"Study to assess the usefulness, effectiveness and feasibility for future use of the consultations done using telephone/whatsapp in rheumatic diseases during CoVID-19 pandemic",Telehealth,Telehealth,Telehealth,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46339,None
1473,2609,CTRI/2020/08/027345,CTRI,2020-08-24,2020-08-31,False,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,Not Recruiting,Phase 3,Interventional,India,Re-purposing of Anti HCV drugs for the treatment of COVID-19 diseasr,Drug,Daclatasvir + Sofosbuvir vs. Ledipasvir + Sofosbuvir,Daclatasvir; Sofosbuvir; Ledipasvir,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45932,None
1474,2610,CTRI/2020/08/027346,CTRI,2020-08-24,2020-08-25,False,Shri Dhanwantry Ayurevdic College and Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,India,To assess the clinical efficacy of Ayurvedic interventions in managing asymptomatic to mild cases of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46229,None
1475,2611,CTRI/2020/08/027359,CTRI,2020-08-24,2020-09-15,False,Bhaikaka University,Not Recruiting,Not Applicable,Interventional,India,"A study regarding knowledge, attitude and practice about immunity boosting measures for prevention of COVID-19 infection among healthcare workers at tertiary care hospital",Other,Other,Other,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46829,None
1476,2613,CTRI/2020/08/027394,CTRI,2020-08-26,2020-02-09,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,Assessment of response of ivermectin on virological clearance in COVID 19 patients,Drug,Ivermectin,Ivermectin,56,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46873,None
1477,2615,CTRI/2020/08/027397,CTRI,2020-08-26,2020-03-09,True,Indian Administrative Service,Recruiting,Phase 2,Interventional,India,Role of Siddha medicine in the management of Covid-19 positive patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46165,None
1478,2626,CTRI/2020/08/027465,CTRI,2020-08-29,2020-04-09,True,Government of West Bengal,Recruiting,Phase 1/Phase 2,Interventional,India,Nasal Wash and Gargle to Mitigate COVID-19,Drug,Mouthwash,Mouthwash,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45634,None
1479,2628,CTRI/2020/08/027501,CTRI,2020-08-31,2020-10-09,False,NatureCeuticals Sdn Bhd,Not Recruiting,Not Applicable,Interventional,India,A study to assess aspects of safety and efficacy of NuvastaticÃ¢?Â¢ (C5OSEW5050ESA) as an immunomodulator supportive treatment to the standard care of treatment in Covid 19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44303,None
1480,2630,CTRI/2020/08/027475,CTRI,2020-08-31,2020-01-09,True,Cadila Pharnmaceuticals,Recruiting,Phase 3,Interventional,India,A Randomized Controlled Trial Of An Immunomodulator Mycobacterium w In Mild To Moderate Covid-19 Pneumonia,Drug,Mycobacterium,Mycobacterium,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45627,None
1481,2631,CTRI/2020/08/027502,CTRI,2020-08-31,2020-10-09,False,Dr. Souvik Maitra,Not Recruiting,Not Applicable,Interventional,India,Comparison two types of artificial respiration in severe COVID-19 patients,Other (physical),Mechanical ventilation,Mechanical ventilation,216,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44862,None
1482,2632,CTRI/2020/08/027477,CTRI,2020-08-31,2020-03-09,True,Dhanvantari Clinic Ayurveda Health Care and Research Center,Not Recruiting,Phase 2,Interventional,India,Evaluation of safety and efficacy of T-AYU-HM Premium and Onion steam vaporization/nebulization in Covid-19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46654,None
1483,2633,CTRI/2020/08/027499,CTRI,2020-08-31,2020-05-09,True,Indian Administrative Service,Recruiting,Phase 2,Interventional,India,Role of siddha medicine in the management of covid -19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46927,None
1484,2638,CTRI/2020/08/027491,CTRI,2020-08-31,2020-06-09,True,District Administration,Not Recruiting,Phase 2,Interventional,India,benefits of Siddha medicines in covid-19 positive patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46256,None
1485,2639,CTRI/2020/08/027503,CTRI,2020-08-31,2021-06-15,False,Dr. Souvik Maitra,Not Recruiting,Not Applicable,Interventional,India,Effect of blood thinning medicine in COVID-19 infection,Drug,Aspirin,Aspirin,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44980,None
1486,2640,CTRI/2020/08/027467,CTRI,2020-08-31,2020-08-31,False,Uttar Pradesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,India,Effect of Allo-vedic Preparation Raj Nirwan Bati (RNB) on Severe COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46524,None
1487,2645,CTRI/2020/09/027535,CTRI,2020-09-01,2020-08-09,True,CSIR Central Drug Research Institute,Recruiting,Phase 3,Interventional,India,"Efficacy and safety study of antiviral Umifenovir therapy in non-severe COVID-
19 patients.",Drug,Umifenovir,Umifenovir,132,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45236,None
1488,2647,CTRI/2020/09/027548,CTRI,2020-09-02,2020-12-09,False,Jagdale Industries Pvt Ltd,Not Recruiting,Not Applicable,Interventional,India,Effects of health drink additional to standard of care treatment in COVID 19 patients.,Supplement,Nutritional Supplement,Nutritional Supplement,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47125,None
1489,2654,CTRI/2020/09/027616,CTRI,2020-09-05,2021-01-13,False,Rajiv Gandhi University of Health Sciences,Not Recruiting,Phase 1,Interventional,India,Oral medicine trial for COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47155,None
1490,2655,CTRI/2020/09/027615,CTRI,2020-09-05,2020-11-09,False,Dr. Vishal Narwane,Not Recruiting,Not Applicable,Interventional,India,Clinical trial of homeopathic medicine arsenic album as add on therapy in hospitalized patients admitted with Covid 19 disease.,Other,Homeopathy,Homeopathy,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46648,None
1491,2660,CTRI/2020/09/027622,CTRI,2020-09-07,2020-08-09,True,Dr. Shikha seth,Not Recruiting,Not Applicable,Interventional,India,Role of female sex hormone in COVID 19 patients,Clinical Presentation,No Intervention,No Intervention,64,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46908,None
1492,2661,CTRI/2020/09/027661,CTRI,2020-09-08,2020-09-15,False,Central Ayurveda Research Institute for Hepatobiliary Disorders,Not Recruiting,Phase 3/Phase 4,Interventional,India,Preventive Study among COVID 19 frontline warriors and their families,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47273,None
1493,2662,CTRI/2020/09/027674,CTRI,2020-09-08,2020-08-09,True,Bharat Biotech International Limited,Recruiting,Phase 1/Phase 2,Interventional,India,"A Phase 1, Followed by a Phase 2, vaccine given Randomly in subjects in different sites
to Evaluate the Safety, side effects, and resistance of the Virus Vaccine, BBV152D Administered between the layers of the skin(intradermal) in Healthy Volunteers.",ATMP,Vaccine,Vaccine,124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46312,None
1494,2663,CTRI/2020/09/027684,CTRI,2020-09-09,2020-09-15,False,SGT University,Recruiting,Not Applicable,Interventional,India,"Protective effect of re-vaccination with
BCG against COVID-19 in healthcare workers Ã¢?? A Pilot Study
",ATMP,Vaccine,Vaccine,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47179,None
1495,2665,CTRI/2020/09/027687,CTRI,2020-09-09,2020-09-16,False,Dr. Shobha,Not Recruiting,Not Applicable,Interventional,India,"Assessment of effect of steam inhalation, saline gargling and povidone Iodine gargling on reduction of symptoms and prevention of spread of COVID 19",Drug,Povidone iodine,Povidone iodine,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47280,None
1496,2667,CTRI/2020/09/027685,CTRI,2020-09-09,2020-09-16,False,Chirayu Medical College and Hospital,Not Recruiting,Not Applicable,Interventional,India,Clinical Study to Investigate Safety and Efficacy of ImmunoSEB and ProbioSEB,Supplement,Nutritional Supplement,Nutritional Supplement,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47321,None
1497,2670,CTRI/2020/09/027741,CTRI,2020-09-10,2020-09-15,False,Cadila Pharnmaceuticals,Recruiting,Not Applicable,Interventional,India,Role of heat killed Mycobacterium w (Sepsivac) in Corona virus disease 2019 (COVID-19),Drug,Mycobacterium,Mycobacterium,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47197,None
1498,2673,CTRI/2020/09/027775,CTRI,2020-09-11,2020-09-19,False,Genecell Co LTD,Not Recruiting,Phase 2,Interventional,India,Efficacy and safety clinical study of ES16001 as an adjunct in COVID positive patients.,Drug,ES16001,ES16001,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47367,None
1499,2675,CTRI/2020/09/027786,CTRI,2020-09-14,2020-01-10,True,Government of Tamil Nadu,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic Management of Covid 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46950,None
1500,2679,CTRI/2020/09/027817,CTRI,2020-09-15,2020-09-18,False,Bioved Pharmaceuticals Pvt Ltd,Recruiting,Phase 3,Interventional,India,A Phase III Clinical Study to assess the Safety and Efficacy of Ayurvedic Tablets combined with the current available medicine and its impact on lab parameters in Subjects with Uncomplicated Moderate COVID-19 infection.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46041,None
1501,2680,CTRI/2020/09/027841,CTRI,2020-09-16,2020-09-22,False,Sami Sabinsa Group Limited,Not Recruiting,Not Applicable,Interventional,India,"In this study IMMUACTIVE would be compared with an inert substance, as a supplement in treatment of COVID-19 patients.",Supplement,Nutritional Supplement,Nutritional Supplement,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47174,None
1502,2681,CTRI/2020/09/027829,CTRI,2020-09-16,2020-09-20,False,Saint Lukes Mid America Heart Institute,Not Recruiting,Phase 3,Interventional,"Argentina, India, Brazil, United States, Mexico",DARE-19 (Dapagliflozin in Respiratory failure in patients with COVID-19),Drug,Dapagliflozin,Dapagliflozin,900,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45521,None
1503,2682,CTRI/2020/09/027842,CTRI,2020-09-16,2020-01-10,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Effect of Teleyoga on health care workers involved in Covid 19 duty,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47591,None
1504,2683,CTRI/2020/09/027882,CTRI,2020-09-17,2020-09-28,False,Patanjali Research Institute,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial to Evaluate the effect of an Ayurvedic Regimen administered in (COVID Ã¢?? 19) Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47632,None
1505,2687,CTRI/2020/09/027904,CTRI,2020-09-18,2020-02-10,True,Dr. M Christopher,Not Recruiting,Not Applicable,Interventional,India,Autologous whole blood injection as treatment for Covid-19 infection,ATMP,Whole blood,Whole blood,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47392,None
1506,2688,CTRI/2020/09/027903,CTRI,2020-09-18,2020-09-22,False,Intas Pharmaceuticals Ltd,Recruiting,Phase 2,Interventional,India,Testing the efficacy and safety of a blood product COVID-19 Hyper-Immuneglobulin (Human) Solution in Participants with Active COVID-19,ATMP,Immunoglobulin,Immunoglobulin,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47147,None
1507,2689,CTRI/2020/09/027910,CTRI,2020-09-18,2020-10-15,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,India,Transcendental Meditation (TM) to reduce stress and improve immunity of health care providers during COVID-19 pandemic,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45292,None
1508,2691,CTRI/2020/09/027914,CTRI,2020-09-19,2020-09-22,False,Dabur India Ltd,Recruiting,Phase 2/Phase 3,Interventional,India,"Evaluation of efficacy of Fixed Ayurvedic Regimen of Giloy Ki Ghan Vati,Tulsi Tablets,Kalmegh Tablets and Dabur Chyawanprash in COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47442,None
1509,2693,CTRI/2020/09/027915,CTRI,2020-09-21,2020-01-10,True,"Ministry of Ayush, Government of India",Not Recruiting,Not Applicable,Interventional,India,Tele-yoga for prevention and management of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,136,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46754,None
1510,2694,CTRI/2020/09/027941,CTRI,2020-09-21,2020-09-26,False,Biocon Limited,Not Recruiting,Phase 4,Interventional,India,Single arm study of Itolizumab in the treatment of COVID 19 complication.,Drug,Itolizumab,Itolizumab,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46023,None
1511,2695,CTRI/2020/09/027938,CTRI,2020-09-21,2020-09-25,False,Particle Life Sciences,Not Recruiting,Phase 3,Interventional,India,Study of Particle Life Sciences Formulation in management of COVID-19,Drug,Particle Life Sciences Formulation vs. Hydroxychloroquine + Azithromycin,Particle Life Sciences Formulation; Hydroxychloroquine; Azithromycin,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47586,None
1512,2696,CTRI/2020/09/027916,CTRI,2020-09-21,2020-01-10,True,Government of Tamil Nadu,Not Recruiting,Not Applicable,Interventional,India,Covid19 Post Treatment Restorative Healthcare,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47333,None
1513,2697,CTRI/2020/09/027974,CTRI,2020-09-22,2020-10-15,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 2,Interventional,India,Clinical Evaluation of Chyawanprash for the prevention of COVID-19 among Health Care Personnel .,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47658,None
1514,2698,CTRI/2020/09/027944,CTRI,2020-09-22,2020-09-22,False,Public Health Department,Not Recruiting,Phase 3,Interventional,India,"An open label, prospective comparative study to evaluate the proposed therapy in adults with mild symptomatic COVID-19 patients receiving the standard treatment of COVID infection.",Drug,Ivermectin + Cefixime + Montelukast + Ascoril syrup vs. Vitamins + Antacids,Ivermectin; Cefixime; Montelukast; Ascoril syrup; Vitamins; Antacids,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46392,None
1515,2699,CTRI/2020/09/027975,CTRI,2020-09-22,2020-02-10,True,HopeAyurvedic Medicine Pvt Ltd,Not Recruiting,Phase 3,Interventional,India,Utility of Medihope as an addon therapy for Covid 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,880,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47748,None
1516,2701,CTRI/2020/09/027992,CTRI,2020-09-23,2020-09-25,False,Dr. Om Shrivastava,Not Recruiting,Not Applicable,Interventional,India,Investigator Initiated  Study to Evaluate the Effectiveness and Safety of Thymosin ÃŽÂ±-1 (TÃŽÂ±1) in Moderate COVID-19 Patients,Drug,Thymosin,Thymosin,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46389,None
1517,2702,CTRI/2020/09/028045,CTRI,2020-09-24,2020-09-28,False,Poonam Joshi,Not Recruiting,Not Applicable,Interventional,India,Online learning programme for providing cardiopulmonary resuscitation among Nurses,Other,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44046,None
1518,2703,CTRI/2020/09/028044,CTRI,2020-09-24,2020-09-30,False,Windlas Biotech Private Limited,Recruiting,Phase 4,Interventional,India,Phase IV study to evaluate the safety and efficacy of Artemisinin- a herbal supplement on COVID-19 subjects,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47432,None
1519,2704,CTRI/2020/09/028043,CTRI,2020-09-24,2020-09-21,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 4,Interventional,India,"Clinical study to assess role of Vasa Ghana, Guduchi Ghana and Vasa-Guduchi
Ghana in therapeutic management of symptoms in Covid19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47443,None
1520,2706,CTRI/2020/09/028046,CTRI,2020-09-24,2020-05-10,True,Central Council for Research in Homoeopathy,Not Recruiting,Not Applicable,Interventional,India,Homoeopathy management for covid 19 patients,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45038,None
1521,2713,CTRI/2020/09/028086,CTRI,2020-09-28,2020-08-10,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Effect of 12-weeks of Online Sudarshan Kriya Yoga practice on Burnout and Health Parameters among COVID-19 Frontline Warriors.,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,43,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47819,None
1522,2714,CTRI/2020/09/028088,CTRI,2020-09-28,2020-10-31,False,Vivek Chauhan,Not Recruiting,Not Applicable,Interventional,India,"Open Label Randomized trial of Colchicine, Aspirin and Montelukast in Covid-19",Drug,Colchicine + Aspirin + Montelukast,Colchicine; Aspirin; Montelukast,34,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47829,None
1523,2717,CTRI/2020/09/028131,CTRI,2020-09-29,2020-02-10,True,Ambrosia Food Farm Co,Recruiting,Not Applicable,Interventional,India,A study of Cordyceps Capsules as an Add-On Therapy in patients with moderate COVID 19 Infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46887,None
1524,2718,CTRI/2020/09/028122,CTRI,2020-09-29,2020-06-10,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,Homoeopathy in the prevention of COVID-19,Other,Homeopathy,Homeopathy,15992,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47851,None
1525,2720,CTRI/2020/09/028133,CTRI,2020-09-29,2020-05-10,True,LK Wellness,Recruiting,Not Applicable,Interventional,India,Oral VIRAHALT (Novel Immunomodulatory Herbal combination) Compared to standard of care in Subjects with Moderate to Severe COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47866,None
1526,2722,CTRI/2020/09/028158,CTRI,2020-09-30,2020-05-10,True,LK Wellness,Recruiting,Not Applicable,Interventional,India,Oral VIRANORM (Ayurvedic Proprietary Medicine) Compared to Placebo in Subjects with Asymptomatic or Mild COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47896,None
1527,2727,CTRI/2020/09/028164,CTRI,2020-09-30,2021-04-10,False,National Institute of Homoeopathy,Not Recruiting,Not Applicable,Interventional,India,A clinical trail to know the efficacy of Homoeopathic medicine as an adjuvant therapy to Standard treatment in COVID-19 patients,Other,Homeopathy,Homeopathy,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47843,None
1528,2728,CTRI/2020/10/028195,CTRI,2020-10-01,2020-08-10,True,"Ministry of Ayush, Government of India",Not Recruiting,Not Applicable,Interventional,India,The role of Yogic breathing techniques in progression and recovery from COVID-19.,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47893,None
1529,2731,CTRI/2020/10/028179,CTRI,2020-10-01,2020-07-10,True,Mohammad Anwar Hossain,No Status Given,Not Applicable,Interventional,Bangladesh,An experimental study to find out the impact of post COVID physiotherapy and rehabilitation in Bangladesh,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47847,None
1530,2732,CTRI/2020/10/028230,CTRI,2020-10-05,2020-12-10,False,Government of India AYUSH EMR scheme,Not Recruiting,Phase 2,Interventional,India,clinical trial of Pippali Rasayana and Nagaradi Kashaya Ghana Vati combination as an adjuvant treatment with ICMR guided medicines in Covid-19 positive mildly symptomatic cases,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47188,None
1531,2733,CTRI/2020/10/028233,CTRI,2020-10-05,2020-10-10,False,"Ministry of Ayush, Government of India",Not Recruiting,Not Applicable,Interventional,India,Study on use of Homoeopathy Medicines in Treatment of Covid 19 cases,Other,Homeopathy,Homeopathy,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47982,None
1532,2734,CTRI/2020/10/028231,CTRI,2020-10-05,2020-12-10,False,Dr. Kapil G Zirpe,Recruiting,Not Applicable,Interventional,India,Proof of Concept Study of Ketoji (Liquid) for its Effectiveness in Treatment and Management of COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47237,None
1533,2735,CTRI/2020/10/028234,CTRI,2020-10-05,2020-12-10,False,Medical College Kolkata,Not Recruiting,Phase 4,Interventional,India,Study to compare the effect of different antiviral medicines in  COVID-19 infected sick children,Drug,Hydroxychloroquine + Zinc + Vitamins vs. Doxycycline + Zinc + Vitamins vs. + Zinc + Vitamins,Hydroxychloroquine; Zinc; Vitamins,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47844,None
1534,2738,CTRI/2020/10/028253,CTRI,2020-10-06,2020-10-10,False,Dr. Abhijit R Lodha,Not Recruiting,Phase 2,Interventional,India,A clinical trial to test the effectiveness of thalidomide in reducing immune dysfunction in covid-19 disease.,Drug,Thalidomide,Thalidomide,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47986,None
1535,2740,CTRI/2020/10/028256,CTRI,2020-10-06,2020-10-13,False,Tata Memorial Hospital Research Administrative Council,Not Recruiting,Not Applicable,Interventional,India,A study to know whether we can supervise cancer patients infected with COVID-19 from without admission in hospitals. We will test how much helpful is a software called Datos health along with pulse oximeter and thermometer in this supervision by doctors.,Other (software),eHealth,eHealth,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48118,None
1536,2741,CTRI/2020/10/028250,CTRI,2020-10-06,2020-10-14,False,Indian Council of Medical Research,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the effects of stem cells in patients with Acute Respiratory Distress syndrome caused by Pneumonia due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48119,None
1537,2743,CTRI/2020/10/028280,CTRI,2020-10-07,2020-10-15,False,"Directorate of AYUSH, Government of NCT of Delhi",Not Recruiting,Not Applicable,Interventional,India,A Study to Evaluate Efficacy of Selected Homoeopathic Medicines in Prevention of COVID-19,Other,Homeopathy,Homeopathy,18000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48199,None
1538,2744,CTRI/2020/10/028277,CTRI,2020-10-07,2020-12-10,False,Gufic Biosciences,Not Recruiting,Phase 3,Interventional,India,"A study to assess the safety and effectiveness of Thymosin ÃŽÂ±-1 (TÃŽÂ±1) used for the treatment of Moderate to severe COVID 19 Patients.

",Drug,Thymosin,Thymosin,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47691,None
1539,2746,CTRI/2020/10/028279,CTRI,2020-10-07,2020-12-10,False,Central Council for Research in Homoeopathy,Not Recruiting,Not Applicable,Interventional,India,Standard of care with homoeopathy as adjuvant in COVID19,Other,Homeopathy,Homeopathy,128,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48085,None
1540,2749,CTRI/2020/10/028297,CTRI,2020-10-08,2020-10-26,False,Dept of Health and Family Welfare Government of West Bengal,Not Recruiting,Phase 2,Interventional,India,Cotrimoxazole in hospitalised patients with moderate to early-severe COVID-19 infection,Drug,Cotrimoxazole,Cotrimoxazole,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48268,None
1541,2750,CTRI/2020/10/028333,CTRI,2020-10-09,2020-10-13,False,Shri Sarveshwar Seva Sahkari Samstha,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Prospective on evaluation of use of , Ã¢??AyurCoro3Ã¢?? as an add on medication  for the treatment purpose in COVID-19 patients",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48137,None
1542,2751,CTRI/2020/10/028335,CTRI,2020-10-09,2020-12-10,False,Piramal Enterprises Limited,Not Recruiting,Phase 3,Interventional,India,A clinical study to assess the efficacy and safety of Tinefcon in patients with moderate COVID-19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45359,None
1543,2752,CTRI/2020/10/028324,CTRI,2020-10-09,2020-09-10,True,Bhaktivedanta Hospital and Research Institute,Not Recruiting,Not Applicable,Interventional,India,"Evaluation of use of , Ã¢??study medication Ã¢??for prophylaxis in frontline health care workers involved in treating COVID-19 patients",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47697,None
1544,2753,CTRI/2020/10/028326,CTRI,2020-10-09,2020-10-20,False,Manashi Chakrabarti Foundation,Not Recruiting,Not Applicable,Interventional,India,Assessment of memory cells response to Mycobacterium Indicus Pranii vaccination,ATMP,Vaccine,Vaccine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48214,None
1545,2754,CTRI/2020/10/028325,CTRI,2020-10-09,2020-10-19,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Comparison of Tocilizumab Vs Itolizumab in covid 19 patient.,Drug,Tocilizumab vs. Itolizumab,Tocilizumab; Itolizumab,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48319,None
1546,2757,CTRI/2020/10/028364,CTRI,2020-10-12,2020-10-19,False,Vedicinals India Pvt Ltd,Not Recruiting,Phase 2,Interventional,India,"A clinical trial to evaluate the effectiveness and safety of Vedicinals-9-a Herbal Formulation in Mild to Moderate COVID-19
Patients.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48152,None
1547,2761,CTRI/2020/10/028362,CTRI,2020-10-12,2020-10-15,False,Dr. Anuja Santosh Kulkarni,Not Recruiting,Not Applicable,Interventional,India,Study to assess the efficacy of deep breathing Pranayama technique in  addition to conventional allopathic treatment in management of COVID19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,278,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48109,None
1548,2762,CTRI/2020/10/028376,CTRI,2020-10-13,2020-10-22,False,Arber Biosciences Pte Ltd,Not Recruiting,Not Applicable,Interventional,India,A Clinical Study to evaluate the safety and efficacy of CoviToneÃ¢?Â¢ in Mild to moderate Covid patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48426,None
1549,2768,CTRI/2020/10/028414,CTRI,2020-10-15,2020-02-11,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2,Interventional,India,Clinical study of an Ayurveda formulation containing Gold and Indian Gooseberry along with Tulasi juice as an add on therapy in standard care of COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48010,None
1550,2769,CTRI/2020/10/028423,CTRI,2020-10-15,2020-10-28,False,PNB Vesper Life Science Pvt Ltd,Recruiting,Phase 2,Interventional,India,A clinical study to see the effects and safety of PNB-001 in patients with moderate COVID-19 infection,Drug,PNB-001,PNB-001,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47514,None
1551,2770,CTRI/2020/10/028424,CTRI,2020-10-15,2020-10-30,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,Clinical study to evaluate the effect of Ayurveda intervention as a prophylaxis for COVID-19 in Healthcare workers,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48294,None
1552,2772,CTRI/2020/10/028437,CTRI,2020-10-16,2020-02-11,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,Effect of Ayurvedic Treatment Regimen in COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,380,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47956,None
1553,2776,CTRI/2020/10/028472,CTRI,2020-10-19,2020-10-29,False,Sparsh Foundation,Not Recruiting,Not Applicable,Interventional,India,Study of Edaravone as adjunctive treatment in COVID,Drug,Edaravone,Edaravone,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47524,None
1554,2778,CTRI/2020/10/028471,CTRI,2020-10-19,2020-02-11,True,NGR Vishnu Sri,Not Recruiting,Not Applicable,Interventional,India,"Effect of the drug Ã¢??ImmuneÃ¢??- an Ayurveda medication in COVID-19 patients
",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48593,None
1555,2779,CTRI/2020/10/028486,CTRI,2020-10-20,2020-02-11,True,Pragya Jain Shrimal,Not Recruiting,Phase 1,Interventional,India,Yoga for COVID-19 Patients with mild symptoms,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48223,None
1556,2782,CTRI/2020/10/028485,CTRI,2020-10-20,2020-02-11,True,Pragya Jain Shrimal,Not Recruiting,Phase 1,Interventional,India,Yoga for COVID-19 healthcare workers,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48619,None
1557,2790,CTRI/2020/10/028568,CTRI,2020-10-22,2020-10-26,False,RV New Vision Healthcare Pvt Ltd,Not Recruiting,Phase 2,Interventional,India,"Evaluate Safety 
and Efficacy of RV Forte Capsule as an immunomodulator in adult 
Covid 19 positive patients",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45761,None
1558,2791,CTRI/2020/10/028566,CTRI,2020-10-22,2020-02-11,True,Pragya Jain Shrimal,Not Recruiting,Phase 1,Interventional,India,Yoga for COVID-19 asymptomatic patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48585,None
1559,2792,CTRI/2020/10/028537,CTRI,2020-10-22,2020-10-22,False,Shree Baidyanath Ayurved Bhawan Pvt Ltd,Not Recruiting,Phase 2,Interventional,India,Clinical trial of Ayurvedic Medicines in Patients with Asymptomatic and/or Mild Symptoms of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48342,None
1560,2793,CTRI/2020/10/028570,CTRI,2020-10-22,2020-05-11,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,To study the effect of Vyaghradi Kashay tablet on COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48600,None
1561,2796,CTRI/2020/10/028597,CTRI,2020-10-23,2020-06-11,True,Harshamitra Superspecialty Cancer Centre and Research Institute,Not Recruiting,Phase 2,Interventional,India,Low dose lung X-ray therapy for COVID-19,Other,Radiation,Radiation,61,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48730,None
1562,2798,CTRI/2020/10/028602,CTRI,2020-10-23,2020-03-11,True,BerGenBio ASA,Not Recruiting,Phase 2,Interventional,"India, South Africa",Phase II Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients,Drug,Bemcentinib,Bemcentinib,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48797,None
1563,2800,CTRI/2020/10/028581,CTRI,2020-10-23,2020-10-23,False,Dr. Tushar Patel,Not Recruiting,Not Applicable,Interventional,India,Clinical trial to study the effect of Budesonide taken through inhalation in mild COVID cases,Drug,Budesonide,Budesonide,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47042,None
1564,2801,CTRI/2020/10/028580,CTRI,2020-10-23,2020-10-26,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of an online training module with lectures and videos regarding maternal and newborn care during COVID 19 pandemic on the knowledge and acceptability among nursing students,Other,Other,Other,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48581,None
1565,2802,CTRI/2020/10/028637,CTRI,2020-10-26,2020-04-11,True,All India Institute of Medical Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Best Larnyngoscopes for tracheal intubation in covid patient with intubation box,Other (device),Larnyngoscopes,Larnyngoscopes,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44357,None
1566,2803,CTRI/2020/10/028635,CTRI,2020-10-26,2020-02-11,True,NRI Academy of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,India,use of VIRUNIL an Ayurvedic medicie as a supportive treatment in management of COVID-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48783,None
1567,2812,CTRI/2020/10/028695,CTRI,2020-10-28,2020-05-11,True,No Sponsor Name Given,Not Recruiting,Phase 4,Interventional,India,Can Vitamin C reduces COVID-19 symptoms,Drug,Vitamin C,Vitamin C,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43749,None
1568,2815,CTRI/2020/11/028799,CTRI,2020-11-02,2020-02-11,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,The study of psychological interventions either individually or in groups and comparing its effect in reduction of  psychological distress  in covid-19 positive patients.,Other (psych),Psychological,Psychological,55,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45864,None
1569,2817,CTRI/2020/11/028811,CTRI,2020-11-02,2020-07-11,True,Apollo Hospitals,Not Recruiting,Not Applicable,Interventional,India,Role of Physiotherapist in enhancing functional aerobic capacity in pulmonary rehabilitation in Covid-19 Patients.,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48960,None
1570,2819,CTRI/2020/11/028779,CTRI,2020-11-02,2020-05-11,True,Biological E. Limited,Not Recruiting,Phase 1,Interventional,India,Effect of SARS-CoV-2 Equine Antiserum Immunoglobulin (Purified F(ab)2 fragment) in hospitalised COVID-19 patients with moderate disease.,ATMP,Immunoglobulin,Immunoglobulin,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48578,None
1571,2822,CTRI/2020/11/028827,CTRI,2020-11-03,2020-04-11,True,Central Council for Research in Yoga and Naturopathy,Not Recruiting,Not Applicable,Interventional,India,Yoga program on COVID 19 patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,86,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46946,None
1572,2826,CTRI/2020/11/028905,CTRI,2020-11-04,2020-12-11,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 1/Phase 2,Interventional,India,An academic trial to study the prophylactic activity of Vishasura Kudineer(VSK)in healthcare workers exposed/non-exposed to COVID-19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48668,None
1573,2827,CTRI/2020/11/028903,CTRI,2020-11-04,2020-09-11,True,Dr. Jeyaram,Not Recruiting,Not Applicable,Interventional,India,Telephonic intervention for people tested positive for Covid,Telehealth,Telehealth,Telehealth,0,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48964,None
1574,2828,CTRI/2020/11/028897,CTRI,2020-11-04,2020-11-16,False,Bhargava Phytolab Pvt Ltd,Not Recruiting,Phase 3,Interventional,India,"To Evaluate the Efficacy and Safety of ANT-V Syrup to show antiviral action of upper respiratory
tract like common cold and act as an immune booster to fight against infection, flu, fever, sore
throat, nasal and chest congestion Breathlessness in COVID-19 patients.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48480,None
1575,2834,CTRI/2020/11/028959,CTRI,2020-11-06,2020-06-11,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Effect of recombinant erythropoietin in covid-19 patients.,Drug,recombinant erythropoietin,recombinant erythropoietin,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48272,None
1576,2835,CTRI/2020/11/028976,CTRI,2020-11-09,2020-11-11,False,Bharat Biotech International Limited,Recruiting,Phase 3,Interventional,India,"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Immunogenicity,and Lot-to-Lot consistency of BBV152, a Whole virion Inactivated Vaccine in Adults greater than or equal to 18 Years of Age.",ATMP,Vaccine,Vaccine,25800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48057,None
1577,2836,CTRI/2020/11/029025,CTRI,2020-11-10,2020-11-15,False,Pankajakasthuri Herbal Research Foundation,Recruiting,Not Applicable,Interventional,India,An open label observational study on post covid complications and radiological pattern changes on those patients treated with ZingiVir H .,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49174,None
1578,2846,CTRI/2020/11/029032,CTRI,2020-11-10,2020-11-16,False,Biological E. Limited,Recruiting,Phase 1/Phase 2,Interventional,India,Biological EÃ¢??s novel Covid-19 vaccine of SARS-CoV-2 for protection against Covid-19 disease.,ATMP,Vaccine,Vaccine,360,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48329,None
1579,2853,CTRI/2020/11/029038,CTRI,2020-11-11,2020-10-19,True,Alchem Phytoceuticals,Not Recruiting,Phase 3,Interventional,India,"Can combination of Haldi, Pomegranate and Zinger extract tablets help in reducing duration of hospital stay of mild to moderate COVID-19 patients.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48233,None
1580,2857,CTRI/2020/11/029058,CTRI,2020-11-11,2020-11-20,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,Study to assess the impact of COVID 19 infection on pulmonary function tests in children,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49392,None
1581,2858,CTRI/2020/11/029063,CTRI,2020-11-12,2020-12-11,False,Uttar Pradesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,India,To study the effect of povidone iodine gargle and nasal drops on disease transmissibility in SARS-CoV-2 infected patients,Drug,Povidone iodine,Povidone iodine,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48939,None
1582,2864,CTRI/2020/11/029130,CTRI,2020-11-16,2020-11-16,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,The lying in prone position effect on oxygen saturation in patients in early stage and not intubated having mild to moderate Lung Disease with COVID-19,Procedure,Positioning,Positioning,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49155,None
1583,2869,CTRI/2020/11/029146,CTRI,2020-11-16,2020-11-23,False,JFD Limited,Not Recruiting,Not Applicable,Interventional,India,Use of a new breathing device for covid 19 patients,Other (physical),Mechanical ventilation,Mechanical ventilation,240,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48879,None
1584,2870,CTRI/2020/11/029170,CTRI,2020-11-17,2020-11-20,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Lignocaine nebulisation in covid pneumonia,Drug,Lignocaine,Lignocaine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49412,None
1585,2877,CTRI/2020/11/029166,CTRI,2020-11-17,2020-01-12,True,Dr. Sant Prabhudasji,Not Recruiting,Phase 3,Interventional,India,Curaneum 20 for Covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46785,None
1586,2880,CTRI/2020/11/029233,CTRI,2020-11-19,2020-12-15,False,Naveen Naik B,Not Recruiting,Not Applicable,Interventional,India,An observation and comparison of the efficacy and relative satisfaction of Health Care Workers while being monitored by the  standard BUDDY technique versus the Remote Audio Visual Doffing Surveillance (RADS) of the doffing process during the COVID 19 Pandemic,Other (psych),No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49177,None
1587,2883,CTRI/2020/11/029232,CTRI,2020-11-19,2020-11-25,False,No Sponsor Name Given,Not Recruiting,Phase 3,Interventional,India,Role Of Montelukast In Management Of COVID 19,Drug,Montelukast,Montelukast,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49293,None
1588,2884,CTRI/2020/11/029230,CTRI,2020-11-19,2020-11-20,False,No Sponsor Name Given,Not Recruiting,Phase 3,Interventional,India,ROLE OF VITAMIN C IN MANAGEMENT OF COVID 19,Drug,Vitamin C,Vitamin C,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49295,None
1589,2886,CTRI/2020/11/029263,CTRI,2020-11-20,2020-11-30,False,Glenmark Pharmaceuticals Ltd,Not Recruiting,Phase 4,Interventional,India,A clinical study on Favipiravir in mild to moderate COVID-19 patients,Drug,Favipiravir,Favipiravir,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46353,None
1590,2887,CTRI/2020/11/029265,CTRI,2020-11-20,2020-11-30,False,"Ministry of Ayush, Government of India",Recruiting,Phase 3,Interventional,India,Preventive trial of Homoeopathic medicines in COVID-19,Drug,Homeopathy,Homeopathy,20000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48401,None
1591,2890,CTRI/2020/11/029289,CTRI,2020-11-23,2020-11-25,False,Arul Anandar College,Not Recruiting,Phase 2/Phase 3,Interventional,India,A clinical trial of Siddha drugs M V kashayam (Internally) for the management   and  treatment of COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48077,None
1592,2892,CTRI/2020/11/029305,CTRI,2020-11-24,2020-11-25,False,Self-sponsored,Not Recruiting,Not Applicable,Interventional,India,Clarithromycin in Post Covid 19 parenchymal organizing pneumonia,Drug,Clarithromycin,Clarithromycin,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48195,None
1593,2893,CTRI/2020/11/029328,CTRI,2020-11-24,2020-11-30,False,Indus Biotech Private Limited,Not Recruiting,Phase 2,Interventional,India,A phase II study to evaluate safety and effectiveness of IND02 Capsules in patients who are hospitalized SARS-CoV2 positive patients with mild to moderate COVID-19 at COVID management centres offering Ayurvedic care.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,118,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49552,None
1594,2895,CTRI/2020/11/029356,CTRI,2020-11-25,2020-11-25,False,BLDEDU,Not Recruiting,Phase 2,Interventional,India,A clinical study to compare high flow nasal oxygen and non invasive ventilation in patients with covid-19.,Other (physical),Mechanical ventilation,Mechanical ventilation,82,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49432,None
1595,2896,CTRI/2020/11/029346,CTRI,2020-11-25,2020-11-26,False,LV Prasad Eye Institute,Not Recruiting,Not Applicable,Interventional,India,Spectrum of eye infections in COVID-19 affected individuals,Clinical Presentation,No Intervention,No Intervention,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48444,None
1596,2899,CTRI/2020/11/029396,CTRI,2020-11-26,2020-01-12,True,Myself Health Check Ltd,Not Recruiting,Not Applicable,Interventional,India,Safety of an aerosol having as its active ingredient 8.4 % sodium bicarbonate and xylitol 5% when administered to the nasopharynx and oropharynx,Drug,Xylitol + Sodium bicarbonate,Xylitol; Sodium bicarbonate,325,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49442,None
1597,2900,CTRI/2020/11/029399,CTRI,2020-11-26,2020-10-12,True,Central Council for Research in Homoeopathy,Not Recruiting,Phase 1,Interventional,India,Develop homeopathic Nosodes for Immunity Against COVID 19.,Other,Homeopathy,Homeopathy,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49714,None
1598,2905,CTRI/2020/11/029388,CTRI,2020-11-26,2020-11-27,False,Vitrobio SAS,Not Recruiting,Not Applicable,Interventional,India,Pirdal Nasal Spray in preventing symptomatic manifestation of disease in Covid-19 proven cases,Drug,Pirdal,Pirdal,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49529,None
1599,2908,CTRI/2020/11/029444,CTRI,2020-11-27,2020-03-12,True,Shri Vishwavati Ayurved Chikitsalaya and Research Centre,Not Recruiting,Phase 3/Phase 4,Interventional,India,A clinical trial to study effect of Madhav Rasayan tablets in COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49712,None
1600,2911,ACTRN12620000788976,ANZCTR,2020-08-05,2021-04-01,False,Mucpharm Pty Ltd,Recruiting,Phase 1,Interventional,Australia,Safety and efficacy of intranasal delivery of BromAcÂ® (Bromelain & Acetylcysteine) in swab positive SARS-CoV-2 COVID-19 patients,Drug,Bromelain + Acetylcysteine,Bromelain; Acetylcysteine,40,https://anzctr.org.au/ACTRN12620000788976.aspx,None
1601,2913,ISRCTN11466448,ISRCTN,2020-11-23,2020-11-30,False,University Hospitals Coventry and Warwickshire NHS Trust,Recruiting,Not Applicable,Interventional,United Kingdom,A randomized trial to assess the effects of physical and mental health rehabilitation for people recovering from COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,535,http://isrctn.com/ISRCTN11466448,None
1602,2915,ISRCTN11970082,ISRCTN,2020-11-20,2020-08-16,True,"Indian Institute of Technology, Madras",Recruiting,Not Applicable,Interventional,India,Effect of the drug indomethacin in the treatment of COVID-19 patients,Drug,Indomethacin,Indomethacin,250,http://isrctn.com/ISRCTN11970082,None
1603,2916,ISRCTN31062548,ISRCTN,2020-09-07,2020-09-14,True,NHS Greater Glasgow and Clyde,Recruiting,Phase 2,Interventional,United Kingdom,"GETAFIX (Glasgow Early Treatment Arm Favipiravir) â€“ a study to compare the effectiveness of adding the antiviral drug favipiravir to standard care in COVID-19 patients, compared with standard care alone",Drug,Favipiravir,Favipiravir,302,http://isrctn.com/ISRCTN31062548,EUCTR2020-001904-41
1604,2917,ISRCTN93382525,ISRCTN,2020-08-03,2020-12-10,False,South London and Maudsley NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,STAR (Study of Trauma And Recovery): a trial of trauma-focused psychological therapy for psychosis,Not relevant,Not relevant,Not relevant,300,http://isrctn.com/ISRCTN93382525,None
1605,2918,ISRCTN17898730,ISRCTN,2020-04-23,2020-07-04,False,Psychosocial Innovation Network,Recruiting,Not Applicable,Interventional,Serbia,Expressive writing for the reduction of psychological difficulties during the COVID-19 pandemic,Other (psych),Psychological,Psychological,150,http://isrctn.com/ISRCTN17898730,None
1606,2919,EUCTR2020-002504-39-DE,EU Clinical Trials Register,2020-08-14,2020-10-11,False,"University Hospital, Hamburg-Eppendorf",Authorised,Phase 3,Interventional,Germany,Hamburg Edoxaban foR anticoagulation in COvid-19 study,Drug,Edoxaban,Edoxaban,172,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002504-39,None
1607,2920,EUCTR2020-004695-18-DE,EU Clinical Trials Register,2020-10-15,2020-02-12,True,Heinrich-Heine University,Authorised,Phase 2,Interventional,Germany,Plasma from Covid 19 recovered patients or camostat as a therapy for early SARS-CoV-2 infection in high risk individuals,ATMP,Plasma,Plasma,994,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004695-18,None
1608,2921,EUCTR2020-002119-23-IT,EU Clinical Trials Register,2020-09-22,2020-11-16,False,Istituto Europeo di Oncologia,Authorised,Phase 2,Interventional,Italy,prevention of complications from COVID-19 in cancer patients under active treatment,Clinical Presentation,No Intervention,No Intervention,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002119-23,None
1609,2922,EUCTR2020-003872-42-IT,EU Clinical Trials Register,2020-11-23,2020-06-11,True,Istituto di Farmacologia Traslazionale (IFT),Authorised,Phase 2,Interventional,Italy,Antiviral and Immunomodulatory Interferon-Beta in high-risk COVID-19 patients,Drug,Interferon beta,Interferon beta,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003872-42,None
1610,2923,EUCTR2020-004408-32-GR,EU Clinical Trials Register,2020-10-01,2020-10-23,False,Amyndas Pharmaceuticals S.A.,Authorised,Phase 2,Interventional,Greece,Clinical trial of the investigational drug AMY-101 for the treatment of patients with severe COVID-19.,Drug,AMY-101,AMY-101,62,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004408-32,None
1611,2924,EUCTR2020-001391-15-IE,EU Clinical Trials Register,2020-03-31,2020-04-24,False,Royal College of Surgeons Ireland,Authorised,Phase 2,Interventional,Ireland,"A randomized double-blind placebo-controlled, pilot trial of intravenous plasma-purified alpha-1 antitrypsin for severe COVID-19 illness.",ATMP,Alpha-1-proteinase inhibitor,Alpha-1-proteinase inhibitor,36,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001391-15,None
1612,2926,ChiCTR2000038256,ChiCTR,2020-09-15,2020-09-07,True,North Sichuan Medical College,Recruiting,Not Applicable,Interventional,China,Motion Modelling for Sedentary Behavior during the novel coronavirus pneumonia (COVID-19) pandemic: 10-min High Intensity Interval Training (HIIT) with Music Therapy (MT),Other,No Intervention,No Intervention,118,http://www.chictr.org.cn/showproj.aspx?proj=61345,None
1613,2927,ChiCTR2000038255,ChiCTR,2020-09-15,2020-05-25,True,Beijing Normal University,Recruiting,Not Applicable,Interventional,China,Establishment of psychological assistance system for the bereaved during the COVID-19 pandemic,Other (psych),Psychological,Psychological,300,http://www.chictr.org.cn/showproj.aspx?proj=61390,None
1614,2931,RBR-6m69fc,REBEC,2020-04-02,2020-01-04,True,University of Sevilla,Recruiting,Not Applicable,Interventional,Spain,"Therapeutic Pulmonary Telerehabilitation Protocol in patients affected by COVID-19, confined in their homes",Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9664,None
1615,2934,RBR-8969zg,REBEC,2020-04-13,2020-04-14,False,University de São Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,Treatment of 2019-nCoV Pneumonia with N-acetylcysteine,Drug,N-acetylcysteine,N-acetylcysteine,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9718,None
1616,2935,RBR-658khm,REBEC,2020-04-22,2020-01-04,True,Centro Medico Mazzei,Recruiting,Not Applicable,Interventional,Brazil,"Telemedicine in the Covid-19 pandemic in Brazil
in a medical clinic in the supplementary health sector in SÃ£o Paulo, Brazil",Telehealth,Telehealth,Telehealth,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9688,None
1617,2936,RBR-6w5tbk,REBEC,2020-04-29,2020-04-30,False,Hospital Universitário de Brasília,Not Recruiting,Not Applicable,Interventional,Brazil,Effects of tests for covid-19 on the preservation of the healthcare workforce during pandemia in Brazil,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9810,None
1618,2937,RBR-5s2mqg,REBEC,2020-05-05,2020-04-27,True,"University of Campinas, Brazil",Recruiting,Phase 2/Phase 3,Interventional,Brazil,The effect of an inhibitor of pulmonary inflammation in patients with Covid-19,Drug,Icatibant acetate,Icatibant acetate,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9693,None
1619,2938,RBR-3k4wxb,REBEC,2020-05-05,2020-01-05,True,Hospital Santo António,Not Recruiting,Phase 2,Interventional,Brazil,"Evaluation of the use of Hydroxychlorochine in Chinese flu
",Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9773,None
1620,2939,RBR-4vm3yy,REBEC,2020-05-15,2020-04-19,True,Instituto Estadual de Hematologia Arthur Siqueira Cavalcanti,Recruiting,Not Applicable,Interventional,Brazil,Effect of convalescent plasma in patients with severe COVI-19,ATMP,Plasma,Plasma,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9901,None
1621,2941,RBR-2dxyx4,REBEC,2020-06-02,2020-04-06,True,Hospital Universitário Clementino Fraga Filho,Not Recruiting,Not Applicable,Interventional,Brazil,Mechanical ventilator for use in patients with respiratory failure due to Covid-19 (VExCO),Other (physical),Mechanical ventilation,Mechanical ventilation,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10001,None
1622,2943,RBR-949z6v,REBEC,2020-05-06,2020-05-30,False,Faculdade de Medicina de Ribeirão Preto,Recruiting,Phase 2,Interventional,Brazil,Full versus prophylactic anticoagulation for the treatment of severe forms of Covid-19:,Drug,Heparin,Heparin,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9870,None
1623,2944,RBR-876qb5,REBEC,2020-06-08,2020-05-27,True,Hospital das Clínicas de Ribeirão Preto,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Treatment of severe cases of Covid-19 with Eculizumab,Drug,Eculizumab,Eculizumab,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9903,None
1624,2946,RBR-3zdynp,REBEC,2020-06-23,2020-03-16,True,Victor Côrtes Pourchet de Carvalho,Recruiting,Phase 4,Interventional,Brazil,Using Tocilizumab in critically ill patients with COVID-19.,Drug,Tocilizumab,Tocilizumab,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9995,None
1625,2948,RBR-4wnx2q,REBEC,2020-06-26,2020-06-06,True,Universidade Estadual do Centro Oeste,Recruiting,Not Applicable,Interventional,Brazil,Pulmonary rehabilitation in individuals affected by Covid-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10123,None
1626,2949,RBR-5kkpg6,REBEC,2020-06-28,2020-06-29,False,Federal University of Pernambuco,Not Recruiting,Not Applicable,Interventional,Brazil,"Effect of eating habits and exposure to light on sleep, emotion, memory and headache in college students during the COVID-19 pandemic",Other,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10110,None
1627,2950,RBR-7jqpnw,REBEC,2020-06-29,2020-01-07,True,University of Pernambuco,Not Recruiting,Phase 3,Interventional,Brazil,"Effect of COVID-19 convalescent plasma produced by HEMOPE: A randomized study, with a comparative group in several centers",ATMP,Plasma,Plasma,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10116,None
1628,2951,RBR-3rywwg,REBEC,2020-07-10,2020-01-06,True,Faculdade de Medicina de São José do Rio Preto (FAMERP),Recruiting,Phase 2,Interventional,Brazil,"A clinical, randomized study to evaluate the efficacy and safety of Naproxen compared to placebo in combination with Azithromycin or Levofloxacin in patients with Severe Acute Respiratory Syndrome during the Covid-19 pandemic",Drug,"Naproxen, Amoxacillin or Clavulanate, Azithromycin or Levofloxacin, Oseltamivir",Naproxen; Amoxacillin; Clavulanate; Azithromycin; Levofloxacin; Oseltamivir,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9819,None
1629,2952,RBR-7jrxqm,REBEC,2020-07-10,2020-01-06,True,Universidade do Estado da Bahia,Recruiting,Not Applicable,Interventional,Brazil,Effect of a special nutritional oral supplement use on inflammation in patients with COVID-19,Supplement,Nutritional Supplement,Nutritional Supplement,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9944,None
1630,2954,RBR-45kf9p,REBEC,2020-07-13,2020-06-29,True,University de São Paulo,Recruiting,Not Applicable,Interventional,Brazil,CoV-Hep study : Comparative study between different anti-coagulation strategies in continuous hemodialysis in COVID-19 patients,Drug,Sodium Citrate vs. Heparin,Sodium Citrate; Heparin,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9913,None
1631,2955,RBR-7drpyr,REBEC,2020-07-13,2020-06-20,True,"University of Campinas, Brazil",Not Recruiting,Not Applicable,Interventional,Brazil,Effect of two covers to prevent injuries caused to professionals working in the health area due to the use of personal protective equipment,Other (device),Barrier devices,Barrier devices,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10034,None
1632,2958,RBR-5ysj54,REBEC,2020-07-27,2020-07-15,True,Universidade Federal do Rio de Janeiro,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,BCG vaccine use to prevent COVID-19 in health care workers,ATMP,Vaccine,Vaccine,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10111,None
1633,2960,RBR-3g5f9f,REBEC,2020-07-29,2020-08-28,False,Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein,Not Recruiting,Not Applicable,Interventional,Brazil,"Educational intervention by cell phone to increase informed choices at childbirth, in the context of the Covid-19 pandemic.",Other,Other,Other,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10283,None
1634,2961,RBR-8jyhxh,REBEC,2020-07-30,2020-11-04,False,Hospital das Clínicas de Ribeirão Preto,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Clinical trial for the treatment of COVID-19 with Chloroquine and Colchicine,Drug,Hydroxychloroquine + Colchicine,Hydroxychloroquine; Colchicine,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10257,None
1635,2965,RBR-2w7ghc,REBEC,2020-08-07,2020-07-20,True,Maria do Rosario Toscano von Flach - Salvador,Recruiting,Not Applicable,Interventional,Brazil,"Online meditation as an aid in reducing symptoms of Depression, Anxiety and Psychological Stress in Resident Physicians
during COVID-19 pandemic in Brazil",Other (psych),Psychological,Psychological,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10234,None
1636,2967,RBR-7d7ngw,REBEC,2020-08-07,2020-07-15,True,Hospital Geral Roberto Santos,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Early prone position in patients on spontaneous ventilation,Procedure,Positioning,Positioning,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10240,None
1637,2968,RBR-2k66ft,REBEC,2020-08-10,2020-08-20,False,Rodrigo S Biondi ,Not Recruiting,Not Applicable,Interventional,Brazil,"Randomized,  study to evaluate early prone position in patients with COVID-19
",Procedure,Positioning,Positioning,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10094,None
1638,2969,RBR-9y32yy,REBEC,2020-05-24,2020-01-07,True,Sao Paulo State University (Universidade Estadual Paulista),Not Recruiting,Not Applicable,Interventional,Brazil,Acute and chronic cardiovascular and respiratory changes in COVID-19 hospitalized patients and the effect of physical rehabilitation supervised by telecommunication,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9959,None
1639,2970,RBR-4vy54v,REBEC,2020-08-11,2020-07-15,True,Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS),Not Recruiting,Not Applicable,Interventional,Brazil,On-Line Collectives in Mental Health: Transdisciplinary Action for Groups Vulnerable to COVID-19,Other (psych),Psychological,Psychological,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10103,None
1640,2971,RBR-4pfygr,REBEC,2020-08-13,2020-07-27,True,Cryopraxis,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,"Clinical study to assess the safety and tolerability of administration, directly into a vein, of human umbilical cord and placental blood plasma (PlasmacordÂ®) in patients with Severe acute respiratory syndrome resulting from Sars-Cov-2 infection (fever, cough headache, muscle aches and difficulty breathing)",ATMP,Cells (stem cells),Cells (stem cells),Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10300,None
1641,2973,RBR-3rdhgm,REBEC,2020-05-14,2020-01-05,True,Faculdade de Medicina de Botucatu,Recruiting,Not Applicable,Interventional,Brazil,The role of early dialysis in the evolution of patients with COVID19,Other (device),Dialysis,Dialysis,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9733,None
1642,2974,RBR-9xs978,REBEC,2020-08-24,2020-06-17,True,Hospital Universitario Walter Cantidio,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Telehealth for patients with dementia at the Hospital UniversitÃ¡rio Walter Cantidio-UFC,Telehealth,Telehealth,Telehealth,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10125,None
1643,2975,RBR-2z3f7k,REBEC,2020-05-04,2020-04-29,True,"Federal Institute of Education, Science and Technology of Rio de Janeiro",Recruiting,Not Applicable,Interventional,Brazil,"Artificial ventilation setting in patients infected with COVID-19
",Other (physical),Mechanical ventilation,Mechanical ventilation,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9725,None
1644,2976,RBR-2kjm6y,REBEC,2020-08-26,2020-05-22,True,Blade Therapeutics,Recruiting,Phase 2,Interventional,"Brazil, United States",A phase 2 randomized double-blind placebo-controlled study to evaluate safety of BLD-2660 and its activity against COVID-19 virus in hospitalized subjects recently diagnosed with COVID-19 in comparison to standard of care treatment,Drug,BLD-2660,BLD-2660,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10389,None
1645,2977,RBR-72bg24,REBEC,2020-08-27,2020-08-31,False,Instituto de Tecnologia do Paraná,Not Recruiting,Not Applicable,Interventional,Brazil,SARS-CoV-2 quick analysis in breath device,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10429,None
1646,2978,RBR-3fz9yr,REBEC,2020-08-31,2020-10-06,False,Paulo Roberto Slud Brofman,Not Recruiting,Not Applicable,Interventional,Brazil,Use of mesenchymal cells for the treatment of patients with respiratory syndrome caused by new coronavirus,ATMP,Cells (mesenchymal),Cells (mesenchymal),Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10204,None
1647,2979,RBR-5vpyh4,REBEC,2020-07-06,2020-08-28,False,"Pesquisador - Belo Horizonte, MG, Brazil",Recruiting,Phase 2,Interventional,Brazil,Use of Anti-IL-17 in patients with Covid-19 associated pneumonia,Drug,Anti-IL-17,Anti-IL-17,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9729,None
1648,2980,RBR-2fvjjm,REBEC,2020-08-11,2020-08-18,False,Universidade Federal de Minas Gerais,Recruiting,Not Applicable,Interventional,Brazil,Hyperbaric Oxygen Therapy for hospitalized patients with Covid-19,Drug,Oxygen,Oxygen,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10039,None
1649,2985,RBR-9rnkbs,REBEC,2020-09-22,2020-01-09,True,Pontificia Universidade Catolica do Rio Grande do Sul,Recruiting,Not Applicable,Interventional,Brazil,Effectiveness of an equipment to reduce the dispersion of particles in emergency dental care during the Covid-19 pandemic,Other,Other,Other,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10530,None
1650,2986,RBR-8nfx26,REBEC,2020-09-22,2020-10-10,False,Brazilian National Council for Scientific and Technological Development (CNPq),Not Recruiting,Phase 2,Interventional,Brazil,Effect of Inhaled Nitric Oxide for the treatment of COVID-19,Drug,Nitric Oxide,Nitric Oxide,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10112,None
1651,2987,RBR-97nt6j,REBEC,2020-09-24,2020-09-25,False,Associação Brasileira de Ozonioterapia (ABOZ),Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Multicenter Study of the Integrative and Complementary Practice of the Use of Ozone Gas in Outpatients with Covid-19,Drug,Ozone,Ozone,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10463,None
1652,2988,RBR-5v3k5d,REBEC,2020-10-02,2020-05-07,True,Sociedade Brasileira de Ozonioterapia Médica (SOBOM),Recruiting,Phase 3,Interventional,Brazil,Study of the use of ozone therapy adjunct to the treatment of Covid-19 infections,Drug,Ozone,Ozone,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10467,None
1653,2989,RBR-8h7q82,REBEC,2020-10-02,2020-01-05,True,Universidade Federal de Roraima,Not Recruiting,Phase 2,Interventional,Brazil,"The effect of chloroquine, hydroxychloroquine OR ivermectin in patients with severe manifestations of coronavirus",Drug,Chloroquine vs. Hydroxychloroquine vs. Ivermectin,Chloroquine; Hydroxychloroquine; Ivermectin,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10560,None
1654,2990,RBR-2xxrrq,REBEC,2020-10-02,2020-08-13,True,Universidade Federal de  São Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,The effect of cardiac massage training in patients with cardiac arrest with COVID-19 positioned in the ventral position.,Procedure,Cardiac massage,Cardiac massage,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10408,None
1655,2992,RBR-825p57,REBEC,2020-10-08,2020-09-20,True,Federal University of São Carlos,Recruiting,Not Applicable,Interventional,Brazil,Telerehabilitation for elderly people with Alzheimer's disease and their caregivers,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9943,None
1656,2993,RBR-4nr86m,REBEC,2020-08-24,2020-08-06,True,Universidade Federal do Rio de Janeiro,Recruiting,Phase 2,Interventional,Brazil,Effects of Nitazoxanide Administration to Patients in the Initial Phase of COVID-19,Drug,Nitazoxanide,Nitazoxanide,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10311,None
1657,2994,RBR-58ftdj,REBEC,2020-10-28,2020-10-08,True,University de São Paulo,Recruiting,Not Applicable,Interventional,Brazil,"Evaluation of the Effectiveness of an Oral Antiseptic in Improving the Clinical Status, Decreasing Viral Load and Its Prolonged Action in Patients with COVID-19",Drug,Mouthwash,Mouthwash,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10239,None
1658,2995,RBR-9b6kvp,REBEC,2020-10-29,2020-02-11,True,Universidade Federal do Rio Grande,Not Recruiting,Not Applicable,Interventional,Brazil,"Effect of a Cloth Mask Physical Exercise session on Cardiovascular health, Feeling and Exercise Effort, Oxygen Quantity and Jumping Performance: Recommendation for Physical Mask Exercise during and after the COVID-19 global outbreak",Other (device),Masks,Masks,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10606,None
1659,2996,RBR-4kjqtg,REBEC,2020-08-05,2020-05-08,True,Universidade Federal de Goias,Recruiting,Phase 2,Interventional,Brazil,Testing of BCG vaccine against COVID-19,ATMP,Vaccine,Vaccine,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10338,None
1660,2997,RBR-8x8g36,REBEC,2020-10-29,2020-01-11,True,Instituto Federal do Paraná,Not Recruiting,Phase 3,Interventional,Brazil,Effectiveness of a mouthwash and toothpaste containing PHTALOX in controlling symptoms of COVID-19 and flu,Drug,Mouthwash,Mouthwash,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10682,None
1661,2998,RBR-5d7hkv,REBEC,2020-11-03,2020-11-09,False,Escola de Educação Física e Esporte de Ribeirão Preto,Recruiting,Not Applicable,Interventional,Brazil,Effect of Moderate Physical Training on a bicycle associated with altitude simulation on the health status of people recovered from COVID-19 (AEROBI-COVID),Other (exercise),Exercise,Exercise,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10638,None
1662,2999,RBR-2fvw6v,REBEC,2020-11-16,2021-05-04,False,Universidade Federal de Alfenas,Not Recruiting,Not Applicable,Interventional,Brazil,"Analysis of motor response time, electromyography and muscle strength in volunteers from the group at risk for covid-19 submitted to a home exercise protocol: randomized controlled clinical trial, cross over

",Other (exercise),Exercise,Exercise,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10450,None
1663,3000,RBR-2z5t7z,REBEC,2020-11-16,2020-04-10,True,Anhembi Morumbi,Recruiting,Phase 1,Interventional,Brazil,Light on COVID-19,Other (device),infrared LED,infrared LED,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10620,None
1664,3001,RBR-4jh63b,REBEC,2020-11-19,2020-11-23,False,StemCorp,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Evaluation of stem cells treatment in Covid-19 patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10602,None
1665,3037,NCT04244591,ClinicalTrials.gov,2020-01-23,2020-01-26,False,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,China,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,Drug,Corticosteroids,Methylprednisolone,80,https://clinicaltrials.gov/show/NCT04244591,None
1666,3039,NCT04251767,ClinicalTrials.gov,2020-01-30,2020-02-05,False,The Second Hospital of Nanjing Medical University,Not Recruiting,Not Applicable,Interventional,China,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,ATMP,Intestinal microbiome,Intestinal microbiome,0,https://clinicaltrials.gov/show/NCT04251767,None
1667,3040,NCT04251871,ClinicalTrials.gov,2020-01-28,2020-01-22,True,Beijing 302 Hospital,Recruiting,Not Applicable,Interventional,China,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,150,https://clinicaltrials.gov/show/NCT04251871,None
1668,3041,NCT04252118,ClinicalTrials.gov,2020-01-27,2020-01-27,False,Beijing 302 Hospital,Recruiting,Phase 1,Interventional,China,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04252118,None
1669,3042,NCT04252274,ClinicalTrials.gov,2020-01-29,2020-01-30,False,Shanghai Public Health Clinical Center,Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,Drug,Darunavir + Cobicistat,Darunavir; Cobicistat,30,https://clinicaltrials.gov/show/NCT04252274,None
1670,3043,NCT04252664,ClinicalTrials.gov,2020-01-31,2020-02-12,False,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Mild and Moderate COVID-19,Drug,Remdesivir,Remdesivir,308,https://clinicaltrials.gov/show/NCT04252664,None
1671,3044,NCT04252820,ClinicalTrials.gov,2020-01-31,2020-03-01,False,Dr. Negrin University Hospital,Not Recruiting,Not Applicable,Interventional,Spain,Prevention of Perioperative Hypothermia in Transurethral Resection Under Spinal Anaesthesia,Not relevant,Not relevant,Not relevant,215,https://clinicaltrials.gov/show/NCT04252820,None
1672,3045,NCT04252885,ClinicalTrials.gov,2020-01-30,2020-01-28,True,Guangzhou Eighth People's Hospital,Not Recruiting,Phase 4,Interventional,China,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,Drug,Lopinavir/ritonavir vs. umifenovir,Lopinavir/ritonavir; Umifenovir,86,https://clinicaltrials.gov/show/NCT04252885,None
1673,3046,NCT04254874,ClinicalTrials.gov,2020-02-02,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",Drug,Interferon + Umifenovir vs. Umifenovir,Interferon; Umifenovir,100,https://clinicaltrials.gov/show/NCT04254874,None
1674,3047,NCT04255017,ClinicalTrials.gov,2020-02-02,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",Drug,Umeprevir vs. Oseltamivir vs. lopinavir/ritonavir,Umeprevir; Oseltamivir; Lopinavir/ritonavir,400,https://clinicaltrials.gov/show/NCT04255017,None
1675,3050,NCT04257656,ClinicalTrials.gov,2020-01-31,2020-02-06,False,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Severe COVID-19,Drug,Remdesivir,Remdesivir,237,https://clinicaltrials.gov/show/NCT04257656,None
1676,3053,NCT04260594,ClinicalTrials.gov,2020-02-06,2020-02-07,False,Jieming QU,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,Drug,Umifenovir,Umifenovir,380,https://clinicaltrials.gov/show/NCT04260594,None
1677,3054,NCT04261270,ClinicalTrials.gov,2020-02-04,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 3,Interventional,China,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",Drug,ASCO9F + Ritonavir vs. Ritonavir + Oseltamivir vs. Oseltamivir,ASCO9F; Ritonavir; Oseltamivir,60,https://clinicaltrials.gov/show/NCT04261270,None
1678,3055,NCT04261426,ClinicalTrials.gov,2020-02-06,2020-02-10,False,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,ATMP,Immunoglobulin,Immunoglobulin,80,https://clinicaltrials.gov/show/NCT04261426,None
1679,3056,NCT04261517,ClinicalTrials.gov,2020-02-06,2020-02-06,False,Shanghai Public Health Clinical Center,Not Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,30,https://clinicaltrials.gov/show/NCT04261517,None
1680,3057,NCT04261907,ClinicalTrials.gov,2020-02-06,2020-02-07,False,The First Affiliated Hospital of Zhejiang University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,Drug,SC09 + ritonavir vs. lopinavir/ritonavir,ASC09; lopinavir/ritonavir,160,https://clinicaltrials.gov/show/NCT04261907,None
1681,3059,NCT04263402,ClinicalTrials.gov,2020-02-02,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,Drug,Corticosteroids,Methylprednisolone,100,https://clinicaltrials.gov/show/NCT04263402,None
1682,3060,NCT04264533,ClinicalTrials.gov,2020-02-04,2020-02-14,False,ZhiYong Peng,Not Recruiting,Phase 2,Interventional,China,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,Drug,Vitamin C,Vitamin C,56,https://clinicaltrials.gov/show/NCT04264533,None
1683,3061,NCT04264858,ClinicalTrials.gov,2020-02-08,2020-03-17,False,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,ATMP,Immunoglobulin,Immunoglobulin,10,https://clinicaltrials.gov/show/NCT04264858,None
1684,3062,NCT04268537,ClinicalTrials.gov,2020-02-08,2020-02-10,False,"Southeast University, China",Not Recruiting,Phase 2,Interventional,No Country Given,Immunoregulatory Therapy for 2019-nCoV,Drug,PD1 vs. thymosin,PD1; Thymosin,120,https://clinicaltrials.gov/show/NCT04268537,None
1685,3063,NCT04269525,ClinicalTrials.gov,2020-02-07,2020-02-06,True,ZhiYong Peng,Recruiting,Phase 2,Interventional,China,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),16,https://clinicaltrials.gov/show/NCT04269525,None
1686,3066,NCT04273321,ClinicalTrials.gov,2020-02-15,2020-02-14,True,"Beijing Chaoyang Hospital, Capital Medical University",Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Corticosteroids in COVID-19,Drug,Corticosteroids,Methylprednisolone,86,https://clinicaltrials.gov/show/NCT04273321,None
1687,3067,NCT04273529,ClinicalTrials.gov,2020-02-14,2020-02-20,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,Drug,Thalidomide,Thalidomide,100,https://clinicaltrials.gov/show/NCT04273529,None
1688,3068,NCT04273581,ClinicalTrials.gov,2020-02-14,2020-02-18,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,Drug,Thalidomide + Corticosteroids,Thalidomide; Methylprednisolone,40,https://clinicaltrials.gov/show/NCT04273581,None
1689,3069,NCT04273646,ClinicalTrials.gov,2020-02-14,2020-04-20,False,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),48,https://clinicaltrials.gov/show/NCT04273646,None
1690,3070,NCT04273763,ClinicalTrials.gov,2020-02-14,2020-02-16,False,The Second Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),Drug,Bromhexine + Umifenovir + Interferon alpha vs. Umifenovir + interferon alpha,Bromhexine; Umifenovir; interferon alpha,18,https://clinicaltrials.gov/show/NCT04273763,None
1691,3072,NCT04275245,ClinicalTrials.gov,2020-02-06,2020-02-03,True,Tang-Du Hospital,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,Drug,Mepolizumab,Mepolizumab,20,https://clinicaltrials.gov/show/NCT04275245,None
1692,3074,NCT04275414,ClinicalTrials.gov,2020-02-14,2020-02-15,False,Qilu Hospital of Shandong University,Not Recruiting,Phase 2,Interventional,"China, Italy",Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,Drug,Bevacizumab,Bevacizumab,27,https://clinicaltrials.gov/show/NCT04275414,None
1693,3076,NCT04276688,ClinicalTrials.gov,2020-02-11,2020-02-10,True,University of Hong Kong,Not Recruiting,Phase 2,Interventional,Hong Kong,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",Drug,Lopinavir/ritonavir + Ribavirin + Interferon beta,Lopinavir/ritonavir; Ribavirin; Interferon beta,127,https://clinicaltrials.gov/show/NCT04276688,None
1694,3077,NCT04276896,ClinicalTrials.gov,2020-02-17,2020-03-24,False,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1/Phase 2,Interventional,China,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,ATMP,Vaccine,Vaccine,100,https://clinicaltrials.gov/show/NCT04276896,None
1695,3078,NCT04276987,ClinicalTrials.gov,2020-02-16,2020-02-15,True,Ruijin Hospital,Not Recruiting,Phase 1,Interventional,China,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04276987,None
1696,3080,NCT04278963,ClinicalTrials.gov,2020-02-19,2020-02-27,False,China Academy of Chinese Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,https://clinicaltrials.gov/show/NCT04278963,None
1697,3081,NCT04279197,ClinicalTrials.gov,2020-02-15,2020-04-23,False,ShuGuang Hospital,Recruiting,Phase 2,Interventional,China,Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,https://clinicaltrials.gov/show/NCT04279197,None
1698,3085,NCT04280224,ClinicalTrials.gov,2020-02-13,2020-02-15,False,Xinxiang Medical University,Recruiting,Phase 1,Interventional,China,NK Cells Treatment for COVID-19,ATMP,Cells (NK),Cells (NK),30,https://clinicaltrials.gov/show/NCT04280224,None
1699,3086,NCT04280588,ClinicalTrials.gov,2020-02-20,2020-02-22,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Phase 2,Interventional,China,Fingolimod in COVID-19,Drug,Fingolimod,Fingolimod,0,https://clinicaltrials.gov/show/NCT04280588,None
1700,3088,NCT04281693,ClinicalTrials.gov,2020-02-20,2020-02-01,True,Affiliated Hospital to Academy of Military Medical Sciences,Not Recruiting,Not Applicable,Interventional,China,A New Screening Strategy for 2019 Novel Coronavirus Infection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,230,https://clinicaltrials.gov/show/NCT04281693,None
1701,3089,NCT04282902,ClinicalTrials.gov,2020-02-10,2020-02-04,False,Huilan Zhang,Recruiting,Phase 3,Interventional,China,A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection,Drug,Pirfenidone,Pirfenidone,294,https://clinicaltrials.gov/show/NCT04282902,ChiCTR2000030333
1702,3092,NCT04285190,ClinicalTrials.gov,2020-02-19,2020-02-26,False,"Tasly Pharmaceuticals, Inc.",Not Recruiting,Not Applicable,Interventional,No Country Given,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,0,https://clinicaltrials.gov/show/NCT04285190,None
1703,3094,NCT04286503,ClinicalTrials.gov,2020-02-25,2020-02-23,True,"Beijing You'an Hospital, Capital Medical University",Not Recruiting,Phase 4,Interventional,No Country Given,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,Drug,Carrimycin vs. lopinavir/ritonavir or Umifenovir or chloroquine,Carrimycin; lopinavir; ritonavir; Umifenovir; chloroquine,520,https://clinicaltrials.gov/show/NCT04286503,None
1704,3095,NCT04287686,ClinicalTrials.gov,2020-02-21,2020-02-01,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,ACE enzyme,0,https://clinicaltrials.gov/show/NCT04287686,None
1705,3096,NCT04288102,ClinicalTrials.gov,2020-02-24,2020-03-05,False,Beijing 302 Hospital,Not Recruiting,Phase 2,Interventional,China,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04288102,None
1706,3099,NCT04290858,ClinicalTrials.gov,2020-02-27,2020-03-01,False,Xijing Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection,Drug,Nitric oxide,Nitric oxide,0,https://clinicaltrials.gov/show/NCT04290858,None
1707,3100,NCT04290871,ClinicalTrials.gov,2020-02-27,2020-03-23,False,Xijing Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,Drug,Nitric oxide,Nitric oxide,0,https://clinicaltrials.gov/show/NCT04290871,None
1708,3101,NCT04291053,ClinicalTrials.gov,2020-02-27,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,550,https://clinicaltrials.gov/show/NCT04291053,None
1709,3102,NCT04291729,ClinicalTrials.gov,2020-02-27,2020-02-17,True,The Ninth Hospital of Nanchang,Not Recruiting,Phase 4,Interventional,China,Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Danoprevir + Ritonavir (w/ or w/o Interferon),Danoprevir; Ritonavir; Interferon,11,https://clinicaltrials.gov/show/NCT04291729,None
1710,3105,NCT04292730,ClinicalTrials.gov,2020-02-28,2020-03-15,True,Gilead Sciences,Not Recruiting,Phase 3,Interventional,"Netherlands, Sweden, Japan, United Kingdom, Iran, Italy, Singapore, France, Germany, China, United States, South Korea, Taiwan, Hong Kong, Switzerland, Spain",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,Drug,Remdesivir,Remdesivir,1113,https://clinicaltrials.gov/show/NCT04292730,EUCTR2020-000842-32; ISRCTN85762140
1711,3106,NCT04292899,ClinicalTrials.gov,2020-02-28,2020-03-06,True,Gilead Sciences,Not Recruiting,Phase 3,Interventional,"Netherlands, Sweden, Japan, United Kingdom, Italy, Singapore, France, Germany, China, United States, South Korea, Taiwan, Hong Kong, Switzerland, Spain",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19),Drug,Remdesivir,Remdesivir,4891,https://clinicaltrials.gov/show/NCT04292899,EUCTR2020-000841-15; ISRCTN15874265
1712,3108,NCT04293692,ClinicalTrials.gov,2020-02-24,2020-02-24,False,Puren Hospital Affiliated to Wuhan University of Science and Technology,Not Recruiting,Not Applicable,Interventional,China,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,ATMP,Cells (mesenchymal),Cells (mesenchymal),0,https://clinicaltrials.gov/show/NCT04293692,None
1713,3109,NCT04293887,ClinicalTrials.gov,2020-02-15,2020-03-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 1,Interventional,No Country Given,Efficacy and Safety of IFN-a2ÃŸ in the Treatment of Novel Coronavirus Patients,Drug,Interferon alfa,Interferon alfa,328,https://clinicaltrials.gov/show/NCT04293887,None
1714,3110,NCT04295551,ClinicalTrials.gov,2020-03-03,2020-03-14,False,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,https://clinicaltrials.gov/show/NCT04295551,None
1715,3111,NCT04296643,ClinicalTrials.gov,2020-03-03,2020-04-01,False,McMaster University,Recruiting,Not Applicable,Interventional,"Israel, Canada",Medical Masks vs N95 Respirators for COVID-19,Other (device),Masks,Masks,576,https://clinicaltrials.gov/show/NCT04296643,None
1716,3112,NCT04298060,ClinicalTrials.gov,2020-02-28,2020-07-01,False,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2,Interventional,China,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),Drug,DAS181,DAS181,280,https://clinicaltrials.gov/show/NCT04298060,None
1717,3114,NCT04299152,ClinicalTrials.gov,2020-02-28,2020-11-10,False,Tianhe Stem Cell Biotechnologies Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,ATMP,Cells (stem cells),Cells (stem cells),20,https://clinicaltrials.gov/show/NCT04299152,None
1718,3116,NCT04299724,ClinicalTrials.gov,2020-03-05,2020-02-15,True,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1,Interventional,China,Safety and Immunity of Covid-19 aAPC Vaccine,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04299724,None
1719,3117,NCT04302519,ClinicalTrials.gov,2020-02-27,2020-03-05,False,"CAR-T (Shanghai) Biotechnology Co., Ltd.",Not Recruiting,Phase 1,Interventional,No Country Given,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04302519,None
1720,3120,NCT04303299,ClinicalTrials.gov,2020-02-24,2020-08-19,False,Rajavithi Hospital,Recruiting,Phase 3,Interventional,Thailand,"Favipiravir, Protease Inhibitors, Oseltamivir -Gpo, Hydroxychloroquine for Treatment of COVID-19",Drug,"Various Combinations of: Oseltamivir, Chloroquine, Lopipinavir/Ritonavir, Darunavir/ritonavir, Favipiravir",Oseltamivir; Hydroxychloroquine; Lopinavir; Ritonavir; Darunavir; Favipiravir,320,https://clinicaltrials.gov/show/NCT04303299,None
1721,3121,NCT04303507,ClinicalTrials.gov,2020-03-06,2020-04-29,True,University of Oxford,Recruiting,Not Applicable,Interventional,"Pakistan, Lao People's Democratic Republic, United Kingdom, Italy, Indonesia, Thailand",Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,Drug,Chloroquine or Hydroxychloroquine,Chloroquine; hydroxychloroquine,40000,https://clinicaltrials.gov/show/NCT04303507,EUCTR2020-001441-39; ISRCTN10207947
1722,3122,NCT04304053,ClinicalTrials.gov,2020-03-05,2020-03-18,True,Fundació Lluita contra la SIDA,Not Recruiting,Phase 3,Interventional,Spain,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,Drug (Chemoprophylaxis),Darunavir + cobicistat + hydroxychloroquine,Darunavir; cobicistat; hydroxychloroquine,2300,https://clinicaltrials.gov/show/NCT04304053,EUCTR2020-001031-27
1723,3123,NCT04304313,ClinicalTrials.gov,2020-02-14,2020-02-09,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 3,Interventional,China,A Pilot Study of Sildenafil in COVID-19,Drug,Sildenafil,Sildenafil,10,https://clinicaltrials.gov/show/NCT04304313,None
1724,3124,NCT04305106,ClinicalTrials.gov,2020-03-09,2020-03-17,False,Qilu Hospital of Shandong University,Recruiting,Not Applicable,Interventional,China,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,Drug,Bevacizumab,Bevacizumab,140,https://clinicaltrials.gov/show/NCT04305106,None
1725,3125,NCT04305457,ClinicalTrials.gov,2020-03-09,2020-03-21,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,Drug,Nitric oxide,Nitric oxide,70,https://clinicaltrials.gov/show/NCT04305457,None
1726,3127,NCT04306055,ClinicalTrials.gov,2020-03-08,2020-03-13,False,Guangzhou Blood Center,Not Recruiting,Not Applicable,Interventional,China,Blood Donor Recruitment During Epidemic of COVID-19,Other,No Intervention,No Intervention,19491,https://clinicaltrials.gov/show/NCT04306055,None
1727,3128,NCT04306393,ClinicalTrials.gov,2020-03-10,2020-03-21,True,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,Drug,Nitric oxide,Nitric oxide,200,https://clinicaltrials.gov/show/NCT04306393,EUCTR2020-001490-68
1728,3132,NCT04307693,ClinicalTrials.gov,2020-03-10,2020-03-11,False,Asan Medical Center,Not Recruiting,Phase 2,Interventional,South Korea,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),Drug,Lopinavir/ritonavir vs. hydroxychloroquine,Lopinavir/ritonavir; Hydroxychloroquine,65,https://clinicaltrials.gov/show/NCT04307693,None
1729,3134,NCT04308317,ClinicalTrials.gov,2020-03-04,2020-03-05,False,Henan Provincial People's Hospital,Recruiting,Phase 4,Interventional,China,Tetrandrine Tablets Used in the Treatment of COVID-19,Drug,Tetrandrine,Tetrandrine,60,https://clinicaltrials.gov/show/NCT04308317,None
1730,3135,NCT04308668,ClinicalTrials.gov,2020-03-11,2020-03-17,False,University of Minnesota,Not Recruiting,Phase 3,Interventional,"Canada, United States",Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1309,https://clinicaltrials.gov/show/NCT04308668,None
1731,3136,NCT04310228,ClinicalTrials.gov,2020-03-09,2020-03-08,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,Drug,Favipiravir + tocilizumab vs. favipiravir vs. tocilizumab,Favipiravir; tocilizumab,150,https://clinicaltrials.gov/show/NCT04310228,ChiCTR2000030894
1732,3137,NCT04310865,ClinicalTrials.gov,2020-03-15,2020-11-01,False,Zhong Wang,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,116,https://clinicaltrials.gov/show/NCT04310865,None
1733,3138,NCT04311177,ClinicalTrials.gov,2020-03-13,2020-04-09,False,University of Minnesota,Not Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Not Requiring Hospitalization,Drug,ARB (Losartan),ARB (Losartan),580,https://clinicaltrials.gov/show/NCT04311177,None
1734,3140,NCT04311697,ClinicalTrials.gov,2020-03-14,2020-05-15,False,"NeuroRx, Inc.",Recruiting,Phase 2,Interventional,"Israel, United States",Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure,Drug,Aviptadil,Aviptadil,165,https://clinicaltrials.gov/show/NCT04311697,None
1735,3142,NCT04312243,ClinicalTrials.gov,2020-03-15,2020-04-07,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,NO Prevention of COVID-19 for Healthcare Providers,Drug,Nitric oxide,Nitric oxide,470,https://clinicaltrials.gov/show/NCT04312243,None
1736,3144,NCT04312997,ClinicalTrials.gov,2020-03-16,2020-06-16,False,"Pulmotect, Inc.",Recruiting,Phase 2,Interventional,United States,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,Drug,"PUL-042, unspecified immunomodulatory drug",PUL-042 (unspecified immunomodulatory drug),100,https://clinicaltrials.gov/show/NCT04312997,None
1737,3145,NCT04313023,ClinicalTrials.gov,2020-03-16,2020-06-09,False,"Pulmotect, Inc.",Recruiting,Phase 2,Interventional,United States,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,Drug,"PUL-042, unspecified immunomodulatory drug",PUL-042 (unspecified immunomodulatory drug),200,https://clinicaltrials.gov/show/NCT04313023,None
1738,3146,NCT04313127,ClinicalTrials.gov,2020-03-15,2020-03-16,False,CanSino Biologics Inc.,Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,ATMP,Adenovirus vector,Adenovirus vector,108,https://clinicaltrials.gov/show/NCT04313127,None
1739,3147,NCT04313322,ClinicalTrials.gov,2020-03-15,2020-03-16,False,Stem Cells Arabia,Recruiting,Phase 1,Interventional,Jordan,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),5,https://clinicaltrials.gov/show/NCT04313322,None
1740,3152,NCT04315298,ClinicalTrials.gov,2020-03-15,2020-03-18,False,Regeneron Pharmaceuticals,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,Drug,Sarilumab,Sarilumab,1912,https://clinicaltrials.gov/show/NCT04315298,None
1741,3153,NCT04315480,ClinicalTrials.gov,2020-03-14,2020-03-12,True,Universit Politecnica delle Marche,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,Drug,Tocilizumab,Tocilizumab,38,https://clinicaltrials.gov/show/NCT04315480,None
1742,3155,NCT04315896,ClinicalTrials.gov,2020-03-18,2020-04-14,False,"National Institute of Respiratory Diseases, Mexico",Not Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Drug,Hydroxychloroquine,Hydroxychloroquine,500,https://clinicaltrials.gov/show/NCT04315896,None
1743,3156,NCT04315948,ClinicalTrials.gov,2020-03-13,2020-03-22,True,INSERM,Recruiting,Phase 3,Interventional,"Belgium, Austria, Luxembourg, France",Trial of Treatments for COVID-19 in Hospitalized Adults,Drug,Remdesivir vs. Lopinavir/ritonavir vs. Lopinavir/ritonavir + Interferon beta vs. Hydroxychloroquine,Remdesivir; Lopinavir/ritonavir; Interferon beta; Hydroxychloroquine,3100,https://clinicaltrials.gov/show/NCT04315948,EUCTR2020-000936-23
1744,3157,NCT04315987,ClinicalTrials.gov,2020-03-18,2020-06-01,False,Azidus Brasil,Not Recruiting,Phase 2,Interventional,Brazil,NestaCellÂ® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),90,https://clinicaltrials.gov/show/NCT04315987,None
1745,3159,NCT04316377,ClinicalTrials.gov,2020-03-13,2020-03-25,False,"University Hospital, Akershus",Not Recruiting,Phase 4,Interventional,Norway,Norwegian Coronavirus Disease 2019 Study,Drug,Hydroxychloroquine,Hydroxychloroquine,53,https://clinicaltrials.gov/show/NCT04316377,None
1746,3160,NCT04316728,ClinicalTrials.gov,2020-03-14,2020-03-01,True,"Centro Studi Internazionali, Italy",Not Recruiting,Not Applicable,Interventional,Italy,Clinical Performance of the VivaDiag â„¢ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04316728,None
1747,3162,NCT04317040,ClinicalTrials.gov,2020-03-19,2020-04-08,False,"OncoImmune, Inc.",Not Recruiting,Phase 3,Interventional,United States,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,ATMP,Gene-derived protein,Gene-derived protein,243,https://clinicaltrials.gov/show/NCT04317040,None
1748,3163,NCT04317092,ClinicalTrials.gov,2020-03-19,2020-03-19,True,National Cancer Institute,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),Drug,Tocilizumab,Tocilizumab,400,https://clinicaltrials.gov/show/NCT04317092,EUCTR2020-001110-38
1749,3164,NCT04318015,ClinicalTrials.gov,2020-03-19,2020-04-14,False,"National Institute of Respiratory Diseases, Mexico",Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,400,https://clinicaltrials.gov/show/NCT04318015,None
1750,3169,NCT04318431,ClinicalTrials.gov,2020-03-20,2020-04-14,False,Centre Hospitalier Intercommunal Creteil,Not Recruiting,Not Applicable,Interventional,France,Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children,Clinical Presentation (Epidemiology),No Intervention,No Intervention,605,https://clinicaltrials.gov/show/NCT04318431,None
1751,3170,NCT04318444,ClinicalTrials.gov,2020-03-20,2020-03-29,False,Columbia University,Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1600,https://clinicaltrials.gov/show/NCT04318444,None
1752,3175,NCT04319445,ClinicalTrials.gov,2020-03-20,2020-03-22,False,Wake Forest University,Recruiting,Not Applicable,Interventional,United States,Mindfulness During COVID-19,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04319445,None
1753,3176,NCT04319731,ClinicalTrials.gov,2020-03-22,2020-03-20,True,University of Utah,Recruiting,Phase 1,Interventional,United States,A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure,ATMP,Human Amniotic Fluid,Human Amniotic Fluid,10,https://clinicaltrials.gov/show/NCT04319731,None
1754,3177,NCT04319900,ClinicalTrials.gov,2020-03-20,2020-03-05,False,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2/Phase 3,Interventional,China,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,Drug,Chloroquine + Favipiravir vs. Favipiravir,Chloroquine; favipiravir,150,https://clinicaltrials.gov/show/NCT04319900,ChiCTR2000030987
1755,3179,NCT04320056,ClinicalTrials.gov,2020-03-19,2020-04-20,False,Laval University,Recruiting,Not Applicable,Interventional,Canada,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),Drug,Oxygen,Oxygen,216,https://clinicaltrials.gov/show/NCT04320056,None
1756,3180,NCT04320238,ClinicalTrials.gov,2020-03-21,2020-01-21,True,Shanghai Jiaotong University,Recruiting,Phase 3,Interventional,China,Experimental Trial of rhIFNa Nasal Drops to Prevent 2019-nCOV in Medical Staff,Drug,Interferon Alpha vs. Interferon Alpha + Thymosin Alpha,Interferon alpha; Thymosin alpha,2944,https://clinicaltrials.gov/show/NCT04320238,None
1757,3181,NCT04320277,ClinicalTrials.gov,2020-03-20,2020-05-16,False,Hospital of Prato,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",Drug,Baricitinib,Baricitinib,200,https://clinicaltrials.gov/show/NCT04320277,None
1758,3184,NCT04320615,ClinicalTrials.gov,2020-03-23,2020-04-03,True,Roche,Not Recruiting,Phase 3,Interventional,"Netherlands, Canada, United Kingdom, Italy, France, Germany, Denmark, United States, Spain",A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,450,https://clinicaltrials.gov/show/NCT04320615,EUCTR2020-001154-22
1759,3187,NCT04320953,ClinicalTrials.gov,2020-03-21,2020-03-16,True,Changhai Hospital,Not Recruiting,Not Applicable,Interventional,China,Non-contact Endoscopy at Covid-19 Outbreak,Other (device),Non-contact Endoscopy,Non-contact Endoscopy,5,https://clinicaltrials.gov/show/NCT04320953,None
1760,3188,NCT04321096,ClinicalTrials.gov,2020-03-23,2020-04-04,True,Aarhus University,Recruiting,Phase 1/Phase 2,Interventional,Denmark,The Impact of Camostat Mesilate on COVID-19 Infection,Drug,Camostat Mesilate,Camostat Mesilate,580,https://clinicaltrials.gov/show/NCT04321096,EUCTR2020-001200-42
1761,3189,NCT04321174,ClinicalTrials.gov,2020-03-18,2020-04-17,False,Darrell Tan,Recruiting,Phase 3,Interventional,Canada,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,Drug,Lopinavir/ritonavir,Lopinavir/ritonavir,1220,https://clinicaltrials.gov/show/NCT04321174,None
1762,3191,NCT04321278,ClinicalTrials.gov,2020-03-23,2020-03-28,False,Hospital Israelita Albert Einstein,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; azithromycin,440,https://clinicaltrials.gov/show/NCT04321278,None
1763,3193,NCT04321421,ClinicalTrials.gov,2020-03-23,2020-03-17,True,Foundation IRCCS San Matteo Hospital,Not Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Critical Patients With COVID-19,ATMP,Plasma,Plasma,49,https://clinicaltrials.gov/show/NCT04321421,None
1764,3195,NCT04321928,ClinicalTrials.gov,2020-03-20,2020-04-01,False,University of Pecs,Recruiting,Not Applicable,Interventional,Hungary,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,Other,Health Education,Health Education,7576,https://clinicaltrials.gov/show/NCT04321928,None
1765,3196,NCT04321993,ClinicalTrials.gov,2020-03-24,2020-04-17,False,Lisa Barrett,Recruiting,Phase 2,Interventional,Canada,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. baricitinib vs. sarilumab,lopinavir/ritonavir; hydroxychloroquine; sarilumab,800,https://clinicaltrials.gov/show/NCT04321993,None
1766,3197,NCT04322123,ClinicalTrials.gov,2020-03-24,2020-04-01,True,Hospital do Coração,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; azithromycin,630,https://clinicaltrials.gov/show/NCT04322123,RBR-9d8z6m
1767,3200,NCT04322344,ClinicalTrials.gov,2020-03-23,2020-03-23,False,University of Catanzaro,Recruiting,Phase 2/Phase 3,Interventional,Italy,Escin in Patients With Covid-19 Infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,https://clinicaltrials.gov/show/NCT04322344,None
1768,3201,NCT04322396,ClinicalTrials.gov,2020-03-23,2020-04-06,False,Chronic Obstructive Pulmonary Disease Trial Network,Recruiting,Phase 2,Interventional,Denmark,Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine + Azithromycin,Hydroxychloroquine; azithromycin,226,https://clinicaltrials.gov/show/NCT04322396,None
1769,3204,NCT04322565,ClinicalTrials.gov,2020-03-24,2020-04-20,True,AOU di Parma,Recruiting,Phase 2,Interventional,Italy,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,Drug,Colchicine,Colchicine,310,https://clinicaltrials.gov/show/NCT04322565,EUCTR2020-001258-23
1770,3205,NCT04322682,ClinicalTrials.gov,2020-03-23,2020-03-23,True,Montreal Heart Institute,Recruiting,Phase 3,Interventional,"Canada, South Africa, Brazil, United States, Spain",Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),Drug,Colchicine,Colchicine,6000,https://clinicaltrials.gov/show/NCT04322682,EUCTR2020-001689-12
1771,3206,NCT04322773,ClinicalTrials.gov,2020-03-24,2020-04-05,True,Marius Henriksen,Not Recruiting,Phase 2,Interventional,Denmark,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,Drug,Tocilizumab vs. sarilumab,Tocilizumab; sarilumab,20,https://clinicaltrials.gov/show/NCT04322773,EUCTR2020-001275-32
1772,3208,NCT04323228,ClinicalTrials.gov,2020-03-23,2020-09-01,False,King Saud University,Recruiting,Phase 2/Phase 3,Interventional,Saudi Arabia,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,Supplement,Oral nutrition supplement,Oral nutrition supplement,40,https://clinicaltrials.gov/show/NCT04323228,None
1773,3209,NCT04323332,ClinicalTrials.gov,2020-03-08,2020-03-01,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Not Recruiting,Phase 3,Interventional,China,Traditional Chinese Medicine for Severe COVID-19,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,50,https://clinicaltrials.gov/show/NCT04323332,None
1774,3210,NCT04323345,ClinicalTrials.gov,2020-03-23,2020-04-15,False,Misr University for Science and Technology,Recruiting,Phase 3,Interventional,Egypt,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,https://clinicaltrials.gov/show/NCT04323345,None
1775,3211,NCT04323514,ClinicalTrials.gov,2020-03-18,2020-03-13,True,University of Palermo,Recruiting,Not Applicable,Interventional,Italy,Use of Ascorbic Acid in Patients With COVID 19,Drug,Vitamin C,Vitamin C,500,https://clinicaltrials.gov/show/NCT04323514,None
1776,3213,NCT04323631,ClinicalTrials.gov,2020-03-25,2020-04-30,False,Rambam Health Care Campus,Not Recruiting,Phase 1,Interventional,No Country Given,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04323631,None
1777,3217,NCT04323800,ClinicalTrials.gov,2020-03-24,2020-06-10,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Stem Coronavirus (CSSC-001),ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04323800,None
1778,3221,NCT04324073,ClinicalTrials.gov,2020-03-25,2020-03-27,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2/Phase 3,Interventional,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,Drug,Sarilumab,Sarilumab,239,https://clinicaltrials.gov/show/NCT04324073,EUCTR2020-001246-18
1779,3222,NCT04324190,ClinicalTrials.gov,2020-03-26,2020-04-08,False,Gunther Meinlschmidt,Recruiting,Not Applicable,Interventional,Germany,DIgital Online SuPport for COVID-19 StrEss,Other (psych),Psychological,Psychological,600,https://clinicaltrials.gov/show/NCT04324190,None
1780,3223,NCT04324463,ClinicalTrials.gov,2020-03-25,2020-04-21,False,Population Health Research Institute,Recruiting,Phase 3,Interventional,"Russian Federation, Egypt, Philippines, Pakistan, Chile, Ecuador, Canada, United Arab Emirates, India, Brazil, Saudi Arabia, Colombia",Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,Drug,Chloroquine + azithromycin,Chloroquine; azithromycin,4000,https://clinicaltrials.gov/show/NCT04324463,None
1781,3224,NCT04324489,ClinicalTrials.gov,2020-03-25,2020-03-06,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,DAS181 for Severe COVID-19: Compassionate Use,Drug,DAS181,DAS181,4,https://clinicaltrials.gov/show/NCT04324489,None
1782,3225,NCT04324528,ClinicalTrials.gov,2020-03-25,2020-03-27,True,Dr. Alexander Supady,Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04324528,DRKS00021300
1783,3226,NCT04324606,ClinicalTrials.gov,2020-03-20,2020-04-23,True,University of Oxford,Not Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,A Study of a Candidate COVID-19 Vaccine (COV001),ATMP,Vaccine,Vaccine,1090,https://clinicaltrials.gov/show/NCT04324606,EUCTR2020-001072-15; ISRCTN15281137
1784,3230,NCT04324996,ClinicalTrials.gov,2020-03-25,2020-02-21,True,Chongqing Public Health Medical Center,Recruiting,Phase 1/Phase 2,Interventional,China,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,ATMP,Cells (NK),Cells (NK),90,https://clinicaltrials.gov/show/NCT04324996,None
1785,3232,NCT04325061,ClinicalTrials.gov,2020-03-25,2020-04-03,True,Dr. Negrin University Hospital,Not Recruiting,Phase 4,Interventional,Spain,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,Drug,Corticosteroids,Dexamethasone,200,https://clinicaltrials.gov/show/NCT04325061,EUCTR2020-001278-31
1786,3234,NCT04325633,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,Drug,Naproxen,Naproxen,584,https://clinicaltrials.gov/show/NCT04325633,None
1787,3236,NCT04325672,ClinicalTrials.gov,2020-03-26,2020-04-01,False,Mayo Clinic,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit Coronavirus Associated Complications,ATMP,Plasma,Plasma,0,https://clinicaltrials.gov/show/NCT04325672,None
1788,3237,NCT04325867,ClinicalTrials.gov,2020-03-21,2020-03-31,False,Professor Adrian Covic,Recruiting,Not Applicable,Interventional,Romania,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,Other,Other,Other,200,https://clinicaltrials.gov/show/NCT04325867,None
1789,3238,NCT04325893,ClinicalTrials.gov,2020-03-25,2020-04-01,False,"University Hospital, Angers",Not Recruiting,Phase 3,Interventional,"Monaco, France",Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,259,https://clinicaltrials.gov/show/NCT04325893,None
1790,3239,NCT04325906,ClinicalTrials.gov,2020-03-26,2020-04-02,False,Rush University Medical Center,Recruiting,Not Applicable,Interventional,United States,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,Other (device),Nasal cannula,Nasal cannula,346,https://clinicaltrials.gov/show/NCT04325906,None
1791,3241,NCT04326036,ClinicalTrials.gov,2020-03-26,2020-03-25,True,"Black Tie Medical, Inc.",Recruiting,Phase 1,Interventional,United States,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,ATMP,Stromal Vascular Fraction,Stromal Vascular Fraction,10,https://clinicaltrials.gov/show/NCT04326036,None
1792,3242,NCT04326075,ClinicalTrials.gov,2020-03-26,2020-10-01,False,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Interventional,Italy,Early CPAP in COVID-19 Patients With Respiratory Failure.,Other (physical),Mechanical ventilation,Mechanical ventilation,900,https://clinicaltrials.gov/show/NCT04326075,None
1793,3243,NCT04326114,ClinicalTrials.gov,2020-03-26,2020-07-26,False,Complutense University of Madrid,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,Other (training),Other,Other,240,https://clinicaltrials.gov/show/NCT04326114,None
1794,3246,NCT04326426,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Vanda Pharmaceuticals,Recruiting,Phase 3,Interventional,United States,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,Drug,Tradipitant,Tradipitant,300,https://clinicaltrials.gov/show/NCT04326426,None
1795,3247,NCT04326452,ClinicalTrials.gov,2020-03-25,2020-03-27,False,TMC HealthCare,Recruiting,Not Applicable,Interventional,United States,Treating COVID-19 With a Bidirectional Oxygenation Valve,Other (device),Bidirectional Oxygenation Valve,Bidirectional Oxygenation Valve,30,https://clinicaltrials.gov/show/NCT04326452,None
1796,3249,NCT04326790,ClinicalTrials.gov,2020-03-26,2020-04-03,True,National and Kapodistrian University of Athens,Recruiting,Phase 2,Interventional,Gibraltar,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,Drug,Colchicine,Colchicine,180,https://clinicaltrials.gov/show/NCT04326790,EUCTR2020-001455-40
1797,3251,NCT04327206,ClinicalTrials.gov,2020-03-25,2020-03-30,True,Murdoch Childrens Research Institute,Recruiting,Phase 3,Interventional,"Netherlands, United Kingdom, Australia, Spain",BCG Vaccination to Protect Healthcare Workers Against COVID-19,ATMP,Vaccine,Vaccine,10078,https://clinicaltrials.gov/show/NCT04327206,EUCTR2020-002503-19
1798,3252,NCT04327349,ClinicalTrials.gov,2020-03-24,2020-03-28,True,Mazandaran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04327349,IRCT20181104041551N1
1799,3253,NCT04327388,ClinicalTrials.gov,2020-03-26,2020-03-28,True,Sanofi,Not Recruiting,Phase 3,Interventional,"Russian Federation, Japan, Chile, Canada, Italy, France, Israel, Brazil, Germany, Spain, Argentina",Sarilumab COVID-19,Drug,Sarilumab,Sarilumab,420,https://clinicaltrials.gov/show/NCT04327388,EUCTR2020-001162-12
1800,3254,NCT04327401,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Hospital Sírio-Libanês,Not Recruiting,Phase 3,Interventional,Brazil,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,Drug,Dexamethasone,Dexamethasone,299,https://clinicaltrials.gov/show/NCT04327401,None
1801,3260,NCT04328012,ClinicalTrials.gov,2020-03-27,2020-04-06,False,Bassett Healthcare,Recruiting,Phase 2/Phase 3,Interventional,United States,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. ARB (Losartan),Lopinavir/ritonavir; Hydroxychloroquine; ARB (Losartan),4000,https://clinicaltrials.gov/show/NCT04328012,None
1802,3261,NCT04328129,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Institut Pasteur,Recruiting,Not Applicable,Interventional,"Guadeloupe, New Caledonia, French Guiana",Household Transmission Investigation Study for COVID-19 in Tropical Regions,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1300,https://clinicaltrials.gov/show/NCT04328129,None
1803,3262,NCT04328272,ClinicalTrials.gov,2020-03-25,2020-03-28,False,Dr. Umar Farooq,Not Recruiting,Phase 3,Interventional,Pakistan,Effectiveness of Hydroxychloroquine in Covid-19 Patients,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,75,https://clinicaltrials.gov/show/NCT04328272,None
1804,3263,NCT04328285,ClinicalTrials.gov,2020-03-25,2020-04-14,True,CHU de Saint Etienne,Not Recruiting,Phase 3,Interventional,France,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1200,https://clinicaltrials.gov/show/NCT04328285,EUCTR2020-001188-96
1805,3264,NCT04328441,ClinicalTrials.gov,2020-03-27,2020-03-25,True,UMC Utrecht,Not Recruiting,Phase 3,Interventional,Netherlands,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,ATMP,Vaccine,Vaccine,1500,https://clinicaltrials.gov/show/NCT04328441,None
1806,3266,NCT04328467,ClinicalTrials.gov,2020-03-27,2020-04-06,False,University of Minnesota,Not Recruiting,Phase 3,Interventional,United States,Pre-exposure Prophylaxis for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1500,https://clinicaltrials.gov/show/NCT04328467,None
1807,3267,NCT04328480,ClinicalTrials.gov,2020-03-30,2020-04-17,False,Estudios Clínicos Latino América,Recruiting,Phase 3,Interventional,Argentina,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,Drug,Colchicine,Colchicine,2500,https://clinicaltrials.gov/show/NCT04328480,None
1808,3268,NCT04328493,ClinicalTrials.gov,2020-03-27,2020-04-07,False,University of Oxford,Recruiting,Phase 2,Interventional,Vietnam,The Vietnam Chloroquine Treatment on COVID-19,Drug,Chloroquine,Chloroquine,250,https://clinicaltrials.gov/show/NCT04328493,None
1809,3269,NCT04328961,ClinicalTrials.gov,2020-03-23,2020-03-31,False,University of Washington,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,Hydroxychloroquine; Vitamin C,829,https://clinicaltrials.gov/show/NCT04328961,None
1810,3271,NCT04329533,ClinicalTrials.gov,2020-03-26,2020-04-13,False,University of Arizona,Not Recruiting,Not Applicable,Interventional,United States,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,Other (psych),Psychological,Psychological,101,https://clinicaltrials.gov/show/NCT04329533,None
1811,3274,NCT04329572,ClinicalTrials.gov,2020-03-29,2020-04-23,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,400,https://clinicaltrials.gov/show/NCT04329572,None
1812,3275,NCT04329611,ClinicalTrials.gov,2020-03-29,2020-04-13,False,Dr. Michael Hill,Not Recruiting,Phase 3,Interventional,Canada,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,148,https://clinicaltrials.gov/show/NCT04329611,None
1813,3276,NCT04329650,ClinicalTrials.gov,2020-03-31,2020-04-15,True,Judit Pich Martínez,Recruiting,Phase 2,Interventional,Spain,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,Drug,Siltuximab vs. Corticosteroids,Siltuximab; Methylprednisolone,200,https://clinicaltrials.gov/show/NCT04329650,EUCTR2020-001413-20
1814,3277,NCT04329832,ClinicalTrials.gov,2020-03-30,2020-03-30,False,"Intermountain Health Care, Inc.",Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,Drug,Hydroxychloroquine vs. Azithromycin,Hydroxychloroquine; azithromycin,85,https://clinicaltrials.gov/show/NCT04329832,None
1815,3278,NCT04330144,ClinicalTrials.gov,2020-03-30,2020-04-01,True,Gangnam Severance Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2486,https://clinicaltrials.gov/show/NCT04330144,KCT0004907
1816,3280,NCT04330300,ClinicalTrials.gov,2020-03-30,2020-04-30,False,"National University of Ireland, Galway",Not Recruiting,Phase 4,Interventional,Ireland,Coronavirus (COVID-19) ACEi/ARB Investigation,Drug,ACE inhibitors or ARBs vs. Calcium Channel Blockers or Thiazide/Thiazide-like diuretics ,ACE inhibitors; ARBs; Calcium Channel Blockers; Thiazide/Thiazide-like diuretics ,2414,https://clinicaltrials.gov/show/NCT04330300,None
1817,3281,NCT04330495,ClinicalTrials.gov,2020-03-31,2020-04-06,True,Instituto de Investigacin Marqus de Valdecilla,Not Recruiting,Phase 4,Interventional,No Country Given,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,800,https://clinicaltrials.gov/show/NCT04330495,EUCTR2020-001357-52
1818,3283,NCT04330586,ClinicalTrials.gov,2020-03-31,2020-04-01,True,Korea University Guro Hospital,Recruiting,Phase 2,Interventional,South Korea,A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19,Drug,Ciclesonide + hydroxychloroquine vs. hydroxychloroquine,Ciclesonide; hydroxychloroquine ,94,https://clinicaltrials.gov/show/NCT04330586,KCT0005105 
1819,3285,NCT04331054,ClinicalTrials.gov,2020-03-29,2020-04-13,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Protective Role of Inhaled Steroids for Covid-19 Infection,Drug,Corticosteroids + formoterol,Budesonide; formoterol,436,https://clinicaltrials.gov/show/NCT04331054,EUCTR2020-001306-35
1820,3288,NCT04331366,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Emory University,Not Recruiting,Not Applicable,Interventional,United States,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,Other (device),Bidirectional Oxygenation Valve,Bidirectional Oxygenation Valve,2,https://clinicaltrials.gov/show/NCT04331366,None
1821,3289,NCT04331470,ClinicalTrials.gov,2020-03-30,2020-04-04,True,Fasa University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,Drug,Levamisole + budesonide/formoterol + lopinavir/ritonavir + hydroxychloroquine,Levamisole; budesonide; formoterol; Lopinavir/ritonavir; hydroxychloroquine,30,https://clinicaltrials.gov/show/NCT04331470,IRCT20200324046852N1
1822,3292,NCT04331600,ClinicalTrials.gov,2020-03-30,2020-04-16,True,Wroclaw Medical University,Recruiting,Phase 4,Interventional,Poland,Chloroquine as Antiviral Treatment in Coronavirus Infection 2020,Drug,Chloroquine,Chloroquine,400,https://clinicaltrials.gov/show/NCT04331600,EUCTR2020-001469-35
1823,3293,NCT04331613,ClinicalTrials.gov,2020-02-06,2020-01-27,True,Chinese Academy of Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,ATMP,Cells (IMRC),Cells (IMRC),9,https://clinicaltrials.gov/show/NCT04331613,None
1824,3294,NCT04331665,ClinicalTrials.gov,2020-04-01,2020-04-20,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,Drug,Ruxolitinib,Ruxolitinib,64,https://clinicaltrials.gov/show/NCT04331665,None
1825,3295,NCT04331795,ClinicalTrials.gov,2020-04-01,2020-04-04,False,University of Chicago,Not Recruiting,Phase 2,Interventional,United States,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",Drug,Tocilizumab,Tocilizumab,32,https://clinicaltrials.gov/show/NCT04331795,None
1826,3296,NCT04331808,ClinicalTrials.gov,2020-03-31,2020-03-30,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),Drug,Tocilizumab,Tocilizumab,228,https://clinicaltrials.gov/show/NCT04331808,EUCTR2020-001246-18
1827,3297,NCT04331834,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Barcelona Institute for Global Health,Not Recruiting,Phase 3,Interventional,Spain,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,440,https://clinicaltrials.gov/show/NCT04331834,None
1828,3299,NCT04331899,ClinicalTrials.gov,2020-03-27,2020-04-24,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,Drug,Interferon lambda,Interferon lambda,120,https://clinicaltrials.gov/show/NCT04331899,None
1829,3301,NCT04332081,ClinicalTrials.gov,2020-03-30,2020-04-06,False,NYU Langone Health,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients,Drug,Oxygen,Oxygen,20,https://clinicaltrials.gov/show/NCT04332081,None
1830,3302,NCT04332094,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,Recruiting,Phase 2,Interventional,Spain,"Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19",Drug,Hydroxychloroquine + Azithromycin + Tocilizumab,Hydroxychloroquine; azithromycin; tocilizumab,276,https://clinicaltrials.gov/show/NCT04332094,None
1831,3303,NCT04332380,ClinicalTrials.gov,2020-03-30,2020-05-01,False,Del Rosario University,Not Recruiting,Phase 2,Interventional,Colombia,Convalescent Plasma for Patients With COVID-19: A Pilot Study,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04332380,None
1832,3304,NCT04332666,ClinicalTrials.gov,2020-03-27,2020-09-30,False,Erasme University Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",Drug,Angiotensin (1-7),Angiotensin (1-7),60,https://clinicaltrials.gov/show/NCT04332666,None
1833,3305,NCT04332835,ClinicalTrials.gov,2020-03-31,2020-08-08,False,Del Rosario University,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,"Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study",ATMP (+ Drug),Plasma + Hydroxychloroquine vs. Hydroxychloroquine,Plasma; Hydroxychloroquine,92,https://clinicaltrials.gov/show/NCT04332835,None
1834,3307,NCT04332991,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Massachusetts General Hospital,Not Recruiting,Phase 3,Interventional,United States,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,479,https://clinicaltrials.gov/show/NCT04332991,None
1835,3308,NCT04333225,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Baylor Research Institute,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,228,https://clinicaltrials.gov/show/NCT04333225,None
1836,3309,NCT04333251,ClinicalTrials.gov,2020-03-27,2020-04-01,False,Baylor Research Institute,Not Recruiting,Phase 1,Interventional,No Country Given,Study Testing Convalescent Plasma vs Best Supportive Care,ATMP,Plasma,Plasma,115,https://clinicaltrials.gov/show/NCT04333251,None
1837,3310,NCT04333355,ClinicalTrials.gov,2020-03-31,2020-05-08,False,Hospital San Jose Tec de Monterrey,Recruiting,Phase 1,Interventional,Mexico,Safety in Convalescent Plasma Transfusion to COVID-19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04333355,None
1838,3311,NCT04333407,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Imperial College London,Recruiting,Not Applicable,Interventional,United Kingdom,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,Drug,Aspirin + clopidogrel + rivaroxaban + atorvastatin + omeprazole,Aspirin; clopidogrel; rivaroxaban; atorvastatin; omeprazole,3170,https://clinicaltrials.gov/show/NCT04333407,None
1839,3312,NCT04333550,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Application of Desferal to Treat COVID-19,Drug,Deferoxamine,Deferoxamine,50,https://clinicaltrials.gov/show/NCT04333550,None
1840,3313,NCT04333589,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,Drug,Favipiravir,Favipiravir,210,https://clinicaltrials.gov/show/NCT04333589,None
1841,3314,NCT04333628,ClinicalTrials.gov,2020-04-01,2020-06-01,False,"HaEmek Medical Center, Israel",Not Recruiting,Phase 2/Phase 3,Interventional,Israel,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,Drug,Chloroquine,Chloroquine,5,https://clinicaltrials.gov/show/NCT04333628,None
1842,3315,NCT04333654,ClinicalTrials.gov,2020-04-01,2020-04-12,False,Sanofi,Not Recruiting,Phase 1,Interventional,"Belgium, France, Netherlands, United States",Hydroxychloroquine in Outpatient Adults With COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,8,https://clinicaltrials.gov/show/NCT04333654,None
1843,3317,NCT04333732,ClinicalTrials.gov,2020-03-31,2020-09-04,True,Washington University in St. Louis,Recruiting,Phase 3,Interventional,"Netherlands, Australia, Canada, South Africa, United Kingdom, Zimbabwe, Ireland, Zambia, United States, Uganda, Ghana",CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION,Drug (Chemoprophylaxis),Chloroquine/hydroxychloroquine,Chloroquine; hydroxychloroquine,30000,https://clinicaltrials.gov/show/NCT04333732,ISRCTN99916292
1844,3321,NCT04334005,ClinicalTrials.gov,2020-03-29,2020-04-10,False,University of Granada,Not Recruiting,Not Applicable,Interventional,Spain,Vitamin D on Prevention and Treatment of COVID-19,Drug,Vitamin D,Vitamin D,200,https://clinicaltrials.gov/show/NCT04334005,None
1845,3322,NCT04334044,ClinicalTrials.gov,2020-04-01,2020-04-15,False,Grupo Cooperativo Hemopatías Malignas,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Treatment of SARS Caused by COVID-19 With Ruxolitinib,Drug,Ruxolitinib,Ruxolitinib,20,https://clinicaltrials.gov/show/NCT04334044,None
1846,3323,NCT04334148,ClinicalTrials.gov,2020-04-02,2020-04-22,False,Adrian Hernandez,Not Recruiting,Phase 3,Interventional,United States,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1363,https://clinicaltrials.gov/show/NCT04334148,None
1847,3325,NCT04334265,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,750,https://clinicaltrials.gov/show/NCT04334265,None
1848,3327,NCT04334382,ClinicalTrials.gov,2020-04-02,2020-04-02,False,"Intermountain Health Care, Inc.",Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,Drug,Hydroxychloroquine vs. azithromycin,Hydroxychloroquine; azithromycin,1550,https://clinicaltrials.gov/show/NCT04334382,None
1849,3328,NCT04334434,ClinicalTrials.gov,2020-04-02,2020-08-20,False,Kubra Koce,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04334434,None
1850,3329,NCT04334460,ClinicalTrials.gov,2020-04-02,2020-05-04,False,Blade Therapeutics,Not Recruiting,Phase 2,Interventional,"Brazil, United States",Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,Drug,BLD-2660,BLD-2660,120,https://clinicaltrials.gov/show/NCT04334460,None
1851,3330,NCT04334512,ClinicalTrials.gov,2020-04-02,2020-06-22,False,ProgenaBiome,Recruiting,Phase 2,Interventional,United States,A Study of Quintuple Therapy to Treat COVID-19 Infection,Drug,Hydroxychloroquine + azithromycin + vitamin C + vitamin D + zinc,Hydroxychloroquine; azithromycin; vitamin C; vitamin D; zinc,600,https://clinicaltrials.gov/show/NCT04334512,None
1852,3331,NCT04334629,ClinicalTrials.gov,2020-04-02,2020-05-26,False,King's College London,Recruiting,Phase 4,Interventional,United Kingdom,LIBERATE Trial in COVID-19,Drug,Ibuprofen,Ibuprofen,230,https://clinicaltrials.gov/show/NCT04334629,None
1853,3332,NCT04334850,ClinicalTrials.gov,2020-04-02,2020-04-20,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,Other,Other,Other,194,https://clinicaltrials.gov/show/NCT04334850,EUCTR2020-001324-33
1854,3334,NCT04334928,ClinicalTrials.gov,2020-04-02,2020-04-15,False,Plan Nacional sobre el Sida (PNS),Recruiting,Phase 3,Interventional,Spain,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,Drug,Emtricitabine/tenofovir disoproxil + hydroxychloroquine vs. hydroxychloroquine vs. Emtricitabine/tenofovir disoproxil,Emtricitabine/tenofovir disoproxil; hydroxychloroquine,4000,https://clinicaltrials.gov/show/NCT04334928,None
1855,3335,NCT04334967,ClinicalTrials.gov,2020-04-02,2020-03-30,True,Providence Health & Services,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,Drug,Hydroxychloroquine vs. Vitamin C,Hydroxychloroquine; Vitamin C,13,https://clinicaltrials.gov/show/NCT04334967,None
1856,3336,NCT04334980,ClinicalTrials.gov,2020-03-31,2020-10-01,False,Symvivo Corporation,Recruiting,Phase 1,Interventional,"Australia, Canada, United States","Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",ATMP,Vaccine,Vaccine,12,https://clinicaltrials.gov/show/NCT04334980,None
1857,3338,NCT04335032,ClinicalTrials.gov,2020-04-01,2020-11-09,False,S.L.A. Pharma AG,Not Recruiting,Phase 3,Interventional,No Country Given,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),Drug,Eicosapentaenoic acid,Eicosapentaenoic acid,284,https://clinicaltrials.gov/show/NCT04335032,None
1858,3339,NCT04335071,ClinicalTrials.gov,2020-04-02,2020-04-26,False,"University Hospital, Bern",Not Recruiting,Phase 2,Interventional,Switzerland,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),Drug,Tocilizumab,Tocilizumab,5,https://clinicaltrials.gov/show/NCT04335071,None
1859,3340,NCT04335084,ClinicalTrials.gov,2020-04-02,2020-06-22,False,ProgenaBiome,Recruiting,Phase 2,Interventional,United States,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",Drug,Hydroxychloroquine + vitamin C + vitamin D + zinc,Hydroxychloroquine; vitamin C; vitamin D; zinc,600,https://clinicaltrials.gov/show/NCT04335084,None
1860,3341,NCT04335097,ClinicalTrials.gov,2020-04-01,2020-04-22,False,Lars Wik,Recruiting,Not Applicable,Interventional,Norway,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,Other (device),Biosensors,Biosensors,214,https://clinicaltrials.gov/show/NCT04335097,None
1861,3342,NCT04335123,ClinicalTrials.gov,2020-03-31,2020-04-04,False,University of Kansas Medical Center,Not Recruiting,Phase 1,Interventional,United States,Study of Open Label Losartan in COVID-19,Drug,ARB (Losartan),ARB (Losartan),34,https://clinicaltrials.gov/show/NCT04335123,None
1862,3343,NCT04335136,ClinicalTrials.gov,2020-04-01,2020-04-30,True,Apeiron Biologics,Recruiting,Phase 2,Interventional,"Russian Federation, United Kingdom, United States, Germany, Austria, Denmark",Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,ACE enzyme,200,https://clinicaltrials.gov/show/NCT04335136,EUCTR2020-001172-15
1863,3346,NCT04335201,ClinicalTrials.gov,2020-03-31,2020-04-06,True,IRCCS Ospedale San Raffaele,Not Recruiting,Phase 2,Interventional,No Country Given,Defibrotide in COVID-19 Pneumonia,Drug,Defibrotide,Defibrotide,50,https://clinicaltrials.gov/show/NCT04335201,EUCTR2020-001513-20
1864,3347,NCT04335279,ClinicalTrials.gov,2020-04-01,2020-04-09,False,Lady Davis Institute,Not Recruiting,Not Applicable,Interventional,Canada,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,Other (psych),Psychological,Psychological,172,https://clinicaltrials.gov/show/NCT04335279,None
1865,3348,NCT04335305,ClinicalTrials.gov,2020-03-31,2020-04-09,True,MedSIR,Recruiting,Phase 2,Interventional,Spain,Checkpoint Blockade in COVID-19 Pandemic,Drug,Tocilizumab + Pembrolizumab,Tocilizumab; pembrolizumab,24,https://clinicaltrials.gov/show/NCT04335305,EUCTR2020-001160-28
1866,3352,NCT04335786,ClinicalTrials.gov,2020-04-02,2020-04-17,True,Radboud University,Recruiting,Phase 4,Interventional,Netherlands,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,Drug,Valsartan,Valsartan,651,https://clinicaltrials.gov/show/NCT04335786,EUCTR2020-001320-34
1867,3353,NCT04335851,ClinicalTrials.gov,2020-04-02,2020-04-06,False,Biruni University,Not Recruiting,Not Applicable,Interventional,Turkey,Video-Based Exercises and Well-Being During Social Isolation,Other (exercise),Exercise,Exercise,68,https://clinicaltrials.gov/show/NCT04335851,None
1868,3355,NCT04336254,ClinicalTrials.gov,2020-03-28,2020-04-06,False,Renmin Hospital of Wuhan University,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04336254,None
1869,3356,NCT04336332,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Rutgers University,Recruiting,Phase 2,Interventional,United States,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,Hydroxychloroquine; azithromycin,160,https://clinicaltrials.gov/show/NCT04336332,None
1870,3359,NCT04336410,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Inovio Pharmaceuticals,Not Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",Drug,INO-4800,INO-4800,120,https://clinicaltrials.gov/show/NCT04336410,None
1871,3360,NCT04336462,ClinicalTrials.gov,2020-03-25,2020-02-15,True,Shanghai Asclepius Meditec Inc.,Recruiting,Not Applicable,Interventional,China,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,Drug,Hydrogen + Oxygen vs Oxygen,Hydrogen; oxygen,100,https://clinicaltrials.gov/show/NCT04336462,None
1872,3362,NCT04336748,ClinicalTrials.gov,2020-04-04,2020-04-01,True,Medical University of Vienna,Not Recruiting,Phase 3,Interventional,No Country Given,HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers,Drug,Hydroxychloroquine,Hydroxychloroquine,440,https://clinicaltrials.gov/show/NCT04336748,None
1873,3364,NCT04336774,ClinicalTrials.gov,2020-04-03,2020-07-01,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,CAPTION AI to Minimize Risk of COVID Exposure,Other (software),Other,Other,0,https://clinicaltrials.gov/show/NCT04336774,None
1874,3366,NCT04336904,ClinicalTrials.gov,2020-04-03,2020-03-25,True,Giuliano Rizzardini,Not Recruiting,Phase 3,Interventional,Italy,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,Drug,Favipiravir,Favipiravir,100,https://clinicaltrials.gov/show/NCT04336904,None
1875,3368,NCT04337008,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Renin Angiotensin System - CoronaVirus,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04337008,None
1876,3377,NCT04337541,ClinicalTrials.gov,2020-04-02,2020-04-02,False,"Rigshospitalet, Denmark",Not Recruiting,Not Applicable,Interventional,Denmark,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Other (device),Masks,Masks,6000,https://clinicaltrials.gov/show/NCT04337541,None
1877,3379,NCT04337788,ClinicalTrials.gov,2020-04-03,2020-05-01,False,"University Hospital, Limoges",Not Recruiting,Not Applicable,Interventional,No Country Given,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,Telehealth,Telehealth,Telehealth,200,https://clinicaltrials.gov/show/NCT04337788,None
1878,3380,NCT04337918,ClinicalTrials.gov,2020-04-06,2020-05-08,False,Sanotize Research and Development corp.,Recruiting,Phase 2,Interventional,Canada,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,Drug,Nitric oxide,Nitric oxide,200,https://clinicaltrials.gov/show/NCT04337918,None
1879,3382,NCT04337996,ClinicalTrials.gov,2020-04-01,2020-07-13,False,Tourcoing Hospital,Recruiting,Not Applicable,Interventional,France,Dynamic Evaluation of COVID-19 Diagnostic Tests,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,165,https://clinicaltrials.gov/show/NCT04337996,None
1880,3383,NCT04338009,ClinicalTrials.gov,2020-04-01,2020-03-31,True,University of Pennsylvania,Recruiting,Not Applicable,Interventional,United States,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,152,https://clinicaltrials.gov/show/NCT04338009,None
1881,3384,NCT04338074,ClinicalTrials.gov,2020-04-06,2020-06-01,False,University of Alabama at Birmingham,Recruiting,Phase 2,Interventional,United States,TXA and Corona Virus 2019 (COVID19) in Outpatients,Drug,Tranexamic acid,Tranexamic acid,100,https://clinicaltrials.gov/show/NCT04338074,None
1882,3386,NCT04338126,ClinicalTrials.gov,2020-04-06,2021-09-30,False,University of Alabama at Birmingham,Not Recruiting,Phase 2,Interventional,United States,Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients,Drug,Tranexamic acid,Tranexamic acid,60,https://clinicaltrials.gov/show/NCT04338126,None
1883,3389,NCT04338568,ClinicalTrials.gov,2020-04-04,2020-04-16,False,Hasselt University,Recruiting,Not Applicable,Interventional,Belgium,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04338568,None
1884,3391,NCT04338698,ClinicalTrials.gov,2020-04-04,2020-04-22,False,Shehnoor Azhar,Recruiting,Phase 3,Interventional,Pakistan,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",Drug,"Monotherapy and all Combinations of: Hydroxychloroquine, oseltamivir, and azithromycin",Hydroxychloroquine; osletamivir; azithromycin,500,https://clinicaltrials.gov/show/NCT04338698,None
1885,3392,NCT04338802,ClinicalTrials.gov,2020-04-01,2020-04-02,False,Huilan Zhang,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,Drug,Nintedanib,Nintedanib,96,https://clinicaltrials.gov/show/NCT04338802,None
1886,3393,NCT04338828,ClinicalTrials.gov,2020-04-05,2020-04-18,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,Drug,Nitric oxide,Nitric oxide,260,https://clinicaltrials.gov/show/NCT04338828,None
1887,3394,NCT04338906,ClinicalTrials.gov,2020-04-03,2020-06-01,False,Heinrich-Heine University,Not Recruiting,Phase 4,Interventional,No Country Given,Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19,Drug,Camostat Mesilate + hydroxychloroquine vs. hydroxychloroquine,Camostat Mesilate; hydroxychloroquine,334,https://clinicaltrials.gov/show/NCT04338906,None
1888,3397,NCT04338958,ClinicalTrials.gov,2020-04-07,2020-04-22,True,University of Jena,Recruiting,Phase 2,Interventional,Germany,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,Drug,Ruxolitinib,Ruxolitinib,200,https://clinicaltrials.gov/show/NCT04338958,EUCTR2020-001481-11
1889,3402,NCT04339660,ClinicalTrials.gov,2020-04-02,2020-02-01,True,Puren Hospital Affiliated to Wuhan University of Science and Technology,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04339660,None
1890,3404,NCT04339712,ClinicalTrials.gov,2020-04-01,2020-04-02,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,Drug,Anakinra or Tocilizumab,Anakinra; Tocilizumab,40,https://clinicaltrials.gov/show/NCT04339712,EUCTR2020-001039-29
1891,3406,NCT04339816,ClinicalTrials.gov,2020-04-06,2020-05-13,True,Frantisek Duska,Not Recruiting,Phase 3,Interventional,Czech Republic,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,Hydroxychloroquine; azithromycin,3,https://clinicaltrials.gov/show/NCT04339816,EUCTR2020-001456-18
1892,3408,NCT04340050,ClinicalTrials.gov,2020-04-07,2020-04-10,False,University of Chicago,Not Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04340050,None
1893,3410,NCT04340232,ClinicalTrials.gov,2020-04-03,2020-11-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy of Baricitinib for COVID-19,Drug,Baricitinib,Baricitinib,80,https://clinicaltrials.gov/show/NCT04340232,None
1894,3411,NCT04340349,ClinicalTrials.gov,2020-04-02,2020-05-11,False,Instituto Nacional de Rehabilitacion,Recruiting,Phase 1,Interventional,Mexico,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,Drug (Chemoprophylaxis),Hydroxychloroquine + bromhexine vs. bromhexine,Hydroxychloroquine; bromhexine,140,https://clinicaltrials.gov/show/NCT04340349,None
1895,3412,NCT04340414,ClinicalTrials.gov,2020-03-03,2020-02-20,True,Peking Union Medical College Hospital,Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,Drug,Oxygen,Oxygen,10,https://clinicaltrials.gov/show/NCT04340414,None
1896,3415,NCT04340557,ClinicalTrials.gov,2020-04-06,2020-03-27,True,Sharp HealthCare,Recruiting,Phase 4,Interventional,United States,Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection,Drug,Losartan,Losartan,200,https://clinicaltrials.gov/show/NCT04340557,None
1897,3418,NCT04341038,ClinicalTrials.gov,2020-04-07,2020-04-01,False,Hospital Universitari de Bellvitge,Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,Drug,Tacrolimus + Corticosteroids,Tacrolimus; Methylprednisolone,84,https://clinicaltrials.gov/show/NCT04341038,EUCTR2020-001445-39
1898,3420,NCT04341142,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,550,https://clinicaltrials.gov/show/NCT04341142,None
1899,3422,NCT04341207,ClinicalTrials.gov,2020-04-08,2020-04-03,True,Institut Gustave Roussy,Recruiting,Phase 2,Interventional,France,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,1000,https://clinicaltrials.gov/show/NCT04341207,EUCTR2020-001250-21
1900,3423,NCT04341285,ClinicalTrials.gov,2020-03-30,2020-08-01,False,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Interventional,Germany,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04341285,None
1901,3424,NCT04341389,ClinicalTrials.gov,2020-04-07,2020-04-12,False,"Insitute of Biotechnology, Academy of Military Medical Sciences, PLA of China",Not Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),ATMP,Vaccine,Vaccine,508,https://clinicaltrials.gov/show/NCT04341389,None
1902,3425,NCT04341415,ClinicalTrials.gov,2020-04-07,2020-04-09,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Not Applicable,Interventional,France,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,Procedure,Auricular neuromodulation,Auricular neuromodulation,60,https://clinicaltrials.gov/show/NCT04341415,None
1903,3427,NCT04341493,ClinicalTrials.gov,2020-04-07,2020-04-06,True,Hugo Mendieta Zeron,Recruiting,Phase 4,Interventional,Mexico,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,Drug,Hydroxychloroquine vs. Nitazoxanide,Hydroxychloroquine; nitazoxanide,86,https://clinicaltrials.gov/show/NCT04341493,None
1904,3430,NCT04341584,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,Drug,Anakinra,Anakinra,240,https://clinicaltrials.gov/show/NCT04341584,EUCTR2020-001246-18
1905,3431,NCT04341610,ClinicalTrials.gov,2020-04-07,2020-04-20,False,"Rigshospitalet, Denmark",Not Recruiting,Phase 1/Phase 2,Interventional,Denmark,ASC Therapy for Patients With Severe Respiratory COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),0,https://clinicaltrials.gov/show/NCT04341610,None
1906,3432,NCT04341675,ClinicalTrials.gov,2020-04-05,2020-04-24,False,University of Cincinnati,Recruiting,Phase 2,Interventional,United States,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,Drug,Sirolimus,Sirolimus,30,https://clinicaltrials.gov/show/NCT04341675,None
1907,3433,NCT04341688,ClinicalTrials.gov,2020-04-06,2020-08-01,False,Aga Khan University,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,Drug,Mouthwash,Mouthwash,50,https://clinicaltrials.gov/show/NCT04341688,None
1908,3437,NCT04341870,ClinicalTrials.gov,2020-04-06,2020-04-11,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2/Phase 3,Interventional,France,"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO",Drug,Sarilumab + Azithromycin + Hydroxychloroquine vs. Sarilumab,Sarilumab; azithromycin; hydroxychloroquine,27,https://clinicaltrials.gov/show/NCT04341870,EUCTR2020-001246-18
1909,3438,NCT04341922,ClinicalTrials.gov,2020-04-07,2020-05-09,False,Karolinska Institutet,Not Recruiting,Not Applicable,Interventional,Sweden,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,Other (psych),Psychological,Psychological,670,https://clinicaltrials.gov/show/NCT04341922,None
1910,3439,NCT04341935,ClinicalTrials.gov,2020-04-06,2021-01-30,False,University of Miami,Not Recruiting,Phase 4,Interventional,United States,Effects of DPP4 Inhibition on COVID-19,Drug,Linagliptin,Linagliptin,20,https://clinicaltrials.gov/show/NCT04341935,None
1911,3441,NCT04342156,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Tan Tock Seng Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04342156,None
1912,3442,NCT04342169,ClinicalTrials.gov,2020-04-07,2020-04-04,True,University of Utah,Recruiting,Phase 2,Interventional,United States,University of Utah COVID-19 Hydrochloroquine Trial,Drug,Hydroxychloroquine,Hydroxychloroquine,400,https://clinicaltrials.gov/show/NCT04342169,None
1913,3443,NCT04342182,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Erasmus Medical Center,Not Recruiting,Phase 2/Phase 3,Interventional,Netherlands,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),ATMP,Plasma,Plasma,426,https://clinicaltrials.gov/show/NCT04342182,None
1914,3447,NCT04342650,ClinicalTrials.gov,2020-04-04,2020-04-08,False,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,Not Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,Drug,Chloroquine,Chloroquine,152,https://clinicaltrials.gov/show/NCT04342650,None
1915,3448,NCT04342663,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Washington University in St. Louis,Not Recruiting,Phase 2,Interventional,United States,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",Drug,Fluvoxamine,Fluvoxamine,152,https://clinicaltrials.gov/show/NCT04342663,None
1916,3449,NCT04342689,ClinicalTrials.gov,2020-04-08,2020-06-03,False,Yale University,Recruiting,Phase 3,Interventional,United States,The Role of Resistant Starch in COVID-19 Infection,Supplement,Resistant Potato Starch,Resistant Potato Starch,1500,https://clinicaltrials.gov/show/NCT04342689,None
1917,3451,NCT04342728,ClinicalTrials.gov,2020-04-08,2020-04-08,False,The Cleveland Clinic,Recruiting,Not Applicable,Interventional,United States,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,Drug,Zinc + Vitamin C vs Zinc vs. Vitamin C,Zinc; vitamin C,520,https://clinicaltrials.gov/show/NCT04342728,None
1918,3454,NCT04342897,ClinicalTrials.gov,2020-04-10,2020-04-20,False,Eli Lilly and Company,Not Recruiting,Phase 2,Interventional,United States,A Study of LY3127804 in Participants With COVID-19,Drug,LY3127804,LY3127804,95,https://clinicaltrials.gov/show/NCT04342897,None
1919,3455,NCT04343001,ClinicalTrials.gov,2020-04-08,2020-10-01,False,London School of Hygiene and Tropical Medicine,Not Recruiting,Phase 3,Interventional,"Pakistan, Nigeria",Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,Drug,"Monotherapy and all Combinations of: ARB (Losartan), simvastatin, and aspirin",ARB (Losartan); simvastatin; aspirin,0,https://clinicaltrials.gov/show/NCT04343001,None
1920,3456,NCT04343092,ClinicalTrials.gov,2020-04-05,2020-04-18,False,University of Baghdad,Not Recruiting,Phase 1,Interventional,Iraq,Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management,Drug,Ivermectin + hydroxychloroquine vs. hydroxychloroquine,Ivermectin; hydroxychloroquine,16,https://clinicaltrials.gov/show/NCT04343092,None
1921,3457,NCT04343144,ClinicalTrials.gov,2020-04-09,2020-04-15,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Nivolumab (OptivoÂ®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",Drug,Nivolumab,Nivolumab,92,https://clinicaltrials.gov/show/NCT04343144,EUCTR2020-001246-18
1922,3458,NCT04343183,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Ochsner Health System,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,Drug,Oxygen,Oxygen,48,https://clinicaltrials.gov/show/NCT04343183,None
1923,3459,NCT04343248,ClinicalTrials.gov,2020-04-08,2020-05-12,False,Romark Laboratories L.C.,Recruiting,Phase 3,Interventional,United States,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),Drug (Chemoprophylaxis),Nitazoxanide,Nitazoxanide,800,https://clinicaltrials.gov/show/NCT04343248,None
1924,3460,NCT04343261,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Saint Francis Care,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Treatment of COVID 19,ATMP,Plasma,Plasma,48,https://clinicaltrials.gov/show/NCT04343261,None
1925,3463,NCT04343651,ClinicalTrials.gov,2020-03-31,2020-04-01,False,"CytoDyn, Inc.",Not Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,Drug,Leronlimab,Leronlimab,86,https://clinicaltrials.gov/show/NCT04343651,None
1926,3465,NCT04343690,ClinicalTrials.gov,2020-04-09,2020-03-27,True,Duke University,Not Recruiting,Not Applicable,Interventional,United States,COPING With COVID-19( CWC-19),Other (psych),Psychological,Psychological,0,https://clinicaltrials.gov/show/NCT04343690,None
1927,3466,NCT04343729,ClinicalTrials.gov,2020-04-09,2020-04-18,False,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,Not Recruiting,Phase 2,Interventional,Brazil,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,Drug,Corticosteroids,Methylprednisolone,416,https://clinicaltrials.gov/show/NCT04343729,None
1928,3468,NCT04343768,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Drug,Hydroxychloroquine + Lopinavir/ritonavir + interferon beta 1a vs. hydroxychloroquine + Lopinavir/ritonavir + interferon beta 1b vs. hydroxychloroquine + Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir; interferon beta,60,https://clinicaltrials.gov/show/NCT04343768,None
1929,3470,NCT04343794,ClinicalTrials.gov,2020-02-20,2020-04-01,False,University of Hong Kong,Recruiting,Not Applicable,Interventional,Hong Kong,Using BiovitalsÂ® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,Other (device),Biosensors,Biosensors,200,https://clinicaltrials.gov/show/NCT04343794,None
1930,3472,NCT04343963,ClinicalTrials.gov,2020-04-09,2020-04-04,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Pyridostigmine in Severe SARS-CoV-2 Infection,Drug,Pyridostigmine,Pyridostigmine,436,https://clinicaltrials.gov/show/NCT04343963,None
1931,3473,NCT04343989,ClinicalTrials.gov,2020-04-09,2020-03-31,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,90,https://clinicaltrials.gov/show/NCT04343989,None
1932,3475,NCT04344015,ClinicalTrials.gov,2020-04-09,2020-04-13,False,Thomas Jefferson University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Plasma Collection,ATMP,Plasma,Plasma,2000,https://clinicaltrials.gov/show/NCT04344015,None
1933,3476,NCT04344041,ClinicalTrials.gov,2020-04-09,2020-04-15,True,"University Hospital, Angers",Recruiting,Phase 3,Interventional,France,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),Drug,Vitamin D,Vitamin D,260,https://clinicaltrials.gov/show/NCT04344041,EUCTR2020-001602-34
1934,3477,NCT04344080,ClinicalTrials.gov,2020-04-09,2020-04-01,False,"University Hospital, Hamburg-Eppendorf",Recruiting,Not Applicable,Interventional,Germany,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,Other (device),Cytokine Adsorber,Cytokine Adsorber,24,https://clinicaltrials.gov/show/NCT04344080,DRKS00021199
1935,3478,NCT04344106,ClinicalTrials.gov,2020-04-08,2020-04-01,True,ELHARRAR Xavier,Recruiting,Not Applicable,Interventional,France,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Procedure,Positioning,Positioning,25,https://clinicaltrials.gov/show/NCT04344106,None
1936,3483,NCT04344210,ClinicalTrials.gov,2020-04-07,2020-04-17,False,Federal University of Rio Grande do Sul,Not Recruiting,Not Applicable,Interventional,Brazil,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,Telehealth,Telehealth,Telehealth,149,https://clinicaltrials.gov/show/NCT04344210,None
1937,3484,NCT04344236,ClinicalTrials.gov,2020-04-08,2020-04-09,False,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,Drug,Povidone Iodine,Povidone Iodine,48,https://clinicaltrials.gov/show/NCT04344236,None
1938,3486,NCT04344288,ClinicalTrials.gov,2020-04-10,2020-04-21,True,Hospices Civils de Lyon,Not Recruiting,Phase 2,Interventional,France,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,Drug,Corticosteroids,Prednisone,11,https://clinicaltrials.gov/show/NCT04344288,EUCTR2020-001553-48
1939,3488,NCT04344379,ClinicalTrials.gov,2020-03-27,2020-04-17,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,France,Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus,Drug (Chemoprophylaxis),Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,122,https://clinicaltrials.gov/show/NCT04344379,EUCTR2020-001273-73
1940,3489,NCT04344431,ClinicalTrials.gov,2020-04-09,2020-04-14,False,Direction Centrale du Service de Sant des Armes,Recruiting,Phase 2/Phase 3,Interventional,France,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),Drug,Oxygen,Oxygen,100,https://clinicaltrials.gov/show/NCT04344431,None
1941,3490,NCT04344444,ClinicalTrials.gov,2020-04-10,2020-04-13,False,LCMC Health,Not Recruiting,Phase 3,Interventional,United States,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,600,https://clinicaltrials.gov/show/NCT04344444,None
1942,3491,NCT04344457,ClinicalTrials.gov,2020-04-08,2020-04-16,False,"Perseverance Research Center, LLC",Recruiting,Phase 1/Phase 2,Interventional,United States,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",Drug,Hydroxychloroquine + Indomethacin + Azithromycin,Hydroxychloroquine; Indomethacin; Azithromycin,80,https://clinicaltrials.gov/show/NCT04344457,None
1943,3493,NCT04344535,ClinicalTrials.gov,2020-04-10,2020-04-08,True,Stony Brook University,Recruiting,Phase 1/Phase 2,Interventional,United States,Convalescent Plasma vs. Standard Plasma for COVID-19,ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04344535,None
1944,3494,NCT04344548,ClinicalTrials.gov,2020-04-10,2020-04-13,False,National University of Colombia,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia,ATMP,Cells (NK),Cells (NK),10,https://clinicaltrials.gov/show/NCT04344548,None
1945,3495,NCT04344561,ClinicalTrials.gov,2020-04-10,2020-05-25,False,Johns Hopkins University,Recruiting,Not Applicable,Interventional,United States,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,Procedure,Positioning,Positioning,70,https://clinicaltrials.gov/show/NCT04344561,None
1946,3496,NCT04344600,ClinicalTrials.gov,2020-04-10,2020-05-29,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection,Drug,Interferon lambda,Interferon lambda,164,https://clinicaltrials.gov/show/NCT04344600,None
1947,3497,NCT04344665,ClinicalTrials.gov,2020-04-09,2020-04-23,False,Population Health Research Institute,Not Recruiting,Not Applicable,Interventional,Canada,Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology (PVC-RAM) Trial,Telehealth,Telehealth,Telehealth,905,https://clinicaltrials.gov/show/NCT04344665,None
1948,3498,NCT04344730,ClinicalTrials.gov,2020-04-09,2020-04-10,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,Drug,"Dexamethasone, Oxygen",Dexamethasone; Oxygen,550,https://clinicaltrials.gov/show/NCT04344730,EUCTR2020-001457-43
1949,3499,NCT04344756,ClinicalTrials.gov,2020-04-09,2020-04-20,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Tinzaparin or Heparin,Tinzaparin; Heparin,808,https://clinicaltrials.gov/show/NCT04344756,EUCTR2020-001246-18
1950,3500,NCT04344782,ClinicalTrials.gov,2020-04-09,2020-04-15,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,"Trial Evaluating Efficacy and Safety of Bevacizumab (AvastinÂ®/ZeribevÂ®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Bevacizumab,Bevacizumab,130,https://clinicaltrials.gov/show/NCT04344782,EUCTR2020-001246-18
1951,3505,NCT04344951,ClinicalTrials.gov,2020-04-06,2020-04-06,True,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Recruiting,Phase 2,Interventional,Greece,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Drug,Chloroquine,Chloroquine,60,https://clinicaltrials.gov/show/NCT04344951,EUCTR2020-001345-38
1952,3508,NCT04345276,ClinicalTrials.gov,2020-04-10,2020-03-18,False,Huo-Shen-Shan Hospital,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Danoprevir + Ritonavir,Danoprevir; Ritonavir,10,https://clinicaltrials.gov/show/NCT04345276,ChiCTR2000031734
1953,3509,NCT04345289,ClinicalTrials.gov,2020-04-10,2020-05-01,True,Thomas Benfield,Recruiting,Phase 3,Interventional,Denmark,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Drug (+ ATMP),Plamsa vs. Sarilumab vs. Hydroxychloroquine vs. Baricitinib,Plamsa; Sarilumab; Hydroxychloroquine; Baricitinib,1100,https://clinicaltrials.gov/show/NCT04345289,EUCTR2020-001367-88
1954,3511,NCT04345406,ClinicalTrials.gov,2020-04-11,2020-04-15,False,Tanta University,Not Recruiting,Phase 3,Interventional,Egypt,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,Drug,ACE inhibitors,ACE inhibitors,60,https://clinicaltrials.gov/show/NCT04345406,None
1955,3512,NCT04345445,ClinicalTrials.gov,2020-04-08,2020-04-15,False,University of Malaya,Not Recruiting,Phase 3,Interventional,Malaysia,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,Drug,Tocilizumab vs. Corticosteroids,Tocilizumab; Methylprednisolone,310,https://clinicaltrials.gov/show/NCT04345445,None
1956,3514,NCT04345523,ClinicalTrials.gov,2020-04-02,2020-04-03,False,Cristina Avendaño-Solá,Recruiting,Phase 2,Interventional,Spain,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients,ATMP,Plasma,Plasma,278,https://clinicaltrials.gov/show/NCT04345523,None
1957,3516,NCT04345549,ClinicalTrials.gov,2020-04-10,2020-02-26,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,18,https://clinicaltrials.gov/show/NCT04345549,None
1958,3517,NCT04345601,ClinicalTrials.gov,2020-04-10,2020-12-01,False,Baylor University,Not Recruiting,Phase 1,Interventional,United States,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04345601,None
1959,3518,NCT04345614,ClinicalTrials.gov,2020-04-07,2020-04-08,False,"CalciMedica, Inc.",Recruiting,Phase 2,Interventional,"Puerto Rico, United States",A Study of Auxora in Patients With Severe COVID-19 Pneumonia,Drug,CM4620-Injectable Emulsion,CM4620-Injectable Emulsion,400,https://clinicaltrials.gov/show/NCT04345614,None
1960,3520,NCT04345653,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Hackensack Meridian Health,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,44,https://clinicaltrials.gov/show/NCT04345653,None
1961,3521,NCT04345679,ClinicalTrials.gov,2020-04-11,2020-04-14,False,Orthosera Kft.,Not Recruiting,Phase 1,Interventional,No Country Given,Anti COVID-19 Convalescent Plasma Therapy,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04345679,None
1962,3522,NCT04345692,ClinicalTrials.gov,2020-04-09,2020-03-26,True,Queen's Medical Centre,Not Recruiting,Phase 3,Interventional,United States,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,Drug,Hydroxychloroquine,Hydroxychloroquine,17,https://clinicaltrials.gov/show/NCT04345692,None
1963,3523,NCT04345848,ClinicalTrials.gov,2020-04-07,2020-04-28,False,"University Hospital, Geneva",Recruiting,Phase 3,Interventional,Switzerland,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,Drug,Heparin,Heparin,200,https://clinicaltrials.gov/show/NCT04345848,None
1964,3524,NCT04345861,ClinicalTrials.gov,2020-04-05,2020-04-11,False,"University Hospital, Montpellier",Not Recruiting,Phase 2/Phase 3,Interventional,France,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; azithormycin,7,https://clinicaltrials.gov/show/NCT04345861,None
1965,3525,NCT04345887,ClinicalTrials.gov,2020-04-10,2020-04-21,False,Istanbul University-Cerrahpasa,Not Recruiting,Phase 4,Interventional,Turkey,Spironolactone in Covid-19 Induced ARDS,Drug,Spironolactone,Spironolactone,60,https://clinicaltrials.gov/show/NCT04345887,None
1966,3526,NCT04345991,ClinicalTrials.gov,2020-04-10,2020-04-15,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 2,Interventional,France,"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort",ATMP,Plasma,Plasma,120,https://clinicaltrials.gov/show/NCT04345991,EUCTR2020-001246-18
1967,3527,NCT04346017,ClinicalTrials.gov,2020-04-13,2020-03-20,True,Francis Corazza,Recruiting,Not Applicable,Interventional,Belgium,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04346017,None
1968,3530,NCT04346082,ClinicalTrials.gov,2020-04-07,2020-08-01,False,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Interventional,Hong Kong,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,Other (psych),Psychological,Psychological,30,https://clinicaltrials.gov/show/NCT04346082,None
1969,3532,NCT04346147,ClinicalTrials.gov,2020-04-07,2020-04-13,False,Hospital Universitario de Fuenlabrada,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,Drug,"Lopinavir/ritonavir vs. Imatinib vs. Baricitinib

All in comibination with Hydroxychloroquine ",Hydroxychloroquine; Lopinavir/ritonavir; Imatinib; Baricitinib,165,https://clinicaltrials.gov/show/NCT04346147,None
1970,3538,NCT04346329,ClinicalTrials.gov,2020-04-10,2020-04-20,False,National University of Colombia,Not Recruiting,Phase 3,Interventional,Colombia,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,86,https://clinicaltrials.gov/show/NCT04346329,None
1971,3540,NCT04346355,ClinicalTrials.gov,2020-04-12,2020-03-31,True,Azienda Unita Sanitaria Locale Reggio Emilia,Not Recruiting,Phase 2,Interventional,Italy,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,Drug,Tocilizumab,Tocilizumab,126,https://clinicaltrials.gov/show/NCT04346355,EUCTR2020-001386-37
1972,3541,NCT04346368,ClinicalTrials.gov,2020-03-23,2020-04-01,False,Guangzhou Institute of Respiratory Disease,Not Recruiting,Phase 1/Phase 2,Interventional,China,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04346368,None
1973,3542,NCT04346420,ClinicalTrials.gov,2020-04-08,2020-04-09,False,"University Clinic, UCLouvain",Not Recruiting,Not Applicable,Interventional,Belgium,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,Other (device),Masks,Masks,12,https://clinicaltrials.gov/show/NCT04346420,None
1974,3543,NCT04346446,ClinicalTrials.gov,2020-04-14,2020-04-20,True,"Institute of Liver and Biliary Sciences, India",Not Recruiting,Phase 2,Interventional,India,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,ATMP,Plasma,Plasma,29,https://clinicaltrials.gov/show/NCT04346446,CTRI/2020/04/024706
1975,3544,NCT04346589,ClinicalTrials.gov,2020-04-09,2020-04-15,False,A.O. Ospedale Papa Giovanni XXIII,Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04346589,None
1976,3546,NCT04346615,ClinicalTrials.gov,2020-04-09,2020-04-25,False,"Biohaven Pharmaceuticals, Inc.",Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,Drug,Vazegepant,Vazegepant,120,https://clinicaltrials.gov/show/NCT04346615,None
1977,3547,NCT04346628,ClinicalTrials.gov,2020-04-10,2020-07-12,False,Stanford University,Recruiting,Phase 2,Interventional,United States,Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19,Drug,Favipiravir,Favipiravir,120,https://clinicaltrials.gov/show/NCT04346628,None
1978,3548,NCT04346667,ClinicalTrials.gov,2020-04-13,2020-04-14,False,"Government of Punjab, Specialized Healthcare and Medical Education Department",Recruiting,Phase 4,Interventional,Pakistan,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,Hydroxychloroquine; chloroquine ,400,https://clinicaltrials.gov/show/NCT04346667,None
1979,3549,NCT04346693,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Burnasyan Federal Medical Biophysical Center,Not Recruiting,Phase 3,Interventional,Russian Federation,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,Drug,Dalargin + Hydroxychloroquine + azithromycin + / - tocilizumab vs. Hydroxychloroquine + azithromycin + / - tocilizumab,Dalargin; Hydroxychloroquine; azithromycin; tocilizumab,320,https://clinicaltrials.gov/show/NCT04346693,None
1980,3550,NCT04346797,ClinicalTrials.gov,2020-04-06,2020-04-16,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 2,Interventional,France,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",Drug,Eculizumab,Eculizumab,120,https://clinicaltrials.gov/show/NCT04346797,EUCTR2020-001246-18
1981,3552,NCT04346927,ClinicalTrials.gov,2020-04-13,2020-08-10,False,Yasemin Çırak,Not Recruiting,Not Applicable,Interventional,No Country Given,Telerehabilitation for Patients Diagnosed With Coronavirus,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04346927,None
1982,3553,NCT04346953,ClinicalTrials.gov,2020-04-13,2020-08-20,False,Istinye University,Not Recruiting,Not Applicable,Interventional,No Country Given,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),Other (exercise),Exercise,Exercise,128,https://clinicaltrials.gov/show/NCT04346953,None
1983,3554,NCT04347031,ClinicalTrials.gov,2020-04-07,2020-04-08,False,Burnasyan Federal Medical Biophysical Center,Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19,Drug,"Mefloquine, Hydroxychloroquine, Azithormycin, Tocilizumab",Mefloquine; Hydroxychloroquine; Azithormycin; Tocilizumab,320,https://clinicaltrials.gov/show/NCT04347031,None
1984,3556,NCT04347226,ClinicalTrials.gov,2020-04-02,2020-04-16,False,Matthew Dallos,Recruiting,Phase 2,Interventional,United States,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,Drug,Anti-Interleukin-8,Anti-Interleukin-8,138,https://clinicaltrials.gov/show/NCT04347226,None
1985,3557,NCT04347239,ClinicalTrials.gov,2020-04-13,2020-04-15,False,"CytoDyn, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),Drug,Leronlimab,Leronlimab,390,https://clinicaltrials.gov/show/NCT04347239,None
1986,3560,NCT04347382,ClinicalTrials.gov,2020-04-11,2020-04-30,False,Sohaib Ashraf,Not Recruiting,Phase 3,Interventional,Pakistan,Honey & Nigella Sativa Trial Against COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,313,https://clinicaltrials.gov/show/NCT04347382,None
1987,3563,NCT04347512,ClinicalTrials.gov,2020-04-11,2020-06-02,False,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,No Country Given,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Azithromycin; Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04347512,None
1988,3564,NCT04347538,ClinicalTrials.gov,2020-04-11,2020-05-01,False,Vanderbilt University,Not Recruiting,Not Applicable,Interventional,United States,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,Procedure,Saline Nasal Irrigation,Saline Nasal Irrigation,90,https://clinicaltrials.gov/show/NCT04347538,None
1989,3565,NCT04347681,ClinicalTrials.gov,2020-04-08,2020-04-18,False,King Fahad Specialist Hospital,Recruiting,Phase 2,Interventional,Saudi Arabia,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,ATMP,Plasma,Plasma,575,https://clinicaltrials.gov/show/NCT04347681,None
1990,3571,NCT04347889,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Stony Brook University,Not Recruiting,Phase 2,Interventional,No Country Given,Preventing COVID-19 in Healthcare Workers With HCQ: A RCT,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,Hydroxychloroquine; Vitamin C,0,https://clinicaltrials.gov/show/NCT04347889,None
1991,3572,NCT04347915,ClinicalTrials.gov,2020-04-14,2020-05-06,False,Bukwang Pharmaceutical,Recruiting,Phase 2,Interventional,South Korea,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,Drug,Clevudine vs. Hydroxychloroquine,Clevudine; Hydroxychloroquine,60,https://clinicaltrials.gov/show/NCT04347915,None
1992,3574,NCT04347941,ClinicalTrials.gov,2020-04-08,2020-07-11,False,University College Hospital Galway,Recruiting,Not Applicable,Interventional,Ireland,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,Procedure,Positioning,Positioning,200,https://clinicaltrials.gov/show/NCT04347941,None
1993,3575,NCT04347954,ClinicalTrials.gov,2020-04-13,2020-08-15,False,Stanford University,Recruiting,Phase 1/Phase 2,Interventional,United States,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),Drug,Povidone Iodine,Povidone Iodine,45,https://clinicaltrials.gov/show/NCT04347954,None
1994,3576,NCT04347980,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Centre Chirurgical Marie Lannelongue,Recruiting,Phase 3,Interventional,France,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,Drug,Dexamethasone + Hydroxychloroquine vs. Hydroxychloroquine,Dexamethasone; Hydroxychloroquine,122,https://clinicaltrials.gov/show/NCT04347980,None
1995,3578,NCT04348071,ClinicalTrials.gov,2020-04-13,2020-11-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Ruxolitinib for COVID-19,Drug,Ruxolitinib,Ruxolitinib,80,https://clinicaltrials.gov/show/NCT04348071,None
1996,3581,NCT04348305,ClinicalTrials.gov,2020-04-11,2020-04-17,True,Scandinavian Critical Care Trials Group,Not Recruiting,Phase 3,Interventional,Denmark,Hydrocortisone for COVID-19 and Severe Hypoxia,Drug,Corticosteroids,Hydrocortisone,1000,https://clinicaltrials.gov/show/NCT04348305,EUCTR2020-001395-15
1997,3582,NCT04348370,ClinicalTrials.gov,2020-03-30,2020-04-20,False,Texas A&M University,Recruiting,Phase 4,Interventional,United States,BCG Vaccine for Health Care Workers as Defense Against COVID 19,ATMP,Vaccine,Vaccine,1800,https://clinicaltrials.gov/show/NCT04348370,None
1998,3583,NCT04348383,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Recruiting,Phase 2,Interventional,Spain,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,Drug,Defibrotide,Defibrotide,120,https://clinicaltrials.gov/show/NCT04348383,None
1999,3585,NCT04348409,ClinicalTrials.gov,2020-04-03,2020-05-25,False,Azidus Brasil,Recruiting,Not Applicable,Interventional,Brazil,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,Drug,Nitazoxanide,Nitazoxanide,50,https://clinicaltrials.gov/show/NCT04348409,None
2000,3587,NCT04348435,ClinicalTrials.gov,2020-04-14,2020-05-14,False,Hope Biosciences,Recruiting,Phase 2,Interventional,United States,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04348435,None
2001,3589,NCT04348461,ClinicalTrials.gov,2020-04-10,2020-04-06,True,Instituto de Investigación Sanitaria Fundación Jiménez Díaz,Not Recruiting,Phase 2,Interventional,No Country Given,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04348461,None
2002,3590,NCT04348474,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Hydroxychloroquine + Azithromycin ,Hydroxychloroquine; Azithromycin ,200,https://clinicaltrials.gov/show/NCT04348474,None
2003,3591,NCT04348500,ClinicalTrials.gov,2020-04-13,2020-04-24,False,Cedars-Sinai Medical Center,Not Recruiting,Phase 2,Interventional,United States,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,Drug,Clazakizumab,Clazakizumab,17,https://clinicaltrials.gov/show/NCT04348500,None
2004,3592,NCT04348513,ClinicalTrials.gov,2020-04-09,2020-05-29,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Recruiting,Phase 2,Interventional,Greece,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,Drug,Triiodothyronine,Triiodothyronine,60,https://clinicaltrials.gov/show/NCT04348513,None
2005,3594,NCT04348656,ClinicalTrials.gov,2020-04-13,2020-05-14,False,Hamilton Health Sciences Corporation,Recruiting,Phase 3,Interventional,"Canada, United States",CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),ATMP,Plasma,Plasma,1200,https://clinicaltrials.gov/show/NCT04348656,None
2006,3595,NCT04348695,ClinicalTrials.gov,2020-04-13,2020-04-12,False,Fundación de Investigación HM Hospita​les​,Recruiting,Phase 2,Interventional,Spain,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,Drug,Ruxolitinib + Simvastatin,Ruxolitinib; Simvastatin,94,https://clinicaltrials.gov/show/NCT04348695,EUCTR2020-001405-23
2007,3596,NCT04348877,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Interventional,Egypt,Plasma Rich Antibodies From Recovered Patients From COVID19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04348877,None
2008,3597,NCT04348929,ClinicalTrials.gov,2020-04-10,2020-04-16,False,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Birth Experience During COVID-19 Confinement,Clinical Presentation,No Intervention,No Intervention,927,https://clinicaltrials.gov/show/NCT04348929,None
2009,3599,NCT04349098,ClinicalTrials.gov,2020-04-14,2020-04-17,True,Karyopharm Therapeutics Inc,Recruiting,Phase 2,Interventional,"United Kingdom, France, Israel, United States, Austria, Spain",Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,Drug,Selinexor,Selinexor,230,https://clinicaltrials.gov/show/NCT04349098,EUCTR2020-001411-25
2010,3601,NCT04349228,ClinicalTrials.gov,2020-04-14,2020-04-28,False,Abderrahmane Mami Hospital,Not Recruiting,Phase 3,Interventional,Tunisia,Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04349228,None
2011,3602,NCT04349241,ClinicalTrials.gov,2020-04-13,2020-04-18,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy and Safety of Favipiravir in Management of COVID-19,Drug,Favipiravir,Favipiravir,100,https://clinicaltrials.gov/show/NCT04349241,None
2012,3603,NCT04349371,ClinicalTrials.gov,2020-04-12,2020-04-01,True,Columbia University,Recruiting,Phase 2,Interventional,United States,Saved From COVID-19,Drug (Chemoprophylaxis),Chloroquine,Chloroquine,350,https://clinicaltrials.gov/show/NCT04349371,None
2013,3604,NCT04349410,ClinicalTrials.gov,2020-04-11,2020-04-11,False,The Camelot Foundation,Not Recruiting,Phase 2/Phase 3,Interventional,United States,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,Drug (+ ATMP),Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Doxycycline vs. Hydroxychloroquine + Clindamycin vs. Hydroxychloroquine  + Clindamycin + Primaquine vs. Remdesivir vs. Tocilizumab vs. Corticosteroids vs. Interferon alpha vs. Losartan vs. Plasma,Hydroxychloroquine;  Azithromycin;  Doxycycline; Clindamycin; Primaquine; Remdesivir; Tocilizumab; Corticosteroids; Interferon alpha; Losartan; Plasma,1800,https://clinicaltrials.gov/show/NCT04349410,None
2014,3606,NCT04349592,ClinicalTrials.gov,2020-04-12,2020-04-14,False,Hamad Medical Corporation,Recruiting,Not Applicable,Interventional,Qatar,Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,456,https://clinicaltrials.gov/show/NCT04349592,None
2015,3607,NCT04349618,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Interventional,France,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,Other (physical),Mechanical ventilation,Mechanical ventilation,200,https://clinicaltrials.gov/show/NCT04349618,None
2016,3608,NCT04349631,ClinicalTrials.gov,2020-04-06,2020-04-22,False,Hope Biosciences,Not Recruiting,Phase 2,Interventional,United States,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),56,https://clinicaltrials.gov/show/NCT04349631,None
2017,3610,NCT04350086,ClinicalTrials.gov,2020-04-13,2020-04-20,False,"University Hospital, Limoges",Not Recruiting,Phase 4,Interventional,France,Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,Drug,Dexmedetomidine,Dexmedetomidine,0,https://clinicaltrials.gov/show/NCT04350086,None
2018,3612,NCT04350281,ClinicalTrials.gov,2020-04-13,2020-04-09,True,University of Hong Kong,Not Recruiting,Phase 2,Interventional,Hong Kong,Double Therapy With IFN-beta 1b and Hydroxychloroquine,Drug,Interferon beta + Hydroxychloroquine vs. Hydroxychloroquine,Interferon beta; Hydroxychloroquine,60,https://clinicaltrials.gov/show/NCT04350281,None
2019,3613,NCT04350320,ClinicalTrials.gov,2020-04-14,2020-04-30,False,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Recruiting,Phase 3,Interventional,Spain,Trial to Study the Benefit of Colchicine in Patients With COVID-19,Drug,Colchicine,Colchicine,102,https://clinicaltrials.gov/show/NCT04350320,None
2020,3614,NCT04350450,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Montefiore Medical Center,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04350450,None
2021,3615,NCT04350476,ClinicalTrials.gov,2020-04-14,2020-04-17,False,Vivek Reddy,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Remote Monitoring,Clinical Presentation,No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04350476,None
2022,3616,NCT04350580,ClinicalTrials.gov,2020-04-08,2020-04-11,True,Centre Hospitalier St. Anne,Recruiting,Phase 3,Interventional,France,Polyvalent Immunoglobulin in COVID-19 Related ARds,ATMP,Immunoglobulin,Immunoglobulin,138,https://clinicaltrials.gov/show/NCT04350580,EUCTR2020-001570-30
2023,3617,NCT04350593,ClinicalTrials.gov,2020-04-14,2020-04-22,True,Saint Luke's Health System,Recruiting,Phase 3,Interventional,"Brazil, United States",Dapagliflozin in Respiratory Failure in Patients With COVID-19,Drug,Dapagliflozin,Dapagliflozin,900,https://clinicaltrials.gov/show/NCT04350593,EUCTR2020-001473-79
2024,3618,NCT04350671,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Interferon Beta 1a in Hospitalized COVID-19 Patients,Drug,Interferon beta + Lopinavir/Ritonavir + Hydroxychlroquine vs. Lopinavir/Ritonavir + Hydroxychloroquine,Interferon beta; Lopinavir/Ritonavir; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04350671,None
2025,3619,NCT04350684,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Umifenovir in Hospitalized COVID-19 Patients,Drug,Umifenovir + Interferon beta + Lopinavir/Ritonavir + Hydroxychloroquine vs. Interferon beta + Lopinavir/Ritonavir + Hydroxycholroquine,Umifenovir; Interferon beta; Lopinavir/Ritonavir; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04350684,None
2026,3621,NCT04350723,ClinicalTrials.gov,2020-04-14,2020-06-10,False,St. Joseph's Healthcare Hamilton,Recruiting,Not Applicable,Interventional,"Saudi Arabia, Canada",Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial,Procedure,Positioning,Positioning,350,https://clinicaltrials.gov/show/NCT04350723,None
2027,3622,NCT04350736,ClinicalTrials.gov,2020-04-14,2020-04-23,False,Theravance Biopharma,Not Recruiting,Phase 1,Interventional,United Kingdom,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",Drug,TD-0903,TD-0903,54,https://clinicaltrials.gov/show/NCT04350736,None
2028,3623,NCT04350931,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,ATMP,Vaccine,Vaccine,900,https://clinicaltrials.gov/show/NCT04350931,None
2029,3625,NCT04351152,ClinicalTrials.gov,2020-04-15,2020-04-30,False,"Humanigen, Inc.",Recruiting,Phase 3,Interventional,United States,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19,Drug,Lenzilumab,Lenzilumab,300,https://clinicaltrials.gov/show/NCT04351152,None
2030,3626,NCT04351191,ClinicalTrials.gov,2020-04-14,2020-04-15,False,"Government of Punjab, Specialized Healthcare and Medical Education Department",Recruiting,Phase 4,Interventional,Pakistan,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,Hydroxychloroquine; Chloroquine ,400,https://clinicaltrials.gov/show/NCT04351191,None
2031,3627,NCT04351295,ClinicalTrials.gov,2020-04-15,2020-04-20,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacy of Faviprevir in COVID-19 Treatment,Drug,Favipiravir,Favipiravir,90,https://clinicaltrials.gov/show/NCT04351295,None
2032,3628,NCT04351347,ClinicalTrials.gov,2020-04-15,2020-06-16,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment,Drug,Chloroquine + Nitazoxanide vs. Chloroquine + Ivermectin vs. Chloroquine ,Chloroquine; Nitazoxanide; Ivermectin,300,https://clinicaltrials.gov/show/NCT04351347,None
2033,3629,NCT04351490,ClinicalTrials.gov,2020-04-14,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19,Drug,Zinv + Vitamin D,Zinc; Vitamin D,3140,https://clinicaltrials.gov/show/NCT04351490,None
2034,3631,NCT04351516,ClinicalTrials.gov,2020-04-15,2020-04-21,True,"University Hospital, Tübingen",Not Recruiting,Phase 2/Phase 3,Interventional,Germany,Test and Treat COVID 65plus+,Drug,Hydroxychloroquine,Hydroxychloroquine,350,https://clinicaltrials.gov/show/NCT04351516,EUCTR2020-001482-37
2035,3633,NCT04351542,ClinicalTrials.gov,2020-04-14,2020-03-06,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda for Flu Like Illness During Covid-19 Outbreak,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,32,https://clinicaltrials.gov/show/NCT04351542,None
2036,3635,NCT04351581,ClinicalTrials.gov,2020-04-14,2020-05-18,True,"Copenhagen University Hospital, Gentofte",Recruiting,Not Applicable,Interventional,Denmark,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,215,https://clinicaltrials.gov/show/NCT04351581,EUCTR2020-001544-26
2037,3636,NCT04351620,ClinicalTrials.gov,2020-04-14,2020-04-01,True,University of Chicago,Recruiting,Phase 1,Interventional,United States,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,20,https://clinicaltrials.gov/show/NCT04351620,None
2038,3640,NCT04351724,ClinicalTrials.gov,2020-04-10,2020-04-16,True,Medical University of Vienna,Recruiting,Phase 2/Phase 3,Interventional,Austria,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),Drug,"Chloroquine or Hydroxychloroquine vs. lopinavir/ritonavir

Substudies: Rovaroxaban, Clazakizumab, Candesartan",Chloroquine; Hydroxychloroquine; Lopinavir/Ritonavir; Rovaroxaban; Clazakizumab; Candesartan,500,https://clinicaltrials.gov/show/NCT04351724,EUCTR2020-001302-30
2039,3641,NCT04351763,ClinicalTrials.gov,2020-04-14,2020-04-27,False,Nicolaus Copernicus University,Recruiting,Phase 2/Phase 3,Interventional,Poland,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,Drug,Amiodarone or Verapamil,Amiodarone; Verapamil,804,https://clinicaltrials.gov/show/NCT04351763,None
2040,3642,NCT04351789,ClinicalTrials.gov,2020-04-11,2020-05-01,False,"Copenhagen University Hospital, Hvidovre",Recruiting,Not Applicable,Interventional,Denmark,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,Other (psych),Psychological,Psychological,66,https://clinicaltrials.gov/show/NCT04351789,None
2041,3643,NCT04351906,ClinicalTrials.gov,2020-04-09,2020-05-03,False,University of Giessen,Recruiting,Not Applicable,Interventional,Germany,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,Other (device),ECCO2R,ECCO2R,20,https://clinicaltrials.gov/show/NCT04351906,None
2042,3644,NCT04351919,ClinicalTrials.gov,2020-04-15,2020-05-05,False,Abderrahmane Mami Hospital,Not Recruiting,Phase 4,Interventional,Tunisia,Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+),Drug,Hydroxychloroquein + Azithromycin,Hydroxychloroquine; Azithromycin,0,https://clinicaltrials.gov/show/NCT04351919,None
2043,3645,NCT04352348,ClinicalTrials.gov,2020-03-31,2020-03-31,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,Prognosis,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04352348,None
2044,3646,NCT04352400,ClinicalTrials.gov,2020-04-03,2020-04-01,True,University Hospital Padova,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),Drug,Nafamostat,Nafamostat,256,https://clinicaltrials.gov/show/NCT04352400,None
2045,3647,NCT04352465,ClinicalTrials.gov,2020-04-15,2020-05-01,False,Azidus Brasil,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients,Drug,Methotrexate,Methotrexate,42,https://clinicaltrials.gov/show/NCT04352465,None
2046,3652,NCT04352608,ClinicalTrials.gov,2020-04-14,2020-04-16,False,"Sinovac Research and Development Co., Ltd.",Not Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),ATMP,Vaccine,Vaccine,744,https://clinicaltrials.gov/show/NCT04352608,None
2047,3655,NCT04352751,ClinicalTrials.gov,2020-04-16,2020-05-01,False,Hilton Pharma,Recruiting,Not Applicable,Interventional,Pakistan,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,ATMP,Plasma,Plasma,2000,https://clinicaltrials.gov/show/NCT04352751,None
2048,3657,NCT04352803,ClinicalTrials.gov,2020-04-16,2020-04-01,True,Regeneris Medical,Not Recruiting,Phase 1,Interventional,No Country Given,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04352803,None
2049,3659,NCT04352933,ClinicalTrials.gov,2020-04-07,2020-05-11,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Phase 3,Interventional,United Kingdom,PROLIFIC ChemoprophylaxisTrial (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,https://clinicaltrials.gov/show/NCT04352933,EUCTR2020-001331-26
2050,3660,NCT04352946,ClinicalTrials.gov,2020-04-16,2020-04-24,False,GeoSentinel Foundation,Not Recruiting,Phase 3,Interventional,United States,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,374,https://clinicaltrials.gov/show/NCT04352946,None
2051,3661,NCT04352959,ClinicalTrials.gov,2020-04-15,2020-04-27,False,Claude Bernard University,Recruiting,Not Applicable,Interventional,France,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,Drug,Bêta-cyclodextrin + citrox,Bêta-cyclodextrin; citrox,206,https://clinicaltrials.gov/show/NCT04352959,None
2052,3663,NCT04353037,ClinicalTrials.gov,2020-04-09,2020-04-07,True,UnitedHealth Group,Recruiting,Phase 2,Interventional,United States,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,Drug,Hydroxychloroquine,Hydroxychloroquine,850,https://clinicaltrials.gov/show/NCT04353037,None
2053,3664,NCT04353128,ClinicalTrials.gov,2020-04-16,2020-04-20,False,Instituto de Investigación Hospital Universitario La Paz,Recruiting,Phase 2/Phase 3,Interventional,Spain,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Drug (Chemoprophylaxis),Melatonin,Melatonin,450,https://clinicaltrials.gov/show/NCT04353128,None
2054,3667,NCT04353180,ClinicalTrials.gov,2020-04-10,2020-10-01,False,Kafrelsheikh University,Not Recruiting,Phase 3,Interventional,Egypt,Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 (Randomized),Drug,Isotretinoin,Isotretinoin,1000,https://clinicaltrials.gov/show/NCT04353180,None
2055,3668,NCT04353206,ClinicalTrials.gov,2020-04-16,2020-06-27,False,Noah Merin,Recruiting,Phase 1,Interventional,United States,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04353206,None
2056,3670,NCT04353271,ClinicalTrials.gov,2020-03-25,2020-04-17,False,University of South Alabama,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Trial of Hydroxychloroquine In Covid-19 Kinetics,Drug,Hydroxychloroquine,Hydroxychloroquine,58,https://clinicaltrials.gov/show/NCT04353271,None
2057,3671,NCT04353284,ClinicalTrials.gov,2020-04-16,2020-06-19,False,Yale University,Recruiting,Phase 2,Interventional,United States,Camostat Mesylate in COVID-19 Outpatients,Drug,Camostat Mesilate,Camostat Mesilate,114,https://clinicaltrials.gov/show/NCT04353284,None
2058,3674,NCT04353518,ClinicalTrials.gov,2020-04-16,2020-04-30,False,Cadila Pharnmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,Drug,Mycobacterium,Mycobacterium,4000,https://clinicaltrials.gov/show/NCT04353518,None
2059,3677,NCT04353596,ClinicalTrials.gov,2020-04-14,2020-04-15,True,Medical University Innsbruck,Recruiting,Phase 4,Interventional,"Germany, Austria",Stopping ACE-inhibitors in COVID-19,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,208,https://clinicaltrials.gov/show/NCT04353596,EUCTR2020-001206-35
2060,3679,NCT04353674,ClinicalTrials.gov,2020-04-07,2020-04-28,False,Lawson Health Research Institute,Recruiting,Not Applicable,Interventional,Canada,Modulation of Hyperinflammation in COVID-19,Other (device),Dialysis,Dialysis,40,https://clinicaltrials.gov/show/NCT04353674,None
2061,3680,NCT04354155,ClinicalTrials.gov,2020-04-13,2020-06-02,False,Neil Goldenberg,Recruiting,Phase 2,Interventional,United States,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,Drug,Heparin,Heparin,38,https://clinicaltrials.gov/show/NCT04354155,None
2062,3681,NCT04354259,ClinicalTrials.gov,2020-04-16,2020-05-13,False,"University Health Network, Toronto",Recruiting,Phase 2,Interventional,Canada,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19,Drug,Interferon lambda,Interferon lambda,140,https://clinicaltrials.gov/show/NCT04354259,None
2063,3683,NCT04354389,ClinicalTrials.gov,2020-04-15,2020-07-25,False,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,Italy,DAS181 for STOP COVID-19,Drug,DAS181,DAS181,0,https://clinicaltrials.gov/show/NCT04354389,None
2064,3684,NCT04354428,ClinicalTrials.gov,2020-04-16,2020-04-16,False,University of Washington,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Treatment for COVID-19 in High-Risk Adult Outpatients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine vs. Vitamin C + Folic Acid,Azithromycin; Hydroxychloroquine; Vitamin C; Folic Acid,300,https://clinicaltrials.gov/show/NCT04354428,None
2065,3685,NCT04354441,ClinicalTrials.gov,2020-04-14,2020-05-01,False,Sir Mortimer B. Davis - Jewish General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women,Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04354441,None
2066,3689,NCT04354597,ClinicalTrials.gov,2020-04-09,2020-05-01,False,King Hussein Cancer Center,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients,Drug (Chemoprophylaxis),Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,200,https://clinicaltrials.gov/show/NCT04354597,None
2067,3690,NCT04354610,ClinicalTrials.gov,2020-04-14,2020-04-27,False,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,57,https://clinicaltrials.gov/show/NCT04354610,None
2068,3692,NCT04354714,ClinicalTrials.gov,2020-04-16,2020-06-30,False,Washington University in St. Louis,Not Recruiting,Phase 2,Interventional,United States,Ruxolitinib to Combat COVID-19,Drug,Ruxolitinib,Ruxolitinib,0,https://clinicaltrials.gov/show/NCT04354714,None
2069,3697,NCT04354805,ClinicalTrials.gov,2020-04-17,2020-08-01,False,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Administration of Chlorpromazine as a Treatment for COVID-19,Drug,Chlorpromazine,Chlorpromazine,100,https://clinicaltrials.gov/show/NCT04354805,None
2070,3699,NCT04354831,ClinicalTrials.gov,2020-04-14,2020-05-11,False,Medical College of Wisconsin,Recruiting,Phase 2,Interventional,United States,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,ATMP,Plasma,Plasma,131,https://clinicaltrials.gov/show/NCT04354831,None
2071,3701,NCT04354870,ClinicalTrials.gov,2020-04-16,2020-04-03,True,NYU Langone Health,Not Recruiting,Phase 2,Interventional,United States,COVID-19 PrEP HCW HCQ Study,Drug,Hydroxychloroquine,Hydroxychloroquine,130,https://clinicaltrials.gov/show/NCT04354870,None
2072,3702,NCT04355026,ClinicalTrials.gov,2020-04-15,2020-04-10,True,Celje General Hospital,Recruiting,Phase 4,Interventional,Slovenia,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,Drug,Bromhexine + Hydroxychloroquine vs. Hydroxychloroquine,Bromhexine; Hydroxychloroquine,90,https://clinicaltrials.gov/show/NCT04355026,None
2073,3703,NCT04355052,ClinicalTrials.gov,2020-04-16,2020-04-11,True,Sheba Medical Center,Recruiting,Phase 3,Interventional,Israel,"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus",Drug,Camostat Mesilate + Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Camostat Mesilate; Hydroxychloroquine; Azithromycin,250,https://clinicaltrials.gov/show/NCT04355052,None
2074,3704,NCT04355143,ClinicalTrials.gov,2020-04-14,2020-05-01,False,"University of California, Los Angeles",Recruiting,Phase 2,Interventional,United States,Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19),Drug,Colchicine,Colchicine,150,https://clinicaltrials.gov/show/NCT04355143,None
2075,3705,NCT04355234,ClinicalTrials.gov,2020-04-17,2020-05-04,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",Clinical Presentation (Epidemiology),No Intervention,No Intervention,2200,https://clinicaltrials.gov/show/NCT04355234,None
2076,3706,NCT04355247,ClinicalTrials.gov,2020-04-17,2020-04-14,True,Auxilio Mutuo Cancer Center,Recruiting,Phase 2,Interventional,Puerto Rico,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,Drug (Chemoprophylaxis),Corticosteroids,Methylprednisolone,20,https://clinicaltrials.gov/show/NCT04355247,None
2077,3708,NCT04355351,ClinicalTrials.gov,2020-04-17,2020-05-05,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Study of Immune Response During SARS-CoV-2 Infection - (COVID-19),Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04355351,None
2078,3709,NCT04355429,ClinicalTrials.gov,2020-04-17,2020-05-05,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),Drug,Captopril,Captopril,230,https://clinicaltrials.gov/show/NCT04355429,None
2079,3714,NCT04355533,ClinicalTrials.gov,2020-04-17,2020-07-29,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1920,https://clinicaltrials.gov/show/NCT04355533,None
2080,3717,NCT04355637,ClinicalTrials.gov,2020-04-15,2020-04-21,True,Sara Varea,Recruiting,Phase 4,Interventional,Spain,Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,Drug,Corticosteroids,Budesonide,300,https://clinicaltrials.gov/show/NCT04355637,EUCTR2020-001616-18
2081,3720,NCT04355728,ClinicalTrials.gov,2020-04-13,2020-04-25,False,Camillo Ricordi,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Use of UC-MSCs for COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04355728,None
2082,3722,NCT04355754,ClinicalTrials.gov,2020-04-16,2020-04-15,True,Medical University of Gdańsk,Recruiting,Not Applicable,Interventional,Poland,Ventil Device Usefulness in Mechanically Ventilated ICU Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,40,https://clinicaltrials.gov/show/NCT04355754,None
2083,3726,NCT04355897,ClinicalTrials.gov,2020-04-15,2020-04-28,False,The Christ Hospital,Recruiting,Phase 1,Interventional,United States,CoVID-19 Plasma in Treatment of COVID-19 Patients,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04355897,None
2084,3727,NCT04355936,ClinicalTrials.gov,2020-04-17,2020-05-19,False,Laboratorio Elea,Recruiting,Phase 4,Interventional,Argentina,Telmisartan for Treatment of COVID-19 Patients,Drug,Telmisartan,Telmisartan,400,https://clinicaltrials.gov/show/NCT04355936,None
2085,3732,NCT04356482,ClinicalTrials.gov,2020-04-17,2020-05-20,False,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,Recruiting,Phase 1/Phase 2,Interventional,Mexico,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,ATMP,Plasma,Plasma,90,https://clinicaltrials.gov/show/NCT04356482,None
2086,3733,NCT04356508,ClinicalTrials.gov,2020-04-10,2020-04-14,False,Dr. Gerry Gin Wai Kwok,Not Recruiting,Phase 2,Interventional,No Country Given,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,Drug,Nivolumab,Nivolumab,15,https://clinicaltrials.gov/show/NCT04356508,None
2087,3734,NCT04356534,ClinicalTrials.gov,2020-04-15,2020-04-19,False,Royal College of Surgeons in Ireland - Medical University of Bahrain,Not Recruiting,Not Applicable,Interventional,Bahrain,Convalescent Plasma Trial in COVID -19 Patients,ATMP,Plasma,Plasma,40,https://clinicaltrials.gov/show/NCT04356534,None
2088,3737,NCT04356677,ClinicalTrials.gov,2020-04-20,2020-11-01,False,"Bausch Health Americas, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study to Evaluate the Safety and Efficacy of VIRAZOLEÂ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,Drug,Ribavirin,Ribavirin,50,https://clinicaltrials.gov/show/NCT04356677,None
2089,3738,NCT04356690,ClinicalTrials.gov,2020-04-17,2020-05-08,False,Boston Medical Center,Recruiting,Phase 2,Interventional,United States,Etoposide in Patients With COVID-19 Infection,Drug,Etoposide,Etoposide,64,https://clinicaltrials.gov/show/NCT04356690,None
2090,3739,NCT04356833,ClinicalTrials.gov,2020-04-14,2020-04-22,True,"University College, London",Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Rt-PA for ARDS Due to COVID-19,Drug,Recombinant Tissue-Plasminogen Activator,Recombinant Tissue-Plasminogen Activator,24,https://clinicaltrials.gov/show/NCT04356833,EUCTR2020-001640-26
2091,3741,NCT04356937,ClinicalTrials.gov,2020-04-19,2020-04-20,False,Massachusetts General Hospital,Not Recruiting,Phase 3,Interventional,United States,Efficacy of Tocilizumab on Patients With COVID-19,Drug,Tocilizumab,Tocilizumab,243,https://clinicaltrials.gov/show/NCT04356937,None
2092,3742,NCT04357028,ClinicalTrials.gov,2020-04-19,2020-07-13,False,Kasr El Aini Hospital,Recruiting,Phase 3,Interventional,Egypt,Measles Vaccine in HCW,ATMP,Vaccine,Vaccine,200,https://clinicaltrials.gov/show/NCT04357028,None
2093,3744,NCT04357106,ClinicalTrials.gov,2020-04-14,2020-04-13,True,Centro de Hematologia y Medicina Interna,Recruiting,Phase 2,Interventional,Mexico,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04357106,None
2094,3747,NCT04357327,ClinicalTrials.gov,2020-04-15,2020-04-16,False,Università degli Studi dell'Insubria,Not Recruiting,Not Applicable,Interventional,Italy,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,122,https://clinicaltrials.gov/show/NCT04357327,None
2095,3748,NCT04357340,ClinicalTrials.gov,2020-04-13,2020-04-02,True,Tehran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,40,https://clinicaltrials.gov/show/NCT04357340,None
2096,3749,NCT04357366,ClinicalTrials.gov,2020-04-20,2020-04-15,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),Drug,Anakinra + trimethoprim/sulfamethoxazole,Anakinra; trimethoprim; sulfamethoxazole,500,https://clinicaltrials.gov/show/NCT04357366,EUCTR2020-001466-11
2097,3752,NCT04357444,ClinicalTrials.gov,2020-04-10,2020-10-23,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 2,Interventional,France,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,Drug,ILT101,ILT101,30,https://clinicaltrials.gov/show/NCT04357444,EUCTR2020-001571-32
2098,3753,NCT04357457,ClinicalTrials.gov,2020-04-20,2020-09-03,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,Drug,Almitrine,Almitrine,212,https://clinicaltrials.gov/show/NCT04357457,EUCTR2020-001909-22
2099,3757,NCT04357613,ClinicalTrials.gov,2020-04-20,2020-09-01,False,Versailles Hospital,Not Recruiting,Phase 2,Interventional,France,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,Drug,Imatinib,Imatinib,99,https://clinicaltrials.gov/show/NCT04357613,None
2100,3759,NCT04357730,ClinicalTrials.gov,2020-04-18,2020-05-14,False,Denver Health and Hospital Authority,Recruiting,Phase 2,Interventional,United States,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection,Drug,Alteplase,Alteplase,60,https://clinicaltrials.gov/show/NCT04357730,None
2101,3761,NCT04357782,ClinicalTrials.gov,2020-04-17,2020-04-16,True,Veteran Affairs Medical Center,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,Drug,Vitamin C,Vitamin C,20,https://clinicaltrials.gov/show/NCT04357782,None
2102,3762,NCT04357808,ClinicalTrials.gov,2020-04-14,2020-04-13,True,Maria del Rosario Garcia de Vicuña Pinedo,Not Recruiting,Phase 2,Interventional,Spain,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),Drug,Sarilumab,Sarilumab,30,https://clinicaltrials.gov/show/NCT04357808,EUCTR2020-001634-36
2103,3765,NCT04357860,ClinicalTrials.gov,2020-04-20,2020-04-27,True,Maimonides Biomedical Research Institute of Cordoba,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Sarilumab in Adults With COVID-19,Drug,Sarilumab,Sarilumab,120,https://clinicaltrials.gov/show/NCT04357860,EUCTR2020-001531-27
2104,3768,NCT04357990,ClinicalTrials.gov,2020-04-20,2020-09-04,False,Kerecis Ltd.,Recruiting,Not Applicable,Interventional,Iceland,Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19,Drug,Omega 3,Omega 3,128,https://clinicaltrials.gov/show/NCT04357990,None
2105,3769,NCT04358003,ClinicalTrials.gov,2020-04-20,2020-05-20,False,Marker Therapeutics AG,Recruiting,Not Applicable,Interventional,United States,Plasma Adsorption in Patients With Confirmed COVID-19,Other (device),Plasma Adsorption Cartridge,Plasma Adsorption Cartridge,2000,https://clinicaltrials.gov/show/NCT04358003,None
2106,3772,NCT04358068,ClinicalTrials.gov,2020-04-20,2020-05-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,20,https://clinicaltrials.gov/show/NCT04358068,None
2107,3773,NCT04358081,ClinicalTrials.gov,2020-04-08,2020-05-01,False,Novartis Pharmaceuticals,Not Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Azithromycin; Hydroxychloroquine,20,https://clinicaltrials.gov/show/NCT04358081,None
2108,3776,NCT04358406,ClinicalTrials.gov,2020-04-16,2020-07-30,False,BioAegis Therapeutics Inc.,Recruiting,Phase 2,Interventional,Spain,Rhu-pGSN for Severe Covid-19 Pneumonia,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04358406,None
2109,3779,NCT04358549,ClinicalTrials.gov,2020-04-16,2020-04-17,False,"Fujifilm Pharmaceuticals U.S.A., Inc.",Not Recruiting,Phase 2,Interventional,United States,Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19,Drug,Favipiravir,Favipiravir,50,https://clinicaltrials.gov/show/NCT04358549,None
2110,3781,NCT04358614,ClinicalTrials.gov,2020-04-19,2020-03-16,True,Fabrizio Cantini,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Baricitinib Therapy in COVID-19,Drug,Baricitinib,Baricitinib,12,https://clinicaltrials.gov/show/NCT04358614,None
2111,3784,NCT04358783,ClinicalTrials.gov,2020-04-21,2020-04-27,False,Hospital Universitario Dr. Jose E. Gonzalez,Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04358783,None
2112,3785,NCT04358809,ClinicalTrials.gov,2020-04-21,2020-04-30,False,Cadila Pharnmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",Drug,Mycobacterium,Mycobacterium,480,https://clinicaltrials.gov/show/NCT04358809,None
2113,3786,NCT04358835,ClinicalTrials.gov,2020-04-16,2020-09-01,False,Johns Hopkins University,Not Recruiting,Not Applicable,Interventional,No Country Given,Keto-diet for Intubated Critical Care COVID-19,Other (nutrition),Nutrition,Nutrition,0,https://clinicaltrials.gov/show/NCT04358835,None
2114,3787,NCT04358926,ClinicalTrials.gov,2020-04-21,2020-04-30,False,Assaf-Harofeh Medical Center,Not Recruiting,Not Applicable,Interventional,Israel,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04358926,None
2115,3788,NCT04358939,ClinicalTrials.gov,2020-04-16,2020-04-27,False,CHU de Tours,Recruiting,Not Applicable,Interventional,France,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),Procedure,Positioning,Positioning,404,https://clinicaltrials.gov/show/NCT04358939,None
2116,3790,NCT04359095,ClinicalTrials.gov,2020-04-15,2020-08-18,False,National University of Colombia,Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Lopinavir/Ritonavir vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin; Lopinavir/Ritonavir,1200,https://clinicaltrials.gov/show/NCT04359095,None
2117,3793,NCT04359225,ClinicalTrials.gov,2020-04-16,2020-06-30,False,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Comparison of 3D and 2D Telemedicine During Covid 19,Telehealth,Telehealth,Telehealth,80,https://clinicaltrials.gov/show/NCT04359225,None
2118,3794,NCT04359251,ClinicalTrials.gov,2020-04-13,2020-03-05,True,"Southeast University, China",Not Recruiting,Not Applicable,Interventional,China,Different PEEP Settings of COVID-19 Induced ARDS,Other (physical),Mechanical ventilation,Mechanical ventilation,20,https://clinicaltrials.gov/show/NCT04359251,None
2119,3795,NCT04359264,ClinicalTrials.gov,2020-04-16,2020-04-20,False,"St. Michael's Hospital, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial,Other,Other,Other,392,https://clinicaltrials.gov/show/NCT04359264,None
2120,3796,NCT04359277,ClinicalTrials.gov,2020-04-20,2020-04-21,False,NYU Langone Health,Not Recruiting,Phase 3,Interventional,United States,A Randomized Trial of Anticoagulation Strategies in COVID-19,Drug,"Enoxaparin, Heparin",Enoxaparin; Heparin,77,https://clinicaltrials.gov/show/NCT04359277,None
2121,3797,NCT04359290,ClinicalTrials.gov,2020-04-15,2020-07-01,False,Philipps University Marburg Medical Center,Not Recruiting,Phase 2,Interventional,Germany,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,Drug,Ruxolitinib,Ruxolitinib,15,https://clinicaltrials.gov/show/NCT04359290,None
2122,3798,NCT04359303,ClinicalTrials.gov,2020-04-09,2020-07-01,False,Javier Hidalgo Tallón,Not Recruiting,Phase 3,Interventional,Spain,Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients,Drug,Ozone,Ozone,50,https://clinicaltrials.gov/show/NCT04359303,None
2123,3799,NCT04359316,ClinicalTrials.gov,2020-04-18,2020-04-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,Azithromycin in Hospitalized COVID-19 Patients,Drug,Azithromycin vs. Hydroxychloroquine,Azithromycin; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04359316,None
2124,3800,NCT04359329,ClinicalTrials.gov,2020-04-21,2020-04-20,True,Sharon Nachman,Recruiting,Phase 2,Interventional,United States,Estrogen Patch for COVID-19 Symptoms,Drug,Estradiol,Estradiol,110,https://clinicaltrials.gov/show/NCT04359329,None
2125,3803,NCT04359511,ClinicalTrials.gov,2020-04-20,2020-06-01,False,CHU de Tours,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Drug,Corticosteroids,Prednisone; Hydrocortisone,210,https://clinicaltrials.gov/show/NCT04359511,None
2126,3804,NCT04359537,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Shaheed Zulfiqar Ali Bhutto Medical University,Recruiting,Phase 2,Interventional,Pakistan,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,200,https://clinicaltrials.gov/show/NCT04359537,None
2127,3806,NCT04359615,ClinicalTrials.gov,2020-04-18,2020-04-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,Favipiravir in Hospitalized COVID-19 Patients,Drug,Favipiravir + Hydroxychloroquine vs. Hydroxychloroquine,Favipiravir; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04359615,None
2128,3807,NCT04359654,ClinicalTrials.gov,2020-04-21,2020-06-16,False,"University College, London",Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Dornase Alfa for Treatment of COVID-19,Drug,Dornase alfa,Dornase alfa,50,https://clinicaltrials.gov/show/NCT04359654,None
2129,3809,NCT04359680,ClinicalTrials.gov,2020-04-20,2020-05-13,False,Romark Laboratories L.C.,Recruiting,Phase 3,Interventional,United States,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection,Drug (Chemoprophylaxis),Nitazoxanide,Nitazoxanide,4000,https://clinicaltrials.gov/show/NCT04359680,None
2130,3812,NCT04359810,ClinicalTrials.gov,2020-04-21,2020-04-21,False,Max R. O'Donnell,Recruiting,Phase 2,Interventional,"Brazil, United States",Plasma Therapy of COVID-19 in Severely Ill Patients,ATMP,Plasma,Plasma,219,https://clinicaltrials.gov/show/NCT04359810,None
2131,3815,NCT04359862,ClinicalTrials.gov,2020-04-21,2020-04-16,True,Fundación para la Investigación del Hospital Clínico de la Comunidad Valenciana (INCLIVA),Recruiting,Phase 4,Interventional,Spain,Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection,Drug,Sevoflurane vs. Propofol,Sevoflurane; Propofol,50,https://clinicaltrials.gov/show/NCT04359862,None
2132,3816,NCT04359875,ClinicalTrials.gov,2020-04-18,2020-04-01,True,CHU de Tours,Not Recruiting,Not Applicable,Interventional,France,A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment,Telehealth,Telehealth,Telehealth,22000,https://clinicaltrials.gov/show/NCT04359875,None
2133,3817,NCT04359901,ClinicalTrials.gov,2020-04-20,2020-04-10,True,Westyn Branch-Elliman,Recruiting,Phase 2,Interventional,United States,Sarilumab for Patients With Moderate COVID-19 Disease,Drug,Sarilumab,Sarilumab,120,https://clinicaltrials.gov/show/NCT04359901,None
2134,3820,NCT04359953,ClinicalTrials.gov,2020-04-17,2020-04-25,True,"University Hospital, Strasbourg",Recruiting,Phase 3,Interventional,France,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",Drug,Hydroxychloroquine + Telmisartan + Azithromycin,Hydroxychloroquine; Telmisartan; Azithromycin,1600,https://clinicaltrials.gov/show/NCT04359953,EUCTR2020-001303-16
2135,3822,NCT04360122,ClinicalTrials.gov,2020-04-15,2020-05-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,Drug (Chemoprophylaxis),Levamisole + Isoprinosine vs. Levamisole vs. Isoprinosine,Levamisole; Isoprinosine,100,https://clinicaltrials.gov/show/NCT04360122,None
2136,3824,NCT04360356,ClinicalTrials.gov,2020-04-19,2020-05-01,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,Drug,Ivermectin + Nitazoxanide,Ivermectin; Nitazoxanide,100,https://clinicaltrials.gov/show/NCT04360356,None
2137,3827,NCT04360551,ClinicalTrials.gov,2020-04-21,2020-07-01,False,University of Hawaii,Recruiting,Phase 2,Interventional,United States,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,Drug,Telmisartan,Telmisartan,40,https://clinicaltrials.gov/show/NCT04360551,None
2138,3830,NCT04360759,ClinicalTrials.gov,2020-04-22,2020-05-01,False,University of Cape Town,Not Recruiting,Phase 3,Interventional,South Africa,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,Drug,Chloroquine or hydroxychloroquine,Chloroquine; hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04360759,None
2139,3831,NCT04360811,ClinicalTrials.gov,2020-04-22,2020-04-17,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,3600,https://clinicaltrials.gov/show/NCT04360811,None
2140,3832,NCT04360824,ClinicalTrials.gov,2020-04-13,2020-05-06,False,University of Iowa,Recruiting,Phase 4,Interventional,United States,Covid-19 Associated Coagulopathy,Drug,Enoxaparin,Enoxaparin,170,https://clinicaltrials.gov/show/NCT04360824,None
2141,3833,NCT04360837,ClinicalTrials.gov,2020-04-22,2020-05-06,False,Szeged University,Recruiting,Not Applicable,Interventional,Hungary,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04360837,None
2142,3836,NCT04360876,ClinicalTrials.gov,2020-04-22,2020-09-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2,Interventional,No Country Given,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial,Drug,Corticosteroids,Dexamethasone,0,https://clinicaltrials.gov/show/NCT04360876,None
2143,3838,NCT04360980,ClinicalTrials.gov,2020-04-22,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,Drug,Colchicine,Colchicine,80,https://clinicaltrials.gov/show/NCT04360980,None
2144,3840,NCT04361032,ClinicalTrials.gov,2020-04-22,2020-09-04,False,Abderrahmane Mami Hospital,Not Recruiting,Phase 3,Interventional,Tunisia,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia",Drug,Tocilizumab,Tocilizumab,260,https://clinicaltrials.gov/show/NCT04361032,None
2145,3842,NCT04361214,ClinicalTrials.gov,2020-04-22,2020-05-05,False,University of Chicago,Recruiting,Phase 1,Interventional,United States,Leflunomide in Mild COVID-19 Patients,Drug,Leflunomide,Leflunomide,20,https://clinicaltrials.gov/show/NCT04361214,None
2146,3843,NCT04361253,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Brigham and Women's Hospital,Recruiting,Phase 3,Interventional,United States,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,ATMP,Plasma,Plasma,220,https://clinicaltrials.gov/show/NCT04361253,None
2147,3844,NCT04361318,ClinicalTrials.gov,2020-04-18,2020-05-01,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,Drug,Hydroxychloroquine + Nitazoxanide,Hydroxychloroquine; Nitazoxanide,100,https://clinicaltrials.gov/show/NCT04361318,None
2148,3845,NCT04361344,ClinicalTrials.gov,2020-04-16,2020-05-19,False,Centre Hospitalier de Pau,Recruiting,Not Applicable,Interventional,France,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04361344,None
2149,3846,NCT04361422,ClinicalTrials.gov,2020-04-21,2020-12-01,False,Tanta University,Not Recruiting,Phase 3,Interventional,No Country Given,Isotretinoin in Treatment of COVID-19,Drug,Isotretinoin,Isotretinoin,300,https://clinicaltrials.gov/show/NCT04361422,None
2150,3847,NCT04361435,ClinicalTrials.gov,2020-04-12,2020-05-01,False,St. Justine's Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Lung Recruitment Device for COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,50,https://clinicaltrials.gov/show/NCT04361435,None
2151,3848,NCT04361448,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Jessa Hospital,Not Recruiting,Not Applicable,Interventional,Belgium,Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04361448,None
2152,3849,NCT04361461,ClinicalTrials.gov,2020-04-22,2020-04-30,False,Apsen Farmaceutica S.A.,Not Recruiting,Phase 3,Interventional,Brazil,Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19),Drug,Hydroxychloroquine + Azythromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithormycin,0,https://clinicaltrials.gov/show/NCT04361461,None
2153,3850,NCT04361474,ClinicalTrials.gov,2020-04-22,2020-05-18,True,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Phase 3,Interventional,France,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,Drug,Corticosteroids,Budesonide,120,https://clinicaltrials.gov/show/NCT04361474,EUCTR2020-001667-85
2154,3852,NCT04361526,ClinicalTrials.gov,2020-04-21,2020-04-17,True,Manuel Castella,Recruiting,Not Applicable,Interventional,Spain,Pilot Study on Cytokine Filtration in COVID-19 ARDS,Other (device),Cytokine Adsorber,Cytokine Adsorber,40,https://clinicaltrials.gov/show/NCT04361526,None
2155,3853,NCT04361552,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Emory University,Not Recruiting,Phase 3,Interventional,United States,Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection),Drug,Tocilizumab,Tocilizumab,0,https://clinicaltrials.gov/show/NCT04361552,None
2156,3857,NCT04361643,ClinicalTrials.gov,2020-04-23,2020-10-27,False,Hospital Universitario Getafe,Not Recruiting,Phase 4,Interventional,Spain,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,Drug,Lenalidomide,Lenalidomide,120,https://clinicaltrials.gov/show/NCT04361643,None
2157,3859,NCT04361838,ClinicalTrials.gov,2020-04-16,2020-06-01,False,Kansas City Heart Rhythm Institute,Recruiting,Not Applicable,Interventional,United States,The COVID-19 ICU PRAYER Study,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04361838,None
2158,3862,NCT04361916,ClinicalTrials.gov,2020-04-14,2020-04-21,False,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Interventional,Italy,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),Other,Other,Other,37,https://clinicaltrials.gov/show/NCT04361916,None
2159,3863,NCT04361942,ClinicalTrials.gov,2020-04-17,2020-05-01,True,Red de Terapia Celular,Recruiting,Phase 2,Interventional,Spain,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04361942,EUCTR2020-001682-36
2160,3865,NCT04362059,ClinicalTrials.gov,2020-04-20,2020-06-18,True,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,Drug,Bovactant,Bovactant,24,https://clinicaltrials.gov/show/NCT04362059,EUCTR2020-001886-35
2161,3867,NCT04362085,ClinicalTrials.gov,2020-04-20,2020-05-11,False,"St. Michael's Hospital, Toronto",Recruiting,Phase 3,Interventional,Canada,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,Drug,Heparin,Heparin,462,https://clinicaltrials.gov/show/NCT04362085,None
2162,3868,NCT04362111,ClinicalTrials.gov,2020-04-21,2020-07-29,False,University of Alabama at Birmingham,Recruiting,Phase 3,Interventional,United States,Early Treatment of Cytokine Storm Syndrome in Covid-19,Drug,Anakinra,Anakinra,30,https://clinicaltrials.gov/show/NCT04362111,None
2163,3869,NCT04362124,ClinicalTrials.gov,2020-04-21,2020-08-01,False,University of Antioquia,Not Recruiting,Phase 3,Interventional,Colombia,Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.,ATMP,Vaccine,Vaccine,0,https://clinicaltrials.gov/show/NCT04362124,None
2164,3871,NCT04362189,ClinicalTrials.gov,2020-04-21,2020-06-30,False,Hope Biosciences,Not Recruiting,Phase 2,Interventional,United States,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04362189,None
2165,3874,NCT04362332,ClinicalTrials.gov,2020-04-20,2020-04-14,True,UMC Utrecht,Not Recruiting,Phase 4,Interventional,Netherlands,"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19",Drug,Chloroquine vs. hydroxychloroquine,Chloroquine; hydroxychloroquine,25,https://clinicaltrials.gov/show/NCT04362332,None
2166,3876,NCT04362358,ClinicalTrials.gov,2020-04-21,2020-05-01,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Interventional,No Country Given,Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic,Other (psych),Psychological,Psychological,120,https://clinicaltrials.gov/show/NCT04362358,None
2167,3885,NCT04363060,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Nantes University Hospital,Not Recruiting,Phase 3,Interventional,France,Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit,Drug,Azithromycin + Amoxicillin/Clavulanate vs. Amoxicillin/Clavulanate,Azithromycin; Amoxicillin/Clavulanate,104,https://clinicaltrials.gov/show/NCT04363060,None
2168,3887,NCT04363177,ClinicalTrials.gov,2020-04-21,2020-11-01,False,Karolinska Institutet,Not Recruiting,Not Applicable,Interventional,"Sweden, Hong Kong, China",Global Mental Health of Urban Mothers,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04363177,None
2169,3888,NCT04363203,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Dr. Salomeh Keyhani,Not Recruiting,Phase 3,Interventional,United States,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),Drug,Hydroxychloroquine vs. Azithromycin,Hydroxychloroquine; Azithromycin,300,https://clinicaltrials.gov/show/NCT04363203,None
2170,3889,NCT04363216,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Thomas Jefferson University,Not Recruiting,Phase 2,Interventional,No Country Given,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,Drug,Vitamin C,Vitamin C,66,https://clinicaltrials.gov/show/NCT04363216,None
2171,3893,NCT04363346,ClinicalTrials.gov,2020-04-23,2020-05-14,False,University of Minnesota,Recruiting,Phase 1,Interventional,United States,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,Drug,FT516,FT516,12,https://clinicaltrials.gov/show/NCT04363346,None
2172,3894,NCT04363372,ClinicalTrials.gov,2020-04-24,2020-06-01,False,4D Pharma,Recruiting,Phase 2,Interventional,United Kingdom,A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19,Drug,MRx-4DP0004,MRx-4DP0004,90,https://clinicaltrials.gov/show/NCT04363372,None
2173,3895,NCT04363385,ClinicalTrials.gov,2020-04-21,2020-05-31,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Interventional,France,Collection of Biological Samples With Clinical Characterization of Covid-19 Patients,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04363385,None
2174,3896,NCT04363437,ClinicalTrials.gov,2020-04-23,2020-04-26,False,Maimonides Medical Center,Recruiting,Phase 2,Interventional,United States,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,Drug,Colchicine,Colchicine,70,https://clinicaltrials.gov/show/NCT04363437,None
2175,3897,NCT04363450,ClinicalTrials.gov,2020-04-23,2020-04-27,False,Louisiana State University Health Sciences Center in New Orleans,Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1700,https://clinicaltrials.gov/show/NCT04363450,None
2176,3898,NCT04363463,ClinicalTrials.gov,2020-04-22,2020-08-28,False,Centre Hospitalier Régional d'Orleans,Recruiting,Not Applicable,Interventional,France,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,Procedure,Positioning,Positioning,400,https://clinicaltrials.gov/show/NCT04363463,None
2177,3900,NCT04363502,ClinicalTrials.gov,2020-04-23,2020-05-07,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,30,https://clinicaltrials.gov/show/NCT04363502,None
2178,3901,NCT04363528,ClinicalTrials.gov,2020-04-23,2020-04-24,False,Versailles Hospital,Recruiting,Not Applicable,Interventional,France,Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04363528,None
2179,3902,NCT04363541,ClinicalTrials.gov,2020-04-23,2020-08-27,False,Instituto Nacional de Perinatología,Recruiting,Not Applicable,Interventional,Mexico,Local Thermotherapy for Patients With Mild-to-moderate COVID-19,Other (device),Heating pad,Heating pad,274,https://clinicaltrials.gov/show/NCT04363541,None
2180,3903,NCT04363606,ClinicalTrials.gov,2020-04-24,2020-05-27,False,CHU de Saint Etienne,Recruiting,Not Applicable,Interventional,France,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,Clinical Presentation,No Intervention,No Intervention,82,https://clinicaltrials.gov/show/NCT04363606,None
2181,3905,NCT04363736,ClinicalTrials.gov,2020-04-21,2020-05-05,False,Roche,Not Recruiting,Phase 2,Interventional,United States,A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,100,https://clinicaltrials.gov/show/NCT04363736,None
2182,3906,NCT04363749,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities,Other,Other,Other,30,https://clinicaltrials.gov/show/NCT04363749,None
2183,3908,NCT04363814,ClinicalTrials.gov,2020-04-19,2020-06-10,False,Inmunotek S.L.,Recruiting,Phase 3,Interventional,Dominican Republic,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Drug,Bactek-R,Bactek-R,100,https://clinicaltrials.gov/show/NCT04363814,None
2184,3909,NCT04363827,ClinicalTrials.gov,2020-04-24,2020-05-14,False,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Recruiting,Phase 2,Interventional,Italy,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),Drug (+ Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2300,https://clinicaltrials.gov/show/NCT04363827,None
2185,3910,NCT04363840,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Louisiana State University Health Sciences Center in New Orleans,Not Recruiting,Phase 2,Interventional,No Country Given,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",Drug,Aspirin + Vitamin D vs. Aspirin,Aspirin; Vitamin D,1080,https://clinicaltrials.gov/show/NCT04363840,None
2186,3911,NCT04363853,ClinicalTrials.gov,2020-04-17,2020-06-01,False,Instituto Nacional de Cancerología,Not Recruiting,Phase 2,Interventional,Mexico,Tocilizumab Treatment in Patients With COVID-19,Drug,Tocilizumab,Tocilizumab,200,https://clinicaltrials.gov/show/NCT04363853,None
2187,3912,NCT04363866,ClinicalTrials.gov,2020-04-24,2020-08-01,False,Oregon Health and Science University,Not Recruiting,Phase 2,Interventional,United States,Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19),Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04363866,None
2188,3913,NCT04364009,ClinicalTrials.gov,2020-04-17,2020-04-27,True,CHU de Tours,Not Recruiting,Phase 3,Interventional,France,Anakinra for COVID-19 Respiratory Symptoms,Drug,Anakinra,Anakinra,71,https://clinicaltrials.gov/show/NCT04364009,EUCTR2020-001734-36
2189,3914,NCT04364022,ClinicalTrials.gov,2020-04-23,2020-04-23,False,Calmy Alexandra,Recruiting,Phase 3,Interventional,Switzerland,Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Lopinavir/Ritonavir,Hydroxychloroquine; Lopinavir/Ritonavir,300,https://clinicaltrials.gov/show/NCT04364022,None
2190,3915,NCT04364594,ClinicalTrials.gov,2020-04-22,2020-03-26,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Interventional,Italy,COVID-19 Search in Conjunctival Cells,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04364594,None
2191,3918,NCT04364737,ClinicalTrials.gov,2020-04-22,2020-04-17,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,ATMP,Plasma,Plasma,300,https://clinicaltrials.gov/show/NCT04364737,None
2192,3919,NCT04364763,ClinicalTrials.gov,2020-04-20,2020-08-05,False,"Renibus Therapuetics, Inc.",Recruiting,Phase 2,Interventional,United States,A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study),Drug,Stannous protoporphyrin,Stannous protoporphyrin,252,https://clinicaltrials.gov/show/NCT04364763,None
2193,3920,NCT04364802,ClinicalTrials.gov,2020-04-25,2020-04-29,False,Alexandra Kejner,Recruiting,Phase 2,Interventional,United States,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,Drug,Povidone Iodine,Povidone Iodine,300,https://clinicaltrials.gov/show/NCT04364802,None
2194,3921,NCT04364815,ClinicalTrials.gov,2020-04-22,2020-12-01,False,University of the Philippines,Not Recruiting,Phase 3,Interventional,Philippines,The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04364815,None
2195,3922,NCT04364828,ClinicalTrials.gov,2020-04-22,2021-01-01,False,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Interventional,No Country Given,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04364828,None
2196,3923,NCT04364893,ClinicalTrials.gov,2020-04-07,2020-04-09,False,D'Or Institute for Research and Education,Recruiting,Not Applicable,Interventional,Brazil,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,700,https://clinicaltrials.gov/show/NCT04364893,None
2197,3925,NCT04365101,ClinicalTrials.gov,2020-04-22,2020-05-13,False,Celularity Incorporated,Recruiting,Phase 1/Phase 2,Interventional,United States,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19,ATMP,Cells (NK),Cells (NK),86,https://clinicaltrials.gov/show/NCT04365101,None
2198,3926,NCT04365127,ClinicalTrials.gov,2020-04-24,2020-04-27,False,Sara Ghandehari,Not Recruiting,Phase 1,Interventional,United States,Progesterone for the Treatment of COVID-19 in Hospitalized Men,Drug,Progesterone,Progesterone,40,https://clinicaltrials.gov/show/NCT04365127,None
2199,3927,NCT04365153,ClinicalTrials.gov,2020-04-24,2020-04-24,False,The Cleveland Clinic,Not Recruiting,Phase 2,Interventional,United States,Canakinumab in Covid-19 Cardiac Injury (The Three C Study),Drug,Canakinumab,Canakinumab,45,https://clinicaltrials.gov/show/NCT04365153,None
2200,3929,NCT04365231,ClinicalTrials.gov,2020-04-23,2020-04-01,True,"Hospital St. Joseph, Marseille",Not Recruiting,Phase 3,Interventional,France,Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,0,https://clinicaltrials.gov/show/NCT04365231,None
2201,3930,NCT04365309,ClinicalTrials.gov,2020-04-24,2020-02-10,True,Xijing Hospital,Recruiting,Phase 2/Phase 3,Interventional,China,Protective Effect of Aspirin on COVID-19 Patients,Drug,Aspirin,Aspirin,128,https://clinicaltrials.gov/show/NCT04365309,None
2202,3935,NCT04365439,ClinicalTrials.gov,2020-04-18,2020-04-27,False,Enos Bernasconi,Not Recruiting,Not Applicable,Interventional,No Country Given,Convalescent Plasma for COVID-19,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04365439,None
2203,3936,NCT04365517,ClinicalTrials.gov,2020-04-14,2020-12-29,False,University of Milan,Not Recruiting,Phase 3,Interventional,Italy,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,Drug,Sitagliptin,Sitagliptin,170,https://clinicaltrials.gov/show/NCT04365517,None
2204,3938,NCT04365582,ClinicalTrials.gov,2020-04-23,2020-05-07,False,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Phase 3,Interventional,France,OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome,Drug,Hydroxychloroquine vs. Azithromycin vs. Lopinavir/ritonavir,Hydroxychloroquine; Azithromycin; Lopinavir/ritonavir,640,https://clinicaltrials.gov/show/NCT04365582,None
2205,3940,NCT04365608,ClinicalTrials.gov,2020-04-24,2020-03-20,True,Lazarski University,Recruiting,Not Applicable,Interventional,Poland,Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment,Other (physical),Mechanical ventilation,Mechanical ventilation,90,https://clinicaltrials.gov/show/NCT04365608,None
2206,3942,NCT04365699,ClinicalTrials.gov,2020-04-25,2020-04-08,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Cardiovascular Effects of COVID-19,Drug,AT-001,AT-001,500,https://clinicaltrials.gov/show/NCT04365699,None
2207,3944,NCT04365738,ClinicalTrials.gov,2020-04-26,2020-03-11,True,Istanbul Bilgi University,Not Recruiting,Not Applicable,Interventional,Turkey,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,270,https://clinicaltrials.gov/show/NCT04365738,None
2208,3949,NCT04365972,ClinicalTrials.gov,2020-04-24,2020-04-23,True,Tel Aviv University,Not Recruiting,Not Applicable,Interventional,Israel,Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic,Other (psych),Psychological,Psychological,20,https://clinicaltrials.gov/show/NCT04365972,None
2209,3950,NCT04365985,ClinicalTrials.gov,2020-04-26,2020-04-29,False,William Beaumont Hospitals,Recruiting,Phase 2,Interventional,United States,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,Drug,"Ketamine, Naltrexone",Ketamine; Naltrexone,500,https://clinicaltrials.gov/show/NCT04365985,None
2210,3952,NCT04366050,ClinicalTrials.gov,2020-04-24,2020-05-11,False,"University of California, San Diego",Recruiting,Phase 2,Interventional,United States,Ramipril for the Treatment of COVID-19,Drug,Ramipril,Ramipril,560,https://clinicaltrials.gov/show/NCT04366050,None
2211,3953,NCT04366063,ClinicalTrials.gov,2020-04-20,2020-04-05,False,Royan Institute,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),60,https://clinicaltrials.gov/show/NCT04366063,IRCT20200217046526N2
2212,3954,NCT04366089,ClinicalTrials.gov,2020-04-22,2020-03-26,True,Dr. Roberto Poscia,Recruiting,Phase 2,Interventional,Italy,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,Drug,Oxygen + Ozone,Oxygen; Ozone,152,https://clinicaltrials.gov/show/NCT04366089,None
2213,3955,NCT04366115,ClinicalTrials.gov,2020-04-26,2020-11-01,False,AVM Biotechnology LLC,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS,Drug,AVM0703,AVM0703,8,https://clinicaltrials.gov/show/NCT04366115,None
2214,3956,NCT04366141,ClinicalTrials.gov,2020-04-24,2020-05-01,False,University of British Columbia,Recruiting,Not Applicable,Interventional,Canada,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box,Other (device),Barrier,Barrier,120,https://clinicaltrials.gov/show/NCT04366141,None
2215,3958,NCT04366180,ClinicalTrials.gov,2020-04-27,2020-04-24,True,Biosearch S.A.,Recruiting,Not Applicable,Interventional,Spain,Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers,Supplement,Probiotics,Probiotics,314,https://clinicaltrials.gov/show/NCT04366180,None
2216,3961,NCT04366232,ClinicalTrials.gov,2020-04-27,2020-08-19,True,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,Not Recruiting,Phase 2,Interventional,France,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV),Drug,Anakinra + Ruxolitinib vs. Anakinra,Anakinra; Ruxolitinib,2,https://clinicaltrials.gov/show/NCT04366232,EUCTR2020-001963-10
2217,3962,NCT04366245,ClinicalTrials.gov,2020-04-22,2020-04-23,False,Andalusian Network for Design and Translation of Advanced Therapies,Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection,ATMP,Plasma,Plasma,72,https://clinicaltrials.gov/show/NCT04366245,None
2218,3963,NCT04366271,ClinicalTrials.gov,2020-04-23,2020-05-07,True,Hospital Infantil Universitario Niño Jesús,Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),106,https://clinicaltrials.gov/show/NCT04366271,EUCTR2020-001450-22
2219,3964,NCT04366297,ClinicalTrials.gov,2020-04-23,2020-01-12,True,Lazarski University,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,Other (device),Intraosseous/Intravenous access device,Intraosseous/Intravenous access device,41,https://clinicaltrials.gov/show/NCT04366297,None
2220,3965,NCT04366323,ClinicalTrials.gov,2020-04-22,2020-04-27,True,Andalusian Network for Design and Translation of Advanced Therapies,Not Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),26,https://clinicaltrials.gov/show/NCT04366323,EUCTR2020-001364-29
2221,3966,NCT04366739,ClinicalTrials.gov,2020-04-24,2020-04-29,False,Centre Hospitalier St. Anne,Not Recruiting,Phase 3,Interventional,France,Repurposing of Chlorpromazine in Covid-19 Treatment,Drug,Chlorpromazine,Chlorpromazine,40,https://clinicaltrials.gov/show/NCT04366739,None
2222,3970,NCT04366791,ClinicalTrials.gov,2020-04-24,2020-04-23,True,Emory University,Recruiting,Phase 1/Phase 2,Interventional,United States,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,Other,Radiation,Radiation,10,https://clinicaltrials.gov/show/NCT04366791,None
2223,3971,NCT04366817,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,Other (psych),No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04366817,None
2224,3973,NCT04366856,ClinicalTrials.gov,2020-04-26,2020-06-26,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),Procedure,Positioning,Positioning,500,https://clinicaltrials.gov/show/NCT04366856,None
2225,3974,NCT04366882,ClinicalTrials.gov,2020-04-22,2020-04-14,True,Jessa Hospital,Recruiting,Not Applicable,Interventional,Belgium,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,45,https://clinicaltrials.gov/show/NCT04366882,None
2226,3975,NCT04366908,ClinicalTrials.gov,2020-04-25,2020-04-28,False,Maimonides Biomedical Research Institute of Cordoba,Not Recruiting,Phase 2,Interventional,No Country Given,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,Drug,Calcifediol,Calcifediol,1008,https://clinicaltrials.gov/show/NCT04366908,None
2227,3978,NCT04366947,ClinicalTrials.gov,2020-04-23,2020-04-14,True,Lazarski University,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access in Suspected/Confirmed COVID-19 Patient,Other (device),Intraosseous/Intravenous access device,Intraosseous/Intravenous access device,60,https://clinicaltrials.gov/show/NCT04366947,None
2228,3979,NCT04366960,ClinicalTrials.gov,2020-04-24,2020-05-14,True,Niguarda Hospital,Recruiting,Phase 3,Interventional,Italy,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,Drug,Enoxaparin,Enoxaparin,2712,https://clinicaltrials.gov/show/NCT04366960,EUCTR2020-001708-41
2229,3982,NCT04367077,ClinicalTrials.gov,2020-04-27,2020-04-28,False,"Athersys, Inc",Recruiting,Phase 2/Phase 3,Interventional,United States,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),ATMP,Cells (stem cells),Cells (stem cells),400,https://clinicaltrials.gov/show/NCT04367077,None
2230,3985,NCT04367168,ClinicalTrials.gov,2020-04-24,2020-05-27,False,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2,Interventional,Mexico,Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease,Drug,Colchicine,Colchicine,174,https://clinicaltrials.gov/show/NCT04367168,None
2231,3991,NCT04367545,ClinicalTrials.gov,2020-04-27,2020-04-16,True,"University Hospital, Rouen",Not Recruiting,Not Applicable,Interventional,France,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,130,https://clinicaltrials.gov/show/NCT04367545,None
2232,3992,NCT04367636,ClinicalTrials.gov,2020-04-20,2020-04-20,False,University of Ghent,Not Recruiting,Not Applicable,Interventional,Belgium,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04367636,None
2233,3993,NCT04367662,ClinicalTrials.gov,2020-04-16,2020-04-09,True,"University Hospital, Rouen",Not Recruiting,Not Applicable,Interventional,France,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,Clinical Presentation,No Intervention,No Intervention,99,https://clinicaltrials.gov/show/NCT04367662,None
2234,3998,NCT04367831,ClinicalTrials.gov,2020-04-27,2020-05-02,False,Columbia University,Recruiting,Phase 4,Interventional,United States,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,Drug,Enoxaparin,Enoxaparin,100,https://clinicaltrials.gov/show/NCT04367831,None
2235,4003,NCT04368013,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Johan Normark,Not Recruiting,Not Applicable,Interventional,Sweden,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",Prognosis,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04368013,None
2236,4007,NCT04368156,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Carlos Tornero,Recruiting,Not Applicable,Interventional,Spain,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,90,https://clinicaltrials.gov/show/NCT04368156,None
2237,4011,NCT04368260,ClinicalTrials.gov,2020-04-24,2020-04-24,False,University of Virginia,Recruiting,Not Applicable,Interventional,United States,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,40,https://clinicaltrials.gov/show/NCT04368260,None
2238,4012,NCT04368299,ClinicalTrials.gov,2020-04-25,2020-05-01,False,Chinese University of Hong Kong,Recruiting,Not Applicable,Interventional,Hong Kong,Telemedicine for Follow-up of Systemic Lupus Erythematosus,Telehealth,Telehealth,Telehealth,150,https://clinicaltrials.gov/show/NCT04368299,None
2239,4015,NCT04368377,ClinicalTrials.gov,2020-04-23,2020-04-06,True,University of Milan,Not Recruiting,Phase 2,Interventional,Italy,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,Drug,Tirofiban + Clopidogrel + Aspirin + Fondaparinux,Tirofiban; Clopidogrel; Aspirin; Fondaparinux,5,https://clinicaltrials.gov/show/NCT04368377,None
2240,4018,NCT04368676,ClinicalTrials.gov,2020-04-26,2020-06-25,False,Lawson Health Research Institute,Recruiting,Phase 1,Interventional,Canada,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness,Traditional Medicine (other),Traditional Medicine,Traditional Medicine,60,https://clinicaltrials.gov/show/NCT04368676,None
2241,4019,NCT04368728,ClinicalTrials.gov,2020-04-27,2020-04-29,True,Biontech SE,Recruiting,Phase 2/Phase 3,Interventional,"Turkey, South Africa, Brazil, Germany, United States, Argentina","Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals",ATMP,Vaccine,Vaccine,43998,https://clinicaltrials.gov/show/NCT04368728,EUCTR2020-002641-42
2242,4022,NCT04368845,ClinicalTrials.gov,2020-04-20,2020-05-11,False,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,Recruiting,Not Applicable,Interventional,Greece,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04368845,None
2243,4026,NCT04368923,ClinicalTrials.gov,2020-04-24,2020-03-15,True,Cairo University,Not Recruiting,Not Applicable,Interventional,Egypt,Management of Covid-19 Patients During Home Isolation,Drug,Oxygen,Oxygen,60,https://clinicaltrials.gov/show/NCT04368923,None
2244,4028,NCT04368988,ClinicalTrials.gov,2020-04-24,2020-05-25,False,Novavax,Not Recruiting,Phase 1/Phase 2,Interventional,"Australia, United States",Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant,ATMP,Vaccine,Vaccine,1419,https://clinicaltrials.gov/show/NCT04368988,None
2245,4029,NCT04369066,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Institut Curie,Recruiting,Not Applicable,Interventional,France,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur",Clinical Presentation,No Intervention,No Intervention,2800,https://clinicaltrials.gov/show/NCT04369066,None
2246,4030,NCT04369274,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Massachusetts General Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,Other (physical),Mechanical ventilation,Mechanical ventilation,30,https://clinicaltrials.gov/show/NCT04369274,None
2247,4032,NCT04369365,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Dr. Matthias Preusser,Recruiting,Phase 2,Interventional,Austria,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",Drug (Chemoprophylaxis),Azithromycin,Azithromycin,200,https://clinicaltrials.gov/show/NCT04369365,None
2248,4033,NCT04369378,ClinicalTrials.gov,2020-04-24,2020-08-19,False,Lake Erie College of Osteopathic Medicine,Recruiting,Not Applicable,Interventional,United States,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04369378,None
2249,4034,NCT04369456,ClinicalTrials.gov,2020-04-27,2020-04-22,True,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,Clinical Presentation,No Intervention,No Intervention,115,https://clinicaltrials.gov/show/NCT04369456,None
2250,4036,NCT04369742,ClinicalTrials.gov,2020-04-25,2020-04-15,True,NYU Langone Health,Not Recruiting,Phase 2,Interventional,United States,Treating COVID-19 With Hydroxychloroquine (TEACH),Drug,Hydroxychloroquine,Hydroxychloroquine,626,https://clinicaltrials.gov/show/NCT04369742,None
2251,4037,NCT04369794,ClinicalTrials.gov,2020-04-27,2020-08-10,False,"University of Campinas, Brazil",Recruiting,Phase 4,Interventional,Brazil,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04369794,None
2252,4039,NCT04369820,ClinicalTrials.gov,2020-04-29,2020-03-31,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,C5a Receptor Expression - COVID-19 (C5-COV),Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04369820,None
2253,4042,NCT04370015,ClinicalTrials.gov,2020-04-27,2020-05-15,False,"Services Institute of Medical Sciences, Pakistan",Not Recruiting,Not Applicable,Interventional,No Country Given,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,374,https://clinicaltrials.gov/show/NCT04370015,None
2254,4046,NCT04370223,ClinicalTrials.gov,2020-04-27,2020-05-25,False,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,Not Recruiting,Phase 3,Interventional,Spain,Ozone Auto-hemotherapy for COVID-19 Pneumonia,Drug,Ozone,Ozone,208,https://clinicaltrials.gov/show/NCT04370223,None
2255,4047,NCT04370236,ClinicalTrials.gov,2020-04-29,2020-10-21,False,"Inmune Bio, Inc.",Recruiting,Phase 2/Phase 3,Interventional,United States,INB03 for the Treatment of Pulmonary Complications From COVID-19,Drug,XPro1595,XPro1595,366,https://clinicaltrials.gov/show/NCT04370236,None
2256,4050,NCT04370288,ClinicalTrials.gov,2020-04-29,2020-04-19,False,Mashhad University of Medical Sciences,Recruiting,Phase 1,Interventional,Iran,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,Drug,Methylene blue + Vitamin C + N-acetyl cysteine,Methylene blue; Vitamin C; N-acetyl cysteine,20,https://clinicaltrials.gov/show/NCT04370288,IRCT20191228045924N1
2257,4054,NCT04370834,ClinicalTrials.gov,2020-04-30,2020-05-28,False,National Cancer Institute (NCI),Not Recruiting,Phase 2,Interventional,United States,Tocilizumab for Patients With Cancer and COVID-19 Disease,Drug,Tocilizumab,Tocilizumab,217,https://clinicaltrials.gov/show/NCT04370834,None
2258,4055,NCT04370886,ClinicalTrials.gov,2020-04-28,2020-04-30,False,Guangzhou Blood Center,Not Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19,Other,No Intervention,No Intervention,456517,https://clinicaltrials.gov/show/NCT04370886,None
2259,4056,NCT04370938,ClinicalTrials.gov,2020-04-29,2020-04-29,False,University of Pittsburgh,Recruiting,Not Applicable,Interventional,United States,Provider Burnout During COVID-19,Other (psych),Psychological,Psychological,250,https://clinicaltrials.gov/show/NCT04370938,None
2260,4057,NCT04371029,ClinicalTrials.gov,2020-04-28,2020-04-28,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Interventional,France,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,Other,Polysomnography,Polysomnography,25,https://clinicaltrials.gov/show/NCT04371029,None
2261,4058,NCT04371107,ClinicalTrials.gov,2020-04-27,2020-04-29,False,CHU de Amiens,Not Recruiting,Phase 3,Interventional,France,Proactive Care of Ambulatory COVID19 Patients,Drug,Azithromycin,Azithromycin,64,https://clinicaltrials.gov/show/NCT04371107,None
2262,4065,NCT04371367,ClinicalTrials.gov,2020-04-29,2020-04-27,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Phase 2,Interventional,France,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )",Drug,Avdoralimab,Avdoralimab,168,https://clinicaltrials.gov/show/NCT04371367,None
2263,4066,NCT04371393,ClinicalTrials.gov,2020-04-28,2020-04-30,False,Icahn School of Medicine at Mount Sinai,Recruiting,Phase 3,Interventional,United States,MSCs in COVID-19 ARDS,ATMP,Cells (mesenchymal),Cells (mesenchymal),300,https://clinicaltrials.gov/show/NCT04371393,None
2264,4067,NCT04371406,ClinicalTrials.gov,2020-04-29,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,0,https://clinicaltrials.gov/show/NCT04371406,None
2265,4068,NCT04371419,ClinicalTrials.gov,2020-04-28,2020-05-13,False,"National Bureau of Economic Research, Inc.",Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Health Messaging to Underserved Communities,Other,Health Education,Health Education,15475,https://clinicaltrials.gov/show/NCT04371419,None
2266,4070,NCT04371510,ClinicalTrials.gov,2020-04-28,2020-04-22,True,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,Clinical Presentation,No Intervention,No Intervention,115,https://clinicaltrials.gov/show/NCT04371510,None
2267,4071,NCT04371523,ClinicalTrials.gov,2020-04-28,2020-05-01,False,St. Joseph's Healthcare Hamilton,Not Recruiting,Phase 3,Interventional,Canada,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1100,https://clinicaltrials.gov/show/NCT04371523,None
2268,4073,NCT04371601,ClinicalTrials.gov,2020-03-25,2020-03-01,True,Fuzhou General Hospital,Not Recruiting,Phase 1,Interventional,China,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,ATMP (+ Drug),Cells (mesenchymal) + Oseltamivir + Oxygen + Hormones vs. Oseltamivir + Oxygen + Hormones,Cells (mesenchymal); Oseltamivir; Oxygen; Hormones,60,https://clinicaltrials.gov/show/NCT04371601,None
2269,4077,NCT04371822,ClinicalTrials.gov,2020-04-29,2020-08-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,Egypt,Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients,Drug,"SnPP Protoporphyrin, Porphyrin",SnPP Protoporphyrin; Porphyrin,56,https://clinicaltrials.gov/show/NCT04371822,None
2270,4080,NCT04371926,ClinicalTrials.gov,2020-04-29,2020-06-01,False,Texas Cardiac Arrhythmia Research Foundation,Not Recruiting,Not Applicable,Interventional,No Country Given,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04371926,None
2271,4081,NCT04371952,ClinicalTrials.gov,2020-04-27,2020-06-01,False,Nantes University Hospital,Not Recruiting,Phase 3,Interventional,France,DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19),Drug,Doxycycline,Doxycycline,330,https://clinicaltrials.gov/show/NCT04371952,None
2272,4082,NCT04371965,ClinicalTrials.gov,2020-04-29,2020-09-01,False,Poitiers University Hospital,Not Recruiting,Phase 2,Interventional,France,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19",Drug,Povidone Iodine,Povidone Iodine,24,https://clinicaltrials.gov/show/NCT04371965,None
2273,4083,NCT04371978,ClinicalTrials.gov,2020-04-30,2020-10-01,False,Rabin Medical Center,Recruiting,Phase 3,Interventional,Israel,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,Drug,Linagliptin,Linagliptin,100,https://clinicaltrials.gov/show/NCT04371978,None
2274,4084,NCT04372004,ClinicalTrials.gov,2020-04-29,2020-05-08,False,Texas Cardiac Arrhythmia Research Foundation,Recruiting,Phase 1,Interventional,United States,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04372004,None
2275,4085,NCT04372017,ClinicalTrials.gov,2020-04-25,2020-05-14,False,Sanford Health,Not Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1,https://clinicaltrials.gov/show/NCT04372017,None
2276,4086,NCT04372030,ClinicalTrials.gov,2020-04-22,2020-05-01,False,UCLouvain,Not Recruiting,Not Applicable,Interventional,No Country Given,Health Care Use During the Covid19 Crisis,Health System,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04372030,None
2277,4089,NCT04372082,ClinicalTrials.gov,2020-04-30,2020-05-01,False,"University Hospital, Lille",Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19,Drug,Hydroxychloroquine vs. Diltiazem/Niclosamide,Hydroxychloroquine; Diltiazem/Niclosamide,480,https://clinicaltrials.gov/show/NCT04372082,None
2278,4090,NCT04372186,ClinicalTrials.gov,2020-04-29,2020-05-14,True,"Genentech, Inc.",Not Recruiting,Phase 3,Interventional,"South Africa, Peru, Kenya, Brazil, United States, Mexico",A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,379,https://clinicaltrials.gov/show/NCT04372186,PER-027-20
2279,4095,NCT04372589,ClinicalTrials.gov,2020-04-24,2020-05-20,False,University of Manitoba,Recruiting,Phase 2/Phase 3,Interventional,"Brazil, Mexico, Canada, United States",Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ),Drug,Heparin,Heparin,3000,https://clinicaltrials.gov/show/NCT04372589,None
2280,4096,NCT04372602,ClinicalTrials.gov,2020-04-30,2020-10-12,False,Washington University in St. Louis,Recruiting,Phase 2,Interventional,United States,Duvelisib to Combat COVID-19,Drug,Duvelisib,Duvelisib,28,https://clinicaltrials.gov/show/NCT04372602,None
2281,4097,NCT04372628,ClinicalTrials.gov,2020-04-30,2020-06-01,False,Vanderbilt University,Recruiting,Phase 2,Interventional,United States,Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19,Drug,Hydroxychloroquein vs. Lopinavir/ritonavir,Hydroxychloroquein; Lopinavir/ritonavir,600,https://clinicaltrials.gov/show/NCT04372628,None
2282,4098,NCT04372680,ClinicalTrials.gov,2020-04-30,2020-04-22,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound,Other (physical),Mechanical ventilation,Mechanical ventilation,200,https://clinicaltrials.gov/show/NCT04372680,None
2283,4099,NCT04372693,ClinicalTrials.gov,2020-04-27,2020-09-01,False,Cairo University,Recruiting,Not Applicable,Interventional,Egypt,Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement,Other,Other,Other,180,https://clinicaltrials.gov/show/NCT04372693,None
2284,4100,NCT04372979,ClinicalTrials.gov,2020-04-24,2020-09-14,False,Direction Centrale du Service de Sant des Armes,Recruiting,Phase 3,Interventional,France,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,ATMP,Plasma,Plasma,80,https://clinicaltrials.gov/show/NCT04372979,None
2285,4102,NCT04373044,ClinicalTrials.gov,2020-04-17,2020-05-01,False,University of Southern California,Recruiting,Phase 2,Interventional,United States,"Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19",Drug,Baricitinib + one of Hydroxychloroquine or Lopinavir/ritonavir or Remdesivir,Baricitinib; Hydroxychloroquine; Lopinavir/ritonavir; Remdesivir,144,https://clinicaltrials.gov/show/NCT04373044,None
2286,4103,NCT04373096,ClinicalTrials.gov,2020-04-30,2020-06-01,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers,Other (device),Hood,Hood,42,https://clinicaltrials.gov/show/NCT04373096,None
2287,4105,NCT04373135,ClinicalTrials.gov,2020-04-30,2020-05-08,False,"University of California, Los Angeles",Not Recruiting,Not Applicable,Interventional,United States,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",Other,Other,Other,2500,https://clinicaltrials.gov/show/NCT04373135,None
2288,4107,NCT04373161,ClinicalTrials.gov,2020-04-30,2020-03-20,True,Swedish Hospital,Not Recruiting,Not Applicable,Interventional,United States,Home Pulse Oximeter Use in Patients With COVID-19,Other (device),Biosensors,Biosensors,209,https://clinicaltrials.gov/show/NCT04373161,None
2289,4108,NCT04373200,ClinicalTrials.gov,2020-04-22,2020-05-25,False,Rennes University Hospital,Recruiting,Not Applicable,Interventional,France,Human Ab Response & immunoMONItoring of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,75,https://clinicaltrials.gov/show/NCT04373200,None
2290,4110,NCT04373291,ClinicalTrials.gov,2020-05-01,2020-05-18,True,Bandim Health Project,Recruiting,Phase 3,Interventional,Denmark,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,ATMP,Vaccine,Vaccine,1500,https://clinicaltrials.gov/show/NCT04373291,EUCTR2020-001888-90
2291,4111,NCT04373382,ClinicalTrials.gov,2020-04-30,2020-07-27,False,"Mount Sinai Hospital, Canada",Not Recruiting,Not Applicable,Interventional,Canada,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,Other (psych),Psychological,Psychological,882,https://clinicaltrials.gov/show/NCT04373382,None
2292,4112,NCT04373460,ClinicalTrials.gov,2020-04-30,2020-06-03,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit SARS-CoV-2 Associated Complications,ATMP,Plasma,Plasma,1344,https://clinicaltrials.gov/show/NCT04373460,None
2293,4114,NCT04373707,ClinicalTrials.gov,2020-05-01,2020-05-13,False,CHU de Nancy,Recruiting,Phase 4,Interventional,France,Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19,Drug,Heparin,Heparin,602,https://clinicaltrials.gov/show/NCT04373707,None
2294,4115,NCT04373733,ClinicalTrials.gov,2020-05-01,2020-05-01,True,Chelsea and Westminster Hospital NHS Foundation Trust,Recruiting,Phase 3,Interventional,United Kingdom,Early Intervention in COVID-19: Favipiravir Verses Standard Care,Drug,Favipiravir vs. Hydroxychloroquine + Azithromycin + Zinc,Favipiravir; Hydroxychloroquine; Azithromycin; Zinc,450,https://clinicaltrials.gov/show/NCT04373733,EUCTR2020-001449-38
2295,4118,NCT04373824,ClinicalTrials.gov,2020-04-26,2020-04-25,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Interventional,India,Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,Drug,Ivermectin,Ivermectin,50,https://clinicaltrials.gov/show/NCT04373824,None
2296,4120,NCT04374019,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Susanne Arnold,Recruiting,Phase 2,Interventional,United States,Novel Agents for Treatment of High-risk COVID-19 Positive Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Ivermectin vs. Hydroxychloroquine vs. Camostat Mesilate,Azithromycin; Hydroxychloroquine; Ivermectin; Camostat Mesilate,240,https://clinicaltrials.gov/show/NCT04374019,None
2297,4121,NCT04374032,ClinicalTrials.gov,2020-04-30,2020-05-01,False,Bosnalijek D.D,Not Recruiting,Phase 2/Phase 3,Interventional,Bosnia and Herzegovina,Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection,Drug,Metenkefalin + Tridecactide,Metenkefalin; Tridecactide,120,https://clinicaltrials.gov/show/NCT04374032,None
2298,4125,NCT04374084,ClinicalTrials.gov,2020-04-20,2020-05-10,False,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences",Recruiting,Not Applicable,Interventional,China,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,https://clinicaltrials.gov/show/NCT04374084,None
2299,4129,NCT04374149,ClinicalTrials.gov,2020-04-20,2020-04-30,False,Prisma Health-Upstate,Not Recruiting,Phase 2,Interventional,United States,Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS,ATMP (+ Drug),Plasma vs. Plasma + Ruxolitinib,Plasma; Ruxolitinib,20,https://clinicaltrials.gov/show/NCT04374149,None
2300,4132,NCT04374461,ClinicalTrials.gov,2020-05-01,2020-05-01,True,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of N-acetylcysteine in Patients With COVID-19 Infection,Drug,N-acetylcysteine,N-acetylcysteine,84,https://clinicaltrials.gov/show/NCT04374461,CTRI/2020/06/026194
2301,4133,NCT04374474,ClinicalTrials.gov,2020-04-29,2021-01-10,False,Lawson Health Research Institute,Not Recruiting,Phase 4,Interventional,Canada,Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,0,https://clinicaltrials.gov/show/NCT04374474,None
2302,4134,NCT04374487,ClinicalTrials.gov,2020-04-29,2020-05-09,False,Max Healthcare Insititute Limited,Not Recruiting,Phase 2,Interventional,India,Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04374487,None
2303,4136,NCT04374526,ClinicalTrials.gov,2020-05-02,2020-05-27,False,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Recruiting,Phase 2/Phase 3,Interventional,Italy,Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.,ATMP,Plasma,Plasma,182,https://clinicaltrials.gov/show/NCT04374526,None
2304,4137,NCT04374539,ClinicalTrials.gov,2020-05-02,2020-04-29,True,Fundació Clínic per a la Recerca Biomèdica,Recruiting,Phase 2,Interventional,Spain,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,ATMP,Plasma,Plasma,116,https://clinicaltrials.gov/show/NCT04374539,None
2305,4138,NCT04374552,ClinicalTrials.gov,2020-05-02,2020-05-05,False,Rutgers University,Not Recruiting,Phase 2,Interventional,United States,Asymptomatic COVID-19 Trial,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,0,https://clinicaltrials.gov/show/NCT04374552,None
2306,4139,NCT04374565,ClinicalTrials.gov,2020-04-27,2020-05-05,False,University of Virginia,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia,ATMP,Plasma,Plasma,29,https://clinicaltrials.gov/show/NCT04374565,None
2307,4140,NCT04374591,ClinicalTrials.gov,2020-05-02,2020-08-01,False,Mansoura University,Not Recruiting,Not Applicable,Interventional,Egypt,The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia,Drug,Sodium Bicarbonate,Sodium Bicarbonate,180,https://clinicaltrials.gov/show/NCT04374591,None
2308,4145,NCT04374786,ClinicalTrials.gov,2020-05-01,2020-05-15,False,University of Arizona,Recruiting,Not Applicable,Interventional,United States,Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic,Other (psych),Psychological,Psychological,328,https://clinicaltrials.gov/show/NCT04374786,None
2309,4147,NCT04374903,ClinicalTrials.gov,2020-05-03,2020-05-01,True,King Hussein Cancer Center,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Sirolimus,Azithromycin; Hydroxychloroquine; Sirolimus,58,https://clinicaltrials.gov/show/NCT04374903,None
2310,4148,NCT04374942,ClinicalTrials.gov,2020-04-30,2020-04-30,True,Megan Landes,Recruiting,Phase 3,Interventional,Canada,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,988,https://clinicaltrials.gov/show/NCT04374942,ISRCTN14326006
2311,4149,NCT04375046,ClinicalTrials.gov,2020-05-01,2020-09-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,No Country Given,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,Drug,ACE enzyme,ACE enzyme,24,https://clinicaltrials.gov/show/NCT04375046,None
2312,4150,NCT04375098,ClinicalTrials.gov,2020-05-03,2020-05-04,False,Pontificia Universidad Católica de Chile,Not Recruiting,Phase 2,Interventional,Chile,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,ATMP,Plasma,Plasma,58,https://clinicaltrials.gov/show/NCT04375098,None
2313,4151,NCT04375124,ClinicalTrials.gov,2020-05-01,2020-04-25,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Treatment of Angiotensin Peptide (1-7) for COVID-19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04375124,None
2314,4154,NCT04375202,ClinicalTrials.gov,2020-04-29,2020-04-18,False,University of Perugia,Recruiting,Phase 2,Interventional,Italy,Colchicine in COVID-19: a Pilot Study,Drug,Colchicine,Colchicine,308,https://clinicaltrials.gov/show/NCT04375202,EUCTR2020-001475-33
2315,4155,NCT04375397,ClinicalTrials.gov,2020-05-04,2020-06-06,False,AbbVie,Recruiting,Phase 2,Interventional,United States,Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury,Drug,Ibrutinib,Ibrutinib,46,https://clinicaltrials.gov/show/NCT04375397,None
2316,4161,NCT04375735,ClinicalTrials.gov,2020-04-22,2020-07-01,False,Lawson Health Research Institute,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,London's Exogenous Surfactant Study for COVID19,Drug,Bovine Lipid Extract Surfactant,Bovine Lipid Extract Surfactant,20,https://clinicaltrials.gov/show/NCT04375735,None
2317,4164,NCT04375774,ClinicalTrials.gov,2020-04-17,2020-05-01,False,"University Clinic, UCLouvain",Recruiting,Not Applicable,Interventional,Belgium,Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE),Other (device),Masks,Masks,10,https://clinicaltrials.gov/show/NCT04375774,None
2318,4165,NCT04376034,ClinicalTrials.gov,2020-04-19,2020-04-16,True,West Virginia University,Recruiting,Phase 3,Interventional,United States,Convalescent Plasma Collection and Treatment in Pediatrics and Adults,ATMP,Plasma,Plasma,240,https://clinicaltrials.gov/show/NCT04376034,None
2319,4167,NCT04376476,ClinicalTrials.gov,2020-04-28,2020-05-05,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,Host-pathogen Interactions During SARS-CoV-2 Infection,Clinical Presentation,No Intervention,No Intervention,450,https://clinicaltrials.gov/show/NCT04376476,None
2320,4168,NCT04376515,ClinicalTrials.gov,2020-03-31,2020-03-20,True,"University of California, Irvine",Not Recruiting,Not Applicable,Interventional,United States,Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19),Other (psych),Psychological,Psychological,300,https://clinicaltrials.gov/show/NCT04376515,None
2321,4170,NCT04376593,ClinicalTrials.gov,2020-05-03,2020-05-01,True,"University of California, Davis",Recruiting,Phase 1,Interventional,United States,PET/CT Imaging in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04376593,None
2322,4174,NCT04376788,ClinicalTrials.gov,2020-05-01,2020-05-20,False,Ain Shams University,Recruiting,Phase 2,Interventional,Egypt,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,ATMP (+ Drug),Plasma + Methylene Blue,Plasma; Methylene Blue,15,https://clinicaltrials.gov/show/NCT04376788,None
2323,4175,NCT04376814,ClinicalTrials.gov,2020-05-03,2020-03-29,True,Baqiyatallah Medical Sciences University,Not Recruiting,Not Applicable,Interventional,Iran,Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19,Drug,Favipiravir + Hydroxychloroquine vs. Lopinavir/ritonavir + Hydroxychloroquine,Favipiravir; Hydroxychloroquine; Lopinavir/ritonavir,40,https://clinicaltrials.gov/show/NCT04376814,None
2324,4176,NCT04376840,ClinicalTrials.gov,2020-05-04,2020-05-28,False,CHU de Reims,Recruiting,Not Applicable,Interventional,France,Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19,Clinical Presentation,No Intervention,No Intervention,270,https://clinicaltrials.gov/show/NCT04376840,None
2325,4184,NCT04377165,ClinicalTrials.gov,2020-05-04,2020-05-06,False,University of Queensland,Not Recruiting,Not Applicable,Interventional,No Country Given,Innovative Tool to Limit Spread of SARS-CoV-2 (COVID 19) in Residential Aged Care Facilities,Other,Other,Other,34,https://clinicaltrials.gov/show/NCT04377165,None
2326,4185,NCT04377308,ClinicalTrials.gov,2020-04-18,2020-05-01,False,University of Toledo,Recruiting,Phase 4,Interventional,United States,Fluoxetine to Reduce Intubation and Death After COVID19 Infection,Drug,Fluoxetine,Fluoxetine,2000,https://clinicaltrials.gov/show/NCT04377308,None
2327,4186,NCT04377334,ClinicalTrials.gov,2020-04-16,2020-10-01,False,"University Hospital, Tübingen",Not Recruiting,Phase 2,Interventional,Germany,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04377334,None
2328,4190,NCT04377477,ClinicalTrials.gov,2020-05-04,2020-05-10,False,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,Recruiting,Not Applicable,Interventional,Italy,COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19),Other,Radiation,Radiation,30,https://clinicaltrials.gov/show/NCT04377477,None
2329,4192,NCT04377503,ClinicalTrials.gov,2020-05-02,2020-05-01,True,Hospital Sao Domingos,Not Recruiting,Phase 2,Interventional,No Country Given,Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19,Drug,Tocilizumab vs. Corticosteroids,Tocilizumab; Methylprednisolone,40,https://clinicaltrials.gov/show/NCT04377503,None
2330,4193,NCT04377568,ClinicalTrials.gov,2020-04-30,2020-10-07,False,The Hospital for Sick Children,Recruiting,Phase 2,Interventional,Canada,Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04377568,None
2331,4196,NCT04377620,ClinicalTrials.gov,2020-05-04,2020-05-24,False,Incyte Corporation,Recruiting,Phase 3,Interventional,"Russian Federation, United States",Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT),Drug,Ruxolitinib,Ruxolitinib,500,https://clinicaltrials.gov/show/NCT04377620,None
2332,4197,NCT04377646,ClinicalTrials.gov,2020-05-01,2020-05-04,False,Military Hospital of Tunis,Not Recruiting,Phase 3,Interventional,Tunisia,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine + Zinc,Hydroxychloroquine + Zinc,660,https://clinicaltrials.gov/show/NCT04377646,None
2333,4198,NCT04377659,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Memorial Sloan Kettering Cancer Center,Not Recruiting,Phase 2,Interventional,United States,Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection,Drug,Tocilizumab,Tocilizumab,9,https://clinicaltrials.gov/show/NCT04377659,None
2334,4199,NCT04377672,ClinicalTrials.gov,2020-05-04,2020-05-28,False,Johns Hopkins University,Recruiting,Phase 1,Interventional,United States,Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19),ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04377672,None
2335,4201,NCT04377711,ClinicalTrials.gov,2020-05-05,2020-06-08,False,Covis Pharma,Recruiting,Phase 3,Interventional,United States,A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients,Drug,Ciclesonide,Ciclesonide,400,https://clinicaltrials.gov/show/NCT04377711,None
2336,4203,NCT04377737,ClinicalTrials.gov,2020-05-04,2020-05-15,False,Fondation Lenval,Not Recruiting,Not Applicable,Interventional,France,Incidence of Covid-19 in School Children,Clinical Presentation (Epidemiology),No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04377737,None
2337,4204,NCT04377750,ClinicalTrials.gov,2020-04-23,2020-04-08,True,Hadassah Medical Organization,Recruiting,Phase 4,Interventional,Israel,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,Drug,Tocilizumab,Tocilizumab,500,https://clinicaltrials.gov/show/NCT04377750,None
2338,4207,NCT04377789,ClinicalTrials.gov,2020-05-01,2020-03-20,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Effect of Quercetin on Prophylaxis and Treatment of COVID-19,Drug (Chemoprophylaxis),Quercetin,Quercetin,50,https://clinicaltrials.gov/show/NCT04377789,None
2339,4208,NCT04377802,ClinicalTrials.gov,2020-05-04,2020-05-17,False,King Fahad Specialist Hospital,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Safe Return to Regular Clinical Operation After COVID-19 Pandemic,Health System,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04377802,None
2340,4210,NCT04377997,ClinicalTrials.gov,2020-05-01,2020-05-15,False,Massachusetts General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19,Drug,Enoxaparin,Enoxaparin,300,https://clinicaltrials.gov/show/NCT04377997,None
2341,4211,NCT04378244,ClinicalTrials.gov,2020-05-04,2021-01-12,False,Aveni Foundation,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,Other,Gene Therapy,Gene Therapy,18,https://clinicaltrials.gov/show/NCT04378244,None
2342,4212,NCT04378257,ClinicalTrials.gov,2020-05-02,2020-06-01,False,Sultan Qaboos University,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic,Other (psych),Psychological,Psychological,70,https://clinicaltrials.gov/show/NCT04378257,None
2343,4216,NCT04378712,ClinicalTrials.gov,2020-04-29,2020-01-21,True,Guangzhou Institute of Respiratory Disease,Not Recruiting,Not Applicable,Interventional,China,Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19),Drug,Hydrogen + Oxygen,Hydrogen; Oxygen,90,https://clinicaltrials.gov/show/NCT04378712,None
2344,4217,NCT04378738,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Acibadem University,Recruiting,Not Applicable,Interventional,Turkey,Social Media and Covid19 Pandemic,Other,No Intervention,No Intervention,212,https://clinicaltrials.gov/show/NCT04378738,None
2345,4219,NCT04378803,ClinicalTrials.gov,2020-05-04,2020-05-13,False,University of Miami,Not Recruiting,Not Applicable,Interventional,United States,Mindfulness Training for Seniors,Other (psych),Psychological,Psychological,53,https://clinicaltrials.gov/show/NCT04378803,None
2346,4223,NCT04378920,ClinicalTrials.gov,2020-05-05,2020-04-14,True,Institut de Cancérologie Strasbourg Europe (ICANS),Recruiting,Phase 1/Phase 2,Interventional,France,"A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes",Drug,Trans Crocetin,Trans Crocetin,90,https://clinicaltrials.gov/show/NCT04378920,None
2347,4224,NCT04379037,ClinicalTrials.gov,2020-05-05,2020-06-27,False,Nemechek Technologies,Recruiting,Not Applicable,Interventional,Argentina,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,50,https://clinicaltrials.gov/show/NCT04379037,None
2348,4226,NCT04379076,ClinicalTrials.gov,2020-05-05,2020-05-14,False,Revimmune,Recruiting,Phase 2,Interventional,United Kingdom,InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort,Drug,CYT107,CYT107,48,https://clinicaltrials.gov/show/NCT04379076,None
2349,4228,NCT04379154,ClinicalTrials.gov,2020-04-28,2020-04-14,True,Hôpital Foch,Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19),Other,Other,Other,60,https://clinicaltrials.gov/show/NCT04379154,None
2350,4232,NCT04379271,ClinicalTrials.gov,2020-05-01,2020-06-11,True,Immunic AG,Recruiting,Phase 2/Phase 3,Interventional,"Germany, Bulgaria","A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)",Drug,Vidofludimus calcium,Vidofludimus calcium,230,https://clinicaltrials.gov/show/NCT04379271,EUCTR2020-001264-28
2351,4236,NCT04379336,ClinicalTrials.gov,2020-05-04,2020-05-04,False,TASK Applied Science,Recruiting,Phase 3,Interventional,South Africa,BCG Vaccination for Healthcare Workers in COVID-19 Pandemic,ATMP,Vaccine,Vaccine,500,https://clinicaltrials.gov/show/NCT04379336,None
2352,4237,NCT04379375,ClinicalTrials.gov,2020-05-04,2020-07-27,False,Medical College of Wisconsin,Not Recruiting,Not Applicable,Interventional,United States,Nudges to Improve Health Behaviors That Limit COVID-19 Spread,Other,Other,Other,45,https://clinicaltrials.gov/show/NCT04379375,None
2353,4239,NCT04379453,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Hospital Israelita Albert Einstein,Recruiting,Not Applicable,Interventional,Brazil,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses,Procedure,Percutaneous Cardiovascular Intervention,Percutaneous Cardiovascular Intervention,10,https://clinicaltrials.gov/show/NCT04379453,None
2354,4241,NCT04379479,ClinicalTrials.gov,2020-05-01,2020-05-01,False,"National Polytechnic Institute, Mexico",Not Recruiting,Phase 2,Interventional,Mexico,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),Drug,Dialyzable Leukocyte,Dialyzable Leukocyte,562,https://clinicaltrials.gov/show/NCT04379479,None
2355,4242,NCT04379492,ClinicalTrials.gov,2020-05-05,2020-05-05,False,Memorial Sloan Kettering Cancer Center,Not Recruiting,Phase 2,Interventional,United States,A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04379492,None
2356,4243,NCT04379518,ClinicalTrials.gov,2020-05-06,2020-09-04,False,Roswell Park Cancer Institute,Recruiting,Phase 1/Phase 2,Interventional,United States,Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients,Drug,Interferon alfa + Rintatolimod,Interferon alfa; Rintatolimod,44,https://clinicaltrials.gov/show/NCT04379518,None
2357,4244,NCT04379531,ClinicalTrials.gov,2020-04-30,2020-04-25,True,Department of Health Care of Moscow,Not Recruiting,Not Applicable,Interventional,Russian Federation,LDCT in COVID-19 Pneumonia: a Prospective Moscow Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,230,https://clinicaltrials.gov/show/NCT04379531,None
2358,4246,NCT04379661,ClinicalTrials.gov,2020-05-05,2020-04-03,True,Columbia University,Not Recruiting,Not Applicable,Interventional,United States,SUNLIGHT Study: Online Support Groups for MS to Address COVID-19,Other,Other,Other,32,https://clinicaltrials.gov/show/NCT04379661,None
2359,4247,NCT04380376,ClinicalTrials.gov,2020-05-06,2020-04-30,True,"Federal State Budgetary Institution, Pulmonology Scientific Research Institute",Recruiting,Phase 2,Interventional,Russian Federation,Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia,Drug,Melphalan,Melphalan,60,https://clinicaltrials.gov/show/NCT04380376,None
2360,4248,NCT04380402,ClinicalTrials.gov,2020-05-01,2020-05-20,False,Mount Auburn Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Atorvastatin as Adjunctive Therapy in COVID-19,Drug,Atorvastatin,Atorvastatin,300,https://clinicaltrials.gov/show/NCT04380402,None
2361,4249,NCT04380519,ClinicalTrials.gov,2020-05-06,2020-04-23,True,"R-Pharm International, LLC",Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),Drug,RPH -104 vs. Olokizumab,RPH -104; Olokizumab,372,https://clinicaltrials.gov/show/NCT04380519,None
2362,4250,NCT04380532,ClinicalTrials.gov,2020-04-29,2020-05-15,False,Immunitor LLC,Not Recruiting,Phase 1/Phase 2,Interventional,"Mongolia, Canada",Tableted COVID-19 Therapeutic Vaccine,ATMP,Vaccine,Vaccine,20,https://clinicaltrials.gov/show/NCT04380532,None
2363,4252,NCT04380701,ClinicalTrials.gov,2020-05-06,2020-04-23,True,Biontech SE,Recruiting,Phase 1/Phase 2,Interventional,Germany,A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults,ATMP,Vaccine,Vaccine,456,https://clinicaltrials.gov/show/NCT04380701,EUCTR2020-001038-36
2364,4256,NCT04380818,ClinicalTrials.gov,2020-05-04,2020-06-05,False,Grupo de Investigación Clínica en Oncología Radioterapia (GICOR),Recruiting,Not Applicable,Interventional,Spain,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,Other (+ Drug),"Radiation with or without hydroxychloroquine, lopinavir/ritonavir, azithromycin, cortocosteroids, Heparin, oxygen",Radiation; hydroxychloroquine; lopinavir/ritonavir; azithromycin; methylprednisolone; dexamethasone; prednisone; Heparin; oxygen,106,https://clinicaltrials.gov/show/NCT04380818,None
2365,4259,NCT04380909,ClinicalTrials.gov,2020-05-07,2020-05-06,True,University of Bern,Recruiting,Not Applicable,Interventional,Switzerland,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,Other (psych),Psychological,Psychological,80,https://clinicaltrials.gov/show/NCT04380909,None
2366,4260,NCT04380935,ClinicalTrials.gov,2020-05-04,2020-05-18,False,Indonesia University,Recruiting,Phase 2/Phase 3,Interventional,Indonesia,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04380935,None
2367,4261,NCT04380961,ClinicalTrials.gov,2020-05-07,2020-04-24,True,Janssen Pharmaceutical,Recruiting,Phase 2,Interventional,"Russian Federation, Argentina, South Africa, Brazil, United States, Mexico, Spain",A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,Drug,Sirukumab,Sirukumab,270,https://clinicaltrials.gov/show/NCT04380961,None
2368,4263,NCT04381000,ClinicalTrials.gov,2020-05-07,2020-04-01,True,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,Not Recruiting,Not Applicable,Interventional,Greece,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,170,https://clinicaltrials.gov/show/NCT04381000,None
2369,4264,NCT04381052,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Columbia University,Not Recruiting,Phase 2,Interventional,United States,Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,30,https://clinicaltrials.gov/show/NCT04381052,None
2370,4268,NCT04381338,ClinicalTrials.gov,2020-05-04,2020-05-10,False,University of Padova,Not Recruiting,Not Applicable,Interventional,Italy,Rehabilitation for People With COVID-19 in ICU,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,92,https://clinicaltrials.gov/show/NCT04381338,None
2371,4270,NCT04381364,ClinicalTrials.gov,2020-05-07,2020-05-29,True,Dr. Ola Blennow,Recruiting,Phase 2,Interventional,Sweden,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),Drug,Ciclesonide,Ciclesonide,446,https://clinicaltrials.gov/show/NCT04381364,EUCTR2020-001928-34
2372,4271,NCT04381377,ClinicalTrials.gov,2020-05-07,2020-04-29,True,NPO Petrovax,Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Efficacy and Safety of PolyoxidoniumÂ® in Hospitalized Patients With Coronavirus Disease COVID-19,Drug,Azoximer bromide,Azoximer bromide,394,https://clinicaltrials.gov/show/NCT04381377,None
2373,4273,NCT04381845,ClinicalTrials.gov,2020-05-06,2020-12-10,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,Immunity and Infections in the Psychiatric Population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04381845,None
2374,4274,NCT04381858,ClinicalTrials.gov,2020-05-06,2020-05-06,False,Centenario Hospital Miguel Hidalgo,Not Recruiting,Phase 3,Interventional,Mexico,Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia,ATMP,Plasma vs. Immunoglobulin,Plasma; Immunoglobulin,196,https://clinicaltrials.gov/show/NCT04381858,None
2375,4275,NCT04381871,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Al-Neelain University,Not Recruiting,Phase 2/Phase 3,Interventional,Sudan,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,Drug,Gum Arabic,Gum Arabic,110,https://clinicaltrials.gov/show/NCT04381871,None
2376,4276,NCT04381884,ClinicalTrials.gov,2020-05-05,2020-05-18,False,Laboratorio Elea,Not Recruiting,Phase 2,Interventional,Argentina,Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19,Drug,Ivermectin,Ivermectin,45,https://clinicaltrials.gov/show/NCT04381884,None
2377,4277,NCT04381923,ClinicalTrials.gov,2020-05-07,2021-02-15,False,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,United States,COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia,Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04381923,None
2378,4278,NCT04381962,ClinicalTrials.gov,2020-05-07,2020-05-29,True,University of Oxford,Recruiting,Phase 3,Interventional,United Kingdom,A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2),Drug,Azithromycin,Azithromycin,800,https://clinicaltrials.gov/show/NCT04381962,EUCTR2020-001740-26
2379,4279,NCT04381988,ClinicalTrials.gov,2020-05-08,2020-05-07,True,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy,Drug,Hydroxychloroquine,Hydroxychloroquine,132,https://clinicaltrials.gov/show/NCT04381988,None
2380,4280,NCT04382040,ClinicalTrials.gov,2020-05-07,2020-05-08,False,MGC Pharmaceuticals,Recruiting,Phase 2,Interventional,"India, Israel","A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19",Drug,Artemisinin + Curcumin + Frankincense + Vitamin C,Artemisinin; Curcumin; Frankincense; Vitamin C,50,https://clinicaltrials.gov/show/NCT04382040,None
2381,4281,NCT04382066,ClinicalTrials.gov,2020-05-07,2020-05-12,False,PharmaMar,Not Recruiting,Phase 1,Interventional,Spain,Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19,Drug,Plitidepsin,Plitidepsin,46,https://clinicaltrials.gov/show/NCT04382066,None
2382,4282,NCT04382092,ClinicalTrials.gov,2020-05-06,2020-03-23,True,"University Clinic, UCLouvain",Not Recruiting,Not Applicable,Interventional,Belgium,Co-infection Management in COVID-19 Critically Ill,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,32,https://clinicaltrials.gov/show/NCT04382092,None
2383,4283,NCT04382131,ClinicalTrials.gov,2020-05-08,2020-06-23,False,University of Edinburgh,Recruiting,Not Applicable,Interventional,United Kingdom,Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19),Procedure,Nasal irrigation,Nasal irrigation,405,https://clinicaltrials.gov/show/NCT04382131,None
2384,4286,NCT04382391,ClinicalTrials.gov,2020-04-14,2020-05-08,False,Allegheny Singer Research Institute,Recruiting,Not Applicable,Interventional,United States,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,20,https://clinicaltrials.gov/show/NCT04382391,None
2385,4292,NCT04382547,ClinicalTrials.gov,2020-05-08,2020-05-11,False,Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus,Recruiting,Phase 1/Phase 2,Interventional,Belarus,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04382547,None
2386,4293,NCT04382560,ClinicalTrials.gov,2020-05-05,2020-05-02,True,University of Parma,Not Recruiting,Not Applicable,Interventional,Italy,Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic,Other (psych),Psychological,Psychological,69,https://clinicaltrials.gov/show/NCT04382560,None
2387,4294,NCT04382586,ClinicalTrials.gov,2020-05-07,2020-07-06,False,BeiGene,Recruiting,Phase 2,Interventional,"Brazil, United States",Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants,Drug,Zanubrutinib,Zanubrutinib,52,https://clinicaltrials.gov/show/NCT04382586,None
2388,4295,NCT04382625,ClinicalTrials.gov,2020-04-14,2020-10-01,False,Kootenai Health,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,Drug,Hydroxychloroquine,Hydroxychloroquine,120,https://clinicaltrials.gov/show/NCT04382625,None
2389,4296,NCT04382729,ClinicalTrials.gov,2020-05-08,2020-04-17,True,University of Turin,Recruiting,Not Applicable,Interventional,Italy,Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,https://clinicaltrials.gov/show/NCT04382729,None
2390,4297,NCT04382755,ClinicalTrials.gov,2020-05-07,2020-05-22,False,"University Hospital, Ghent",Recruiting,Phase 2,Interventional,Belgium,ZilucoplanÂ® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure,Drug,Zilucoplan,Zilucoplan,81,https://clinicaltrials.gov/show/NCT04382755,None
2391,4298,NCT04382768,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Química Luar,Recruiting,Not Applicable,Interventional,Argentina,Inhaled Ibuprofen to Treat COVID-19,Drug,Ibuprofen,Ibuprofen,40,https://clinicaltrials.gov/show/NCT04382768,None
2392,4301,NCT04382950,ClinicalTrials.gov,2020-05-08,2020-07-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,No Country Given,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,Drug,ACE enzyme + retonic acid,ACE enzyme + retonic acid,24,https://clinicaltrials.gov/show/NCT04382950,None
2393,4302,NCT04383002,ClinicalTrials.gov,2020-05-01,2020-09-02,False,"University Health Network, Toronto",Recruiting,Phase 1,Interventional,Canada,High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients),Drug,Nitric Oxide,Nitric Oxide,20,https://clinicaltrials.gov/show/NCT04383002,None
2394,4305,NCT04383535,ClinicalTrials.gov,2020-05-06,2020-05-15,False,Hospital Italiano de Buenos Aires,Not Recruiting,Not Applicable,Interventional,Argentina,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,ATMP,Plasma,Plasma,333,https://clinicaltrials.gov/show/NCT04383535,None
2395,4306,NCT04383548,ClinicalTrials.gov,2020-04-17,2020-06-01,False,Assiut University,Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,ATMP,Immunoglobulin,Immunoglobulin,100,https://clinicaltrials.gov/show/NCT04383548,None
2396,4307,NCT04383574,ClinicalTrials.gov,2020-05-09,2020-05-22,False,"Sinovac Research and Development Co., Ltd.",Not Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19),ATMP,Vaccine,Vaccine,422,https://clinicaltrials.gov/show/NCT04383574,None
2397,4308,NCT04383587,ClinicalTrials.gov,2020-05-07,2020-05-06,True,Mayo Clinic,Not Recruiting,Not Applicable,Interventional,United States,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04383587,None
2398,4309,NCT04383613,ClinicalTrials.gov,2020-05-05,2020-05-15,False,"St. Michael's Hospital, Toronto",Recruiting,Not Applicable,Interventional,Canada,Prone Positioning for Patients on General Medical Wards With COVID19,Procedure,Positioning,Positioning,350,https://clinicaltrials.gov/show/NCT04383613,None
2399,4313,NCT04383717,ClinicalTrials.gov,2020-05-04,2020-05-05,False,Cairo University,Not Recruiting,Phase 3,Interventional,No Country Given,Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial,Drug,Levamisole + Isoprinosine vs. Azithromycin + Hydroxychloroquine,Levamisole; Isoprinosine; Azithromycin; Hydroxychloroquine,60,https://clinicaltrials.gov/show/NCT04383717,None
2400,4321,NCT04384380,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Taoyuan General Hospital,Not Recruiting,Not Applicable,Interventional,Taiwan,Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,33,https://clinicaltrials.gov/show/NCT04384380,None
2401,4324,NCT04384458,ClinicalTrials.gov,2020-05-08,2020-07-20,False,Federal University of Ceara,Recruiting,Not Applicable,Interventional,Brazil,Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis,Drug (Chemoprophylaxis),Hydroxychloroquine + Zinc,Hydroxychloroquine; Zinc,400,https://clinicaltrials.gov/show/NCT04384458,None
2402,4326,NCT04384497,ClinicalTrials.gov,2020-05-07,2020-05-07,False,Joakim Dillner,Recruiting,Phase 1/Phase 2,Interventional,Sweden,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04384497,None
2403,4327,NCT04384549,ClinicalTrials.gov,2020-05-06,2020-05-20,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers,ATMP,Vaccine,Vaccine,1120,https://clinicaltrials.gov/show/NCT04384549,EUCTR2020-001678-31
2404,4328,NCT04384588,ClinicalTrials.gov,2020-04-29,2020-04-07,True,Fundacion Arturo Lopez Perez,Recruiting,Phase 2/Phase 3,Interventional,Chile,COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID),ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04384588,None
2405,4331,NCT04384731,ClinicalTrials.gov,2020-05-07,2020-05-29,False,Dr. Christophe Lenclud,Recruiting,Phase 2,Interventional,France,CurosurfÂ® in Adult Acute Respiratory Distress Syndrome Due to COVID-19,Drug,Poractant alfa,Poractant alfa,20,https://clinicaltrials.gov/show/NCT04384731,None
2406,4333,NCT04384900,ClinicalTrials.gov,2020-05-11,2020-05-11,False,"Copenhagen University Hospital, North Zealand",Recruiting,Not Applicable,Interventional,Denmark,Accelerated Prone Position Ventilation of Patients With COVID-19,Procedure,Positioning,Positioning,150,https://clinicaltrials.gov/show/NCT04384900,None
2407,4335,NCT04384965,ClinicalTrials.gov,2020-05-08,2020-05-12,False,Centre for Addiction and Mental Health,Recruiting,Not Applicable,Interventional,Canada,Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic,Other (psych),Electroconvulsive Therapy,Electroconvulsive Therapy,200,https://clinicaltrials.gov/show/NCT04384965,None
2408,4337,NCT04385017,ClinicalTrials.gov,2020-05-10,2020-05-11,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Role of Inflammasomes in COVID-19 Disease,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04385017,None
2409,4338,NCT04385043,ClinicalTrials.gov,2020-05-04,2020-05-01,True,University of Catanzaro,Recruiting,Phase 2/Phase 3,Interventional,Italy,Hyperimmune Plasma in Patients With COVID-19 Severe Infection,ATMP,Plasma,Plasma,400,https://clinicaltrials.gov/show/NCT04385043,None
2410,4340,NCT04385095,ClinicalTrials.gov,2020-04-24,2020-03-16,False,Synairgen Research Limited,Recruiting,Phase 2,Interventional,United Kingdom,Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection,Drug,Interferon beta,Interferon beta,820,https://clinicaltrials.gov/show/NCT04385095,EUCTR2020-001023-14; ISRCTN14241621
2411,4341,NCT04385108,ClinicalTrials.gov,2020-05-05,2020-03-04,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,Predictive Immune Biomarkers for COVID-19 Pathogenesis,Clinical Presentation,No Intervention,No Intervention,170,https://clinicaltrials.gov/show/NCT04385108,None
2412,4345,NCT04385186,ClinicalTrials.gov,2020-05-06,2020-06-20,False,"National Blood Center Foundation, Hemolife",Not Recruiting,Phase 2,Interventional,Colombia,Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04385186,None
2413,4346,NCT04385199,ClinicalTrials.gov,2020-05-09,2020-05-04,True,Henry Ford Health System,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Patients With COVID-19,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04385199,None
2414,4350,NCT04385264,ClinicalTrials.gov,2020-04-21,2020-05-12,False,University of Lausanne,Not Recruiting,Phase 2/Phase 3,Interventional,Switzerland,#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,800,https://clinicaltrials.gov/show/NCT04385264,None
2415,4351,NCT04385576,ClinicalTrials.gov,2020-04-28,2020-05-15,False,University of Malaya,Recruiting,Not Applicable,Interventional,Malaysia,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box""",Other (physical),Mechanical ventilation,Mechanical ventilation,30,https://clinicaltrials.gov/show/NCT04385576,None
2416,4352,NCT04385771,ClinicalTrials.gov,2020-04-19,2020-09-01,False,Dr. Alexander Supady,Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Other (device),Cytokine Adsorber,Cytokine Adsorber,80,https://clinicaltrials.gov/show/NCT04385771,None
2417,4353,NCT04385810,ClinicalTrials.gov,2020-04-29,2020-04-27,True,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Not Applicable,Interventional,France,Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19,Clinical Presentation,No Intervention,No Intervention,23,https://clinicaltrials.gov/show/NCT04385810,None
2418,4355,NCT04385849,ClinicalTrials.gov,2020-05-07,2020-06-01,False,"ImmunityBio, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19,Drug,N-803,N-803,30,https://clinicaltrials.gov/show/NCT04385849,None
2419,4356,NCT04385901,ClinicalTrials.gov,2020-05-06,2020-05-19,False,University of Missouri-Columbia,Recruiting,Not Applicable,Interventional,United States,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,72,https://clinicaltrials.gov/show/NCT04385901,None
2420,4358,NCT04385940,ClinicalTrials.gov,2020-05-08,2020-06-01,False,University of Alberta,Not Recruiting,Phase 3,Interventional,No Country Given,Vitamin D and COVID-19 Management,Drug,Vitamin D,Vitamin D,64,https://clinicaltrials.gov/show/NCT04385940,None
2421,4360,NCT04386070,ClinicalTrials.gov,2020-04-30,2020-11-15,True,University of Birmingham,Not Recruiting,Phase 3,Interventional,No Country Given,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Drug,Lopinavir/ritonavir vs. Hydroxychloroquine vs. Lopinavir/ritonavir + Hydroxychloroquine,Lopinavir/ritonavir; Hydroxychloroquine,6400,https://clinicaltrials.gov/show/NCT04386070,EUCTR2020-001448-24
2422,4363,NCT04386239,ClinicalTrials.gov,2020-05-07,2020-05-01,True,ASST Fatebenefratelli Sacco,Not Recruiting,Phase 1,Interventional,No Country Given,Study on the Use of Sarilumab in Patients With COVID-19 Infection,Drug,Sarilumab,Sarilumab,40,https://clinicaltrials.gov/show/NCT04386239,None
2423,4365,NCT04386291,ClinicalTrials.gov,2020-05-11,2020-05-25,False,"Research Foundation for Mental Hygiene, Inc.",Recruiting,Not Applicable,Interventional,United States,Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,360,https://clinicaltrials.gov/show/NCT04386291,None
2424,4368,NCT04386447,ClinicalTrials.gov,2020-05-12,2020-09-01,False,AOU di Parma,Not Recruiting,Phase 2,Interventional,"Italy, France",Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19,Drug,Oxytocin,Oxytocin,145,https://clinicaltrials.gov/show/NCT04386447,None
2425,4372,NCT04386668,ClinicalTrials.gov,2020-05-12,2020-05-26,False,"University College, London",Not Recruiting,Not Applicable,Interventional,United Kingdom,Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic,Other (psych),Psychological,Psychological,80,https://clinicaltrials.gov/show/NCT04386668,None
2426,4373,NCT04386694,ClinicalTrials.gov,2020-05-08,2020-05-18,False,University of Nove de Julho,Not Recruiting,Not Applicable,Interventional,Brazil,Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19,Other,Photobiomodulation therapy + static magnetic field,Photobiomodulation therapy; static magnetic field,30,https://clinicaltrials.gov/show/NCT04386694,None
2427,4376,NCT04386850,ClinicalTrials.gov,2020-05-11,2020-04-14,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Oral 25-hydroxyvitamin D3 and COVID-19,Drug,Vitamin D,Vitamin D,1500,https://clinicaltrials.gov/show/NCT04386850,IRCT20200401046909N1; IRCT20200401046909N2
2428,4378,NCT04387240,ClinicalTrials.gov,2020-05-12,2020-12-01,False,Princess Nourah Bint Abdulrahman University,Not Recruiting,Phase 2,Interventional,Saudi Arabia,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19,Drug,Artesunate,Artesunate,22,https://clinicaltrials.gov/show/NCT04387240,None
2429,4379,NCT04387253,ClinicalTrials.gov,2020-05-12,2020-05-23,False,Poitiers University Hospital,Recruiting,Not Applicable,Interventional,France,Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04387253,None
2430,4381,NCT04387292,ClinicalTrials.gov,2020-05-12,2020-09-07,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Not Applicable,Interventional,France,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04387292,None
2431,4382,NCT04387409,ClinicalTrials.gov,2020-05-11,2020-05-25,False,Vakzine Projekt Management GmbH,Not Recruiting,Phase 3,Interventional,Germany,Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic,Drug,VPM1002,VPM1002,59,https://clinicaltrials.gov/show/NCT04387409,None
2432,4384,NCT04387760,ClinicalTrials.gov,2020-05-09,2020-08-11,False,Royal College of Surgeons in Ireland - Medical University of Bahrain,Recruiting,Phase 2,Interventional,Bahrain,Favipiravir vs Hydroxychloroquine in COVID -19,Drug,Hydroxychloroquine vs. Favipiravir,Hydroxychloroquine; Favipiravir,150,https://clinicaltrials.gov/show/NCT04387760,None
2433,4390,NCT04387955,ClinicalTrials.gov,2020-04-29,2020-04-30,False,Poitiers University Hospital,Recruiting,Not Applicable,Interventional,France,Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID),Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04387955,None
2434,4391,NCT04388410,ClinicalTrials.gov,2020-05-12,2020-08-25,False,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19,ATMP,Plasma,Plasma,410,https://clinicaltrials.gov/show/NCT04388410,None
2435,4400,NCT04388683,ClinicalTrials.gov,2020-05-13,2020-05-12,True,Tufts Medical Center,Recruiting,Phase 2,Interventional,United States,Inhaled Nitric Oxide for Preventing Progression in COVID-19,Drug,Nitric Oxide,Nitric Oxide,42,https://clinicaltrials.gov/show/NCT04388683,None
2436,4401,NCT04388709,ClinicalTrials.gov,2020-05-12,2020-09-01,False,Icahn School of Medicine at Mount Sinai,Not Recruiting,Phase 2,Interventional,United States,Interferon Lambda Therapy for COVID-19,Drug,Interferon lambda,Interferon lambda,66,https://clinicaltrials.gov/show/NCT04388709,None
2437,4403,NCT04389294,ClinicalTrials.gov,2020-05-08,2020-05-05,True,"Hospital for Special Surgery, New York",Recruiting,Not Applicable,Interventional,United States,HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04389294,None
2438,4405,NCT04389333,ClinicalTrials.gov,2020-05-09,2020-03-26,True,Changhai Hospital,Not Recruiting,Not Applicable,Interventional,China,Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic,Other,Other,Other,40,https://clinicaltrials.gov/show/NCT04389333,None
2439,4406,NCT04389359,ClinicalTrials.gov,2020-05-12,2020-09-01,True,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1500,https://clinicaltrials.gov/show/NCT04389359,EUCTR2020-004144-28; ISRCTN88057279
2440,4407,NCT04389372,ClinicalTrials.gov,2020-05-05,2020-03-15,True,Fondazione IRCCS Istituto Neurologico Carlo Besta,Recruiting,Not Applicable,Interventional,Italy,"Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse",Other (psych),Psychological,Psychological,50,https://clinicaltrials.gov/show/NCT04389372,None
2441,4408,NCT04389385,ClinicalTrials.gov,2020-05-12,2020-05-01,True,TC Erciyes University,Not Recruiting,Phase 1,Interventional,Turkey,COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo),ATMP,Exosomes,Exosomes,60,https://clinicaltrials.gov/show/NCT04389385,None
2442,4409,NCT04389411,ClinicalTrials.gov,2020-05-13,2020-10-01,False,McGill University,Not Recruiting,Phase 3,Interventional,No Country Given,The COvid-19 Symptom MOntelukast Trial,Drug,Montelukast,Montelukast,600,https://clinicaltrials.gov/show/NCT04389411,None
2443,4410,NCT04389450,ClinicalTrials.gov,2020-05-14,2020-10-01,False,Pluristem Ltd.,Recruiting,Phase 2,Interventional,"Israel, United States","Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19",ATMP,Cells (mesenchymal),Cells (mesenchymal),140,https://clinicaltrials.gov/show/NCT04389450,None
2444,4417,NCT04389580,ClinicalTrials.gov,2020-05-12,2020-06-01,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,No Country Given,Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus,Drug,Isotretinoin + Tamoxifen,Isotretinoin; Tamoxifen,160,https://clinicaltrials.gov/show/NCT04389580,None
2445,4420,NCT04389671,ClinicalTrials.gov,2020-05-13,2020-10-01,False,Windtree Therapeutics,Not Recruiting,Phase 1/Phase 2,Interventional,United States,The Safety and Preliminary Efficacy of Lucinactant in Adults With COVID-19,Drug,Lucinactant,Lucinactant,30,https://clinicaltrials.gov/show/NCT04389671,None
2446,4422,NCT04389710,ClinicalTrials.gov,2020-04-27,2020-04-15,True,Thomas Jefferson University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for the Treatment of COVID-19,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04389710,None
2447,4423,NCT04389801,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Hesham Al-Inany,Not Recruiting,Phase 4,Interventional,No Country Given,Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection,Drug,Deferoxamine,Deferoxamine,200,https://clinicaltrials.gov/show/NCT04389801,None
2448,4424,NCT04389840,ClinicalTrials.gov,2020-05-13,2020-06-03,False,Chimerix,Recruiting,Phase 2/Phase 3,Interventional,United States,Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure,Drug,Heparin,Heparin,524,https://clinicaltrials.gov/show/NCT04389840,None
2449,4425,NCT04389944,ClinicalTrials.gov,2020-05-12,2020-03-31,True,"University Hospital, Basel",Not Recruiting,Not Applicable,Interventional,Switzerland,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19,ATMP,Plasma,Plasma,15,https://clinicaltrials.gov/show/NCT04389944,None
2450,4427,NCT04390022,ClinicalTrials.gov,2020-05-07,2020-07-31,False,Clínica Universidad de Navarra,Not Recruiting,Phase 2,Interventional,Spain,Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial,Drug,Ivermectin,Ivermectin,24,https://clinicaltrials.gov/show/NCT04390022,None
2451,4428,NCT04390061,ClinicalTrials.gov,2020-05-13,2020-06-01,True,Universit Politecnica delle Marche,Not Recruiting,Phase 2,Interventional,No Country Given,TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia,Drug,Tofacitinib + Hydroxycloroquine vs. Hydroxycloroquine,Tofacitinib; Hydroxycloroquine,116,https://clinicaltrials.gov/show/NCT04390061,EUCTR2020-002035-30
2452,4431,NCT04390139,ClinicalTrials.gov,2020-05-07,2020-05-13,False,Banc de Sang i Teixits,Recruiting,Phase 1/Phase 2,Interventional,Spain,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04390139,None
2453,4432,NCT04390152,ClinicalTrials.gov,2020-05-12,2020-09-01,False,BioXcellerator,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04390152,None
2454,4434,NCT04390178,ClinicalTrials.gov,2020-04-10,2020-04-10,False,Joakim Dillner,Not Recruiting,Phase 1/Phase 2,Interventional,Sweden,Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19),ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04390178,None
2455,4435,NCT04390191,ClinicalTrials.gov,2020-05-12,2020-05-07,True,Icahn School of Medicine at Mount Sinai,Recruiting,Not Applicable,Interventional,United States,Early CPAP in COVID-19 Confirmed or Suspected Patients,Other (device),CPAP,CPAP,200,https://clinicaltrials.gov/show/NCT04390191,None
2456,4436,NCT04390217,ClinicalTrials.gov,2020-05-13,2020-10-31,False,"Leading BioSciences, Inc",Not Recruiting,Phase 2,Interventional,No Country Given,LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia,Drug,LB1148,LB1148,120,https://clinicaltrials.gov/show/NCT04390217,None
2457,4438,NCT04390412,ClinicalTrials.gov,2020-05-13,2020-05-04,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Low Dose Radiotherapy in COVID-19 Pneumonia,Other,Radiation,Radiation,5,https://clinicaltrials.gov/show/NCT04390412,IRCT20200509047366N1
2458,4439,NCT04390464,ClinicalTrials.gov,2020-05-08,2020-05-08,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Phase 4,Interventional,United Kingdom,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),Drug,Ravulizumab vs. Baricitinib,Ravulizumab; Baricitinib,1167,https://clinicaltrials.gov/show/NCT04390464,EUCTR2020-001354-22; ISRCTN11188345
2459,4440,NCT04390477,ClinicalTrials.gov,2020-05-07,2020-05-04,True,Bioithas SL,Recruiting,Not Applicable,Interventional,Spain,Study to Evaluate the Effect of a Probiotic in COVID-19,Supplement,Probiotics,Probiotics,40,https://clinicaltrials.gov/show/NCT04390477,None
2460,4441,NCT04390503,ClinicalTrials.gov,2020-05-14,2020-05-01,True,Columbia University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for COVID-19 Close Contacts,ATMP,Plasma,Plasma,200,https://clinicaltrials.gov/show/NCT04390503,None
2461,4442,NCT04390516,ClinicalTrials.gov,2020-05-14,2020-03-24,True,Dascena,Not Recruiting,Not Applicable,Interventional,United States,Respiratory Decompensation and Model for the Triage of COVID-19 Patients,Prognosis,No Intervention,No Intervention,197,https://clinicaltrials.gov/show/NCT04390516,None
2462,4444,NCT04390594,ClinicalTrials.gov,2020-05-14,2020-08-13,False,Institut Pasteur,Recruiting,Phase 3,Interventional,Senegal,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,186,https://clinicaltrials.gov/show/NCT04390594,None
2463,4445,NCT04391101,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Hospital San Vicente Fundación,Not Recruiting,Phase 3,Interventional,Colombia,Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19),ATMP,Plasma,Plasma,231,https://clinicaltrials.gov/show/NCT04391101,None
2464,4446,NCT04391127,ClinicalTrials.gov,2020-05-12,2020-05-04,True,Centenario Hospital Miguel Hidalgo,Not Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection,Drug,Hydroxychloroquine vs. Ivermectin,Hydroxychloroquine; Ivermectin,108,https://clinicaltrials.gov/show/NCT04391127,None
2465,4447,NCT04391140,ClinicalTrials.gov,2020-05-10,2020-05-13,False,Vall d'Hebron Research Institute (VHIR),Recruiting,Not Applicable,Interventional,Spain,Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS,Procedure,Positioning,Positioning,248,https://clinicaltrials.gov/show/NCT04391140,None
2466,4449,NCT04391179,ClinicalTrials.gov,2020-05-15,2020-05-31,False,University of Michigan,Recruiting,Phase 2,Interventional,United States,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19,Drug,Dipyridamole,Dipyridamole,80,https://clinicaltrials.gov/show/NCT04391179,None
2467,4450,NCT04391309,ClinicalTrials.gov,2020-05-14,2020-07-01,False,Implicit Bioscience,Not Recruiting,Phase 2,Interventional,United States,IC14 (Anti-CD14) Treatment in Patients With SARS-CoV-2 (COVID-19),Drug,IC14,IC14,300,https://clinicaltrials.gov/show/NCT04391309,None
2468,4453,NCT04391712,ClinicalTrials.gov,2020-05-04,2020-04-30,True,Lowell General Hospital,Not Recruiting,Phase 2,Interventional,United States,Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease,Other (device),Cold Laser Therapy,Cold Laser Therapy,10,https://clinicaltrials.gov/show/NCT04391712,None
2469,4455,NCT04391829,ClinicalTrials.gov,2020-05-13,2020-08-31,False,UZ Brussel,Recruiting,Not Applicable,Interventional,Belgium,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04391829,None
2470,4460,NCT04392115,ClinicalTrials.gov,2020-05-15,2020-06-15,False,Ottawa Hospital Research Institute,Not Recruiting,Not Applicable,Interventional,No Country Given,The PREPARE for COVID Trial,Other (exercise),Exercise,Exercise,372,https://clinicaltrials.gov/show/NCT04392115,None
2471,4461,NCT04392128,ClinicalTrials.gov,2020-05-15,2020-09-02,False,Institut de Cancérologie Strasbourg Europe (ICANS),Not Recruiting,Phase 2,Interventional,France,Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE),Drug,Hydroxychloroquine vs. Azithromycin,Hydroxychloroquine; Azithromycin,0,https://clinicaltrials.gov/show/NCT04392128,None
2472,4462,NCT04392141,ClinicalTrials.gov,2020-05-15,2020-04-01,False,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Colchicine Plus Phenolic Monoterpenes to Treat COVID-19,Drug,Colchicine + Phenolic Monoterpenes,Colchicine; Phenolic Monoterpenes,200,https://clinicaltrials.gov/show/NCT04392141,IRCT20150623022884N3
2473,4463,NCT04392219,ClinicalTrials.gov,2020-04-29,2020-04-10,True,Ridgeback Biotherapeutics,Not Recruiting,Phase 1,Interventional,"United Kingdom, United States","COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers",Drug,EIDD-2801,EIDD-2801,130,https://clinicaltrials.gov/show/NCT04392219,None
2474,4464,NCT04392232,ClinicalTrials.gov,2020-05-15,2020-05-05,True,TriHealth Inc.,Recruiting,Phase 2,Interventional,United States,A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04392232,None
2475,4466,NCT04392323,ClinicalTrials.gov,2020-05-15,2020-05-13,True,Northwell Health,Recruiting,Not Applicable,Interventional,United States,Incidence of COVID-19 Test Conversion in Post-surgical Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04392323,None
2476,4469,NCT04392414,ClinicalTrials.gov,2020-05-13,2020-05-01,True,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",Not Recruiting,Phase 2,Interventional,Russian Federation,Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04392414,None
2477,4470,NCT04392427,ClinicalTrials.gov,2020-05-12,2020-10-01,False,Mansoura University,Not Recruiting,Phase 3,Interventional,Egypt,New Antiviral Drugs for Treatment of COVID-19,Drug,Nitazoxanide + Ribavirin + Ivermectin,Nitazoxanide; Ribavirin; Ivermectin,100,https://clinicaltrials.gov/show/NCT04392427,None
2478,4471,NCT04392453,ClinicalTrials.gov,2020-05-15,2020-05-01,True,Fondazione Don Carlo Gnocchi Onlus,Not Recruiting,Not Applicable,Interventional,No Country Given,Upper Limb Robotic Rehabilitation During COVID-19 Outbreak,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,40,https://clinicaltrials.gov/show/NCT04392453,None
2479,4472,NCT04392713,ClinicalTrials.gov,2020-05-05,2020-04-15,True,"Combined Military Hospital, Pakistan",Recruiting,Not Applicable,Interventional,Pakistan,Efficacy of Ivermectin in COVID-19,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04392713,None
2480,4473,NCT04392778,ClinicalTrials.gov,2020-04-25,2020-04-01,True,SBu Dr. Sadi Konuk Egitim ve Arastirma Hastanesi,Recruiting,Phase 1/Phase 2,Interventional,Turkey,Clinical Use of Stem Cells for the Treatment of Covid-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04392778,None
2481,4474,NCT04392869,ClinicalTrials.gov,2020-05-09,2019-10-23,True,University of Granada,Not Recruiting,Not Applicable,Interventional,Spain,The Effects of Mindfulness-based Training in Undergraduate Students of Translation and Interpreting,Other (psych),Psychological,Psychological,75,https://clinicaltrials.gov/show/NCT04392869,None
2482,4475,NCT04392973,ClinicalTrials.gov,2020-05-10,2020-05-21,False,King Abdullah International Medical Research Center,Recruiting,Not Applicable,Interventional,Saudi Arabia,FAvipiravir and HydroxyChloroquine Combination Therapy,Drug,Favipiravir + Hydroxychloroquine,Favipiravir; Hydroxychloroquine,520,https://clinicaltrials.gov/show/NCT04392973,None
2483,4476,NCT04393038,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Abivax S.A.,Recruiting,Phase 2/Phase 3,Interventional,"Belgium, United Kingdom, Italy, France, Brazil, Germany, Spain, Mexico",ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19,Drug,ABX464,ABX464,1034,https://clinicaltrials.gov/show/NCT04393038,PER-069-20; EUCTR2020-001673-75
2484,4477,NCT04393051,ClinicalTrials.gov,2020-05-16,2020-05-20,False,AOU Pisana,Not Recruiting,Phase 2,Interventional,Italy,Baricitinib Compared to Standard Therapy in Patients With COVID-19,Drug,Baricitinib,Baricitinib,126,https://clinicaltrials.gov/show/NCT04393051,None
2485,4478,NCT04393077,ClinicalTrials.gov,2020-05-11,2020-05-10,True,Istanbul Saglik Bilimleri University,Not Recruiting,Not Applicable,Interventional,Turkey,Emotional Freedom Technique (EFT) Effect on Nurses,Other (psych),Psychological,Psychological,80,https://clinicaltrials.gov/show/NCT04393077,None
2486,4481,NCT04393246,ClinicalTrials.gov,2020-05-16,2020-07-03,False,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms,Drug,EDP1815 vs. Ambrisentan + Dapagliflozin,EDP1815; Ambrisentan; Dapagliflozin,1407,https://clinicaltrials.gov/show/NCT04393246,None
2487,4482,NCT04393311,ClinicalTrials.gov,2020-05-15,2020-12-01,False,Stanford University,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients,Drug,Ulinastatin,Ulinastatin,160,https://clinicaltrials.gov/show/NCT04393311,None
2488,4485,NCT04393415,ClinicalTrials.gov,2020-05-15,2020-05-25,False,Aljazeera Hospital,Recruiting,Not Applicable,Interventional,Egypt,Using PRP and Cord Blood in Treatment of Covid -19,ATMP,Cells (stem cells),Cells (stem cells),100,https://clinicaltrials.gov/show/NCT04393415,None
2489,4488,NCT04393636,ClinicalTrials.gov,2020-05-11,2020-06-05,False,Academic Hospital Maastricht,Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,Other (software),eHealth,eHealth,394,https://clinicaltrials.gov/show/NCT04393636,None
2490,4490,NCT04393727,ClinicalTrials.gov,2020-05-16,2020-05-01,True,AOU Pisana,Not Recruiting,Phase 2,Interventional,Italy,Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19,ATMP,Plasma,Plasma,1,https://clinicaltrials.gov/show/NCT04393727,None
2491,4491,NCT04393792,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Hampshire Hospitals NHS Foundation Trust,Recruiting,Phase 1,Interventional,United Kingdom,SINUS WASH Pilot Study in Adults Testing Positive for COVID-19,Drug,Povidone Iodine,Povidone Iodine,40,https://clinicaltrials.gov/show/NCT04393792,EUCTR2020-001721-31
2492,4493,NCT04393818,ClinicalTrials.gov,2020-05-18,2020-05-05,True,Fundació d'investigació Sanitària de les Illes Balears,Not Recruiting,Phase 3,Interventional,Spain,Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19,Other (psych),Psychological,Psychological,560,https://clinicaltrials.gov/show/NCT04393818,None
2493,4494,NCT04393948,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Brigham and Women's Hospital,Recruiting,Not Applicable,Interventional,United States,Lung Irradiation for COVID-19 Pneumonia,Other,Radiation,Radiation,48,https://clinicaltrials.gov/show/NCT04393948,None
2494,4495,NCT04393961,ClinicalTrials.gov,2020-04-24,2020-04-05,True,ProofPilot,Recruiting,Not Applicable,Interventional,United States,At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,https://clinicaltrials.gov/show/NCT04393961,None
2495,4498,NCT04394013,ClinicalTrials.gov,2020-05-18,2020-08-26,False,Monash University Malaysia,Recruiting,Not Applicable,Interventional,Malaysia,A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period,Other (psych),Psychological,Psychological,70,https://clinicaltrials.gov/show/NCT04394013,None
2496,4500,NCT04394039,ClinicalTrials.gov,2020-05-13,2020-06-01,False,"National University, Singapore",Not Recruiting,Not Applicable,Interventional,Singapore,Post-Pandemic Perception of Public Space in Singapore,Other,No Intervention,No Intervention,34,https://clinicaltrials.gov/show/NCT04394039,None
2497,4502,NCT04394117,ClinicalTrials.gov,2020-05-18,2020-06-19,False,The George Institute for Global Health,Recruiting,Phase 4,Interventional,Australia,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease,Drug,ARBs,ARBs,605,https://clinicaltrials.gov/show/NCT04394117,None
2498,4503,NCT04394169,ClinicalTrials.gov,2020-05-13,2020-05-25,False,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Interventional,Spain,Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.,Other,Other,Other,102,https://clinicaltrials.gov/show/NCT04394169,None
2499,4504,NCT04394182,ClinicalTrials.gov,2020-05-15,2020-04-21,True,Fundación Genesiscare,Recruiting,Not Applicable,Interventional,Spain,Ultra Low Doses of Therapy With Radiation Applicated to COVID-19,Other,"Radiation (with Lopinavir/ritonavir, Hydroxychloroquine, Azithromycin, Piperacillin/tazobactam, Heparin, Corticosteroids, Tocilizumab)",Radiation; Lopinavir/ritonavir; Hydroxychloroquine; Azithromycin; Piperacillin/tazobactam; Heparin; Methylprednisolone; Tocilizumab,15,https://clinicaltrials.gov/show/NCT04394182,None
2500,4506,NCT04394208,ClinicalTrials.gov,2020-05-15,2020-08-16,False,Cairo University,Recruiting,Phase 3,Interventional,Egypt,Silymarin in COVID-19 Pneumonia,Drug,Silymarin,Silymarin,50,https://clinicaltrials.gov/show/NCT04394208,None
2501,4507,NCT04394377,ClinicalTrials.gov,2020-05-08,2020-06-21,False,Brazilian Clinical Research Institute,Recruiting,Phase 4,Interventional,Brazil,Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial,Drug,Rivaroxaban + Heparin,Rivaroxaban; Heparin,600,https://clinicaltrials.gov/show/NCT04394377,None
2502,4509,NCT04394403,ClinicalTrials.gov,2020-05-13,2020-05-14,False,Hebrew University of Jerusalem,Recruiting,Not Applicable,Interventional,Israel,Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress,Other (psych),Psychological,Psychological,120,https://clinicaltrials.gov/show/NCT04394403,None
2503,4510,NCT04394416,ClinicalTrials.gov,2020-05-08,2020-06-02,False,"University of Maryland, Baltimore",Recruiting,Phase 3,Interventional,United States,Trial of Imatinib for Hospitalized Adults With COVID-19,Drug,Imatinib,Imatinib,204,https://clinicaltrials.gov/show/NCT04394416,None
2504,4512,NCT04394442,ClinicalTrials.gov,2020-05-17,2020-03-21,True,Samah Lutfy,Recruiting,Phase 2,Interventional,Saudi Arabia,Hydroxychloroquine in COVID-19 Patients,Drug,Hydroxychloroquine,Hydroxychloroquine,200,https://clinicaltrials.gov/show/NCT04394442,None
2505,4513,NCT04394455,ClinicalTrials.gov,2020-05-03,2020-06-30,False,Universidad Nacional Autónoma de Honduras,Recruiting,Not Applicable,Interventional,Honduras,Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms,Other (psych),Psychological,Psychological,236,https://clinicaltrials.gov/show/NCT04394455,None
2506,4514,NCT04394793,ClinicalTrials.gov,2020-05-17,2020-06-13,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Low Dose Radiation Therapy for Covid-19 Pneumonia,Other,Radiation,Radiation,10,https://clinicaltrials.gov/show/NCT04394793,None
2507,4515,NCT04395105,ClinicalTrials.gov,2020-05-16,2020-05-21,False,Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,Recruiting,Phase 3,Interventional,Argentina,"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial",Drug,Corticosteroids,Dexamethasone,284,https://clinicaltrials.gov/show/NCT04395105,None
2508,4516,NCT04395144,ClinicalTrials.gov,2020-05-15,2020-05-15,False,Hôpital de Verdun,Recruiting,Not Applicable,Interventional,Canada,COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss,Procedure,Positioning,Positioning,346,https://clinicaltrials.gov/show/NCT04395144,None
2509,4517,NCT04395170,ClinicalTrials.gov,2020-05-15,2020-09-01,False,Lifefactors Zona Franca,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.,ATMP,Plasma vs. Immunoglobulin,Plasma; Immunoglobulin,75,https://clinicaltrials.gov/show/NCT04395170,None
2510,4520,NCT04395430,ClinicalTrials.gov,2020-02-03,2020-09-01,False,KK Women's and Children's Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19,Other (exercise),Exercise,Exercise,40,https://clinicaltrials.gov/show/NCT04395430,None
2511,4521,NCT04395456,ClinicalTrials.gov,2020-05-19,2020-07-01,False,Amyndas Pharmaceuticals S.A.,Not Recruiting,Phase 2,Interventional,No Country Given,A Phase 2 Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE),Drug,AMY-101,AMY-101,144,https://clinicaltrials.gov/show/NCT04395456,None
2512,4524,NCT04395599,ClinicalTrials.gov,2020-05-19,2020-05-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Interventional,No Country Given,Risk of Air Contamination During Visceral Surgery in COVID19 Patients,Other,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04395599,None
2513,4526,NCT04395716,ClinicalTrials.gov,2020-05-19,2020-07-01,False,ProgenaBiome,Not Recruiting,Phase 1,Interventional,United States,A Study of ResCureâ„¢ to Treat COVID-19 Infection,Drug,Unspecified Therapy,Unspecified Therapy,50,https://clinicaltrials.gov/show/NCT04395716,None
2514,4529,NCT04395768,ClinicalTrials.gov,2020-05-18,2020-09-09,False,"National Institute of Integrative Medicine, Australia",Recruiting,Phase 2,Interventional,Australia,International ALLIANCE Study of Therapies to Prevent Progression of COVID-19,Drug,Vitamin C + Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B vs. Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B ,Vitamin C; Hydroxychloroquine; Azithromycin; Zinc; Vitamin D; Vitamin B,200,https://clinicaltrials.gov/show/NCT04395768,None
2515,4532,NCT04395807,ClinicalTrials.gov,2020-05-18,2020-06-03,False,Lund University,Recruiting,Not Applicable,Interventional,Sweden,Helmet CPAP Versus HFNC in COVID-19,Other (device),CPAP vs. Nasal cannula,CPAP; Nasal cannula,120,https://clinicaltrials.gov/show/NCT04395807,None
2516,4538,NCT04395976,ClinicalTrials.gov,2020-05-19,2020-06-10,False,British Ayurvedic Medical Council,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda as Prophylaxis for Suspected COVID-19 Patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,https://clinicaltrials.gov/show/NCT04395976,None
2517,4539,NCT04396067,ClinicalTrials.gov,2020-05-18,2020-10-01,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,No Country Given,Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment,Drug,Retinoic acid,Retinoic acid,360,https://clinicaltrials.gov/show/NCT04396067,None
2518,4540,NCT04396106,ClinicalTrials.gov,2020-05-16,2020-05-26,True,"Atea Pharmaceuticals, Inc.",Recruiting,Phase 2,Interventional,"Belgium, South Africa, Ukraine, Brazil, Romania, United States, Moldova, Republic of",Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19),Drug,AT-527,AT-527,190,https://clinicaltrials.gov/show/NCT04396106,EUCTR2020-002869-34
2519,4543,NCT04396314,ClinicalTrials.gov,2020-05-15,2021-01-01,False,University of Lleida,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness of Basic Body Awareness Therapy in Post-traumatic Stress Disorders: A Randomized Clinical Trial,Other (psych),Psychological,Psychological,54,https://clinicaltrials.gov/show/NCT04396314,None
2520,4548,NCT04397328,ClinicalTrials.gov,2020-05-13,2020-05-19,False,Lawson Health Research Institute,Not Recruiting,Phase 3,Interventional,No Country Given,COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,336,https://clinicaltrials.gov/show/NCT04397328,None
2521,4551,NCT04397497,ClinicalTrials.gov,2020-05-20,2020-05-22,False,IRCCS Ospedale San Raffaele,Not Recruiting,Phase 2,Interventional,Italy,Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19),Drug,Mavrilimumab,Mavrilimumab,50,https://clinicaltrials.gov/show/NCT04397497,None
2522,4552,NCT04397523,ClinicalTrials.gov,2020-05-20,2020-04-30,True,Institute for Transfusion Medicine of RNM,Recruiting,Not Applicable,Interventional,North Macedonia,Efficacy and Safety of COVID-19 Convalescent Plasma,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04397523,None
2523,4553,NCT04397562,ClinicalTrials.gov,2020-05-19,2020-04-29,True,Biocad,Not Recruiting,Phase 3,Interventional,Russian Federation,A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19,Drug,Levilimab,Levilimab,206,https://clinicaltrials.gov/show/NCT04397562,None
2524,4557,NCT04397666,ClinicalTrials.gov,2020-05-20,2020-05-15,True,Versailles Hospital,Recruiting,Not Applicable,Interventional,France,RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,68,https://clinicaltrials.gov/show/NCT04397666,None
2525,4558,NCT04397692,ClinicalTrials.gov,2020-05-19,2020-06-13,False,Beyond Air Inc.,Recruiting,Not Applicable,Interventional,United States,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial),Drug,Nitric Oxide,Nitric Oxide,20,https://clinicaltrials.gov/show/NCT04397692,None
2526,4559,NCT04397705,ClinicalTrials.gov,2020-05-20,2020-06-01,False,The Christie NHS Foundation Trust,Not Recruiting,Phase 1,Interventional,United Kingdom,Remote Monitoring of Cancer Patients With Suspected Covid-19,Other (device),Biosensors,Biosensors,30,https://clinicaltrials.gov/show/NCT04397705,None
2527,4560,NCT04397796,ClinicalTrials.gov,2020-05-18,2020-08-03,False,"NantKwest, Inc.",Recruiting,Phase 1,Interventional,United States,Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation,ATMP,Cells (mesenchymal),Cells (mesenchymal),45,https://clinicaltrials.gov/show/NCT04397796,None
2528,4566,NCT04398004,ClinicalTrials.gov,2020-05-17,2020-05-06,True,Hellenic Institute for the Study of Sepsis,Not Recruiting,Phase 2,Interventional,Greece,Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early,Drug,Clarithromycin,Clarithromycin,90,https://clinicaltrials.gov/show/NCT04398004,EUCTR2020-001882-36
2529,4568,NCT04398147,ClinicalTrials.gov,2020-05-18,2020-08-01,False,CanSino Biologics Inc.,Not Recruiting,Phase 1/Phase 2,Interventional,Canada,Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada,ATMP,Vaccine,Vaccine,696,https://clinicaltrials.gov/show/NCT04398147,None
2530,4570,NCT04398277,ClinicalTrials.gov,2020-05-20,2020-05-01,True,Kent State University,Recruiting,Not Applicable,Interventional,United States,A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic,Other (psych),Psychological,Psychological,1000,https://clinicaltrials.gov/show/NCT04398277,None
2531,4571,NCT04398290,ClinicalTrials.gov,2020-05-20,2020-12-01,False,Roger Alvarez,Not Recruiting,Phase 2,Interventional,United States,iNOPulse for COVID-19,Drug,Nitric Oxide,Nitric Oxide,0,https://clinicaltrials.gov/show/NCT04398290,None
2532,4572,NCT04398303,ClinicalTrials.gov,2020-05-20,2020-05-01,True,Aspire Health Science,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,ACT-20 in Patients With Severe COVID-19 Pneumonia,Drug,ACT-20,ACT-20,70,https://clinicaltrials.gov/show/NCT04398303,None
2533,4573,NCT04399005,ClinicalTrials.gov,2020-05-19,2020-05-25,False,The First Affiliated Hospital of Zhejiang Chinese Medical University,Not Recruiting,Not Applicable,Interventional,China,The Efficacy Comparing Daily and After-each-case Room Disinfection.,Other,Other,Other,240,https://clinicaltrials.gov/show/NCT04399005,None
2534,4574,NCT04399109,ClinicalTrials.gov,2020-05-21,2020-05-20,True,Dr. Sze-Yuan Ooi,Recruiting,Not Applicable,Interventional,Australia,Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER),Other (software),eHealth,eHealth,2000,https://clinicaltrials.gov/show/NCT04399109,None
2535,4575,NCT04399252,ClinicalTrials.gov,2020-05-19,2020-06-24,False,Duke University,Recruiting,Not Applicable,Interventional,United States,Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19,Supplement,Lactobaciltus rhamnosus,Lactobaciltus rhamnosus,1000,https://clinicaltrials.gov/show/NCT04399252,None
2536,4576,NCT04399317,ClinicalTrials.gov,2020-05-18,2020-05-28,False,Hamad Medical Corporation,Recruiting,Not Applicable,Interventional,Qatar,Flow Controlled Ventilation in ARDS Associated With COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,20,https://clinicaltrials.gov/show/NCT04399317,None
2537,4577,NCT04399356,ClinicalTrials.gov,2020-05-19,2020-10-01,False,Tufts Medical Center,Recruiting,Phase 2,Interventional,United States,Niclosamide for Mild to Moderate COVID-19,Drug,Niclosamide,Niclosamide,100,https://clinicaltrials.gov/show/NCT04399356,None
2538,4579,NCT04399681,ClinicalTrials.gov,2020-05-21,2020-05-10,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04399681,None
2539,4581,NCT04399746,ClinicalTrials.gov,2020-05-19,2020-03-15,True,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,Recruiting,Not Applicable,Interventional,Mexico,Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19,Drug,Ivermectin + Azithromycin + Cholecalciferol,Ivermectin; Azithromycin; Cholecalciferol,30,https://clinicaltrials.gov/show/NCT04399746,None
2540,4582,NCT04399798,ClinicalTrials.gov,2020-05-13,2020-05-15,False,IRCCS Policlinico San Matteo,Not Recruiting,Phase 2,Interventional,No Country Given,Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial,Drug,Baricitinib,Baricitinib,13,https://clinicaltrials.gov/show/NCT04399798,None
2541,4583,NCT04399889,ClinicalTrials.gov,2020-05-21,2020-06-18,False,"Joanne Kurtzberg, MD",Recruiting,Phase 1/Phase 2,Interventional,United States,hCT-MSCs for COVID19 ARDS,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04399889,None
2542,4584,NCT04399967,ClinicalTrials.gov,2020-05-19,2020-06-13,False,University of Hong Kong,Recruiting,Not Applicable,Interventional,China,"COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via ""Quit to Win"" Contest 2020",Other,Other,Other,842,https://clinicaltrials.gov/show/NCT04399967,None
2543,4585,NCT04399980,ClinicalTrials.gov,2020-05-21,2020-05-20,True,The Cleveland Clinic,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,30,https://clinicaltrials.gov/show/NCT04399980,None
2544,4587,NCT04400019,ClinicalTrials.gov,2020-05-20,2020-09-01,False,University of Malaga,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1930,https://clinicaltrials.gov/show/NCT04400019,None
2545,4588,NCT04400032,ClinicalTrials.gov,2020-04-27,2020-05-15,False,Ottawa Hospital Research Institute,Recruiting,Phase 1,Interventional,Canada,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome - Vanguard,ATMP,Cells (mesenchymal),Cells (mesenchymal),9,https://clinicaltrials.gov/show/NCT04400032,None
2546,4589,NCT04400058,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Octapharma,Recruiting,Phase 3,Interventional,United States,Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression,ATMP,Immunoglobulin,Immunoglobulin,208,https://clinicaltrials.gov/show/NCT04400058,None
2547,4590,NCT04400279,ClinicalTrials.gov,2020-05-21,2020-06-01,False,University of British Columbia,Not Recruiting,Not Applicable,Interventional,Canada,The COVID-19 Pandemic and Exercise Study,Other (exercise),Exercise,Exercise,334,https://clinicaltrials.gov/show/NCT04400279,None
2548,4591,NCT04400305,ClinicalTrials.gov,2020-05-21,2020-05-20,True,University of Victoria,Recruiting,Not Applicable,Interventional,Canada,"""Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention""",Other (software),eHealth,eHealth,40,https://clinicaltrials.gov/show/NCT04400305,None
2549,4594,NCT04400799,ClinicalTrials.gov,2020-05-15,2020-06-15,False,University of Zurich,Recruiting,Phase 3,Interventional,Switzerland,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19,Drug,Heparin,Heparin,1000,https://clinicaltrials.gov/show/NCT04400799,None
2550,4597,NCT04400890,ClinicalTrials.gov,2020-05-22,2020-09-12,False,Dr. Marvin McCreary,Recruiting,Phase 2,Interventional,United States,Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of a Plant Polyphenol for COVID-19,Drug,Resveratrol,Resveratrol,200,https://clinicaltrials.gov/show/NCT04400890,None
2551,4598,NCT04400929,ClinicalTrials.gov,2020-05-08,2020-06-02,False,Singapore General Hospital,Recruiting,Phase 2,Interventional,Singapore,Using GM-CSF as a Host Directed Therapeutic Against COVID-19,Drug,Sargramostim,Sargramostim,30,https://clinicaltrials.gov/show/NCT04400929,None
2552,4600,NCT04401046,ClinicalTrials.gov,2020-05-22,2020-05-20,True,Institut Paoli-Calmettes,Recruiting,Not Applicable,Interventional,France,COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,Other (psych),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04401046,None
2553,4606,NCT04401150,ClinicalTrials.gov,2020-05-21,2020-08-14,False,University of Sherbrooke,Recruiting,Phase 3,Interventional,Canada,Lessening Organ Dysfunction With VITamin C - COVID-19,Drug,Vitamin C,Vitamin C,800,https://clinicaltrials.gov/show/NCT04401150,None
2554,4608,NCT04401202,ClinicalTrials.gov,2020-05-21,2020-05-21,False,King Abdulaziz University,Recruiting,Phase 2,Interventional,Saudi Arabia,Nigella Sativa in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,https://clinicaltrials.gov/show/NCT04401202,None
2555,4613,NCT04401410,ClinicalTrials.gov,2020-05-21,2020-11-04,False,Baylor University,Recruiting,Phase 1,Interventional,United States,Anti-SARS Cov-2 T Cell Infusions for COVID 19,ATMP,Cells (T),Cells (T),58,https://clinicaltrials.gov/show/NCT04401410,None
2556,4614,NCT04401423,ClinicalTrials.gov,2020-05-21,2020-08-01,False,Columbia University,Recruiting,Phase 2,Interventional,United States,TXA127 for the Treatment of Severe COVID-19,Drug,TXA127,TXA127,100,https://clinicaltrials.gov/show/NCT04401423,None
2557,4616,NCT04401475,ClinicalTrials.gov,2020-05-21,2020-09-01,False,Edesa Biotech Inc.,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With Moderate to Severe COVID-19",Drug,EB05,EB05,865,https://clinicaltrials.gov/show/NCT04401475,None
2558,4617,NCT04401527,ClinicalTrials.gov,2020-05-21,2020-07-22,False,Hope Pharmaceuticals,Not Recruiting,Phase 2,Interventional,United States,Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite,Drug,Sodium Nitrite,Sodium Nitrite,0,https://clinicaltrials.gov/show/NCT04401527,None
2559,4619,NCT04401644,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Somerset NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04401644,None
2560,4620,NCT04402060,ClinicalTrials.gov,2020-05-22,2020-05-28,False,"Apellis Pharmaceuticals, Inc.",Recruiting,Phase 1/Phase 2,Interventional,"Brazil, United States",A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19,Drug,APL-9,APL-9,66,https://clinicaltrials.gov/show/NCT04402060,None
2561,4621,NCT04402203,ClinicalTrials.gov,2020-05-19,2020-05-01,True,Bangladesh Medical Research Council (BMRC),Recruiting,Phase 2/Phase 3,Interventional,Bangladesh,Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh,Drug,Favipiravir,Favipiravir,50,https://clinicaltrials.gov/show/NCT04402203,None
2562,4625,NCT04402840,ClinicalTrials.gov,2020-05-22,2020-04-24,True,West Virginia University,Recruiting,Not Applicable,Interventional,United States,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS),Procedure,Stellate Ganglion Block,Stellate Ganglion Block,5,https://clinicaltrials.gov/show/NCT04402840,None
2563,4626,NCT04402866,ClinicalTrials.gov,2020-05-22,2020-06-24,True,Theravance Biopharma,Recruiting,Phase 2,Interventional,"Ukraine, United Kingdom, Romania, Moldova, Republic of",TD-0903 for ALI Associated With COVID-19,Drug,TD-0903,TD-0903,222,https://clinicaltrials.gov/show/NCT04402866,EUCTR2020-001807-18
2564,4627,NCT04402879,ClinicalTrials.gov,2020-05-22,2020-11-10,False,University of Calgary,Recruiting,Not Applicable,Interventional,Canada,CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals,Procedure,Positioning,Positioning,596,https://clinicaltrials.gov/show/NCT04402879,None
2565,4628,NCT04402892,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04402892,None
2566,4630,NCT04402918,ClinicalTrials.gov,2020-05-18,2020-05-17,True,CHU de Besançon,Recruiting,Not Applicable,Interventional,France,Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy,Clinical Presentation,No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04402918,None
2567,4631,NCT04402944,ClinicalTrials.gov,2020-05-12,2020-07-05,False,Boston Children's Hospital,Recruiting,Phase 2,Interventional,United States,Pulmozyme to Improve COVID-19 ARDS Outcomes,Drug,Dornase alfa,Dornase alfa,60,https://clinicaltrials.gov/show/NCT04402944,None
2568,4635,NCT04403100,ClinicalTrials.gov,2020-05-23,2020-06-03,False,Cardresearch,Recruiting,Phase 3,Interventional,Brazil,"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: ""The Hope Coalition - 1""",Drug,Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine vs. Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir,1968,https://clinicaltrials.gov/show/NCT04403100,None
2569,4636,NCT04403243,ClinicalTrials.gov,2020-05-20,2020-05-08,True,Lomonosov Moscow State University Medical Research and Educational Center,Recruiting,Phase 2,Interventional,Russian Federation,COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial,Drug,Colchicine vs. Ruxolitinib vs. Secukinumab,Colchicine; Ruxolitinib; Secukinumab,70,https://clinicaltrials.gov/show/NCT04403243,None
2570,4637,NCT04403269,ClinicalTrials.gov,2020-05-18,2020-05-05,True,Versailles Hospital,Recruiting,Phase 2,Interventional,France,"NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE",ATMP,Immunoglobulin,Immunoglobulin,35,https://clinicaltrials.gov/show/NCT04403269,None
2571,4639,NCT04403477,ClinicalTrials.gov,2020-05-20,2020-05-20,False,Bangabandhu Sheikh Mujib Medical University,Recruiting,Phase 2,Interventional,Bangladesh,Convalescent Plasma Therapy in Severe COVID-19 Infection,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04403477,None
2572,4640,NCT04403555,ClinicalTrials.gov,2020-05-23,2020-06-01,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Ivermectin and Doxycycine in COVID-19 Treatment,Drug,Ivermectin + Doxycycine vs. Chloroquine,Ivermectin; Doxycycline; Chloroquine,200,https://clinicaltrials.gov/show/NCT04403555,None
2573,4643,NCT04403646,ClinicalTrials.gov,2020-05-22,2020-06-01,False,Hospital de Clínicas José de San Martín,Not Recruiting,Not Applicable,Interventional,No Country Given,Tannin Specific Natural Extract for COVID-19 Infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,140,https://clinicaltrials.gov/show/NCT04403646,None
2574,4645,NCT04403685,ClinicalTrials.gov,2020-05-24,2020-05-08,True,Beneficência Portuguesa de São Paulo,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers,Drug,Tocilizumab,Tocilizumab,129,https://clinicaltrials.gov/show/NCT04403685,None
2575,4647,NCT04403906,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Somerset NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,Somerset and South Essex Coronavirus Antigen Testing,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04403906,None
2576,4651,NCT04404192,ClinicalTrials.gov,2020-05-21,2020-11-01,False,"VistaGen Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,United States,PH94B in the Treatment of Adjustment Disorder With Anxiety,Other (psych),PH94B,PH94B,30,https://clinicaltrials.gov/show/NCT04404192,None
2577,4652,NCT04404218,ClinicalTrials.gov,2020-05-24,2020-08-04,False,"University Health Network, Toronto",Recruiting,Phase 2,Interventional,Canada,The AÃ§aÃ­ Berry COVID-19 Anti-Inflammation Trial,Supplement,Acai Berry,Acai Berry,480,https://clinicaltrials.gov/show/NCT04404218,None
2578,4655,NCT04404426,ClinicalTrials.gov,2020-05-22,2020-11-02,False,Rennes University Hospital,Recruiting,Not Applicable,Interventional,France,CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome,Drug,Citrulline,Citrulline,100,https://clinicaltrials.gov/show/NCT04404426,None
2579,4657,NCT04405076,ClinicalTrials.gov,2020-05-13,2020-05-29,False,"ModernaTX, Inc.",Not Recruiting,Phase 2,Interventional,United States,"Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older",ATMP,Vaccine,Vaccine,600,https://clinicaltrials.gov/show/NCT04405076,None
2580,4658,NCT04405102,ClinicalTrials.gov,2020-05-26,2020-09-16,False,Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec,Recruiting,Phase 2,Interventional,Canada,COVID-19 Ozanimod Intervention Study,Drug,Ozanimod,Ozanimod,48,https://clinicaltrials.gov/show/NCT04405102,None
2581,4660,NCT04405271,ClinicalTrials.gov,2020-05-26,2020-07-31,False,Hospital Italiano de Buenos Aires,Not Recruiting,Phase 3,Interventional,Argentina,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Drug (Chemoprophylaxis),Emtricitabine + Tenofovir alafenamide,Emtricitabine; Tenofovir alafenamide,1378,https://clinicaltrials.gov/show/NCT04405271,None
2582,4662,NCT04405310,ClinicalTrials.gov,2020-05-26,2020-05-20,True,Grupo Mexicano para el Estudio de la Medicina Intensiva,Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial,ATMP,Plasma,Plasma,80,https://clinicaltrials.gov/show/NCT04405310,None
2583,4665,NCT04405492,ClinicalTrials.gov,2020-05-19,2020-05-25,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1210,https://clinicaltrials.gov/show/NCT04405492,None
2584,4666,NCT04405544,ClinicalTrials.gov,2020-05-26,2020-05-22,True,Ministry of Health of Russia,Not Recruiting,Not Applicable,Interventional,Russian Federation,Determination of Acute Encephalopathy Predictors in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,51,https://clinicaltrials.gov/show/NCT04405544,None
2585,4669,NCT04405908,ClinicalTrials.gov,2020-05-25,2020-06-19,False,Clover Biopharmaceuticals,Recruiting,Phase 1,Interventional,Australia,SCB-2019 as COVID-19 Vaccine,ATMP,Vaccine,Vaccine,150,https://clinicaltrials.gov/show/NCT04405908,None
2586,4670,NCT04405921,ClinicalTrials.gov,2020-05-26,2020-07-01,False,Centre Hôpital Universitaire Farhat Hached,Not Recruiting,Phase 3,Interventional,Tunisia,"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19",Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,200,https://clinicaltrials.gov/show/NCT04405921,None
2587,4671,NCT04405934,ClinicalTrials.gov,2020-05-07,2020-07-01,False,"University College, London",Not Recruiting,Not Applicable,Interventional,No Country Given,COG-UK Project Hospital-Onset COVID-19 Infections Study,Genomics,Genomics,Genomics,2000,https://clinicaltrials.gov/show/NCT04405934,None
2588,4673,NCT04405986,ClinicalTrials.gov,2020-05-08,2020-05-19,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Interventional,France,Exploring Brain Damages After COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,38,https://clinicaltrials.gov/show/NCT04405986,None
2589,4674,NCT04405999,ClinicalTrials.gov,2020-05-18,2020-05-14,True,"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health",Not Recruiting,Phase 4,Interventional,Russian Federation,Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease,Drug (Chemoprophylaxis),Bromhexine hydrochloride,Bromhexine hydrochloride,50,https://clinicaltrials.gov/show/NCT04405999,None
2590,4676,NCT04406064,ClinicalTrials.gov,2020-05-26,2021-01-01,False,"Children's Hospital Medical Center, Cincinnati",Not Recruiting,Phase 2,Interventional,United States,Viral Specific T-cells for Treatment of COVID-19,ATMP,Cells (T),Cells (T),100,https://clinicaltrials.gov/show/NCT04406064,None
2591,4678,NCT04406181,ClinicalTrials.gov,2020-04-28,2020-05-18,False,UZ Brussel,Recruiting,Not Applicable,Interventional,Belgium,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04406181,None
2592,4680,NCT04406246,ClinicalTrials.gov,2020-05-24,2020-05-21,True,Materno-Perinatal Hospital of the State of Mexico,Recruiting,Phase 4,Interventional,Mexico,Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide,Drug,Nitazoxanide,Nitazoxanide,150,https://clinicaltrials.gov/show/NCT04406246,None
2593,4682,NCT04406389,ClinicalTrials.gov,2020-05-26,2020-10-13,False,Weill Medical College of Cornell University,Recruiting,Phase 4,Interventional,United States,Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial),Drug,"Heparin, Fondapariniux, Argatroban",Heparin; Fondapariniux; Argatroban,186,https://clinicaltrials.gov/show/NCT04406389,None
2594,4683,NCT04406493,ClinicalTrials.gov,2020-05-23,2020-04-28,True,Hillel Yaffe Medical Center,Recruiting,Not Applicable,Interventional,Israel,Monitoring COVID-19 Patients' Lung Fluid Using Impedance Technique,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04406493,None
2595,4684,NCT04406532,ClinicalTrials.gov,2020-05-22,2021-01-20,False,Albert Einstein College of Medicine,Not Recruiting,Not Applicable,Interventional,No Country Given,Home-Based Covid-19 Rehabilitation Program,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04406532,None
2596,4694,NCT04407182,ClinicalTrials.gov,2020-05-25,2020-05-04,True,Catalysis SL,Recruiting,Phase 2,Interventional,Ecuador,Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19,Supplement,Viusid + Asbrip,Viusid + Asbrip,80,https://clinicaltrials.gov/show/NCT04407182,None
2597,4696,NCT04407208,ClinicalTrials.gov,2020-05-16,2020-05-01,True,Biofarma,Not Recruiting,Phase 1,Interventional,Indonesia,Convalescent Plasma Therapy in Patients With COVID-19,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04407208,None
2598,4701,NCT04407390,ClinicalTrials.gov,2020-05-22,2020-06-01,False,University of Copenhagen,Recruiting,Phase 2,Interventional,Denmark,Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly,Supplement,Nicotinamide riboside,Nicotinamide riboside,100,https://clinicaltrials.gov/show/NCT04407390,None
2599,4705,NCT04407507,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V.,Not Recruiting,Phase 2,Interventional,No Country Given,"Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms",Drug,Ivermectin,Ivermectin,66,https://clinicaltrials.gov/show/NCT04407507,None
2600,4713,NCT04407689,ClinicalTrials.gov,2020-05-27,2020-06-08,False,Revimmune,Recruiting,Phase 2,Interventional,France,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort,Drug,Interleukin-7,Interleukin-7,48,https://clinicaltrials.gov/show/NCT04407689,None
2601,4717,NCT04408027,ClinicalTrials.gov,2020-05-26,2020-06-01,False,The Hospital for Sick Children,Not Recruiting,Not Applicable,Interventional,Canada,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions,Other (psych),Psychological,Psychological,20,https://clinicaltrials.gov/show/NCT04408027,None
2602,4718,NCT04408040,ClinicalTrials.gov,2020-05-15,2020-07-14,False,"Northside Hospital, Inc.",Recruiting,Phase 2,Interventional,United States,Use of Convalescent Plasma for COVID-19,ATMP,Plasma,Plasma,700,https://clinicaltrials.gov/show/NCT04408040,None
2603,4719,NCT04408066,ClinicalTrials.gov,2020-04-30,2020-04-30,False,LumiraDx UK Limited,Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19: A POC Test Under Research & Evaluation,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2000,https://clinicaltrials.gov/show/NCT04408066,None
2604,4720,NCT04408131,ClinicalTrials.gov,2020-05-28,2020-05-28,False,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04408131,None
2605,4721,NCT04408157,ClinicalTrials.gov,2020-05-26,2020-05-20,True,King's College London,Recruiting,Not Applicable,Interventional,United Kingdom,A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,548,https://clinicaltrials.gov/show/NCT04408157,None
2606,4724,NCT04408209,ClinicalTrials.gov,2020-05-25,2020-04-23,True,National and Kapodistrian University of Athens,Recruiting,Not Applicable,Interventional,Greece,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04408209,None
2607,4726,NCT04408235,ClinicalTrials.gov,2020-05-26,2020-06-01,True,AOU di Modena,Not Recruiting,Phase 3,Interventional,Italy,High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy,Drug,Heparin,Heparin,300,https://clinicaltrials.gov/show/NCT04408235,EUCTR2020-001972-13
2608,4727,NCT04408287,ClinicalTrials.gov,2020-05-20,2020-09-15,False,Lawson Health Research Institute,Not Recruiting,Not Applicable,Interventional,Canada,Improving Activity Engagement Among Persons With SCI During COVID-19,Other (exercise),Exercise,Exercise,50,https://clinicaltrials.gov/show/NCT04408287,None
2609,4732,NCT04408456,ClinicalTrials.gov,2020-05-24,2020-03-01,True,Postgraduate Institute of Medical Education and Research,Not Recruiting,Phase 3,Interventional,India,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,325,https://clinicaltrials.gov/show/NCT04408456,None
2610,4736,NCT04409262,ClinicalTrials.gov,2020-05-28,2020-06-16,False,Roche,Recruiting,Phase 3,Interventional,"Russian Federation, France, Brazil, United States, Spain",A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia,Drug,Tocilizumab + Remdesivir vs. Remdesivir,Tocilizumab; Remdesivir,500,https://clinicaltrials.gov/show/NCT04409262,None
2611,4737,NCT04409483,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Epicentre,Not Recruiting,Phase 3,Interventional,No Country Given,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger,Drug,Lopinavir/ritonavir,Lopinavir/ritonavir,0,https://clinicaltrials.gov/show/NCT04409483,None
2612,4738,NCT04409496,ClinicalTrials.gov,2020-05-26,2020-06-02,False,University of Hong Kong,Not Recruiting,Not Applicable,Interventional,Hong Kong,Chat-based Support for Preventing Smoking Relapse,Other,Other,Other,108,https://clinicaltrials.gov/show/NCT04409496,None
2613,4739,NCT04409509,ClinicalTrials.gov,2020-05-28,2020-07-01,False,CSL Behring,Recruiting,Phase 2,Interventional,United States,Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19),Drug,Garadacimab,Garadacimab,124,https://clinicaltrials.gov/show/NCT04409509,None
2614,4740,NCT04409522,ClinicalTrials.gov,2020-05-28,2020-05-12,True,Mohammad Sadegh Bagheri Baghdasht,Recruiting,Not Applicable,Interventional,Iran,Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients,Drug,Melatonin,Melatonin,55,https://clinicaltrials.gov/show/NCT04409522,None
2615,4743,NCT04409821,ClinicalTrials.gov,2020-05-22,2020-06-01,False,"Rigshospitalet, Denmark",Not Recruiting,Not Applicable,Interventional,No Country Given,Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04409821,None
2616,4744,NCT04409834,ClinicalTrials.gov,2020-05-28,2020-08-05,False,The TIMI Study Group,Recruiting,Phase 4,Interventional,United States,Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial,Drug,Heparin,Heparin,750,https://clinicaltrials.gov/show/NCT04409834,None
2617,4746,NCT04409873,ClinicalTrials.gov,2020-05-28,2020-12-07,False,"University of California, San Francisco",Not Recruiting,Phase 2,Interventional,United States,Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19),Drug,Mouthwash,Mouthwash,150,https://clinicaltrials.gov/show/NCT04409873,None
2618,4747,NCT04409886,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Maimonides Medical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients,Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04409886,None
2619,4749,NCT04409925,ClinicalTrials.gov,2020-05-13,2020-11-01,False,McGill University,Not Recruiting,Phase 1,Interventional,No Country Given,DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1),Drug,rhDNase I,rhDNase I,25,https://clinicaltrials.gov/show/NCT04409925,None
2620,4751,NCT04410016,ClinicalTrials.gov,2020-05-22,2020-05-25,False,University of Nottingham,Recruiting,Not Applicable,Interventional,United Kingdom,Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study,Other (psych),Psychological,Psychological,45,https://clinicaltrials.gov/show/NCT04410016,None
2621,4753,NCT04410159,ClinicalTrials.gov,2020-05-27,2020-06-22,False,Universiti Sains Islam Malaysia,Not Recruiting,Phase 2,Interventional,Malaysia,Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients,Drug,Povidone Iodine vs. Essential Oil,Povidone Iodine; Essential Oil,20,https://clinicaltrials.gov/show/NCT04410159,None
2622,4755,NCT04410328,ClinicalTrials.gov,2020-05-28,2020-10-21,False,Rutgers University,Recruiting,Phase 3,Interventional,United States,Aggrenox To Treat Acute Covid-19,Drug,Dipyridamole,Dipyridamole,132,https://clinicaltrials.gov/show/NCT04410328,None
2623,4756,NCT04410458,ClinicalTrials.gov,2020-05-29,2020-05-31,False,Guangzhou Blood Center,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial),Other,Other,Other,506517,https://clinicaltrials.gov/show/NCT04410458,None
2624,4759,NCT04410510,ClinicalTrials.gov,2020-05-27,2020-09-30,False,Hospital Universitario San Ignacio,Recruiting,Phase 2/Phase 3,Interventional,Colombia,P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19,Drug,P2Et,P2Et,100,https://clinicaltrials.gov/show/NCT04410510,None
2625,4760,NCT04410536,ClinicalTrials.gov,2020-05-25,2020-06-15,False,Fondazione IRCCS Istituto Neurologico Carlo Besta,Recruiting,Not Applicable,Interventional,Italy,Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency,Other,Other,Other,25,https://clinicaltrials.gov/show/NCT04410536,None
2626,4761,NCT04410549,ClinicalTrials.gov,2020-05-21,2020-06-01,False,IRCCS Ospedale San Raffaele,Recruiting,Not Applicable,Interventional,"Brazil, Italy",Pulmonary Optical Coherence Tomography in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04410549,None
2627,4762,NCT04410562,ClinicalTrials.gov,2020-05-26,2020-05-13,True,Barcelona Institute for Global Health,Recruiting,Phase 3,Interventional,Spain,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy,Drug,Hydroxychloroquine,Hydroxychloroquine,714,https://clinicaltrials.gov/show/NCT04410562,EUCTR2020-001587-29
2628,4763,NCT04410692,ClinicalTrials.gov,2020-05-27,2020-05-15,True,"National University, Singapore",Not Recruiting,Not Applicable,Interventional,Singapore,Can the Prediction Market Improve Predictions of COVID-19?,Other,Other,Other,560,https://clinicaltrials.gov/show/NCT04410692,None
2629,4768,NCT04411433,ClinicalTrials.gov,2020-05-23,2020-05-08,True,"Ministry of Health, Turkey",Recruiting,Phase 3,Interventional,Turkey,Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19,Drug,Favipiravir vs. Favipiravir + Hydroxychloroquine vs. Favipiravir + Azithromycin vs. Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Favipiravir; Azithromycin; Hydroxychloroquine,1000,https://clinicaltrials.gov/show/NCT04411433,None
2630,4769,NCT04411446,ClinicalTrials.gov,2020-05-26,2020-08-11,False,Vitamin D Study Group,Recruiting,Phase 4,Interventional,Argentina,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,Drug,Vitamin D,Vitamin D,1264,https://clinicaltrials.gov/show/NCT04411446,None
2631,4774,NCT04411602,ClinicalTrials.gov,2020-05-22,2020-04-07,True,Ascension South East Michigan,Recruiting,Phase 1,Interventional,United States,Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD,ATMP,Plasma,Plasma,90,https://clinicaltrials.gov/show/NCT04411602,None
2632,4775,NCT04411628,ClinicalTrials.gov,2020-05-29,2020-05-28,True,Eli Lilly and Company,Not Recruiting,Phase 1,Interventional,United States,A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19,Drug,LY3819253,LY3819253,24,https://clinicaltrials.gov/show/NCT04411628,None
2633,4776,NCT04411667,ClinicalTrials.gov,2020-05-29,2020-04-28,True,Dr. George Sakoulas,Not Recruiting,Phase 4,Interventional,United States,Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19,ATMP,Immunoglobulin,Immunoglobulin,34,https://clinicaltrials.gov/show/NCT04411667,None
2634,4778,NCT04412018,ClinicalTrials.gov,2020-05-29,2020-06-04,False,Canadian Medical and Surgical Knowledge Translation Research Group,Recruiting,Phase 2,Interventional,Canada,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19,Drug,Icosapent ethyl,Icosapent ethyl,100,https://clinicaltrials.gov/show/NCT04412018,None
2635,4780,NCT04412057,ClinicalTrials.gov,2020-05-29,2020-06-09,False,Aevi Genomic Medicine,Recruiting,Phase 2,Interventional,United States,Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury,Drug,CERC-002,CERC-002,82,https://clinicaltrials.gov/show/NCT04412057,None
2636,4781,NCT04412239,ClinicalTrials.gov,2020-05-30,2020-04-20,True,Health Science Center of Xi'an Jiaotong University,Recruiting,Not Applicable,Interventional,Pakistan,To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,200,https://clinicaltrials.gov/show/NCT04412239,None
2637,4782,NCT04412252,ClinicalTrials.gov,2020-05-30,2020-07-06,False,Pfizer,Not Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy,Drug,Tofacitinib,Tofacitinib,0,https://clinicaltrials.gov/show/NCT04412252,None
2638,4785,NCT04412291,ClinicalTrials.gov,2020-06-01,2020-06-11,True,Karolinska University Hospital,Recruiting,Phase 2,Interventional,Sweden,"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study",Drug,Anakinra vs. Tocilizumab,Anakinra; Tocilizumab,120,https://clinicaltrials.gov/show/NCT04412291,EUCTR2020-001748-24
2639,4788,NCT04412330,ClinicalTrials.gov,2020-05-12,2020-05-01,True,University of Kentucky,Recruiting,Not Applicable,Interventional,United States,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,20,https://clinicaltrials.gov/show/NCT04412330,None
2640,4789,NCT04412343,ClinicalTrials.gov,2020-05-29,2020-05-23,True,University of British Columbia,Not Recruiting,Not Applicable,Interventional,Canada,The Seniors COvid-19 Pandemic and Exercise Study,Other (exercise),Exercise,Exercise,241,https://clinicaltrials.gov/show/NCT04412343,None
2641,4790,NCT04412356,ClinicalTrials.gov,2020-05-24,2020-06-04,False,Sahlgrenska University Hospital,Recruiting,Not Applicable,Interventional,Sweden,Timing of Tracheotomy in Covid-19 Patients,Other,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04412356,None
2642,4793,NCT04412395,ClinicalTrials.gov,2020-05-15,2020-06-01,False,"National Research Center, Egypt",Not Recruiting,Phase 2,Interventional,Egypt,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease,Supplement,Lactoferrin,Lactoferrin,516,https://clinicaltrials.gov/show/NCT04412395,None
2643,4796,NCT04412486,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Dr. Gailen D. Marshall Jr.,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma (CCP) Transfusion,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04412486,None
2644,4797,NCT04412538,ClinicalTrials.gov,2020-05-21,2020-05-15,True,Chinese Academy of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,ATMP,Vaccine,Vaccine,942,https://clinicaltrials.gov/show/NCT04412538,None
2645,4800,NCT04412668,ClinicalTrials.gov,2020-06-01,2020-06-12,False,"aTyr Pharma, Inc.",Not Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19,Drug,ATYR1923,ATYR1923,30,https://clinicaltrials.gov/show/NCT04412668,None
2646,4802,NCT04412772,ClinicalTrials.gov,2020-06-01,2020-06-12,False,Queen's Medical Centre,Recruiting,Phase 3,Interventional,United States,Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS,Drug,Tocilizumab,Tocilizumab,300,https://clinicaltrials.gov/show/NCT04412772,None
2647,4803,NCT04412785,ClinicalTrials.gov,2020-06-01,2020-06-30,False,University of Pennsylvania,Recruiting,Phase 1,Interventional,United States,Cyclosporine in Patients With Moderate COVID-19,Drug,Cyclosporine,Cyclosporine,20,https://clinicaltrials.gov/show/NCT04412785,None
2648,4804,NCT04413006,ClinicalTrials.gov,2020-05-21,2020-05-25,False,University of Manitoba,Recruiting,Not Applicable,Interventional,Canada,Self-compassion for Chronic Pain Virtual Group Treatment Program,Other (psych),Psychological,Psychological,28,https://clinicaltrials.gov/show/NCT04413006,None
2649,4809,NCT04413747,ClinicalTrials.gov,2020-05-29,2020-08-15,False,Health Ricerca E Sviluppo S.r.l.,Not Recruiting,Not Applicable,Interventional,Italy,Yoga Pranayama Adjuvant to Treat Burden COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,https://clinicaltrials.gov/show/NCT04413747,None
2650,4810,NCT04413838,ClinicalTrials.gov,2020-06-02,2020-06-15,False,Hospices Civils de Lyon,Not Recruiting,Phase 2,Interventional,France,Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection,Drug,Nivolumab,Nivolumab,120,https://clinicaltrials.gov/show/NCT04413838,None
2651,4811,NCT04413864,ClinicalTrials.gov,2020-04-21,2020-04-24,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,Drug,Dexmedetomidine,Dexmedetomidine,50,https://clinicaltrials.gov/show/NCT04413864,None
2652,4814,NCT04413968,ClinicalTrials.gov,2020-06-02,2020-06-02,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,"COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants",Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04413968,None
2653,4816,NCT04414098,ClinicalTrials.gov,2020-05-29,2020-06-01,False,Marcelo Iastrebner,Not Recruiting,Phase 2,Interventional,No Country Given,Ruxolitinib in the Treatment of Covid-19,Drug,Ruxolitinib,Ruxolitinib,100,https://clinicaltrials.gov/show/NCT04414098,None
2654,4817,NCT04414124,ClinicalTrials.gov,2020-06-01,2020-07-02,False,Kaleido Biosciences,Recruiting,Not Applicable,Interventional,United States,A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19,Drug,KB109,KB109,400,https://clinicaltrials.gov/show/NCT04414124,None
2655,4818,NCT04414293,ClinicalTrials.gov,2020-06-01,2020-10-01,False,Hospital Provincial de Castellón,Not Recruiting,Not Applicable,Interventional,Spain,Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis,Other,Radiation,Radiation,41,https://clinicaltrials.gov/show/NCT04414293,None
2656,4819,NCT04414371,ClinicalTrials.gov,2020-05-31,2020-05-20,True,Rutgers University,Recruiting,Not Applicable,Interventional,United States,Tools for Wellbeing COVID-19 National Study of Undergraduate Students,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,200,https://clinicaltrials.gov/show/NCT04414371,None
2657,4821,NCT04414618,ClinicalTrials.gov,2020-05-26,2020-07-02,False,RedHill Biopharma Limited,Not Recruiting,Phase 2,Interventional,"Israel, United States",A Study of Opaganib in Coronavirus Disease 2019 Pneumonia,Drug,Opaganib,Opaganib,40,https://clinicaltrials.gov/show/NCT04414618,None
2658,4824,NCT04415060,ClinicalTrials.gov,2020-06-02,2020-06-15,False,Sunnybrook Health Sciences Centre,Recruiting,Phase 3,Interventional,Canada,SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival,Drug,Isoflurane + Sevoflurane,Isoflurane; Sevoflurane,752,https://clinicaltrials.gov/show/NCT04415060,None
2659,4825,NCT04415073,ClinicalTrials.gov,2020-05-29,2020-05-30,False,Syndax Pharmaceuticals,Not Recruiting,Phase 2,Interventional,United States,A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19,Drug,Axatilimab,Axatilimab,186,https://clinicaltrials.gov/show/NCT04415073,None
2660,4826,NCT04415086,ClinicalTrials.gov,2020-06-01,2020-06-01,False,University of São Paulo General Hospital,Recruiting,Phase 2,Interventional,Brazil,Treatment of Patients With COVID-19 With Convalescent Plasma,ATMP,Plasma,Plasma,120,https://clinicaltrials.gov/show/NCT04415086,None
2661,4828,NCT04415879,ClinicalTrials.gov,2020-06-01,2020-06-01,False,The Cleveland Clinic,Not Recruiting,Not Applicable,Interventional,United States,Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.,Other (device),Masks,Masks,20,https://clinicaltrials.gov/show/NCT04415879,None
2662,4830,NCT04416048,ClinicalTrials.gov,2020-06-02,2020-08-01,True,Charité University,Not Recruiting,Phase 3,Interventional,Germany,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,Drug,Rivaroxaban,Rivaroxaban,400,https://clinicaltrials.gov/show/NCT04416048,EUCTR2020-002282-33
2663,4832,NCT04416113,ClinicalTrials.gov,2020-05-24,2020-08-01,False,Cairo University,Not Recruiting,Not Applicable,Interventional,No Country Given,Photodynamic Therapy for the Treatment of COVID-19,Other,Photodynamic Therapy,Photodynamic Therapy,60,https://clinicaltrials.gov/show/NCT04416113,None
2664,4833,NCT04416139,ClinicalTrials.gov,2020-05-30,2020-05-01,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2,Interventional,Mexico,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,https://clinicaltrials.gov/show/NCT04416139,None
2665,4835,NCT04416308,ClinicalTrials.gov,2020-05-27,2020-05-29,False,Rennes University Hospital,Recruiting,Not Applicable,Interventional,France,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB),Clinical Presentation (Epidemiology),No Intervention,No Intervention,13000,https://clinicaltrials.gov/show/NCT04416308,None
2666,4836,NCT04416334,ClinicalTrials.gov,2020-06-03,2020-08-19,False,Instituto de Investigacin Marqus de Valdecilla,Recruiting,Phase 3,Interventional,Spain,PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS,Drug,Colchicine,Colchicine,954,https://clinicaltrials.gov/show/NCT04416334,None
2667,4838,NCT04416360,ClinicalTrials.gov,2020-05-19,2020-05-05,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak,Other (psych),No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04416360,None
2668,4840,NCT04416399,ClinicalTrials.gov,2020-06-03,2020-07-16,False,University of Oxford,Recruiting,Phase 2,Interventional,United Kingdom,STerOids in COVID-19 Study,Drug,Corticosteroids,Budesonide,478,https://clinicaltrials.gov/show/NCT04416399,None
2669,4844,NCT04416919,ClinicalTrials.gov,2020-05-13,2020-07-15,False,University of Oklahoma,Recruiting,Not Applicable,Interventional,United States,Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment,Other (device),Masks,Masks,20,https://clinicaltrials.gov/show/NCT04416919,None
2670,4845,NCT04417257,ClinicalTrials.gov,2020-05-28,2020-06-29,False,Laurent Pharmaceuticals Inc.,Recruiting,Phase 2,Interventional,"Canada, United States",Study of LAU-7b for the Treatment of COVID-19 Disease in Adults,Drug,LAU-7b,LAU-7b,240,https://clinicaltrials.gov/show/NCT04417257,None
2671,4846,NCT04417270,ClinicalTrials.gov,2020-06-01,2020-06-12,False,Northwell Health,Recruiting,Not Applicable,Interventional,United States,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge,Other (device),Biosensors,Biosensors,50,https://clinicaltrials.gov/show/NCT04417270,None
2672,4847,NCT04417335,ClinicalTrials.gov,2020-05-25,2020-04-16,True,Radboud University,Not Recruiting,Phase 4,Interventional,Netherlands,Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination,ATMP,Vaccine,Vaccine,2014,https://clinicaltrials.gov/show/NCT04417335,EUCTR2020-001591-15; NL8547
2673,4849,NCT04418128,ClinicalTrials.gov,2020-06-03,2020-06-10,False,Gyeongsang National University Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia,Drug,Nafamostat Mesylate,Nafamostat Mesylate,84,https://clinicaltrials.gov/show/NCT04418128,None
2674,4851,NCT04418206,ClinicalTrials.gov,2020-05-18,2020-06-01,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04418206,None
2675,4855,NCT04418505,ClinicalTrials.gov,2020-06-03,2020-09-02,False,Vielight Inc.,Recruiting,Not Applicable,Interventional,"Canada, United States",Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms,Other,Photobiomodulation,Photobiomodulation,280,https://clinicaltrials.gov/show/NCT04418505,None
2676,4856,NCT04418518,ClinicalTrials.gov,2020-06-03,2020-06-24,False,Weill Medical College of Cornell University,Recruiting,Phase 3,Interventional,United States,A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness,ATMP,Plasma,Plasma,1200,https://clinicaltrials.gov/show/NCT04418518,None
2677,4857,NCT04418531,ClinicalTrials.gov,2020-06-03,2020-06-01,True,Piero Luigi Ruggenenti,Not Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in COVID 19 Patients,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04418531,None
2678,4861,NCT04418947,ClinicalTrials.gov,2020-05-29,2020-06-15,False,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,United States,Project Resurgence Communication Trial,Other,Other,Other,11120,https://clinicaltrials.gov/show/NCT04418947,None
2679,4862,NCT04419025,ClinicalTrials.gov,2020-06-03,2020-09-23,False,Cambridge Health Alliance,Recruiting,Phase 4,Interventional,United States,Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease,Drug,N-acetylcysteine,N-acetylcysteine,200,https://clinicaltrials.gov/show/NCT04419025,None
2680,4866,NCT04419623,ClinicalTrials.gov,2020-06-03,2020-07-09,True,"Telios Pharma, Inc.",Recruiting,Phase 1/Phase 2,Interventional,United States,A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer,Drug,TL-895,TL-895,146,https://clinicaltrials.gov/show/NCT04419623,PER-042-20; EUCTR2020-002259-39
2681,4867,NCT04420247,ClinicalTrials.gov,2020-06-02,2020-04-16,True,Centro de Estudos e Pesquisa em Emergências Médicas e Terapia Intensiva (CEPETI),Not Recruiting,Phase 3,Interventional,Brazil,Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19,Drug,Chloroquine or Hydroxychloroquine,Chloroquine; Hydroxychloroquine,142,https://clinicaltrials.gov/show/NCT04420247,None
2682,4868,NCT04420260,ClinicalTrials.gov,2020-05-25,2020-07-01,False,Unidad de Investigación Genética Molecular,Not Recruiting,Not Applicable,Interventional,No Country Given,Primary Prevention of Infection by COVID-19 in Health Providers,Drug (Chemoprophylaxis),"Oropharygeal spray, Immunostimulant",Oropharygeal spray; Immunostimulant,300,https://clinicaltrials.gov/show/NCT04420260,None
2683,4869,NCT04420273,ClinicalTrials.gov,2020-06-03,2020-07-02,False,Northwestern University,Not Recruiting,Not Applicable,Interventional,United States,Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04420273,None
2684,4871,NCT04420299,ClinicalTrials.gov,2020-06-05,2020-06-04,False,Fundación de Investigación HM Hospita​les​,Recruiting,Phase 2,Interventional,Spain,Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19,Drug,Bemiparin,Bemiparin,120,https://clinicaltrials.gov/show/NCT04420299,EUCTR2020-001548-24
2685,4873,NCT04420338,ClinicalTrials.gov,2020-06-05,2020-06-05,False,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,"SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study",Clinical Presentation (Epidemiology),No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04420338,None
2686,4874,NCT04420364,ClinicalTrials.gov,2020-06-04,2020-07-01,False,Brigham and Women's Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease,Other,Immunosupression,Immunosupression,50,https://clinicaltrials.gov/show/NCT04420364,None
2687,4875,NCT04420390,ClinicalTrials.gov,2020-05-14,2020-05-01,True,"Hospital San Carlos, Madrid",Recruiting,Not Applicable,Interventional,Spain,Low Dose Radiotherapy for COVID-19 Pneumonitis,Other,Radiation,Radiation,41,https://clinicaltrials.gov/show/NCT04420390,None
2688,4879,NCT04420676,ClinicalTrials.gov,2020-06-04,2020-09-24,False,Medical University of Graz,Recruiting,Not Applicable,Interventional,Austria,Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection,Supplement,Probiotics,Probiotics,108,https://clinicaltrials.gov/show/NCT04420676,None
2689,4880,NCT04420741,ClinicalTrials.gov,2020-06-04,2020-06-15,True,Par Johansson,Recruiting,Phase 2,Interventional,Denmark,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,Drug,Ilopros,Ilopros,80,https://clinicaltrials.gov/show/NCT04420741,EUCTR2020-001296-33
2690,4881,NCT04420806,ClinicalTrials.gov,2020-06-05,2020-03-14,True,University of Erlangen-Nornberg Medical School,Not Recruiting,Not Applicable,Interventional,Germany,Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women,Other (exercise),Exercise,Exercise,21,https://clinicaltrials.gov/show/NCT04420806,None
2691,4883,NCT04421391,ClinicalTrials.gov,2020-06-04,2020-06-08,False,Therapeutic Solutions International,Recruiting,Not Applicable,Interventional,United States,QuadraMune(TM) for Prevention of COVID-19,Supplement,Nutritional Supplement,Nutritional Supplement,500,https://clinicaltrials.gov/show/NCT04421391,None
2692,4884,NCT04421404,ClinicalTrials.gov,2020-06-03,2020-06-09,False,Dr. Priscilla Hsue,Not Recruiting,Phase 2,Interventional,United States,Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04421404,None
2693,4885,NCT04421508,ClinicalTrials.gov,2020-06-05,2020-07-12,False,Bellerophon Pulse Technologies,Not Recruiting,Phase 3,Interventional,United States,A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19,Drug,Nitric Oxide,Nitric Oxide,500,https://clinicaltrials.gov/show/NCT04421508,None
2694,4886,NCT04421534,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19,Drug,Lactoferrin,Lactoferrin,150,https://clinicaltrials.gov/show/NCT04421534,None
2695,4887,NCT04421612,ClinicalTrials.gov,2020-06-04,2020-04-02,True,Haukeland University Hospital,Recruiting,Not Applicable,Interventional,Norway,Coping With 2020 - No Health Without Mental Health,Other (psych),Psychological,Psychological,400,https://clinicaltrials.gov/show/NCT04421612,None
2696,4888,NCT04421625,ClinicalTrials.gov,2020-05-18,2020-06-15,False,Institut de Cancérologie de l'Ouest,Recruiting,Not Applicable,Interventional,France,Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,12000,https://clinicaltrials.gov/show/NCT04421625,None
2697,4889,NCT04421664,ClinicalTrials.gov,2020-06-05,2020-03-25,True,McGill University,Not Recruiting,Phase 3,Interventional,"Canada, United States",Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,70,https://clinicaltrials.gov/show/NCT04421664,None
2698,4891,NCT04422353,ClinicalTrials.gov,2020-06-07,2020-05-01,True,Federal University of Rio Grande do Sul,Recruiting,Not Applicable,Interventional,Brazil,Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease,Other (exercise),Exercise,Exercise,60,https://clinicaltrials.gov/show/NCT04422353,None
2699,4896,NCT04422509,ClinicalTrials.gov,2020-06-03,2020-10-03,False,Radboud University,Recruiting,Phase 1/Phase 2,Interventional,Netherlands,Lanadelumab for Treatment of COVID-19 Disease,Drug,Lanadelumab,Lanadelumab,80,https://clinicaltrials.gov/show/NCT04422509,None
2700,4899,NCT04422561,ClinicalTrials.gov,2020-06-06,2020-05-31,True,Zagazig University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Prophylactic Ivermectin in COVID-19 Contacts,Drug (Chemoprophylaxis),Ivermectin,Ivermectin,340,https://clinicaltrials.gov/show/NCT04422561,None
2701,4902,NCT04422613,ClinicalTrials.gov,2020-06-05,2020-05-28,True,"University Hospital, Toulouse",Not Recruiting,Not Applicable,Interventional,France,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,73,https://clinicaltrials.gov/show/NCT04422613,None
2702,4904,NCT04422678,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Alexandria University,Not Recruiting,Phase 3,Interventional,No Country Given,The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia,Drug,Imatinib,Imatinib,30,https://clinicaltrials.gov/show/NCT04422678,None
2703,4908,NCT04422977,ClinicalTrials.gov,2020-06-05,2020-06-08,False,Centre Hospitalier Saint Joseph Saint Luc de Lyon,Not Recruiting,Not Applicable,Interventional,No Country Given,Serological Study of the Exposure of Personnel to Sars-cov-2,Clinical Presentation (Epidemiology),No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04422977,None
2704,4910,NCT04423042,ClinicalTrials.gov,2020-06-05,2020-07-30,False,University of Calgary,Not Recruiting,Phase 3,Interventional,No Country Given,Tocilizumab in Coronavirus-19 Positive Patients,Drug,Tocilizumab,Tocilizumab,30,https://clinicaltrials.gov/show/NCT04423042,None
2705,4911,NCT04423289,ClinicalTrials.gov,2020-06-06,2020-03-31,True,Vall d'Hebron Research Institute (VHIR),Not Recruiting,Not Applicable,Interventional,Spain,Telematic Monitoring Through a Mobile Application of Patients With COVID-19,Other (software),eHealth,eHealth,150,https://clinicaltrials.gov/show/NCT04423289,None
2706,4916,NCT04423861,ClinicalTrials.gov,2020-06-08,2020-12-01,False,Azidus Brasil,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19,Drug,Nitazoxanide,Nitazoxanide,380,https://clinicaltrials.gov/show/NCT04423861,None
2707,4918,NCT04423991,ClinicalTrials.gov,2020-06-08,2020-03-10,True,Dascena,Not Recruiting,Not Applicable,Interventional,United States,Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning,Other (software),Machine Learning,Machine Learning,290,https://clinicaltrials.gov/show/NCT04423991,None
2708,4921,NCT04424056,ClinicalTrials.gov,2020-06-08,2020-09-01,False,Assistance Publique – Hôpitaux de Marseille,Not Recruiting,Phase 3,Interventional,France,"A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease",Drug,Anakinra + Ruxolitinib vs. Tocilizumab + Ruxolitinib,Anakinra; Ruxolitinib; Tocilizumab,216,https://clinicaltrials.gov/show/NCT04424056,None
2709,4922,NCT04424082,ClinicalTrials.gov,2020-06-07,2020-06-09,False,Karolinska Institutet,Recruiting,Not Applicable,Interventional,Sweden,External Dead Space in Ventilated COVID-19 Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,40,https://clinicaltrials.gov/show/NCT04424082,None
2710,4923,NCT04424134,ClinicalTrials.gov,2020-05-27,2020-05-16,True,Lomonosov Moscow State University Medical Research and Educational Center,Recruiting,Phase 3,Interventional,Russian Federation,BromhexIne And Spironolactone For Coron?VirUs Infection Requiring HospiTalization,Drug,Bromhexine + Spironolactone,Bromhexine; Spironolactone,80,https://clinicaltrials.gov/show/NCT04424134,None
2711,4926,NCT04424797,ClinicalTrials.gov,2020-06-05,2020-07-13,False,Poudre Valley Health System,Recruiting,Not Applicable,Interventional,United States,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol,Procedure,Positioning,Positioning,100,https://clinicaltrials.gov/show/NCT04424797,None
2712,4929,NCT04424901,ClinicalTrials.gov,2020-05-29,2020-05-03,True,UConn Health,Recruiting,Phase 2,Interventional,United States,Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19,Drug,Dipyridamole,Dipyridamole,100,https://clinicaltrials.gov/show/NCT04424901,None
2713,4932,NCT04425005,ClinicalTrials.gov,2020-06-08,2020-05-10,True,University of São Paulo,Recruiting,Not Applicable,Interventional,Brazil,Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric,Other (exercise),Exercise,Exercise,70,https://clinicaltrials.gov/show/NCT04425005,None
2714,4935,NCT04425252,ClinicalTrials.gov,2020-06-09,2020-06-25,False,"Clear Creek Bio, Inc.",Recruiting,Phase 1/Phase 2,Interventional,United States,Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19,Drug,Brequinar,Brequinar,24,https://clinicaltrials.gov/show/NCT04425252,None
2715,4936,NCT04425317,ClinicalTrials.gov,2020-05-27,2020-06-24,False,CRG UZ Brussel,Recruiting,Not Applicable,Interventional,Belgium,Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,https://clinicaltrials.gov/show/NCT04425317,None
2716,4938,NCT04425460,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Zhejiang Hisun Pharmaceutical Co. Ltd.,Not Recruiting,Phase 3,Interventional,"Germany, China, Romania","A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19",Drug,Favipiravir,Favipiravir,256,https://clinicaltrials.gov/show/NCT04425460,None
2717,4939,NCT04425499,ClinicalTrials.gov,2020-06-08,2020-06-01,True,University of Montreal,Not Recruiting,Not Applicable,Interventional,No Country Given,A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial,Other,Other,Other,60,https://clinicaltrials.gov/show/NCT04425499,None
2718,4940,NCT04425538,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Tufts Medical Center,Recruiting,Phase 2,Interventional,United States,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).,Drug,Infliximab,Infliximab,17,https://clinicaltrials.gov/show/NCT04425538,None
2719,4941,NCT04425616,ClinicalTrials.gov,2020-06-03,2020-05-29,True,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer,Other,Welfare,Welfare,1100,https://clinicaltrials.gov/show/NCT04425616,None
2720,4942,NCT04425707,ClinicalTrials.gov,2020-06-08,2020-06-09,False,"Ministry of Health and Population, Egypt",Recruiting,Not Applicable,Interventional,Egypt,Ivermectin In Treatment of COVID 19 Patients,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04425707,None
2721,4943,NCT04425720,ClinicalTrials.gov,2020-06-02,2020-09-01,False,Montefiore Medical Center,Recruiting,Not Applicable,Interventional,United States,Use of Remote Monitoring for COVID-19 Patient,Other (device),Biosensors,Biosensors,300,https://clinicaltrials.gov/show/NCT04425720,None
2722,4944,NCT04425733,ClinicalTrials.gov,2020-06-08,2020-07-07,False,Merck Sharp & Dohme Corp.,Not Recruiting,Phase 1,Interventional,No Country Given,MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009),Drug,MK-5475,MK-5475,0,https://clinicaltrials.gov/show/NCT04425733,None
2723,4946,NCT04425772,ClinicalTrials.gov,2020-05-09,2020-06-12,False,"HeNan Sincere Biotech Co., Ltd",Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Azvudine,Azvudine,342,https://clinicaltrials.gov/show/NCT04425772,None
2724,4947,NCT04425837,ClinicalTrials.gov,2020-05-29,2020-07-01,False,Fundación Santa Fe de Bogotá,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19,ATMP,Plasma,Plasma,236,https://clinicaltrials.gov/show/NCT04425837,None
2725,4951,NCT04425915,ClinicalTrials.gov,2020-06-07,2020-06-14,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Phase 3,Interventional,India,Efficacy of Convalescent Plasma Therapy in Patients With COVID-19,ATMP,Plasma,Plasma,400,https://clinicaltrials.gov/show/NCT04425915,None
2726,4952,NCT04426006,ClinicalTrials.gov,2020-06-09,2020-06-01,True,Institut Bergonié,Not Recruiting,Not Applicable,Interventional,France,Serological Response to SARS-Cov-2 Virus in Personnel of the Institut BergoniÃ© in the Context of the COVID-19 Pandemic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,550,https://clinicaltrials.gov/show/NCT04426006,None
2727,4957,NCT04426292,ClinicalTrials.gov,2020-06-08,2020-05-12,True,UZ Brussel,Recruiting,Not Applicable,Interventional,Belgium,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3500,https://clinicaltrials.gov/show/NCT04426292,None
2728,4958,NCT04426305,ClinicalTrials.gov,2020-06-03,2020-05-21,True,University of Ghent,Recruiting,Not Applicable,Interventional,Belgium,Community Health Workers Against COVID19,Other (psych),Psychological,Psychological,140,https://clinicaltrials.gov/show/NCT04426305,None
2729,4959,NCT04426318,ClinicalTrials.gov,2020-06-09,2020-06-14,False,"University of Wisconsin, Madison",Recruiting,Not Applicable,Interventional,United States,COVID-19 and the Healthy Minds Program for Educators,Other (psych),Psychological,Psychological,800,https://clinicaltrials.gov/show/NCT04426318,None
2730,4960,NCT04426344,ClinicalTrials.gov,2020-06-03,2020-10-01,False,Washington University in St. Louis,Not Recruiting,Not Applicable,Interventional,United States,Core Warming of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04426344,None
2731,4961,NCT04426695,ClinicalTrials.gov,2020-06-08,2020-06-10,True,Regeneron Pharmaceuticals,Recruiting,Phase 1/Phase 2,Interventional,"Chile, Brazil, Romania, United States, Moldova, Republic of","Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19",Drug,REGN10933 vs. REGN10987,REGN10933; REGN10987,2970,https://clinicaltrials.gov/show/NCT04426695,EUCTR2020-002537-15
2732,4962,NCT04427098,ClinicalTrials.gov,2020-05-29,2020-05-22,False,AOU di Bologna Policlinico S.Orsola-Malpighi,Recruiting,Phase 2,Interventional,Italy,Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients,Drug,Enoxaparin,Enoxaparin,300,https://clinicaltrials.gov/show/NCT04427098,EUCTR2020-001308-40
2733,4963,NCT04427137,ClinicalTrials.gov,2020-06-10,2020-06-09,True,Centre for Addiction and Mental Health,Recruiting,Not Applicable,Interventional,Canada,Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic,Other (psych),Electroconvulsive Therapy,Electroconvulsive Therapy,50,https://clinicaltrials.gov/show/NCT04427137,None
2734,4965,NCT04427254,ClinicalTrials.gov,2020-05-26,2021-01-01,False,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Not Applicable,Interventional,France,Study of the Sars-Cov2 Neuroinvasiveness - COVID19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04427254,None
2735,4971,NCT04427566,ClinicalTrials.gov,2020-06-05,2020-07-23,False,Ohio State University Comprehensive Cancer Center,Recruiting,Phase 2,Interventional,United States,Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise,Other,Radiation,Radiation,24,https://clinicaltrials.gov/show/NCT04427566,None
2736,4972,NCT04427631,ClinicalTrials.gov,2020-06-03,2020-06-22,False,Cambridgeshire Community Services NHS Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,Exploring Interventions for Glue Ear During Covid-19,Other,Other,Other,20,https://clinicaltrials.gov/show/NCT04427631,None
2737,4975,NCT04427865,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19,Drug (Chemoprophylaxis),Lactoferrin,Lactoferrin,200,https://clinicaltrials.gov/show/NCT04427865,None
2738,4976,NCT04427878,ClinicalTrials.gov,2020-06-10,2020-07-01,False,CHU de Nice,Not Recruiting,Not Applicable,Interventional,France,Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?,Clinical Presentation,No Intervention,No Intervention,5,https://clinicaltrials.gov/show/NCT04427878,None
2739,4977,NCT04428008,ClinicalTrials.gov,2020-06-07,2020-09-01,False,Inova Health System,Not Recruiting,Phase 2,Interventional,No Country Given,Thymosin Alpha 1 to Prevent COVID-19 Infection in Elderly Renal Dialysis Patients,Drug,Thymalfasin,Thymalfasin,240,https://clinicaltrials.gov/show/NCT04428008,None
2740,4978,NCT04428021,ClinicalTrials.gov,2020-06-07,2020-06-15,False,AOU Città della Salute e della Scienza di Torino,Recruiting,Phase 2,Interventional,Italy,Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure,ATMP,Plasma,Plasma,180,https://clinicaltrials.gov/show/NCT04428021,None
2741,4979,NCT04428073,ClinicalTrials.gov,2020-06-08,2020-07-01,False,GeneCure Biotechnologies,Not Recruiting,Phase 1,Interventional,No Country Given,Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,ATMP,Vaccine,Vaccine,32,https://clinicaltrials.gov/show/NCT04428073,None
2742,4980,NCT04428099,ClinicalTrials.gov,2020-06-09,2020-01-13,True,University of the Balearic Islands,Recruiting,Not Applicable,Interventional,Spain,Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression,Telehealth,Telehealth,Telehealth,186,https://clinicaltrials.gov/show/NCT04428099,None
2743,4981,NCT04428268,ClinicalTrials.gov,2020-04-26,2020-03-10,True,Hospital Universitario Dr. Jose E. Gonzalez,Recruiting,Phase 2,Interventional,Mexico,Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia,Drug,Chloroquine vs. Chloroquine + Losartan,Chloroquine; Losartan,20,https://clinicaltrials.gov/show/NCT04428268,None
2744,4982,NCT04428801,ClinicalTrials.gov,2020-04-08,2021-01-10,False,Celltex Therapeutics Corporation,Not Recruiting,Phase 2,Interventional,No Country Given,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),200,https://clinicaltrials.gov/show/NCT04428801,None
2745,4983,NCT04429334,ClinicalTrials.gov,2020-05-29,2020-08-01,False,Inotrem,Not Recruiting,Phase 2,Interventional,France,"Safety, Tolerability and Efficacy of Nangibotide in Mechanically Ventilated Patients With COVID-19 and Features of Systemic Inflammation",Drug,Nangibotide,Nangibotide,60,https://clinicaltrials.gov/show/NCT04429334,None
2746,4985,NCT04429529,ClinicalTrials.gov,2020-06-09,2020-06-09,False,Tychan Pte Ltd.,Not Recruiting,Phase 1,Interventional,Singapore,"Safety of TY027, a Treatment for COVID-19, in Humans",Drug,TY027,TY027,32,https://clinicaltrials.gov/show/NCT04429529,None
2747,4986,NCT04429555,ClinicalTrials.gov,2020-06-09,2020-11-01,False,MediciNova,Not Recruiting,Phase 2,Interventional,No Country Given,"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS",Drug,Ibudilast,Ibudilast,40,https://clinicaltrials.gov/show/NCT04429555,None
2748,4987,NCT04429594,ClinicalTrials.gov,2020-06-10,2020-07-28,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Study of the Incidence of SARS-CoV-2 Infection (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04429594,None
2749,4989,NCT04429711,ClinicalTrials.gov,2020-05-24,2020-05-12,True,Sheba Medical Center,Recruiting,Not Applicable,Interventional,Israel,Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04429711,None
2750,4990,NCT04429724,ClinicalTrials.gov,2020-06-10,2020-07-06,False,Tourcoing Hospital,Recruiting,Not Applicable,Interventional,France,Health Professional Exposure Assessment to Covid-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04429724,None
2751,4991,NCT04429763,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Trustem,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04429763,None
2752,4993,NCT04429828,ClinicalTrials.gov,2020-06-11,2020-06-13,False,University of Nottingham,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Psychological Wellbeing for Healthcare Students,Other (psych),Psychological,Psychological,45,https://clinicaltrials.gov/show/NCT04429828,None
2753,4994,NCT04429854,ClinicalTrials.gov,2020-06-09,2020-05-02,True,UZ Leuven,Recruiting,Phase 2,Interventional,Belgium,Donated Antibodies Working Against nCoV,ATMP,Plasma,Plasma,483,https://clinicaltrials.gov/show/NCT04429854,None
2754,4995,NCT04429867,ClinicalTrials.gov,2020-06-10,2020-05-07,True,WellStar Health System,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,700,https://clinicaltrials.gov/show/NCT04429867,None
2755,5000,NCT04430608,ClinicalTrials.gov,2020-05-26,2020-05-25,True,"Copenhagen University Hospital, North Zealand",Recruiting,Not Applicable,Interventional,Denmark,Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients,Other (device),Biosensors,Biosensors,72,https://clinicaltrials.gov/show/NCT04430608,None
2756,5001,NCT04431180,ClinicalTrials.gov,2020-06-12,2020-06-13,False,Guangzhou Blood Center,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#,Other,Other,Other,403535,https://clinicaltrials.gov/show/NCT04431180,None
2757,5004,NCT04431466,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Federal University of São Carlos,Recruiting,Phase 2,Interventional,Brazil,A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19,Drug,Ivermectin,Ivermectin,64,https://clinicaltrials.gov/show/NCT04431466,None
2758,5007,NCT04432051,ClinicalTrials.gov,2020-06-11,2020-05-26,True,Gaziosmanpasa Taksim Research and Education Hospital,Recruiting,Not Applicable,Interventional,Turkey,The Use of Lung Ultrasonography in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04432051,None
2759,5008,NCT04432103,ClinicalTrials.gov,2020-06-12,2020-06-19,False,Centro Medico ABC,Not Recruiting,Phase 3,Interventional,No Country Given,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,ATMP,Plasma,Plasma,36,https://clinicaltrials.gov/show/NCT04432103,None
2760,5009,NCT04432272,ClinicalTrials.gov,2020-06-12,2020-07-16,False,William Beaumont Hospitals,Recruiting,Phase 2,Interventional,United States,ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS),ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04432272,None
2761,5010,NCT04432324,ClinicalTrials.gov,2020-06-12,2020-06-02,True,"Grifols, S.A.",Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19),ATMP,Immunoglobulin,Immunoglobulin,100,https://clinicaltrials.gov/show/NCT04432324,EUCTR2020-001696-32
2762,5012,NCT04432766,ClinicalTrials.gov,2020-06-12,2020-10-20,False,Bio-Thera Solutions,Not Recruiting,Phase 1/Phase 2,Interventional,United States,A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients,Drug,BAT2020,BAT2020,174,https://clinicaltrials.gov/show/NCT04432766,None
2763,5014,NCT04432805,ClinicalTrials.gov,2020-06-15,2020-06-15,False,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,160,https://clinicaltrials.gov/show/NCT04432805,None
2764,5018,NCT04432987,ClinicalTrials.gov,2020-06-15,2020-05-25,True,Acibadem University,Recruiting,Phase 2,Interventional,Turkey,Dornase Alpha for the Treatment of COVID-19,Drug,Dornase alfa,Dornase alfa,60,https://clinicaltrials.gov/show/NCT04432987,None
2765,5020,NCT04433013,ClinicalTrials.gov,2020-06-14,2020-07-01,False,Nanyang Technological University,Not Recruiting,Phase 3,Interventional,No Country Given,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,https://clinicaltrials.gov/show/NCT04433013,None
2766,5023,NCT04433078,ClinicalTrials.gov,2020-06-10,2020-06-22,False,Temple University,Recruiting,Phase 2,Interventional,United States,RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM,Drug,Doxycycline,Doxycycline,20,https://clinicaltrials.gov/show/NCT04433078,None
2767,5031,NCT04433910,ClinicalTrials.gov,2020-05-06,2020-08-30,True,Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen,Recruiting,Phase 2,Interventional,Germany,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,ATMP,Plasma,Plasma,106,https://clinicaltrials.gov/show/NCT04433910,EUCTR2020-001310-38
2768,5032,NCT04433949,ClinicalTrials.gov,2020-06-12,2020-06-12,False,Emory University,Recruiting,Phase 3,Interventional,United States,Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19,Other,Radiation,Radiation,52,https://clinicaltrials.gov/show/NCT04433949,None
2769,5033,NCT04433988,ClinicalTrials.gov,2020-06-13,2020-12-13,False,Sadat City University,Not Recruiting,Phase 1/Phase 2,Interventional,Egypt,Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients,Drug,Pentoxifylline,Pentoxifylline,200,https://clinicaltrials.gov/show/NCT04433988,None
2770,5036,NCT04434131,ClinicalTrials.gov,2020-06-09,2020-04-28,True,University of New Mexico,Recruiting,Phase 2,Interventional,United States,Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04434131,None
2771,5039,NCT04434248,ClinicalTrials.gov,2020-06-13,2020-04-23,True,Chromis LLC,Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,Drug,Favipiravir,Favipiravir,330,https://clinicaltrials.gov/show/NCT04434248,None
2772,5042,NCT04435015,ClinicalTrials.gov,2020-06-16,2021-02-01,False,Yale University,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications,Drug,Camostat Mesilate,Camostat Mesilate,200,https://clinicaltrials.gov/show/NCT04435015,None
2773,5048,NCT04435184,ClinicalTrials.gov,2020-06-16,2020-07-09,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Crizanlizumab for Treating COVID-19 Vasculopathy,Drug,Crizanlizumab,Crizanlizumab,40,https://clinicaltrials.gov/show/NCT04435184,None
2774,5050,NCT04435275,ClinicalTrials.gov,2020-06-09,2020-06-30,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,Virtual Assistant for COVID-19 PPE,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04435275,None
2775,5051,NCT04435314,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Azidus Brasil,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19,Drug,Nitazoxanide,Nitazoxanide,200,https://clinicaltrials.gov/show/NCT04435314,None
2776,5053,NCT04435353,ClinicalTrials.gov,2020-06-14,2020-03-22,True,Astana Medical University,Recruiting,Not Applicable,Interventional,Kazakhstan,Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19,Other,Vibroacoustic Therapy,Vibroacoustic Therapy,200,https://clinicaltrials.gov/show/NCT04435353,None
2777,5055,NCT04435522,ClinicalTrials.gov,2020-06-15,2020-09-21,False,Rhode Island Hospital,Recruiting,Phase 1,Interventional,United States,Maraviroc in Patients With Moderate and Severe COVID-19,Drug,Maraviroc,Maraviroc,16,https://clinicaltrials.gov/show/NCT04435522,None
2778,5056,NCT04435587,ClinicalTrials.gov,2020-06-15,2020-07-01,False,Mahidol University,Not Recruiting,Phase 4,Interventional,Thailand,Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection,Drug,Ivermectin vs. Hydroxychloroquine + Darunavir/ritonavir,Ivermectin; Hydroxychloroquine; Darunavir/ritonavir,80,https://clinicaltrials.gov/show/NCT04435587,None
2779,5057,NCT04435717,ClinicalTrials.gov,2020-06-11,2020-05-04,True,Hospital Universitario Ramón y Cajal,Recruiting,Phase 2,Interventional,Spain,Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01),Drug,Tocilizumab,Tocilizumab,78,https://clinicaltrials.gov/show/NCT04435717,None
2780,5058,NCT04435795,ClinicalTrials.gov,2020-06-16,2020-09-14,False,McGill University,Recruiting,Phase 2/Phase 3,Interventional,Canada,Inhaled Ciclesonide for Outpatients With COVID19,Drug,Ciclesonide,Ciclesonide,454,https://clinicaltrials.gov/show/NCT04435795,None
2781,5059,NCT04435808,ClinicalTrials.gov,2020-06-04,2020-04-14,True,University of New Mexico,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1,https://clinicaltrials.gov/show/NCT04435808,None
2782,5060,NCT04436276,ClinicalTrials.gov,2020-06-15,2020-07-15,True,Janssen Pharmaceutical,Recruiting,Phase 1/Phase 2,Interventional,"Belgium, United States",A Study of Ad26.COV2.S in Adults (COVID-19),ATMP,Vaccine,Vaccine,1045,https://clinicaltrials.gov/show/NCT04436276,EUCTR2020-001483-28
2783,5061,NCT04436458,ClinicalTrials.gov,2020-06-16,2020-12-01,False,"First Wave Bio, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Niclosamide In Moderate COVID-19,Drug,Niclosamide,Niclosamide,100,https://clinicaltrials.gov/show/NCT04436458,None
2784,5062,NCT04436471,ClinicalTrials.gov,2020-06-16,2020-06-17,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19",ATMP,Vaccine,Vaccine,38,https://clinicaltrials.gov/show/NCT04436471,None
2785,5065,NCT04437693,ClinicalTrials.gov,2020-06-17,2020-08-31,False,Hamad Medical Corporation,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,https://clinicaltrials.gov/show/NCT04437693,None
2786,5067,NCT04437719,ClinicalTrials.gov,2020-06-17,2020-06-29,False,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Not Applicable,Interventional,France,"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic",Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04437719,None
2787,5068,NCT04437823,ClinicalTrials.gov,2020-06-17,2020-06-01,True,Jinnah Hospital,Recruiting,Phase 2,Interventional,Pakistan,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04437823,None
2788,5069,NCT04437875,ClinicalTrials.gov,2020-06-16,2020-06-17,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19",ATMP,Vaccine,Vaccine,38,https://clinicaltrials.gov/show/NCT04437875,None
2789,5072,NCT04438057,ClinicalTrials.gov,2020-06-17,2020-08-12,False,Metro Infectious Disease Consultants,Recruiting,Phase 2,Interventional,United States,Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19,ATMP,Plasma,Plasma,150,https://clinicaltrials.gov/show/NCT04438057,None
2790,5073,NCT04438070,ClinicalTrials.gov,2020-06-17,2020-04-10,True,St. Joseph's Healthcare Hamilton,Recruiting,Not Applicable,Interventional,Canada,COVID Screening Strategies in Homeless Shelters,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04438070,None
2791,5076,NCT04438694,ClinicalTrials.gov,2020-06-16,2020-06-01,True,Cairo University,Recruiting,Phase 1/Phase 2,Interventional,Egypt,Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection,ATMP,Plasma,Plasma,67,https://clinicaltrials.gov/show/NCT04438694,None
2792,5077,NCT04438837,ClinicalTrials.gov,2020-06-18,2020-07-01,False,Rambam Health Care Campus,Not Recruiting,Not Applicable,Interventional,Israel,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,582,https://clinicaltrials.gov/show/NCT04438837,None
2793,5078,NCT04438850,ClinicalTrials.gov,2020-04-10,2020-07-31,False,IRCCS Don Calabria Ospedale Sacro Cuore,Recruiting,Phase 2,Interventional,"Italy, Spain",COVidIVERmectin: Ivermectin for Treatment of Covid-19,Drug,Ivermectin,Ivermectin,102,https://clinicaltrials.gov/show/NCT04438850,None
2794,5083,NCT04438980,ClinicalTrials.gov,2020-06-18,2020-05-15,True,Fundación Miguel Servet,Recruiting,Phase 3,Interventional,Spain,Glucocorticoids in COVID-19 (CORTIVID),Drug,Corticosteroids,Methylprednisolone,72,https://clinicaltrials.gov/show/NCT04438980,EUCTR2020-001827-15
2795,5085,NCT04439006,ClinicalTrials.gov,2020-06-17,2020-07-22,False,Jennifer Woyach,Recruiting,Phase 2,Interventional,United States,Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization,Drug,Ibrutinib,Ibrutinib,72,https://clinicaltrials.gov/show/NCT04439006,None
2796,5086,NCT04439045,ClinicalTrials.gov,2020-06-03,2020-06-24,False,"University Health Network, Toronto",Recruiting,Phase 3,Interventional,Canada,Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity,Drug,VPM1002,VPM1002,3626,https://clinicaltrials.gov/show/NCT04439045,None
2797,5087,NCT04439071,ClinicalTrials.gov,2020-06-17,2020-07-09,True,PTC Therapeutics,Recruiting,Phase 2/Phase 3,Interventional,"Brazil, Australia, Spain, United States",A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19),Drug,PTC299,PTC299,380,https://clinicaltrials.gov/show/NCT04439071,EUCTR2020-001872-13
2798,5089,NCT04439825,ClinicalTrials.gov,2020-06-18,2020-07-15,False,DeNova Research,Not Recruiting,Phase 1,Interventional,United States,Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction,Drug,Botulinum Neurotoxin,Botulinum Neurotoxin,45,https://clinicaltrials.gov/show/NCT04439825,None
2799,5092,NCT04441385,ClinicalTrials.gov,2020-06-18,2020-06-26,True,Hospital Universitario Infanta Leonor,Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).,Drug,Maraviroc,Maraviroc,200,https://clinicaltrials.gov/show/NCT04441385,EUCTR2020-002011-21
2800,5093,NCT04441398,ClinicalTrials.gov,2020-06-18,2020-07-01,False,Azidus Brasil,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients,Drug,Nitazoxanide,Nitazoxanide,300,https://clinicaltrials.gov/show/NCT04441398,None
2801,5094,NCT04441424,ClinicalTrials.gov,2020-06-12,2020-04-03,True,Alkarkh Health Directorate-Baghdad,Not Recruiting,Not Applicable,Interventional,Iraq,Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients,ATMP (+ Drug),Plasma + Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin,Plasma; Hydroxychloroquine; Azithromycin,49,https://clinicaltrials.gov/show/NCT04441424,None
2802,5098,NCT04441632,ClinicalTrials.gov,2020-06-18,2020-06-15,True,Cedars-Sinai Medical Center,Not Recruiting,Not Applicable,Interventional,United States,Effect of Positive Attitudes on Behavior and Wellness,Other (psych),Psychological,Psychological,24,https://clinicaltrials.gov/show/NCT04441632,None
2803,5099,NCT04441684,ClinicalTrials.gov,2020-05-20,2020-04-17,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Interventional,France,"Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1800,https://clinicaltrials.gov/show/NCT04441684,None
2804,5101,NCT04441918,ClinicalTrials.gov,2020-06-06,2020-06-05,True,"Shanghai Junshi Bioscience Co., Ltd.",Recruiting,Phase 1,Interventional,China,"Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects",Drug,JS016,JS016,40,https://clinicaltrials.gov/show/NCT04441918,None
2805,5102,NCT04441996,ClinicalTrials.gov,2020-06-19,2020-07-17,False,Emory University,Recruiting,Phase 4,Interventional,United States,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04441996,None
2806,5103,NCT04442048,ClinicalTrials.gov,2020-06-19,2020-06-25,False,Canadian Cancer Trials Group,Recruiting,Phase 3,Interventional,Canada,Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure,Drug,IMM-101,IMM-101,1500,https://clinicaltrials.gov/show/NCT04442048,None
2807,5104,NCT04442152,ClinicalTrials.gov,2020-06-19,2020-06-01,True,Promundo,Recruiting,Not Applicable,Interventional,Rwanda,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04442152,None
2808,5106,NCT04442178,ClinicalTrials.gov,2020-06-19,2020-09-15,False,Revimmune,Recruiting,Phase 2,Interventional,United States,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ),Drug,Interleukin-7,Interleukin-7,48,https://clinicaltrials.gov/show/NCT04442178,None
2809,5107,NCT04442191,ClinicalTrials.gov,2020-05-11,2020-05-05,True,"University of Illinois, Chicago",Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as a Possible Treatment for COVID-19,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04442191,None
2810,5115,NCT04442958,ClinicalTrials.gov,2020-06-17,2020-05-15,True,Bagcilar Training and Research Hospital,Not Recruiting,Not Applicable,Interventional,Turkey,Effectiveness of Convalescent Immune Plasma Therapy,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04442958,None
2811,5119,NCT04443270,ClinicalTrials.gov,2020-06-17,2020-07-27,False,Centro Médico Nacional 20 de Noviembre,Not Recruiting,Phase 1,Interventional,Mexico,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Other (Chemoprophylaxis),Chloroquine,Chloroquine,200,https://clinicaltrials.gov/show/NCT04443270,None
2812,5121,NCT04443673,ClinicalTrials.gov,2020-06-18,2020-08-20,False,Instituto Nacional de Enfermedades Respiratorias,Recruiting,Not Applicable,Interventional,Mexico,Glycine Supplement for Severe COVID-19,Supplement,Glycine,Glycine,82,https://clinicaltrials.gov/show/NCT04443673,None
2813,5124,NCT04443725,ClinicalTrials.gov,2020-06-20,2020-07-01,False,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19,Drug,Hydroxychloroquine + Sofosbuvir + Daclatasvir,Hydroxychloroquine; Sofosbuvir; Daclatasvir,100,https://clinicaltrials.gov/show/NCT04443725,None
2814,5127,NCT04443868,ClinicalTrials.gov,2020-06-20,2021-01-01,False,Sanotize Research and Development corp.,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection,Drug,Nitric Oxide,Nitric Oxide,50,https://clinicaltrials.gov/show/NCT04443868,None
2815,5128,NCT04443881,ClinicalTrials.gov,2020-06-18,2020-05-08,True,Fundación Miguel Servet,Recruiting,Phase 2/Phase 3,Interventional,Spain,Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS),Drug,Anakinra,Anakinra,180,https://clinicaltrials.gov/show/NCT04443881,None
2816,5130,NCT04444271,ClinicalTrials.gov,2020-05-27,2020-05-01,True,Dr. Zaineb Akram,Recruiting,Phase 2,Interventional,Pakistan,Mesenchymal Stem Cell Infusion for COVID-19 Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04444271,None
2817,5131,NCT04444297,ClinicalTrials.gov,2020-06-20,2020-07-31,False,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Interventional,United Kingdom,3D Telemedicine During COVID-19: Non-clinical Validation,Telehealth,Telehealth,Telehealth,40,https://clinicaltrials.gov/show/NCT04444297,None
2818,5133,NCT04444323,ClinicalTrials.gov,2020-06-20,2020-09-01,False,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Interventional,United Kingdom,3D Telemedicine During COVID-19: Cohort Study,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04444323,None
2819,5138,NCT04444596,ClinicalTrials.gov,2020-06-18,2020-06-17,True,Medical University Innsbruck,Recruiting,Not Applicable,Interventional,Austria,Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04444596,None
2820,5141,NCT04444674,ClinicalTrials.gov,2020-06-15,2020-06-24,False,University of Oxford,Not Recruiting,Phase 1/Phase 2,Interventional,South Africa,COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection,ATMP,Vaccine,Vaccine,2130,https://clinicaltrials.gov/show/NCT04444674,None
2821,5143,NCT04444700,ClinicalTrials.gov,2020-06-22,2020-07-04,False,University of São Paulo General Hospital,Recruiting,Phase 3,Interventional,Brazil,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic,Drug,Heparin,Heparin,462,https://clinicaltrials.gov/show/NCT04444700,None
2822,5146,NCT04445220,ClinicalTrials.gov,2020-06-22,2020-11-19,False,"Sentien Biotechnologies, Inc.",Recruiting,Phase 1/Phase 2,Interventional,United States,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,ATMP,Cells (mesenchymal),Cells (mesenchymal),22,https://clinicaltrials.gov/show/NCT04445220,None
2823,5147,NCT04445246,ClinicalTrials.gov,2020-06-09,2020-05-23,True,Hamad Medical Corporation,Recruiting,Phase 2,Interventional,Qatar,Inhaled Iloprost for Suspected COVID-19 Respiratory Failure,Drug,Iloprost,Iloprost,40,https://clinicaltrials.gov/show/NCT04445246,None
2824,5149,NCT04445272,ClinicalTrials.gov,2020-06-13,2020-05-22,True,Fundación SEIMC-GESIDA,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,500,https://clinicaltrials.gov/show/NCT04445272,None
2825,5150,NCT04445285,ClinicalTrials.gov,2020-06-22,2020-04-28,True,Jon Simmons,Recruiting,Phase 2,Interventional,United States,Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure,Drug,Dornase alpha,Dornase alpha,44,https://clinicaltrials.gov/show/NCT04445285,None
2826,5151,NCT04445311,ClinicalTrials.gov,2020-06-19,2020-05-31,True,Zagazig University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Ivermectin in Treatment of COVID-19,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04445311,None
2827,5152,NCT04445324,ClinicalTrials.gov,2020-06-22,2020-08-25,False,Centre de Recherche de l'Institut Universitaire en Santé Mentale de Montréal,Not Recruiting,Not Applicable,Interventional,Canada,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19,Other (psych),Psychological,Psychological,30,https://clinicaltrials.gov/show/NCT04445324,None
2828,5153,NCT04445337,ClinicalTrials.gov,2020-06-09,2020-07-01,False,University of Nebraska,Not Recruiting,Not Applicable,Interventional,No Country Given,Stellate Ganglion Blockade in COVID-19 Positive Patients,Clinical Presentation,No Intervention,No Intervention,10,https://clinicaltrials.gov/show/NCT04445337,None
2829,5154,NCT04445376,ClinicalTrials.gov,2020-06-22,2020-07-03,False,Government College University Faisalabad,Not Recruiting,Not Applicable,Interventional,Pakistan,Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.,Other (exercise),Exercise,Exercise,20,https://clinicaltrials.gov/show/NCT04445376,None
2830,5155,NCT04445389,ClinicalTrials.gov,2020-06-19,2020-06-17,True,"Genexine, Inc.",Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults",ATMP,Vaccine,Vaccine,210,https://clinicaltrials.gov/show/NCT04445389,None
2831,5158,NCT04445428,ClinicalTrials.gov,2020-06-22,2020-07-15,False,Bandim Health Project,Recruiting,Phase 4,Interventional,Guinea-Bissau,OPV as Potential Protection Against COVID-19,ATMP,Vaccine,Vaccine,3400,https://clinicaltrials.gov/show/NCT04445428,None
2832,5160,NCT04445454,ClinicalTrials.gov,2020-06-19,2020-06-12,True,University of Liège,Recruiting,Phase 1/Phase 2,Interventional,Belgium,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04445454,None
2833,5161,NCT04445467,ClinicalTrials.gov,2020-06-22,2020-08-01,False,Bayside Health,Recruiting,Phase 2,Interventional,Australia,An Adaptive Clinical Trial of Antivirals for COVID-19 Infection,Drug,Favipiravir,Favipiravir,190,https://clinicaltrials.gov/show/NCT04445467,None
2834,5164,NCT04445597,ClinicalTrials.gov,2020-06-22,2020-05-07,True,UZ Leuven,Recruiting,Not Applicable,Interventional,Belgium,ANalyzing Olfactory Dysfunction Mechanisms In COVID-19,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04445597,None
2835,5166,NCT04445623,ClinicalTrials.gov,2020-06-04,2020-07-01,False,AOUI Verona,Not Recruiting,Phase 3,Interventional,Italy,Prasugrel in Severe COVID-19 Pneumonia,Drug,Prasugrel,Prasugrel,128,https://clinicaltrials.gov/show/NCT04445623,None
2836,5168,NCT04445935,ClinicalTrials.gov,2020-06-23,2020-06-28,False,Hamad Medical Corporation,Recruiting,Phase 4,Interventional,Qatar,Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial,Drug,Bivalirudin,Bivalirudin,100,https://clinicaltrials.gov/show/NCT04445935,None
2837,5170,NCT04446065,ClinicalTrials.gov,2020-06-23,2020-09-30,False,MELISA Institute Genomics & Proteomics Research SpA,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,PrevifenonÂ® as Chemoprophylaxis of COVID-19 in Health Workers,Drug (Chemoprophylaxis),Epigallocatechin gallate,Epigallocatechin gallate,524,https://clinicaltrials.gov/show/NCT04446065,None
2838,5171,NCT04446104,ClinicalTrials.gov,2020-05-11,2020-05-13,False,"National University Hospital, Singapore",Not Recruiting,Phase 3,Interventional,Singapore,A Preventive Treatment for Migrant Workers at High-risk of COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Ivermectin vs. Zinc + Vitamin C vs. Povidone Iodine vs. Vitamin C,Hydroxychloroquine; Ivermectin; Zinc; Vitamin C; Povidone Iodine,4257,https://clinicaltrials.gov/show/NCT04446104,None
2839,5175,NCT04446377,ClinicalTrials.gov,2020-06-23,2020-07-15,False,"AI Therapeutics, Inc.",Recruiting,Phase 2,Interventional,United States,A Study of LAM-002A for the Prevention of Progression of COVID-19,Drug,Apilimod Dimesylate,Apilimod Dimesylate,142,https://clinicaltrials.gov/show/NCT04446377,None
2840,5180,NCT04447235,ClinicalTrials.gov,2020-06-22,2020-07-23,False,Instituto do Câncer do Estado de São Paulo,Recruiting,Phase 2,Interventional,Brazil,Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection,Drug,Ivermectin + Losartan,Ivermectin; Losartan,176,https://clinicaltrials.gov/show/NCT04447235,None
2841,5181,NCT04447469,ClinicalTrials.gov,2020-06-23,2020-07-27,False,"Kiniksa Pharmaceuticals, Ltd.",Recruiting,Phase 2/Phase 3,Interventional,"Chile, South Africa, Peru, Brazil, United States",Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,573,https://clinicaltrials.gov/show/NCT04447469,None
2842,5184,NCT04447781,ClinicalTrials.gov,2020-06-16,2020-07-15,False,International Vaccine Institute,Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19",ATMP,Vaccine,Vaccine,160,https://clinicaltrials.gov/show/NCT04447781,None
2843,5185,NCT04447833,ClinicalTrials.gov,2020-06-20,2020-06-17,True,Uppsala University,Recruiting,Phase 1,Interventional,Sweden,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),9,https://clinicaltrials.gov/show/NCT04447833,None
2844,5186,NCT04448119,ClinicalTrials.gov,2020-06-24,2020-10-16,False,Appili Therapeutics Inc.,Recruiting,Phase 2,Interventional,Canada,Control of COVID-19 Outbreaks in Long Term Care,Drug,Favipiravir,Favipiravir,760,https://clinicaltrials.gov/show/NCT04448119,None
2845,5193,NCT04448756,ClinicalTrials.gov,2020-06-25,2020-07-29,False,Merck KGaA,Recruiting,Phase 2,Interventional,"Brazil, United States",M5049 Study in Participants With Coronavirus Disease 2019 (COVID-19) Pneumonia,Drug,M5049,M5049,150,https://clinicaltrials.gov/show/NCT04448756,None
2846,5194,NCT04448769,ClinicalTrials.gov,2020-06-23,2020-06-26,False,CHU de Nancy,Not Recruiting,Not Applicable,Interventional,France,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,2006,https://clinicaltrials.gov/show/NCT04448769,None
2847,5199,NCT04449276,ClinicalTrials.gov,2020-06-18,2020-06-18,False,CureVac AG,Recruiting,Phase 1,Interventional,"Belgium, Germany","A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults",ATMP,Vaccine,Vaccine,284,https://clinicaltrials.gov/show/NCT04449276,None
2848,5200,NCT04449380,ClinicalTrials.gov,2020-06-23,2020-11-02,False,Emanuele Bosi,Recruiting,Phase 2,Interventional,Italy,Clinical Study for the Treatment With Interferon-ÃŸ-1a (IFNÃŸ-1a) of COVID-19 Patients,Drug,Interferon beta,Interferon beta,126,https://clinicaltrials.gov/show/NCT04449380,None
2849,5201,NCT04449588,ClinicalTrials.gov,2020-06-26,2020-07-23,False,"Staidson (Beijing) Biopharmaceuticals Co., Ltd",Recruiting,Phase 2/Phase 3,Interventional,"China, Indonesia",Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS,Drug,BDB-001,BDB-001,368,https://clinicaltrials.gov/show/NCT04449588,None
2850,5203,NCT04449718,ClinicalTrials.gov,2020-06-16,2020-06-01,True,University of São Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,Vitamin D Supplementation in Patients With COVID-19,Drug,Vitamin D,Vitamin D,240,https://clinicaltrials.gov/show/NCT04449718,None
2851,5206,NCT04449965,ClinicalTrials.gov,2020-06-24,2020-07-01,False,"St. Paul's Hospital, Canada",Not Recruiting,Phase 1,Interventional,No Country Given,Povidone-Iodine Rinses in the Management of COVID-19,Drug,Povidone Iodine,Povidone Iodine,81,https://clinicaltrials.gov/show/NCT04449965,None
2852,5208,NCT04450004,ClinicalTrials.gov,2020-06-18,2020-07-10,False,Medicago,Not Recruiting,Phase 1,Interventional,Canada,"Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.",ATMP,Vaccine,Vaccine,180,https://clinicaltrials.gov/show/NCT04450004,None
2853,5211,NCT04451174,ClinicalTrials.gov,2020-06-26,2020-06-23,True,University of Chile,Recruiting,Phase 3,Interventional,Chile,Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia,Drug,Corticosteroids,Prednisone,184,https://clinicaltrials.gov/show/NCT04451174,None
2854,5212,NCT04451239,ClinicalTrials.gov,2020-06-28,2020-06-30,False,Ameera Gamal Abdelhameed,Not Recruiting,Not Applicable,Interventional,Kuwait,Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis,Drug,Corticosteroids + Cyclosporine,Prednisolone + Cyclosporine,12,https://clinicaltrials.gov/show/NCT04451239,None
2855,5213,NCT04451291,ClinicalTrials.gov,2020-06-26,2020-08-24,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure,ATMP,Cells (decidual stromal),Cells (decidual stromal),20,https://clinicaltrials.gov/show/NCT04451291,None
2856,5217,NCT04451889,ClinicalTrials.gov,2020-06-29,2020-08-01,False,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",Recruiting,Not Applicable,Interventional,Russian Federation,Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,15,https://clinicaltrials.gov/show/NCT04451889,None
2857,5220,NCT04452097,ClinicalTrials.gov,2020-06-28,2021-02-01,False,Baylx Inc.,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS,ATMP,Cells (mesenchymal),Cells (mesenchymal),39,https://clinicaltrials.gov/show/NCT04452097,None
2858,5222,NCT04452435,ClinicalTrials.gov,2020-06-29,2020-07-21,True,Vicore Pharma AB,Not Recruiting,Phase 2,Interventional,"India, United Kingdom",Safety and Efficacy of C21 in Subjects With COVID-19,Drug,C21,C21,106,https://clinicaltrials.gov/show/NCT04452435,EUCTR2020-001502-38
2859,5223,NCT04452474,ClinicalTrials.gov,2020-06-25,2020-06-30,False,"R-Pharm International, LLC",Not Recruiting,Phase 2/Phase 3,Interventional,United States,Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).,Drug,Olokizumab,Olokizumab,376,https://clinicaltrials.gov/show/NCT04452474,None
2860,5225,NCT04452565,ClinicalTrials.gov,2020-06-26,2020-10-15,False,"NeuroActiva, Inc.",Recruiting,Phase 2/Phase 3,Interventional,United States,"NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection",Drug,NA-831 vs. NA-831 + Atazanavir vs. NA-831 + Corticosteroids vs. Atazanavir + Corticosteroids,NA-831; Dexamethasone; Atazanavir,525,https://clinicaltrials.gov/show/NCT04452565,None
2861,5229,NCT04452643,ClinicalTrials.gov,2020-06-26,2020-10-01,False,Inmunotek S.L.,Not Recruiting,Phase 3,Interventional,Mexico,Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel,Drug (Chemoprophylaxis),Bacteria,Bacteria,0,https://clinicaltrials.gov/show/NCT04452643,None
2862,5230,NCT04452669,ClinicalTrials.gov,2020-06-29,2020-08-15,False,Aerogen Pharma Limited,Not Recruiting,Phase 2,Interventional,United States,VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation,Drug,Epoprostenol,Epoprostenol,20,https://clinicaltrials.gov/show/NCT04452669,None
2863,5234,NCT04452773,ClinicalTrials.gov,2020-06-25,2020-07-14,False,Reig Jofre Group,Recruiting,Not Applicable,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Food Supplement ManremycÂ® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers,Supplement,Nutritional Supplement,Nutritional Supplement,315,https://clinicaltrials.gov/show/NCT04452773,None
2864,5235,NCT04452799,ClinicalTrials.gov,2020-06-29,2020-07-01,False,Tanta University,Not Recruiting,Phase 1,Interventional,No Country Given,Hesperidin and Diosmin for Treatment of COVID-19,Drug,Hesperidin + Diosmin,Hesperidin; Diosmin,100,https://clinicaltrials.gov/show/NCT04452799,None
2865,5236,NCT04452812,ClinicalTrials.gov,2020-06-29,2020-07-06,False,Universidad Autónoma de Coahuila,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19,ATMP,Plasma,Plasma,15,https://clinicaltrials.gov/show/NCT04452812,None
2866,5239,NCT04453371,ClinicalTrials.gov,2020-06-26,2020-10-15,False,Negovsky Reanimatology Research Institute,Not Recruiting,Phase 3,Interventional,No Country Given,Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19),Drug,Tissue plasminogen activator,Tissue plasminogen activator,50,https://clinicaltrials.gov/show/NCT04453371,None
2867,5240,NCT04453475,ClinicalTrials.gov,2020-06-29,2020-07-01,False,Jacobs University Bremen gGmbH,Recruiting,Not Applicable,Interventional,Germany,Feasibility and Benefits of Digital Services During the COVID19 Pandemic,Other,Other,Other,1230,https://clinicaltrials.gov/show/NCT04453475,None
2868,5241,NCT04453488,ClinicalTrials.gov,2020-06-30,2020-07-30,False,Fundació Institut Germans Trias i Pujol,Not Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of RUTIÂ® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers,ATMP,Vaccine,Vaccine,315,https://clinicaltrials.gov/show/NCT04453488,None
2869,5243,NCT04453514,ClinicalTrials.gov,2020-06-30,2020-07-21,False,National University of Natural Medicine,Recruiting,Not Applicable,Interventional,United States,Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,200,https://clinicaltrials.gov/show/NCT04453514,None
2870,5246,NCT04453553,ClinicalTrials.gov,2020-06-29,2020-07-02,False,Queen Mary University of London,Not Recruiting,Not Applicable,Interventional,United Kingdom,CICERO- A Care Home Study of COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04453553,None
2871,5249,NCT04453657,ClinicalTrials.gov,2020-06-26,2020-12-01,False,Johns Hopkins University,Recruiting,Not Applicable,Interventional,United States,"Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19",Other (psych),Psychological,Psychological,270,https://clinicaltrials.gov/show/NCT04453657,None
2872,5252,NCT04453774,ClinicalTrials.gov,2020-05-06,2020-10-16,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,At Home Monitoring for Patients With Covid19,Other (device),Remote monitoring,Remote monitoring,1000,https://clinicaltrials.gov/show/NCT04453774,None
2873,5253,NCT04453852,ClinicalTrials.gov,2020-06-03,2020-06-30,False,Vaxine Pty Ltd,Recruiting,Phase 1,Interventional,Australia,Monovalent Recombinant COVID19 Vaccine,ATMP,Vaccine,Vaccine,40,https://clinicaltrials.gov/show/NCT04453852,None
2874,5257,NCT04454307,ClinicalTrials.gov,2020-06-29,2020-07-01,False,Tanta University,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients,Drug,Tramadol,Tramadol,100,https://clinicaltrials.gov/show/NCT04454307,None
2875,5260,NCT04454398,ClinicalTrials.gov,2020-06-30,2020-09-17,False,"Sorrento Therapeutics, Inc.",Recruiting,Phase 1,Interventional,United States,Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19,Drug,STI-1499,STI-1499,33,https://clinicaltrials.gov/show/NCT04454398,None
2876,5261,NCT04454606,ClinicalTrials.gov,2020-06-26,2020-05-01,True,Bangkok Metropolitan Administration Medical College; Vajira Hospital,Not Recruiting,Not Applicable,Interventional,Thailand,The New Silicone N99 Half-Piece Respirator,Other (device),Mask,Mask,43,https://clinicaltrials.gov/show/NCT04454606,None
2877,5262,NCT04455243,ClinicalTrials.gov,2020-07-01,2020-08-01,True,Dr. Tariq Alhawassi,Not Recruiting,Phase 3,Interventional,No Country Given,Inflammatory Regulation Effect of NAC on COVID-19 Treatment,Drug,N-acetyl cysteine,N-acetyl cysteine,1180,https://clinicaltrials.gov/show/NCT04455243,ISRCTN60069084
2878,5263,NCT04455308,ClinicalTrials.gov,2020-06-30,2020-07-21,False,Rennes University Hospital,Not Recruiting,Not Applicable,Interventional,France,COVID-19 and Chilblains,Clinical Presentation,No Intervention,No Intervention,269,https://clinicaltrials.gov/show/NCT04455308,None
2879,5265,NCT04455360,ClinicalTrials.gov,2020-06-26,2020-10-01,False,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial,Other,Other,Other,26,https://clinicaltrials.gov/show/NCT04455360,None
2880,5267,NCT04455958,ClinicalTrials.gov,2020-07-01,2020-11-01,False,Oregon Health and Science University,Not Recruiting,Phase 2,Interventional,United States,Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year,Drug,Lopinavir/ritonavir,Lopinavir/ritonavir,75,https://clinicaltrials.gov/show/NCT04455958,None
2881,5270,NCT04456049,ClinicalTrials.gov,2020-07-01,2020-07-01,False,Ricardo Pereira Mestre,Not Recruiting,Phase 2,Interventional,Switzerland,Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-19,Drug,Enzalutamide,Enzalutamide,90,https://clinicaltrials.gov/show/NCT04456049,None
2882,5271,NCT04456062,ClinicalTrials.gov,2020-06-30,2020-08-04,False,Sunnybrook Health Sciences Centre,Recruiting,Not Applicable,Interventional,Canada,Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,150,https://clinicaltrials.gov/show/NCT04456062,None
2883,5273,NCT04456088,ClinicalTrials.gov,2020-07-01,2020-07-15,False,Beyond Air Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial),Drug,Nitric Oxide,Nitric Oxide,50,https://clinicaltrials.gov/show/NCT04456088,None
2884,5275,NCT04456153,ClinicalTrials.gov,2020-06-30,2020-07-22,False,University of Texas Southwestern Medical Center,Recruiting,Phase 2,Interventional,United States,Atovaquone for Treatment of COVID-19,Drug,Atovaquone,Atovaquone,60,https://clinicaltrials.gov/show/NCT04456153,None
2885,5276,NCT04456361,ClinicalTrials.gov,2020-06-23,2020-04-16,True,Instituto de Medicina Regenerativa,Not Recruiting,Phase 1,Interventional,Mexico,Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),9,https://clinicaltrials.gov/show/NCT04456361,None
2886,5277,NCT04456413,ClinicalTrials.gov,2020-06-30,2020-11-06,False,Hackensack Meridian Health,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection,ATMP,Plasma,Plasma,306,https://clinicaltrials.gov/show/NCT04456413,None
2887,5280,NCT04456452,ClinicalTrials.gov,2020-06-30,2020-07-27,False,Ampio Pharmaceuticals. Inc.,Not Recruiting,Phase 1,Interventional,United States,Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation,Drug,Human serum albumin,Human serum albumin,10,https://clinicaltrials.gov/show/NCT04456452,None
2888,5283,NCT04457349,ClinicalTrials.gov,2020-06-30,2020-07-25,False,Alexandria University,Recruiting,Not Applicable,Interventional,Egypt,Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04457349,None
2889,5284,NCT04457388,ClinicalTrials.gov,2020-06-30,2020-03-25,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Tele-Yoga Therapy for Chronic Pain,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,18,https://clinicaltrials.gov/show/NCT04457388,None
2890,5287,NCT04457609,ClinicalTrials.gov,2020-05-27,2020-07-01,False,Indonesia University,Recruiting,Phase 1,Interventional,Indonesia,Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients,ATMP (+ Drug),Cells (mesenchymal) + Oseltamivir + Azithromycin vs. Oseltamivir + Azithromycin,Cells (mesenchymal); Oseltamivir; Azithromycin,40,https://clinicaltrials.gov/show/NCT04457609,None
2891,5288,NCT04457726,ClinicalTrials.gov,2020-07-02,2020-07-01,True,KK Women's and Children's Hospital,Recruiting,Phase 1/Phase 2,Interventional,Singapore,Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,ATMP,Cells (T),Cells (T),18,https://clinicaltrials.gov/show/NCT04457726,None
2892,5289,NCT04457817,ClinicalTrials.gov,2020-06-24,2020-12-01,False,"University of Colorado, Denver",Not Recruiting,Not Applicable,Interventional,No Country Given,Compensatory Reserve Index (CRI) for Management of COVID-19,Other (device),Compensatory Reserve Index (CRI) Management,Compensatory Reserve Index (CRI) Management,100,https://clinicaltrials.gov/show/NCT04457817,None
2893,5290,NCT04458246,ClinicalTrials.gov,2020-07-01,2020-07-01,False,University of São Paulo,Recruiting,Not Applicable,Interventional,Brazil,Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic,Other (exercise),Exercise,Exercise,140,https://clinicaltrials.gov/show/NCT04458246,None
2894,5291,NCT04458298,ClinicalTrials.gov,2020-06-29,2020-07-01,False,"Orpheris, Inc.",Recruiting,Phase 2,Interventional,United States,A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients,Drug,Dendrimer N-acetyl-cysteine,Dendrimer N-acetyl-cysteine,24,https://clinicaltrials.gov/show/NCT04458298,None
2895,5293,NCT04458363,ClinicalTrials.gov,2020-06-25,2020-07-01,False,Emory University,Recruiting,Phase 1,Interventional,United States,Convalescent Plasma in Pediatric COVID-19,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04458363,None
2896,5294,NCT04458519,ClinicalTrials.gov,2020-07-01,2020-07-16,False,Centre Hospitalier de l'Université de Montréal ,Recruiting,Not Applicable,Interventional,Canada,Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection,Supplement,Probiotics,Probiotics,40,https://clinicaltrials.gov/show/NCT04458519,None
2897,5295,NCT04458948,ClinicalTrials.gov,2020-06-09,2020-03-24,True,University of New Mexico,Not Recruiting,Phase 2,Interventional,United States,Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,10000,https://clinicaltrials.gov/show/NCT04458948,None
2898,5296,NCT04459247,ClinicalTrials.gov,2020-07-03,2020-06-15,True,Postgraduate Institute of Medical Education and Research,Not Recruiting,Not Applicable,Interventional,India,"Short Term, High Dose Vitamin D Supplementation for COVID-19",Drug,Vitamin D,Vitamin D,30,https://clinicaltrials.gov/show/NCT04459247,None
2899,5297,NCT04459286,ClinicalTrials.gov,2020-07-03,2020-10-09,True,Obafemi Awolowo University,Recruiting,Phase 2,Interventional,Nigeria,The Nitazoxanide Plus Atazanavir for COVID-19 Study,Drug,Nitazoxanide + Atazanavir/ritonavir,Nitazoxanide; Atazanavir/ritonavir,98,https://clinicaltrials.gov/show/NCT04459286,PACTR202008855701534
2900,5299,NCT04459325,ClinicalTrials.gov,2020-07-03,2020-06-01,True,AO Generium,Not Recruiting,Phase 3,Interventional,Russian Federation,TigeraseÂ® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19,Drug,Tigerase,Tigerase,100,https://clinicaltrials.gov/show/NCT04459325,None
2901,5304,NCT04459455,ClinicalTrials.gov,2020-06-29,2020-08-19,False,Stony Brook University,Not Recruiting,Not Applicable,Interventional,United States,"Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic",Other,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04459455,None
2902,5305,NCT04459520,ClinicalTrials.gov,2020-07-05,2020-07-23,False,"University of California, Los Angeles",Not Recruiting,Not Applicable,Interventional,United States,Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance,Other,No Intervention,No Intervention,1400,https://clinicaltrials.gov/show/NCT04459520,None
2903,5308,NCT04459676,ClinicalTrials.gov,2020-07-03,2020-07-31,False,Angion Biomedica Corp,Recruiting,Phase 2,Interventional,Brazil,Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia,Drug,ANG-3777,ANG-3777,100,https://clinicaltrials.gov/show/NCT04459676,None
2904,5310,NCT04459702,ClinicalTrials.gov,2020-06-25,2020-07-01,False,ProgenaBiome,Not Recruiting,Phase 2,Interventional,United States,A Study of Combination Therapies to Treat COVID-19 Infection,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin + Lopinavir/ritonavir,Hydroxychloroquine; Azithromycin; Lopinavir/ritonavir,200,https://clinicaltrials.gov/show/NCT04459702,None
2905,5312,NCT04459962,ClinicalTrials.gov,2020-07-03,2020-06-29,True,Ancon Technologies Ltd,Recruiting,Not Applicable,Interventional,United Kingdom,Covid-19 Breath Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04459962,None
2906,5314,NCT04460014,ClinicalTrials.gov,2020-07-06,2020-09-30,False,Karolinska Institutet,Recruiting,Not Applicable,Interventional,Sweden,Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT,Other (psych),Psychological,Psychological,164,https://clinicaltrials.gov/show/NCT04460014,None
2907,5315,NCT04460027,ClinicalTrials.gov,2020-07-01,2020-06-22,True,Athena Robinson,Recruiting,Phase 1,Interventional,United States,W-SUDs for COVID-19,Other (psych),Psychological,Psychological,160,https://clinicaltrials.gov/show/NCT04460027,None
2908,5316,NCT04460105,ClinicalTrials.gov,2020-06-30,2020-10-31,False,Shire,Not Recruiting,Phase 1,Interventional,United States,Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia,Drug,Lanadelumab,Lanadelumab,0,https://clinicaltrials.gov/show/NCT04460105,None
2909,5318,NCT04460183,ClinicalTrials.gov,2020-07-03,2020-07-29,False,Thirty Respiratory Limited,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19,Drug,Nitric Oxide,Nitric Oxide,300,https://clinicaltrials.gov/show/NCT04460183,None
2910,5322,NCT04460534,ClinicalTrials.gov,2020-07-02,2020-05-07,True,GCS Ramsay Sant pour l'Enseignement et la Recherche,Recruiting,Not Applicable,Interventional,France,Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04460534,None
2911,5326,NCT04460651,ClinicalTrials.gov,2020-07-02,2020-08-14,False,Estudios Clínicos Latino América,Recruiting,Phase 3,Interventional,Argentina,PREPARE-IT. Prevention of COVID19 With EPA in Healthcare Providers at Risk - Intervention Trial,Drug,Icosapent ethyl,Icosapent ethyl,2000,https://clinicaltrials.gov/show/NCT04460651,None
2912,5328,NCT04460677,ClinicalTrials.gov,2020-07-06,2020-08-12,False,Rutgers University,Recruiting,Not Applicable,Interventional,United States,ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19,Telehealth,Telehealth,Telehealth,80,https://clinicaltrials.gov/show/NCT04460677,None
2913,5329,NCT04460690,ClinicalTrials.gov,2020-07-06,2020-07-13,False,"University of Wisconsin, Madison",Recruiting,Not Applicable,Interventional,United States,"Rapid, Onsite COVID-19 Detection",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10000,https://clinicaltrials.gov/show/NCT04460690,None
2914,5330,NCT04460703,ClinicalTrials.gov,2020-07-02,2020-07-03,False,Yale University,Not Recruiting,Not Applicable,Interventional,United States,"COVID-19 Vaccine Messaging, Part 1",Other,Other,Other,4000,https://clinicaltrials.gov/show/NCT04460703,None
2915,5331,NCT04461340,ClinicalTrials.gov,2020-07-04,2020-08-15,False,Alexandria University,Recruiting,Phase 2,Interventional,Egypt,Efficacy and Safety of Sirolimus in COVID-19 Infection,Drug,Sirolimus,Sirolimus,40,https://clinicaltrials.gov/show/NCT04461340,None
2916,5332,NCT04461379,ClinicalTrials.gov,2020-07-02,2020-07-21,False,Hospital Universitario Dr. Jose E. Gonzalez,Not Recruiting,Phase 3,Interventional,Mexico,"Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers",ATMP,Vaccine,Vaccine,908,https://clinicaltrials.gov/show/NCT04461379,None
2917,5333,NCT04461925,ClinicalTrials.gov,2020-07-01,2020-05-02,True,Institute of Cell Therapy,Recruiting,Phase 1/Phase 2,Interventional,Ukraine,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04461925,None
2918,5337,NCT04462627,ClinicalTrials.gov,2020-07-07,2020-04-14,True,Hanane El Kenz,Recruiting,Not Applicable,Interventional,Belgium,Reduction of COVID 19 Transmission to Health Care Professionals,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04462627,None
2919,5338,NCT04462757,ClinicalTrials.gov,2020-06-12,2020-05-28,True,University of Manchester,Not Recruiting,Phase 2,Interventional,United Kingdom,SCIL-1Ra in COVID-19 Feasibility & PK/PD,Drug,Anakinra,Anakinra,5,https://clinicaltrials.gov/show/NCT04462757,EUCTR2020-001636-95
2920,5339,NCT04462783,ClinicalTrials.gov,2020-07-07,2020-12-01,False,University of Michigan,Not Recruiting,Not Applicable,Interventional,No Country Given,Emergency Department (ED) Self-Monitoring Pilot COVID-19,Other,Other,Other,200,https://clinicaltrials.gov/show/NCT04462783,None
2921,5340,NCT04462848,ClinicalTrials.gov,2020-06-30,2020-08-01,False,"University of California, Los Angeles",Not Recruiting,Phase 1,Interventional,United States,Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04462848,None
2922,5341,NCT04463004,ClinicalTrials.gov,2020-07-07,2020-09-02,False,Virginia Commonwealth University,Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,60,https://clinicaltrials.gov/show/NCT04463004,None
2923,5342,NCT04463264,ClinicalTrials.gov,2020-06-26,2020-06-26,False,Laboratorios Roemmers,Recruiting,Phase 2/Phase 3,Interventional,Argentina,Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19),Drug,Nitazoxanide,Nitazoxanide,135,https://clinicaltrials.gov/show/NCT04463264,None
2924,5343,NCT04463420,ClinicalTrials.gov,2020-07-04,2020-08-15,True,Baqiyatallah Medical Sciences University,Recruiting,Not Applicable,Interventional,Iran,Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19,Drug,PHR160,PHR160,224,https://clinicaltrials.gov/show/NCT04463420,IRCT20200731048257N1
2925,5344,NCT04463433,ClinicalTrials.gov,2020-04-12,2020-02-01,True,Beijing Normal University,Recruiting,Not Applicable,Interventional,China,Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China,Other (psych),Psychological,Psychological,300,https://clinicaltrials.gov/show/NCT04463433,None
2926,5345,NCT04463472,ClinicalTrials.gov,2020-07-08,2020-06-29,True,"AnGes, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of COVID-19 DNA Vaccine (AG0301-COVID19),ATMP,Vaccine,Vaccine,30,https://clinicaltrials.gov/show/NCT04463472,None
2927,5350,NCT04463849,ClinicalTrials.gov,2020-07-02,2020-06-30,True,University of Milan,Recruiting,Not Applicable,Interventional,Italy,Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients,Clinical Presentation,No Intervention,No Intervention,24,https://clinicaltrials.gov/show/NCT04463849,None
2928,5352,NCT04464395,ClinicalTrials.gov,2020-07-07,2020-07-01,True,"Corvus Pharmaceuticals, Inc.",Recruiting,Phase 1,Interventional,United States,Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients,Drug,CPI-006,CPI-006,60,https://clinicaltrials.gov/show/NCT04464395,None
2929,5353,NCT04464408,ClinicalTrials.gov,2020-06-28,2020-07-23,False,King Abdullah International Medical Research Center,Recruiting,Phase 2/Phase 3,Interventional,Saudi Arabia,Favipiravir Therapy in Adults With Mild COVID-19,Drug,Favipiravir,Favipiravir,576,https://clinicaltrials.gov/show/NCT04464408,None
2930,5354,NCT04464460,ClinicalTrials.gov,2020-07-08,2020-09-25,False,Takeda,Not Recruiting,Phase 1,Interventional,No Country Given,"A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults",Not relevant,Not relevant,Not relevant,0,https://clinicaltrials.gov/show/NCT04464460,None
2931,5355,NCT04464486,ClinicalTrials.gov,2020-06-26,2020-04-21,True,University of Utah,Recruiting,Not Applicable,Interventional,United States,Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic,Other (device),Biosensors,Biosensors,300,https://clinicaltrials.gov/show/NCT04464486,None
2932,5358,NCT04465513,ClinicalTrials.gov,2020-07-08,2020-08-31,False,Hofseth Biocare ASA,Not Recruiting,Not Applicable,Interventional,Canada,Investigation of Safety and Efficacy of CARDIO Softgels in Former Smokers and Asthma Patients With COVID-19 Infection,Supplement,Nutritional Supplement,Nutritional Supplement,100,https://clinicaltrials.gov/show/NCT04465513,None
2933,5360,NCT04465604,ClinicalTrials.gov,2020-07-02,2020-07-01,True,King Faisal Specialist Hospital & Research Center,Recruiting,Not Applicable,Interventional,Saudi Arabia,Hypertonic Saline for COVID-19 Symptoms,Other (device),Masks + Saline,Masks; Saline,50,https://clinicaltrials.gov/show/NCT04465604,None
2934,5362,NCT04465695,ClinicalTrials.gov,2020-07-09,2020-07-14,False,University of Hong Kong,Recruiting,Phase 2,Interventional,China,Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19,Drug,Interferon beta + Colfazimine vs. Colfazimine,Interferon beta; Colfazimine,81,https://clinicaltrials.gov/show/NCT04465695,None
2935,5364,NCT04466098,ClinicalTrials.gov,2020-07-08,2020-07-30,False,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04466098,None
2936,5365,NCT04466280,ClinicalTrials.gov,2020-07-09,2020-07-15,False,Baqiyatallah Medical Sciences University,Recruiting,Not Applicable,Interventional,Iran,"Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19",Drug,Hydroxychloroquine vs. Dentol Gel,Hydroxychloroquine; Dentol Gel,180,https://clinicaltrials.gov/show/NCT04466280,None
2937,5369,NCT04466540,ClinicalTrials.gov,2020-07-03,2020-05-12,True,Hospital Alemo Oswaldo Cruz,Recruiting,Phase 4,Interventional,Brazil,Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19),Drug,Hydroxychloroquine,Hydroxychloroquine,1300,https://clinicaltrials.gov/show/NCT04466540,None
2938,5370,NCT04466605,ClinicalTrials.gov,2020-07-09,2020-03-30,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,India,Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,64,https://clinicaltrials.gov/show/NCT04466605,None
2939,5372,NCT04466657,ClinicalTrials.gov,2020-07-09,2020-11-01,False,Obafemi Awolowo University,Not Recruiting,Not Applicable,Interventional,Nigeria,Antioxidant Therapy for COVID-19 Study,Supplement,Nutritional Supplement,Nutritional Supplement,90,https://clinicaltrials.gov/show/NCT04466657,None
2940,5373,NCT04466670,ClinicalTrials.gov,2020-07-08,2020-07-08,False,University of São Paulo General Hospital,Recruiting,Phase 3,Interventional,Brazil,Hemostasis in COVID-19: an Adaptive Clinical Trial,Drug,"Heparin, Aspirin, Enoxaparin",Heparin; Aspirin; Enoxaparin,310,https://clinicaltrials.gov/show/NCT04466670,None
2941,5374,NCT04466683,ClinicalTrials.gov,2020-06-20,2020-08-28,False,Ohio State University Comprehensive Cancer Center,Recruiting,Phase 2,Interventional,United States,Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia,Other,Radiation,Radiation,100,https://clinicaltrials.gov/show/NCT04466683,None
2942,5375,NCT04466800,ClinicalTrials.gov,2020-07-09,2020-07-30,False,Rennes University Hospital,Recruiting,Not Applicable,Interventional,France,Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,160,https://clinicaltrials.gov/show/NCT04466800,None
2943,5378,NCT04467047,ClinicalTrials.gov,2020-07-07,2020-07-25,False,Hospital de Clinicas de Porto Alegre,Not Recruiting,Phase 1,Interventional,No Country Given,Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,https://clinicaltrials.gov/show/NCT04467047,None
2944,5379,NCT04467086,ClinicalTrials.gov,2020-06-30,2020-12-01,False,Ottawa Hospital Research Institute,Not Recruiting,Phase 3,Interventional,No Country Given,Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation,Drug,Propranolol Hydrochloride,Propranolol Hydrochloride,108,https://clinicaltrials.gov/show/NCT04467086,None
2945,5381,NCT04467151,ClinicalTrials.gov,2020-07-09,2020-10-01,False,Kashif Khan,Not Recruiting,Phase 2,Interventional,United States,"Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19",ATMP,Plasma,Plasma,0,https://clinicaltrials.gov/show/NCT04467151,None
2946,5382,NCT04467840,ClinicalTrials.gov,2020-07-09,2020-08-21,False,RedHill Biopharma Limited,Recruiting,Phase 2/Phase 3,Interventional,"Israel, Brazil, Russian Federation, Mexico","Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia",Drug,Opaganib,Opaganib,270,https://clinicaltrials.gov/show/NCT04467840,None
2947,5383,NCT04467918,ClinicalTrials.gov,2020-07-03,2020-07-06,False,University of São Paulo,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms,Drug,Cannabidiol,Cannabidiol,100,https://clinicaltrials.gov/show/NCT04467918,None
2948,5385,NCT04468009,ClinicalTrials.gov,2020-07-09,2020-06-25,True,Hospital de Infecciosas Francisco Javier Muñiz,Recruiting,Phase 2,Interventional,Argentina,Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma,ATMP,Plasma,Plasma,36,https://clinicaltrials.gov/show/NCT04468009,None
2949,5387,NCT04468087,ClinicalTrials.gov,2020-07-03,2020-12-01,False,Hospital do Coração,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,Antiviral Agents Against COVID-19 Infection,Drug,Atazanavir vs. Daclatasvir vs. Sofusbuvir vs. Favipiravir,Atazanavir; Daclatasvir; Sofusbuvir; Favipiravir,1005,https://clinicaltrials.gov/show/NCT04468087,None
2950,5388,NCT04468139,ClinicalTrials.gov,2020-07-05,2020-06-20,True,"Ministry of Health, Saudi Arabia",Recruiting,Phase 4,Interventional,Saudi Arabia,"The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19",Drug,Quercetin + Bromelain + Zinc + Vitamin C,Quercetin; Bromelain; Zinc; Vitamin C,60,https://clinicaltrials.gov/show/NCT04468139,None
2951,5394,NCT04468646,ClinicalTrials.gov,2020-07-07,2020-06-15,True,Dr. Fridoon Jawad Ahmad,Recruiting,Phase 3,Interventional,Pakistan,To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients,Drug,NK-1R antagonist,NK-1R antagonist,100,https://clinicaltrials.gov/show/NCT04468646,None
2952,5396,NCT04468893,ClinicalTrials.gov,2020-07-10,2020-05-20,True,Universidad Internacional de Valencia,Recruiting,Not Applicable,Interventional,Mexico,Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19,Other (psych),Psychological,Psychological,128,https://clinicaltrials.gov/show/NCT04468893,None
2953,5397,NCT04468958,ClinicalTrials.gov,2020-07-08,2020-08-05,False,"SAb Biotherapeutics, Inc.",Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants",Drug,SAB-185,SAB-185,28,https://clinicaltrials.gov/show/NCT04468958,None
2954,5398,NCT04468971,ClinicalTrials.gov,2020-07-10,2020-09-29,False,"Cellenkos, Inc.",Recruiting,Phase 1,Interventional,United States,REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia,Drug,CK0802,CK0802,45,https://clinicaltrials.gov/show/NCT04468971,None
2955,5399,NCT04469114,ClinicalTrials.gov,2020-07-10,2020-09-16,False,Hospital Israelita Albert Einstein,Recruiting,Phase 2,Interventional,Brazil,Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia,Drug,Tofacitinib,Tofacitinib,260,https://clinicaltrials.gov/show/NCT04469114,None
2956,5401,NCT04469179,ClinicalTrials.gov,2020-07-08,2020-08-20,False,"SAb Biotherapeutics, Inc.",Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19",Drug,SAB-185,SAB-185,21,https://clinicaltrials.gov/show/NCT04469179,None
2957,5402,NCT04469621,ClinicalTrials.gov,2020-06-28,2020-07-17,False,Sanofi,Not Recruiting,Phase 1,Interventional,"Russian Federation, Chile, Mexico, Brazil, Argentina",A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19,Drug,SAR443122,SAR443122,68,https://clinicaltrials.gov/show/NCT04469621,None
2958,5403,NCT04469634,ClinicalTrials.gov,2020-07-13,2020-07-31,False,Institute of Tropical Medicine,Not Recruiting,Not Applicable,Interventional,Belgium,Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04469634,None
2959,5406,NCT04470258,ClinicalTrials.gov,2020-06-10,2020-08-02,False,Escola de Saúde Pública do Ceará,Recruiting,Not Applicable,Interventional,Brazil,Elmo Respiratory Support Project - COVID-19,Other,Respiratory support,Respiratory support,10,https://clinicaltrials.gov/show/NCT04470258,None
2960,5407,NCT04470297,ClinicalTrials.gov,2020-07-12,2020-09-01,False,Associação Fundo de Incentivo à Pesquisa,Not Recruiting,Phase 2,Interventional,No Country Given,Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19,Drug,Ramelteon,Ramelteon,100,https://clinicaltrials.gov/show/NCT04470297,None
2961,5410,NCT04470427,ClinicalTrials.gov,2020-07-11,2020-07-27,False,"ModernaTX, Inc.",Not Recruiting,Phase 3,Interventional,United States,"A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19",ATMP,Vaccine,Vaccine,30000,https://clinicaltrials.gov/show/NCT04470427,None
2962,5411,NCT04470531,ClinicalTrials.gov,2020-07-11,2020-07-12,False,Bangabandhu Sheikh Mujib Medical University,Recruiting,Phase 2,Interventional,Bangladesh,Role of Co-trimoxazole in Severe COVID-19 Patients,Drug,Co-trimoxazole,Co-trimoxazole,94,https://clinicaltrials.gov/show/NCT04470531,None
2963,5412,NCT04470544,ClinicalTrials.gov,2020-07-09,2020-07-28,False,Alan Bryce,Recruiting,Phase 2,Interventional,United States,Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19,Drug,Camostat Mesilate,Camostat Mesilate,264,https://clinicaltrials.gov/show/NCT04470544,None
2964,5415,NCT04470609,ClinicalTrials.gov,2020-07-13,2020-07-10,True,Chinese Academy of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ?60 Years,ATMP,Vaccine,Vaccine,471,https://clinicaltrials.gov/show/NCT04470609,None
2965,5416,NCT04470622,ClinicalTrials.gov,2020-07-13,2020-07-20,False,Heron Therapeutics,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1),Drug,Aprepitan,Aprepitan,100,https://clinicaltrials.gov/show/NCT04470622,None
2966,5418,NCT04470739,ClinicalTrials.gov,2020-07-12,2020-05-30,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04470739,None
2967,5419,NCT04470999,ClinicalTrials.gov,2020-07-09,2020-04-15,True,Dr. Serhat Gumrukcu,Recruiting,Not Applicable,Interventional,United States,Changes in Cellular Immune Profile During COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,25,https://clinicaltrials.gov/show/NCT04470999,None
2968,5421,NCT04471519,ClinicalTrials.gov,2020-07-11,2020-07-13,False,Bharat Biotech International Limited,Not Recruiting,Phase 1/Phase 2,Interventional,India,Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers,ATMP,Vaccine,Vaccine,755,https://clinicaltrials.gov/show/NCT04471519,None
2969,5422,NCT04471636,ClinicalTrials.gov,2020-07-09,2020-09-18,False,Ludwig Maximilian University of Munich,Recruiting,Not Applicable,Interventional,Germany,Telemedicine in Outpatient Covid-19 Patients,Telehealth,Telehealth,Telehealth,600,https://clinicaltrials.gov/show/NCT04471636,None
2970,5425,NCT04471766,ClinicalTrials.gov,2020-07-14,2020-07-20,False,Bandim Health Project,Recruiting,Not Applicable,Interventional,Guinea-Bissau,Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention,Other (device),Masks,Masks,66000,https://clinicaltrials.gov/show/NCT04471766,None
2971,5426,NCT04471831,ClinicalTrials.gov,2020-07-07,2020-07-13,False,"University of Lagos, Nigeria",Not Recruiting,Not Applicable,Interventional,No Country Given,"Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled Study",Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04471831,None
2972,5430,NCT04472494,ClinicalTrials.gov,2020-07-14,2020-08-24,False,Bristol-Myers Squibb,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise,Drug,Abatacept,Abatacept,129,https://clinicaltrials.gov/show/NCT04472494,None
2973,5431,NCT04472559,ClinicalTrials.gov,2020-07-13,2020-12-25,False,"University of California, Los Angeles",Not Recruiting,Not Applicable,Interventional,No Country Given,Acupressure for COVID-19 Related Quality of Life and Stress,Other,Other,Other,200,https://clinicaltrials.gov/show/NCT04472559,None
2974,5433,NCT04472585,ClinicalTrials.gov,2020-07-14,2020-07-14,False,Sohaib Ashraf,Recruiting,Phase 1/Phase 2,Interventional,Pakistan,Efficacy of Subcutaneous Ivermectin With or Without Zinc and Nigella Sativa in COVID-19 Patients,Drug,Ivermectin vs. Ivermectin + Zinc vs. Ivermectin + Nigella Sativa,Zinc; Ivermectin; Nigella Sativa,40,https://clinicaltrials.gov/show/NCT04472585,None
2975,5434,NCT04472611,ClinicalTrials.gov,2020-07-14,2020-08-01,False,Yale University,Not Recruiting,Phase 3,Interventional,United States,Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial,Drug,Colchicine + Rosuvastatin,Colchicine; Rosuvastatin,466,https://clinicaltrials.gov/show/NCT04472611,None
2976,5436,NCT04473053,ClinicalTrials.gov,2020-07-09,2020-07-03,True,University of Edinburgh,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Rapid Experimental Medicine for COVID-19,Drug,Nafamostat Mesilate vs. TD139,Nafamostat Mesilate; TD139,60,https://clinicaltrials.gov/show/NCT04473053,EUCTR2020-002230-32; ISRCTN14212905
2977,5441,NCT04473170,ClinicalTrials.gov,2020-07-14,2020-04-04,True,Abu Dhabi Stem Cells Center,Not Recruiting,Phase 1/Phase 2,Interventional,United Arab Emirates,Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19,ATMP,Cells (Non-Hematopoietic Peripheral),Cells (Non-Hematopoietic Peripheral),146,https://clinicaltrials.gov/show/NCT04473170,None
2978,5443,NCT04473248,ClinicalTrials.gov,2020-07-14,2020-06-28,True,Spartan Bioscience Inc.,Not Recruiting,Not Applicable,Interventional,Canada,Spartan COVID-19 System: Evaluation of Clinical Sample Collection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,27,https://clinicaltrials.gov/show/NCT04473248,None
2979,5444,NCT04473261,ClinicalTrials.gov,2020-07-14,2020-07-14,False,Sohaib Ashraf,Recruiting,Phase 1/Phase 2,Interventional,Pakistan,Efficacy of Iodine Complex Against COVID-19 Patients,Drug,Iodine Complex,Iodine Complex,30,https://clinicaltrials.gov/show/NCT04473261,None
2980,5448,NCT04473599,ClinicalTrials.gov,2020-07-13,2020-04-17,True,"University of California, Berkeley",Recruiting,Not Applicable,Interventional,United States,Stay Well at Home: a Text-messaging Study Social Distancing,Other,Health Education,Health Education,200,https://clinicaltrials.gov/show/NCT04473599,None
2981,5449,NCT04473898,ClinicalTrials.gov,2020-07-14,2020-06-19,True,KTO Karatay University,Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation After Coronavirus,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,36,https://clinicaltrials.gov/show/NCT04473898,None
2982,5451,NCT04474080,ClinicalTrials.gov,2020-07-08,2021-01-15,False,St. Joseph's Healthcare Hamilton,Not Recruiting,Not Applicable,Interventional,Canada,Reducing Burnout Among Frontline Healthcare Workers During COVID-19,Other (psych),Psychological,Psychological,1080,https://clinicaltrials.gov/show/NCT04474080,None
2983,5456,NCT04474340,ClinicalTrials.gov,2020-07-15,2020-05-21,True,"Ministry of Health, Kuwait",Recruiting,Phase 1,Interventional,Kuwait,COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients,ATMP,Plasma,Plasma,300,https://clinicaltrials.gov/show/NCT04474340,None
2984,5459,NCT04474483,ClinicalTrials.gov,2020-05-15,2020-11-06,False,State University of New York at Buffalo,Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,Drug,Melatonin,Melatonin,30,https://clinicaltrials.gov/show/NCT04474483,None
2985,5462,NCT04475081,ClinicalTrials.gov,2020-07-14,2020-08-17,False,Louisiana State University Health Sciences Center in New Orleans,Not Recruiting,Phase 3,Interventional,No Country Given,Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis,ATMP,Vaccine,Vaccine,60,https://clinicaltrials.gov/show/NCT04475081,None
2986,5463,NCT04475107,ClinicalTrials.gov,2020-07-14,2020-07-09,True,Shin Poong Pharmaceutical Co. Ltd.,Recruiting,Phase 2,Interventional,South Korea,The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients,Drug,Pyronaridine-Artesunate,Pyronaridine-Artesunate,76,https://clinicaltrials.gov/show/NCT04475107,None
2987,5464,NCT04475120,ClinicalTrials.gov,2020-07-16,2020-04-15,True,University of Rome Tor Vergata,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients,Drug,Liposomal lactoferrin,Liposomal lactoferrin,60,https://clinicaltrials.gov/show/NCT04475120,None
2988,5465,NCT04475185,ClinicalTrials.gov,2020-07-15,2020-07-20,False,Nantes University Hospital,Recruiting,Not Applicable,Interventional,France,Safety and Effectiveness Assessment of the MakAir Artificial Ventilator,Other (physical),Mechanical ventilation,Mechanical ventilation,117,https://clinicaltrials.gov/show/NCT04475185,None
2989,5467,NCT04475302,ClinicalTrials.gov,2020-07-16,2020-07-01,True,"Tuberculosis Research Centre, India",Recruiting,Phase 3,Interventional,India,BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots,ATMP,Vaccine,Vaccine,2175,https://clinicaltrials.gov/show/NCT04475302,None
2990,5470,NCT04475562,ClinicalTrials.gov,2020-07-15,2020-04-06,True,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Interventional,Netherlands,Can the Electronic Nose Smell COVID-19?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,219,https://clinicaltrials.gov/show/NCT04475562,None
2991,5471,NCT04475575,ClinicalTrials.gov,2020-07-15,2020-04-06,True,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Interventional,Netherlands,Can the Electronic Nose Smell COVID-19 Antibodies?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,222,https://clinicaltrials.gov/show/NCT04475575,None
2992,5472,NCT04475588,ClinicalTrials.gov,2020-07-16,2020-05-01,True,Biocon Limited,Not Recruiting,Phase 2,Interventional,India,Efficacy and Safety of Itolizumab in COVID-19 Complications,Drug,Itolizumab vs. Hydroxychloroquine,Itolizumab; Hydroxychloroquine,30,https://clinicaltrials.gov/show/NCT04475588,None
2993,5473,NCT04475601,ClinicalTrials.gov,2020-06-08,2020-07-15,False,Andreas Josefsson,Recruiting,Phase 2,Interventional,Sweden,Enzalutamide Treatment in COVID-19,Drug,Enzalutamide,Enzalutamide,500,https://clinicaltrials.gov/show/NCT04475601,None
2994,5474,NCT04475913,ClinicalTrials.gov,2020-07-14,2018-07-11,True,October University for Modern Sciences and Arts,Not Recruiting,Not Applicable,Interventional,Egypt,Digital vs Analog Impression in Cases of All-on-4 - Prosthesis,Other,Other,Other,56,https://clinicaltrials.gov/show/NCT04475913,None
2995,5475,NCT04475991,ClinicalTrials.gov,2020-07-15,2020-11-01,False,Hospital General de México Dr. Eduardo Liceaga,Not Recruiting,Phase 2,Interventional,Mexico,Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults,Drug,"Maraviroc vs. Favipiravir vs. Maraviroc + Favipiravir (w/ or w/o Enoxaparin, hydroxychloroquine, chloroquine, azithormycin)",Maraviroc; Favipiravir; Enoxaparin; hydroxychloroquine; chloroquine; azithormycin,100,https://clinicaltrials.gov/show/NCT04475991,None
2996,5478,NCT04476667,ClinicalTrials.gov,2020-07-13,2020-06-15,True,Queen's University,Recruiting,Not Applicable,Interventional,Canada,"Online Delivery of Psychotherapy, Tailored to Patients' Suffering From Mental Health Problems Due to COVID-19",Other (psych),Psychological,Psychological,80,https://clinicaltrials.gov/show/NCT04476667,None
2997,5479,NCT04476680,ClinicalTrials.gov,2020-07-16,2020-09-01,False,Royal Centre for Defence Medicine,Not Recruiting,Not Applicable,Interventional,United Kingdom,Reducing Asymptomatic Infection With Vitamin D in Coronavirus Disease,Drug,Vitamin D,Vitamin D,4400,https://clinicaltrials.gov/show/NCT04476680,None
2998,5482,NCT04476888,ClinicalTrials.gov,2020-07-16,2020-04-26,True,Aga Khan University,Recruiting,Not Applicable,Interventional,Pakistan,Convalescent Plasma Treatment in COVID-19,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04476888,None
2999,5484,NCT04476927,ClinicalTrials.gov,2020-06-16,2020-08-01,False,Nanose Medical Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Detection of COVID-19 Subjects Using DiaNose Exhalation Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04476927,None
3000,5485,NCT04476940,ClinicalTrials.gov,2020-07-13,2020-09-01,False,Meharry Medical College,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Breastfeeding Guideline for African-Americans,Other,Health Education,Health Education,200,https://clinicaltrials.gov/show/NCT04476940,None
3001,5486,NCT04476953,ClinicalTrials.gov,2020-07-15,2020-08-03,False,Mayo Clinic,Recruiting,Phase 2,Interventional,United States,COVID-FISETIN: Pilot in Covid-19 of Fisetin to Alleviate Dysfunction and Inflammation,Drug,Fisetin,Fisetin,70,https://clinicaltrials.gov/show/NCT04476953,None
3002,5487,NCT04476979,ClinicalTrials.gov,2020-07-16,2020-07-16,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 2,Interventional,French Guiana,Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19,Drug,Tocilizumab + Dexamethasone vs. Dexamethasone,Tocilizumab; Dexamethasone,120,https://clinicaltrials.gov/show/NCT04476979,EUCTR2020-001246-18
3003,5488,NCT04476992,ClinicalTrials.gov,2020-07-16,2020-07-24,False,"Federal State Budgetary Scientific Institution, Research Institute of Cardiology",Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement,Drug,Nitric Oxide,Nitric Oxide,20,https://clinicaltrials.gov/show/NCT04476992,None
3004,5489,NCT04477083,ClinicalTrials.gov,2020-07-14,2020-07-15,False,Mansoura University,Not Recruiting,Not Applicable,Interventional,Egypt,"Development and Validation of ""Ready-to-Use"" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19",Drug,Hydroxychloroquine,Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04477083,None
3005,5491,NCT04477642,ClinicalTrials.gov,2020-04-22,2020-08-01,False,Beth Israel Deaconess Medical Center,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Abatacept for Patients With COVID-19 and Respiratory Distress,Drug,Abatacept,Abatacept,0,https://clinicaltrials.gov/show/NCT04477642,None
3006,5492,NCT04477655,ClinicalTrials.gov,2020-07-15,2020-05-03,True,Hospital Civil de Guadalajara,Recruiting,Not Applicable,Interventional,Mexico,Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure,Procedure,Positioning,Positioning,200,https://clinicaltrials.gov/show/NCT04477655,None
3007,5493,NCT04477668,ClinicalTrials.gov,2020-07-09,2020-10-01,False,King Abdullah International Medical Research Center,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Helmet Non-Invasive Ventilation for COVID-19 Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,320,https://clinicaltrials.gov/show/NCT04477668,None
3008,5496,NCT04477954,ClinicalTrials.gov,2020-07-16,2020-07-06,True,La Asociación Argentina de Medicina Hiperbárica e Investigación (AAMHEI),Recruiting,Phase 2,Interventional,Argentina,Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia,Drug,Oxygen,Oxygen,80,https://clinicaltrials.gov/show/NCT04477954,None
3009,5497,NCT04477993,ClinicalTrials.gov,2020-07-13,2020-07-17,False,Vanderson Geraldo Rocha,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19,Drug,Ruxolitinib,Ruxolitinib,200,https://clinicaltrials.gov/show/NCT04477993,None
3010,5498,NCT04478019,ClinicalTrials.gov,2020-07-15,2020-07-07,True,"University of Wisconsin, Madison",Recruiting,Phase 1,Interventional,United States,SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding,Drug,Povidone Iodine,Povidone Iodine,94,https://clinicaltrials.gov/show/NCT04478019,None
3011,5499,NCT04478071,ClinicalTrials.gov,2020-07-15,2020-08-22,False,"University of Texas Health Science Center, Houston",Recruiting,Phase 2,Interventional,United States,Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19),Drug,Vadadustat,Vadadustat,300,https://clinicaltrials.gov/show/NCT04478071,None
3012,5500,NCT04478539,ClinicalTrials.gov,2020-07-14,2020-06-01,True,Zan Mitrev Clinic,Recruiting,Not Applicable,Interventional,North Macedonia,Extracorporeal Blood Purification as a Treatment Modality for COVID-19,Other (physical),Blood purification,Blood purification,35,https://clinicaltrials.gov/show/NCT04478539,None
3013,5504,NCT04479163,ClinicalTrials.gov,2020-06-29,2020-06-04,True,Fundación Infant,Not Recruiting,Not Applicable,Interventional,Argentina,Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2,ATMP,Plasma,Plasma,165,https://clinicaltrials.gov/show/NCT04479163,None
3014,5505,NCT04479202,ClinicalTrials.gov,2020-05-13,2020-02-08,True,Chinese Medical Association,Not Recruiting,Phase 4,Interventional,China,The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,76,https://clinicaltrials.gov/show/NCT04479202,None
3015,5509,NCT04479332,ClinicalTrials.gov,2020-07-16,2020-08-01,False,National Taiwan University Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19),Health System,No Intervention,No Intervention,334,https://clinicaltrials.gov/show/NCT04479332,None
3016,5511,NCT04479358,ClinicalTrials.gov,2020-07-13,2020-09-10,False,University of Chicago,Recruiting,Phase 2,Interventional,United States,Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19,Drug,Tocilizumab,Tocilizumab,332,https://clinicaltrials.gov/show/NCT04479358,None
3017,5513,NCT04479540,ClinicalTrials.gov,2020-07-06,2020-05-26,True,Hôpital Foch,Recruiting,Not Applicable,Interventional,France,Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04479540,None
3018,5517,NCT04480112,ClinicalTrials.gov,2020-07-19,2020-06-02,True,Boston University,Recruiting,Not Applicable,Interventional,United States,Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults,Other,Other,Other,150,https://clinicaltrials.gov/show/NCT04480112,None
3019,5518,NCT04480138,ClinicalTrials.gov,2020-07-20,2020-08-11,False,Cadila Healthcare Ltd,Recruiting,Phase 2,Interventional,Mexico,Pegylated Interferon - a2b With SARSCoV- 2 (COVID-19),Drug,Interferon alpha,Interferon alpha,40,https://clinicaltrials.gov/show/NCT04480138,None
3020,5519,NCT04480333,ClinicalTrials.gov,2020-07-13,2020-09-15,False,"NeuroActiva, Inc.",Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831",Drug,Remdesivir,Remdesivir,45,https://clinicaltrials.gov/show/NCT04480333,None
3021,5521,NCT04480411,ClinicalTrials.gov,2020-07-17,2021-01-01,False,Stanford University,Not Recruiting,Not Applicable,Interventional,United States,Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04480411,None
3022,5522,NCT04480424,ClinicalTrials.gov,2020-07-20,2020-09-17,False,"Grifols, S.A.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19),ATMP,Immunoglobulin,Immunoglobulin,100,https://clinicaltrials.gov/show/NCT04480424,None
3023,5525,NCT04480593,ClinicalTrials.gov,2020-07-12,2020-06-02,True,D'Or Institute for Research and Education,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,https://clinicaltrials.gov/show/NCT04480593,None
3024,5526,NCT04480606,ClinicalTrials.gov,2020-07-16,2020-08-01,False,Istinye University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the Physical Activity Level of the Elderly in Social Isolation,Other (exercise),Exercise,Exercise,88,https://clinicaltrials.gov/show/NCT04480606,None
3025,5527,NCT04480632,ClinicalTrials.gov,2020-07-17,2020-08-01,False,Fundación Cardiovascular de Colombia,Not Recruiting,Phase 2,Interventional,Colombia,Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis,ATMP,Plasma,Plasma,44,https://clinicaltrials.gov/show/NCT04480632,None
3026,5533,NCT04481633,ClinicalTrials.gov,2020-07-21,2020-09-09,False,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,800,https://clinicaltrials.gov/show/NCT04481633,None
3027,5535,NCT04481685,ClinicalTrials.gov,2020-07-15,2020-07-20,False,University of Kansas Medical Center,Recruiting,Phase 2,Interventional,United States,"A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)",Drug,ATI-450,ATI-450,36,https://clinicaltrials.gov/show/NCT04481685,None
3028,5539,NCT04482387,ClinicalTrials.gov,2020-07-17,2020-07-24,False,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,DigiVis: Self-testing Vision App for Telephone Consultations,Telehealth,Telehealth,Telehealth,250,https://clinicaltrials.gov/show/NCT04482387,None
3029,5540,NCT04482595,ClinicalTrials.gov,2020-07-17,2020-11-11,False,Humanetics Corporation,Recruiting,Phase 2,Interventional,United States,BIO 300 Oral Suspension in Discharged COVID-19 Patients,Drug,Genistein,Genistein,66,https://clinicaltrials.gov/show/NCT04482595,None
3030,5541,NCT04482621,ClinicalTrials.gov,2020-07-21,2020-09-14,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial,Drug,Decitabine,Decitabine,40,https://clinicaltrials.gov/show/NCT04482621,None
3031,5542,NCT04482634,ClinicalTrials.gov,2020-07-21,2020-09-01,False,Koç University,Recruiting,Not Applicable,Interventional,Turkey,Tele-rehabilitation Versus Home Exercise Program in COVID-19,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,122,https://clinicaltrials.gov/show/NCT04482634,None
3032,5543,NCT04482647,ClinicalTrials.gov,2020-07-21,2020-06-17,True,M.D. Anderson Cancer Center,Recruiting,Phase 1,Interventional,United States,Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic,Other (psych),Psychological,Psychological,50,https://clinicaltrials.gov/show/NCT04482647,None
3033,5544,NCT04482673,ClinicalTrials.gov,2020-07-01,2020-07-31,False,Medical University of South Carolina,Recruiting,Phase 4,Interventional,United States,Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection,Drug (Chemoprophylaxis),Vitamin D,Vitamin D,140,https://clinicaltrials.gov/show/NCT04482673,None
3034,5545,NCT04482699,ClinicalTrials.gov,2020-07-20,2020-12-30,False,Rapa Therapeutics LLC,Not Recruiting,Phase 1/Phase 2,Interventional,United States,RAPA-501-Allo Off-the-Shelf Therapy of COVID-19,ATMP,Cells (Allogeneic),Cells (Allogeneic),88,https://clinicaltrials.gov/show/NCT04482699,None
3035,5546,NCT04482712,ClinicalTrials.gov,2020-07-21,2021-01-01,False,"University of Texas Health Science Center, San Antonio",Not Recruiting,Phase 1/Phase 2,Interventional,United States,Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS,Drug,Sirolimus,Sirolimus,20,https://clinicaltrials.gov/show/NCT04482712,None
3036,5547,NCT04483375,ClinicalTrials.gov,2020-07-17,2020-07-24,False,Sinocelltech Ltd.,Recruiting,Phase 1,Interventional,China,"Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects",Drug,SCTA01,SCTA01,33,https://clinicaltrials.gov/show/NCT04483375,None
3037,5549,NCT04483635,ClinicalTrials.gov,2020-06-29,2020-11-30,False,St. Justine's Hospital,Not Recruiting,Phase 3,Interventional,Canada,PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams,Drug,Vitamin D,Vitamin D,2414,https://clinicaltrials.gov/show/NCT04483635,None
3038,5550,NCT04483752,ClinicalTrials.gov,2020-07-21,2020-06-08,True,Centre Chirurgical Marie Lannelongue,Recruiting,Not Applicable,Interventional,France,Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04483752,None
3039,5551,NCT04483830,ClinicalTrials.gov,2020-07-22,2020-06-05,True,CLINEDEM,Not Recruiting,Phase 2/Phase 3,Interventional,Mexico,Suloexide in the Treatment of Early Stages of COVID-19,Drug,Suloexide,Suloexide,243,https://clinicaltrials.gov/show/NCT04483830,None
3040,5553,NCT04483960,ClinicalTrials.gov,2020-07-22,2020-07-28,False,University of Melbourne,Recruiting,Phase 3,Interventional,Australia,"Australasian COVID-19 Trial (ASCOT): An International Multi-Centre Randomised Clinical Trial to Assess the Clinical, Virological and Immunological Outcomes in Patients Diagnosed With SARS-CoV-2 Infection (COVID-19)",Drug (+ ATMP),Lopinavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir vs. Plasma,Hydroxychloroquine; Lopinavir/ritonavir; Plasma,2400,https://clinicaltrials.gov/show/NCT04483960,None
3041,5554,NCT04483973,ClinicalTrials.gov,2020-07-13,2020-12-01,False,"Sound Pharmaceuticals, Incorporated",Not Recruiting,Phase 2,Interventional,No Country Given,SPI-1005 Treatment in Severe COVID-19 Patients,Drug,Ebselen,Ebselen,60,https://clinicaltrials.gov/show/NCT04483973,None
3042,5555,NCT04484025,ClinicalTrials.gov,2020-07-13,2020-12-01,False,"Sound Pharmaceuticals, Incorporated",Not Recruiting,Phase 2,Interventional,No Country Given,SPI-1005 Treatment in Moderate COVID-19 Patients,Drug,Ebselen,Ebselen,60,https://clinicaltrials.gov/show/NCT04484025,None
3043,5556,NCT04484207,ClinicalTrials.gov,2020-07-21,2020-07-06,True,"Research Foundation for Mental Hygiene, Inc.",Recruiting,Not Applicable,Interventional,United States,Addressing COVID-19 Mental Health Problems Among US Veterans,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04484207,None
3044,5557,NCT04484493,ClinicalTrials.gov,2020-07-22,2020-08-08,False,Benha University,Not Recruiting,Phase 3,Interventional,Egypt,Corticosteroid Nasal Spray in COVID-19 Anosmia,Drug,Corticosteroids,momentasone furatenasal,100,https://clinicaltrials.gov/show/NCT04484493,None
3045,5560,NCT04485130,ClinicalTrials.gov,2020-07-22,2020-12-01,False,"University of California, San Francisco",Not Recruiting,Phase 2,Interventional,United States,DISulfiram for COvid-19 (DISCO) Trial,Drug,Disulfiram,Disulfiram,60,https://clinicaltrials.gov/show/NCT04485130,None
3046,5561,NCT04485169,ClinicalTrials.gov,2020-07-21,2020-04-01,True,UNICEF,Not Recruiting,Not Applicable,Interventional,Pakistan,Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm;,ATMP,Plasma,Plasma,280,https://clinicaltrials.gov/show/NCT04485169,None
3047,5565,NCT04485429,ClinicalTrials.gov,2020-07-20,2020-07-20,False,D'Or Institute for Research and Education,Recruiting,Phase 3,Interventional,Brazil,Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia,Drug,Corticosteroids vs. Heparin vs. Corticosteroids + Heparin,Methylprednisolone; Heparin,268,https://clinicaltrials.gov/show/NCT04485429,None
3048,5566,NCT04486001,ClinicalTrials.gov,2020-07-22,2020-12-15,False,"Sorrento Therapeutics, Inc.",Not Recruiting,Phase 1,Interventional,United States,Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19,ATMP,Cells (Allogeneic adipose),Cells (Allogeneic adipose),20,https://clinicaltrials.gov/show/NCT04486001,None
3049,5567,NCT04486144,ClinicalTrials.gov,2020-07-20,2020-05-20,True,HealthQuilt,Recruiting,Not Applicable,Interventional,United States,Impact Nerium Oleander on Symptoms and Mortality: A Feasibility Study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,https://clinicaltrials.gov/show/NCT04486144,None
3050,5568,NCT04486313,ClinicalTrials.gov,2020-07-23,2020-08-13,False,Romark Laboratories L.C.,Recruiting,Phase 3,Interventional,United States,Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19,Drug,Nitazoxanide,Nitazoxanide,800,https://clinicaltrials.gov/show/NCT04486313,None
3051,5571,NCT04486482,ClinicalTrials.gov,2020-07-23,2020-07-01,True,Kaleido Biosciences,Recruiting,Not Applicable,Interventional,United States,A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function,Drug,KB109,KB109,50,https://clinicaltrials.gov/show/NCT04486482,None
3052,5572,NCT04486508,ClinicalTrials.gov,2020-07-22,2020-07-30,False,Rajaie Cardiovascular Medical and Research Center,Recruiting,Phase 3,Interventional,Iran,Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19,Drug,Enoxaparin or heparin vs. Atorvastatin,Enoxaparin; heparin; Atorvastatin,600,https://clinicaltrials.gov/show/NCT04486508,None
3053,5575,NCT04487171,ClinicalTrials.gov,2020-07-24,2020-07-21,True,CHU de Amiens,Recruiting,Not Applicable,Interventional,France,Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic,Other (psych),No Intervention,No Intervention,248,https://clinicaltrials.gov/show/NCT04487171,None
3054,5577,NCT04487210,ClinicalTrials.gov,2020-07-22,2020-10-07,False,Medigen Vaccine Biologics Corp.,Recruiting,Phase 1,Interventional,Taiwan,A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19,Drug,MVC-COV1901,MVC-COV1901,45,https://clinicaltrials.gov/show/NCT04487210,None
3055,5578,NCT04487444,ClinicalTrials.gov,2020-07-22,2020-09-10,False,Rhode Island Hospital,Recruiting,Phase 2,Interventional,United States,Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection,Drug,Thymosin alpha,Thymosin alpha,80,https://clinicaltrials.gov/show/NCT04487444,None
3056,5579,NCT04487574,ClinicalTrials.gov,2020-07-22,2020-07-25,False,RSV Therapeutics LLC,Not Recruiting,Phase 3,Interventional,Russian Federation,A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19,Drug,XC221,XC221,118,https://clinicaltrials.gov/show/NCT04487574,None
3057,5580,NCT04487639,ClinicalTrials.gov,2020-07-21,2020-07-10,True,"University Hospital, Clermont-Ferrand",Recruiting,Not Applicable,Interventional,France,Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04487639,None
3058,5584,NCT04487886,ClinicalTrials.gov,2020-07-23,2020-08-01,False,Emory University,Not Recruiting,Phase 2,Interventional,United States,Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19),Drug,Duvelisib,Duvelisib,80,https://clinicaltrials.gov/show/NCT04487886,None
3059,5586,NCT04487964,ClinicalTrials.gov,2020-07-24,2020-01-01,True,Egyptian Biomedical Research Network,Recruiting,Not Applicable,Interventional,Egypt,Complementary Intervention for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,https://clinicaltrials.gov/show/NCT04487964,None
3060,5588,NCT04487990,ClinicalTrials.gov,2020-07-23,2020-06-29,True,University of São Paulo General Hospital,Recruiting,Not Applicable,Interventional,Brazil,CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19,Drug,Heparin,Heparin,90,https://clinicaltrials.gov/show/NCT04487990,None
3061,5589,NCT04488081,ClinicalTrials.gov,2020-07-14,2020-07-31,False,QuantumLeap Healthcare Collaborative,Recruiting,Phase 2,Interventional,United States,I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients,Drug,"Remdesivir, Cenicriviroc, Icatibant, Razuprotafib, Apremilast",Remdesivir; Cenicriviroc; Icatibant; Razuprotafib; Apremilast,1500,https://clinicaltrials.gov/show/NCT04488081,None
3062,5591,NCT04488484,ClinicalTrials.gov,2020-07-20,2020-07-01,True,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Interventional,France,Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,450,https://clinicaltrials.gov/show/NCT04488484,None
3063,5595,NCT04488575,ClinicalTrials.gov,2020-07-23,2020-08-26,False,"Evelo Biosciences, Inc.",Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection,Drug,EDP1815,EDP1815,60,https://clinicaltrials.gov/show/NCT04488575,None
3064,5597,NCT04488796,ClinicalTrials.gov,2020-07-22,2020-09-07,False,"Western University, Canada",Recruiting,Not Applicable,Interventional,Canada,STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers,Other,Other,Other,145,https://clinicaltrials.gov/show/NCT04488796,None
3065,5598,NCT04489446,ClinicalTrials.gov,2020-07-25,2020-08-19,False,Andrés Bello National University,Recruiting,Phase 1/Phase 2,Interventional,Chile,Sildenafil in COVID-19,Drug,Sildenafil,Sildenafil,40,https://clinicaltrials.gov/show/NCT04489446,None
3066,5599,NCT04489628,ClinicalTrials.gov,2020-07-24,2020-08-01,False,University Hospitals Cleveland Medical Center,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Tele-health Enabled Clinical Trial for COVID-19,Drug,Vitamin D,Vitamin D,110,https://clinicaltrials.gov/show/NCT04489628,None
3067,5600,NCT04490200,ClinicalTrials.gov,2020-07-19,2020-11-30,False,University of Brasilia,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness of a Novel Respirator With Chitosan Nanoparticles,Other (device),Masks,Masks,1000,https://clinicaltrials.gov/show/NCT04490200,None
3068,5601,NCT04490239,ClinicalTrials.gov,2020-07-20,2020-10-09,False,Joshua Sharp,Not Recruiting,Phase 1,Interventional,United States,Intranasal Heparin Tolerability Study,Drug,Heparin,Heparin,6,https://clinicaltrials.gov/show/NCT04490239,None
3069,5602,NCT04490278,ClinicalTrials.gov,2020-07-23,2020-09-29,False,Washington University in St. Louis,Recruiting,Not Applicable,Interventional,United States,CoV-PICS: A Virtual Post-ICU Clinic,Telehealth,Telehealth,Telehealth,80,https://clinicaltrials.gov/show/NCT04490278,None
3070,5603,NCT04490486,ClinicalTrials.gov,2020-07-27,2021-03-01,False,Joshua M Hare,Not Recruiting,Phase 1,Interventional,United States,Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),21,https://clinicaltrials.gov/show/NCT04490486,None
3071,5606,NCT04490824,ClinicalTrials.gov,2020-07-27,2020-10-01,False,Institute of Progressive Medicine,Recruiting,Not Applicable,Interventional,United States,Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals,Drug,Excellerated Water,Excellerated Water,100,https://clinicaltrials.gov/show/NCT04490824,None
3072,5608,NCT04490850,ClinicalTrials.gov,2020-07-28,2020-07-15,True,Institut Pasteur,Recruiting,Not Applicable,Interventional,French Guiana,COVID-19 Seroprevalence Study in French Guiana,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04490850,None
3073,5613,NCT04491240,ClinicalTrials.gov,2020-07-27,2020-07-20,True,Samara Regional Medical Center Dinasty,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.,Procedure,Exosome Inhalation,Exosome Inhalation,30,https://clinicaltrials.gov/show/NCT04491240,None
3074,5616,NCT04491994,ClinicalTrials.gov,2020-07-28,2020-04-10,True,UNICEF,Not Recruiting,Phase 3,Interventional,Pakistan,Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression,Other,Hydroxychloroquine,Hydroxychloroquine,540,https://clinicaltrials.gov/show/NCT04491994,None
3075,5619,NCT04492228,ClinicalTrials.gov,2020-07-25,2020-09-01,False,Ospedale Policlinico San Martino,Recruiting,Not Applicable,Interventional,Italy,Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome,Other (nutrition),Nutrition,Nutrition,100,https://clinicaltrials.gov/show/NCT04492228,None
3076,5620,NCT04492254,ClinicalTrials.gov,2020-07-22,2020-07-01,False,Thrombosis Research Institute,Not Recruiting,Phase 3,Interventional,No Country Given,Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients,Drug,Enoxaparin,Enoxaparin,1370,https://clinicaltrials.gov/show/NCT04492254,EUCTR2020-003125-39
3077,5622,NCT04492358,ClinicalTrials.gov,2020-07-28,2020-10-22,False,Maria Joyera Rodriguez,Recruiting,Phase 2/Phase 3,Interventional,Spain,"Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center",Drug,Colchicine + Prednisone,Colchicine; Prednisone,144,https://clinicaltrials.gov/show/NCT04492358,None
3078,5625,NCT04492410,ClinicalTrials.gov,2020-07-28,2020-07-21,True,Centre Antoine Lacassagne,Recruiting,Not Applicable,Interventional,France,COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID),Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04492410,None
3079,5626,NCT04492501,ClinicalTrials.gov,2020-07-28,2020-04-01,True,UNICEF,Not Recruiting,Not Applicable,Interventional,Pakistan,Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan,ATMP (+Drug),"Plasma, Cells (mesenchymal), Tocilizumab, Remdesivir",Plasma; Cells (mesenchymal); Tocilizumab; Remdesivir,600,https://clinicaltrials.gov/show/NCT04492501,None
3080,5627,NCT04492514,ClinicalTrials.gov,2020-07-28,2020-05-20,True,Kristin Hudock,Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation,Drug,Mavrilimumab,Mavrilimumab,60,https://clinicaltrials.gov/show/NCT04492514,None
3081,5628,NCT04492527,ClinicalTrials.gov,2020-07-28,2020-07-28,False,University of British Columbia,Recruiting,Not Applicable,Interventional,Canada,Student-delivered Telehealth Program for COVID-19 Education and Health Promotion,Telehealth,Telehealth,Telehealth,75,https://clinicaltrials.gov/show/NCT04492527,None
3082,5630,NCT04492891,ClinicalTrials.gov,2020-07-20,2020-11-23,False,"Bryan Burt, MD",Recruiting,Phase 2,Interventional,United States,Cyclosporine For The Treatment Of COVID-19(+),Drug,Cyclosporine,Cyclosporine,75,https://clinicaltrials.gov/show/NCT04492891,None
3083,5633,NCT04493242,ClinicalTrials.gov,2020-07-29,2020-09-01,False,"Direct Biologics, LLC",Not Recruiting,Phase 2,Interventional,No Country Given,Extracellular Vesicle Infusion Therapy for Severe COVID-19,Drug,DB-001,DB-001,60,https://clinicaltrials.gov/show/NCT04493242,None
3084,5635,NCT04493294,ClinicalTrials.gov,2020-07-29,2020-11-01,False,International Geriatric Radiotherapy Group,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis,Other,Radiation,Radiation,500,https://clinicaltrials.gov/show/NCT04493294,None
3085,5637,NCT04493359,ClinicalTrials.gov,2020-07-29,2020-07-25,True,University of São Paulo,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19,Drug,Renin-angiotensin system inhibitors,Renin-angiotensin system inhibitors,240,https://clinicaltrials.gov/show/NCT04493359,None
3086,5638,NCT04494204,ClinicalTrials.gov,2020-07-28,2020-08-07,False,Puneet Mittal,Recruiting,Phase 2/Phase 3,Interventional,India,Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,https://clinicaltrials.gov/show/NCT04494204,None
3087,5639,NCT04494386,ClinicalTrials.gov,2020-07-24,2020-07-23,True,"Restem, LLC.",Recruiting,Phase 1/Phase 2,Interventional,United States,Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS,ATMP,Cells (ULSC),Cells (ULSC),60,https://clinicaltrials.gov/show/NCT04494386,None
3088,5640,NCT04494399,ClinicalTrials.gov,2020-07-28,2020-07-29,False,University of Hong Kong,Recruiting,Phase 2,Interventional,Hong Kong,IFN Beta-1b and Ribavirin for Covid-19,Drug,Interferon beta + Ribavirin,Interferon beta; Ribavirin,96,https://clinicaltrials.gov/show/NCT04494399,None
3089,5641,NCT04494646,ClinicalTrials.gov,2020-07-29,2020-09-08,False,NYU Langone Health,Recruiting,Phase 2/Phase 3,Interventional,United States,BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19),Drug,Bardoxolone methyl,Bardoxolone methyl,440,https://clinicaltrials.gov/show/NCT04494646,None
3090,5642,NCT04494724,ClinicalTrials.gov,2020-07-21,2020-07-13,True,The Methodist Hospital System,Recruiting,Phase 2,Interventional,United States,Clazakizumab vs. Placebo - COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,60,https://clinicaltrials.gov/show/NCT04494724,None
3091,5644,NCT04494867,ClinicalTrials.gov,2020-07-29,2020-08-19,False,Sharp HealthCare,Recruiting,Not Applicable,Interventional,United States,Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04494867,None
3092,5646,NCT04494984,ClinicalTrials.gov,2020-07-29,2020-07-27,True,Inmunova S.A.,Not Recruiting,Phase 2/Phase 3,Interventional,Argentina,"A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.",Drug,INM005,INM005,242,https://clinicaltrials.gov/show/NCT04494984,None
3093,5647,NCT04495101,ClinicalTrials.gov,2020-07-28,2020-07-29,True,"Grifols, S.A.",Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19,Drug,Prolastin,Prolastin,100,https://clinicaltrials.gov/show/NCT04495101,EUCTR2020-001953-36
3094,5648,NCT04495543,ClinicalTrials.gov,2020-07-23,2020-08-01,False,"St. Michael's Hospital, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Mitigating Suicide Risk With Single Session 'Brief Skills for Safer Living',Other (psych),Psychological,Psychological,75,https://clinicaltrials.gov/show/NCT04495543,None
3095,5650,NCT04495803,ClinicalTrials.gov,2020-07-30,2020-08-10,False,St. Joseph's Healthcare Hamilton,Not Recruiting,Not Applicable,Interventional,No Country Given,Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19),Other (psych),Psychological,Psychological,120,https://clinicaltrials.gov/show/NCT04495803,None
3096,5651,NCT04495816,ClinicalTrials.gov,2020-07-30,2020-07-15,True,Icahn School of Medicine at Mount Sinai,Recruiting,Phase 2,Interventional,United States,COVID-19 Anosmia Study,Drug,Omega 3,Omega 3,126,https://clinicaltrials.gov/show/NCT04495816,None
3097,5652,NCT04495842,ClinicalTrials.gov,2020-07-30,2020-10-01,False,Franklin School of Integrative Health Sciences,Recruiting,Not Applicable,Interventional,United States,The Effect of Aromatherapy on COVID-19-induced Anxiety,Other,Aromatherapy,Aromatherapy,65,https://clinicaltrials.gov/show/NCT04495842,None
3098,5654,NCT04495933,ClinicalTrials.gov,2020-07-13,2020-07-13,True,University of Queensland,Recruiting,Phase 1,Interventional,Australia,"A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults",ATMP,Vaccine,Vaccine,216,https://clinicaltrials.gov/show/NCT04495933,ACTRN12620000674932; ISRCTN51232965
3099,5658,NCT04496245,ClinicalTrials.gov,2020-07-26,2020-08-24,False,University of Queensland,Recruiting,Phase 3,Interventional,Australia,Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85,Drug,OM85,OM85,1000,https://clinicaltrials.gov/show/NCT04496245,None
3100,5662,NCT04497272,ClinicalTrials.gov,2020-08-03,2020-08-07,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Assesment of the Metabolomic Signature in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04497272,None
3101,5663,NCT04497298,ClinicalTrials.gov,2020-07-31,2020-08-10,False,Institut Pasteur,Recruiting,Phase 1,Interventional,"Belgium, France",Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine,ATMP,Vaccine,Vaccine,90,https://clinicaltrials.gov/show/NCT04497298,None
3102,5665,NCT04497324,ClinicalTrials.gov,2020-07-31,2020-08-20,True,Universidad Peruana Cayetano Heredia,Not Recruiting,Phase 2,Interventional,Peru,PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04497324,PER-016-20
3103,5666,NCT04497389,ClinicalTrials.gov,2020-06-09,2020-10-28,False,University of Utah,Recruiting,Phase 1/Phase 2,Interventional,United States,Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients,ATMP,Human Amniotic Fluid,Human Amniotic Fluid,60,https://clinicaltrials.gov/show/NCT04497389,None
3104,5668,NCT04497415,ClinicalTrials.gov,2020-08-02,2020-10-21,False,"Research Foundation for Mental Hygiene, Inc.",Recruiting,Not Applicable,Interventional,United States,The COVID-19 and Healthcare Workers: An Active Intervention,Other,Other,Other,1200,https://clinicaltrials.gov/show/NCT04497415,None
3105,5670,NCT04497454,ClinicalTrials.gov,2020-07-31,2020-05-08,True,University of São Paulo General Hospital,Recruiting,Not Applicable,Interventional,Brazil,Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,128,https://clinicaltrials.gov/show/NCT04497454,None
3106,5672,NCT04497519,ClinicalTrials.gov,2020-07-27,2020-09-15,False,University Medical Center Groningen,Not Recruiting,Phase 1,Interventional,Netherlands,Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers,Drug,Hydroxychloroquine,Hydroxychloroquine,12,https://clinicaltrials.gov/show/NCT04497519,None
3107,5674,NCT04497623,ClinicalTrials.gov,2020-07-27,2020-07-28,False,Fundación Neumológica Colombiana,Not Recruiting,Not Applicable,Interventional,Colombia,"Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons.",Other (physical),Mechanical ventilation,Mechanical ventilation,5,https://clinicaltrials.gov/show/NCT04497623,None
3108,5678,NCT04497922,ClinicalTrials.gov,2020-07-30,2020-08-20,False,Brigham and Women's Hospital,Not Recruiting,Not Applicable,Interventional,United States,Virtual White Boards for Patient Satisfaction,Other,Other,Other,100,https://clinicaltrials.gov/show/NCT04497922,None
3109,5679,NCT04497987,ClinicalTrials.gov,2020-07-31,2020-08-02,False,Eli Lilly and Company,Recruiting,Phase 3,Interventional,United States,A Study of LY3819253 (LY-CoV555) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff,Drug (Chemoprophylaxis),LY3819253,LY3819253,2400,https://clinicaltrials.gov/show/NCT04497987,None
3110,5682,NCT04498273,ClinicalTrials.gov,2020-08-03,2020-09-07,False,Frank C Sciurba,Recruiting,Phase 3,Interventional,United States,COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80,Drug,Apixaban,Apixaban,7000,https://clinicaltrials.gov/show/NCT04498273,None
3111,5685,NCT04498325,ClinicalTrials.gov,2020-07-30,2020-12-31,False,Washington University in St. Louis,Not Recruiting,Phase 1,Interventional,United States,"Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)",Drug,NT-I7,NT-I7,42,https://clinicaltrials.gov/show/NCT04498325,None
3112,5686,NCT04498377,ClinicalTrials.gov,2020-07-31,2020-10-09,False,Generon (Shanghai) Corporation Ltd.,Recruiting,Phase 2,Interventional,United States,Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19,Drug,F-652,F-652,38,https://clinicaltrials.gov/show/NCT04498377,None
3113,5688,NCT04498442,ClinicalTrials.gov,2020-08-03,2020-05-22,True,Beth Israel Deaconess Medical Center,Recruiting,Not Applicable,Interventional,United States,"A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls",Clinical Presentation (Epidemiology),No Intervention,No Intervention,30000,https://clinicaltrials.gov/show/NCT04498442,None
3114,5691,NCT04498936,ClinicalTrials.gov,2020-04-14,2020-07-15,False,Assiut University,Not Recruiting,Phase 4,Interventional,Egypt,Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19,Drug,Sofosbuvir + Ledipasvir vs. Nitazoxanide,Sofosbuvir; Ledipasvir; Nitazoxanide,240,https://clinicaltrials.gov/show/NCT04498936,None
3115,5693,NCT04499313,ClinicalTrials.gov,2020-07-27,2020-08-02,False,Chattogram General Hospital,Recruiting,Phase 3,Interventional,Bangladesh,Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19,Drug,Corticosteroids,Dexamethasone; Methylprednisolone,60,https://clinicaltrials.gov/show/NCT04499313,None
3116,5695,NCT04499391,ClinicalTrials.gov,2020-07-31,2020-12-12,False,Milton S. Hershey Medical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Project ECHO in Nursing Homes,Telehealth,Telehealth,Telehealth,100,https://clinicaltrials.gov/show/NCT04499391,None
3117,5696,NCT04499677,ClinicalTrials.gov,2020-06-16,2020-09-24,False,"University College, London",Recruiting,Phase 2,Interventional,United Kingdom,FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals,Drug,Favipiravir + Lopinavir/ritonavir vs. Favipiravir vs. Lopinavir/ritonavir,Favipiravir; Lopinavir/ritonavir,240,https://clinicaltrials.gov/show/NCT04499677,None
3118,5697,NCT04500067,ClinicalTrials.gov,2020-07-15,2020-05-07,True,Biopharma Plasma LLC,Not Recruiting,Phase 3,Interventional,Ukraine,"Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment",ATMP,Immunoglobulin,Immunoglobulin,76,https://clinicaltrials.gov/show/NCT04500067,None
3119,5698,NCT04500132,ClinicalTrials.gov,2020-08-04,2020-05-28,False,Enzychem Lifesciences Corporation,Recruiting,Phase 2,Interventional,South Korea,To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia,Drug,EC-18,EC-18,60,https://clinicaltrials.gov/show/NCT04500132,KCT0005344
3120,5699,NCT04500366,ClinicalTrials.gov,2020-07-31,2020-08-26,False,McMaster University,Recruiting,Not Applicable,Interventional,Canada,GERAS Frailty Rehabilitation at Home During COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,70,https://clinicaltrials.gov/show/NCT04500366,None
3121,5700,NCT04500418,ClinicalTrials.gov,2020-08-04,2020-08-25,True,Charité University,Recruiting,Phase 2,Interventional,Germany,CharitÃ© Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients,Drug,Cenicriviroc,Cenicriviroc,183,https://clinicaltrials.gov/show/NCT04500418,EUCTR2020-001493-29
3122,5702,NCT04500626,ClinicalTrials.gov,2020-07-31,2020-10-01,False,Ottawa Hospital Research Institute,Not Recruiting,Phase 2/Phase 3,Interventional,Canada,Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients,Drug,Oxygen,Oxygen,234,https://clinicaltrials.gov/show/NCT04500626,None
3123,5706,NCT04501445,ClinicalTrials.gov,2020-08-04,2020-09-14,False,Rush University Medical Center,Recruiting,Not Applicable,Interventional,United States,Psychological Symptoms and Families of COVID-19 Patients,Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04501445,None
3124,5707,NCT04501458,ClinicalTrials.gov,2020-08-05,2020-05-18,True,Surgical Systems Research Group,Recruiting,Not Applicable,Interventional,Kenya,Western Kenya Integrated COVID-19 Response,Health System,Health System,Health System,200000,https://clinicaltrials.gov/show/NCT04501458,None
3125,5708,NCT04501783,ClinicalTrials.gov,2020-08-05,2020-05-20,True,"R-Pharm International, LLC",Not Recruiting,Phase 3,Interventional,Russian Federation,Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19,Drug,Favipiravir,Favipiravir,168,https://clinicaltrials.gov/show/NCT04501783,None
3126,5709,NCT04501796,ClinicalTrials.gov,2020-07-27,2020-08-01,False,NeoImmuneTech,Recruiting,Phase 1,Interventional,United States,A Trial of NT-I7 in COVID-19 (SPESELPIS),Drug,NT-I7,NT-I7,30,https://clinicaltrials.gov/show/NCT04501796,None
3127,5711,NCT04501965,ClinicalTrials.gov,2020-08-03,2020-06-01,True,Institute for Research and Development of Medicinal and Food Plants of Guinea,Recruiting,Phase 2,Interventional,Guinea,Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients,Drug,Hydroxychloroquine + Azithromycin vs. Quinquina-Stevia + Azythromycin vs. 4Plants + Azythromycin,Hydroxychloroquine; Azithromycin; Quinquina-Stevia; 4Plants,231,https://clinicaltrials.gov/show/NCT04501965,None
3128,5712,NCT04501978,ClinicalTrials.gov,2020-08-03,2020-08-04,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 3,Interventional,"Singapore, Spain, Denmark, United States",ACTIV-3: Therapeutics for Inpatients With COVID-19,Drug,LY3819253,LY3819253,10000,https://clinicaltrials.gov/show/NCT04501978,None
3129,5714,NCT04502056,ClinicalTrials.gov,2020-08-02,2020-07-31,True,"National Bureau of Economic Research, Inc.",Not Recruiting,Not Applicable,Interventional,United States,Covid-19 Messaging to Underserved Communities - 2nd Experiment,Other,Other,Other,20000,https://clinicaltrials.gov/show/NCT04502056,None
3130,5715,NCT04502069,ClinicalTrials.gov,2020-07-10,2020-08-01,False,RedHill Biopharma Limited,Not Recruiting,Phase 1/Phase 2,Interventional,Israel,Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen,Drug,Opaganib,Opaganib,0,https://clinicaltrials.gov/show/NCT04502069,None
3131,5717,NCT04502342,ClinicalTrials.gov,2020-08-04,2020-06-01,True,Institute for Research and Development of Medicinal and Food Plants of Guinea,Recruiting,Phase 2,Interventional,Guinea,"Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients",Drug,Hydroxychloroquine + Azithromycin vs. Cospherunate + Azithromycin vs. Cospherunate + Phytomedicine + Azithromycin,Hydroxychloroquine; Azithromycin; Cospherunate; Phytomedicine,30,https://clinicaltrials.gov/show/NCT04502342,None
3132,5718,NCT04502433,ClinicalTrials.gov,2020-08-03,2020-09-01,True,Chiesi Farmaceutici,Not Recruiting,Phase 2,Interventional,No Country Given,Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19),Drug,Poractant alfa,Poractant alfa,85,https://clinicaltrials.gov/show/NCT04502433,EUCTR2020-002632-75
3133,5719,NCT04502472,ClinicalTrials.gov,2020-08-04,2020-06-06,True,Inova Health Care Services,Recruiting,Phase 2/Phase 3,Interventional,United States,Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma,ATMP,Plasma,Plasma,200,https://clinicaltrials.gov/show/NCT04502472,None
3134,5720,NCT04502667,ClinicalTrials.gov,2020-08-04,2020-07-15,True,"Coordinación de Investigación en Salud, Mexico",Recruiting,Phase 3,Interventional,Mexico,Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19,Drug,Vitamin D,Vitamin D,40,https://clinicaltrials.gov/show/NCT04502667,None
3135,5725,NCT04504240,ClinicalTrials.gov,2020-08-06,2020-08-01,True,Chattogram General Hospital,Recruiting,Phase 3,Interventional,Bangladesh,Role of Famotidine in the Symptomatic Improvement of COVID-19 Patients,Drug,Famotidine,Famotidine,200,https://clinicaltrials.gov/show/NCT04504240,None
3136,5726,NCT04504877,ClinicalTrials.gov,2020-08-04,2020-06-16,True,University of São Paulo,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19,Other (psych),Cannabidiol,Cannabidiol,120,https://clinicaltrials.gov/show/NCT04504877,None
3137,5727,NCT04505098,ClinicalTrials.gov,2020-08-05,2020-08-07,False,Kaiser Permanente,Recruiting,Phase 4,Interventional,United States,A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults,Drug,Icosapent ethyl,Icosapent ethyl,16500,https://clinicaltrials.gov/show/NCT04505098,None
3138,5728,NCT04505592,ClinicalTrials.gov,2020-08-06,2020-09-25,False,Hooman Poor,Recruiting,Phase 2,Interventional,United States,Tenecteplase in Patients With COVID-19,Drug,Tenecteplase,Tenecteplase,60,https://clinicaltrials.gov/show/NCT04505592,None
3139,5732,NCT04505761,ClinicalTrials.gov,2020-07-03,2020-08-01,False,Radboud University,Recruiting,Not Applicable,Interventional,Netherlands,"The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19",Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,40,https://clinicaltrials.gov/show/NCT04505761,None
3140,5733,NCT04505774,ClinicalTrials.gov,2020-08-06,2020-09-04,False,Dr. Matthew Neal,Recruiting,Phase 4,Interventional,United States,Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4),Drug,Heparin,Heparin,2000,https://clinicaltrials.gov/show/NCT04505774,None
3141,5739,NCT04507256,ClinicalTrials.gov,2020-08-07,2020-08-18,False,AstraZeneca,Not Recruiting,Phase 1,Interventional,United Kingdom,AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19,Drug,AZD7442,AZD7442,60,https://clinicaltrials.gov/show/NCT04507256,None
3142,5741,NCT04507867,ClinicalTrials.gov,2020-08-06,2020-08-01,True,Anáhuac University,Not Recruiting,Not Applicable,Interventional,No Country Given,Effect of a Nss to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III,Other (nutrition),Nutrition,Nutrition,240,https://clinicaltrials.gov/show/NCT04507867,None
3143,5743,NCT04508075,ClinicalTrials.gov,2020-08-07,2020-08-10,False,PT Bio Farma,Recruiting,Phase 3,Interventional,Indonesia,"Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine",ATMP,Vaccine,Vaccine,1620,https://clinicaltrials.gov/show/NCT04508075,None
3144,5744,NCT04508439,ClinicalTrials.gov,2020-08-05,2020-06-20,True,Hospital Regional de Alta Especialidad de Ixtapaluca,Recruiting,Not Applicable,Interventional,Mexico,Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection,Drug,Enoxaparin,Enoxaparin,130,https://clinicaltrials.gov/show/NCT04508439,None
3145,5748,NCT04508868,ClinicalTrials.gov,2020-08-10,2020-08-17,False,Uppsala University,Recruiting,Not Applicable,Interventional,Sweden,Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19,Other (psych),Psychological,Psychological,154,https://clinicaltrials.gov/show/NCT04508868,None
3146,5753,NCT04508985,ClinicalTrials.gov,2020-08-10,2020-09-01,False,McGill University,Not Recruiting,Not Applicable,Interventional,No Country Given,The McGill RAAS-COVID-19 Trial,Drug,RAAS inhibitor,RAAS inhibitor,40,https://clinicaltrials.gov/show/NCT04508985,None
3147,5756,NCT04509947,ClinicalTrials.gov,2020-08-11,2020-08-11,False,Janssen Pharmaceutical,Recruiting,Phase 1,Interventional,Japan,A Study of Ad26.COV2.S in Adults (COVID-19),ATMP,Vaccine,Vaccine,250,https://clinicaltrials.gov/show/NCT04509947,None
3148,5760,NCT04510038,ClinicalTrials.gov,2020-08-10,2020-09-01,False,Miami Cardiac and Vascular Institute,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Colchicine vs Current Standard of Care in Hospitalized Patients With COVID-19 and Cardiac Injury,Drug,Colchicine,Colchicine,75,https://clinicaltrials.gov/show/NCT04510038,None
3149,5761,NCT04510194,ClinicalTrials.gov,2020-08-07,2020-11-01,False,University of Minnesota,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,MET-Covid -- Outpatient Metformin Use for Covid-19.,Drug,Metformin,Metformin,70,https://clinicaltrials.gov/show/NCT04510194,None
3150,5762,NCT04510207,ClinicalTrials.gov,2020-08-03,2020-07-16,True,China National Biotec Group Co. Ltd,Recruiting,Phase 3,Interventional,"Egypt, United Arab Emirates, Bahrain, Jordan","A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above",ATMP,Vaccine,Vaccine,45000,https://clinicaltrials.gov/show/NCT04510207,None
3151,5763,NCT04510233,ClinicalTrials.gov,2020-08-10,2020-09-01,False,Tanta University,Not Recruiting,Phase 2,Interventional,No Country Given,Ivermectin Nasal Spray for COVID19 Patients,Drug,Ivermectin,Ivermectin,60,https://clinicaltrials.gov/show/NCT04510233,None
3152,5764,NCT04510402,ClinicalTrials.gov,2020-08-10,2020-08-01,True,Brigham and Women's Hospital,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects,Drug,Povidine iodine,Povidine iodine,50,https://clinicaltrials.gov/show/NCT04510402,None
3153,5766,NCT04510454,ClinicalTrials.gov,2020-08-11,2020-09-01,False,Centre Leon Berard,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04510454,None
3154,5768,NCT04510493,ClinicalTrials.gov,2020-08-11,2020-10-23,False,"University Hospital, Basel",Recruiting,Phase 3,Interventional,Switzerland,Canakinumab in Patients With COVID-19 and Type 2 Diabetes,Drug,Canakinumab,Canakinumab,116,https://clinicaltrials.gov/show/NCT04510493,None
3155,5771,NCT04510662,ClinicalTrials.gov,2020-08-11,2020-08-01,True,Abraham Edgar Gracia-Ramos,Recruiting,Phase 2,Interventional,Mexico,Telmisartan in Respiratory Failure Due to COVID-19,Drug,Telmisartan,Telmisartan,60,https://clinicaltrials.gov/show/NCT04510662,None
3156,5773,NCT04511650,ClinicalTrials.gov,2020-08-07,2020-10-21,False,Aerpio Therapeutics,Recruiting,Phase 2,Interventional,United States,"A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19)",Drug,Razuprotafib,Razuprotafib,180,https://clinicaltrials.gov/show/NCT04511650,None
3157,5775,NCT04511819,ClinicalTrials.gov,2020-08-08,2020-08-28,False,Fulcrum Therapeutics,Recruiting,Phase 3,Interventional,"Brazil, Mexico, United States",Losmapimod Safety and Efficacy in COVID-19,Drug,Losmapimod,Losmapimod,410,https://clinicaltrials.gov/show/NCT04511819,None
3158,5776,NCT04511923,ClinicalTrials.gov,2020-08-10,2020-09-01,False,University College Hospital Galway,Not Recruiting,Phase 1/Phase 2,Interventional,Ireland,Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury,Drug,Heparin,Heparin,40,https://clinicaltrials.gov/show/NCT04511923,None
3159,5777,NCT04511949,ClinicalTrials.gov,2020-08-12,2020-07-12,True,Centre de Recherches et d'Études Surla Pathologie Tropicale,Recruiting,Not Applicable,Interventional,France,COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04511949,None
3160,5779,NCT04512027,ClinicalTrials.gov,2020-08-11,2020-09-15,True,Composite Interceptive Med Science,Not Recruiting,Not Applicable,Interventional,India,Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.,Drug,Protectin-M,Protectin-M,10,https://clinicaltrials.gov/show/NCT04512027,CTRI/2020/09/027833
3161,5780,NCT04512079,ClinicalTrials.gov,2020-08-11,2020-09-08,True,Valentin Fuster,Recruiting,Phase 4,Interventional,United States,FREEDOM COVID-19 Anticoagulation Strategy,Drug,Apixaban vs. Enoxaparin,Apixaban; Enoxaparin,3600,https://clinicaltrials.gov/show/NCT04512079,CTRI/2020/11/029345
3162,5783,NCT04513158,ClinicalTrials.gov,2020-08-06,2020-08-14,False,Dr. Joseph M. Flynn,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04513158,None
3163,5784,NCT04513184,ClinicalTrials.gov,2020-08-12,2020-07-14,True,Edda Sciutto Conde,Recruiting,Phase 2,Interventional,Mexico,Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19,Drug,Corticosteroids,Dexamthasone,60,https://clinicaltrials.gov/show/NCT04513184,None
3164,5786,NCT04513314,ClinicalTrials.gov,2020-08-12,2021-11-01,False,University of Miami,Not Recruiting,Phase 4,Interventional,United States,Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium,Drug,Valporate vs. Valporate + Quetiapine,Valporate; Quetiapine,20,https://clinicaltrials.gov/show/NCT04513314,None
3165,5787,NCT04513470,ClinicalTrials.gov,2020-08-10,2020-08-01,True,Hadassah Medical Organization,Not Recruiting,Phase 1,Interventional,Israel,Allocetra-OTS in COVID-19,ATMP,Cells (mononuclear),Cells (mononuclear),5,https://clinicaltrials.gov/show/NCT04513470,None
3166,5792,NCT04513990,ClinicalTrials.gov,2020-06-05,2020-04-09,True,M.D. Anderson Cancer Center,Recruiting,Not Applicable,Interventional,United States,Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1500,https://clinicaltrials.gov/show/NCT04513990,None
3167,5795,NCT04514302,ClinicalTrials.gov,2020-08-12,2020-10-20,False,Hospital San Jose Tec de Monterrey,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody Fragments (INOSARS) for Hospitalized Patients With COVID-19,ATMP,Immunoglobulin,Immunoglobulin,51,https://clinicaltrials.gov/show/NCT04514302,None
3168,5796,NCT04514627,ClinicalTrials.gov,2020-07-08,2020-07-13,False,"University of California, Los Angeles",Recruiting,Not Applicable,Interventional,United States,Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,100,https://clinicaltrials.gov/show/NCT04514627,None
3169,5797,NCT04514705,ClinicalTrials.gov,2020-08-11,2020-08-11,False,Universidade Metodista de Piracicaba,Recruiting,Not Applicable,Interventional,Brazil,Characteristics in Post Covid-19 Patients,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04514705,None
3170,5799,NCT04514900,ClinicalTrials.gov,2020-07-20,2020-09-23,False,University of South Carolina,Not Recruiting,Not Applicable,Interventional,United States,Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program,Other,Other,Other,120,https://clinicaltrials.gov/show/NCT04514900,None
3171,5801,NCT04515147,ClinicalTrials.gov,2020-08-13,2020-09-28,False,CureVac AG,Recruiting,Phase 2,Interventional,"Peru, Panama","A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19",ATMP,Vaccine,Vaccine,660,https://clinicaltrials.gov/show/NCT04515147,None
3172,5805,NCT04516512,ClinicalTrials.gov,2020-08-17,2020-09-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,Assessment of SARS-CoV-2 Seroprevalence in Detention,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04516512,None
3173,5806,NCT04516564,ClinicalTrials.gov,2020-08-13,2020-09-01,False,Akesobio Australia Pty Ltd,Recruiting,Phase 1,Interventional,New Zealand,"A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects",Drug,AK119,AK119,32,https://clinicaltrials.gov/show/NCT04516564,None
3174,5808,NCT04516759,ClinicalTrials.gov,2020-08-14,2020-08-12,True,St. George Street Capital Ltd,Recruiting,Phase 2,Interventional,United Kingdom,AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19,Drug,AZD1656,AZD1656,150,https://clinicaltrials.gov/show/NCT04516759,EUCTR2020-002211-21
3175,5809,NCT04516811,ClinicalTrials.gov,2020-08-12,2020-09-21,False,South African National Blood Service,Recruiting,Phase 3,Interventional,South Africa,Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19,ATMP,Plasma,Plasma,600,https://clinicaltrials.gov/show/NCT04516811,None
3176,5811,NCT04516837,ClinicalTrials.gov,2020-08-16,2020-08-31,False,Peking University People's Hospital,Recruiting,Phase 2,Interventional,China,Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19),Drug,Eltrombopag,Eltrombopag,120,https://clinicaltrials.gov/show/NCT04516837,None
3177,5813,NCT04516915,ClinicalTrials.gov,2020-08-10,2020-06-15,True,University Hospitals Coventry and Warwickshire NHS Trust,Recruiting,Phase 2,Interventional,United Kingdom,IMU-838 and Oseltamivir in the Treatment of COVID-19,Drug,IMU-838 vs. IMU-838 + Oseltamivir,IMU-838; Oseltamivir,120,https://clinicaltrials.gov/show/NCT04516915,None
3178,5815,NCT04516941,ClinicalTrials.gov,2020-08-05,2020-10-01,False,"University Hospital, Bern",Not Recruiting,Phase 3,Interventional,Switzerland,CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19,Drug,Edoxaban vs. Colchicine vs. Edoxaban + Colchicine,Edoxaban; Colchicine,420,https://clinicaltrials.gov/show/NCT04516941,None
3179,5816,NCT04516954,ClinicalTrials.gov,2020-08-17,2020-08-01,True,Vinmec Research Institute of Stem Cell and Gene Technology,Recruiting,Phase 1,Interventional,Vietnam,Convalescent Plasma for COVID-19 Patients,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04516954,None
3180,5817,NCT04517006,ClinicalTrials.gov,2020-08-14,2021-01-01,False,University of Toronto,Not Recruiting,Not Applicable,Interventional,No Country Given,Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,1542,https://clinicaltrials.gov/show/NCT04517006,None
3181,5818,NCT04517123,ClinicalTrials.gov,2020-08-14,2020-09-01,False,Johns Hopkins University,Recruiting,Not Applicable,Interventional,United States,"Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The ""PRONE"" Study",Procedure,Positioning,Positioning,100,https://clinicaltrials.gov/show/NCT04517123,None
3182,5820,NCT04517162,ClinicalTrials.gov,2020-08-14,2020-08-19,False,Janette Furuzawa Carballeda,Recruiting,Phase 1,Interventional,Mexico,Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients,Drug,Collagen-Polyvinylpyrrolidone,Collagen-Polyvinylpyrrolidone,90,https://clinicaltrials.gov/show/NCT04517162,None
3183,5821,NCT04517188,ClinicalTrials.gov,2020-08-15,2020-10-15,False,Halodine LLC,Not Recruiting,Phase 4,Interventional,No Country Given,Halodine Nasal Antiseptic in Patients With COVID-19,Drug,Povidone Iodine,Povidone Iodine,40,https://clinicaltrials.gov/show/NCT04517188,None
3184,5822,NCT04517422,ClinicalTrials.gov,2020-08-16,2020-08-19,False,"AB Biotics, SA",Recruiting,Not Applicable,Interventional,Mexico,Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19,Supplement,Probiotics,Probiotics,300,https://clinicaltrials.gov/show/NCT04517422,None
3185,5826,NCT04518514,ClinicalTrials.gov,2020-07-28,2020-04-20,True,RWTH Aachen University,Recruiting,Not Applicable,Interventional,Germany,Telemedical Risk Assessment and Preoperative Evaluation (TAPE),Telehealth,Telehealth,Telehealth,100,https://clinicaltrials.gov/show/NCT04518514,None
3186,5828,NCT04518969,ClinicalTrials.gov,2020-04-25,2020-05-03,False,Dr. David de Bels,Recruiting,Not Applicable,Interventional,Belgium,Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19,Other (device),Cytokine Adsorber,Cytokine Adsorber,24,https://clinicaltrials.gov/show/NCT04518969,None
3187,5830,NCT04519125,ClinicalTrials.gov,2020-08-18,2020-08-30,False,Hospital Universitario San Ignacio,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia,Drug (Chemoprophylaxis),Tenofovir + Emtricitabine,Tenofovir; Emtricitabine,950,https://clinicaltrials.gov/show/NCT04519125,None
3188,5831,NCT04519216,ClinicalTrials.gov,2020-08-12,2020-07-31,True,"University of California, Davis",Recruiting,Not Applicable,Interventional,United States,Breastfeeding Education in the Time of COVID-19,Other,Other,Other,39,https://clinicaltrials.gov/show/NCT04519216,None
3189,5834,NCT04519320,ClinicalTrials.gov,2020-08-18,2020-05-18,True,CHU de Besançon,Recruiting,Not Applicable,Interventional,France,Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae,Clinical Presentation,No Intervention,No Intervention,140,https://clinicaltrials.gov/show/NCT04519320,None
3190,5836,NCT04519385,ClinicalTrials.gov,2020-08-17,2020-03-01,True,South Valley University,Not Recruiting,Not Applicable,Interventional,Egypt,Toclizumam Versus Dexamethasone in Severe Covid-19 Cases,Drug,Tocilizumab vs. Dexamethasone,Tocilizumab; Dexamethasone,69,https://clinicaltrials.gov/show/NCT04519385,None
3191,5838,NCT04519411,ClinicalTrials.gov,2020-08-18,2020-05-21,True,Mayo Clinic,Recruiting,Not Applicable,Interventional,United States,Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure,Other (physical),Mechanical ventilation,Mechanical ventilation,10,https://clinicaltrials.gov/show/NCT04519411,None
3192,5839,NCT04519424,ClinicalTrials.gov,2020-08-18,2020-09-01,False,CSL Behring,Not Recruiting,Phase 2,Interventional,United States,CSL324 in COVID-19,Drug,CSL324,CSL324,0,https://clinicaltrials.gov/show/NCT04519424,None
3193,5842,NCT04520620,ClinicalTrials.gov,2020-07-22,2020-05-02,True,CHU de Saint Etienne,Not Recruiting,Phase 4,Interventional,France,Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention,Drug,Enoxaparin,Enoxaparin,0,https://clinicaltrials.gov/show/NCT04520620,EUCTR2020-001823-15
3194,5845,NCT04521036,ClinicalTrials.gov,2020-08-18,2020-12-01,False,Vinmec Research Institute of Stem Cell and Gene Technology,Not Recruiting,Phase 1/Phase 2,Interventional,Vietnam,Convalescent Plasma for COVID-19 Patients (CPCP),ATMP,Plasma,Plasma,44,https://clinicaltrials.gov/show/NCT04521036,None
3195,5846,NCT04521296,ClinicalTrials.gov,2020-07-07,2020-08-01,False,Daewoong Pharmaceutical Co.,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo,Drug,DWJ1248,DWJ1248,90,https://clinicaltrials.gov/show/NCT04521296,None
3196,5847,NCT04521309,ClinicalTrials.gov,2020-05-07,2020-06-19,False,Dow University of Health Sciences,Recruiting,Phase 1,Interventional,Pakistan,SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients,ATMP,Immunoglobulin,Immunoglobulin,50,https://clinicaltrials.gov/show/NCT04521309,None
3197,5848,NCT04521322,ClinicalTrials.gov,2020-08-19,2020-07-24,True,Ariel Dogliotti,Recruiting,Phase 4,Interventional,Argentina,Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease,Drug (Chemoprophylaxis),Iota-Carrageenan,Iota-Carrageenan,400,https://clinicaltrials.gov/show/NCT04521322,None
3198,5849,NCT04521400,ClinicalTrials.gov,2020-08-18,2020-08-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2,Interventional,No Country Given,"the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19",Drug,Interferon beta + Lopinavir/ritonavir,Interferon beta; Lopinavir/ritonavir,100,https://clinicaltrials.gov/show/NCT04521400,None
3199,5852,NCT04522089,ClinicalTrials.gov,2020-08-12,2020-08-24,False,Adimmune Corporation,Recruiting,Phase 1,Interventional,Taiwan,A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine,ATMP,Vaccine,Vaccine,70,https://clinicaltrials.gov/show/NCT04522089,None
3200,5853,NCT04522128,ClinicalTrials.gov,2020-05-12,2020-05-22,False,University of Manchester,Recruiting,Not Applicable,Interventional,United Kingdom,Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?,Other (psych),Psychological,Psychological,969,https://clinicaltrials.gov/show/NCT04522128,None
3201,5855,NCT04522466,ClinicalTrials.gov,2020-08-19,2020-04-03,True,CHU de Saint Etienne,Not Recruiting,Phase 3,Interventional,France,Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients,Drug,Hydroxychloroquine,Hydroxychloroquine,7,https://clinicaltrials.gov/show/NCT04522466,EUCTR2020-001281-11
3202,5856,NCT04522492,ClinicalTrials.gov,2020-08-07,2020-08-11,False,Hospital de Clinicas de Porto Alegre,Recruiting,Not Applicable,Interventional,Brazil,Impact of COVID-19 on Mental Health of Patients With Skin Picking,Other (psych),Psychological,Psychological,20,https://clinicaltrials.gov/show/NCT04522492,None
3203,5857,NCT04522817,ClinicalTrials.gov,2020-08-20,2020-10-05,False,"Caladrius Biosciences, Inc.",Recruiting,Phase 1,Interventional,United States,CLBS119 for Repair of COVID-19 Induced Pulmonary Damage,Drug,CLBS119,CLBS119,12,https://clinicaltrials.gov/show/NCT04522817,None
3204,5858,NCT04522830,ClinicalTrials.gov,2020-08-18,2020-07-30,True,"Beech Tree Labs, Inc.",Recruiting,Phase 2,Interventional,United States,A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19,Drug,Thimerosal,Thimerosal,40,https://clinicaltrials.gov/show/NCT04522830,None
3205,5859,NCT04522986,ClinicalTrials.gov,2020-08-20,2020-09-01,False,"Rohto Pharmaceutical Co., Ltd.",Not Recruiting,Phase 1,Interventional,Japan,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),6,https://clinicaltrials.gov/show/NCT04522986,None
3206,5862,NCT04523090,ClinicalTrials.gov,2020-08-20,2020-08-27,False,University of Cape Town,Recruiting,Phase 2/Phase 3,Interventional,South Africa,Catalysing the Containment of COVID-19,Drug,Nitazoxanide,Nitazoxanide,960,https://clinicaltrials.gov/show/NCT04523090,None
3207,5863,NCT04523246,ClinicalTrials.gov,2020-08-20,2020-09-01,False,Barbara Carlson,Recruiting,Phase 1,Interventional,United States,Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents,ATMP,Vaccine,Vaccine,250,https://clinicaltrials.gov/show/NCT04523246,None
3208,5864,NCT04523831,ClinicalTrials.gov,2020-08-19,2020-06-01,True,Dhaka Medical College,Not Recruiting,Phase 3,Interventional,Bangladesh,Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection,Drug,Ivermectin + Doxycycline,Ivermectin; Doxycycline,400,https://clinicaltrials.gov/show/NCT04523831,None
3209,5865,NCT04524052,ClinicalTrials.gov,2020-08-19,2020-08-01,True,Daewoong Pharmaceutical Co.,Not Recruiting,Phase 1,Interventional,No Country Given,"To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19",Drug,DWRX2003,DWRX2003,32,https://clinicaltrials.gov/show/NCT04524052,None
3210,5866,NCT04524156,ClinicalTrials.gov,2020-04-30,2020-10-04,False,Erasme University Hospital,Not Recruiting,Not Applicable,Interventional,Belgium,COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04524156,None
3211,5868,NCT04524507,ClinicalTrials.gov,2020-08-21,2020-08-27,False,"University of North Carolina, Chapel Hill",Recruiting,Phase 2,Interventional,United States,COVID-19 Antibody Plasma Research Study in Hospitalized Patients,ATMP,Plasma,Plasma,56,https://clinicaltrials.gov/show/NCT04524507,None
3212,5870,NCT04524598,ClinicalTrials.gov,2020-08-20,2020-07-20,True,"Limbix Health, Inc.",Recruiting,Not Applicable,Interventional,United States,A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19,Other (psych),Psychological,Psychological,410,https://clinicaltrials.gov/show/NCT04524598,None
3213,5871,NCT04524663,ClinicalTrials.gov,2020-04-10,2020-11-01,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients,Drug,Camostat Mesilate,Camostat Mesilate,120,https://clinicaltrials.gov/show/NCT04524663,None
3214,5873,NCT04524962,ClinicalTrials.gov,2020-08-19,2020-09-15,False,Cartesian Therapeutics,Recruiting,Phase 1/Phase 2,Interventional,United States,Study of Descartes-30 in Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04524962,None
3215,5875,NCT04525378,ClinicalTrials.gov,2020-07-31,2020-07-01,True,D'Or Institute for Research and Education,Recruiting,Phase 1,Interventional,Brazil,MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04525378,None
3216,5877,NCT04525417,ClinicalTrials.gov,2020-08-21,2020-04-25,True,Groupe d’Etude sur le Risque d’Expositiondes Soignants aux agents infectieux (GERES),Recruiting,Not Applicable,Interventional,France,Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04525417,None
3217,5880,NCT04525742,ClinicalTrials.gov,2020-06-28,2020-07-05,False,Gaziosmanpasa Taksim Research and Education Hospital,Not Recruiting,Not Applicable,Interventional,Turkey,COVID-19 Pandemic and Parents of Disabled Children,Other,No Intervention,No Intervention,309,https://clinicaltrials.gov/show/NCT04525742,None
3218,5881,NCT04525820,ClinicalTrials.gov,2020-08-17,2020-12-01,False,Dr. Jorg Leuppi,Not Recruiting,Not Applicable,Interventional,Switzerland,"High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study",Drug,Vitamin D,Vitamin D,80,https://clinicaltrials.gov/show/NCT04525820,None
3219,5883,NCT04526054,ClinicalTrials.gov,2020-08-03,2020-09-03,False,Hôpital Foch,Recruiting,Not Applicable,Interventional,France,Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04526054,None
3220,5884,NCT04526145,ClinicalTrials.gov,2020-08-10,2020-09-14,False,Ohio State University,Not Recruiting,Not Applicable,Interventional,No Country Given,OUR Stress/ Emotion Management for Black/African American Women With Hypertension,Other (psych),Psychological,Psychological,30,https://clinicaltrials.gov/show/NCT04526145,None
3221,5886,NCT04526717,ClinicalTrials.gov,2020-07-30,2020-12-01,False,Joseah Bio,Not Recruiting,Phase 1,Interventional,No Country Given,Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection,Drug,MPT0B640,MPT0B640,15,https://clinicaltrials.gov/show/NCT04526717,None
3222,5888,NCT04526821,ClinicalTrials.gov,2020-08-21,2020-09-01,False,Universidad Peruana Cayetano Heredia,Not Recruiting,Phase 2,Interventional,Peru,Lactoferrin for Prevention of COVID-19 in Health Care Workers,Drug (Chemoprophylaxis),Lactoferrin,Lactoferrin,336,https://clinicaltrials.gov/show/NCT04526821,None
3223,5889,NCT04526912,ClinicalTrials.gov,2020-08-21,2020-08-28,False,Viela Bio,Recruiting,Phase 1,Interventional,United States,Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection,Drug,VIB7734,VIB7734,48,https://clinicaltrials.gov/show/NCT04526912,None
3224,5891,NCT04527133,ClinicalTrials.gov,2020-08-24,2020-06-11,True,Aviron LLC,Not Recruiting,Not Applicable,Interventional,Russian Federation,An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19,Drug,Aprotinin,Aprotinin,30,https://clinicaltrials.gov/show/NCT04527133,None
3225,5892,NCT04527198,ClinicalTrials.gov,2020-06-02,2020-09-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Brainstem Dysfunction in COVID-19 Critically Ill Patients: a Prospective Observational Study,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04527198,None
3226,5893,NCT04527211,ClinicalTrials.gov,2020-08-24,2020-09-07,False,Javeriana University,Not Recruiting,Phase 3,Interventional,Colombia,Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel,Drug,Ivermectin,Ivermectin,550,https://clinicaltrials.gov/show/NCT04527211,None
3227,5894,NCT04527224,ClinicalTrials.gov,2020-08-21,2020-12-01,False,Nature Cell Co. Ltd.,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,https://clinicaltrials.gov/show/NCT04527224,None
3228,5896,NCT04527354,ClinicalTrials.gov,2020-08-24,2020-09-08,False,Pharmenterprise LLC,Not Recruiting,Phase 2,Interventional,Russian Federation,Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia,Drug,Treamid,Treamid,60,https://clinicaltrials.gov/show/NCT04527354,None
3229,5897,NCT04527432,ClinicalTrials.gov,2020-08-24,2020-11-01,False,The Royal Wolverhampton Hospitals NHS Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19 Health Professional Impact Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04527432,None
3230,5900,NCT04527562,ClinicalTrials.gov,2020-08-25,2020-07-14,True,Dhaka Medical College,Recruiting,Not Applicable,Interventional,Bangladesh,Colchicine in Moderate Symptomatic COVID-19 Patients,Drug,Colchicine,Colchicine,300,https://clinicaltrials.gov/show/NCT04527562,None
3231,5901,NCT04527575,ClinicalTrials.gov,2020-08-11,2020-07-27,True,State Research Center of Virology and Biotechnology (VECTOR),Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"Study of the Safety, Reactogenicity and Immunogenicity of ""EpiVacCorona"" Vaccine for the Prevention of COVID-19",ATMP,Vaccine,Vaccine,100,https://clinicaltrials.gov/show/NCT04527575,None
3232,5903,NCT04527614,ClinicalTrials.gov,2020-08-18,2020-09-24,False,Sciensano,Recruiting,Not Applicable,Interventional,Belgium,Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04527614,None
3233,5904,NCT04528329,ClinicalTrials.gov,2020-08-24,2020-08-30,False,ClinAmygate,Recruiting,Phase 4,Interventional,Egypt,Anosmia and / or Ageusia and Early Corticosteroid Use,Drug,Corticosteroids,Dexamthasone,300,https://clinicaltrials.gov/show/NCT04528329,None
3234,5905,NCT04528368,ClinicalTrials.gov,2020-08-19,2020-08-18,True,D'Or Institute for Research and Education,Recruiting,Phase 2,Interventional,Brazil,Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04528368,None
3235,5906,NCT04528641,ClinicalTrials.gov,2020-08-19,2020-08-10,True,ReiThera Srl,Recruiting,Phase 1,Interventional,Italy,GRAd-COV2 Vaccine Against COVID-19,ATMP,Vaccine,Vaccine,90,https://clinicaltrials.gov/show/NCT04528641,None
3236,5907,NCT04528667,ClinicalTrials.gov,2020-08-20,2020-12-01,False,"Sorrento Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19,Drug,Abivertinib Maleate,Abivertinib Maleate,400,https://clinicaltrials.gov/show/NCT04528667,None
3237,5908,NCT04528771,ClinicalTrials.gov,2020-08-25,2020-10-31,False,Robert Schilz,Not Recruiting,Phase 1,Interventional,United States,S-Nitrosylation Therapy of COVID-19,Drug,S-Nitrosylation,S-Nitrosylation,21,https://clinicaltrials.gov/show/NCT04528771,None
3238,5909,NCT04528888,ClinicalTrials.gov,2020-08-21,2020-09-01,False,Massimo Girardis,Not Recruiting,Phase 3,Interventional,No Country Given,Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection,Drug,Enoxaparin vs. Enoxaparin + Corticosteroids vs. Corticosteroids + Heparin,Methylprednisolone; Heparin; Enoxaparin,210,https://clinicaltrials.gov/show/NCT04528888,None
3239,5911,NCT04528927,ClinicalTrials.gov,2020-05-06,2020-05-15,False,Abderrahmane Mami Hospital,Not Recruiting,Phase 3,Interventional,Tunisia,"Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia",Not relevant,Not relevant,Not relevant,0,https://clinicaltrials.gov/show/NCT04528927,None
3240,5916,NCT04529499,ClinicalTrials.gov,2020-08-19,2020-08-20,False,Dr. Reddy's Laboratories Limited,Recruiting,Phase 3,Interventional,Kuwait,Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients,Drug,Favipiravir,Favipiravir,780,https://clinicaltrials.gov/show/NCT04529499,None
3241,5917,NCT04529525,ClinicalTrials.gov,2020-08-21,2020-08-19,True,Instituto de Cardiología de Corrientes,Recruiting,Phase 2/Phase 3,Interventional,Argentina,Ivermectin to Prevent Hospitalizations in COVID-19,Drug,Ivermectin,Ivermectin,500,https://clinicaltrials.gov/show/NCT04529525,None
3242,5918,NCT04530357,ClinicalTrials.gov,2020-08-26,2020-09-19,False,Research Institute for Biological Safety Problems,Not Recruiting,Phase 1/Phase 2,Interventional,Kazakhstan,"Reactogenicity, Safety and Immunogenicity of QazCovid-inÂ® COVID-19 Vaccine",ATMP,Vaccine,Vaccine,244,https://clinicaltrials.gov/show/NCT04530357,None
3243,5919,NCT04530370,ClinicalTrials.gov,2020-08-26,2020-05-29,True,South Valley University,Recruiting,Phase 1,Interventional,Egypt,Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04530370,None
3244,5920,NCT04530396,ClinicalTrials.gov,2020-08-25,2020-09-07,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Recruiting,Phase 3,Interventional,Russian Federation,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19",ATMP,Vaccine,Vaccine,40000,https://clinicaltrials.gov/show/NCT04530396,None
3245,5921,NCT04530409,ClinicalTrials.gov,2020-08-24,2020-08-26,False,ClinAmygate,Recruiting,Phase 4,Interventional,Egypt,Timing of Corticosteroids in COVID-19,Drug,Corticosteroids,Dexamthasone,450,https://clinicaltrials.gov/show/NCT04530409,None
3246,5922,NCT04530422,ClinicalTrials.gov,2020-08-26,2020-04-15,True,Almaza Military Fever Hospital,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment,Drug,Sofosbuvir + Ledipasvir vs. Oseltamivir + Hydroxychloroquine + Azithromycin,Sofosbuvir; Ledipasvir; Oseltamivir; Hydroxychloroquine; Azithromycin,250,https://clinicaltrials.gov/show/NCT04530422,None
3247,5923,NCT04530435,ClinicalTrials.gov,2020-08-25,2020-10-06,False,"Copenhagen University Hospital, Bispebjerg",Recruiting,Not Applicable,Interventional,Denmark,PEP Flute-selfcare in COVID-19,Other (device),Positive Expiratory Pressure flute,Positive Expiratory Pressure flute,400,https://clinicaltrials.gov/show/NCT04530435,None
3248,5924,NCT04530448,ClinicalTrials.gov,2020-08-20,2020-10-05,False,West Virginia University,Recruiting,Phase 4,Interventional,United States,Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization,Drug,Sodium bicarbonate,Sodium bicarbonate,40,https://clinicaltrials.gov/show/NCT04530448,None
3249,5926,NCT04530474,ClinicalTrials.gov,2020-08-26,2020-10-01,False,Temple University,Not Recruiting,Phase 3,Interventional,United States,Outpatient Use of Ivermectin in COVID-19,Drug,Ivermectin,Ivermectin,200,https://clinicaltrials.gov/show/NCT04530474,None
3250,5927,NCT04530539,ClinicalTrials.gov,2020-08-26,2020-09-18,False,Lancaster General Hospital,Not Recruiting,Not Applicable,Interventional,United States,The Effect of Melatonin and Vitamin C on COVID-19,Drug,Melatonin vs. Vitamin C,Melatonin; Vitamin C,150,https://clinicaltrials.gov/show/NCT04530539,None
3251,5928,NCT04530578,ClinicalTrials.gov,2020-08-17,2020-06-01,True,"Clinica San Camilo, Argentina",Recruiting,Phase 4,Interventional,Argentina,Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19,Drug,Heparin,Heparin,200,https://clinicaltrials.gov/show/NCT04530578,None
3252,5929,NCT04530604,ClinicalTrials.gov,2020-08-25,2020-10-01,False,Gregory Yanik,Recruiting,Phase 1,Interventional,United States,Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS),Drug,Defibrotide,Defibrotide,12,https://clinicaltrials.gov/show/NCT04530604,None
3253,5930,NCT04530617,ClinicalTrials.gov,2020-08-26,2020-10-05,False,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2,Interventional,Mexico,Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients,Drug,Camostat Mesilate vs. Artemisia,Camostat Mesilate; Artemisia,360,https://clinicaltrials.gov/show/NCT04530617,None
3254,5931,NCT04530656,ClinicalTrials.gov,2020-08-27,2020-08-28,False,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 1,Interventional,China,Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell),ATMP,Vaccine,Vaccine,168,https://clinicaltrials.gov/show/NCT04530656,None
3255,5939,NCT04531618,ClinicalTrials.gov,2020-08-19,2020-08-13,True,Columbia University,Recruiting,Not Applicable,Interventional,United States,Mother-infant Bonding During COVID-19,Other,Other,Other,280,https://clinicaltrials.gov/show/NCT04531618,None
3256,5941,NCT04531748,ClinicalTrials.gov,2020-08-27,2020-12-01,False,Dr. Reena Mehra,Not Recruiting,Phase 2,Interventional,No Country Given,Selective Estrogen Modulation and Melatonin in Early COVID-19,Drug,Toremifene + Melatonin vs. Melatonin,Toremifene; Melatonin,390,https://clinicaltrials.gov/show/NCT04531748,None
3257,5942,NCT04531774,ClinicalTrials.gov,2020-08-26,2020-08-28,False,Naser Morina,Recruiting,Not Applicable,Interventional,Switzerland,RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19,Other (psych),Psychological,Psychological,160,https://clinicaltrials.gov/show/NCT04531774,None
3258,5943,NCT04532294,ClinicalTrials.gov,2020-08-27,2020-09-08,False,BeiGene,Recruiting,Phase 1,Interventional,Australia,"Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants",ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04532294,None
3259,5944,NCT04532372,ClinicalTrials.gov,2020-08-25,2020-09-18,False,City of Hope Medical Center,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy,Drug,Leflunomide,Leflunomide,30,https://clinicaltrials.gov/show/NCT04532372,None
3260,5946,NCT04532554,ClinicalTrials.gov,2020-08-24,2020-10-26,False,ClinAmygate,Not Recruiting,Phase 4,Interventional,Egypt,Growth Hormone in Obese Cases With Covid-19,Clinical Presentation,No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04532554,None
3261,5948,NCT04532931,ClinicalTrials.gov,2020-08-26,2020-09-03,False,Shin Poong Pharmaceutical Co. Ltd.,Recruiting,Phase 2,Interventional,South Africa,COVID-19 Treatment in South Africa,Drug,Artesunate-Amodiaquine vs. Pyronaridine-Artesunate vs. Favipiravir + Nitazoxanide vs. Sofosbuvir/daclatasvir,Artesunate-Amodiaquine; Pyronaridine-Artesunate; Favipiravir; Nitazoxanide; Sofosbuvir/daclatasvir,250,https://clinicaltrials.gov/show/NCT04532931,None
3262,5949,NCT04533048,ClinicalTrials.gov,2020-08-22,2020-08-07,True,"Mabwell (Shanghai) Bioscience Co., Ltd.",Not Recruiting,Phase 1,Interventional,China,A Clinical Study to Evaluate MW33 Injection,Drug,MW33,MW33,42,https://clinicaltrials.gov/show/NCT04533048,None
3263,5950,NCT04533347,ClinicalTrials.gov,2020-08-28,2020-10-01,False,60 Degrees Pharmaceuticals LLC,Not Recruiting,Phase 2,Interventional,No Country Given,A Double-blind Placebo-controlled Study to Assess the Efficacy and Safety of Oral Tafenoquine Versus Placebo in Patients With Mild to Moderate COVID-19 Disease,Drug,Tafenoquine,Tafenoquine,275,https://clinicaltrials.gov/show/NCT04533347,None
3264,5952,NCT04533399,ClinicalTrials.gov,2020-08-28,2020-08-17,True,Novavax,Recruiting,Phase 2,Interventional,South Africa,A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults,ATMP,Vaccine,Vaccine,4400,https://clinicaltrials.gov/show/NCT04533399,None
3265,5954,NCT04534478,ClinicalTrials.gov,2020-08-31,2020-09-07,False,Vall d'Hebron Research Institute (VHIR),Not Recruiting,Phase 4,Interventional,No Country Given,Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19,Drug,Prednisone,Prednisone,120,https://clinicaltrials.gov/show/NCT04534478,None
3266,5959,NCT04534673,ClinicalTrials.gov,2020-04-20,2020-08-05,False,Soroka University Medical Center,Recruiting,Phase 2,Interventional,Israel,Pegylated Interferon Lambda for Treatment of COVID-19 Infection,Drug,Interferon lambda,Interferon lambda,40,https://clinicaltrials.gov/show/NCT04534673,None
3267,5961,NCT04534725,ClinicalTrials.gov,2020-08-30,2020-11-01,False,Peter MacCallum Cancer Centre,Not Recruiting,Phase 3,Interventional,No Country Given,COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;,Drug,"Interferon alpha, Selinexor, Lenzilumab",Interferon alpha; Selinexor; Lenzilumab,2282,https://clinicaltrials.gov/show/NCT04534725,None
3268,5962,NCT04534790,ClinicalTrials.gov,2020-08-05,2020-07-24,True,Instituto Mexicano del Seguro Social,Recruiting,Not Applicable,Interventional,Mexico,Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia,Other,Radiation,Radiation,30,https://clinicaltrials.gov/show/NCT04534790,None
3269,5963,NCT04534803,ClinicalTrials.gov,2020-08-21,2020-09-01,False,Harvard University,Not Recruiting,Phase 3,Interventional,No Country Given,BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST),ATMP,Vaccine,Vaccine,2100,https://clinicaltrials.gov/show/NCT04534803,None
3270,5964,NCT04535063,ClinicalTrials.gov,2020-08-29,2020-04-18,True,Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,Recruiting,Phase 3,Interventional,Argentina,Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia,ATMP,Plasma,Plasma,200,https://clinicaltrials.gov/show/NCT04535063,None
3271,5967,NCT04535167,ClinicalTrials.gov,2020-08-21,2020-09-09,False,Pfizer,Recruiting,Phase 1,Interventional,United States,"First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending Dose And Extended Infusion of PF 07304814 In Hospitalized Participants With COVID-19.",Drug,PF-07304814,PF-07304814,56,https://clinicaltrials.gov/show/NCT04535167,None
3272,5969,NCT04535674,ClinicalTrials.gov,2020-08-31,2020-10-09,False,Apogenix AG,Recruiting,Phase 2,Interventional,"Russian Federation, Spain",Asunercept in Patients With Severe COVID-19,Drug,Asunercept,Asunercept,400,https://clinicaltrials.gov/show/NCT04535674,None
3273,5970,NCT04535700,ClinicalTrials.gov,2020-08-27,2020-09-18,False,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Recruiting,Phase 4,Interventional,Spain,Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19,Drug,Pioglitazone,Pioglitazone,76,https://clinicaltrials.gov/show/NCT04535700,None
3274,5971,NCT04535778,ClinicalTrials.gov,2020-08-12,2020-09-28,False,King's College London,Not Recruiting,Not Applicable,Interventional,United Kingdom,COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04535778,None
3275,5972,NCT04535791,ClinicalTrials.gov,2020-07-30,2020-07-15,True,"Coordinación de Investigación en Salud, Mexico",Recruiting,Phase 3,Interventional,Mexico,Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers,Drug (Chemoprophylaxis),Vitamin D,Vitamin D,400,https://clinicaltrials.gov/show/NCT04535791,None
3276,5973,NCT04535856,ClinicalTrials.gov,2020-08-28,2020-10-26,False,Ina-Respond,Not Recruiting,Phase 1,Interventional,Indonesia,Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),9,https://clinicaltrials.gov/show/NCT04535856,None
3277,5974,NCT04535869,ClinicalTrials.gov,2020-08-28,2020-09-04,False,Mansoura University,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19),Drug,Sofosbuvir/daclatasvir,Sofosbuvir/daclatasvir,50,https://clinicaltrials.gov/show/NCT04535869,None
3278,5975,NCT04536051,ClinicalTrials.gov,2020-09-01,2020-06-02,True,University of Oxford,Recruiting,Phase 3,Interventional,Brazil,A Study of a Candidate COVID-19 Vaccine (COV003),ATMP,Vaccine,Vaccine,10300,https://clinicaltrials.gov/show/NCT04536051,None
3279,5976,NCT04536090,ClinicalTrials.gov,2020-08-31,2020-11-01,False,Institut de Recherches Cliniques de Montréal (IRCM),Not Recruiting,Phase 2,Interventional,No Country Given,Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19,Drug,Isoquercetin,Isoquercetin,150,https://clinicaltrials.gov/show/NCT04536090,None
3280,5978,NCT04536298,ClinicalTrials.gov,2020-08-27,2020-12-01,False,Brigham and Women's Hospital,Not Recruiting,Phase 3,Interventional,United States,Vitamin D and COVID-19 Trial,Drug,Vitamin D,Vitamin D,2700,https://clinicaltrials.gov/show/NCT04536298,None
3281,5979,NCT04536350,ClinicalTrials.gov,2020-08-21,2021-01-01,False,Dr. Jorg Leuppi,Not Recruiting,Phase 1,Interventional,Switzerland,Inhaled Aviptadil for the Prevention of COVID-19 Related ARDS,Drug,Aviptadil,Aviptadil,80,https://clinicaltrials.gov/show/NCT04536350,None
3282,5980,NCT04536363,ClinicalTrials.gov,2020-08-29,2020-10-01,False,Alonso Vera Torres,Not Recruiting,Phase 2,Interventional,No Country Given,Cri Analog PG1 Effectiveness and Safety in Covid-19,Drug,Prostaglandin E1,Prostaglandin E1,284,https://clinicaltrials.gov/show/NCT04536363,None
3283,5981,NCT04536441,ClinicalTrials.gov,2020-08-26,2020-04-01,True,University Tunku Abdul Rahman,Not Recruiting,Not Applicable,Interventional,Malaysia,Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order,Other (psych),Psychological,Psychological,161,https://clinicaltrials.gov/show/NCT04536441,None
3284,5982,NCT04536935,ClinicalTrials.gov,2020-08-22,2020-09-01,False,University of Washington,Not Recruiting,Not Applicable,Interventional,No Country Given,Mobile Mental Health Apps for Suicide Prevention,Other (psych),Psychological,Psychological,2000,https://clinicaltrials.gov/show/NCT04536935,None
3285,5984,NCT04537130,ClinicalTrials.gov,2020-09-02,2020-12-01,False,Instituto Oncologico Dr Rosell,Not Recruiting,Phase 1,Interventional,Spain,Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge,ATMP,Vaccine,Vaccine,40,https://clinicaltrials.gov/show/NCT04537130,None
3286,5985,NCT04537208,ClinicalTrials.gov,2020-09-02,2020-09-03,False,Sanofi,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older,ATMP,Vaccine,Vaccine,440,https://clinicaltrials.gov/show/NCT04537208,None
3287,5986,NCT04537299,ClinicalTrials.gov,2020-09-01,2020-12-01,False,Mayo Clinic,Not Recruiting,Phase 2,Interventional,United States,COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes,Drug,Fisetin,Fisetin,150,https://clinicaltrials.gov/show/NCT04537299,None
3288,5988,NCT04537351,ClinicalTrials.gov,2020-08-25,2020-08-24,True,Cynata Therapeutics Limited,Recruiting,Phase 1/Phase 2,Interventional,Australia,The MEseNchymal coviD-19 Trial: a Pilot Study to Investigate Early Efficacy of MSCs in Adults With COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04537351,None
3289,5990,NCT04537572,ClinicalTrials.gov,2020-09-01,2020-09-01,False,Salveo Diagnostics,Not Recruiting,Not Applicable,Interventional,No Country Given,A Comparison of Sample Collection Methods for SARS-COV-2 Antibody Testing,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04537572,None
3290,5991,NCT04537585,ClinicalTrials.gov,2020-08-29,2020-11-01,False,Dr. Guyguy K Tshima,Not Recruiting,Not Applicable,Interventional,Democratic Republic of Congo,"COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7",Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04537585,None
3291,5993,NCT04537663,ClinicalTrials.gov,2020-08-28,2020-08-25,True,UMC Utrecht,Recruiting,Phase 4,Interventional,Netherlands,Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults,ATMP,Vaccine,Vaccine,5200,https://clinicaltrials.gov/show/NCT04537663,None
3292,5994,NCT04537806,ClinicalTrials.gov,2020-09-01,2020-11-01,False,Sage Therapeutics,Not Recruiting,Phase 3,Interventional,No Country Given,A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19,Drug,Brexanolone,Brexanolone,100,https://clinicaltrials.gov/show/NCT04537806,None
3293,5995,NCT04537858,ClinicalTrials.gov,2020-08-29,2020-06-18,True,University of São Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19,Other,Virtual Reality,Virtual Reality,50,https://clinicaltrials.gov/show/NCT04537858,None
3294,5996,NCT04537949,ClinicalTrials.gov,2020-09-02,2020-09-09,True,Biontech SE,Recruiting,Phase 1/Phase 2,Interventional,Germany,A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults,ATMP,Vaccine,Vaccine,120,https://clinicaltrials.gov/show/NCT04537949,EUCTR2020-003267-26
3295,5997,NCT04537962,ClinicalTrials.gov,2020-07-14,2020-06-11,True,Hospital Israelita Albert Einstein,Recruiting,Not Applicable,Interventional,Brazil,"Evaluationof the Load of SARS-CoV-2 Virus in Oral Cavity, Oropharinge and Saliva of Patients With Covid-19 After Disinfection With Oral Antimicrobial Solutions: a Pilot Study",Drug,Mouthwash,Mouthwash,70,https://clinicaltrials.gov/show/NCT04537962,None
3296,6001,NCT04539275,ClinicalTrials.gov,2020-08-27,2020-11-16,False,VA Office of Research and Development,Recruiting,Phase 3,Interventional,United States,COVID-19 (VA CURES-1),ATMP,Plasma,Plasma,702,https://clinicaltrials.gov/show/NCT04539275,None
3297,6002,NCT04539626,ClinicalTrials.gov,2020-09-03,2020-10-01,False,Centro Médico Nacional 20 de Noviembre,Not Recruiting,Not Applicable,Interventional,No Country Given,Estrogen Therapy in Non-severe COVID-19 Patients,Drug,Estrogen,Estrogen,60,https://clinicaltrials.gov/show/NCT04539626,None
3298,6003,NCT04539795,ClinicalTrials.gov,2020-09-03,2020-11-01,False,University of Alabama at Birmingham,Recruiting,Phase 1/Phase 2,Interventional,United States,COVID-19 Study of Safety and Tolerability of Alvelestat,Drug,Alvelestat,Alvelestat,15,https://clinicaltrials.gov/show/NCT04539795,None
3299,6004,NCT04539821,ClinicalTrials.gov,2020-09-03,2020-10-01,False,VA Office of Research and Development,Recruiting,Not Applicable,Interventional,United States,Virtual Pain Care Management (COVID-19),Telehealth,Telehealth,Telehealth,60,https://clinicaltrials.gov/show/NCT04539821,None
3300,6006,NCT04539873,ClinicalTrials.gov,2020-08-29,2020-11-30,False,Fundacion Universitaria de Ciencias de la Salud,Not Recruiting,Phase 3,Interventional,Colombia,Impact of Colchicine in Hospitalized Colombian Patients With COVID-19,Drug,Colchicine,Colchicine,128,https://clinicaltrials.gov/show/NCT04539873,None
3301,6008,NCT04540185,ClinicalTrials.gov,2020-09-04,2020-11-01,False,"NeuroActiva, Inc.",Recruiting,Phase 3,Interventional,"New Zealand, United States",A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19,ATMP (+ drug),Vaccine + NA-831 vs Vaccine vs. NA-831,Vaccine; NA-831,3600,https://clinicaltrials.gov/show/NCT04540185,None
3302,6009,NCT04540393,ClinicalTrials.gov,2020-08-26,2020-09-02,False,AstraZeneca,Not Recruiting,Phase 3,Interventional,Russian Federation,AZD1222 Vaccine for the Prevention of COVID-19,ATMP,Vaccine,Vaccine,100,https://clinicaltrials.gov/show/NCT04540393,None
3303,6010,NCT04540406,ClinicalTrials.gov,2020-09-03,2020-10-01,False,Notitia Biotechnologies Company,Not Recruiting,Phase 2,Interventional,United States,NBT-NM108 as an Early Treatment of Suspected or Confirmed COVID-19 in Patients With Prediabetes or Type 2 Diabetes,Drug,NBT-NM108,NBT-NM108,100,https://clinicaltrials.gov/show/NCT04540406,None
3304,6011,NCT04540419,ClinicalTrials.gov,2020-08-17,2020-09-11,False,NPO Petrovax,Not Recruiting,Phase 3,Interventional,Russian Federation,Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19,ATMP,Vaccine,Vaccine,500,https://clinicaltrials.gov/show/NCT04540419,None
3305,6013,NCT04540926,ClinicalTrials.gov,2020-09-02,2020-09-01,True,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia,Drug,Cyclosporine,Cyclosporine,200,https://clinicaltrials.gov/show/NCT04540926,None
3306,6014,NCT04540939,ClinicalTrials.gov,2020-09-04,2020-10-19,False,University of Michigan,Recruiting,Not Applicable,Interventional,United States,Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy,Other (psych),Psychological,Psychological,60,https://clinicaltrials.gov/show/NCT04540939,None
3307,6016,NCT04541485,ClinicalTrials.gov,2020-09-07,2020-10-06,False,Daewoong Pharmaceutical Co.,Not Recruiting,Phase 1,Interventional,No Country Given,"To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)",Drug,DWRX2003,DWRX2003,40,https://clinicaltrials.gov/show/NCT04541485,None
3308,6017,NCT04541979,ClinicalTrials.gov,2020-06-05,2020-06-04,True,Region Skåne,Recruiting,Phase 2,Interventional,Sweden,Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19,Drug,Aerosolized DNase I,Aerosolized DNase I,100,https://clinicaltrials.gov/show/NCT04541979,None
3309,6018,NCT04542031,ClinicalTrials.gov,2020-09-07,2020-10-01,False,The Royal Wolverhampton Hospitals NHS Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL,Other,No Intervention,No Intervention,7911,https://clinicaltrials.gov/show/NCT04542031,None
3310,6021,NCT04542122,ClinicalTrials.gov,2020-08-31,2020-09-03,False,"University Hospital, Caen",Not Recruiting,Not Applicable,Interventional,No Country Given,Moral Judgements and Choices of Caregivers in the Time of COVID-19 Pandemic,Other,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04542122,None
3311,6023,NCT04542213,ClinicalTrials.gov,2020-09-03,2020-08-01,True,Hospital Regional de Alta Especialidad del Bajio,Recruiting,Phase 3,Interventional,Mexico,Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19,Drug,Linagliptin,Linagliptin,28,https://clinicaltrials.gov/show/NCT04542213,None
3312,6024,NCT04542330,ClinicalTrials.gov,2020-09-07,2020-09-15,False,Bandim Health Project,Recruiting,Phase 3,Interventional,Denmark,Using BCG to Protect Senior Citizens During the COVID-19 Pandemic,ATMP,Vaccine,Vaccine,1900,https://clinicaltrials.gov/show/NCT04542330,None
3313,6025,NCT04542343,ClinicalTrials.gov,2020-09-03,2020-10-01,False,Charles Drew University of Medicine and Science,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Risk Reduction Among African American Parishioners,Other,Other,Other,265,https://clinicaltrials.gov/show/NCT04542343,None
3314,6026,NCT04542395,ClinicalTrials.gov,2020-09-03,2020-12-01,False,Charles Drew University of Medicine and Science,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents,Other,Other,Other,310,https://clinicaltrials.gov/show/NCT04542395,None
3315,6027,NCT04542408,ClinicalTrials.gov,2020-09-06,2020-11-12,False,"University Hospital, Hamburg-Eppendorf",Recruiting,Phase 3,Interventional,Germany,Hamburg Edoxaban for Anticoagulation in COVID-19 Study,Drug,Edoxaban or Heparin,Edoxaban; Heparin,172,https://clinicaltrials.gov/show/NCT04542408,None
3316,6028,NCT04542421,ClinicalTrials.gov,2020-09-04,2020-07-01,True,"University of Colorado, Denver",Recruiting,Not Applicable,Interventional,United States,Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,90,https://clinicaltrials.gov/show/NCT04542421,None
3317,6029,NCT04542434,ClinicalTrials.gov,2020-09-04,2020-11-01,False,"First Wave Bio, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Niclosamide in COVID-19,Drug,Niclosamide,Niclosamide,148,https://clinicaltrials.gov/show/NCT04542434,None
3318,6030,NCT04542447,ClinicalTrials.gov,2020-09-06,2020-09-01,True,NatureCeuticals Sdn Bhd,Recruiting,Phase 1,Interventional,India,To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.,Drug,Nuvastatic,Nuvastatic,10,https://clinicaltrials.gov/show/NCT04542447,None
3319,6032,NCT04542694,ClinicalTrials.gov,2020-09-04,2020-05-21,True,"Promomed, LLC",Not Recruiting,Phase 3,Interventional,Russian Federation,Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,Drug,Favipiravir,Favipiravir,200,https://clinicaltrials.gov/show/NCT04542694,None
3320,6033,NCT04542850,ClinicalTrials.gov,2020-08-16,2020-11-01,False,Royal College of Surgeons in Ireland - Medical University of Bahrain,Not Recruiting,Not Applicable,Interventional,Bahrain,"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19",Supplement,5-ALA-Phosphate + SFC (5-ALA + SFC),5-ALA-Phosphate; SFC (5-ALA + SFC),40,https://clinicaltrials.gov/show/NCT04542850,None
3321,6034,NCT04542876,ClinicalTrials.gov,2020-09-08,2020-05-01,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,India,Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,46,https://clinicaltrials.gov/show/NCT04542876,None
3322,6036,NCT04542941,ClinicalTrials.gov,2020-08-31,2020-06-16,True,Makerere University,Not Recruiting,Not Applicable,Interventional,Uganda,Assessment of Safety and Efficacy of CCP,ATMP,Plasma,Plasma,136,https://clinicaltrials.gov/show/NCT04542941,None
3323,6038,NCT04542967,ClinicalTrials.gov,2020-09-04,2020-06-23,True,Hospital Central Militar,Recruiting,Phase 2,Interventional,Mexico,Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease,ATMP,Plasma,Plasma,150,https://clinicaltrials.gov/show/NCT04542967,None
3324,6040,NCT04542993,ClinicalTrials.gov,2020-09-08,2020-09-08,False,Swedish Medical Center,Recruiting,Phase 2,Interventional,United States,Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy,Drug,Zinc,Zinc,60,https://clinicaltrials.gov/show/NCT04542993,None
3325,6041,NCT04543006,ClinicalTrials.gov,2020-09-08,2020-09-08,False,"University Hospital, Grenoble",Not Recruiting,Not Applicable,Interventional,No Country Given,Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,170,https://clinicaltrials.gov/show/NCT04543006,None
3326,6042,NCT04543760,ClinicalTrials.gov,2020-09-08,2020-10-01,False,"Hospital St. Joseph, Marseille",Recruiting,Not Applicable,Interventional,France,Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19,Procedure,Positioning,Positioning,18,https://clinicaltrials.gov/show/NCT04543760,None
3327,6050,NCT04545008,ClinicalTrials.gov,2020-09-01,2020-09-01,False,Prisma Health-Upstate,Not Recruiting,Phase 1,Interventional,No Country Given,Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19,Drug,Famotidine vs. N-Acetyl vs. Famotidine + N-Acetyl,Famotidine; N-Acetyl,42,https://clinicaltrials.gov/show/NCT04545008,None
3328,6052,NCT04545242,ClinicalTrials.gov,2020-09-05,2020-10-07,False,Dr. Negrin University Hospital,Not Recruiting,Phase 4,Interventional,Spain,Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions,Drug,Corticosteroids,Dexamethasone,980,https://clinicaltrials.gov/show/NCT04545242,None
3329,6053,NCT04545541,ClinicalTrials.gov,2020-09-05,2020-11-01,False,Australian National University,Recruiting,Phase 2/Phase 3,Interventional,United States,Nebulised Heparin in Patients With Severe COVID-19,Drug,Heparin,Heparin,202,https://clinicaltrials.gov/show/NCT04545541,None
3330,6054,NCT04545749,ClinicalTrials.gov,2020-09-02,2020-09-25,False,"United Biomedical Inc., Asia",Recruiting,Phase 1,Interventional,Taiwan,"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine",ATMP,Vaccine,Vaccine,60,https://clinicaltrials.gov/show/NCT04545749,None
3331,6056,NCT04546737,ClinicalTrials.gov,2020-09-10,2020-09-08,True,CHU de Amiens,Recruiting,Not Applicable,Interventional,France,"Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients",Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04546737,None
3332,6058,NCT04546841,ClinicalTrials.gov,2020-08-26,2020-11-27,False,"University Hospital, Tübingen",Recruiting,Phase 1,Interventional,Germany,Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults,ATMP,Vaccine,Vaccine,36,https://clinicaltrials.gov/show/NCT04546841,None
3333,6060,NCT04547127,ClinicalTrials.gov,2020-09-10,2020-04-29,True,"Grifols, S.A.",Recruiting,Phase 2,Interventional,Spain,A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19),ATMP,Plasma,Plasma,200,https://clinicaltrials.gov/show/NCT04547127,None
3334,6061,NCT04547140,ClinicalTrials.gov,2020-09-10,2020-11-01,False,"Grifols, S.A.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19),ATMP,Alpha-1-proteinase inhibitor,Alpha-1-proteinase inhibitor,100,https://clinicaltrials.gov/show/NCT04547140,None
3335,6063,NCT04547257,ClinicalTrials.gov,2020-04-29,2020-12-15,False,ExThera Medical Europe BV,Not Recruiting,Not Applicable,Interventional,Netherlands,Safety & Performance Evaluation of Seraph 100 in Treatment of Pts With COVID-19,Other (device),Blood filter,Blood filter,42,https://clinicaltrials.gov/show/NCT04547257,None
3336,6064,NCT04547283,ClinicalTrials.gov,2020-09-09,2020-06-14,True,Atrium Health,Recruiting,Not Applicable,Interventional,United States,Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19,Procedure,Positioning,Positioning,40,https://clinicaltrials.gov/show/NCT04547283,None
3337,6065,NCT04547634,ClinicalTrials.gov,2020-08-17,2020-07-01,True,University of Malaga,Recruiting,Not Applicable,Interventional,Spain,Telerehabilitation in Oncology Patients,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04547634,None
3338,6066,NCT04547660,ClinicalTrials.gov,2020-09-09,2020-07-16,True,Hospital de Clinicas de Porto Alegre,Recruiting,Phase 3,Interventional,Brazil,Convalescent Plasma for Severe COVID-19 Patients,ATMP,Plasma,Plasma,160,https://clinicaltrials.gov/show/NCT04547660,None
3339,6069,NCT04548531,ClinicalTrials.gov,2020-09-09,2020-09-10,False,Massachusetts General Hospital,Recruiting,Not Applicable,Interventional,United States,Engaging Patients in Colon Cancer Screening Decisions During COVID-19,Health System,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04548531,None
3340,6070,NCT04548544,ClinicalTrials.gov,2020-09-11,2019-10-18,True,"University of California, San Francisco",Not Recruiting,Not Applicable,Interventional,United States,A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19,Other (psych),Psychological,Psychological,21,https://clinicaltrials.gov/show/NCT04548544,None
3341,6071,NCT04548557,ClinicalTrials.gov,2020-09-07,2020-09-15,False,University of Health Sciences Lahore,Not Recruiting,Phase 3,Interventional,Pakistan,Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial,ATMP,Immunoglobulin,Immunoglobulin,60,https://clinicaltrials.gov/show/NCT04548557,None
3342,6074,NCT04548934,ClinicalTrials.gov,2020-09-02,2020-09-13,False,Institute of Mountain Emergency Medicine,Not Recruiting,Not Applicable,Interventional,No Country Given,Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic,Other,Other,Other,28,https://clinicaltrials.gov/show/NCT04548934,None
3343,6075,NCT04549337,ClinicalTrials.gov,2020-09-09,2020-09-25,False,"Rigshospitalet, Denmark",Recruiting,Not Applicable,Interventional,Denmark,Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19,Other (exercise),Exercise,Exercise,10,https://clinicaltrials.gov/show/NCT04549337,None
3344,6077,NCT04549376,ClinicalTrials.gov,2020-09-11,2020-07-01,True,"Pi Research Consultancy Center, Bangladesh",Recruiting,Phase 2,Interventional,Bangladesh,Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo,Drug,Povidone Iodine,Povidone Iodine,200,https://clinicaltrials.gov/show/NCT04549376,None
3345,6081,NCT04550325,ClinicalTrials.gov,2020-09-10,2020-08-05,True,"Kamada, Ltd.",Recruiting,Phase 1/Phase 2,Interventional,Israel,"Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19",ATMP,Immunoglobulin,Immunoglobulin,12,https://clinicaltrials.gov/show/NCT04550325,None
3346,6082,NCT04550338,ClinicalTrials.gov,2020-09-13,2020-12-01,False,University of Alabama at Birmingham,Not Recruiting,Phase 3,Interventional,No Country Given,Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure,Drug,Tranexamic acid,Tranexamic acid,100,https://clinicaltrials.gov/show/NCT04550338,None
3347,6085,NCT04551274,ClinicalTrials.gov,2020-09-01,2020-10-01,False,Simon Fraser University,Not Recruiting,Not Applicable,Interventional,Canada,Music Therapy in Frontline Healthcare Workers,Other (psych),Psychological,Psychological,20,https://clinicaltrials.gov/show/NCT04551274,None
3348,6086,NCT04551339,ClinicalTrials.gov,2020-09-09,2020-09-28,False,Mayo Clinic,Recruiting,Not Applicable,Interventional,United States,Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19,Drug,Zinc,Zinc,4500,https://clinicaltrials.gov/show/NCT04551339,None
3349,6088,NCT04551547,ClinicalTrials.gov,2020-09-15,2020-10-31,False,"Sinovac Research and Development Co., Ltd.",Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19,ATMP,Vaccine,Vaccine,552,https://clinicaltrials.gov/show/NCT04551547,None
3350,6090,NCT04551755,ClinicalTrials.gov,2020-09-03,2020-09-01,True,Bangladesh Medical Research Council (BMRC),Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19,Drug,Ivermectin + Doxycycline,Ivermectin; Doxycycline,188,https://clinicaltrials.gov/show/NCT04551755,None
3351,6091,NCT04551768,ClinicalTrials.gov,2020-09-15,2020-11-01,False,"Bausch Health Americas, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study to Evaluate the Safety and Efficacy of VIRAZOLEÂ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,Drug,Virazole,Virazole,50,https://clinicaltrials.gov/show/NCT04551768,None
3352,6092,NCT04551781,ClinicalTrials.gov,2020-09-13,2020-04-01,True,South Valley University,Not Recruiting,Not Applicable,Interventional,Egypt,Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis,Drug,Corticosteroids,Prednisone,450,https://clinicaltrials.gov/show/NCT04551781,None
3353,6093,NCT04551898,ClinicalTrials.gov,2020-09-10,2020-10-30,False,BeiGene,Not Recruiting,Phase 2,Interventional,No Country Given,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19),Drug,BGB-DXP593,BGB-DXP593,180,https://clinicaltrials.gov/show/NCT04551898,None
3354,6094,NCT04551911,ClinicalTrials.gov,2020-09-15,2020-10-26,False,"OPKO Health, Inc.",Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19,Drug,CTAP101,CTAP101,160,https://clinicaltrials.gov/show/NCT04551911,None
3355,6097,NCT04552483,ClinicalTrials.gov,2020-09-09,2020-06-08,True,Universidade Federal do Rio de Janeiro,Not Recruiting,Phase 2,Interventional,Brazil,Effects of Early Use of Nitazoxanide in Patients With COVID-19,Drug,Nitazoxanide,Nitazoxanide,392,https://clinicaltrials.gov/show/NCT04552483,None
3356,6098,NCT04552951,ClinicalTrials.gov,2020-05-21,2020-04-04,True,Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias (FINBA),Recruiting,Phase 4,Interventional,Spain,Effect of Vitamin D on Morbidity and Mortality of the COVID-19,Drug,Vitamin D,Vitamin D,80,https://clinicaltrials.gov/show/NCT04552951,None
3357,6100,NCT04553705,ClinicalTrials.gov,2020-09-15,2020-09-20,False,Beni-Suef University,Recruiting,Phase 2/Phase 3,Interventional,Saudi Arabia,"Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)",Drug,"Omega 3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice",Omega 3; Nigella Sativa; Indian Costus; Quinine; Anise Seed; Deglycyrrhizinated Licorice,200,https://clinicaltrials.gov/show/NCT04553705,None
3358,6102,NCT04554264,ClinicalTrials.gov,2020-09-02,2020-09-01,True,CHU de Amiens,Recruiting,Not Applicable,Interventional,France,Complicated Grief in ICU in the Aftermath of COVID-19,Other (psych),No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04554264,None
3359,6103,NCT04554433,ClinicalTrials.gov,2020-09-17,2020-12-01,False,Mansoura University,Not Recruiting,Phase 3,Interventional,No Country Given,New Treatment for COVID-19 Using Ethanol Vapor Inhalation .,Drug,Ethanol + Aspirin,Ethanol; Aspirin,80,https://clinicaltrials.gov/show/NCT04554433,None
3360,6105,NCT04554992,ClinicalTrials.gov,2020-08-26,2020-03-20,True,The Methodist Hospital System,Not Recruiting,Phase 1,Interventional,United States,Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019),ATMP,Plasma,Plasma,350,https://clinicaltrials.gov/show/NCT04554992,None
3361,6106,NCT04555005,ClinicalTrials.gov,2020-06-11,2020-03-10,True,Instituto de Investigación Hospital Universitario La Paz,Not Recruiting,Not Applicable,Interventional,Spain,Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19,Other (psych),Psychological,Psychological,1000,https://clinicaltrials.gov/show/NCT04555005,None
3362,6108,NCT04555122,ClinicalTrials.gov,2020-04-29,2020-09-29,False,"University of California, Irvine",Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Ad Intervention,Other,Other,Other,52500,https://clinicaltrials.gov/show/NCT04555122,None
3363,6109,NCT04555148,ClinicalTrials.gov,2020-09-16,2020-09-20,False,Green Cross Corporation,Recruiting,Phase 2,Interventional,South Korea,COVIDIG (COVID-19 Hyper-ImmunoGlobulin),ATMP,Immunoglobulin,Immunoglobulin,60,https://clinicaltrials.gov/show/NCT04555148,None
3364,6111,NCT04555213,ClinicalTrials.gov,2020-09-16,2020-09-30,False,Noxopharm Limited,Recruiting,Phase 1,Interventional,"Moldova, Republic of",A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19,Drug,NOX66,NOX66,40,https://clinicaltrials.gov/show/NCT04555213,None
3365,6119,NCT04557046,ClinicalTrials.gov,2020-09-17,2020-06-26,True,LumiraDx UK Limited,Recruiting,Not Applicable,Interventional,United States,Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04557046,None
3366,6120,NCT04557241,ClinicalTrials.gov,2020-09-16,2020-10-01,False,Indiana University,Not Recruiting,Not Applicable,Interventional,No Country Given,Brief Informational Intervention for COVID-19 Misinformation Prophylaxis,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04557241,None
3367,6122,NCT04557605,ClinicalTrials.gov,2020-09-09,2020-09-14,False,University of Saskatchewan,Not Recruiting,Not Applicable,Interventional,Canada,Effects of a Face Mask on Oxygenation During Exercise,Other,Other,Other,14,https://clinicaltrials.gov/show/NCT04557605,None
3368,6123,NCT04558021,ClinicalTrials.gov,2020-09-18,2020-10-08,False,Imuneks Farma ilac San. Tic. A.S.,Recruiting,Phase 3,Interventional,Turkey,A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19,Drug,Niclosamide,Niclosamide,200,https://clinicaltrials.gov/show/NCT04558021,None
3369,6124,NCT04558125,ClinicalTrials.gov,2020-09-19,2020-09-08,True,Cedars-Sinai Medical Center,Not Recruiting,Phase 4,Interventional,United States,Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism,Drug,Tenecteplase,Tenecteplase,45,https://clinicaltrials.gov/show/NCT04558125,None
3370,6129,NCT04558411,ClinicalTrials.gov,2020-09-20,2020-09-12,True,Rutgers University,Recruiting,Not Applicable,Interventional,United States,"Pilot Study of a Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students",Other (psych),Psychological,Psychological,150,https://clinicaltrials.gov/show/NCT04558411,None
3371,6130,NCT04558424,ClinicalTrials.gov,2020-09-21,2020-10-01,False,Bangabandhu Sheikh Mujib Medical University,Not Recruiting,Not Applicable,Interventional,Bangladesh,"RCT,Double Blind, Placebo to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU",Drug,Zinc + Vitamin C,Zinc; Vitamin C,50,https://clinicaltrials.gov/show/NCT04558424,None
3372,6132,NCT04558450,ClinicalTrials.gov,2020-08-31,2020-09-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN),Clinical Presentation,No Intervention,No Intervention,360,https://clinicaltrials.gov/show/NCT04558450,None
3373,6133,NCT04558463,ClinicalTrials.gov,2020-09-03,2020-04-16,True,Indonesia University,Recruiting,Phase 3,Interventional,Indonesia,The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19,Drug,Favipiravir vs. Oseltamivir,Favipiravir; Oseltamivir,100,https://clinicaltrials.gov/show/NCT04558463,None
3374,6134,NCT04558476,ClinicalTrials.gov,2020-09-14,2020-09-01,True,University of Liège,Recruiting,Phase 2,Interventional,Belgium,Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation,ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04558476,None
3375,6139,NCT04559035,ClinicalTrials.gov,2020-09-21,2020-09-24,False,Augusta University,Recruiting,Not Applicable,Interventional,United States,Nasal Irrigation to Reduce COVID-19 Morbidity,Procedure,Nasal Irrigation,Nasal Irrigation,200,https://clinicaltrials.gov/show/NCT04559035,None
3376,6140,NCT04559074,ClinicalTrials.gov,2020-08-26,2020-10-23,False,Queen Mary University of London,Recruiting,Phase 4,Interventional,United Kingdom,Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,1000,https://clinicaltrials.gov/show/NCT04559074,None
3377,6143,NCT04560231,ClinicalTrials.gov,2020-07-11,2020-06-01,True,Lahore General Hospital,Recruiting,Phase 1,Interventional,Pakistan,Remdesivir in COVID-19 Lahore General Hospital,Drug,Remdesivir,Remdesivir,30,https://clinicaltrials.gov/show/NCT04560231,None
3378,6147,NCT04560881,ClinicalTrials.gov,2020-09-16,2020-09-16,False,Laboratorio Elea,Not Recruiting,Phase 3,Interventional,Argentina,"Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)",ATMP,Vaccine,Vaccine,3000,https://clinicaltrials.gov/show/NCT04560881,None
3379,6149,NCT04561063,ClinicalTrials.gov,2020-09-21,2020-12-01,False,"University of Witwatersrand, South Africa",Not Recruiting,Phase 2,Interventional,South Africa,COVID-19 Prophylaxis South Africa (COVER HCW),Drug (Chemoprophylaxis),Nitazoxanide vs. Sofosbuvir/daclatasvir,Nitazoxanide; Sofosbuvir/daclatasvir,1950,https://clinicaltrials.gov/show/NCT04561063,None
3380,6150,NCT04561076,ClinicalTrials.gov,2020-09-07,2020-12-09,False,Hengenix Biotech Inc,Not Recruiting,Phase 1,Interventional,No Country Given,Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers,Drug,HLX70,HLX70,24,https://clinicaltrials.gov/show/NCT04561076,None
3381,6154,NCT04561154,ClinicalTrials.gov,2020-09-09,2020-06-11,True,Centre Hospitalier le Mans,Recruiting,Not Applicable,Interventional,France,Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV,Other (psych),No Intervention,No Intervention,134,https://clinicaltrials.gov/show/NCT04561154,None
3382,6155,NCT04561180,ClinicalTrials.gov,2020-09-22,2020-12-01,False,"Evergreen Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Study to Evaluate the Efficacy and Safety of EG-HPCP-03a Compared to DEX in Patients With COVID-19 Pneumonia,Drug,EG-HPCP-03a + Corticosteroids,EG-HPCP-03a; Dexamethasone,96,https://clinicaltrials.gov/show/NCT04561180,None
3383,6157,NCT04561219,ClinicalTrials.gov,2020-09-22,2020-04-19,True,Universidade Federal do Rio de Janeiro,Not Recruiting,Phase 2,Interventional,Brazil,Nitazoxanide Therapy for Patients With COVID-19 Pneumonia,Drug,Nitazoxanide,Nitazoxanide,500,https://clinicaltrials.gov/show/NCT04561219,None
3384,6160,NCT04563065,ClinicalTrials.gov,2020-09-19,2020-08-01,True,Universidad Politécnica de Madrid,Recruiting,Not Applicable,Interventional,Spain,Active Pregnancy Against COVID-19,Other (exercise),Exercise,Exercise,280,https://clinicaltrials.gov/show/NCT04563065,None
3385,6162,NCT04563208,ClinicalTrials.gov,2020-09-21,2020-12-01,False,"University of Witwatersrand, South Africa",Not Recruiting,Phase 2,Interventional,South Africa,Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19,Drug,Ribavirin + Nitazoxanide,Ribavirin; Nitazoxanide,40,https://clinicaltrials.gov/show/NCT04563208,None
3386,6165,NCT04563650,ClinicalTrials.gov,2020-09-18,2020-09-18,False,CHU de Amiens,Recruiting,Not Applicable,Interventional,France,COVID-19 Serology and Immunosenescence,Clinical Presentation (Epidemiology),No Intervention,No Intervention,330,https://clinicaltrials.gov/show/NCT04563650,None
3387,6166,NCT04563676,ClinicalTrials.gov,2020-09-23,2020-09-22,True,CHU de Amiens,Recruiting,Not Applicable,Interventional,France,Physiopathology and Sequelae of COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04563676,None
3388,6167,NCT04563689,ClinicalTrials.gov,2020-09-22,2020-06-18,True,Dentaid SL,Not Recruiting,Not Applicable,Interventional,Colombia,Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients,Drug,Mouthwash,Mouthwash,23,https://clinicaltrials.gov/show/NCT04563689,None
3389,6168,NCT04563702,ClinicalTrials.gov,2020-09-21,2020-09-21,False,Vaxart,Not Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults,ATMP,Vaccine,Vaccine,35,https://clinicaltrials.gov/show/NCT04563702,None
3390,6169,NCT04564040,ClinicalTrials.gov,2020-08-27,2020-10-12,False,AstraZeneca,Recruiting,Phase 1,Interventional,Germany,A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole,Drug,Acalabrutinib,Acalabrutinib,40,https://clinicaltrials.gov/show/NCT04564040,None
3391,6172,NCT04565249,ClinicalTrials.gov,2020-09-15,2020-10-22,False,"Pliant Therapeutics, Inc.",Recruiting,Phase 2,Interventional,United States,"Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19",Drug,PLN-74809,PLN-74809,36,https://clinicaltrials.gov/show/NCT04565249,None
3392,6173,NCT04565379,ClinicalTrials.gov,2020-09-23,2020-09-25,False,Shaperon,Recruiting,Phase 2,Interventional,Romania,Clinical Trial to Investigate the Efficacy and Safety of NuSepinÂ® in COVID-19 Pneumonia Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),60,https://clinicaltrials.gov/show/NCT04565379,None
3393,6174,NCT04565392,ClinicalTrials.gov,2020-09-21,2020-12-01,False,drpykessupplements.com,Not Recruiting,Phase 4,Interventional,United States,Study of Famotidine With Vitamins C and D for Pandemic Coronavirus,Drug,Famotidine,Famotidine,216,https://clinicaltrials.gov/show/NCT04565392,None
3394,6175,NCT04565509,ClinicalTrials.gov,2020-09-24,2020-11-20,False,Washington University in St. Louis,Recruiting,Not Applicable,Interventional,United States,Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic,Other,Other,Other,2500,https://clinicaltrials.gov/show/NCT04565509,None
3395,6177,NCT04565665,ClinicalTrials.gov,2020-09-22,2020-07-29,True,M.D. Anderson Cancer Center,Recruiting,Phase 1,Interventional,United States,Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),70,https://clinicaltrials.gov/show/NCT04565665,None
3396,6179,NCT04566276,ClinicalTrials.gov,2020-09-15,2021-01-01,False,Chulalongkorn University,Not Recruiting,Phase 1,Interventional,Thailand,ChulaCov19 mRNA Vaccine in Healthy Adults,ATMP,Vaccine,Vaccine,96,https://clinicaltrials.gov/show/NCT04566276,None
3397,6180,NCT04566770,ClinicalTrials.gov,2020-09-22,2020-09-24,False,CanSino Biologics Inc.,Recruiting,Phase 2,Interventional,China,A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),ATMP,Vaccine,Vaccine,481,https://clinicaltrials.gov/show/NCT04566770,None
3398,6182,NCT04567173,ClinicalTrials.gov,2020-09-24,2020-09-21,True,University of the Philippines,Recruiting,Phase 2/Phase 3,Interventional,Philippines,Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19,ATMP,Plasma,Plasma,136,https://clinicaltrials.gov/show/NCT04567173,None
3399,6184,NCT04567810,ClinicalTrials.gov,2020-09-18,2020-09-18,False,Stanford University,Recruiting,Phase 1,Interventional,Australia,"Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)",ATMP,Immunoglobulin,Immunoglobulin,48,https://clinicaltrials.gov/show/NCT04567810,None
3400,6187,NCT04567953,ClinicalTrials.gov,2020-09-25,2020-07-28,True,Paradigm Laboratories LLC,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Tests With Saliva Specimens,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2000,https://clinicaltrials.gov/show/NCT04567953,None
3401,6192,NCT04568096,ClinicalTrials.gov,2020-09-26,2020-11-01,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,No Country Given,Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19,Drug,Retinoic acid + Tamoxifen,Retinoic acid; Tamoxifen,160,https://clinicaltrials.gov/show/NCT04568096,None
3402,6195,NCT04568356,ClinicalTrials.gov,2020-09-27,2020-04-24,True,"E25Bio, Inc.",Not Recruiting,Not Applicable,Interventional,United States,A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04568356,None
3403,6198,NCT04568525,ClinicalTrials.gov,2020-09-23,2020-07-01,True,Kyrgyz State Medical Academy,Not Recruiting,Not Applicable,Interventional,Kyrgyzstan,Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,195,https://clinicaltrials.gov/show/NCT04568525,None
3404,6201,NCT04568707,ClinicalTrials.gov,2020-08-31,2020-10-15,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES),Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04568707,None
3405,6202,NCT04568811,ClinicalTrials.gov,2020-09-28,2020-09-26,True,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 1,Interventional,China,The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine,ATMP,Vaccine,Vaccine,89,https://clinicaltrials.gov/show/NCT04568811,None
3406,6204,NCT04568863,ClinicalTrials.gov,2020-09-28,2020-06-20,True,Pharmamel S.L.,Recruiting,Phase 2,Interventional,Spain,Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19,Drug,Melatonin,Melatonin,18,https://clinicaltrials.gov/show/NCT04568863,None
3407,6205,NCT04568876,ClinicalTrials.gov,2020-09-24,2020-10-23,False,Epitech Group SpA,Recruiting,Phase 4,Interventional,Italy,Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients,Drug,Palmitoylethanolamide,Palmitoylethanolamide,40,https://clinicaltrials.gov/show/NCT04568876,None
3408,6206,NCT04568889,ClinicalTrials.gov,2020-09-24,2020-09-28,False,Harvard University,Not Recruiting,Not Applicable,Interventional,No Country Given,Minnesota COVID-19 Testing Project,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04568889,None
3409,6207,NCT04569188,ClinicalTrials.gov,2020-09-04,2020-05-15,True,Azienda Socio Sanitaria Territoriale di Mantova,Not Recruiting,Phase 2,Interventional,Italy,Convalescent Plasma in COVID-19 Elderly Patients,ATMP,Plasma,Plasma,21,https://clinicaltrials.gov/show/NCT04569188,None
3410,6208,NCT04569227,ClinicalTrials.gov,2020-09-28,2020-11-16,False,Enzychem Lifesciences Corporation,Not Recruiting,Phase 2,Interventional,No Country Given,Prevention of COVID-19 Infection to Severe Pneumonia or ARDS,Drug (Chemoprophylaxis),EC-18,EC-18,60,https://clinicaltrials.gov/show/NCT04569227,None
3411,6209,NCT04569266,ClinicalTrials.gov,2020-09-10,2020-08-07,True,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Not Applicable,Interventional,France,Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,200,https://clinicaltrials.gov/show/NCT04569266,None
3412,6212,NCT04569383,ClinicalTrials.gov,2020-09-21,2020-10-05,False,"University Hospital, Hamburg-Eppendorf",Recruiting,Phase 1,Interventional,Germany,"Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19",ATMP,Vaccine,Vaccine,30,https://clinicaltrials.gov/show/NCT04569383,None
3413,6213,NCT04569825,ClinicalTrials.gov,2020-09-29,2020-08-01,True,University of Anbar,Recruiting,Phase 1,Interventional,Iraq,Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease,Drug,Ophtamesone,Ophtamesone,250,https://clinicaltrials.gov/show/NCT04569825,None
3414,6215,NCT04569877,ClinicalTrials.gov,2020-09-25,2020-09-24,True,University of Giessen,Recruiting,Phase 2,Interventional,Germany,GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia,Drug,Molgramostim,Molgramostim,238,https://clinicaltrials.gov/show/NCT04569877,EUCTR2020-001654-21
3415,6216,NCT04570202,ClinicalTrials.gov,2020-09-28,2020-11-20,False,CHU de Tours,Recruiting,Not Applicable,Interventional,France,Health cAre woRkers exposeD to COVID-19,Other (psych),Psychological,Psychological,900,https://clinicaltrials.gov/show/NCT04570202,None
3416,6217,NCT04570254,ClinicalTrials.gov,2020-09-26,2020-08-19,True,Unidad Temporal COVID-19 en Centro Citibanamex,Not Recruiting,Not Applicable,Interventional,Mexico,Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19,Drug,Vitamin C + Vitamin E + Melatonin + N-acetyl cysteine + Pentoxifylline,Vitamin C; Vitamin E; Melatonin; N-acetyl cysteine; Pentoxifylline,11,https://clinicaltrials.gov/show/NCT04570254,None
3417,6218,NCT04570384,ClinicalTrials.gov,2020-09-17,2020-10-15,False,"Asklepion Pharmaceuticals, LLC",Recruiting,Phase 2,Interventional,United States,Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness,Drug,L-Citrulline,L-Citrulline,60,https://clinicaltrials.gov/show/NCT04570384,None
3418,6219,NCT04570397,ClinicalTrials.gov,2020-09-29,2020-11-01,False,Brigham and Women's Hospital,Not Recruiting,Phase 3,Interventional,United States,Ravulizumab and COVID-19,Drug,Ravulizumab,Ravulizumab,32,https://clinicaltrials.gov/show/NCT04570397,None
3419,6220,NCT04570449,ClinicalTrials.gov,2020-09-29,2020-09-01,True,Milton S. Hershey Medical Center,Not Recruiting,Phase 1,Interventional,United States,Pilot Randomized Controlled Trial: Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19),Drug,Fluoxetine,Fluoxetine,40,https://clinicaltrials.gov/show/NCT04570449,None
3420,6221,NCT04570462,ClinicalTrials.gov,2020-07-21,2020-05-18,True,Northwell Health,Recruiting,Not Applicable,Interventional,United States,Mild Hypothermia for COVID-19 ARDS,Other (device),Cooling Machine,Cooling Machine,20,https://clinicaltrials.gov/show/NCT04570462,None
3421,6222,NCT04570488,ClinicalTrials.gov,2020-09-25,2020-05-15,True,NYU Langone Health,Recruiting,Not Applicable,Interventional,United States,Predicting Favorable Outcomes in Hospitalized Covid-19 Patients,Prognosis,No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04570488,None
3422,6223,NCT04570501,ClinicalTrials.gov,2020-09-28,2021-01-01,False,Stanford University,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients,Drug,Angiotensin,Angiotensin,160,https://clinicaltrials.gov/show/NCT04570501,None
3423,6225,NCT04572360,ClinicalTrials.gov,2020-09-27,2020-10-01,False,Hong Kong Baptist University,Not Recruiting,Not Applicable,Interventional,Hong Kong,Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,172,https://clinicaltrials.gov/show/NCT04572360,None
3424,6226,NCT04572399,ClinicalTrials.gov,2020-09-28,2020-10-30,False,Cedars-Sinai Medical Center,Recruiting,Not Applicable,Interventional,United States,UVA Light Device to Treat COVID-19,Other,Ultraviolet Therapy,Ultraviolet Therapy,5,https://clinicaltrials.gov/show/NCT04572399,None
3425,6227,NCT04572412,ClinicalTrials.gov,2020-09-29,2020-10-01,False,Lancashire Teaching Hospitals NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia,Other,Radiation,Radiation,13,https://clinicaltrials.gov/show/NCT04572412,None
3426,6229,NCT04573153,ClinicalTrials.gov,2020-09-30,2020-09-21,True,ScandiBio Therapeutics AB,Recruiting,Phase 2/Phase 3,Interventional,Turkey,Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients,Drug,Hydroxychloroquine + N-acetyl cysteine + L-carnitine tartrate + nicotinamide riboside + serine vs. Hydroxychloroquine,Hydroxychloroquine; N-acetyl cysteine; L-carnitine tartrate; nicotinamide riboside; serine,400,https://clinicaltrials.gov/show/NCT04573153,None
3427,6230,NCT04573270,ClinicalTrials.gov,2020-09-23,2020-04-24,True,Thomas Advanced Medical LLC,Not Recruiting,Phase 1,Interventional,United States,Mesenchymal Stem Cells for the Treatment of COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04573270,None
3428,6231,NCT04573322,ClinicalTrials.gov,2020-09-29,2020-09-10,True,Diffusion Pharmaceuticals Inc,Recruiting,Phase 1/Phase 2,Interventional,Romania,Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects,Drug,Trans Sodium Crocetinate,Trans Sodium Crocetinate,224,https://clinicaltrials.gov/show/NCT04573322,None
3429,6234,NCT04573361,ClinicalTrials.gov,2020-09-29,2020-05-02,True,Real Centro Universitario Maria Cristina,Not Recruiting,Not Applicable,Interventional,Spain,Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain,Health System,No Intervention,No Intervention,723,https://clinicaltrials.gov/show/NCT04573361,None
3430,6236,NCT04573764,ClinicalTrials.gov,2020-10-01,2020-10-01,False,Steno Diabetes Center Copenhagen,Not Recruiting,Not Applicable,Interventional,No Country Given,Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19,Supplement,"D-beta-hydroxybutyrate-(R)-1,3 butanediol monoester","D-beta-hydroxybutyrate-(R)-1,3 butanediol monoester",12,https://clinicaltrials.gov/show/NCT04573764,None
3431,6237,NCT04573855,ClinicalTrials.gov,2020-09-30,2020-12-01,False,D'Or Institute for Research and Education,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19,ATMP,Immunoglobulin,Immunoglobulin,41,https://clinicaltrials.gov/show/NCT04573855,None
3432,6239,NCT04574050,ClinicalTrials.gov,2020-09-28,2020-12-03,False,King's College Hospital NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,No Country Given,SELF-BREATHE RCT for Chronic Breathlessness,Other,Other,Other,40,https://clinicaltrials.gov/show/NCT04574050,None
3433,6240,NCT04574219,ClinicalTrials.gov,2020-09-24,2020-10-01,False,"Children's Hospital Medical Center, Cincinnati",Not Recruiting,Not Applicable,Interventional,"Canada, United States",Virtual Parental Presence on Induction,Not relevant,Not relevant,Not relevant,184,https://clinicaltrials.gov/show/NCT04574219,None
3434,6242,NCT04574869,ClinicalTrials.gov,2020-09-16,2020-10-01,False,"ReAlta Life Sciences, Inc.",Not Recruiting,Phase 1,Interventional,United States,A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure,Drug,RLS-0071,RLS-0071,42,https://clinicaltrials.gov/show/NCT04574869,None
3435,6246,NCT04575558,ClinicalTrials.gov,2020-05-18,2020-06-30,False,Latin American Cooperative Oncology Group,Not Recruiting,Phase 2,Interventional,Brazil,HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19,Not relevant,Not relevant,Not relevant,0,https://clinicaltrials.gov/show/NCT04575558,None
3436,6249,NCT04576312,ClinicalTrials.gov,2020-09-28,2020-06-29,True,UNION therapeutics,Recruiting,Phase 1,Interventional,Denmark,Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19,Drug,UNI911,UNI911,44,https://clinicaltrials.gov/show/NCT04576312,None
3437,6251,NCT04576728,ClinicalTrials.gov,2020-09-24,2020-10-06,False,Biotest,Recruiting,Phase 2,Interventional,Spain,Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19,Drug,Trimodulin,Trimodulin,164,https://clinicaltrials.gov/show/NCT04576728,None
3438,6253,NCT04577235,ClinicalTrials.gov,2020-09-29,2020-06-05,True,Gaziosmanpasa Taksim Research and Education Hospital,Not Recruiting,Not Applicable,Interventional,Turkey,Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores.,Clinical Presentation,No Intervention,No Intervention,29,https://clinicaltrials.gov/show/NCT04577235,None
3439,6254,NCT04577378,ClinicalTrials.gov,2020-04-13,2020-10-20,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,Egypt,Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19,Drug,Isotretinoin + Itraconazole vs. Isotretinoin,Isotretinoin; Itraconazole,45,https://clinicaltrials.gov/show/NCT04577378,None
3440,6255,NCT04577534,ClinicalTrials.gov,2020-09-03,2020-08-14,True,Jarmo Oksi,Recruiting,Phase 3,Interventional,Finland,COVID-19: Salvage TOcilizumab as a Rescue Measure,Drug,Tocilizumab,Tocilizumab,90,https://clinicaltrials.gov/show/NCT04577534,EUCTR2020-002039-31
3441,6256,NCT04578158,ClinicalTrials.gov,2020-10-06,2020-10-29,False,Liaquat University of Medical & Health Sciences,Recruiting,Phase 2,Interventional,Pakistan,Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19,Supplement,Quercetin Phytosome,Quercetin Phytosome,200,https://clinicaltrials.gov/show/NCT04578158,None
3442,6258,NCT04578210,ClinicalTrials.gov,2020-10-01,2020-09-04,True,Instituto de Investigación Hospital Universitario La Paz,Recruiting,Phase 1/Phase 2,Interventional,Spain,Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia,ATMP,Cells (T) vs. Cells (NK),Cells (T); Cells (NK),58,https://clinicaltrials.gov/show/NCT04578210,None
3443,6259,NCT04578236,ClinicalTrials.gov,2020-10-04,2020-11-01,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,No Country Given,"Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)",Drug,Retinoic acid + Captopril,Retinoic acid; Captopril,360,https://clinicaltrials.gov/show/NCT04578236,None
3444,6264,NCT04579549,ClinicalTrials.gov,2020-10-06,2020-09-29,True,"University of Wisconsin, Madison",Recruiting,Not Applicable,Interventional,United States,Repeat Testing for SARS-CoV-2,Clinical Presentation (Epidemiology),No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04579549,None
3445,6268,NCT04579640,ClinicalTrials.gov,2020-10-06,2020-10-27,False,Queen Mary University of London,Not Recruiting,Phase 3,Interventional,United Kingdom,Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections,Drug,Vitamin D,Vitamin D,6200,https://clinicaltrials.gov/show/NCT04579640,None
3446,6269,NCT04581018,ClinicalTrials.gov,2020-08-11,2020-08-13,False,Siew Chien NG,Recruiting,Not Applicable,Interventional,Hong Kong,An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection,Supplement,Nutritional Supplement,Nutritional Supplement,50,https://clinicaltrials.gov/show/NCT04581018,None
3447,6270,NCT04581031,ClinicalTrials.gov,2020-05-04,2020-07-11,False,The Christie NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,COntinuous Signs Monitoring In Covid-19 Patients,Other (device),Biosensors,Biosensors,60,https://clinicaltrials.gov/show/NCT04581031,None
3448,6277,NCT04581161,ClinicalTrials.gov,2020-08-19,2020-08-28,False,Hill-Rom,Recruiting,Not Applicable,Interventional,United States,Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,10,https://clinicaltrials.gov/show/NCT04581161,None
3449,6279,NCT04581200,ClinicalTrials.gov,2020-10-04,2020-12-01,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,Lift Mobile Mindfulness for COVID-19 Distress Symptoms,Other (psych),Psychological,Psychological,300,https://clinicaltrials.gov/show/NCT04581200,None
3450,6280,NCT04581291,ClinicalTrials.gov,2020-10-04,2020-01-01,True,Istanbul Gelisim University,Not Recruiting,Not Applicable,Interventional,Turkey,The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial,Other (exercise),Exercise,Exercise,30,https://clinicaltrials.gov/show/NCT04581291,None
3451,6282,NCT04581746,ClinicalTrials.gov,2020-09-22,2020-10-01,False,Tourcoing Hospital,Not Recruiting,Not Applicable,Interventional,France,Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2),Other,No Intervention,No Intervention,1800,https://clinicaltrials.gov/show/NCT04581746,None
3452,6283,NCT04581811,ClinicalTrials.gov,2020-10-07,2020-11-10,False,University of Alabama at Birmingham,Recruiting,Not Applicable,Interventional,United States,Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS),Procedure,Positioning,Positioning,52,https://clinicaltrials.gov/show/NCT04581811,None
3453,6284,NCT04581863,ClinicalTrials.gov,2020-10-07,2020-12-05,False,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Watch + COVID-19 Pulse,Other (device),Biosensors,Biosensors,850,https://clinicaltrials.gov/show/NCT04581863,None
3454,6286,NCT04581915,ClinicalTrials.gov,2020-09-16,2020-09-08,True,Fatima Mayat,Recruiting,Phase 2/Phase 3,Interventional,South Africa,PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19,Drug,Triazavirin,Triazavirin,420,https://clinicaltrials.gov/show/NCT04581915,None
3455,6288,NCT04581954,ClinicalTrials.gov,2020-10-05,2020-10-02,True,Imperial College London,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,Inflammatory Signal Inhibitors for COVID-19 (MATIS),Drug,Fostamatinib vs. Ruxolitinib,Fostamatinib; Ruxolitinib,456,https://clinicaltrials.gov/show/NCT04581954,EUCTR2020-001750-22
3456,6289,NCT04582201,ClinicalTrials.gov,2020-10-06,2020-09-21,True,"AgenTus Therapeutics, Inc.",Recruiting,Phase 1,Interventional,United States,An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.,Drug,agenT-797,agenT-797,55,https://clinicaltrials.gov/show/NCT04582201,None
3457,6290,NCT04582214,ClinicalTrials.gov,2020-10-06,2020-09-28,True,Hill-Rom,Recruiting,Not Applicable,Interventional,United States,Oscillation and Lung Expansion Therapy in Patients With COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,30,https://clinicaltrials.gov/show/NCT04582214,None
3458,6292,NCT04582318,ClinicalTrials.gov,2020-10-07,2020-11-08,False,"NGM Biopharmaceuticals, Inc",Recruiting,Phase 1/Phase 2,Interventional,Australia,"A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19",Drug,NGM621,NGM621,48,https://clinicaltrials.gov/show/NCT04582318,None
3459,6294,NCT04582344,ClinicalTrials.gov,2020-10-01,2020-09-14,True,Health Institutes of Turkey,Recruiting,Phase 3,Interventional,Turkey,Clinical Trial For SARS-CoV-2 Vaccine (COVID-19),ATMP,Vaccine,Vaccine,13000,https://clinicaltrials.gov/show/NCT04582344,None
3460,6295,NCT04583228,ClinicalTrials.gov,2020-09-25,2020-11-30,False,Hengenix Biotech Inc,Not Recruiting,Phase 1,Interventional,No Country Given,"Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects",Drug,ACE enzyme,ACE enzyme,40,https://clinicaltrials.gov/show/NCT04583228,None
3461,6300,NCT04583410,ClinicalTrials.gov,2020-09-28,2020-10-22,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Efficacy of Nicotine in Preventing COVID-19 Infection in Caregivers,Drug,Nicotine,Nicotine,1633,https://clinicaltrials.gov/show/NCT04583410,None
3462,6301,NCT04583449,ClinicalTrials.gov,2020-10-02,2020-08-19,True,University of East London,Recruiting,Not Applicable,Interventional,United Kingdom,Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic,Other,Other,Other,250,https://clinicaltrials.gov/show/NCT04583449,None
3463,6307,NCT04584437,ClinicalTrials.gov,2020-10-09,2020-10-30,False,GAAD Medical Research Institute Inc.,Not Recruiting,Not Applicable,Interventional,Canada,Treatment of Covid-19 Using Infrared and/or Vitamin C,Other,Infrared Energy + Vitamin C,Infrared Energy; Vitamin C,400,https://clinicaltrials.gov/show/NCT04584437,None
3464,6309,NCT04584541,ClinicalTrials.gov,2020-06-10,2020-06-11,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04584541,None
3465,6310,NCT04584580,ClinicalTrials.gov,2020-10-06,2020-08-01,True,Ain Shams University,Recruiting,Phase 4,Interventional,Egypt,D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia,Drug,Heparin,Heparin,50,https://clinicaltrials.gov/show/NCT04584580,None
3466,6311,NCT04584593,ClinicalTrials.gov,2020-10-12,2020-10-02,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,Pilot Study to Detect SARS-CoV-2 Virus in Sperm,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04584593,None
3467,6314,NCT04584684,ClinicalTrials.gov,2020-10-09,2020-12-01,False,"University of North Carolina, Chapel Hill",Not Recruiting,Phase 2,Interventional,United States,Mouth Rinses for Inactivation of COVID-19,Drug,Hydrogen Peroxide vs. Chlorhexidine Gluconate vs. Ethanol vs. Povidone iodide vs. Cetylpyridinium Chloride,Hydrogen Peroxide; Chlorhexidine Gluconate; Ethanol; Povidone iodide; Cetylpyridinium Chloride,480,https://clinicaltrials.gov/show/NCT04584684,None
3468,6315,NCT04584697,ClinicalTrials.gov,2020-10-07,2020-12-01,False,"Sorrento Therapeutics, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,"Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMGâ„¢) in Outpatients With COVID-19",Drug,STI-2020,STI-2020,50,https://clinicaltrials.gov/show/NCT04584697,None
3469,6316,NCT04584710,ClinicalTrials.gov,2020-10-08,2020-10-13,False,Restorbio Inc.,Recruiting,Phase 2,Interventional,United States,A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults,Drug,RTB101,RTB101,60,https://clinicaltrials.gov/show/NCT04584710,None
3470,6320,NCT04586153,ClinicalTrials.gov,2020-10-12,2020-12-30,False,Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Study to Assess the Effect of Meplazumab on COVID-19,Drug,Meplazumab,Meplazumab,456,https://clinicaltrials.gov/show/NCT04586153,None
3471,6322,NCT04587219,ClinicalTrials.gov,2020-10-13,2020-10-22,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Not Recruiting,Phase 2,Interventional,Russian Federation,"The Study of ""Gam-COVID-Vac"" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older",ATMP,Vaccine,Vaccine,110,https://clinicaltrials.gov/show/NCT04587219,None
3472,6327,NCT04587414,ClinicalTrials.gov,2020-09-08,2019-03-06,True,UKK Institute,Not Recruiting,Not Applicable,Interventional,Finland,eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19,Other (software),eHealth,eHealth,122,https://clinicaltrials.gov/show/NCT04587414,None
3473,6328,NCT04587921,ClinicalTrials.gov,2020-08-18,2020-06-22,True,University of São Paulo General Hospital,Recruiting,Not Applicable,Interventional,Brazil,Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19,Other (device),Biosensors,Biosensors,90,https://clinicaltrials.gov/show/NCT04587921,None
3474,6329,NCT04588415,ClinicalTrials.gov,2020-10-08,2020-11-01,False,Ottawa Hospital Research Institute,Not Recruiting,Not Applicable,Interventional,No Country Given,Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04588415,None
3475,6330,NCT04588441,ClinicalTrials.gov,2020-10-13,2020-12-01,False,University of Florida,Not Recruiting,Phase 2,Interventional,No Country Given,The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19,Drug,Adenosine,Adenosine,30,https://clinicaltrials.gov/show/NCT04588441,None
3476,6331,NCT04588480,ClinicalTrials.gov,2020-10-14,2020-10-21,True,Biontech SE,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults",ATMP,Vaccine,Vaccine,160,https://clinicaltrials.gov/show/NCT04588480,JPRN-jRCT2071200045
3477,6333,NCT04589104,ClinicalTrials.gov,2020-10-12,2020-05-26,True,Duke University,Not Recruiting,Not Applicable,Interventional,United States,Expressive Writing for COVID-19 Resilience,Other (psych),Psychological,Psychological,63,https://clinicaltrials.gov/show/NCT04589104,None
3478,6334,NCT04589117,ClinicalTrials.gov,2020-10-12,2020-05-27,True,Duke University,Not Recruiting,Not Applicable,Interventional,United States,Expressive Writing for COVID-19 Resilience for Parents,Other (psych),Psychological,Psychological,11,https://clinicaltrials.gov/show/NCT04589117,None
3479,6335,NCT04589936,ClinicalTrials.gov,2020-10-06,2020-09-03,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care,Procedure,Positioning,Positioning,56,https://clinicaltrials.gov/show/NCT04589936,None
3480,6336,NCT04589949,ClinicalTrials.gov,2020-10-12,2020-10-12,False,Erasmus Medical Center,Recruiting,Phase 3,Interventional,Netherlands,Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study),ATMP,Plasma,Plasma,690,https://clinicaltrials.gov/show/NCT04589949,None
3481,6337,NCT04590053,ClinicalTrials.gov,2020-10-15,2020-10-20,False,Hadassah Medical Organization,Recruiting,Phase 2,Interventional,Israel,"Allocetra-OTS in COVID-19, Phase II",Drug,Allocetra-OTS,Allocetra-OTS,24,https://clinicaltrials.gov/show/NCT04590053,None
3482,6339,NCT04590209,ClinicalTrials.gov,2020-10-05,2020-10-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome,Clinical Presentation,No Intervention,No Intervention,25,https://clinicaltrials.gov/show/NCT04590209,None
3483,6341,NCT04590261,ClinicalTrials.gov,2020-10-15,2020-11-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,Myeloid Cells in Patients With Covid-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04590261,None
3484,6342,NCT04590274,ClinicalTrials.gov,2020-10-07,2020-11-01,False,International Brain Research Foundation,Not Recruiting,Phase 1,Interventional,No Country Given,Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Drug,Hydroxychloroquine + Azithromycin + Zinc + Vitamin C + Vitamin D + N-acetyl cysteine + Elderberry + Quercetin,Hydroxychloroquine; Azithromycin; Zinc; Vitamin C; Vitamin D; N-acetyl cysteine; Elderberry; Quercetin,5000,https://clinicaltrials.gov/show/NCT04590274,None
3485,6344,NCT04590365,ClinicalTrials.gov,2020-05-28,2020-12-20,False,Swansea University,Not Recruiting,Not Applicable,Interventional,No Country Given,Iota-carrageenan Nasal Spray COVID-19 Prophylaxis for Healthcare Professionals,Drug (Chemoprophylaxis),Carrageenan,Carrageenan,480,https://clinicaltrials.gov/show/NCT04590365,None
3486,6346,NCT04590430,ClinicalTrials.gov,2020-10-08,2020-10-01,True,HiFiBiO Therapeutics,Recruiting,Phase 1,Interventional,United States,"Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults",Drug,HFB30132A,HFB30132A,24,https://clinicaltrials.gov/show/NCT04590430,None
3487,6347,NCT04590469,ClinicalTrials.gov,2020-10-13,2020-11-20,False,University of Exeter,Not Recruiting,Not Applicable,Interventional,No Country Given,Improving Wellbeing and Health for Care Home Residents During COVID-19,Other,Other,Other,2880,https://clinicaltrials.gov/show/NCT04590469,None
3488,6348,NCT04590586,ClinicalTrials.gov,2020-10-14,2020-11-30,False,Amgen,Not Recruiting,Phase 3,Interventional,No Country Given,Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients,Drug,Apremilast,Apremilast,700,https://clinicaltrials.gov/show/NCT04590586,None
3489,6349,NCT04591015,ClinicalTrials.gov,2020-10-05,2020-12-01,False,Scripps Whittier Diabetes Institute,Not Recruiting,Phase 3,Interventional,No Country Given,Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19,Other,Other,Other,172,https://clinicaltrials.gov/show/NCT04591015,None
3490,6350,NCT04591158,ClinicalTrials.gov,2020-09-15,2020-09-15,False,Bridge to Health Medical and Dental USA,Recruiting,Not Applicable,Interventional,Canada,COVID-19 and Lung Ultrasound Utility,Telehealth,Telehealth,Telehealth,100,https://clinicaltrials.gov/show/NCT04591158,None
3491,6351,NCT04591184,ClinicalTrials.gov,2020-09-23,2020-12-01,False,Entos Pharmaceuticals Inc.,Not Recruiting,Phase 1,Interventional,No Country Given,A Clinical Trial of a Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults,ATMP,Vaccine,Vaccine,72,https://clinicaltrials.gov/show/NCT04591184,None
3492,6352,NCT04591210,ClinicalTrials.gov,2020-10-06,2020-10-30,False,Ottawa Heart Institute Research Corporation,Not Recruiting,Phase 3,Interventional,Canada,The COVID-RASi Trial (COVID-19),Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,1155,https://clinicaltrials.gov/show/NCT04591210,None
3493,6353,NCT04591600,ClinicalTrials.gov,2020-10-15,2020-07-01,True,Alkarkh Health Directorate-Baghdad,Not Recruiting,Phase 1/Phase 2,Interventional,Iraq,Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients,Drug,Ivermectin + Doxycyline,Ivermectin; Doxycyline,140,https://clinicaltrials.gov/show/NCT04591600,None
3494,6354,NCT04591613,ClinicalTrials.gov,2020-10-10,2020-10-01,True,Tourcoing Hospital,Not Recruiting,Not Applicable,Interventional,"French Guiana, France",Late Clinical Events Associated With COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04591613,None
3495,6356,NCT04591717,ClinicalTrials.gov,2020-10-13,2020-10-19,False,"ImmunityBio, Inc.",Recruiting,Phase 1,Interventional,United States,Study of the Safety of Prophylactic Vaccination With 2nd Generation E1/E2B/E3-Deleted Adenoviral-COVID-19 in Normal Healthy Volunteers,ATMP,Vaccine,Vaccine,35,https://clinicaltrials.gov/show/NCT04591717,None
3496,6359,NCT04592354,ClinicalTrials.gov,2020-10-15,2020-10-15,False,Terra Biological LLC,Recruiting,Not Applicable,Interventional,United States,Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors,Supplement,Oxaloacetate,Oxaloacetate,40,https://clinicaltrials.gov/show/NCT04592354,None
3497,6361,NCT04592705,ClinicalTrials.gov,2020-10-07,2020-09-11,True,Larkin Community Hospital,Recruiting,Phase 1,Interventional,United States,Measurement of IL-6 and Secondary Inflammatory Markers Before and After Therapeutic Plasma Exchange (TPE) in Hospitalized Patients,Other (device),Plasma exchange,Plasma exchange,10,https://clinicaltrials.gov/show/NCT04592705,None
3498,6362,NCT04592835,ClinicalTrials.gov,2020-10-07,2020-10-19,False,Daewoong Pharmaceutical Co.,Not Recruiting,Phase 1,Interventional,No Country Given,"To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003",Drug,DWRX2003,DWRX2003,24,https://clinicaltrials.gov/show/NCT04592835,None
3499,6363,NCT04593069,ClinicalTrials.gov,2020-10-12,2020-10-07,True,East Limburg Hospital,Recruiting,Not Applicable,Interventional,Belgium,The COGCOV Study in ICU Patients,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04593069,None
3500,6364,NCT04593433,ClinicalTrials.gov,2020-10-13,2021-01-04,False,Jewish General Hospital,Not Recruiting,Not Applicable,Interventional,Canada,A 3-month Cycle of Virtual Guided Tours to Promote Health in Older Community Members in a Context of COVID-19 Induced Social Isolation: a Pilot Study,Other,Other,Other,40,https://clinicaltrials.gov/show/NCT04593433,None
3501,6365,NCT04593641,ClinicalTrials.gov,2020-10-05,2020-09-04,True,Celltrion,Not Recruiting,Phase 1,Interventional,South Korea,"This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)",Drug,CT-P59,CT-P59,18,https://clinicaltrials.gov/show/NCT04593641,None
3502,6367,NCT04593940,ClinicalTrials.gov,2020-09-23,2020-10-15,False,Daniel Benjamin,Recruiting,Phase 3,Interventional,United States,Immune Modulators for Treating COVID-19,Drug,Infliximab + Remdesivir vs. Abatacept + Remdesivir vs.  Remdesivir,Infliximab; Remdesivir; Abatacept,2160,https://clinicaltrials.gov/show/NCT04593940,None
3503,6368,NCT04594278,ClinicalTrials.gov,2020-10-18,2020-11-01,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Burnout Study,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04594278,None
3504,6370,NCT04594330,ClinicalTrials.gov,2020-10-05,2020-06-01,True,Gadjah Mada University,Recruiting,Phase 2,Interventional,Indonesia,Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients,Drug,Coconut oil,Coconut oil,60,https://clinicaltrials.gov/show/NCT04594330,None
3505,6371,NCT04594343,ClinicalTrials.gov,2020-10-18,2020-11-20,False,ETICA,Recruiting,Phase 2,Interventional,Brazil,Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19,Drug,Disulfiram,Disulfiram,200,https://clinicaltrials.gov/show/NCT04594343,None
3506,6374,NCT04594460,ClinicalTrials.gov,2020-10-19,2020-10-31,False,Guangzhou Institute of Respiratory Disease,Not Recruiting,Not Applicable,Interventional,China,Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19),Drug,Hydrogen + Oxygen,Hydrogen; Oxygen,198,https://clinicaltrials.gov/show/NCT04594460,None
3507,6375,NCT04594525,ClinicalTrials.gov,2020-10-12,2020-11-01,False,Hamad Medical Corporation,Not Recruiting,Not Applicable,Interventional,No Country Given,Maternal Telemental Health Interventions in Response to Covid-19*,Other (psych),Psychological,Psychological,58,https://clinicaltrials.gov/show/NCT04594525,None
3508,6376,NCT04594668,ClinicalTrials.gov,2020-10-07,2020-04-24,True,Aarhus University,Recruiting,Phase 2,Interventional,Denmark,Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency,Drug,Senicapoc,Senicapoc,46,https://clinicaltrials.gov/show/NCT04594668,None
3509,6377,NCT04595084,ClinicalTrials.gov,2020-10-19,2020-11-01,False,Cambridge Health Alliance,Not Recruiting,Not Applicable,Interventional,No Country Given,Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use,Other (psych),Psychological,Psychological,240,https://clinicaltrials.gov/show/NCT04595084,None
3510,6378,NCT04595097,ClinicalTrials.gov,2020-10-19,2020-11-01,False,Escola Superior de Ciencias da Saude,Not Recruiting,Not Applicable,Interventional,Brazil,Inspiratory Muscle Training in COVID-19 Patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,120,https://clinicaltrials.gov/show/NCT04595097,None
3511,6381,NCT04595136,ClinicalTrials.gov,2020-10-15,2020-11-02,False,United Medical Specialties,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient,Drug,COVID19-0001-USR,COVID19-0001-USR,60,https://clinicaltrials.gov/show/NCT04595136,None
3512,6384,NCT04595695,ClinicalTrials.gov,2020-10-14,2020-09-03,True,"University of North Carolina, Chapel Hill",Recruiting,Not Applicable,Interventional,United States,The Effect of Clear Masks in Improving Patient Relationships,Other (device),Masks,Masks,100,https://clinicaltrials.gov/show/NCT04595695,None
3513,6385,NCT04595903,ClinicalTrials.gov,2020-10-08,2020-10-01,True,Aethlon Medical Inc.,Not Recruiting,Not Applicable,Interventional,United States,Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With HemopurifierÂ® Device,Other (device),Blood filter,Blood filter,40,https://clinicaltrials.gov/show/NCT04595903,None
3514,6386,NCT04596085,ClinicalTrials.gov,2020-10-19,2020-09-16,True,"The Herb, Inc",Recruiting,Not Applicable,Interventional,India,"Study to Evaluate Efficacy and Safety of ""VIRACIDE"" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)",Drug,Viracide,Viracide,124,https://clinicaltrials.gov/show/NCT04596085,None
3515,6389,NCT04596657,ClinicalTrials.gov,2020-10-15,2020-10-27,False,The Cooper Health System,Recruiting,Not Applicable,Interventional,United States,Vitamin D3 Supplementation to Prevent Respiratory Tract Infections,Drug,Vitamin D,Vitamin D,2099,https://clinicaltrials.gov/show/NCT04596657,None
3516,6390,NCT04596839,ClinicalTrials.gov,2020-10-20,2020-09-04,True,Dr. Alimur Reza,Recruiting,Not Applicable,Interventional,Bangladesh,Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19),Drug,Remdesivir,Remdesivir,60,https://clinicaltrials.gov/show/NCT04596839,None
3517,6392,NCT04597034,ClinicalTrials.gov,2020-10-03,2020-10-02,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Not Applicable,Interventional,Mexico,Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19,Other (device),Membrane,Membrane,35,https://clinicaltrials.gov/show/NCT04597034,None
3518,6393,NCT04597047,ClinicalTrials.gov,2020-10-19,2020-08-20,True,LumiraDx UK Limited,Recruiting,Not Applicable,Interventional,United States,Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04597047,None
3519,6394,NCT04597216,ClinicalTrials.gov,2020-10-13,2020-10-15,False,"University Hospital, Grenoble",Recruiting,Not Applicable,Interventional,France,Exploration of Feasability of Blood and Saliva Proteomic Analysis Through Harvesting by Silica Matrix (NanoDx-CoV-19),Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04597216,None
3520,6396,NCT04597736,ClinicalTrials.gov,2020-10-02,2020-11-01,False,"University Hospital, Clermont-Ferrand",Not Recruiting,Not Applicable,Interventional,France,Relationship Between Biological Profiles and Clinical Evolutions Within the Same Cluster COVID-19 (COVIDCOLLECT),Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04597736,None
3521,6397,NCT04597775,ClinicalTrials.gov,2020-10-18,2020-10-27,False,"Regional Center for Disease Control and Prevention, Jordan",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,93,https://clinicaltrials.gov/show/NCT04597775,None
3522,6402,NCT04598581,ClinicalTrials.gov,2020-10-20,2020-11-02,False,"University Hospital, Basel",Recruiting,Not Applicable,Interventional,Switzerland,"Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19",Other,Radiation,Radiation,22,https://clinicaltrials.gov/show/NCT04598581,None
3523,6403,NCT04598594,ClinicalTrials.gov,2020-10-15,2020-11-01,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients,Drug,Nicotine,Nicotine,220,https://clinicaltrials.gov/show/NCT04598594,None
3524,6405,NCT04598763,ClinicalTrials.gov,2020-10-15,2020-07-01,True,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,https://clinicaltrials.gov/show/NCT04598763,None
3525,6406,NCT04599959,ClinicalTrials.gov,2020-10-22,2020-10-26,False,Boehringer Ingelheim,Recruiting,Not Applicable,Interventional,Mexico,COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With SalivetteÂ® Cortisol for Viral RNA Sampling for RT-qPCR,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,80,https://clinicaltrials.gov/show/NCT04599959,None
3526,6408,NCT04600141,ClinicalTrials.gov,2020-10-22,2020-10-20,True,University of São Paulo,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection: a Randomized Clinical Trial,Drug,Heparin + Tocilizumab,Heparin; Tocilizumab,308,https://clinicaltrials.gov/show/NCT04600141,None
3527,6409,NCT04600440,ClinicalTrials.gov,2020-10-20,2020-04-25,True,Skåne University Hospital,Recruiting,Not Applicable,Interventional,Sweden,Convalescent Plasma in the Treatment of Covid-19,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04600440,None
3528,6410,NCT04600713,ClinicalTrials.gov,2020-10-09,2021-01-01,False,Vastra Gotaland Region,Not Recruiting,Not Applicable,Interventional,No Country Given,Physiotherapist-led Exercise Within Cardiac Rehabilitation and Paroxysmal Atrial Fibrillation and COVID-19.,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,180,https://clinicaltrials.gov/show/NCT04600713,None
3529,6411,NCT04600895,ClinicalTrials.gov,2020-09-15,2020-11-01,False,Appili Therapeutics Inc.,Not Recruiting,Phase 3,Interventional,No Country Given,The Prevent Severe COVID-19 (PRESECO) Study,Drug,Favipiravir,Favipiravir,826,https://clinicaltrials.gov/show/NCT04600895,None
3530,6412,NCT04600999,ClinicalTrials.gov,2020-10-08,2020-10-07,True,University of Pecs,Recruiting,Phase 3,Interventional,Hungary,Clinical Trial of Favipiravir Treatment of Patients With COVID-19,Drug,Favipiravir,Favipiravir,150,https://clinicaltrials.gov/show/NCT04600999,None
3531,6416,NCT04602000,ClinicalTrials.gov,2020-10-18,2020-09-25,True,Celltrion,Recruiting,Phase 2/Phase 3,Interventional,South Korea,To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19,Drug,CT-P59,CT-P59,1020,https://clinicaltrials.gov/show/NCT04602000,None
3532,6418,NCT04602286,ClinicalTrials.gov,2020-10-19,2020-10-28,False,University of Queensland,Recruiting,Not Applicable,Interventional,Australia,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample),Other (psych),Psychological,Psychological,292,https://clinicaltrials.gov/show/NCT04602286,None
3533,6419,NCT04602312,ClinicalTrials.gov,2020-10-19,2020-10-28,False,University of Queensland,Recruiting,Not Applicable,Interventional,Australia,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample),Other (psych),Psychological,Psychological,624,https://clinicaltrials.gov/show/NCT04602312,None
3534,6420,NCT04602442,ClinicalTrials.gov,2020-10-21,2020-10-01,True,Olga Tyumina,Recruiting,Phase 2,Interventional,Russian Federation,Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia,Drug,Exosome,Exosome,90,https://clinicaltrials.gov/show/NCT04602442,None
3535,6423,NCT04602832,ClinicalTrials.gov,2020-10-23,2020-10-14,True,University of British Columbia,Recruiting,Not Applicable,Interventional,Canada,Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19,Other (psych),No Intervention,No Intervention,350,https://clinicaltrials.gov/show/NCT04602832,None
3536,6424,NCT04602871,ClinicalTrials.gov,2020-10-21,2020-07-03,True,Scentech Medical Technologies Ltd,Recruiting,Not Applicable,Interventional,Israel,Early Detection of COVID-19 Using Breath Analysis - Feasibility Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,108,https://clinicaltrials.gov/show/NCT04602871,None
3537,6425,NCT04602884,ClinicalTrials.gov,2020-10-21,2020-09-22,True,Scentech Medical Technologies Ltd,Not Recruiting,Not Applicable,Interventional,Israel,Early Detection of COVID-19 Using Breath Analysis,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04602884,None
3538,6426,NCT04602949,ClinicalTrials.gov,2020-10-21,2020-11-12,False,Scentech Medical Technologies Ltd,Not Recruiting,Not Applicable,Interventional,Israel,Detection of COVID-19 Using Breath Analysis - Validation Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,4000,https://clinicaltrials.gov/show/NCT04602949,None
3539,6427,NCT04603079,ClinicalTrials.gov,2020-10-19,2020-11-01,False,Forman Christian College,Not Recruiting,Not Applicable,Interventional,No Country Given,Nurse Leadership for Hospital Infection Control,Health System,Other,Other,200,https://clinicaltrials.gov/show/NCT04603079,None
3540,6432,NCT04603729,ClinicalTrials.gov,2020-10-21,2020-05-30,True,Fatima Memorial Hospital,Not Recruiting,Phase 3,Interventional,Pakistan,Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease,Drug,Corticosteroids,Dexamethasone; Methylprednisolone,100,https://clinicaltrials.gov/show/NCT04603729,None
3541,6433,NCT04603742,ClinicalTrials.gov,2020-10-21,2020-11-01,False,Weill Medical College of Cornell University,Not Recruiting,Phase 2,Interventional,United States,"Anakinra, COVID-19, Cytokine Storm",Drug,Anakinra,Anakinra,100,https://clinicaltrials.gov/show/NCT04603742,None
3542,6435,NCT04603794,ClinicalTrials.gov,2020-10-21,2020-10-01,True,Ohio State University,Recruiting,Phase 4,Interventional,United States,Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19,Drug,Povidone iodine + Chlorhexidine Gluconate + Hydrogen Peroxide,Povidone iodine; Chlorhexidine Gluconate; Hydrogen Peroxide,60,https://clinicaltrials.gov/show/NCT04603794,None
3543,6436,NCT04603924,ClinicalTrials.gov,2020-10-20,2020-10-07,True,ANA Therapeutics,Recruiting,Phase 2/Phase 3,Interventional,United States,Study of Niclosamide in Moderate Hospitalized Coronavirus-19 (COVID-19) Patients,Drug,Niclosamide,Niclosamide,436,https://clinicaltrials.gov/show/NCT04603924,None
3544,6437,NCT04603963,ClinicalTrials.gov,2020-10-25,2020-06-01,True,Elaine Cristina Pereira,Not Recruiting,Not Applicable,Interventional,Brazil,Inspiratory Muscle Training in Patients With COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,55,https://clinicaltrials.gov/show/NCT04603963,None
3545,6440,NCT04604223,ClinicalTrials.gov,2020-10-26,2020-11-15,False,Dasman Diabetes Institute,Not Recruiting,Phase 4,Interventional,No Country Given,Effect of Pioglitazone on T2DM Patients With COVID-19,Drug,Pioglitazone,Pioglitazone,1506,https://clinicaltrials.gov/show/NCT04604223,None
3546,6442,NCT04604327,ClinicalTrials.gov,2020-10-23,2020-10-26,False,Clínica Universidad de Navarra,Recruiting,Phase 3,Interventional,Spain,Comparison of Two Different Doses of Bemiparin in COVID-19,Drug,Bemiparin,Bemiparin,164,https://clinicaltrials.gov/show/NCT04604327,None
3547,6443,NCT04604678,ClinicalTrials.gov,2020-10-26,2020-11-01,False,AgelessRx,Not Recruiting,Phase 2,Interventional,United States,Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19,Drug,Metformin + Naltrexone,Metformin; Naltrexone,80,https://clinicaltrials.gov/show/NCT04604678,None
3548,6444,NCT04604704,ClinicalTrials.gov,2020-10-26,2020-11-01,False,AgelessRx,Not Recruiting,Phase 2,Interventional,United States,Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome,Drug,Naltrexone + NAD+,Naltrexone; NAD+,60,https://clinicaltrials.gov/show/NCT04604704,None
3549,6445,NCT04604743,ClinicalTrials.gov,2020-10-25,2021-01-01,False,University of Alabama at Birmingham,Not Recruiting,Not Applicable,Interventional,United States,Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama,Other,Other,Other,4,https://clinicaltrials.gov/show/NCT04604743,None
3550,6447,NCT04604977,ClinicalTrials.gov,2020-10-20,2020-09-15,True,Fondazione IRCCS Istituto Neurologico Carlo Besta,Recruiting,Not Applicable,Interventional,Italy,Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine,Other (psych),Psychological,Psychological,25,https://clinicaltrials.gov/show/NCT04604977,None
3551,6450,NCT04605887,ClinicalTrials.gov,2020-10-27,2020-11-01,False,Rambam Health Care Campus,Not Recruiting,Phase 2,Interventional,Israel,Angiotensin 1-7 as a Therapy in the Treatment of COVID-19,Drug,Angiotensin 1-7,Angiotensin 1-7,120,https://clinicaltrials.gov/show/NCT04605887,None
3552,6451,NCT04605926,ClinicalTrials.gov,2020-10-21,2020-11-01,False,Equillium,Not Recruiting,Phase 3,Interventional,Colombia,A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19,Drug,Itolizumab,Itolizumab,800,https://clinicaltrials.gov/show/NCT04605926,None
3553,6453,NCT04606069,ClinicalTrials.gov,2020-10-26,2020-11-01,False,"University of Maryland, Baltimore",Not Recruiting,Phase 1/Phase 2,Interventional,United States,Treat COVID-19 Patients With Regadenoson,Drug,Regadenoson,Regadenoson,40,https://clinicaltrials.gov/show/NCT04606069,None
3554,6455,NCT04606563,ClinicalTrials.gov,2020-10-27,2020-10-09,True,University of British Columbia,Recruiting,Phase 3,Interventional,"Belgium, Japan, Canada, France, United States, Spain",Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?,Drug,Losartan,Losartan,1372,https://clinicaltrials.gov/show/NCT04606563,None
3555,6457,NCT04607915,ClinicalTrials.gov,2020-07-30,2020-11-30,False,Centre for Addiction and Mental Health,Not Recruiting,Not Applicable,Interventional,No Country Given,Technology-enabled Collaborative Care for Diabetes Management During COVID-19,Telehealth,Telehealth,Telehealth,30,https://clinicaltrials.gov/show/NCT04607915,None
3556,6458,NCT04607928,ClinicalTrials.gov,2020-10-28,2020-08-01,True,Institut d'Investigacio Biomedica de Bellvitge,Recruiting,Phase 2,Interventional,Spain,Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19,Drug,Pirfenidone,Pirfenidone,148,https://clinicaltrials.gov/show/NCT04607928,None
3557,6460,NCT04608214,ClinicalTrials.gov,2020-10-12,2020-11-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19),Drug,Alisporivir,Alisporivir,100,https://clinicaltrials.gov/show/NCT04608214,EUCTR2020-002295-13
3558,6461,NCT04608305,ClinicalTrials.gov,2020-10-26,2020-10-28,False,Israel Institute for Biological Research (IIBR),Recruiting,Phase 1/Phase 2,Interventional,Israel,"Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine",ATMP,Vaccine,Vaccine,1040,https://clinicaltrials.gov/show/NCT04608305,None
3559,6464,NCT04609371,ClinicalTrials.gov,2020-10-19,2020-10-21,False,"St. Mary's Research Center, Canada",Recruiting,Not Applicable,Interventional,Canada,PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics,Other (psych),Psychological,Psychological,176,https://clinicaltrials.gov/show/NCT04609371,None
3560,6465,NCT04609423,ClinicalTrials.gov,2020-10-22,2020-11-10,False,Oslo University Hospital,Recruiting,Phase 4,Interventional,Norway,Cod Liver Oil for Covid-19 Prevention Study,Supplement,Cod liver oil,Cod liver oil,80000,https://clinicaltrials.gov/show/NCT04609423,None
3561,6466,NCT04609462,ClinicalTrials.gov,2020-09-24,2020-08-11,True,Fundacion Clinica Valle del Lili,Recruiting,Not Applicable,Interventional,Colombia,High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.,Other (device),Nasal cannula,Nasal cannula,196,https://clinicaltrials.gov/show/NCT04609462,None
3562,6469,NCT04609722,ClinicalTrials.gov,2020-10-26,2020-07-01,True,Adiyaman University Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,60,https://clinicaltrials.gov/show/NCT04609722,None
3563,6472,NCT04609865,ClinicalTrials.gov,2020-10-23,2020-11-04,False,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,No Country Given,Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia,Drug,Lidocaine,Lidocaine,100,https://clinicaltrials.gov/show/NCT04609865,None
3564,6473,NCT04610138,ClinicalTrials.gov,2020-10-28,2020-12-01,False,Clene Nanomedicine,Not Recruiting,Phase 2,Interventional,No Country Given,Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants,Drug,Zinc + Silver,Zinc; Silver,238,https://clinicaltrials.gov/show/NCT04610138,None
3565,6474,NCT04610489,ClinicalTrials.gov,2020-10-27,2020-11-01,False,Carilion Clinic,Not Recruiting,Not Applicable,Interventional,No Country Given,Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,800,https://clinicaltrials.gov/show/NCT04610489,None
3566,6475,NCT04610502,ClinicalTrials.gov,2020-09-15,2020-09-06,True,Caja Costarricense de Seguro Social,Not Recruiting,Phase 2,Interventional,Costa Rica,Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients,ATMP,Immunoglobulin,Immunoglobulin,26,https://clinicaltrials.gov/show/NCT04610502,None
3567,6477,NCT04610541,ClinicalTrials.gov,2020-10-11,2020-10-12,False,University of Pecs,Not Recruiting,Phase 3,Interventional,Hungary,REMdesivir-HU Clinical Study and Severe Covid-19 Patients,Drug,Remdesivir,Remdesivir,2000,https://clinicaltrials.gov/show/NCT04610541,None
3568,6479,NCT04610567,ClinicalTrials.gov,2020-10-24,2020-10-27,False,University of São Paulo General Hospital,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19),Drug,Methotrexate,Methotrexate,100,https://clinicaltrials.gov/show/NCT04610567,None
3569,6480,NCT04610801,ClinicalTrials.gov,2020-10-26,2020-08-08,True,Larkin Community Hospital,Recruiting,Phase 3,Interventional,United States,Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2,Drug,Xylitol,Xylitol,200,https://clinicaltrials.gov/show/NCT04610801,None
3570,6482,NCT04611256,ClinicalTrials.gov,2020-10-29,2020-08-01,True,Hospital Regional Lic. Adolfo López Mateos,Recruiting,Phase 1,Interventional,Mexico,Mesenchymal Stem Cells in Patients Diagnosed With COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04611256,None
3571,6484,NCT04611399,ClinicalTrials.gov,2020-10-08,2020-11-01,False,Fondazione IRCCS Istituto Neurologico Carlo Besta,Not Recruiting,Not Applicable,Interventional,Italy,MIND-VR: Virtual Reality for COVID-19 Operators' Psychological Support,Other (psych),Psychological,Psychological,90,https://clinicaltrials.gov/show/NCT04611399,None
3572,6485,NCT04611425,ClinicalTrials.gov,2020-10-07,2020-11-01,False,Nantes University Hospital,Not Recruiting,Phase 2,Interventional,France,"REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19, the REHSCU Study",Drug,Remimazolam,Remimazolam,30,https://clinicaltrials.gov/show/NCT04611425,None
3573,6486,NCT04611802,ClinicalTrials.gov,2020-10-30,2020-11-01,False,Novavax,Not Recruiting,Phase 3,Interventional,"Puerto Rico, Mexico, United States","A Study Looking at the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults at Risk for SARS-CoV-2",ATMP,Vaccine,Vaccine,30000,https://clinicaltrials.gov/show/NCT04611802,None
3574,6488,NCT04612972,ClinicalTrials.gov,2020-08-18,2020-09-10,False,Universidad Peruana Cayetano Heredia,Recruiting,Phase 3,Interventional,Peru,"Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Adult Population In Peru",ATMP,Vaccine,Vaccine,6000,https://clinicaltrials.gov/show/NCT04612972,None
3575,6489,NCT04613050,ClinicalTrials.gov,2020-10-30,2020-07-02,True,Cairo University,Recruiting,Not Applicable,Interventional,Egypt,Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,https://clinicaltrials.gov/show/NCT04613050,None
3576,6490,NCT04613271,ClinicalTrials.gov,2020-10-25,2020-10-15,True,Ina-Respond,Recruiting,Phase 3,Interventional,Indonesia,Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia,Drug,Favipiravir vs. Favipiravir + Azithromycin,Favipiravir; Azithromycin,210,https://clinicaltrials.gov/show/NCT04613271,None
3577,6491,NCT04613297,ClinicalTrials.gov,2020-11-02,2020-10-19,True,Hôpital Foch,Recruiting,Not Applicable,Interventional,France,HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04613297,None
3578,6492,NCT04613310,ClinicalTrials.gov,2020-10-26,2020-09-25,True,University of Lausanne,Recruiting,Not Applicable,Interventional,Switzerland,PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1250,https://clinicaltrials.gov/show/NCT04613310,None
3579,6493,NCT04613739,ClinicalTrials.gov,2020-10-29,2020-11-02,False,Harvard Pilgrim Health Care,Not Recruiting,Not Applicable,Interventional,No Country Given,Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19,Other,No Intervention,No Intervention,430,https://clinicaltrials.gov/show/NCT04613739,None
3580,6495,NCT04613986,ClinicalTrials.gov,2020-11-02,2020-12-01,False,University of Zurich,Not Recruiting,Not Applicable,Interventional,No Country Given,Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04613986,None
3581,6496,NCT04614012,ClinicalTrials.gov,2020-11-02,2020-07-02,True,Anna Falanga,Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Patients With COVID-19,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04614012,None
3582,6497,NCT04614025,ClinicalTrials.gov,2020-11-02,2020-11-01,True,Pluristem Ltd.,Recruiting,Phase 2,Interventional,"Israel, Germany",Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19,ATMP,Cells (Stromal),Cells (Stromal),40,https://clinicaltrials.gov/show/NCT04614025,None
3583,6498,NCT04614883,ClinicalTrials.gov,2020-11-02,2020-10-21,True,Hôpital Foch,Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04614883,None
3584,6501,NCT04615052,ClinicalTrials.gov,2020-10-29,2020-09-26,True,University of São Paulo,Recruiting,Not Applicable,Interventional,Brazil,Home-based Exercise in COVID-19 Survivors,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,60,https://clinicaltrials.gov/show/NCT04615052,None
3585,6505,NCT04615416,ClinicalTrials.gov,2020-10-26,2020-05-01,True,Columbia University,Recruiting,Not Applicable,Interventional,United States,Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04615416,None
3586,6506,NCT04615429,ClinicalTrials.gov,2020-10-25,2020-09-15,True,Cristina Avendaño-Solá,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04615429,EUCTR2020-002193-27
3587,6509,NCT04615741,ClinicalTrials.gov,2020-10-29,2020-11-01,False,University of Lethbridge,Recruiting,Not Applicable,Interventional,Canada,Finding Wellness in the Pandemic,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04615741,None
3588,6510,NCT04615871,ClinicalTrials.gov,2020-10-29,2020-11-30,False,Vladimir Dzavik,Not Recruiting,Phase 2,Interventional,"Brazil, United Kingdom, Mexico, Canada",Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19,Drug,Semaglutide,Semaglutide,400,https://clinicaltrials.gov/show/NCT04615871,None
3589,6511,NCT04615936,ClinicalTrials.gov,2020-11-02,2020-07-10,True,Sunnybrook Health Sciences Centre,Recruiting,Not Applicable,Interventional,Canada,Nasal Photodisinfection COVID Proof of Concept Study,Drug,Methylene Blue,Methylene Blue,100,https://clinicaltrials.gov/show/NCT04615936,None
3590,6512,NCT04615949,ClinicalTrials.gov,2020-11-02,2020-12-01,False,Cardiol Therapeutics Inc.,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors,Drug,Cannabidiol,Cannabidiol,422,https://clinicaltrials.gov/show/NCT04615949,None
3591,6513,NCT04615975,ClinicalTrials.gov,2020-10-31,2020-11-01,False,University of Padova,Recruiting,Not Applicable,Interventional,Italy,Ketogenic Diet as Protective Factor During COVID-19,Other (nutrition),Nutrition,Nutrition,28,https://clinicaltrials.gov/show/NCT04615975,None
3592,6514,NCT04616001,ClinicalTrials.gov,2020-11-02,2020-11-01,True,Sharp HealthCare,Not Recruiting,Phase 4,Interventional,United States,IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation,ATMP,Immunoglobulin,Immunoglobulin,10,https://clinicaltrials.gov/show/NCT04616001,None
3593,6515,NCT04616846,ClinicalTrials.gov,2020-11-02,2020-08-04,True,Centre Antoine Lacassagne,Recruiting,Not Applicable,Interventional,"Monaco, France",Thromboembolic Risk Screening in Patients With Cancer and COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04616846,None
3594,6518,NCT04616989,ClinicalTrials.gov,2020-10-20,2020-11-01,False,Makerere University,Not Recruiting,Not Applicable,Interventional,No Country Given,Mental Health in Communities Affected by COVID-19 in Uganda,Other (psych),No Intervention,No Intervention,840,https://clinicaltrials.gov/show/NCT04616989,None
3595,6519,NCT04617119,ClinicalTrials.gov,2020-10-28,2020-11-01,False,Dr. Jassim Alghaith,Not Recruiting,Not Applicable,Interventional,Kuwait,The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,38,https://clinicaltrials.gov/show/NCT04617119,None
3596,6520,NCT04617262,ClinicalTrials.gov,2020-11-02,2020-11-01,True,The New School,Not Recruiting,Not Applicable,Interventional,No Country Given,Pilot Feasibility Study of Remote Problem Management Plus for Adults Affected by COVID-19,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04617262,None
3597,6521,NCT04617483,ClinicalTrials.gov,2020-11-04,2020-10-31,True,"Sinovac Research and Development Co., Ltd.",Recruiting,Phase 3,Interventional,China,"Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults",ATMP,Vaccine,Vaccine,1040,https://clinicaltrials.gov/show/NCT04617483,None
3598,6523,NCT04618042,ClinicalTrials.gov,2020-10-23,2020-11-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia,Drug,FX06,FX06,50,https://clinicaltrials.gov/show/NCT04618042,EUCTR2020-002056-20
3599,6528,NCT04619290,ClinicalTrials.gov,2020-11-04,2020-10-12,True,Hospital Regional Lic. Adolfo López Mateos,Recruiting,Phase 1,Interventional,Mexico,Outpatient Treatment With CoVid-19 With Prexablu,Drug,Methylene Blue,Methylene Blue,46,https://clinicaltrials.gov/show/NCT04619290,None
3600,6532,NCT04619628,ClinicalTrials.gov,2020-11-05,2020-12-01,False,"Codagenix, Inc",Not Recruiting,Phase 1,Interventional,United Kingdom,"Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19",ATMP,Vaccine,Vaccine,48,https://clinicaltrials.gov/show/NCT04619628,None
3601,6533,NCT04619680,ClinicalTrials.gov,2020-11-05,2020-11-01,True,Icahn School of Medicine at Mount Sinai,Recruiting,Phase 4,Interventional,United States,The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID-19,Drug,Nintedanib,Nintedanib,120,https://clinicaltrials.gov/show/NCT04619680,None
3602,6534,NCT04619706,ClinicalTrials.gov,2020-11-05,2020-11-15,False,"FSD Pharma, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19,Drug,Palmitoylethanolamide,Palmitoylethanolamide,350,https://clinicaltrials.gov/show/NCT04619706,None
3603,6535,NCT04619719,ClinicalTrials.gov,2020-11-05,2020-11-16,False,NYU Langone Health,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Respiratory Distress,Drug,Oxygen,Oxygen,600,https://clinicaltrials.gov/show/NCT04619719,None
3604,6536,NCT04620798,ClinicalTrials.gov,2020-11-04,2020-09-14,True,Indiana University,Not Recruiting,Not Applicable,Interventional,United States,Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1700,https://clinicaltrials.gov/show/NCT04620798,None
3605,6537,NCT04621058,ClinicalTrials.gov,2020-11-06,2020-11-09,False,Bioaraba Health Research Institute,Recruiting,Phase 3,Interventional,Spain,Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.,Drug,Vitamin D,Vitamin D,108,https://clinicaltrials.gov/show/NCT04621058,None
3606,6538,NCT04621071,ClinicalTrials.gov,2020-11-05,2020-11-16,False,University of Sherbrooke,Not Recruiting,Not Applicable,Interventional,Canada,Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19,Supplement,Probiotics,Probiotics,84,https://clinicaltrials.gov/show/NCT04621071,None
3607,6540,NCT04621123,ClinicalTrials.gov,2020-11-04,2020-10-30,True,Fundació Lluita contra la SIDA,Recruiting,Phase 2,Interventional,Spain,Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients,ATMP,Plasma,Plasma,474,https://clinicaltrials.gov/show/NCT04621123,None
3608,6541,NCT04621149,ClinicalTrials.gov,2020-11-05,2020-11-09,False,"Profact, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,An Outpatient Study Investigating Non-prescription Treatments for COVID-19,Supplement,Chlorine dioxide; zinc acetate; famotidine; lactoferrin; green tea extract,Chlorine dioxide; zinc acetate; famotidine; lactoferrin; green tea extract,120,https://clinicaltrials.gov/show/NCT04621149,None
3609,6543,NCT04621461,ClinicalTrials.gov,2020-11-06,2020-11-01,True,"St. Francis Hospital, New York",Not Recruiting,Phase 4,Interventional,United States,"Hydroxychloroquine, Azithromycin and Zinc for the Treatment of COVID-19 in the Outpatient Setting",Drug,Zinc,Zinc,750,https://clinicaltrials.gov/show/NCT04621461,None
3610,6544,NCT04621903,ClinicalTrials.gov,2020-11-06,2020-10-08,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,26,https://clinicaltrials.gov/show/NCT04621903,None
3611,6545,NCT04622332,ClinicalTrials.gov,2020-11-03,2020-12-15,False,"Sironax USA, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19,Drug,SIR1-365,SIR1-365,60,https://clinicaltrials.gov/show/NCT04622332,None
3612,6547,NCT04622826,ClinicalTrials.gov,2020-11-04,2020-05-15,True,Azienda Unita Sanitaria Locale Toscana Nord Ovest,Recruiting,Phase 2,Interventional,Italy,plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04622826,None
3613,6548,NCT04622865,ClinicalTrials.gov,2020-11-09,2020-06-01,True,AB Science,Recruiting,Phase 2,Interventional,France,Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19,Drug,Masitinib + Isoquercetin,Masitinib; Isoquercetin,200,https://clinicaltrials.gov/show/NCT04622865,EUCTR2020-001635-27
3614,6549,NCT04622891,ClinicalTrials.gov,2020-11-06,2020-04-01,True,South Valley University,Not Recruiting,Not Applicable,Interventional,Egypt,Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection,Drug,Clarithromycin vs. Azithromycin,Clarithromycin; Azithromycin,300,https://clinicaltrials.gov/show/NCT04622891,None
3615,6550,NCT04623021,ClinicalTrials.gov,2020-11-05,2020-09-25,True,Chong Kun Dang Pharmaceutical,Recruiting,Phase 2,Interventional,Russian Federation,A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,Drug,Nafamostat Mesilate,Nafamostat Mesilate,100,https://clinicaltrials.gov/show/NCT04623021,None
3616,6554,NCT04623255,ClinicalTrials.gov,2020-06-11,2020-10-16,False,"University College, London",Recruiting,Phase 2,Interventional,United Kingdom,Randomised Study of Plasma Exchange in Severe COVID-19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04623255,None
3617,6556,NCT04623385,ClinicalTrials.gov,2020-11-08,2020-11-01,True,Kafrelsheikh University,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?,Drug,retinoic acid + testosterone,retinoic acid; testosterone,1000,https://clinicaltrials.gov/show/NCT04623385,None
3618,6557,NCT04623619,ClinicalTrials.gov,2020-11-09,2020-12-15,False,AOU Policlinico Paolo Giaccone Palermo,Not Recruiting,Not Applicable,Interventional,No Country Given,Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease,Drug,Acetyl L-Carnitine,Acetyl L-Carnitine,100,https://clinicaltrials.gov/show/NCT04623619,None
3619,6558,NCT04623671,ClinicalTrials.gov,2020-10-07,2020-11-15,False,Capricor Inc.,Recruiting,Phase 2,Interventional,United States,Intravenous Infusion of CAP-1002 in Patients With COVID-19,Drug,CAP-1002,CAP-1002,60,https://clinicaltrials.gov/show/NCT04623671,None
3620,6565,NCT04625114,ClinicalTrials.gov,2020-11-05,2020-11-04,True,"University Hospital, Ghent",Recruiting,Phase 2,Interventional,Belgium,The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden,Drug,Camostat Mesilate,Camostat Mesilate,150,https://clinicaltrials.gov/show/NCT04625114,None
3621,6569,NCT04625738,ClinicalTrials.gov,2020-11-04,2020-11-06,False,CHU de Nancy,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04625738,None
3622,6570,NCT04625985,ClinicalTrials.gov,2020-10-23,2020-07-14,True,Laboratorios Silanes,Recruiting,Phase 2,Interventional,Mexico,"Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.",Drug,Metformin,Metformin Glycinate,20,https://clinicaltrials.gov/show/NCT04625985,None
3623,6571,NCT04626050,ClinicalTrials.gov,2020-11-10,2020-11-01,True,Weill Medical College of Cornell University,Not Recruiting,Not Applicable,Interventional,United States,"General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19",Other (psych),No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04626050,None
3624,6573,NCT04626089,ClinicalTrials.gov,2020-10-23,2020-11-30,False,Laboratorios Silanes,Not Recruiting,Phase 2,Interventional,Mexico,"Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2",Drug,Metformin,Metformin Glycinate,20,https://clinicaltrials.gov/show/NCT04626089,None
3625,6575,NCT04627233,ClinicalTrials.gov,2020-11-06,2020-12-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 1,Interventional,Iran,Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection,Drug,Ezrin Peptide,Ezrin Peptide,20,https://clinicaltrials.gov/show/NCT04627233,None
3626,6576,NCT04627467,ClinicalTrials.gov,2020-10-30,2020-03-28,True,Fundacion Clinica Valle del Lili,Not Recruiting,Phase 2,Interventional,Colombia,Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID),Drug (Chemoprophylaxis),Chloroquine,Chloroquine,3217,https://clinicaltrials.gov/show/NCT04627467,None
3627,6577,NCT04627519,ClinicalTrials.gov,2020-11-10,2020-12-01,False,Padjadjaran University,Not Recruiting,Phase 2,Interventional,No Country Given,Effectiveness and Safety of Rhea Health ToneÂ® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia,Supplement,Rhea Health Tone,Rhea Health Tone,69,https://clinicaltrials.gov/show/NCT04627519,None
3628,6578,NCT04627584,ClinicalTrials.gov,2020-11-12,2020-11-01,True,"Mabwell (Shanghai) Bioscience Co., Ltd.",Not Recruiting,Phase 2,Interventional,No Country Given,A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19,Drug,MW33 injection,MW33 injection,150,https://clinicaltrials.gov/show/NCT04627584,None
3629,6580,NCT04627675,ClinicalTrials.gov,2020-11-06,2020-12-01,False,Providence Health & Services,Not Recruiting,Phase 1,Interventional,United States,CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2),ATMP,Vaccine,Vaccine,36,https://clinicaltrials.gov/show/NCT04627675,None
3630,6582,NCT04628039,ClinicalTrials.gov,2020-11-09,2021-11-01,False,VA Office of Research and Development,Not Recruiting,Not Applicable,Interventional,United States,"Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs",Clinical Presentation,No Intervention,No Intervention,506,https://clinicaltrials.gov/show/NCT04628039,None
3631,6584,NCT04628143,ClinicalTrials.gov,2020-11-10,2020-11-20,False,Chong Kun Dang Pharmaceutical,Not Recruiting,Phase 2,Interventional,No Country Given,A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,Drug,Nafamostat Mesilate,Nafamostat Mesilate,100,https://clinicaltrials.gov/show/NCT04628143,None
3632,6588,NCT04629105,ClinicalTrials.gov,2020-09-29,2020-07-24,True,Longeveron LLC,Recruiting,Phase 1,Interventional,United States,Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) (RECOVER),ATMP,Cells (mesenchymal),Cells (mesenchymal),70,https://clinicaltrials.gov/show/NCT04629105,None
3633,6589,NCT04629157,ClinicalTrials.gov,2020-11-04,2020-11-05,False,Alder Hey Children's NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04629157,None
3634,6593,NCT04629703,ClinicalTrials.gov,2020-11-13,2020-12-01,False,Rigel Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,"Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects",Drug,Fostamatinib,Fostamatinib,308,https://clinicaltrials.gov/show/NCT04629703,None
3635,6594,NCT04629755,ClinicalTrials.gov,2020-11-09,2020-04-04,True,University of Washington,Not Recruiting,Not Applicable,Interventional,United States,A Smartphone Intervention for Relational and Mental Well Being,Other (psych),Psychological,Psychological,1765,https://clinicaltrials.gov/show/NCT04629755,None
3636,6595,NCT04629989,ClinicalTrials.gov,2020-11-13,2020-11-13,False,"University Clinic, UCLouvain",Recruiting,Not Applicable,Interventional,Belgium,Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19,Other (device),Masks,Masks,27,https://clinicaltrials.gov/show/NCT04629989,None
3637,6597,NCT04630054,ClinicalTrials.gov,2020-11-13,2020-11-15,False,Yale University,Recruiting,Not Applicable,Interventional,Bangladesh,Face Masks to Reduce COVID-19 in Bangladesh,Other (device),Masks,Masks,450000,https://clinicaltrials.gov/show/NCT04630054,None
3638,6599,NCT04631367,ClinicalTrials.gov,2020-11-13,2021-02-01,False,University of Toronto,Not Recruiting,Not Applicable,Interventional,No Country Given,mHealth Intervention for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Uganda,Other (software),eHealth,eHealth,404,https://clinicaltrials.gov/show/NCT04631367,None
3639,6600,NCT04631380,ClinicalTrials.gov,2020-08-04,2020-08-01,True,Hospital do Coração,Recruiting,Not Applicable,Interventional,Brazil,Prayer in Commbate to Corona Virus - Covid -19,Other,Other,Other,200,https://clinicaltrials.gov/show/NCT04631380,None
3640,6602,NCT04631536,ClinicalTrials.gov,2020-10-28,2020-11-10,False,Lebanese American University Medical Center,Not Recruiting,Phase 1,Interventional,No Country Given,Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC,Drug,Atorvostatin,Atorvostatin,80,https://clinicaltrials.gov/show/NCT04631536,None
3641,6603,NCT04631666,ClinicalTrials.gov,2020-11-05,2020-11-23,False,University of Cologne,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,COVID-19 - Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c (Infusion),Drug,DZIF-10c,DZIF-10c,69,https://clinicaltrials.gov/show/NCT04631666,None
3642,6604,NCT04631705,ClinicalTrials.gov,2020-11-10,2020-11-23,False,University of Cologne,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,COVID-19 - Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c (Inhalation),Drug,DZIF-10c,DZIF-10c,69,https://clinicaltrials.gov/show/NCT04631705,None
3643,6606,NCT04632043,ClinicalTrials.gov,2020-11-15,2020-11-18,False,Evangelismos Hospital,Not Recruiting,Not Applicable,Interventional,Greece,Early Versus Delayed Intubation of Patients With COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,80,https://clinicaltrials.gov/show/NCT04632043,None
3644,6607,NCT04632082,ClinicalTrials.gov,2020-11-05,2020-11-05,False,Hospital de Clinicas de Porto Alegre,Recruiting,Not Applicable,Interventional,Brazil,Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19,Other (psych),Psychological,Psychological,2200,https://clinicaltrials.gov/show/NCT04632082,None
3645,6610,NCT04632368,ClinicalTrials.gov,2020-11-11,2020-11-01,True,Duke University,Not Recruiting,Not Applicable,Interventional,No Country Given,Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,80,https://clinicaltrials.gov/show/NCT04632368,None
3646,6611,NCT04632381,ClinicalTrials.gov,2020-11-12,2020-11-16,False,Effector Therapeutics,Not Recruiting,Phase 1,Interventional,No Country Given,Intravenous Zotatifin in Adults With Mild or Moderate COVID-19,Drug,Zotatifin,Zotatifin,36,https://clinicaltrials.gov/show/NCT04632381,None
3647,6612,NCT04632602,ClinicalTrials.gov,2020-11-16,2020-04-04,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure,Procedure,Positioning,Positioning,20,https://clinicaltrials.gov/show/NCT04632602,None
3648,6614,NCT04632706,ClinicalTrials.gov,2020-10-26,2020-09-22,True,MedinCell S.A,Recruiting,Phase 1,Interventional,United Kingdom,Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19,Drug,Ivermectin,Ivermectin,24,https://clinicaltrials.gov/show/NCT04632706,None
3649,6615,NCT04632719,ClinicalTrials.gov,2020-11-14,2020-11-08,True,University of São Paulo,Recruiting,Not Applicable,Interventional,Brazil,The MentalPlusÂ® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,200,https://clinicaltrials.gov/show/NCT04632719,None
3650,6617,NCT04633772,ClinicalTrials.gov,2020-11-06,2020-08-05,True,Erasme University Hospital,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Use of Angiotensin-(1-7) in COVID-19,Drug,Angiotensin (1-7),Angiotensin (1-7),130,https://clinicaltrials.gov/show/NCT04633772,RBR-35734p
3651,6620,NCT04633980,ClinicalTrials.gov,2020-11-16,2020-12-01,False,"University Hospital, Grenoble",Not Recruiting,Phase 1,Interventional,No Country Given,Hydrogen Therapy in Patients With Moderate Covid-19,Drug,Hydrogen,Hydrogen,10,https://clinicaltrials.gov/show/NCT04633980,None
3652,6622,NCT04634370,ClinicalTrials.gov,2020-11-16,2021-01-02,False,Hospital de Clinicas de Porto Alegre,Not Recruiting,Phase 1,Interventional,Brazil,Fase I Clinical Trial on NK Cells for COVID-19,ATMP,Cells (NK),Cells (NK),24,https://clinicaltrials.gov/show/NCT04634370,None
3653,6623,NCT04634422,ClinicalTrials.gov,2020-11-14,2020-11-16,False,Wladimir Szpirt,Not Recruiting,Not Applicable,Interventional,No Country Given,Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure,ATMP,Plasma,Plasma,220,https://clinicaltrials.gov/show/NCT04634422,None
3654,6624,NCT04634799,ClinicalTrials.gov,2020-11-17,2020-11-16,True,Northwestern University,Recruiting,Phase 1/Phase 2,Interventional,United States,Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19,Drug,TM5614,TM5614,80,https://clinicaltrials.gov/show/NCT04634799,None
3655,6625,NCT04635241,ClinicalTrials.gov,2020-11-14,2020-06-01,True,Australian National University,Recruiting,Phase 2/Phase 3,Interventional,"Egypt, Argentina",Inhaled Heparin for Hospitalised COVID-19 Patients,Drug,Heparin,Heparin,656,https://clinicaltrials.gov/show/NCT04635241,None
3656,6627,NCT04635605,ClinicalTrials.gov,2020-09-28,2020-11-01,False,Fondazione Epatocentro Ticino,Not Recruiting,Phase 2,Interventional,Switzerland,Methylene Blue Treatment of COVID-19,Drug,Methylene Blue,Methylene Blue,64,https://clinicaltrials.gov/show/NCT04635605,None
3657,6628,NCT04635618,ClinicalTrials.gov,2020-11-05,2020-11-05,False,Hospital de Clinicas de Porto Alegre,Recruiting,Not Applicable,Interventional,Brazil,Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19,Other (psych),Psychological,Psychological,999,https://clinicaltrials.gov/show/NCT04635618,None
3658,6631,NCT04635943,ClinicalTrials.gov,2020-11-09,2020-08-28,True,Universidad Peruana Cayetano Heredia,Recruiting,Phase 2,Interventional,Peru,Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19,Drug,Ivermectin,Ivermectin,68,https://clinicaltrials.gov/show/NCT04635943,None
3659,6633,NCT04636086,ClinicalTrials.gov,2020-11-17,2020-11-12,True,University of Liège,Recruiting,Phase 4,Interventional,Belgium,Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection,Drug,Vitamin D,Vitamin D,100,https://clinicaltrials.gov/show/NCT04636086,None
3660,6636,NCT04636320,ClinicalTrials.gov,2020-11-18,2020-06-13,True,"University Hospital, Bordeaux",Recruiting,Not Applicable,Interventional,France,Prevalence of Myocardial Scars on CMR After COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,240,https://clinicaltrials.gov/show/NCT04636320,None
3661,6637,NCT04636333,ClinicalTrials.gov,2020-11-17,2020-10-30,True,Jiangsu Provincial Center for Disease Control and Prevention,Recruiting,Phase 1,Interventional,China,Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell),ATMP,Vaccine,Vaccine,216,https://clinicaltrials.gov/show/NCT04636333,None
3662,6639,NCT04636671,ClinicalTrials.gov,2020-11-18,2020-11-25,False,University of Trieste,Not Recruiting,Phase 3,Interventional,No Country Given,Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT),Drug,Corticosteroids,Methylprednisolone; Dexamethasone,680,https://clinicaltrials.gov/show/NCT04636671,None
3663,6640,NCT04636697,ClinicalTrials.gov,2020-11-12,2020-11-19,False,Medicago,Recruiting,Phase 2/Phase 3,Interventional,Canada,Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults,ATMP,Vaccine,Vaccine,30612,https://clinicaltrials.gov/show/NCT04636697,None
3664,6642,NCT04637828,ClinicalTrials.gov,2020-11-17,2020-11-18,False,Genoscience Pharma,Recruiting,Phase 2,Interventional,France,A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection,Drug,GNS561,GNS561,178,https://clinicaltrials.gov/show/NCT04637828,None
3665,6644,NCT04637906,ClinicalTrials.gov,2020-11-18,2020-11-18,False,"University of Campania ""Luigi Vanvitelli""",Not Recruiting,Not Applicable,Interventional,No Country Given,Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2),Supplement,L-arginine,L-arginine,290,https://clinicaltrials.gov/show/NCT04637906,None
3666,6645,NCT04638634,ClinicalTrials.gov,2020-11-19,2020-12-01,False,CSL Behring,Not Recruiting,Phase 1,Interventional,No Country Given,"Pharmacokinetics, Safety, and Tolerability of CSL760, an Anti- COVID-19 Hyperimmune Intravenous Immunoglobulin, in Healthy Adult Subjects",ATMP,Immunoglobulin,Immunoglobulin,24,https://clinicaltrials.gov/show/NCT04638634,None
3667,6646,NCT04638842,ClinicalTrials.gov,2020-11-19,2020-12-15,False,Universidad Internacional de Valencia,Not Recruiting,Not Applicable,Interventional,Mexico,Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19,Other (psych),Psychological,Psychological,42,https://clinicaltrials.gov/show/NCT04638842,None
3668,6647,NCT04639349,ClinicalTrials.gov,2020-11-19,2020-11-19,False,Cairo University,Recruiting,Not Applicable,Interventional,Egypt,Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID,Other (exercise),Exercise,Exercise,40,https://clinicaltrials.gov/show/NCT04639349,None
3669,6648,NCT04639375,ClinicalTrials.gov,2020-11-16,2020-11-15,True,E-MO Biology Inc,Recruiting,Phase 4,Interventional,United States,Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19),ATMP,Vaccine,Vaccine,25,https://clinicaltrials.gov/show/NCT04639375,None
3670,6651,NCT04640181,ClinicalTrials.gov,2020-11-19,2020-12-01,False,St. David's HealthCare,Not Recruiting,Phase 2,Interventional,No Country Given,Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT),Drug,Enoxaparin vs. Rivaroxaban,Enoxaparin; Rivaroxaban,150,https://clinicaltrials.gov/show/NCT04640181,None
3671,6652,NCT04640233,ClinicalTrials.gov,2020-11-17,2020-12-01,True,Dr. Reddy's Laboratories Limited,Not Recruiting,Phase 2/Phase 3,Interventional,India,Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-?ov-2) Infection,ATMP,Vaccine,Vaccine,1600,https://clinicaltrials.gov/show/NCT04640233,CTRI/2020/11/029234
3672,6653,NCT04640402,ClinicalTrials.gov,2020-11-19,2020-11-17,True,Jiangsu Provincial Center for Disease Control and Prevention,Recruiting,Phase 2,Interventional,China,A Phase ? Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells),ATMP,Vaccine,Vaccine,960,https://clinicaltrials.gov/show/NCT04640402,None
3673,6656,NCT04641195,ClinicalTrials.gov,2020-11-19,2020-12-07,False,Harvard University,Not Recruiting,Phase 3,Interventional,India,Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India,Drug,Vitamin D vs. Zinc vs. Vitamin D + Zinc,Vitamin D; Zinc,700,https://clinicaltrials.gov/show/NCT04641195,None
3674,6657,NCT04641481,ClinicalTrials.gov,2020-11-09,2020-11-25,False,Bharat Biotech International Limited,Recruiting,Phase 3,Interventional,India,An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers,ATMP,Vaccine,Vaccine,25800,https://clinicaltrials.gov/show/NCT04641481,None
3675,6660,NCT04642014,ClinicalTrials.gov,2020-11-23,2020-12-01,False,Wroclaw Medical University,Not Recruiting,Not Applicable,Interventional,Poland,Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Evaluation of Therapy Effectiveness,ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04642014,None
3676,6661,NCT04642040,ClinicalTrials.gov,2020-11-21,2020-06-30,True,Sisli Hamidiye Etfal Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04642040,None
3677,6663,NCT04642326,ClinicalTrials.gov,2020-11-16,2020-06-26,True,Rd Global Araştırma Geliştirme Sağlık İlaç,Not Recruiting,Not Applicable,Interventional,Turkey,Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis,Other (device),UVC Therapy,UVC Therapy,50,https://clinicaltrials.gov/show/NCT04642326,None
3678,6664,NCT04642339,ClinicalTrials.gov,2020-11-16,2020-11-01,True,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Not Recruiting,Phase 3,Interventional,No Country Given,"Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela",ATMP,Vaccine,Vaccine,2000,https://clinicaltrials.gov/show/NCT04642339,None
3679,6666,NCT04642950,ClinicalTrials.gov,2020-11-19,2020-11-24,False,Nobelpharma,Not Recruiting,Phase 2/Phase 3,Interventional,Japan,A Phase II/III Study of Sargramostim,Drug,Sargramostim,Sargramostim,60,https://clinicaltrials.gov/show/NCT04642950,None
3680,6667,NCT04643054,ClinicalTrials.gov,2020-11-22,2020-12-01,False,AOU Policlinico Paolo Giaccone Palermo,Not Recruiting,Not Applicable,Interventional,Italy,Efficacy and Safety of Ovotransferrin in COVID-19 Patients,Supplement,Ovotransferrin,Ovotransferrin,100,https://clinicaltrials.gov/show/NCT04643054,None
3681,6671,NCT04643561,ClinicalTrials.gov,2020-11-24,2020-11-01,True,Hadassah Medical Organization,Not Recruiting,Phase 1/Phase 2,Interventional,Israel,Using Travelan to Boost Immune Response in Vitro to COVID-19,Supplement,Travelan,Travelan,5,https://clinicaltrials.gov/show/NCT04643561,None
3682,6672,NCT04643691,ClinicalTrials.gov,2020-11-24,2020-09-11,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Phase 2,Interventional,France,Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS,Drug,Losartan + Spironolactone,Losartan; Spironolactone,90,https://clinicaltrials.gov/show/NCT04643691,EUCTR2020-001766-11
3683,6674,NCT04643964,ClinicalTrials.gov,2020-11-12,2020-11-01,True,Ohio State University,Recruiting,Not Applicable,Interventional,United States,Brief Video Interventions for Depression,Other (psych),Psychological,Psychological,501,https://clinicaltrials.gov/show/NCT04643964,None
3684,6675,NCT04644120,ClinicalTrials.gov,2020-11-23,2020-11-27,False,AbbVie,Not Recruiting,Phase 1,Interventional,United States,Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 Moves Through the Body of Adult Participants Hospitalized With Coronavirus Disease 2019 (COVID-19),Drug,ABBV-47D11,ABBV-47D11,24,https://clinicaltrials.gov/show/NCT04644120,None
3685,6678,NCT04644172,ClinicalTrials.gov,2020-11-23,2020-11-01,True,University of Alabama at Birmingham,Recruiting,Phase 1/Phase 2,Interventional,United States,Improving Thinking in Everyday Life After Covid-19,Other,Other,Other,40,https://clinicaltrials.gov/show/NCT04644172,None
3686,6679,NCT04644185,ClinicalTrials.gov,2020-11-22,2021-02-10,False,Sinocelltech Ltd.,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19,Drug,SCTA01,SCTA01,795,https://clinicaltrials.gov/show/NCT04644185,None
3687,6680,NCT04644198,ClinicalTrials.gov,2020-11-18,2020-12-01,False,The University of The West Indies,Not Recruiting,Phase 2,Interventional,Jamaica,Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04644198,None
3688,6681,NCT04644276,ClinicalTrials.gov,2020-11-18,2020-11-17,True,Philips Clinical & Medical Affairs Global,Not Recruiting,Not Applicable,Interventional,United States,Mask Adhesive Institutional Study,Other (device),Masks,Masks,30,https://clinicaltrials.gov/show/NCT04644276,None
3689,6683,NCT04644328,ClinicalTrials.gov,2020-11-13,2020-11-14,False,"National Bureau of Economic Research, Inc.",Not Recruiting,Not Applicable,Interventional,United States,The Doctors for Coronavirus Prevention Project Thanksgiving Messaging Campaign,Other,Other,Other,20000000,https://clinicaltrials.gov/show/NCT04644328,None
3690,6685,NCT04644705,ClinicalTrials.gov,2020-11-02,2020-11-02,False,Charité University,Recruiting,Phase 1,Interventional,Germany,Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat,Drug,Niclosamide + Camostat Mesilate,Niclosamide' Camostat Mesilate,28,https://clinicaltrials.gov/show/NCT04644705,None
3691,6687,NCT04645407,ClinicalTrials.gov,2020-02-15,2020-02-01,True,ShuGuang Hospital,Not Recruiting,Phase 4,Interventional,China,Effects of Fuzheng Huayu Tablets on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,66,https://clinicaltrials.gov/show/NCT04645407,None
3692,6692,NCT04646044,ClinicalTrials.gov,2020-11-14,2020-11-13,True,Nektar Therapeutics,Recruiting,Phase 1,Interventional,United States,A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19,Drug,Bempegaldesleukin,Bempegaldesleukin,30,https://clinicaltrials.gov/show/NCT04646044,None
3693,6693,NCT04646109,ClinicalTrials.gov,2020-11-15,2020-05-11,True,Afyonkarahisar Health Sciences University,Not Recruiting,Phase 3,Interventional,Turkey,Ivermectin for Severe COVID-19 Management,Drug,Ivermectin,Ivermectin,60,https://clinicaltrials.gov/show/NCT04646109,None
3694,6696,NCT04646590,ClinicalTrials.gov,2020-11-25,2020-12-01,False,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",Not Recruiting,Phase 3,Interventional,China,A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19,ATMP,Vaccine,Vaccine,29000,https://clinicaltrials.gov/show/NCT04646590,None
3695,6698,NCT04646655,ClinicalTrials.gov,2020-11-22,2020-07-27,True,ASST Fatebenefratelli Sacco,Recruiting,Phase 3,Interventional,Italy,Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19,Drug,Enoxaparin,Enoxaparin,300,https://clinicaltrials.gov/show/NCT04646655,None
3696,6699,NCT04647305,ClinicalTrials.gov,2020-11-24,2020-12-01,False,"University of Los Andes, Columbia",Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission,Other (device),Face shield vs. Masks,Face shield; Masks,233,https://clinicaltrials.gov/show/NCT04647305,None
3697,6700,NCT04647604,ClinicalTrials.gov,2020-06-12,2020-06-23,True,Karolinska University Hospital,Recruiting,Phase 2,Interventional,Sweden,Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -,Drug,Omega 3,Omega 3,40,https://clinicaltrials.gov/show/NCT04647604,EUCTR2020-002293-28
3698,6701,NCT04647656,ClinicalTrials.gov,2020-11-29,2021-01-01,False,Assaf-Harofeh Medical Center,Not Recruiting,Not Applicable,Interventional,Israel,Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome,Drug,Oxygen,Oxygen,70,https://clinicaltrials.gov/show/NCT04647656,None
3699,6702,NCT04647734,ClinicalTrials.gov,2020-11-25,2021-01-01,False,"Rigshospitalet, Denmark",Not Recruiting,Not Applicable,Interventional,Denmark,The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19,Other (exercise),Exercise,Exercise,40,https://clinicaltrials.gov/show/NCT04647734,None
3700,6708,NCT04280705,ClinicalTrials.gov,2020-02-20,2020-02-21,True,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 3,Interventional,"Japan, Spain, United Kingdom, Singapore, Germany, Denmark, United States, South Korea, Mexico, Greece",Adaptive COVID-19 Treatment Trial (ACTT),Drug,Remdesivir,Remdesivir,1062,https://clinicaltrials.gov/show/NCT04280705,EUCTR2020-001052-18; JPRN-jRCT2031190264; ISRCTN13035264
3701,6709,NCT04283461,ClinicalTrials.gov,2020-02-21,2020-03-16,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),ATMP,Vaccine,Vaccine,120,https://clinicaltrials.gov/show/NCT04283461,None
3702,6710,NCT04304690,ClinicalTrials.gov,2020-03-09,2020-03-16,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04304690,None
3703,6711,NCT04312009,ClinicalTrials.gov,2020-03-13,2020-04-13,False,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Requiring Hospitalization,Drug,ARB (Losartan),ARB (Losartan),200,https://clinicaltrials.gov/show/NCT04312009,None
3704,6712,NCT04324021,ClinicalTrials.gov,2020-03-25,2020-04-02,True,Swedish Orphan Biovitrum,Not Recruiting,Phase 2/Phase 3,Interventional,"Italy, United States",Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,Drug,Emapalumab + Anakinra,Emapalumab; anakinra,16,https://clinicaltrials.gov/show/NCT04324021,EUCTR2020-001167-93
3705,6713,NCT04326920,ClinicalTrials.gov,2020-03-24,2020-03-24,True,"University Hospital, Ghent",Not Recruiting,Phase 4,Interventional,"Belgium, Italy",Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),Drug,Sargramostim,Sargramostim,80,https://clinicaltrials.gov/show/NCT04326920,EUCTR2020-001254-22
3706,6714,NCT04327505,ClinicalTrials.gov,2020-03-25,2020-06-03,True,Karolinska Institutet,Recruiting,Phase 2/Phase 3,Interventional,"Sweden, Germany, Romania",Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04327505,EUCTR2020-001349-37; DRKS00021626
3707,6715,NCT04329923,ClinicalTrials.gov,2020-03-30,2020-04-09,False,"Ravi Amaravadi, MD",Not Recruiting,Phase 2,Interventional,United States,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),Drug,Hydroxychloroquine,Hydroxychloroquine,173,https://clinicaltrials.gov/show/NCT04329923,None
3708,6716,NCT04330638,ClinicalTrials.gov,2020-03-31,2020-04-03,False,"University Hospital, Ghent",Not Recruiting,Phase 3,Interventional,Belgium,Treatment of COVID-19 Patients With Anti-interleukin Drugs,Drug,Anakinta + Siltuximab vs. Tocilizumab + Anakinra vs. Tocilizumab vs. Siltuximab vs. Anakinra,Anakinra; Siltuximab; Tocilizumab,342,https://clinicaltrials.gov/show/NCT04330638,None
3709,6717,NCT04332107,ClinicalTrials.gov,2020-03-30,2020-05-22,False,Thomas M. Lietman,Recruiting,Phase 3,Interventional,United States,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,Drug,Azithromycin,Azithromycin,2271,https://clinicaltrials.gov/show/NCT04332107,None
3710,6718,NCT04333420,ClinicalTrials.gov,2020-04-01,2020-03-31,True,InflaRx GmbH,Recruiting,Phase 2/Phase 3,Interventional,"Netherlands, Germany","Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",Drug,IFX-1,IFX-1,390,https://clinicaltrials.gov/show/NCT04333420,EUCTR2020-001335-28
3711,6719,NCT04333472,ClinicalTrials.gov,2020-04-01,2021-01-06,False,Can-Fite BioPharma,Not Recruiting,Phase 2,Interventional,Israel,Piclidenoson for Treatment of COVID-19,Drug,Piclidenoson,Piclidenoson,40,https://clinicaltrials.gov/show/NCT04333472,None
3712,6720,NCT04333914,ClinicalTrials.gov,2020-04-01,2020-04-15,True,Centre Leon Berard,Recruiting,Phase 2,Interventional,France,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,Drug,Chloroquine + Nivolumab + Tocilizumab,Chloroquine; Nivolumab; Tocilizumab,219,https://clinicaltrials.gov/show/NCT04333914,EUCTR2020-001373-70
3713,6721,NCT04339426,ClinicalTrials.gov,2020-04-07,2020-04-20,False,HonorHealth Research Institute,Recruiting,Phase 2,Interventional,United States,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,Drug,Atovaquone + azithromycin,Atovaquone; azithromycin,25,https://clinicaltrials.gov/show/NCT04339426,None
3714,6722,NCT04341116,ClinicalTrials.gov,2020-04-04,2020-04-11,False,I-Mab Biopharma Co. Ltd.,Recruiting,Phase 2/Phase 3,Interventional,United States,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),Drug,TJ003234,TJ003234,384,https://clinicaltrials.gov/show/NCT04341116,None
3715,6723,NCT04341441,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Henry Ford Health System,Recruiting,Phase 3,Interventional,United States,Will Hydroxychloroquine Impede or Prevent COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,3000,https://clinicaltrials.gov/show/NCT04341441,None
3716,6724,NCT04343755,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Hackensack Meridian Health,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,ATMP,Plasma,Plasma,52,https://clinicaltrials.gov/show/NCT04343755,None
3717,6725,NCT04343976,ClinicalTrials.gov,2020-04-09,2020-06-22,False,Raymond Chung,Recruiting,Phase 2,Interventional,United States,Pegylated Interferon Lambda Treatment for COVID-19,Drug,Interferon lambda,Interferon lambda,20,https://clinicaltrials.gov/show/NCT04343976,None
3718,6726,NCT04344184,ClinicalTrials.gov,2020-04-09,2021-01-01,False,Virginia Commonwealth University,Not Recruiting,Phase 2,Interventional,United States,SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI),Drug,Vitamin C,Vitamin C,60,https://clinicaltrials.gov/show/NCT04344184,None
3719,6727,NCT04344587,ClinicalTrials.gov,2020-04-08,2020-04-23,False,Boston University,Recruiting,Not Applicable,Interventional,"Spain, United States",Awake Prone Position for Early Hypoxemia in COVID-19,Procedure,Positioning,Positioning,560,https://clinicaltrials.gov/show/NCT04344587,None
3720,6729,NCT04345419,ClinicalTrials.gov,2020-04-11,2020-06-16,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Remdesivir vs Chloroquine in Coronavirus Disease,Drug,Chloroquine vs. Favipiravir vs. Nitazoxanide vs. Ivermectin vs. Niclosamide,Chloroquine; Favipiravir; Nitazoxanide; Ivermectin; Niclosamide,120,https://clinicaltrials.gov/show/NCT04345419,None
3721,6730,NCT04347174,ClinicalTrials.gov,2020-03-31,2020-04-30,True,Cadila Pharnmaceuticals,Recruiting,Not Applicable,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,Drug,Mycobacterium,Mycobacterium,300,https://clinicaltrials.gov/show/NCT04347174,CTRI/2020/04/024846
3722,6732,NCT04348864,ClinicalTrials.gov,2020-04-13,2020-04-16,False,Neuroganics LLC,Recruiting,Not Applicable,Interventional,United States,COVID-19 Diagnostic Self-testing Using Virtual Point-of-care,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04348864,None
3723,6734,NCT04351243,ClinicalTrials.gov,2020-04-15,2020-04-12,True,Kinevant Sciences GmbH,Not Recruiting,Phase 2,Interventional,United States,A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE),Drug,Grimsilumab,Grimsilumab,227,https://clinicaltrials.gov/show/NCT04351243,None
3724,6740,NCT04353336,ClinicalTrials.gov,2020-04-15,2020-03-23,True,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment,Drug,Chloroquine,Chloroquine,200,https://clinicaltrials.gov/show/NCT04353336,None
3725,6741,NCT04355364,ClinicalTrials.gov,2020-04-15,2020-04-21,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Phase 3,Interventional,France,Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE),Drug,Dornase alfa,Dornase alfa,100,https://clinicaltrials.gov/show/NCT04355364,None
3726,6742,NCT04355676,ClinicalTrials.gov,2020-04-17,2020-04-30,False,Karyopharm Therapeutics Inc,Not Recruiting,Phase 2,Interventional,No Country Given,Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19,Drug,Selinexor,Selinexor,0,https://clinicaltrials.gov/show/NCT04355676,None
3727,6743,NCT04355767,ClinicalTrials.gov,2020-04-17,2020-08-11,False,Stanford University,Recruiting,Phase 3,Interventional,United States,Convalescent Plasma in Outpatients With COVID-19,ATMP,Plasma,Plasma,600,https://clinicaltrials.gov/show/NCT04355767,None
3728,6744,NCT04355962,ClinicalTrials.gov,2020-03-26,2020-04-23,False,University of Zurich,Recruiting,Phase 3,Interventional,Switzerland,Sevoflurane in COVID-19 ARDS (SevCov),Drug,Sevoflurane,Sevoflurane,64,https://clinicaltrials.gov/show/NCT04355962,None
3729,6746,NCT04359797,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Vanderbilt University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Patient Positioning Pragmatic Trial,Procedure,Positioning,Positioning,500,https://clinicaltrials.gov/show/NCT04359797,None
3730,6747,NCT04360096,ClinicalTrials.gov,2020-04-21,2021-01-10,False,"NeuroRx, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Inhaled Aviptadil for the Treatment of Moderate and Severe COVID-19,Drug,Aviptadil,Aviptadil,288,https://clinicaltrials.gov/show/NCT04360096,None
3731,6748,NCT04361396,ClinicalTrials.gov,2020-04-22,2020-06-16,False,Centre Hospitalier René Dubos,Recruiting,Not Applicable,Interventional,France,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04361396,None
3732,6749,NCT04362176,ClinicalTrials.gov,2020-04-21,2020-04-24,False,Vanderbilt University,Recruiting,Phase 3,Interventional,United States,Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults,ATMP,Plasma,Plasma,1000,https://clinicaltrials.gov/show/NCT04362176,None
3733,6750,NCT04362813,ClinicalTrials.gov,2020-04-24,2020-04-30,True,Novartis Pharmaceuticals,Not Recruiting,Phase 3,Interventional,"Russian Federation, United Kingdom, Italy, France, United States, Germany, Spain, Hungary",Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia,Drug,Canakinumab,Canakinumab,451,https://clinicaltrials.gov/show/NCT04362813,EUCTR2020-001370-30
3734,6752,NCT04363593,ClinicalTrials.gov,2020-04-24,2020-05-04,False,Centre Hospitalier de Cornouaille,Not Recruiting,Not Applicable,Interventional,France,Serology COVID-19 From the Cornwall Hospital Union,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2587,https://clinicaltrials.gov/show/NCT04363593,None
3735,6753,NCT04365257,ClinicalTrials.gov,2020-04-24,2020-05-13,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),Drug,Prazosin,Prazosin,220,https://clinicaltrials.gov/show/NCT04365257,None
3736,6755,NCT04368000,ClinicalTrials.gov,2020-04-24,2020-04-29,False,University of Utah,Not Recruiting,Not Applicable,Interventional,United States,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,Procedure,Positioning,Positioning,30,https://clinicaltrials.gov/show/NCT04368000,None
3737,6757,NCT04369469,ClinicalTrials.gov,2020-04-28,2020-05-11,True,Alexion Pharmaceuticals,Recruiting,Phase 3,Interventional,"Japan, United Kingdom, France, United States, Spain",Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia,Drug,Ravulizumab,Ravulizumab,270,https://clinicaltrials.gov/show/NCT04369469,JPRN-jRCT2031200126
3738,6758,NCT04369599,ClinicalTrials.gov,2020-04-28,2020-08-11,False,Emory University,Not Recruiting,Not Applicable,Interventional,United States,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest for COVID-19,Other (device),Thoracic Manipulation Vest,Thoracic Manipulation Vest,24,https://clinicaltrials.gov/show/NCT04369599,None
3739,6759,NCT04370262,ClinicalTrials.gov,2020-04-27,2020-04-07,True,Northwell Health,Not Recruiting,Phase 3,Interventional,United States,Multi-site Adaptive Trials for COVID-19,Drug,Hydroxychloroquine + Famotidine vs. Hydroxychloroquine,Hydroxychloroquine; Famotidine,233,https://clinicaltrials.gov/show/NCT04370262,None
3740,6760,NCT04370782,ClinicalTrials.gov,2020-04-26,2020-04-28,False,"St. Francis Hospital, New York",Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,Drug,Hydroxychloroquine + Azithromycin + Zinc vs. Hydroxychloroquine + Doxycycline + Zinc,Hydroxychloroquine; Azithromycin; Zinc; Doxycycline,18,https://clinicaltrials.gov/show/NCT04370782,None
3741,6762,NCT04371640,ClinicalTrials.gov,2020-04-28,2020-07-06,False,Walter K. Kraft,Not Recruiting,Phase 1,Interventional,United States,Sirolimus in COVID-19 Phase 1,Drug,Sirolimus,Sirolimus,0,https://clinicaltrials.gov/show/NCT04371640,None
3742,6764,NCT04374279,ClinicalTrials.gov,2020-05-04,2021-01-04,False,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Not Recruiting,Phase 2,Interventional,United States,Trial to Promote Recovery From COVID-19 With Endocrine Therapy,Drug,Bicalutamide vs. Ivermectin,Bicalutamide; Ivermectin,60,https://clinicaltrials.gov/show/NCT04374279,None
3743,6765,NCT04377100,ClinicalTrials.gov,2020-05-05,2020-12-17,False,National Institute of Mental Health (NIMH),Recruiting,Not Applicable,Interventional,United States,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,Other (psych),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04377100,None
3744,6767,NCT04380688,ClinicalTrials.gov,2020-05-07,2020-06-13,False,AstraZeneca,Not Recruiting,Phase 2,Interventional,United States,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,Drug,Acalabrutinib,Acalabrutinib,62,https://clinicaltrials.gov/show/NCT04380688,None
3745,6770,NCT04381013,ClinicalTrials.gov,2020-05-07,2021-03-01,False,Stanford University,Not Recruiting,Not Applicable,Interventional,United States,Emergency Ventilator Splitting Between Two or More Patients (COVID-19),Other (device),Other,Other,4,https://clinicaltrials.gov/show/NCT04381013,None
3746,6771,NCT04382651,ClinicalTrials.gov,2020-05-08,2020-06-07,False,Novartis Pharmaceuticals,Recruiting,Phase 2,Interventional,United States,Study of Efficacy and Safety of MAS825 in Patients With COVID-19,Drug,MAS825,MAS825,120,https://clinicaltrials.gov/show/NCT04382651,None
3747,6772,NCT04382846,ClinicalTrials.gov,2020-05-07,2020-05-08,False,Tanta University,Recruiting,Phase 3,Interventional,Egypt,Novel Regimens in COVID-19 Treatment,Drug,Nitazoxanide + Azithromycin vs. Ivermectin + Chloroquine vs. Ivermectin + Nitazoxanide vs. Nitazoxanide + Ivermectin + Azithromycin,Nitazoxanide + Ivermectin + Azithromycin + Chloroquine,160,https://clinicaltrials.gov/show/NCT04382846,None
3748,6773,NCT04382924,ClinicalTrials.gov,2020-05-08,2020-08-05,False,Algernon Pharmaceuticals,Not Recruiting,Phase 2/Phase 3,Interventional,"Philippines, Romania, Australia, United States",Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease,Drug,Ifenprodil,Ifenprodil,682,https://clinicaltrials.gov/show/NCT04382924,None
3749,6775,NCT04384445,ClinicalTrials.gov,2020-05-09,2020-09-08,False,Organicell Regenerative Medicine,Recruiting,Phase 1/Phase 2,Interventional,United States,Zofin (Organicell Flow) for Patients With COVID-19,ATMP,Exosomes,Exosomes,20,https://clinicaltrials.gov/show/NCT04384445,None
3750,6777,NCT04386252,ClinicalTrials.gov,2020-05-11,2021-02-01,False,"Aivita Biomedical, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,United States,Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults,ATMP,Vaccine,Vaccine,175,https://clinicaltrials.gov/show/NCT04386252,None
3751,6779,NCT04386616,ClinicalTrials.gov,2020-05-11,2020-06-02,True,"Genentech, Inc.",Not Recruiting,Phase 2,Interventional,"Brazil, Spain, Mexico, United States",A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia,Drug,Astegolimab vs. UTTR1147A,Astegolimab; UTTR1147A,410,https://clinicaltrials.gov/show/NCT04386616,EUCTR2020-002713-17
3752,6782,NCT04388527,ClinicalTrials.gov,2020-05-04,2020-04-30,True,University of Pennsylvania,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma for Mechanically Ventilated Population,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04388527,None
3753,6783,NCT04388826,ClinicalTrials.gov,2020-05-13,2020-06-18,False,Veru Inc.,Recruiting,Phase 2,Interventional,United States,COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111,Drug,Veru-111,Veru-111,40,https://clinicaltrials.gov/show/NCT04388826,None
3754,6788,NCT04395911,ClinicalTrials.gov,2020-05-17,2020-09-10,False,SeaStar Medical,Recruiting,Not Applicable,Interventional,United States,Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections,Other (device),Selective Cytopheretic Device,Selective Cytopheretic Device,30,https://clinicaltrials.gov/show/NCT04395911,None
3755,6789,NCT04397510,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Frederick Health,Recruiting,Phase 4,Interventional,United States,Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury,Drug,Heparin,Heparin,50,https://clinicaltrials.gov/show/NCT04397510,None
3756,6790,NCT04397718,ClinicalTrials.gov,2020-05-14,2020-07-06,False,VA Office of Research and Development,Recruiting,Phase 2,Interventional,United States,Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization,Drug,Degarelix,Degarelix,198,https://clinicaltrials.gov/show/NCT04397718,None
3757,6791,NCT04397757,ClinicalTrials.gov,2020-05-19,2020-05-13,True,University of Pennsylvania,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.,ATMP,Plasma,Plasma,80,https://clinicaltrials.gov/show/NCT04397757,None
3758,6792,NCT04401293,ClinicalTrials.gov,2020-05-20,2020-04-26,True,Northwell Health,Recruiting,Phase 3,Interventional,United States,Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients,Drug,Heparin,Heparin,308,https://clinicaltrials.gov/show/NCT04401293,None
3759,6795,NCT04402957,ClinicalTrials.gov,2020-05-12,2020-10-14,False,Arch Biopartners Inc.,Recruiting,Phase 2,Interventional,"Turkey, United States",LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19),Drug,LSALT peptide,LSALT peptide,60,https://clinicaltrials.gov/show/NCT04402957,None
3760,6796,NCT04402983,ClinicalTrials.gov,2020-05-22,2020-05-27,False,Istanbul Medipol University Hospital,Not Recruiting,Not Applicable,Interventional,Turkey,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,34,https://clinicaltrials.gov/show/NCT04402983,None
3761,6799,NCT04404361,ClinicalTrials.gov,2020-05-22,2020-05-22,False,CTI BioPharma,Recruiting,Phase 3,Interventional,United States,PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer,Drug,Pacritinib,Pacritinib,364,https://clinicaltrials.gov/show/NCT04404361,None
3762,6800,NCT04405570,ClinicalTrials.gov,2020-05-26,2020-06-16,False,Ridgeback Biotherapeutics,Recruiting,Phase 2,Interventional,United States,"A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19",Drug,EIDD-2801,EIDD-2801,204,https://clinicaltrials.gov/show/NCT04405570,None
3763,6801,NCT04405739,ClinicalTrials.gov,2020-05-26,2020-06-16,False,Ridgeback Biotherapeutics,Recruiting,Phase 2,Interventional,United States,The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID),Drug,EIDD-2801,EIDD-2801,80,https://clinicaltrials.gov/show/NCT04405739,None
3764,6802,NCT04405843,ClinicalTrials.gov,2020-05-23,2020-07-14,False,Centro de Estudios en Infectología Pediátrica,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial),Drug,Ivermectin,Ivermectin,476,https://clinicaltrials.gov/show/NCT04405843,None
3765,6803,NCT04407130,ClinicalTrials.gov,2020-05-17,2020-06-16,False,"International Centre for Diarrhoeal Disease Research, Bangladesh",Recruiting,Phase 2,Interventional,Bangladesh,Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.,Drug,Ivermectin + Doxycycline vs. Ivermectin,Ivermectin; Doxycycline,72,https://clinicaltrials.gov/show/NCT04407130,None
3766,6804,NCT04407286,ClinicalTrials.gov,2020-05-19,2020-05-19,False,Arizona State University,Not Recruiting,Phase 1,Interventional,United States,Vitamin D Testing and Treatment for COVID 19,Drug,Vitamin D,Vitamin D,41,https://clinicaltrials.gov/show/NCT04407286,None
3767,6805,NCT04408183,ClinicalTrials.gov,2020-05-22,2020-06-01,False,"GeneOne Life Science, Inc.",Recruiting,Phase 2,Interventional,United States,GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel,Drug (Chemoprophylaxis),GLS-1200,GLS-1200,225,https://clinicaltrials.gov/show/NCT04408183,None
3768,6808,NCT04409327,ClinicalTrials.gov,2020-05-28,2020-07-11,False,Restorbio Inc.,Not Recruiting,Phase 2,Interventional,United States,Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes,Drug,RTB101,RTB101,36,https://clinicaltrials.gov/show/NCT04409327,None
3769,6809,NCT04409743,ClinicalTrials.gov,2020-05-28,2020-06-07,False,Stanford University,Recruiting,Not Applicable,Interventional,United States,Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04409743,None
3770,6810,NCT04410354,ClinicalTrials.gov,2020-04-28,2020-06-16,False,"ViralClear Pharmaceuticals, Inc.",Not Recruiting,Phase 2,Interventional,United States,Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19,Drug,Merimepodib + Remdesivir vs. Remdesivir,Merimepodib; Remdesivir,44,https://clinicaltrials.gov/show/NCT04410354,None
3771,6811,NCT04411680,ClinicalTrials.gov,2020-05-29,2020-08-18,False,"Partner Therapeutics, Inc.",Recruiting,Phase 2,Interventional,United States,Study of Sargramostim in Patients With COVID-19,Drug,Sargramostim,Sargramostim,60,https://clinicaltrials.gov/show/NCT04411680,None
3772,6813,NCT04414631,ClinicalTrials.gov,2020-05-19,2020-08-06,False,"University Hospital, Basel",Recruiting,Phase 2,Interventional,Switzerland,Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,Drug,Conestat alfa,Conestat alfa,120,https://clinicaltrials.gov/show/NCT04414631,None
3773,6814,NCT04415151,ClinicalTrials.gov,2020-06-02,2020-07-29,False,Yale University,Not Recruiting,Phase 2,Interventional,United States,Tofacitinib for Treatment of Moderate COVID-19,Drug,Tofacitinib,Tofacitinib,60,https://clinicaltrials.gov/show/NCT04415151,None
3774,6817,NCT04419610,ClinicalTrials.gov,2020-04-16,2020-10-09,False,Imperial College London,Recruiting,Phase 1,Interventional,United Kingdom,RAS and Coagulopathy in COVID19,Drug,TRV027,TRV027,60,https://clinicaltrials.gov/show/NCT04419610,None
3775,6819,NCT04420182,ClinicalTrials.gov,2020-05-29,2020-08-17,False,Lawson Health Research Institute,Recruiting,Not Applicable,Interventional,Canada,COVID-19 Virtual Care at Home,Other (software),eHealth,eHealth,2000,https://clinicaltrials.gov/show/NCT04420182,None
3776,6820,NCT04421027,ClinicalTrials.gov,2020-06-05,2019-09-07,False,Eli Lilly and Company,Recruiting,Phase 3,Interventional,"Russian Federation, Japan, Mexico, Puerto Rico, United Kingdom, Italy, India, Brazil, Germany, United States, South Korea, Argentina, Spain",A Study of Baricitinib (LY3009104) in Participants With COVID-19,Drug,Baricitinib,Baricitinib,1400,https://clinicaltrials.gov/show/NCT04421027,EUCTR2020-001517-21
3777,6822,NCT04425629,ClinicalTrials.gov,2020-06-08,2020-06-16,True,Regeneron Pharmaceuticals,Recruiting,Phase 1/Phase 2,Interventional,"Romania, United States","Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult Patients With COVID-19",Drug,REGN10933 + REGN10987,REGN10933; REGN10987,2104,https://clinicaltrials.gov/show/NCT04425629,EUCTR2020-003690-21
3778,6823,NCT04426201,ClinicalTrials.gov,2020-06-09,2020-12-20,False,Revimmune,Not Recruiting,Phase 2,Interventional,No Country Given,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ),Drug,Interleukin-7,Interleukin-7,48,https://clinicaltrials.gov/show/NCT04426201,None
3779,6825,NCT04427501,ClinicalTrials.gov,2020-06-09,2020-06-17,False,Eli Lilly and Company,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness,Drug,LY3819253,LY3819253,1200,https://clinicaltrials.gov/show/NCT04427501,None
3780,6826,NCT04431297,ClinicalTrials.gov,2020-06-12,2021-01-01,False,Icahn School of Medicine at Mount Sinai,Not Recruiting,Not Applicable,Interventional,United States,Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic,Other (psych),Psychological,Psychological,30,https://clinicaltrials.gov/show/NCT04431297,None
3781,6828,NCT04431453,ClinicalTrials.gov,2020-06-08,2020-07-21,True,Gilead Sciences,Recruiting,Phase 2/Phase 3,Interventional,"United Kingdom, Italy, Spain, United States","Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734â„¢) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)",Drug,Remdesivir,Remdesivir,52,https://clinicaltrials.gov/show/NCT04431453,EUCTR2020-001803-17
3782,6829,NCT04431856,ClinicalTrials.gov,2020-06-12,2020-05-15,True,University of Miami,Not Recruiting,Not Applicable,Interventional,United States,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment,Other (psych),Psychological,Psychological,80,https://clinicaltrials.gov/show/NCT04431856,None
3783,6830,NCT04432298,ClinicalTrials.gov,2020-06-12,2020-06-20,False,FibroGen,Recruiting,Phase 2,Interventional,United States,"Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Patients With Acute COVID-19 Disease",Drug,Pamrevlumab,Pamrevlumab,130,https://clinicaltrials.gov/show/NCT04432298,None
3784,6832,NCT04433546,ClinicalTrials.gov,2020-05-28,2020-07-15,False,PhaseBio Pharmaceuticals Inc.,Not Recruiting,Phase 2,Interventional,United States,"Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).",Drug,PB1046,PB1046,54,https://clinicaltrials.gov/show/NCT04433546,None
3785,6833,NCT04435379,ClinicalTrials.gov,2020-06-16,2020-06-18,True,Vakzine Projekt Management GmbH,Recruiting,Phase 3,Interventional,Germany,Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic,Drug,VPM1002,VPM1002,2038,https://clinicaltrials.gov/show/NCT04435379,EUCTR2020-001675-33
3786,6835,NCT04440007,ClinicalTrials.gov,2020-06-17,2020-10-09,False,"Sorrento Therapeutics, Inc.",Recruiting,Phase 2,Interventional,United States,Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19,Drug,Abivertinib,Abivertinib,80,https://clinicaltrials.gov/show/NCT04440007,None
3787,6837,NCT04442230,ClinicalTrials.gov,2020-06-17,2020-10-10,False,"Altimmune, Inc.",Recruiting,Phase 2,Interventional,United States,NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19),ATMP,Vaccine,Vaccine,96,https://clinicaltrials.gov/show/NCT04442230,None
3788,6838,NCT04445194,ClinicalTrials.gov,2020-06-16,2020-06-22,False,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine,ATMP,Vaccine,Vaccine,50,https://clinicaltrials.gov/show/NCT04445194,None
3789,6840,NCT04446429,ClinicalTrials.gov,2020-06-22,2020-07-02,False,"Applied Biology, Inc.",Recruiting,Not Applicable,Interventional,Brazil,Anti-Androgen Treatment for COVID-19,Drug,Ivermectin + Azythromycin + Dutasteride vs. Ivermectin + Azythromycin,Ivermectin; Azythromycin; Dutasteride,381,https://clinicaltrials.gov/show/NCT04446429,None
3790,6841,NCT04447534,ClinicalTrials.gov,2020-06-23,2020-06-23,False,Tanta University,Recruiting,Phase 3,Interventional,Egypt,Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19,Drug,Chloroquine + Zinc vs. Chloroquine,Chloroquine; Zinc,200,https://clinicaltrials.gov/show/NCT04447534,None
3791,6842,NCT04453384,ClinicalTrials.gov,2020-06-22,2020-09-01,False,Nantes University Hospital,Recruiting,Phase 2,Interventional,France,Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia,Drug,XAV-19,XAV-19,414,https://clinicaltrials.gov/show/NCT04453384,None
3792,6844,NCT04455815,ClinicalTrials.gov,2020-06-25,2020-09-25,False,Cancer Research UK,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive But Are Able to Stay at Home,Drug,Camostat Mesilate,Camostat Mesilate,389,https://clinicaltrials.gov/show/NCT04455815,None
3793,6845,NCT04456595,ClinicalTrials.gov,2020-06-30,2020-07-21,False,Butantan Institute,Recruiting,Phase 3,Interventional,Brazil,Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals,ATMP,Vaccine,Vaccine,13060,https://clinicaltrials.gov/show/NCT04456595,None
3794,6846,NCT04460443,ClinicalTrials.gov,2020-07-04,2020-08-01,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Sofosbuvir in Treatment of COVID 19,Drug,Sofosbuvir + Ribavirin vs. Sofosbuvir,Sofosbuvir; Ribavirin,60,https://clinicaltrials.gov/show/NCT04460443,None
3795,6847,NCT04463602,ClinicalTrials.gov,2020-07-07,2020-07-25,False,Cadila Healthcare Ltd,Not Recruiting,Phase 2,Interventional,Mexico,Desidustat in the Management of COVID-19 Patients,Drug,Desidustat,Desidustat,24,https://clinicaltrials.gov/show/NCT04463602,None
3796,6848,NCT04466085,ClinicalTrials.gov,2020-07-08,2020-07-12,False,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",Not Recruiting,Phase 2,Interventional,China,Clinical Study of Recombinant Novel Coronavirus Vaccine,ATMP,Vaccine,Vaccine,900,https://clinicaltrials.gov/show/NCT04466085,None
3797,6849,NCT04466241,ClinicalTrials.gov,2020-07-06,2020-11-27,False,Inserm-ANRS,Recruiting,Phase 2/Phase 3,Interventional,Cote d'Ivoire,Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial,Drug,Lopinavir/ritonavir vs. Lopinavir/ritonavir + Telmisartan vs. Lopinavir/ritonavir + Atorvastatin,Telmisartan; Lopinavir/ritonavir; Atorvastatin,294,https://clinicaltrials.gov/show/NCT04466241,None
3798,6852,NCT04469491,ClinicalTrials.gov,2020-07-13,2020-09-20,False,CHU de Amiens,Not Recruiting,Phase 2,Interventional,France,Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study,Drug,Interferon,Interferon,60,https://clinicaltrials.gov/show/NCT04469491,None
3799,6853,NCT04472728,ClinicalTrials.gov,2020-07-06,2020-06-16,True,Biophytis S.A.,Recruiting,Phase 2/Phase 3,Interventional,"Belgium, Puerto Rico, France, Brazil, United States",Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients,Drug,BIO101,BIO101,310,https://clinicaltrials.gov/show/NCT04472728,None
3800,6854,NCT04473690,ClinicalTrials.gov,2020-07-14,2020-12-28,False,"Kentucky BioProcessing, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers,ATMP,Vaccine,Vaccine,180,https://clinicaltrials.gov/show/NCT04473690,None
3801,6855,NCT04476745,ClinicalTrials.gov,2020-07-16,2020-10-05,False,Applied Science Private University,Recruiting,Not Applicable,Interventional,Jordan,The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People,Drug,Vitamin D,Vitamin D,100,https://clinicaltrials.gov/show/NCT04476745,None
3802,6857,NCT04479631,ClinicalTrials.gov,2020-07-14,2020-07-12,True,Brii Biosciences Limited,Not Recruiting,Phase 1,Interventional,China,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196",Drug,BRII-196,BRII-196,16,https://clinicaltrials.gov/show/NCT04479631,None
3803,6858,NCT04479644,ClinicalTrials.gov,2020-07-14,2020-07-13,True,Brii Biosciences Limited,Not Recruiting,Phase 1,Interventional,China,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198",Drug,BRII-196,BRII-196,17,https://clinicaltrials.gov/show/NCT04479644,None
3804,6859,NCT04482686,ClinicalTrials.gov,2020-07-21,2020-12-09,False,ProgenaBiome,Recruiting,Phase 2,Interventional,United States,Trial of Combination Therapy to Treat COVID-19 Infection,Drug,Ivermectin + Doxycycline + Zinc + Vitamin D + Vitamin C vs. Zinc + Vitamin D + Vitamin C,Ivermectin; Doxycycline; Zinc; Vitamin D; Vitamin C,300,https://clinicaltrials.gov/show/NCT04482686,None
3805,6860,NCT04483271,ClinicalTrials.gov,2020-07-18,2020-10-02,False,Applied Science Private University,Recruiting,Not Applicable,Interventional,Jordan,The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm,Drug,Omega 3,Omega 3,100,https://clinicaltrials.gov/show/NCT04483271,None
3806,6861,NCT04487691,ClinicalTrials.gov,2020-07-23,2020-12-08,False,"Regenexx, LLC",Recruiting,Not Applicable,Interventional,United States,Nebulized PL for Post-COVID-19 Syndrome,Drug,Platelet Lysate,Platelet Lysate,40,https://clinicaltrials.gov/show/NCT04487691,None
3807,6864,NCT04492475,ClinicalTrials.gov,2020-07-28,2020-08-04,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 3,Interventional,"Japan, Singapore, United States, South Korea, Mexico",Adaptive COVID-19 Treatment Trial 3 (ACTT-3),Drug,Interferon beta + Remdesivir vs. Remdesivir,Interferon beta; Remdesivir,969,https://clinicaltrials.gov/show/NCT04492475,None
3808,6865,NCT04497649,ClinicalTrials.gov,2020-08-01,2020-07-01,True,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients,Drug,"Sofosbuvir, Daclatsavir, Ribavirin, Ledipasvir",Sofosbuvir; Daclatsavir; Ribavirin; Ledipasvir,100,https://clinicaltrials.gov/show/NCT04497649,None
3809,6866,NCT04497948,ClinicalTrials.gov,2020-06-16,2020-09-21,False,Acerta Pharma B.V.,Not Recruiting,Phase 1,Interventional,"Brazil, United States",Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19,Drug,Acalabrutinib,Acalabrutinib,8,https://clinicaltrials.gov/show/NCT04497948,None
3810,6867,NCT04498247,ClinicalTrials.gov,2020-08-03,2020-08-27,False,Merck Sharp & Dohme Corp.,Not Recruiting,Phase 1/Phase 2,Interventional,"Belgium, Austria, United States","A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)",ATMP,Vaccine,Vaccine,260,https://clinicaltrials.gov/show/NCT04498247,None
3811,6869,NCT04501952,ClinicalTrials.gov,2020-08-05,2020-09-18,True,Gilead Sciences,Recruiting,Phase 3,Interventional,"Denmark, United States",Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734â„¢) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting,Drug,Remdesivir,Remdesivir,1264,https://clinicaltrials.gov/show/NCT04501952,EUCTR2020-003510-12
3812,6870,NCT04504032,ClinicalTrials.gov,2020-08-05,2020-09-02,False,Bill & Melinda Gates Medical Research Institute,Recruiting,Phase 2,Interventional,United States,A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19),Drug,Rivaroxaban,Rivaroxaban,600,https://clinicaltrials.gov/show/NCT04504032,None
3813,6871,NCT04504734,ClinicalTrials.gov,2020-08-04,2020-11-27,False,"Revive Therapeutics, Ltd.",Recruiting,Phase 3,Interventional,United States,Bucillamine in Treatment of Patients With COVID-19,Drug,Bucillamine,Bucillamine,1000,https://clinicaltrials.gov/show/NCT04504734,None
3814,6872,NCT04505722,ClinicalTrials.gov,2020-07-31,2020-09-07,True,Janssen Pharmaceutical,Recruiting,Phase 3,Interventional,"Philippines, Chile, Mexico, South Africa, Ukraine, Peru, Brazil, United States, Colombia, Argentina",A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants,ATMP,Vaccine,Vaccine,60000,https://clinicaltrials.gov/show/NCT04505722,PER-048-20
3815,6873,NCT04506268,ClinicalTrials.gov,2020-08-07,2020-09-09,False,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 SAFE Enrollment,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04506268,None
3816,6874,NCT04508023,ClinicalTrials.gov,2020-08-10,2020-08-13,False,Janssen Pharmaceutical,Recruiting,Phase 3,Interventional,United States,"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection",Drug,Rivaroxaban,Rivaroxaban,4000,https://clinicaltrials.gov/show/NCT04508023,None
3817,6875,NCT04509999,ClinicalTrials.gov,2020-08-07,2020-10-26,False,University of Florida,Recruiting,Phase 3,Interventional,United States,Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection,Drug,Bicalutamide,Bicalutamide,100,https://clinicaltrials.gov/show/NCT04509999,None
3818,6876,NCT04516746,ClinicalTrials.gov,2020-08-17,2020-08-28,True,AstraZeneca,Recruiting,Phase 3,Interventional,"Chile, Peru, United States, Colombia, Argentina","Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults",ATMP,Vaccine,Vaccine,40000,https://clinicaltrials.gov/show/NCT04516746,PER-059-20
3819,6877,NCT04517396,ClinicalTrials.gov,2020-08-17,2020-08-18,False,University of Pennsylvania,Recruiting,Phase 2,Interventional,United States,FEnofibRate as a Metabolic INtervention for COVID-19,Drug,Fenofibrate,Fenofibrate,300,https://clinicaltrials.gov/show/NCT04517396,None
3820,6878,NCT04518410,ClinicalTrials.gov,2020-08-17,2020-08-19,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 2/Phase 3,Interventional,"Puerto Rico, United States",ACTIV-2: A Study for Outpatients With COVID-19,Drug,LY3819253,LY3819253,2000,https://clinicaltrials.gov/show/NCT04518410,None
3821,6879,NCT04519437,ClinicalTrials.gov,2020-07-24,2020-07-26,False,Regeneron Pharmaceuticals,Not Recruiting,Phase 1,Interventional,United States,"Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19",Drug,REGN10933 + REGN10987,REGN10933; REGN10987,974,https://clinicaltrials.gov/show/NCT04519437,None
3822,6881,NCT04523181,ClinicalTrials.gov,2020-08-19,2020-10-08,False,Golden Biotechnology Corporation,Recruiting,Phase 2,Interventional,United States,Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients,Drug,Antroquinonol,Antroquinonol,174,https://clinicaltrials.gov/show/NCT04523181,None
3823,6882,NCT04524715,ClinicalTrials.gov,2020-08-19,2021-03-31,False,Ward Photonics LLC,Not Recruiting,Not Applicable,Interventional,United States,LLLT Treatment of Lung Inflammation in COVID-19,Other (device),Low-Level Laser Therapy,Low-Level Laser Therapy,64,https://clinicaltrials.gov/show/NCT04524715,None
3824,6883,NCT04526990,ClinicalTrials.gov,2020-08-22,2020-09-15,False,CanSino Biologics Inc.,Recruiting,Phase 3,Interventional,"Russian Federation, Pakistan, Chile, Mexico, Argentina",Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above,ATMP,Vaccine,Vaccine,40000,https://clinicaltrials.gov/show/NCT04526990,None
3825,6884,NCT04527081,ClinicalTrials.gov,2020-08-24,2020-08-31,False,"AnGes, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of COVID-19 DNA Vaccine (AG0302-COVID19),ATMP,Vaccine,Vaccine,30,https://clinicaltrials.gov/show/NCT04527081,None
3826,6885,NCT04527471,ClinicalTrials.gov,2020-08-06,2020-09-04,False,Verona Pharma Inc,Recruiting,Phase 2,Interventional,United States,Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19,Drug,Ensifentrine,Ensifentrine,45,https://clinicaltrials.gov/show/NCT04527471,None
3827,6886,NCT04530136,ClinicalTrials.gov,2020-08-26,2020-11-30,False,Pharming Technologies B.V.,Recruiting,Phase 2,Interventional,United States,Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,Drug,Ruconest,Ruconest,120,https://clinicaltrials.gov/show/NCT04530136,None
3828,6888,NCT04535453,ClinicalTrials.gov,2020-08-27,2020-08-28,True,Janssen Pharmaceutical,Recruiting,Phase 2,Interventional,"Netherlands, Germany, Canada, Spain",A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents,ATMP,Vaccine,Vaccine,1210,https://clinicaltrials.gov/show/NCT04535453,EUCTR2020-002584-63
3829,6889,NCT04536376,ClinicalTrials.gov,2020-08-26,2021-01-01,False,Mayo Clinic,Not Recruiting,Not Applicable,Interventional,No Country Given,First Responder Resiliency Program During COVID-19,Other,No Intervention,No Intervention,10,https://clinicaltrials.gov/show/NCT04536376,None
3830,6890,NCT04537975,ClinicalTrials.gov,2020-08-25,2020-09-15,False,SeaStar Medical,Not Recruiting,Not Applicable,Interventional,No Country Given,C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19,Other (device),Blood filter,Blood filter,0,https://clinicaltrials.gov/show/NCT04537975,None
3831,6891,NCT04539262,ClinicalTrials.gov,2020-08-26,2020-09-14,False,Gilead Sciences,Recruiting,Phase 1/Phase 2,Interventional,United States,"Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation",Drug,Remdesivir,Remdesivir,282,https://clinicaltrials.gov/show/NCT04539262,None
3832,6892,NCT04540120,ClinicalTrials.gov,2020-08-13,2020-09-25,False,Olatec Therapeutics LLC,Recruiting,Phase 2,Interventional,"Switzerland, United States",Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome,Drug,Dapansutrile,Dapansutrile,80,https://clinicaltrials.gov/show/NCT04540120,None
3833,6894,NCT04545060,ClinicalTrials.gov,2020-09-04,2020-08-27,True,"Vir Biotechnology, Inc.",Recruiting,Phase 2/Phase 3,Interventional,"Chile, Canada, Peru, United Kingdom, France, Brazil, Austria, United States, Spain",VIR-7831 for the Early Treatment of COVID-19 in Outpatients,Drug,VIR-7831,VIR-7831,1360,https://clinicaltrials.gov/show/NCT04545060,None
3834,6895,NCT04546581,ClinicalTrials.gov,2020-09-08,2020-10-08,True,University of Minnesota,Recruiting,Phase 3,Interventional,"Japan, Spain, Greece, United Kingdom, Denmark, United States, Argentina, Nigeria",Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC),ATMP (+ Drug),Immunoglobulin + Remdesivir vs. Remdesivir,Immunoglobulin; Remdesivir,500,https://clinicaltrials.gov/show/NCT04546581,EUCTR2020-002542-16; JPRN-jRCT2031200174
3835,6896,NCT04549922,ClinicalTrials.gov,2020-09-09,2020-10-22,False,Hospital do Coração,Not Recruiting,Phase 2,Interventional,Brazil,Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19,Drug,ISIS 721744,ISIS 721744,111,https://clinicaltrials.gov/show/NCT04549922,None
3836,6897,NCT04552366,ClinicalTrials.gov,2020-09-15,2020-09-29,False,"Insitute of Biotechnology, Academy of Military Medical Sciences, PLA of China",Not Recruiting,Phase 1,Interventional,China,A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults,ATMP,Vaccine,Vaccine,149,https://clinicaltrials.gov/show/NCT04552366,None
3837,6898,NCT04552379,ClinicalTrials.gov,2020-08-21,2020-12-01,False,Pontificia Universidad Católica de Chile,Recruiting,Phase 3,Interventional,Chile,The Containing Coronavirus Disease 19 (COVID-19) Trial,Drug,Interferon beta,Interferon beta,1240,https://clinicaltrials.gov/show/NCT04552379,None
3838,6900,NCT04555096,ClinicalTrials.gov,2020-09-16,2020-09-09,True,"Galera Therapeutics, Inc.",Recruiting,Phase 2,Interventional,United States,A Trial of GC4419 in Patients With Critical Illness Due to COVID-19,Drug,GC4419,GC4419,50,https://clinicaltrials.gov/show/NCT04555096,None
3839,6902,NCT04558372,ClinicalTrials.gov,2020-09-20,2020-04-01,True,Gadjah Mada University,Recruiting,Not Applicable,Interventional,Indonesia,Genosvid Diagnostic Test for Early Detection of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1543,https://clinicaltrials.gov/show/NCT04558372,None
3840,6903,NCT04559113,ClinicalTrials.gov,2020-09-15,2020-05-01,True,Lahore General Hospital,Recruiting,Not Applicable,Interventional,Pakistan,Methylprednisolone in COVID-19 Patients (Methyl19LGH),Drug,Corticosteroids,Methylprednisolone,200,https://clinicaltrials.gov/show/NCT04559113,None
3841,6904,NCT04560205,ClinicalTrials.gov,2020-07-11,2020-05-01,True,Lahore General Hospital,Recruiting,Phase 1,Interventional,Pakistan,Tocilizumab in COVID-19 Lahore General Hospital,Drug,Tocilizumab,Tocilizumab,50,https://clinicaltrials.gov/show/NCT04560205,None
3842,6905,NCT04560257,ClinicalTrials.gov,2020-07-13,2020-05-01,True,Lahore General Hospital,Recruiting,Not Applicable,Interventional,Pakistan,High Flow Nasal Cannula HFNC In Covid-19 Patients,Other (device),Nasal cannula,Nasal cannula,30,https://clinicaltrials.gov/show/NCT04560257,None
3843,6908,NCT04564716,ClinicalTrials.gov,2020-09-24,2020-09-28,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Not Recruiting,Phase 3,Interventional,Belarus,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus",ATMP,Vaccine,Vaccine,100,https://clinicaltrials.gov/show/NCT04564716,None
3844,6911,NCT04565197,ClinicalTrials.gov,2020-09-24,2020-05-01,True,Lahore General Hospital,Not Recruiting,Phase 1,Interventional,Pakistan,Convalescent Plasma Therapy for COVID-19 Patients,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04565197,None
3845,6912,NCT04568031,ClinicalTrials.gov,2020-08-21,2020-08-23,False,AstraZeneca,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of AZD1222 for the Prevention of COVID-19 in Japan,Drug (Chemoprophylaxis),AZD1222,AZD1222,256,https://clinicaltrials.gov/show/NCT04568031,None
3846,6913,NCT04568122,ClinicalTrials.gov,2020-09-25,2020-11-20,False,Stanford University,Recruiting,Not Applicable,Interventional,United States,"Rapid Turnaround, Home-based Saliva Testing for COVID-19",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,3015,https://clinicaltrials.gov/show/NCT04568122,None
3847,6914,NCT04569786,ClinicalTrials.gov,2020-09-24,2020-10-29,False,Merck Sharp & Dohme Corp.,Recruiting,Phase 1,Interventional,United States,Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001),ATMP,Vaccine,Vaccine,252,https://clinicaltrials.gov/show/NCT04569786,None
3848,6916,NCT04575038,ClinicalTrials.gov,2020-10-01,2020-11-19,False,"Clear Creek Bio, Inc.",Recruiting,Phase 2,Interventional,United States,CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19,Drug,Brequinar,Brequinar,100,https://clinicaltrials.gov/show/NCT04575038,None
3849,6917,NCT04575584,ClinicalTrials.gov,2020-09-30,2020-10-19,True,Merck Sharp & Dohme Corp.,Recruiting,Phase 2/Phase 3,Interventional,"Russian Federation, Chile, South Africa, Ukraine, United Kingdom, France, Israel, Brazil, Poland, United States, South Korea, Colombia, Spain",Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001),Drug,Molnupiravir,Molnupiravir,1300,https://clinicaltrials.gov/show/NCT04575584,EUCTR2020-003367-26
3850,6918,NCT04575610,ClinicalTrials.gov,2020-08-05,2020-11-30,False,Yale University,Recruiting,Phase 2,Interventional,United States,IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC),Drug,PF-06650833,PF-06650833,68,https://clinicaltrials.gov/show/NCT04575610,None
3851,6920,NCT04579393,ClinicalTrials.gov,2020-10-06,2020-10-08,False,"National Heart, Lung, and Blood Institute (NHLBI)",Recruiting,Phase 2,Interventional,United States,Fostamatinib for Hospitalized Adults With COVID-19,Drug,Fostamatinib,Fostamatinib,80,https://clinicaltrials.gov/show/NCT04579393,None
3852,6922,NCT04583189,ClinicalTrials.gov,2020-10-01,2020-10-01,False,Centre Hospitalier Intercommunal Creteil,Not Recruiting,Not Applicable,Interventional,France,Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04583189,None
3853,6923,NCT04583592,ClinicalTrials.gov,2020-10-07,2020-11-09,False,Sagent Pharmaceuticals Inc.,Recruiting,Phase 2,Interventional,United States,Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT),Drug,Camostat Mesilate,Camostat Mesilate,300,https://clinicaltrials.gov/show/NCT04583592,None
3854,6924,NCT04583956,ClinicalTrials.gov,2020-10-09,2020-10-14,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 2,Interventional,United States,ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19,Drug,Risankizumab + Remdesivir vs. Remdesivir,Risankizumab; Remdesivir,200,https://clinicaltrials.gov/show/NCT04583956,None
3855,6925,NCT04583969,ClinicalTrials.gov,2020-10-09,2020-10-19,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 2,Interventional,United States,ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19,Drug,Lenzilumab + Remdesivir vs. Remdesivir,Lenzilumab; Remdesivir,200,https://clinicaltrials.gov/show/NCT04583969,None
3856,6927,NCT04584567,ClinicalTrials.gov,2020-10-06,2020-11-20,False,Hedi Gharsallah,Recruiting,Phase 3,Interventional,Tunisia,"OD-doxy-PNV-COV Old Drug "" DOXY "" for Prevention of New Virus Virus OD-doxy-PNV",Drug,Doxycyclin,Doxycyclin,1100,https://clinicaltrials.gov/show/NCT04584567,None
3857,6930,NCT04588792,ClinicalTrials.gov,2020-10-14,2020-12-11,False,Queen's University,Recruiting,Phase 2/Phase 3,Interventional,Canada,Furosemide as Supportive Therapy for COVID-19 Respiratory Failure,Drug,Furosemide,Furosemide,640,https://clinicaltrials.gov/show/NCT04588792,None
3858,6932,NCT04592549,ClinicalTrials.gov,2020-10-12,2020-12-04,False,Ology Bioservices,Recruiting,Phase 1,Interventional,United States,"This is a Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of ADM03820, a Monoclonal Antibody Cocktail Being Tested for the Treatment and Prevention of COVID-19",Drug,ADM03820,ADM03820,40,https://clinicaltrials.gov/show/NCT04592549,None
3859,6933,NCT04595773,ClinicalTrials.gov,2020-10-20,2020-12-17,False,National Institutes of Health Clinical Center (CC),Not Recruiting,Phase 1/Phase 2,Interventional,United States,"COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE)",Other (exercise),Exercise,Exercise,90,https://clinicaltrials.gov/show/NCT04595773,None
3860,6934,NCT04601077,ClinicalTrials.gov,2020-10-21,2020-11-01,False,Nitric Oxide Innovations LLC,Recruiting,Phase 1/Phase 2,Interventional,United States,The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African Americans,Drug,Nitric Oxide,Nitric Oxide,100,https://clinicaltrials.gov/show/NCT04601077,None
3861,6936,NCT04602507,ClinicalTrials.gov,2020-10-22,2020-12-07,False,CES University,Recruiting,Phase 2,Interventional,Colombia,Ivermectin in Adults With Severe COVID-19.,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04602507,None
3862,6937,NCT04603690,ClinicalTrials.gov,2020-10-24,2020-12-15,False,Liaquat University of Medical & Health Sciences,Not Recruiting,Phase 3,Interventional,No Country Given,Study to Investigate the Benefits of Colchicine in Patients With COVID-19,Drug,Colchicine,Colchicine,0,https://clinicaltrials.gov/show/NCT04603690,None
3863,6938,NCT04603781,ClinicalTrials.gov,2020-10-03,2020-12-04,False,"University of Texas, Austin",Recruiting,Phase 2/Phase 3,Interventional,United States,CBD Oil for Reducing Emotional Impact of COVID-19,Drug,CBD Oil,CBD Oil,120,https://clinicaltrials.gov/show/NCT04603781,None
3864,6939,NCT04604184,ClinicalTrials.gov,2020-10-26,2020-11-03,False,Boehringer Ingelheim,Recruiting,Phase 2,Interventional,United States,ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19,Drug,BI 764198,BI 764198,90,https://clinicaltrials.gov/show/NCT04604184,None
3865,6940,NCT04605588,ClinicalTrials.gov,2020-10-26,2020-12-02,False,Rutgers University,Recruiting,Phase 2,Interventional,United States,A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19,Drug,Nitazoxanide + Ribavirin + Hydroxychloroquine,itazoxanide; Ribavirin; Hydroxychloroquine,70,https://clinicaltrials.gov/show/NCT04605588,None
3866,6942,NCT04606407,ClinicalTrials.gov,2020-10-22,2020-11-25,False,Beyond Air Inc.,Recruiting,Not Applicable,Interventional,Israel,Inhaled NO for the Treatment of Viral Pneumonia in Adults,Drug,Nitric Oxide,Nitric Oxide,90,https://clinicaltrials.gov/show/NCT04606407,None
3867,6943,NCT04606784,ClinicalTrials.gov,2020-10-27,2020-10-28,False,Ampio Pharmaceuticals. Inc.,Recruiting,Phase 1,Interventional,United States,Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress,Drug,Ampion,Ampion,40,https://clinicaltrials.gov/show/NCT04606784,None
3868,6944,NCT04608097,ClinicalTrials.gov,2020-10-28,2020-10-28,False,Uppsala University,Recruiting,Not Applicable,Interventional,Sweden,Understanding Reactions to Emotional Material in the Media During COVID-19,Other,Other,Other,66,https://clinicaltrials.gov/show/NCT04608097,None
3869,6945,NCT04608201,ClinicalTrials.gov,2020-10-23,2020-12-09,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients,Drug,Nicotine,Nicotine,220,https://clinicaltrials.gov/show/NCT04608201,None
3870,6946,NCT04608266,ClinicalTrials.gov,2020-10-28,2020-12-03,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients,Drug,Camostat Mesilate,Camostat Mesilate,596,https://clinicaltrials.gov/show/NCT04608266,None
3871,6947,NCT04609969,ClinicalTrials.gov,2020-10-28,2020-10-13,True,Centre Hospitalier Régional d'Orleans,Not Recruiting,Not Applicable,Interventional,France,Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04609969,None
3872,6949,NCT04614844,ClinicalTrials.gov,2020-11-02,2020-12-15,False,Yale University,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS),Other (psych),Psychological,Psychological,84,https://clinicaltrials.gov/show/NCT04614844,None
3873,6951,NCT04625725,ClinicalTrials.gov,2020-11-10,2020-11-21,True,AstraZeneca,Recruiting,Phase 3,Interventional,"Belgium, United Kingdom, France, United States, Spain","Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.",Drug (Chemoprophylaxis),AZD1061,AZD1061,5000,https://clinicaltrials.gov/show/NCT04625725,EUCTR2020-004356-16
3874,6952,NCT04625972,ClinicalTrials.gov,2020-11-10,2020-12-02,True,AstraZeneca,Recruiting,Phase 3,Interventional,"United Kingdom, United States","Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults",Drug (Chemoprophylaxis),AZD1061,AZD1061,1125,https://clinicaltrials.gov/show/NCT04625972,EUCTR2020-004719-28
3875,6954,NCT04632537,ClinicalTrials.gov,2020-11-04,2020-12-07,False,Henry M. Jackson Foundation for the Advancement of Military Medicine,Recruiting,Phase 3,Interventional,United States,BCG Vaccination to Prevent COVID-19,ATMP,Vaccine,Vaccine,550,https://clinicaltrials.gov/show/NCT04632537,None
3876,6955,NCT04634318,ClinicalTrials.gov,2020-11-17,2020-12-10,False,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,Recruiting,Not Applicable,Interventional,France,Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae (REHABCOVID),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,118,https://clinicaltrials.gov/show/NCT04634318,None
3877,6956,NCT04634409,ClinicalTrials.gov,2020-11-17,2020-10-29,True,Eli Lilly and Company,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness,Drug,LY3819253 + LY3832479 vs. LY3819253,LY3819253; LY3832479,500,https://clinicaltrials.gov/show/NCT04634409,None
3878,6957,NCT04634903,ClinicalTrials.gov,2020-11-11,2020-11-19,False,Stony Brook University,Not Recruiting,Not Applicable,Interventional,United States,"Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19",Other (psych),Psychological,Psychological,2409,https://clinicaltrials.gov/show/NCT04634903,None
3879,6958,NCT04636034,ClinicalTrials.gov,2020-11-18,2020-12-01,False,University Hospital Bispebjerg and Frederiksberg,Not Recruiting,Phase 3,Interventional,Denmark,The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection,Procedure,Sphenopalatine Ganglion Block,Sphenopalatine Ganglion Block,60,https://clinicaltrials.gov/show/NCT04636034,None
3880,6959,NCT04637867,ClinicalTrials.gov,2020-11-16,2020-11-23,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO),Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04637867,None
3881,6960,NCT04638673,ClinicalTrials.gov,2020-11-18,2020-11-19,False,Medical University of South Carolina,Recruiting,Phase 2,Interventional,United States,NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis,Other (device),vagus nerve stimulation,vagus nerve stimulation,30,https://clinicaltrials.gov/show/NCT04638673,None
3882,6961,NCT04639466,ClinicalTrials.gov,2020-11-04,2020-12-23,False,City of Hope Medical Center,Recruiting,Phase 1,Interventional,United States,"A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19",ATMP,Vaccine,Vaccine,129,https://clinicaltrials.gov/show/NCT04639466,None
3883,6962,NCT04640038,ClinicalTrials.gov,2020-11-19,2020-12-01,False,Children's Hospital of Philadelphia,Recruiting,Phase 3,Interventional,United States,Contrast Enhanced Ultrasound in COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04640038,None
3884,6963,NCT04640168,ClinicalTrials.gov,2020-11-19,2020-11-24,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 3,Interventional,United States,Adaptive COVID-19 Treatment Trial 4 (ACTT-4),Drug,Baricitinib + Remdesivir vs. Remdesivir + Corticosteroids,Baricitinib; Remdesivir; Dexamethasone,1500,https://clinicaltrials.gov/show/NCT04640168,None
3885,6964,NCT04640194,ClinicalTrials.gov,2020-11-20,2020-12-07,True,Boehringer Ingelheim,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19,Drug,Alteplase,Alteplase,270,https://clinicaltrials.gov/show/NCT04640194,EUCTR2020-002913-16
3886,6965,NCT04641858,ClinicalTrials.gov,2020-11-22,2020-12-03,False,University of Southern Denmark,Recruiting,Phase 4,Interventional,"Mozambique, Guinea-Bissau, Cape Verde",BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic,ATMP,Vaccine,Vaccine,1050,https://clinicaltrials.gov/show/NCT04641858,None
3887,6966,NCT04642638,ClinicalTrials.gov,2020-11-23,2020-11-30,False,Inovio Pharmaceuticals,Recruiting,Phase 2/Phase 3,Interventional,United States,"Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure",Drug,INO-4800,INO-4800,6578,https://clinicaltrials.gov/show/NCT04642638,None
3888,6967,NCT04643678,ClinicalTrials.gov,2020-11-24,2020-10-30,True,Hamad Medical Corporation,Recruiting,Phase 2/Phase 3,Interventional,Qatar,Anakinra in the Management of COVID-19 Infection,Drug,Anakinra,Anakinra,80,https://clinicaltrials.gov/show/NCT04643678,None
3889,6969,NCT04646603,ClinicalTrials.gov,2020-11-24,2021-01-05,False,Medical University Innsbruck,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients,Drug,MRG-001,MRG-001,12,https://clinicaltrials.gov/show/NCT04646603,None
3890,6970,NCT04646616,ClinicalTrials.gov,2020-11-25,2021-01-06,False,Drexel University,Not Recruiting,Not Applicable,Interventional,United States,CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia.,Other,Other,Other,800,https://clinicaltrials.gov/show/NCT04646616,None
3891,6972,NCT04647695,ClinicalTrials.gov,2020-11-27,2020-11-20,True,University of Hong Kong,Recruiting,Phase 2,Interventional,Hong Kong,IFN-beta 1b and Remdesivir for COVID19,Drug,Interferon beta + Remdesivir vs. Remdesivir,Interferon beta; Remdesivir,100,https://clinicaltrials.gov/show/NCT04647695,None
3892,6973,NCT04647747,ClinicalTrials.gov,2020-11-27,2020-11-30,False,Østfold Hospital Trust,Not Recruiting,Not Applicable,Interventional,No Country Given,Silent Hypoxia and Awake Proning in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04647747,None
3893,6975,NCT04648800,ClinicalTrials.gov,2020-10-18,2020-07-07,True,Hanna Czajka,Recruiting,Phase 3,Interventional,Poland,Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland,ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04648800,EUCTR2020-002111-22
3894,6976,NCT04649086,ClinicalTrials.gov,2020-09-29,2020-06-05,True,"University Hospital, Clermont-Ferrand",Recruiting,Not Applicable,Interventional,France,Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,120,https://clinicaltrials.gov/show/NCT04649086,None
3895,6977,NCT04649151,ClinicalTrials.gov,2020-11-30,2020-11-30,False,"ModernaTX, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,United States,"A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19",ATMP,Vaccine,Vaccine,3000,https://clinicaltrials.gov/show/NCT04649151,None
3896,6980,NCT04649424,ClinicalTrials.gov,2020-11-27,2020-12-01,False,Orthopaedic Innovation Centre,Not Recruiting,Not Applicable,Interventional,Canada,COVID-19 Nasal Swab Trial,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,72,https://clinicaltrials.gov/show/NCT04649424,None
3897,6981,NCT04649515,ClinicalTrials.gov,2020-11-26,2020-12-04,False,Tychan Pte Ltd.,Recruiting,Phase 3,Interventional,Singapore,"Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans",Drug,TY027,TY027,1305,https://clinicaltrials.gov/show/NCT04649515,None
3898,6983,NCT04649736,ClinicalTrials.gov,2020-11-30,2020-10-26,True,Universidad Peruana Cayetano Heredia,Recruiting,Not Applicable,Interventional,Peru,Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,108,https://clinicaltrials.gov/show/NCT04649736,None
3899,6984,NCT04649775,ClinicalTrials.gov,2020-10-14,2020-12-04,False,Duke University,Not Recruiting,Not Applicable,Interventional,No Country Given,AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19,Drug,Oxygen,Oxygen,50,https://clinicaltrials.gov/show/NCT04649775,None
3900,6987,NCT04649879,ClinicalTrials.gov,2020-12-01,2020-12-03,False,Joakim Dillner,Not Recruiting,Phase 2/Phase 3,Interventional,Sweden,Convalescent Plasma for Treatment of COVID-19: An Open Randomised Controlled Trial,ATMP,Plasma,Plasma,920,https://clinicaltrials.gov/show/NCT04649879,None
3901,6994,NCT04650087,ClinicalTrials.gov,2020-11-30,2020-12-01,False,Dr. Thomas Ortel,Not Recruiting,Phase 3,Interventional,No Country Given,COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis,Drug,Apixaban,Apixaban,5320,https://clinicaltrials.gov/show/NCT04650087,None
3902,6997,NCT04651374,ClinicalTrials.gov,2020-11-27,2020-12-01,False,Lawson Health Research Institute,Not Recruiting,Not Applicable,Interventional,Canada,COVID-19 And Geko Evaluation: The CAGE Study,Other (device),Geko device,Geko device,40,https://clinicaltrials.gov/show/NCT04651374,None
3903,6998,NCT04651387,ClinicalTrials.gov,2020-12-01,2021-01-01,False,Neuromed IRCCS,Not Recruiting,Not Applicable,Interventional,No Country Given,Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients,Supplement,Ozonised Oil,Ozonised Oil,74,https://clinicaltrials.gov/show/NCT04651387,None
3904,7001,NCT04651790,ClinicalTrials.gov,2020-11-20,2020-11-27,False,Pontificia Universidad Católica de Chile,Recruiting,Phase 3,Interventional,Chile,"Efficacy, Safety, and Immunogenicity of an Inactivated Vaccine Against COVID-19 in High Infection Risk Adults",ATMP,Vaccine,Vaccine,2300,https://clinicaltrials.gov/show/NCT04651790,None
3905,7002,NCT04652102,ClinicalTrials.gov,2020-12-01,2020-11-30,True,CureVac AG,Not Recruiting,Phase 2/Phase 3,Interventional,Germany,A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults,ATMP,Vaccine,Vaccine,36500,https://clinicaltrials.gov/show/NCT04652102,EUCTR2020-003998-22
3906,7003,NCT04652115,ClinicalTrials.gov,2020-12-01,2021-01-01,False,Brigham and Women's Hospital,Not Recruiting,Phase 2,Interventional,United States,A Single-Arm Safety and Feasibility Study of Defibrotide for the Treatment of Severe COVID-19,Drug,Defibrotide,Defibrotide,42,https://clinicaltrials.gov/show/NCT04652115,None
3907,7005,NCT04652518,ClinicalTrials.gov,2020-12-02,2020-12-01,True,PureTech,Not Recruiting,Phase 2,Interventional,"Romania, United States",LYT-100 in Post-acute COVID-19 Respiratory Disease,Drug,LYT-100,LYT-100,168,https://clinicaltrials.gov/show/NCT04652518,None
3908,7006,NCT04652596,ClinicalTrials.gov,2020-11-30,2021-01-01,False,Boston Medical Center,Not Recruiting,Not Applicable,Interventional,United States,Reducing Food Insecurity During COVID-19,Other,Other,Other,250,https://clinicaltrials.gov/show/NCT04652596,None
3909,7007,NCT04652648,ClinicalTrials.gov,2020-12-02,2020-05-27,True,Bryn Mawr Hospital,Not Recruiting,Phase 4,Interventional,United States,Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,54,https://clinicaltrials.gov/show/NCT04652648,None
3910,7008,NCT04652674,ClinicalTrials.gov,2020-12-02,2020-09-28,True,Cedars-Sinai Medical Center,Recruiting,Not Applicable,Interventional,United States,Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic: A Prospective Randomized Trial,Telehealth,Telehealth,Telehealth,70,https://clinicaltrials.gov/show/NCT04652674,None
3911,7009,NCT04652765,ClinicalTrials.gov,2020-12-02,2021-01-01,False,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Not Recruiting,Phase 1,Interventional,United States,Camostat With Bicalutamide for COVID-19,Drug,Camostat Mesilate + Bicalutamide vs. Camostat Mesilate,Camostat Mesilate; Bicalutamide,60,https://clinicaltrials.gov/show/NCT04652765,None
3912,7011,NCT04653831,ClinicalTrials.gov,2020-10-27,2020-11-08,False,Soroka University Medical Center,Recruiting,Not Applicable,Interventional,Israel,Treatment With Pirfenidone for COVID-19 Related Severe ARDS,Drug,Pirfenidone,Pirfenidone,100,https://clinicaltrials.gov/show/NCT04653831,None
3913,7014,NCT04654325,ClinicalTrials.gov,2020-11-30,2020-12-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,1280,https://clinicaltrials.gov/show/NCT04654325,None
3914,7017,NCT04654481,ClinicalTrials.gov,2020-12-03,2020-12-01,True,Icahn School of Medicine at Mount Sinai,Recruiting,Not Applicable,Interventional,United States,Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic,Other (device),high frequency chest wall oscillation,high frequency chest wall oscillation,30,https://clinicaltrials.gov/show/NCT04654481,None
3915,7019,NCT04655586,ClinicalTrials.gov,2020-12-02,2020-12-04,False,"ARCA Biopharma, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19",Drug,rNAPc2 vs. Heparin,rNAPc2; Heparin,100,https://clinicaltrials.gov/show/NCT04655586,None
3916,7021,NCT04655625,ClinicalTrials.gov,2020-11-26,2020-11-23,True,"AnGes, Inc.",Recruiting,Phase 2/Phase 3,Interventional,Japan,Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19),ATMP,Vaccine,Vaccine,500,https://clinicaltrials.gov/show/NCT04655625,JPRN-jRCT2051200088
3917,7022,NCT04655638,ClinicalTrials.gov,2020-12-03,2021-01-10,False,AOU Policlinico Paolo Giaccone Palermo,Not Recruiting,Not Applicable,Interventional,Italy,HFNT vs. COT in COVID-19,Other (device),Nasal cannula,Nasal cannula,364,https://clinicaltrials.gov/show/NCT04655638,None
3918,7023,NCT04655716,ClinicalTrials.gov,2020-12-04,2021-02-01,False,Guy's and St Thomas' NHS Foundation Trust,Not Recruiting,Phase 3,Interventional,No Country Given,Urine Alkalinisation to Prevent AKI in COVID-19,Drug,Sodium bicarbonate,Sodium bicarbonate,80,https://clinicaltrials.gov/show/NCT04655716,None
3919,7025,NCT04656613,ClinicalTrials.gov,2020-11-30,2020-12-01,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Not Recruiting,Phase 3,Interventional,No Country Given,A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE,ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04656613,None
3920,7026,NCT04656626,ClinicalTrials.gov,2020-12-04,2020-07-07,True,Imam Abdulrahman Bin Faisal University,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Brief Mindfulness Based Intervention to Improve Psychological Wellbeing,Other (psych),Psychological,Psychological,146,https://clinicaltrials.gov/show/NCT04656626,None
3921,7027,NCT04656691,ClinicalTrials.gov,2020-12-04,2020-12-01,True,Dr. Daniel Griffin,Not Recruiting,Phase 4,Interventional,No Country Given,At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19,Drug,Bamlanivimab,Bamlanivimab,7500,https://clinicaltrials.gov/show/NCT04656691,None
3922,7033,NCT04657484,ClinicalTrials.gov,2020-12-05,2020-12-10,False,Postgraduate Institute of Medical Education and Research,Recruiting,Not Applicable,Interventional,India,Comparison of Two Corticosteroid Regimens for Post-COVID Diffuse Lung Disease,Drug,Corticosteroids,Prednisolone,100,https://clinicaltrials.gov/show/NCT04657484,None
3923,7034,NCT04657497,ClinicalTrials.gov,2020-11-09,2020-11-09,False,Ono Pharmaceutical Co. Ltd,Recruiting,Phase 3,Interventional,Japan,A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19),Drug,FOY-305,FOY-305,110,https://clinicaltrials.gov/show/NCT04657497,None
3924,7036,NCT04657809,ClinicalTrials.gov,2020-12-02,2020-12-01,True,Soad Ali,Not Recruiting,Phase 2,Interventional,Egypt,Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia,Drug,Insulin,Insulin,40,https://clinicaltrials.gov/show/NCT04657809,None
3925,7038,NCT04658433,ClinicalTrials.gov,2020-12-05,2020-12-05,False,Applied Science Private University,Recruiting,Not Applicable,Interventional,Jordan,The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People,Drug,Omega 3,Omega 3,100,https://clinicaltrials.gov/show/NCT04658433,None
3926,7039,NCT04658979,ClinicalTrials.gov,2020-12-02,2020-12-01,True,Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec,Recruiting,Not Applicable,Interventional,Canada,Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04658979,None
3927,7040,NCT04659109,ClinicalTrials.gov,2020-11-30,2020-12-01,True,Acticor Biotech,Not Recruiting,Phase 2,Interventional,No Country Given,Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19,Drug,Glenzocimab,Glenzocimab,60,https://clinicaltrials.gov/show/NCT04659109,EUCTR2020-002733-15
3928,7041,NCT04659122,ClinicalTrials.gov,2020-12-04,2021-01-01,False,"Airway Therapeutics, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection,Drug,AT-100,AT-100,9,https://clinicaltrials.gov/show/NCT04659122,None
3929,7045,NCT04659239,ClinicalTrials.gov,2020-12-05,2020-12-01,True,Chinese Academy of Medical Sciences,Not Recruiting,Phase 3,Interventional,"Brazil, Malaysia","The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19",ATMP,Vaccine,Vaccine,34020,https://clinicaltrials.gov/show/NCT04659239,None
3930,7047,NCT04659304,ClinicalTrials.gov,2020-12-07,2021-03-01,False,Enlivex Therapeutics Ltd.,Not Recruiting,Phase 1,Interventional,No Country Given,"Study Evaluating Safety, Tolerability and Efficacy of Allocetra-OTS in Patients With COVID-19",ATMP,Cells (allogenic),Cells (allogenic),50,https://clinicaltrials.gov/show/NCT04659304,None
3931,7049,NCT04659460,ClinicalTrials.gov,2020-07-03,2020-12-15,False,"St. Michael's Hospital, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study,Other (device),Remote Ischemic Conditioning,Remote Ischemic Conditioning,30,https://clinicaltrials.gov/show/NCT04659460,None
3932,7051,NCT04659486,ClinicalTrials.gov,2020-12-01,2020-09-24,True,University of São Paulo,Recruiting,Not Applicable,Interventional,Brazil,Adolescents With COVID-19/MIS-C at HCFMUSP,Other (exercise),Exercise,Exercise,100,https://clinicaltrials.gov/show/NCT04659486,None
3933,7052,NCT04659707,ClinicalTrials.gov,2020-12-07,2021-01-01,False,University of Kansas Medical Center,Not Recruiting,Phase 1,Interventional,No Country Given,Hyperpolarized 129Xe MRI of Survivors of COVID-19,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04659707,None
3934,7053,NCT04659746,ClinicalTrials.gov,2020-12-07,2020-12-09,False,Universidad Autónoma de Encarnación,Not Recruiting,Not Applicable,Interventional,Paraguay,MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay,Other (software),eHealth,eHealth,96,https://clinicaltrials.gov/show/NCT04659746,None
3935,7055,NCT04659772,ClinicalTrials.gov,2020-12-07,2020-12-01,True,Ayan Sen,Recruiting,Phase 2,Interventional,United States,A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,30,https://clinicaltrials.gov/show/NCT04659772,None
3936,7058,NCT04659928,ClinicalTrials.gov,2020-11-30,2020-12-01,False,"University of Texas Health Science Center, Houston",Not Recruiting,Phase 4,Interventional,United States,Evaluation of Aerosol in a Dental Clinic,Other,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04659928,None
3937,7059,NCT04659941,ClinicalTrials.gov,2020-12-08,2020-10-01,True,Universidade Federal do Rio de Janeiro,Recruiting,Phase 2,Interventional,Brazil,Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers,ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04659941,None
3938,7061,NCT04661410,ClinicalTrials.gov,2020-12-07,2020-12-01,True,Drexel University,Recruiting,Not Applicable,Interventional,United States,Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic,Other,Other,Other,60,https://clinicaltrials.gov/show/NCT04661410,None
3939,7062,NCT04661423,ClinicalTrials.gov,2020-12-07,2021-01-01,False,IHU Strasbourg,Not Recruiting,Not Applicable,Interventional,France,Use of RDS MultiSenseÂ® in Post-ICU Patients in the COVID-19 Era,Other (device),Biosensors,Biosensors,60,https://clinicaltrials.gov/show/NCT04661423,None
3940,7064,NCT04661527,ClinicalTrials.gov,2020-09-10,2020-04-22,True,Clínica Universidad de Navarra,Recruiting,Phase 2,Interventional,Spain,Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19,Drug,Sarilumab,Sarilumab,60,https://clinicaltrials.gov/show/NCT04661527,EUCTR2020-001255-40
3941,7065,NCT04661540,ClinicalTrials.gov,2020-12-04,2020-12-01,True,"CalciMedica, Inc.",Not Recruiting,Phase 2,Interventional,United States,A Study of Auxora in Patients With Critical COVID-19 Pneumonia,Drug,CM4620-IE,CM4620-IE,36,https://clinicaltrials.gov/show/NCT04661540,None
3942,7068,NCT04661813,ClinicalTrials.gov,2020-10-29,2021-02-01,False,Case Western Reserve University,Not Recruiting,Not Applicable,Interventional,United States,Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV,Other,Other,Other,75,https://clinicaltrials.gov/show/NCT04661813,None
3943,7069,NCT04661839,ClinicalTrials.gov,2020-12-09,2020-12-01,True,Emergent BioSolutions,Recruiting,Phase 1,Interventional,United States,Phase 1 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered as a Single Dose or a Repeat Dose in Healthy Adults,ATMP,Immunoglobulin,Immunoglobulin,56,https://clinicaltrials.gov/show/NCT04661839,None
3944,7070,NCT04661930,ClinicalTrials.gov,2020-12-09,2020-12-13,False,Hebrew University of Jerusalem,Recruiting,Phase 3,Interventional,Israel,Fenofibrate for Patients With COVID-19 Requiring Hospitalization,Drug,Fenofibrate,Fenofibrate,50,https://clinicaltrials.gov/show/NCT04661930,None
3945,7071,NCT04662021,ClinicalTrials.gov,2020-12-04,2020-12-10,False,Cairo University,Recruiting,Not Applicable,Interventional,Egypt,Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety,Other (psych),Psychological,Psychological,40,https://clinicaltrials.gov/show/NCT04662021,None
3946,7072,NCT04662060,ClinicalTrials.gov,2020-12-08,2021-01-01,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol,Drug,Acebilustat,Acebilustat,120,https://clinicaltrials.gov/show/NCT04662060,None
3947,7073,NCT04662073,ClinicalTrials.gov,2020-12-08,2021-01-01,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol,Drug,Camostat Mesilate,Camostat Mesilate,120,https://clinicaltrials.gov/show/NCT04662073,None
3948,7074,NCT04662086,ClinicalTrials.gov,2020-12-08,2021-01-01,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol,Drug,Acebilustat vs. Camostat Mesilate,Acebilustat; Camostat Mesilate,240,https://clinicaltrials.gov/show/NCT04662086,None
3949,7076,NCT04662671,ClinicalTrials.gov,2020-12-09,2020-11-18,True,EmitBio Inc.,Recruiting,Phase 1/Phase 2,Interventional,United States,"Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19",Other (device),RD-X19,RD-X19,60,https://clinicaltrials.gov/show/NCT04662671,None
3950,7077,NCT04662684,ClinicalTrials.gov,2020-12-08,2020-10-16,True,Science Valley Research Institute,Recruiting,Phase 3,Interventional,Brazil,Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial,Drug,Rivaroxaban,Rivaroxaban,320,https://clinicaltrials.gov/show/NCT04662684,None
3951,7078,NCT04662697,ClinicalTrials.gov,2020-12-09,2020-12-11,False,Medicago,Not Recruiting,Phase 2,Interventional,No Country Given,Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults (USA),ATMP,Vaccine,Vaccine,918,https://clinicaltrials.gov/show/NCT04662697,None
3952,7079,NCT04663555,ClinicalTrials.gov,2020-12-09,2021-01-01,False,Brno University Hospital,Not Recruiting,Phase 4,Interventional,Czech Republic,Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19,Drug,Corticosteroids,Dexamethasone,300,https://clinicaltrials.gov/show/NCT04663555,None
3953,7080,NCT04663594,ClinicalTrials.gov,2020-11-27,2020-12-04,False,University of Oxford,Not Recruiting,Not Applicable,Interventional,No Country Given,Online Culture for Mental Health in People Aged 16-24,Other (psych),Psychological,Psychological,400,https://clinicaltrials.gov/show/NCT04663594,None
3954,7082,NCT04663737,ClinicalTrials.gov,2020-12-01,2020-12-03,False,Dr. Chris Recknor,Recruiting,Phase 2,Interventional,United States,"Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19",Drug,Silmitasertib,Silmitasertib,20,https://clinicaltrials.gov/show/NCT04663737,None
3955,7085,NCT04663945,ClinicalTrials.gov,2020-12-08,2020-12-15,False,"University of Colorado, Denver",Not Recruiting,Not Applicable,Interventional,No Country Given,Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,45,https://clinicaltrials.gov/show/NCT04663945,None
3956,7086,NCT04664010,ClinicalTrials.gov,2020-12-07,2020-02-06,True,Xi'an International Medical Center Hospital,Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,https://clinicaltrials.gov/show/NCT04664010,None
3957,7090,NCT04664101,ClinicalTrials.gov,2020-12-10,2021-01-01,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,"REmotely Monitored, Mobile Health Supported High Intensity Interval Training for Survivors of COVID-19",Other (exercise),Exercise,Exercise,30,https://clinicaltrials.gov/show/NCT04664101,None
3958,7093,NCT04665115,ClinicalTrials.gov,2020-12-10,2020-12-31,False,Academic and Community Cancer Research United,Not Recruiting,Phase 2,Interventional,United States,Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19),Drug,Ibrutinib,Ibrutinib,134,https://clinicaltrials.gov/show/NCT04665115,None
3959,7094,NCT04665193,ClinicalTrials.gov,2020-12-08,2020-11-23,True,University of British Columbia,Recruiting,Not Applicable,Interventional,Canada,An Approach to Screening for COVID-19 at Vancouver Airport,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,900,https://clinicaltrials.gov/show/NCT04665193,None
3960,7100,NCT04666012,ClinicalTrials.gov,2020-12-10,2021-01-01,False,"Cellid Co., Ltd.",Not Recruiting,Phase 1/Phase 2,Interventional,South Korea,Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers,ATMP,Vaccine,Vaccine,150,https://clinicaltrials.gov/show/NCT04666012,None
3961,7103,NCT04666116,ClinicalTrials.gov,2020-04-25,2020-04-01,True,Hospital de Sagunto,Recruiting,Not Applicable,Interventional,Spain,Changes in Viral Load in COVID-19 After Probiotics,Supplement,Probiotics,Probiotics,96,https://clinicaltrials.gov/show/NCT04666116,None
3962,7105,NCT04666233,ClinicalTrials.gov,2020-12-11,2021-01-01,False,University Hospital Padova,Not Recruiting,Not Applicable,Interventional,No Country Given,Personal Protective Equipment for the Prevention of SARS-Cov-2 During Neonatal Resuscitation,Other (device),PPE,PPE,48,https://clinicaltrials.gov/show/NCT04666233,None
3963,7109,NCT04666441,ClinicalTrials.gov,2020-12-10,2020-12-15,False,Regeneron Pharmaceuticals,Not Recruiting,Phase 2,Interventional,United States,A Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection,Drug,REGN10933 + REGN10987,REGN10933; REGN10987,1400,https://clinicaltrials.gov/show/NCT04666441,None
3964,7110,NCT04666493,ClinicalTrials.gov,2020-12-11,2020-12-04,True,Evdokia Anagnostou,Recruiting,Not Applicable,Interventional,Canada,Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04666493,None
3965,7111,NCT04666558,ClinicalTrials.gov,2020-11-30,2020-11-30,False,University of Alberta,Recruiting,Not Applicable,Interventional,Canada,Heal-Me Personalized Online Nutrition and Exercise Routines,Other (exercise),Exercise,Exercise,216,https://clinicaltrials.gov/show/NCT04666558,None
3966,7114,NCT04667247,ClinicalTrials.gov,2020-12-03,2020-12-03,False,Gordon Saxe,Recruiting,Phase 1/Phase 2,Interventional,United States,Mushroom-based Product for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,66,https://clinicaltrials.gov/show/NCT04667247,None
3967,7115,NCT04667286,ClinicalTrials.gov,2020-12-11,2020-12-30,False,AOU di Bologna Policlinico S.Orsola-Malpighi,Not Recruiting,Not Applicable,Interventional,No Country Given,Awake Pronation for Covid-19 Treatment,Procedure,Positioning,Positioning,100,https://clinicaltrials.gov/show/NCT04667286,None
3968,7118,ISRCTN27106947,ISRCTN,2020-12-07,2020-08-09,True,University of Liverpool,Recruiting,Phase 1/Phase 2,Interventional,"United Kingdom, South Africa",A study to assess several different treatments that may be useful for patients with COVID-19,Drug,EIDD-2801,EIDD-2801,180,http://isrctn.com/ISRCTN27106947,EUCTR2020-001860-27
3969,7119,ISRCTN11713182,ISRCTN,2020-12-02,2020-12-21,True,University of Oxford,Recruiting,Not Applicable,Interventional,United Kingdom,Testing the effectiveness of almitrine bismesylate in the treatment of COVID-19,Drug,Almitrine Bimesylate,Almitrine Bimesylate,116,http://isrctn.com/ISRCTN11713182,EUCTR2020-002567-57
3970,7121,ISRCTN19845486,ISRCTN,2020-12-02,2020-01-07,True,University College Dublin,Recruiting,Not Applicable,Interventional,Ireland,"VR Baby, a virtual reality learning environment - does it help medical students to learn about complex topics in obstetrics and gynaecology?",Not relevant,Not relevant,Not relevant,40,http://isrctn.com/ISRCTN19845486,None
3971,7122,ISRCTN77689525,ISRCTN,2020-12-02,2020-08-25,True,Stellenbosch University,Recruiting,Not Applicable,Interventional,"Tanzania, Zambia, Uganda","Sharing Stories: A digital intervention for caregivers with young children in the COVID-19 era to promote child social, emotional and language development, responsive parenting and parental mental wellbeing in Zambia, Tanzania, and Uganda",Other (psych),Psychological,Psychological,720,http://isrctn.com/ISRCTN77689525,None
3972,7124,ISRCTN77941736,ISRCTN,2020-11-23,2020-11-14,True,University of Oxford,Recruiting,Not Applicable,Interventional,United Kingdom,Coping during COVID-19: Peer-delivered training to improve adolescent wellbeing,Other (psych),Psychological,Psychological,120,http://isrctn.com/ISRCTN77941736,None
3973,7127,ISRCTN10989132,ISRCTN,2020-11-06,2021-01-02,False,University of Bristol,Recruiting,Not Applicable,Interventional,United Kingdom,ASK: Improving access to kidney transplantation,Not relevant,Not relevant,Not relevant,60,http://isrctn.com/ISRCTN10989132,None
3974,7129,ISRCTN89951424,ISRCTN,2020-06-11,2020-06-15,False,University of Oxford,Recruiting,Phase 3,Interventional,Brazil,A phase III study to investigate a vaccine against COVID-19,ATMP,Vaccine,Vaccine,10300,http://isrctn.com/ISRCTN89951424,None
3975,7130,ISRCTN59048638,ISRCTN,2020-06-04,2020-06-15,False,CLINEDEM,Not Recruiting,Not Applicable,Interventional,Mexico,Sulodexide in the treatment of COVID-19,Drug,Sulodexide,Sulodexide,200,http://isrctn.com/ISRCTN59048638,None
3976,7132,ISRCTN37530113,ISRCTN,2020-01-31,2017-04-09,True,Central Norway Regional Health Authority,Recruiting,Not Applicable,Interventional,Norway,Enhanced cognitive behavioral therapy for children and adolescents with obsessive compulsive disorder: an open trial,Other (psych),Psychological,Psychological,70,http://isrctn.com/ISRCTN37530113,None
3977,7133,ACTRN12620000417987,ANZCTR,2020-03-30,2020-03-04,True,Australian Defence Force Malaria and Infectious Disease Institute,Not Recruiting,Phase 4,Interventional,Australia,Chloroquine Chemorophylaxis Countermeasure against COVID-19,Drug,Chloroquine,Chloroquine,680,https://anzctr.org.au/ACTRN12620000417987.aspx,None
3978,7134,ACTRN12620000555954,ANZCTR,2020-05-11,2020-06-15,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,"Randomised controlled trial of an app-based intervention, Anchored, to support the mental health of Australians recently unemployed due to COVID-19.",Other (psych),Psychological,Psychological,780,https://anzctr.org.au/ACTRN12620000555954.aspx,None
3979,7135,ACTRN12620000501943,ANZCTR,2020-04-22,2020-05-20,False,Walter and Eliza Hall Institute of Medical Research,Recruiting,Phase 2/Phase 3,Interventional,Australia,COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers: The COVID-SHIELD Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,650,https://anzctr.org.au/ACTRN12620000501943.aspx,None
3980,7136,ACTRN12620000636954,ANZCTR,2020-05-29,2020-07-23,False,South Western Sydney Local Health District,Recruiting,Not Applicable,Interventional,Australia,COACHING FOR COVID-19: A Pilot Study Investigating the Effectiveness of Coaching on Psychological Outcomes in Hospital-Based Senior Doctors,Other (psych),Psychological,Psychological,35,https://anzctr.org.au/ACTRN12620000636954.aspx,None
3981,7137,ACTRN12620001308987,ANZCTR,2020-12-04,2020-09-12,True,Accelagen Pty Ltd,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,"A Phase 1/2 randomized, placebo-controlled, multi-centre study to evaluate the safety and immunogenicity of a novel Receptor Binding Domain (RBD) COVID-19 Vaccine in Healthy Adults",ARMP,Vaccine,Vaccine,255,https://anzctr.org.au/ACTRN12620001308987.aspx,None
3982,7138,ChiCTR2000038672,ChiCTR,2020-09-27,2020-11-05,False,Beijing Ditan Hospital,Not Recruiting,Phase 1,Interventional,China,"A single-site, single-arm,open Phase I Study to Evaluate the Safety,tolerability and pharmacokinetic of CD24Fc in healthy adults",Drug,CD24Fc,CD24Fc,12,http://www.chictr.org.cn/showproj.aspx?proj=59313,None
3983,7139,ChiCTR2000038343,ChiCTR,2020-09-19,2020-10-01,False,The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Evaluation of primary preventive measures in populations at high risk for novel coronavirus pneumonia (COVID-19) sequelae osteonecrosis of the femoral head -- a prospective randomized controlled trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=61668,None
3984,7140,ChiCTR2000038333,ChiCTR,2020-09-18,2020-10-01,False,The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study on Screening and prevention of osteonecrosis of the femoral head during novel coronavirus pneumonia (COVID-19) recovery,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=61769,None
3985,7141,EUCTR2020-003368-24-DE,EU Clinical Trials Register,2020-09-25,2020-07-12,True,Merck Sharp & Dohme Corp.,Authorised,Phase 2/Phase 3,Interventional,"Russian Federation, Philippines, Sweden, Chile, Canada, South Africa, Ukraine, United Kingdom, Italy, France, Israel, Brazil, United States, Germany, Spain, Colombia, Mexico",MK-4482 Ph 2/3 Study in Non-Hospitalized Participants with COVID-19,Drug,MK-4482,MK-4482,1450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003368-24,None
3986,7142,EUCTR2020-002502-75-DE,EU Clinical Trials Register,2020-06-26,2020-11-26,False,"University Hospital, Tübingen",Authorised,Phase 2,Interventional,Germany,Covid-19 Vaccination Trial,ATMP,Vaccine,Vaccine,36,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002502-75,None
3987,7143,EUCTR2020-001632-10-DE,EU Clinical Trials Register,2020-04-20,2020-04-05,True,"University Hospital, Heidelberg",Authorised,Phase 2,Interventional,Germany,A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease,ATMP,Plasma,Plasma,174,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001632-10,None
3988,7150,NL8523,Netherlands Trial Register,2020-04-13,2020-04-26,False,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,Volatile Anaesthetics in COVID-19 â€“ a pilot study,Drug,Isoflurane,Isoflurane,20,https://trialregister.nl/trial/8523,None
3989,7158,NL8521,Netherlands Trial Register,2020-04-13,2020-08-05,False,UMC Amsterdam,Not Recruiting,Not Applicable,Interventional,Netherlands,Continuous positive airway pressure in severe Covid-19 pneumonia,Drug,Oxygen,Oxygen,13,https://trialregister.nl/trial/8521,None
3990,7161,NL8578,Netherlands Trial Register,2020-05-02,2020-07-13,False,Rode Kruis Ziekenhuis Beverwijk,Not Recruiting,Not Applicable,Interventional,Netherlands,Alkaline phosphatase for reducing systemic inflammatory response syndrome (SIRS) in patients with Sars-CoV-2 infection and acute respiratory insufficiency (COVID 19),Drug,Alkaline phosphatase,Alkaline phosphatase,124,https://trialregister.nl/trial/8578,None
3991,7162,NL8577,Netherlands Trial Register,2020-05-06,2020-05-15,False,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,Other (software),eHealth,eHealth,394,https://trialregister.nl/trial/8577,None
3992,7168,NL8609,Netherlands Trial Register,2020-05-11,2020-05-25,False,Radboud University Medical Centre,Not Recruiting,Not Applicable,Interventional,Netherlands,Enhancing the BCG-induced trained immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against COVID-19 (BCG-PLUS),ATMP,Vaccine,Vaccine,100,https://trialregister.nl/trial/8609,None
3993,7174,NL8633,Netherlands Trial Register,2020-05-13,2020-05-13,False,Leiden University Medical Center,Recruiting,Not Applicable,Interventional,Netherlands,"A randomized, double blinded clinical trial of convalescent plasma compared to standard plasma for treatment of hospitalized non-ICU patients with COVID-19 infections",ATMP,Plasma,Plasma,430,https://trialregister.nl/trial/8633,None
3994,7183,NL8726,Netherlands Trial Register,2020-06-23,2020-01-06,True,CHDR,Recruiting,Not Applicable,Interventional,Netherlands,Effect of hydroxychloroquine treatment on the general immunocompetence,Drug,Hydroxychloroquine,Hydroxychloroquine,40,https://trialregister.nl/trial/8726,None
3995,7186,NL8490,Netherlands Trial Register,2020-03-31,2020-12-04,False,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,"An open label randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19
",Drug,Chloroquine vs. hydroxychloroquine,Chloroquine; hydroxychloroquine,950,https://trialregister.nl/trial/8490,None
3996,7187,NL8538,Netherlands Trial Register,2020-04-17,2020-04-17,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,Netherlands,Sleep position related to hospital length of stay in admitted COVID-19 patients,Procedure,Positioning,Positioning,342,https://trialregister.nl/trial/8538,None
3997,7189,NL8787,Netherlands Trial Register,2020-07-21,2020-01-06,True,Leiden University Medical Center,Recruiting,Not Applicable,Interventional,Netherlands,COVID-VTE follow-up study,Clinical Presentation,No Intervention,No Intervention,400,https://trialregister.nl/trial/8787,None
3998,7193,NL8477,Netherlands Trial Register,2020-03-20,2020-03-20,False,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,BCG vaccination for healthcare workers in SARS-CoV-2 pandemic,ATMP,Vaccine,Vaccine,1500,https://trialregister.nl/trial/8477,None
3999,7194,NL8835,Netherlands Trial Register,2020-08-14,2020-06-29,True,Erasmus Medical Center,Recruiting,Not Applicable,Interventional,Netherlands,"Intensive Care Unit specific Virtual Reality (ICU-VR) to improve psychological impairments in survivors of COVID-19; a multicentre, randomised controlled trial.",Other (psych),Psychological,Psychological,80,https://trialregister.nl/trial/8835,None
4000,7197,NL8842,Netherlands Trial Register,2020-08-18,2020-09-04,False,Drs. Sasja Duijff & Eva Potharst,Recruiting,Not Applicable,Interventional,Netherlands,Online Communities,Other (psych),Psychological,Psychological,50,https://trialregister.nl/trial/8842,None
4001,7201,NL8903,Netherlands Trial Register,2020-09-15,2020-09-15,False,Reade Research BV,Recruiting,Not Applicable,Interventional,Netherlands,A diet for the treatment of gout,Not relevant,Not relevant,Not relevant,30,https://trialregister.nl/trial/8903,None
4002,7204,NL8922,Netherlands Trial Register,2020-09-23,2020-01-10,True,Sint Maartenskliniek,Not Recruiting,Not Applicable,Interventional,Netherlands,"COntinuation Versus Interruption of Immunomodulating Drugs in case of an Infectious disease in IMID patients (COVID I2 study), with special attention for COVID 19: a pragmatic, explorative randomized controlled trial",Drug,Immunomodulatory agents,Immunomodulatory agents,2200,https://trialregister.nl/trial/8922,None
4003,7206,NL8947,Netherlands Trial Register,2020-10-04,2020-05-10,True,UMC Amsterdam,Recruiting,Not Applicable,Interventional,Netherlands,ReCOVer: Cognitive Behavioural Therapy for post-COVID-19 fatigue,Other (psych),Psychological,Psychological,114,https://trialregister.nl/trial/8947,None
4004,7207,NL8993,Netherlands Trial Register,2020-10-21,2020-01-07,True,Utrecht University,Recruiting,Not Applicable,Interventional,Netherlands,Online cognitive behavioral therapy for distress in people who lost a loved one during the corona pandemic: A randomized waitlist-controlled trial,Other (psych),Psychological,Psychological,52,https://trialregister.nl/trial/8993,None
4005,7208,NL9007,Netherlands Trial Register,2020-10-29,2020-09-06,True,W. Cahn,Recruiting,Not Applicable,Interventional,Netherlands,"Exercise via videoconferencing for people with severe mental illness during covid-19 times, a feasibility study",Other,Other,Other,70,https://trialregister.nl/trial/9007,None
4006,7209,NL9019,Netherlands Trial Register,2020-10-23,2020-10-23,False,Máxima Medisch Centrum,Not Recruiting,Not Applicable,Interventional,Netherlands,Effect of Iodine treatment in patiÃ«nts with COVID-19 disease,Drug,Potassium Iodine,Potassium Iodine,200,https://trialregister.nl/trial/9019,None
4007,7213,NL8954,Netherlands Trial Register,2020-10-06,2020-01-11,True,UMC Utrecht,Recruiting,Not Applicable,Interventional,Netherlands,A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at home,Other,Other,Other,50,https://trialregister.nl/trial/8954,None
4008,7217,NL9081,Netherlands Trial Register,2020-11-30,2021-11-01,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,Netherlands,Early@home,Telehealth,Telehealth,Telehealth,100,https://trialregister.nl/trial/9081,None
4009,7220,NL8483,Netherlands Trial Register,2020-03-26,2020-03-16,True,Fred Foundation; Noaber Foundation,Recruiting,Not Applicable,Interventional,Netherlands,A weapon against COVID-19: (Social) media and influencers,Other,Other,Other,17000,https://trialregister.nl/trial/8483,None
4010,7224,NCT04323527,ClinicalTrials.gov,2020-03-13,2020-03-23,False,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 (CloroCOVID19),Drug,Chloroquine,Chloroquine,440,https://clinicaltrials.gov/ct2/show/NCT04323527,None
4011,7225,NCT04335552,ClinicalTrials.gov,2020-04-03,2020-04-17,False,Duke University,Recruiting,Phase 2,Interventional,United States,"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection",Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine vs. Azithormycin,Hydroxychloroquine; Azithromycin,500,https://clinicaltrials.gov/ct2/show/NCT04335552,None
4012,7226,NCT04341727,ClinicalTrials.gov,2020-04-04,2020-04-04,False,Washington University in St. Louis,Recruiting,Phase 3,Interventional,United States,"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection (WU352)",Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin vs. Chloroquine vs. Chloroquine + Azithormycin,Hydroxychloroquine; Chloroquine; Azithormycin,500,https://clinicaltrials.gov/ct2/show/NCT04341727,None
4013,7228,NCT04381936,ClinicalTrials.gov,2020-05-07,2020-03-19,True,University of Oxford,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Randomized Evaluation of COVID-19 Therapy,Drug (+ ATMP),"Lopinavir/ritonavir, Corticosteroids, hydroxychloroquine, azithromycin, tocilizumab, Plasma, REGN10933+REGN10987, Aspirin",Lopinavir/ritonavir; dexamethasone; hydrocortisone; methylprednisolone; hydroxychloroquine; azithromycin; tocilizumab; Plasma; REGN10933; REGN10987; Aspirin,12000,https://clinicaltrials.gov/ct2/show/NCT04381936,EUCTR2020-001113-21; ISRCTN50189673
4014,7230,RBR-3cbs3w,REBEC,2020-04-08,2020-04-10,False,EMS Pharmaceuticals,Not Recruiting,Phase 3,Interventional,Brazil,"Randomized, pragmatic, double-blind, placebo-controlled clinical study, evaluation of Hydroxychloroquine for prevention of hospitalizations and respiratory complications in outpatients with confirmed or probable diagnosis of COVID-19",Drug,Hydroxychloroquine,Hydroxychloroquine,1300,http://www.ensaiosclinicos.gov.br/rg/RBR-3cbs3w/,None
4015,7231,NCT04356495,ClinicalTrials.gov,2020-04-11,2020-07-01,False,"University Hospital, Bordeaux",Recruiting,Phase 3,Interventional,France,Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19),Drug,Hydroxychloroquine vs. Imatinib vs. Favipiravir vs. Telmisartan vs. Vitamins,Hydroxychloroquine; Imatinib; Favipiravir; Telmisartan; Vitamins,1057,https://clinicaltrials.gov/show/NCT04356495,EUCTR2020-001435-27
4016,7233,NCT04342221,ClinicalTrials.gov,2020-04-08,2020-03-29,True,"University Hospital, Tübingen",Recruiting,Phase 3,Interventional,Germany,Hydroxychloroquine for COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,220,https://clinicaltrials.gov/ct2/show/NCT04342221,EUCTR2020-001224-33
4017,7234,ISRCTN40580903,ISRCTN,2020-05-15,2020-05-16,False,University of Birmingham,Recruiting,Phase 2,Interventional,United Kingdom,Which treatment could lessen the severity of a coronavirus infection when compared with usual care in an NHS setting?,Drug,Gemtuzumab Ozogamicin,Gemtuzumab Ozogamicin,588,http://isrctn.com/ISRCTN40580903,EUCTR2020-001684-89
4018,7235,NCT04401579,ClinicalTrials.gov,2020-05-22,2020-05-08,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 3,Interventional,"Singapore, South Korea, Mexico, Japan, United States",Adaptive COVID-19 Treatment Trial 2 (ACTT-2),Drug,Baricitinib + Remdesivir vs. Remdesivir,Baricitinib; Remdesivir,1034,https://clinicaltrials.gov/ct2/show/NCT04401579,JPRN-jRCT2031200035
4019,7236,NCT04414267,ClinicalTrials.gov,2020-06-01,2020-05-26,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 4,Interventional,Greece,Bacillus Calmette-gu‚àö¬©rin Vaccination to Prevent COVID-19,ATMP,Vaccine,Vaccine,900,https://clinicaltrials.gov/ct2/show/NCT04414267,EUCTR2020-002448-21
4020,7237,NCT04451083,ClinicalTrials.gov,2020-06-21,2020-07-01,False,Ono Pharmaceutical Co. Ltd,Recruiting,Phase 1,Interventional,Japan,Multiple-dose Study of FOY-305 in Japanese Healthy Adult Male Subjects,Drug,Camostat Mesilate,Camostat Mesilate,14,https://clinicaltrials.gov/ct2/show/NCT04451083,JPRN-JapicCTI-205326
4021,7238,NCT04382053,ClinicalTrials.gov,2020-05-08,2020-05-27,True,Novartis Pharmaceuticals,Recruiting,Phase 2,Interventional,"Denmark, Hungary, Germany, Netherlands, Spain",Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia,Drug,DFV890,DFV890,120,https://clinicaltrials.gov/ct2/show/NCT04382053,EUCTR2020-001870-32
4022,7239,NCT04376684,ClinicalTrials.gov,2020-05-04,2020-05-28,False,GlaxoSmithKline,Recruiting,Phase 2,Interventional,"United Kingdom, Spain, United States, Netherlands, Japan, France, Poland",Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease,Drug,Otilimab,Otilimab,800,https://clinicaltrials.gov/show/NCT04376684,EUCTR2020-001759-42
4023,7240,NCT04400838,ClinicalTrials.gov,2020-05-12,2020-05-28,False,University of Oxford,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Investigating a Vaccine Against COVID-19,ATMP,Vaccine,Vaccine,12330,https://clinicaltrials.gov/ct2/show/NCT04400838,EUCTR2020-001228-32; ISRCTN90906759
4024,7241,NCT04425031,ClinicalTrials.gov,2020-06-05,2020-08-25,False,Aalborg University Hospital,Recruiting,Phase 4,Interventional,Denmark,Handling Oxygenation Targets in COVID-19 (HOT-COVID),Drug,Oxygen,Oxygen,780,https://clinicaltrials.gov/ct2/show/NCT04425031,EUCTR2017-000632-34
4025,7242,NCT04362137,ClinicalTrials.gov,2020-04-22,2020-05-02,False,Novartis Pharmaceuticals,Not Recruiting,Phase 3,Interventional,"United States, Argentina, Brazil, Colombia, France, Germany, Mexico, Peru, Russian Federation, Spain, Turkey, United Kingdom","Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID) (RUXCOVID)",Drug,Ruxolitinib,Ruxolitinib,432,https://clinicaltrials.gov/ct2/show/NCT04362137,EUCTR2020-001662-11; PER-030-20
4026,7243,NCT04346199,ClinicalTrials.gov,2020-04-09,2020-06-12,False,AstraZeneca,Not Recruiting,Phase 2,Interventional,"Argentina, Brazil, Chile, France, Germany, India, Italy, Mexico, Peru, Russian Federation, South Africa, Spain, Turkey",Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. (CALAVI),Drug,Acalabrutinib,Acalabrutinib,163,https://clinicaltrials.gov/ct2/show/NCT04346199,PER-018-20; EUCTR2020-001644-25
4027,7244,NCT04340544,ClinicalTrials.gov,2020-04-03,2020-04-22,False,"University Hospital, Tübingen",Not Recruiting,Phase 2,Interventional,Germany,Hydroxychloroquine for the Treatment of Mild COVID-19 Disease (COMIHY),Drug,Hydroxychloroquine,Hydroxychloroquine,17,https://clinicaltrials.gov/ct2/show/NCT04340544,EUCTR2020-001512-26
4028,7245,ISRCTN30564012,ISRCTN,2020-05-20,2020-05-20,True,University of Dundee,Recruiting,Phase 3,Interventional,United Kingdom,STOP-COVID19: Superiority Trial Of Protease inhibition in COVID-19 (coronavirus infection),Drug,Brensocatib,Brensocatib,300,https://www.isrctn.com/ISRCTN30564012,EUCTR2020-001643-13
4029,7246,NCT04575597,ClinicalTrials.gov,2020-09-30,2020-10-19,False,Merck Sharp & Dohme Corp.,Recruiting,Phase 2/Phase 3,Interventional,"Israel, United States, United Kingdom",Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002),Drug,Molnupiravir,Molnupiravir,1450,https://clinicaltrials.gov/ct2/show/NCT04575597,EUCTR2020-003368-24
4030,7247,NCT04583995,ClinicalTrials.gov,2020-10-09,2020-09-28,True,Novavax,Recruiting,Phase 3,Interventional,United Kingdom,"A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom",ATMP,Vaccine,Vaccine,15000,https://clinicaltrials.gov/ct2/show/NCT04583995,EUCTR2020-004123-16
4031,7248,NCT04614948,ClinicalTrials.gov,2020-11-03,2020-11-06,False,Janssen Pharmaceutical,Not Recruiting,Phase 3,Interventional,"United States, Germany, Spain, South Africa, United Kingdom, Philippines, Colombia, France, Belgium",A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults,ATMP,Vaccine,Vaccine,30000,https://clinicaltrials.gov/ct2/show/NCT04614948,EUCTR2020-003643-29; ISRCTN14722499
4032,7249,NCT04509973 ,ClinicalTrials.gov,2020-08-11,2020-08-27,False,Scandinavian Critical Care Trials Group,Recruiting,Phase 3,Interventional,"India, Denmark, Switzerland, Sweden",Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia,Not relevant,Not relevant,Not relevant,1000,https://clinicaltrials.gov/ct2/show/NCT04509973,None
4033,7250,NCT04452318,ClinicalTrials.gov,2020-06-26,2020-07-13,False,Regeneron Pharmaceuticals,Recruiting,Phase 3,Interventional,"United States, Romania, Moldova",Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay,Drug,REGN10933 + REGN10987,REGN10933 + REGN10987,2000,https://clinicaltrials.gov/ct2/show/NCT04452318,EUCTR2020-003654-71
